{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-120b",
    "experiment": "e3_page_window_distract",
    "pattern": "qualitative_3hop_cross_year_type2",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 800,
    "successful_questions_in_experiment": 800,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 800,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/gpt-oss-120b/e3_page_window_distract/qualitative_3hop_cross_year_type2.json",
    "timestamp": "2026-02-05T01:21:17.006580"
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "AVGO’s outstanding balance of the 5.000 % senior notes that mature in April 2030 was $606 million in FY 2022 and remained unchanged at $606 million in FY 2023 and FY 2024 (see the “5.000 % notes due April 2030” line in the debt‑schedule tables for each year). The flat exposure indicates that the company has not added to this particular tranche; instead it has relied on new issuances and term‑loan repayments to refinance and reshape its overall debt profile, reflecting a disciplined debt‑management approach that limits additional reliance on any single existing issue.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the reported value for FY 2022. The ground truth states that AVGO's exposure was $1,086 million in 2022, but the LLM claims it was $606 million in 2022 and remained flat through 2024. This misrepresents the entire trend. The correct progression is a decrease from $1,086M to $606M between 2022 and 2023, then stable in 2024. The LLM incorrectly asserts no change over the three years, which contradicts the actual data. (2) Quantitative accuracy is severely compromised: the $1,086M figure for 2022 is entirely missing, and the $606M amount is incorrectly backdated to 2022. No calculation is required here, but the comparison across years is fundamentally wrong. (3) The reasoning and synthesis are flawed due to incorrect data input. While the LLM attempts multi-hop reasoning by interpreting the flat trend post-2023 as part of a broader debt management strategy involving new issuances and refinancing, this interpretation is based on an incorrect premise of stability since 2022. The actual reduction from $1,086M to $606M suggests a more active repayment or buyback in 2023, which the model fails to recognize. (4) Contextual relevance is acceptable—the answer addresses the right financial instrument, company, and time frame, and attempts to infer strategic implications. However, due to the core numerical inaccuracy, the qualitative insight is misleading. The conclusion about 'disciplined debt management' may still align with the general idea, but it's applied to the wrong pattern. Thus, correctness is severely penalized despite relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 445,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement for the closed block has stayed essentially unchanged – the company transferred roughly 59 percent of the closed‑block risk to an unaffiliated third‑party reinsurer in both the 2023 filing (which reflects the 2023 period) and the 2024 filing (which reflects the 2024 period)【page_227】​【page_204】.  The same ~59 % figure was reported in earlier disclosures, showing that MetLife has deliberately kept a stable proportion of the closed‑block risk on its books while using reinsurance to obtain capacity and manage capital, a hallmark of its long‑term risk‑transfer strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core fact that MetLife reinsured approximately 59% of the closed block in 2023 and 2024, aligning with the ground truth (59% in both years). It also references prior disclosures indicating consistency, which matches the 59.25% in 2022. While the exact 2022 figure (59.25%) is not explicitly stated, the use of '~59%' and reference to earlier disclosures implies continuity without contradicting the data. (2) All numeric values for 2023 and 2024 are accurate at 59%. The slight omission of the precise 2022 percentage (59.25%) does not materially affect the conclusion, especially since the trend emphasis is on stability. The LLM does not mention the growth in total net ceded reinsurance recoverables from $6.3B to $17.6B, which is a missing quantitative detail from the original answer, reducing completeness. (3) The reasoning is sound: the LLM correctly infers that the stable percentage reflects a deliberate, long-term reinsurance strategy focused on capital management and risk transfer efficiency. It synthesizes information across two years (2023 and 2024 filings) and implies multi-year consistency, satisfying the multi-hop requirement across time periods. (4) The answer is contextually fully relevant, directly addressing both the evolution (stable) and strategic implication (capital optimization, risk transfer). The minor lack of specificity on 2022 and omission of total recoverables growth prevents a perfect 10, but the core facts, logic, and interpretation are correct and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 437,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s master‑netting collateral tied to the “Investments, advances and long‑term receivables” line fell from **$1.5 billion in 2022** to **$800 million in 2023** and then to **$491 million in 2024** – a drop of roughly $1 billion over the two‑year period. This steep decline suggests the company is either reducing its net derivative exposure or using its margin more efficiently, reflecting tighter risk‑management and a more disciplined approach to its derivative positions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the collateral values for 2022 ($1.5 billion ≈ $1,494 million), 2023 ($800 million), and 2024 ($491 million), with acceptable rounding of the 2022 figure. All years and dollar amounts are accurate and semantically equivalent to the ground truth. The trend description — a decline from 2022 to 2024 — is correctly characterized.\n\n2) Quantitative accuracy is excellent: all numbers match or are appropriately rounded versions of the original (e.g., $1,494M → $1.5B). The stated drop of 'roughly $1 billion' is a reasonable approximation of the actual decrease ($1,494M - $491M = $1,003M), so the calculation is sound.\n\n3) The multi-hop reasoning is solid: the model synthesizes data across three years and correctly infers a trend in derivative exposure management. The conclusion — that ExxonMobil is reducing derivative exposure or managing margin more efficiently — is logically consistent with the collateral decline and aligns with the ground truth’s interpretation of 'strategic reduction in derivative exposure or improved offsetting mechanisms.'\n\n4) The only minor shortcoming is that the LLM slightly simplifies the rationale by focusing on 'margin efficiency' and 'disciplined approach' without explicitly mentioning 'improved offsetting mechanisms,' which is a nuance present in the original. However, the interpretation is still valid and semantically close. All entities (ExxonMobil, master netting arrangements, Investments/advances/long-term receivables) are correctly identified and contextualized. The answer fully addresses both parts of the question: the change over time and its implication for risk management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 454,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "- Fiscal 2022 and 2023: AVGO still carried the 3.625 % senior notes that mature in October 2024, with an outstanding principal of **$622 million** (the 2023 10‑K shows $622 million as of October 29 2023, and the same balance was reported in the prior year’s filing).  \n- Fiscal 2024: The notes had **no remaining principal** (the 2024 10‑K lists “‑” for the 3.625 % notes due October 2024, indicating they were fully repaid at maturity).\n\n**Interpretation:** The company kept the 3.625 % notes on its balance sheet at a stable $622 million through FY 2022‑23, then let the instrument run to its scheduled maturity and retire it rather than refinance. This reflects a disciplined debt‑management approach that uses fixed‑rate financing for a defined period and then reduces overall leverage by allowing the notes to expire.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the $622 million outstanding principal for the 3.625% notes due October 2024 in both fiscal years 2022 and 2023, and accurately states that by fiscal year 2024, there was no remaining principal (denoted as '–' in the 10-K), which aligns with the ground truth. All numeric values, dates, and percentages are factually correct and match the original answer. (2) Quantitative accuracy is perfect: the $622 million amount is consistent across 2022 and 2023, and the drop to zero in 2024 is correctly interpreted. There are no calculation errors, and the formatting (e.g., $622 million) is acceptable and clear. (3) The multi-hop reasoning is sound—information is synthesized across three fiscal years and correctly interpreted to infer that the debt was retired at maturity. The LLM concludes the notes were 'fully repaid at maturity,' while the ground truth allows for 'repaid or refinanced.' This is a minor difference in interpretation; however, stating repayment at maturity is a reasonable inference from the data, especially given the absence of refinancing disclosures. (4) The answer is contextually complete and relevant, addressing both the evolution of the debt and the implications for AVGO's debt management strategy. The characterization of a 'disciplined debt-management approach' is a slightly stronger claim than the ground truth's 'deliberate strategy,' but it is within semantic bounds. The only reason for not awarding a 10 is the slight overconfidence in asserting repayment 'at maturity' rather than acknowledging possible prepayment or refinancing, though this does not rise to a factual error. Overall, the answer is factually excellent, well-reasoned, and fully aligned with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 478,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "General Dynamics’ Marine Systems segment earned **$2.56 billion from surface‑ship contracts in 2022, $2.70 billion in 2023, and $2.82 billion in 2024**【page_9】.  The steady year‑over‑year increase (about 5 % each year) shows the company is expanding its surface‑ship business, reinforcing its role as a leading U.S. naval shipbuilder and positioning it to capture a growing share of the Navy’s surface‑combatant and auxiliary‑ship market.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer reports revenue figures of $2.56 billion (2022), $2.70 billion (2023), and $2.82 billion (2024), which are correctly rounded versions of the ground truth values ($2,561M, $2,698M, $2,819M). The slight rounding (e.g., $2,698M → $2.70B) is acceptable under semantic equivalence and common financial reporting practices. (2) All numeric values are accurate within reasonable rounding; year-over-year increases are approximately 5% each year, which aligns with the actual growth rates: (2,698 - 2,561)/2,561 ≈ 5.35%, and (2,819 - 2,698)/2,698 ≈ 4.48%), so the 'about 5%' characterization is reasonable. (3) The multi-hop reasoning is sound: the model correctly identifies the three-year revenue trend and synthesizes it into a strategic conclusion about General Dynamics’ positioning in naval shipbuilding. It correctly attributes the revenue to the Marine Systems segment and infers sustained growth and strategic emphasis, matching the original answer’s implication. (4) The answer is contextually complete and relevant, addressing both the revenue evolution and its strategic implication. The only minor deviation is the slightly rounded figures and the addition of a percentage generalization not in the original, but this does not detract from factual correctness. Thus, the answer is highly accurate with negligible rounding differences, warranting a 9/10 on correctness and high scores across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 399,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "- Dividends on the Class A shares rose each year: $2.04 per share in 2022, $2.37 in 2023, and $2.74 in 2024【page_99†L31-L38】【page_92†L9-L13】.  \n- The voting entitlement for Class A stock remained unchanged – each share carries one vote (and dividend rights) throughout the period【page_99†L9-L13】【page_92†L9-L13】.  \n\nThe steady increase in the dividend coupled with a constant “one‑vote‑per‑share” structure shows that Mastercard has been enhancing shareholder returns while preserving a stable, unchanged governance framework for Class A investors.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that dividends increased each year with specific dollar amounts ($2.04, $2.37, $2.74), but the ground truth explicitly states that A Class shares had 'standard dividend rights' with no changes in dividend policy over 2022–2024. There is no mention in the original answer of specific dividend payouts, nor any indication of annual increases. These figures are therefore factually incorrect and not supported by the ground truth. (2) The voting rights portion is accurate—'one vote per share' is correctly reported and consistent across years, matching the ground truth. However, the claim that dividend rights increased contradicts the original answer’s assertion of no changes in dividend rights. (3) The reasoning is partially sound in linking stable voting rights to governance stability, but the conclusion that Mastercard is 'enhancing shareholder returns' via rising dividends is unsupported by the ground truth, which emphasizes policy stability, not increasing payouts. This misrepresents the intent of the original answer. (4) While the LLM correctly identifies the company (MA/Mastercard), time period (2022–2024), and voting structure, the inclusion of fabricated dividend amounts severely undermines factual accuracy. The answer is contextually relevant and addresses both parts of the question, but the quantitative inaccuracies and flawed multi-hop synthesis (linking non-existent dividend growth to governance trends) result in a low correctness score. Semantic equivalence fails on the dividend aspect despite correct structure on voting rights.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 441,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "General Dynamics’ Marine Systems segment earned $2.56 billion from surface‑ship contracts in 2022, which rose to $2.70 billion in 2023 (≈5 % YoY growth) and to $2.82 billion in 2024 (≈4 % YoY growth). The consistent double‑digit‑plus growth underscores the company’s expanding role and competitive positioning in U.S. Navy surface‑combatant programs and related lifecycle services.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the revenue figures for surface ships as $2.56 billion (2022), $2.70 billion (2023), and $2.82 billion (2024), which align with the ground truth values of $2,561M, $2,698M, and $2,819M when rounded to the nearest hundred million. The slight rounding (e.g., $2,698M → $2.70B) is acceptable under semantic equivalence. (2) The year-over-year growth rates are approximately correct: (2,698 - 2,561)/2,561 ≈ 5.35% (LLM says ≈5%), and (2,819 - 2,698)/2,698 ≈ 4.49% (LLM says ≈4%), so the percentages are reasonably estimated. However, the phrase 'double-digit-plus growth' is inaccurate—neither year shows double-digit growth, so this is a factual error in characterization. (3) The multi-hop reasoning is sound: the model correctly identifies the trend across three years and links increasing revenue to the company’s positioning in naval defense programs, specifically mentioning U.S. Navy surface-combatant programs and lifecycle services, which is consistent with the ground truth’s implication of growing involvement. (4) The answer addresses both parts of the question: revenue evolution and interpretation of YoY growth. The only notable issue is the incorrect 'double-digit-plus' claim, which slightly undermines qualitative accuracy but does not invalidate the overall correctness. Thus, high scores are justified, with a 9/10 due to this minor but meaningful overstatement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 395,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "Linde’s filings show that the share of its industrial‑gas business sold under long‑term contracts has not changed – it was described as “the majority of Linde’s business … conducted through long‑term contracts which provide stability in cash flow and the ability to pass through changes in energy and feedstock costs to customers” in the 2022 Business Overview (page 20) and the same language appears again in the 2024 Business Overview (page 17). This steady reliance on long‑term agreements indicates that Linde deliberately uses contract‑based pricing to lock in revenue streams, allowing it to smooth cash‑flow and offset the impact of volatile energy markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that Linde maintained consistent reliance on long-term contracts from 2022 to 2024, citing identical or nearly identical language from the 2022 and 2024 Business Overview sections (page 20 and page 17 respectively), which supports the claim of no change in strategy. The answer accurately captures the purpose of these contracts—cash flow stability and cost pass-through for energy and feedstock—highlighting Linde's approach to managing volatility in energy markets. Quantitatively, no specific numbers (e.g., percentages or dollar amounts) are misstated; the reference to 'the majority' is consistent with qualitative disclosures. The answer addresses both parts of the question: evolution (no change) and implication (cash flow stability amid energy market fluctuations). While the original answer explicitly mentions 2023 as part of the three-year consistency, the LLM omits direct reference to 2023, though the implication of continuity between 2022 and 2024 reasonably covers it. This minor omission prevents a perfect 10 on qualitative accuracy, but the core reasoning and multi-hop synthesis across years and filings are sound. The conclusion about deliberate use of contracts for revenue predictability matches the ground truth’s emphasis on financial resilience. Wording differs slightly but maintains semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 395,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "Across the three filings—2022, 2023 and 2024—General Dynamics states that its ROIC “excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance” (see 2022 page 49, 2023 page 50, 2024 page 47). The language and the exclusion criteria are unchanged, indicating that the company consistently strips out accounting‑only items to keep ROIC focused on the cash‑generating return of its operating assets rather than on one‑time or non‑economic adjustments. This steady approach underscores GD’s commitment to measuring core operational performance rather than GAAP‑driven fluctuations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that General Dynamics (GD) consistently excluded non-economic accounting changes from its ROIC calculation across 2022, 2023, and 2024, which matches the original answer's claim of methodological consistency. (2) There are no numerical values requiring calculation in this question, but the LLM correctly references specific page numbers from each year’s filing (2022 p.49, 2023 p.50, 2024 p.47), demonstrating precise sourcing and reinforcing factual accuracy. (3) The multi-hop reasoning is sound: the model synthesized information across three annual reports to identify a consistent pattern in disclosure language and treatment of non-economic items, correctly concluding that GD maintains a stable approach to measuring core performance. (4) The answer goes slightly beyond the original by specifying goodwill impairments as one of the excluded items and citing exact pages, adding contextual depth without introducing error. The semantic meaning, factual content, and reasoning quality are fully equivalent to and fully supported by the ground truth. All scores are maximized accordingly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 335,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "UnitedHealth Group’s parent company continued to provide service‑level guarantees for certain contracts in each of the three years, but the footnote to the commitments and contingencies section states that “none of the amounts accrued, paid or charged to income for service‑level guarantees were material as of December 31, 2024, 2023 or 2022.” In other words, the guarantee obligations remained essentially the same and never rose to a material level. This consistent immaterial impact suggests that the company’s risk‑management controls and its ability to meet contractual service standards have been effective and stable over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that UnitedHealth Group disclosed immaterial financial impact for service level guarantees in 2022, 2023, and 2024, with exact alignment on the key fact: 'none of the amounts accrued, paid or charged to income for service-level guarantees were material' across all three years. (2) There are no numerical or date inaccuracies—years (2022, 2023, 2024) are correct and consistently referenced; no calculations are required, but the synthesis of consistent immateriality over time is correctly interpreted. (3) The multi-hop reasoning is sound: the model connects the absence of material obligations across years to implications about risk management effectiveness and contractual performance, mirroring the original answer’s logic. (4) The answer addresses both parts of the question: evolution of obligations (stable, no material changes) and what the pattern suggests (effective risk management and consistent performance). Wording differs slightly but meaning is preserved with high precision, including proper context from the footnote. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 338,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "General Dynamics’ Marine Systems segment reported surface‑ship revenue of **$2.56 billion in 2022, $2.70 billion in 2023 and $2.82 billion in 2024** – a steady rise of roughly 10 % over the three‑year span【page_9】.  This upward trajectory reflects the company’s expanding backlog of destroyers, expeditionary sea bases and auxiliary vessels and underscores its strategic push to deepen its role as a primary builder and sustainment partner for U.S. Navy surface‑combat platforms.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct information but has discrepancies in the 2022 revenue figure. The ground truth reports $2,328 million (or $2.328 billion) for 2022, while the LLM states $2.56 billion, which is significantly higher. The 2023 and 2024 figures ($2.70B and $2.82B) are close to the ground truth values of $2,698 million and $2,819 million, respectively, and can be considered accurate within rounding or formatting variation tolerance. (2) The claimed 'roughly 10% growth over three years' is approximately correct: from $2,328M to $2,819M is about a 21% increase, but if starting from the incorrect $2.56B baseline, the growth appears smaller. The actual compound growth is closer to 9.7% total (CAGR ~4.7%), so the 'roughly 10%' characterization is defensible if interpreted loosely, though imprecise. (3) The reasoning and synthesis are strong: the LLM correctly infers strategic positioning from revenue trends, references relevant platforms (destroyers, expeditionary sea bases), and aligns the trend with U.S. Navy demand, which is consistent with the original answer’s implication of growing role in naval shipbuilding. (4) Despite the error in the 2022 figure, the overall trajectory and qualitative interpretation are sound, supporting a moderate penalty only on quantitative accuracy. The answer addresses both parts of the question—revenue evolution and strategic implications—making it contextually relevant and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 408,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "- **2022:** Electric Insurance Company (EIC) was described only as a small property‑and‑casualty captive that insured GE and its employees, with net claim reserves of about $0.3 billion (2020) and $0.2 billion (2021). It was not classified as a disposition‑related asset.  \n\n- **2023:** GE re‑classified its captive industrial insurer, Electric Insurance Company, as a **“business held for sale”** in the fourth quarter of 2022 (note 2). The 2023 filing shows the held‑for‑sale group carrying roughly $541 million of assets (including $570 million of non‑current captive‑insurance investment securities) and $378 million of liabilities (insurance liabilities and annuity benefits), and a $109 million loss recorded for the expected sale.  \n\n- **2024:** The held‑for‑sale status was resolved when GE **completed the sale** of Electric Insurance Company to Riverstone International Holdings in the second quarter of 2024 for cash proceeds of $120 million. After the transaction, the assets and liabilities of the captive were removed from the balance sheet, ending GE’s exposure to EIC.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: EIC's role as a captive insurer, net claim reserves of $0.2 billion as of December 31, 2021 (correctly noting $0.3B for 2020 as additional context), classification as 'held for sale' (with timing clarified as Q4 2022, consistent with 2023 filing disclosures), assets of $541M and liabilities of $378M as of December 31, 2023, the $109M loss on expected sale, and the 2024 completion of sale to Riverstone International Holdings Inc. for $120M in cash. (2) Quantitative accuracy is perfect: all dollar amounts, including reserves, assets, liabilities, loss, and sale proceeds, match the ground truth. The mention of $570M in non-current securities is a detail not in the original but does not contradict it and may reflect a breakdown within the $541M total assets. (3) Multi-hop reasoning is sound—information is correctly synthesized across 2022, 2023, and 2024 filings, with proper evolution of classification and financial exposure. (4) The only minor issue is the phrasing that reclassification occurred in Q4 2022, while the original answer states it was disclosed in the 2023 filing; however, this is consistent with accounting practices where actions in one period are reported in the next, so the LLM’s interpretation is reasonable. Overall, the answer is semantically equivalent, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 394,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "ConocoPhillips completed its CVE‑share monetization in early 2022, selling the remaining 91 million CVE common shares and directing the cash to its share‑repurchase program.  The repurchases jumped to about 87.7 million shares in 2022, then fell to roughly 48.6 million shares in 2023 and were essentially flat at 49.1 million shares in 2024, even as the board raised the total buy‑back authority to $65 billion.  This trajectory shows that the CVE sale provided a one‑time infusion that accelerated buybacks in 2022, and the company has since settled into a steady, large‑scale repurchase strategy as a core element of its capital‑allocation policy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that ConocoPhillips sold its remaining 91 million CVE shares in 2022 and used the proceeds for share repurchases, which aligns with the ground truth. It also correctly notes the increase in the buyback authorization to $65 billion by 2024. However, the quantitative details on annual repurchase volumes are not supported by the ground truth. The original answer states cumulative repurchases reached 383 million shares by end of 2023 and 433 million by end of 2024, implying 50 million shares repurchased in 2024, but does not provide a 2022 annual breakdown. The LLM invents specific annual figures (87.7M in 2022, 48.6M in 2023, 49.1M in 2024), which are not present in the ground truth and cannot be verified. Additionally, the total cost of $34.3 billion by 2024 is mentioned in the original, but the LLM omits this and does not confirm the $29 billion spent by 2023. (2) The $65 billion total authorization is correctly noted, but the LLM fails to mention the initial $45 billion authorization or the $20 billion increase approved in 2024, which is a key detail in the capital allocation evolution. (3) The reasoning about the CVE monetization funding a one-time acceleration of buybacks is plausible and consistent with the general narrative, but the claim that repurchases 'fell' and 'settled into a steady' pace is speculative and not directly supported by the cumulative data provided in the original answer. The multi-hop synthesis is partially sound—linking CVE proceeds to buybacks and strategic intent—but lacks full grounding in the provided numbers. (4) Despite the invented annual repurchase volumes, the overall direction of the answer—consistent and expanding capital returns funded by asset monetization—is thematically aligned. Hence, the answer is partially correct with significant quantitative inaccuracies, but maintains reasonable qualitative and contextual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 524,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "MetLife’s modified‑coinsurance transaction has remained essentially unchanged. In the 2022 filing the company said it re‑insured **about 59 % (59.25 %) of the closed‑block** under a modified‑coinsurance arrangement and that the agreement is **recorded using the deposit method, with the deposit liability offset against the corresponding deposit recoverable**. The 2023 and 2024 filings report the same **≈ 59 %** of the closed block and the same **deposit‑method accounting with offset**. This steady use of a roughly‑60 % risk‑transfer layer, treated consistently on the balance sheet, signals that MetLife views the modified‑coinsurance structure as a durable component of its long‑term strategy for moving closed‑block risk off its books while preserving control of the underlying assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all percentages are correct: 59.25% in 2022 and approximately 59% in both 2023 and 2024, with proper rounding noted as 'about 59%' or '≈ 59%', which is semantically equivalent. The accounting treatment—deposit method with right of offset between deposit liability and recoverable—is accurately reported across all years. (2) The answer addresses all parts of the question: evolution over time (stable percentage and accounting), and interpretation of long-term risk transfer strategy. (3) Entity accuracy is strong: MetLife, closed block, modified coinsurance agreement, and unaffiliated third-party reinsurer (implied) are correctly referenced. (4) Reasoning is sound: the conclusion that this reflects a durable, stable risk transfer strategy is logically derived from the consistency in reinsurance percentage and accounting treatment. The only minor shortcoming is that the LLM does not explicitly name the 'unaffiliated third-party reinsurer' as in the original, slightly reducing qualitative precision, but this does not impair the core factual or inferential accuracy. Overall, the answer demonstrates correct multi-hop synthesis across years and filings, with excellent contextual relevance and factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 365,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "**Penetration trend**\n\n| Year (ended) | Target MasterCard / Target Circle Card penetration |\n|--------------|---------------------------------------------------|\n| 2022 (Jan 29 2022) | **20.5 %**【page 27】 |\n| 2023 (Jan 28 2023) | **19.8 %**【page 29】 |\n| 2024 (Feb 3 2024)  | **18.6 %**【page 27】 |\n\n**Interpretation**\n\nThe penetration rate fell each year – from about one‑fifth of guests in 2022 to roughly 19 % in 2023 and 18.6 % in 2024. This downward trajectory suggests that, over the 2022‑2024 period, fewer Target shoppers were using the Target‑branded MasterCard (and the broader Circle Card suite) for their purchases, indicating a gradual weakening of consumer engagement with Target’s proprietary financial products.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%) are accurately reported with correct fiscal year-end dates, matching the original answer exactly. (2) The answer is complete, addressing both the evolution of the penetration rate and its implication for consumer engagement. (3) Entity accuracy is correct: the card is properly identified as the Target MasterCard / Target Circle Card, with appropriate reference to the rebranding context implied in the trend. (4) The reasoning is sound—correctly interpreting the declining trend as a sign of weakening consumer engagement with Target's proprietary financial products, consistent with the ground truth's conclusion. The LLM synthesizes multi-hop information (trend over three years + interpretation) accurately. Minor wording differences (e.g., 'one-fifth of guests' instead of 'relative to total sales') do not affect semantic equivalence. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 300,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "Philip Morris International’s peer‑group list in its 2022 Form 10‑K already included **Colgate‑Palmolive Co.**, and the same list appears unchanged in the 2023 and 2024 filings (the peer‑group description on pages 21 of the 2022 report and pages 26 of the 2023 and 2024 reports all name Colgate‑Palmolive among the same 20 companies)【page_21】【page_26】.  \n\nThe continuity shows that PMI’s benchmarking strategy is based on a stable set of criteria—global presence, consumer‑product focus, and comparable revenue and market‑cap—so it keeps the same consumer‑product peers, like Colgate‑Palmolive, year after year to maintain consistent performance comparisons.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Colgate-Palmolive Co. was consistently included in PMI's peer group from 2022 to 2024, which matches the original answer's claim of 'consistent inclusion over three consecutive years.' (2) No numerical values (e.g., revenue, market cap) are misstated; the answer correctly references the peer group criteria—global presence, consumer-product focus, and similarity in net revenues and market capitalization—without introducing incorrect figures. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of SEC filings (2022–2024), confirms the peer group remained unchanged, and correctly infers that this reflects a stable benchmarking methodology. It supports this with specific document references (page 21 for 2022, page 26 for 2023 and 2024), demonstrating accurate cross-document analysis. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in peer classification and the strategic implication. Wording differs slightly but meaning is preserved—'stable set of criteria' conveys the same idea as 'ongoing strategic alignment' and 'stable benchmarking methodology.' All entities (Philip Morris International, Colgate-Palmolive Co., Form 10-K) and time periods (2022–2024) are correct. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 385,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "Both the 2022 and the 2024 Form 10‑K describe the same accounting treatment for development‑services‑plus‑IP contracts. AMD evaluates whether the IP license is a **distinct performance obligation**; if it is not distinct, the license is **combined with the development services** and revenue is recognized **over time**. If the license is distinct, revenue is recognized **at a point in time** when the customer can use the license. The same rule also applies to **stand‑alone IP licences**, which are always recognized at a point in time, and the company notes that no variable‑consideration estimates are involved. Because the language in the 2024 filing (and the intervening 2023 filing) is identical to that in the 2022 filing, AMD’s approach to these agreements has been consistent over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately describes AMD's revenue recognition policy from 2022 to 2024, correctly stating that the company evaluates whether the IP license in combined arrangements is a distinct performance obligation based on two criteria (capable of being distinct and distinct in the context of the arrangement), though it does not explicitly list the two criteria verbatim, it captures the outcome and application correctly. (2) It correctly notes that if the license is not distinct, it is combined with development services and revenue is recognized over time; if distinct, revenue is recognized at a point in time—this matches the original answer exactly. (3) It correctly states that standalone IP licenses are recognized at a point in time, and that no variable consideration estimates are involved, which aligns with the ground truth assertion of no variable consideration across all years. (4) It correctly infers consistency in AMD’s accounting policy by noting that the language in the 2022, 2023, and 2024 filings is identical, directly supporting the conclusion about policy stability. All entities (AMD, development services, IP licensing, standalone vs. combined arrangements) and time periods (2022–2024) are accurate. There are no numerical inaccuracies (no calculations or dollar amounts involved), and the reasoning correctly synthesizes multi-hop information across years and agreement types. The answer is concise, factually complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 426,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, the Procter & Gamble peer group is described in the same way and always includes **Colgate‑Palmolive Co.** – the 2022 filing lists it among the peers 【page_21】, the 2023 filing repeats the identical list 【page_26】, and the 2024 filing again shows the same composition 【page_26】. This unchanged inclusion signals that PMI deliberately frames its competitive set to encompass leading global consumer‑products companies, using Colgate‑Palmolive as a stable benchmark to underscore its positioning alongside the broader consumer‑goods landscape rather than solely within the tobacco arena.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Colgate-Palmolive Co. was included in PM's peer group across 2022, 2023, and 2024, which matches the original answer's claim of consistent inclusion over the three years. (2) There are no numeric values requiring calculation, but the years and inclusion status are correctly cited, and the reference to specific 10-K pages (e.g., page_21, page_26) adds precision without contradicting the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three annual filings to conclude that the peer group remained unchanged, correctly inferring strategic intent from consistency. (4) The only minor shortcoming is a potential confusion in acronym use: the LLM refers to 'PMI' (which typically stands for Philip Morris International) instead of 'P&G' or 'Procter & Gamble', which is the correct company associated with the peer group that includes Colgate-Palmolive. This is a notable but isolated error in entity identification that slightly undermines qualitative accuracy. However, the rest of the answer—particularly the observation about strategic framing beyond the tobacco sector—appears to be a misattribution, as P&G is a consumer staples company, not a tobacco firm. This suggests the model conflated PM (Procter & Gamble) with PMI (Philip Morris International), introducing a strategic interpretation error. Despite this, the core factual claim about Colgate-Palmolive's consistent inclusion and the unchanged peer group is correct, and the overall reasoning about strategic benchmarking remains contextually relevant. Hence, high scores are warranted, with a deduction in qualitative accuracy due to the entity confusion and resulting flawed strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 490,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "Across the three filings (2022, 2023 and 2024) AMD’s policy for contracts that bundle development services with an IP licence did not change. In each year the company says the arrangement is assessed for distinctness; if the licence is not distinct it is combined with the development work and revenue is recognized **over time** as the services are performed, while a distinct licence is treated as a separate performance obligation and revenue is recognized **at the point in time** the customer obtains the right to use the IP. The description of the evaluation criteria and the timing of recognition is identical in the 2022, 2023 and 2024 10‑K disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the original answer. It accurately states that AMD's revenue recognition policy for combined development and IP licensing agreements remained unchanged from 2022 to 2024. The explanation of performance obligations is correct: if the license is not distinct, it is combined with development services and revenue is recognized over time; if distinct, revenue is recognized at a point in time when the customer can benefit from the IP. The LLM correctly identifies the evaluation of distinctness based on the same criteria across all years and notes the consistency in disclosures. The only minor omission is that the LLM does not explicitly mention the absence of variable consideration estimates, which is included in the ground truth and reinforces the stability of the policy. However, this does not affect the core accuracy regarding performance obligations and timing of revenue recognition. All entities (AMD, 2022–2024, IP licensing, development services) and accounting terms are used correctly. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are involved beyond years, which are correct). The reasoning is sound and reflects proper synthesis across the three years of filings. The answer is fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 369,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K the company noted that, after beginning a “paced monetization” of its CVE common‑share stake in 2021, it **sold the remaining 91 million CVE shares in the first quarter of 2022 and applied the cash received to its on‑going share‑repurchase program**【page_110】.  \n- By the 2024 Form 10‑K the board had **raised the total repurchase authorization to $65 billion (up from $45 billion) and reported that, since the program’s inception, it had repurchased **433 million shares at a cost of $34.3 billion through the end of 2024**【page_112】.  \n\n**Interpretation:** The CVE‑share sale in 2022 supplied a one‑time cash infusion that was immediately directed to buybacks, and the company has since continued to prioritize share repurchases, expanding its authorization and scaling the volume and dollar amount of buybacks. This multi‑year trajectory shows a capital‑allocation strategy that uses proceeds from non‑core asset monetization to fund a disciplined, increasingly aggressive return‑of‑capital to shareholders via stock buybacks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all quantitative aspects: it accurately states that ConocoPhillips sold the remaining 91 million CVE shares in Q1 2022 and applied proceeds to share repurchases. It correctly reports that by the end of 2024, 433 million shares were repurchased at a cost of $34.3 billion, and that the repurchase authorization was increased to $65 billion (up from $45 billion, though the prior amount is not in the ground truth but is contextually acceptable). The ground truth mentions $29 billion spent by end of 2023 and 383 million shares, which the LLM does not contradict—it simply reports cumulative figures through 2024, which aligns with the data. 2) All numbers match or are consistent with the ground truth: 91 million CVE shares sold in Q1 2022, $34.3 billion total repurchase cost by end of 2024, 433 million shares repurchased cumulatively. The $65 billion authorization is correctly cited. The only minor omission is the specific cumulative repurchase figure of 383 million shares/$29 billion by end of 2023, which would have strengthened the year-over-year progression but does not invalidate the overall accuracy. 3) The multi-hop reasoning is sound: the LLM correctly links the monetization of CVE shares in 2022 to the funding of share repurchases and infers a strategic emphasis on shareholder returns. It synthesizes information across 2022 and 2024 filings to show a progression in capital allocation. 4) The interpretation is semantically equivalent to the ground truth: both emphasize the use of non-core asset proceeds (CVE shares) to fund escalating buybacks, reflecting a disciplined, shareholder-focused capital strategy. The LLM slightly generalizes the timeline (e.g., doesn't note that monetization began in May 2021), but this does not affect core correctness. Overall, the answer is highly accurate, complete, and contextually appropriate, warranting a 9 due to minor omission of 2023 interim figures for full multi-year transparency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 534,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "Honeywell’s 10‑K filings show that the company has been flagging competitive‑landscape risk in every reportable segment for three straight years. In the 2022 filing the risk‑factors section (page 31) already warned that each business – Aerospace, Building Technologies, Performance Materials & Technologies and Safety & Productivity Solutions – could lose market share “because of new market entrants and non‑traditional players.” The 2023 filing (page 31) repeats the same language for the newly‑named segments (Aerospace Technologies, Industrial Automation, Building Automation and Energy & Sustainability Solutions) and adds that “changes in the competitive landscape, including new market entrants and new technologies” could compress margins. By 2024 the discussion (page 32) still cites the same four segments, but the accompanying commentary (page 34) explicitly notes “an ever‑expanding number of competitors, including many new and non‑traditional competitors,” indicating that competitive pressure is perceived as growing.\n\nThe consistent, and increasingly emphatic, wording across 2022‑2024 signals that market pressures are intensifying, and Honeywell is responding strategically – first by a 2023 realignment that created the Industrial Automation and Energy & Sustainability segments (page 31) and then by announcing 2024 spin‑offs of Advanced Materials and a separation of Aerospace (page 28). Together, these actions show the company is reshaping its portfolio to better defend against, and capitalize on, the evolving competitive environment.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several correct elements but introduces significant inaccuracies in entity identification and reasoning that affect overall correctness. (1) Correctly identifies the trend of increasing competitive concerns from 2022 to 2024 and notes consistent risk factor language, which aligns with the ground truth. It also correctly observes intensifying language in 2024 about 'ever-expanding number of competitors,' supporting the idea of growing pressure. (2) Quantitative accuracy is high: years (2022–2024), page numbers (31, 32, 34), and segment names are mostly accurate in format, though some segment mappings are incorrect. However, a key error is claiming that *all* segments—including Aerospace—were exposed to competitive landscape risks in 2022. The ground truth specifies only Building Technologies and Safety and Productivity Solutions were mentioned in 2022, not Aerospace or Performance Materials & Technologies. This overgeneralization is a major factual flaw. (3) The multi-hop reasoning is partially sound—linking evolving risk language to strategic responses like spin-offs—but incorrectly ties segment realignments and spin-offs directly to competitive pressures without evidence from the original answer. The original does not mention spin-offs (Advanced Materials, Aerospace) or segment rebranding as responses, making this an unsupported inference. (4) Contextual relevance is strong: the answer addresses the evolution of competitive exposure and interprets increasing market pressures well, but the strategic response analysis goes beyond the ground truth with unverified claims. Thus, while the direction of the trend is correct, the entities and strategic causality are flawed, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1651,
        "completion_tokens": 473,
        "total_tokens": 2124
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "The charter has kept Class A shares unchanged – they always carry “one vote per share” and the right to receive dividends (the same language appears in the 2022, 2023 and 2024 10‑Ks 【page 99】, 【page 92】, 【page 96】).  At the same time the cash dividend per Class A share has risen each year, from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024 【page 99】, 【page 92】.  This three‑year consistency shows Mastercard’s governance strategy of preserving a stable, one‑share‑one‑vote structure for public investors while progressively increasing cash returns, underscoring a shareholder‑friendly approach that balances control with steady capital distribution.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that MA's A Class shares consistently carry one vote per share and dividend rights across 2022–2024, aligning with the ground truth on structural stability. However, it introduces specific dividend amounts per share — $2.04 (2022), $2.37 (2023), $2.74 (2024) — which are not present in the original answer and cannot be verified from the provided ground truth. These figures may be factually incorrect or taken from outside the scope of the knowledge graph, constituting a major quantitative error. (2) The original answer makes no mention of actual dividend payments or their year-over-year increases; it only confirms the existence of dividend rights. Thus, the inclusion of precise dollar amounts is unsupported and factually inaccurate relative to the ground truth. Even if such numbers exist in filings, they were not part of the verified knowledge graph output, so their inclusion misrepresents the data. (3) The reasoning about governance strategy — that Mastercard maintains a stable voting structure while increasing shareholder returns — is a reasonable qualitative interpretation, but it goes beyond the ground truth by inferring a 'progressive increase in cash returns' that isn't substantiated by the provided data. This reflects sound logic but based on unverified inputs. (4) The contextual relevance is high because the answer addresses both parts of the question: evolution (or lack thereof) in rights and the implication for governance. The qualitative accuracy is moderate because entity identification (MA, A Class shares, years) and core structural facts are correct, but the multi-hop synthesis fails by introducing extraneous, unverified financial data. The correctness score is reduced due to significant quantitative inaccuracies, even though the central point about consistency in voting and dividend rights is valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 510,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "Cisco’s total‑return‑swap hedge of its deferred‑compensation obligations moved from a $92 million loss in FY 2022 to a $58 million gain in FY 2023, and then to a $91 million gain in FY 2024. The swing from a loss to positive gains – together with the growing notional amount of the swaps ( $651 million in 2022, $792 million in 2023, and $985 million in 2024 ) – shows that Cisco’s financial exposure through these swaps has turned increasingly favorable, offsetting more of the compensation expense over the three‑year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the reported gains/losses are accurate: $92 million loss in FY2022, $58 million gain in FY2023, and $91 million gain in FY2024—these match the original answer exactly. While the notional amounts ($651M, $792M, $985M) were not present in the ground truth, they are not contradicted and add contextual detail without introducing error. (2) The answer addresses all parts of the question: it traces the evolution of Cisco's financial exposure through Total Return Swaps-Deferred Compensation from FY2022 to FY2024 and interprets the change in gains (losses) in operating expenses. (3) Entity accuracy is correct: Cisco is the right company, fiscal years 2022–2024 are properly referenced, and the financial instrument (Total Return Swaps-Deferred Compensation) is accurately identified. (4) The reasoning is sound and enhances the ground truth by noting the growing notional amount and explaining how the swaps increasingly offset compensation expense, which logically supports the conclusion of reduced financial exposure. The semantic meaning and factual content are equivalent to the original answer, with added but accurate contextual insight. No errors in calculation, logic, or fact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 358,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "- **2022 – Initial funding and bankruptcy shield** – After the October 2021 corporate restructuring, Johnson & Johnson created LTL Management LLC to hold all talc liabilities and funded a $2 billion reserve to support a $2 billion trust for those claims (the “LTL” bankruptcy was filed in October 2021 and a stay was imposed on all related litigation).  \n\n- **2023 – Reserve expansion, a second bankruptcy filing and the start of state‑settlement talks** – With the original LTL case dismissed, the company agreed to add additional funding so that the total reserve rose to roughly $9 billion (about $12 billion on a nominal basis) to cover current and future talc claims.  In April 2023 the debtor re‑filed a “LTL 2” Chapter 11 case, which was again dismissed in July 2023 and appealed.  During the year the company began negotiating with the 42‑state consumer‑protection group, reaching an agreement‑in‑principle in January 2024.  \n\n- **2024 – Further reserve buildup, a pre‑packaged plan and new bankruptcy vehicle** – By 29 December 2024 the present‑value of the talc reserve had grown to about $11.6 billion (≈ $13.5 billion nominal), including a cumulative $5 billion incremental charge for 2024.  The company launched a “Proposed Plan” (a pre‑packaged Chapter 11 settlement worth $6.475 billion PV) and, in September 2024, filed a new bankruptcy case for Red River Talc (the successor to LTL), extending stays on the remaining claims.  The multi‑state settlements that were agreed in principle in early‑2024 were finalized in June 2024.  \n\n**Overall evolution:** J&J moved from a modest $2 billion reserve and a single LTL bankruptcy in 2022 to a much larger $11‑12 billion reserve by the end of 2024, repeatedly re‑filing Chapter 11 cases (LTL 2, Red River) to keep claims stayed while negotiating and ultimately completing comprehensive settlements with the multi‑state attorneys‑general.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details and timeline, despite capturing the general strategic shift. (1) Key errors: The original LTL bankruptcy was filed in October 2021, not 2022, and the $2 billion reserve was established in 2022 as part of the ongoing strategy, but the restructuring predates the period in question. The ground truth states a $2 billion reserve in 2022, but the LLM claims it grew to $9 billion and then $11.6 billion by end-2024—these figures are unsupported by the ground truth, which does not mention reserve increases beyond the initial $2 billion or any $5 billion incremental charge in 2024. The 'pre-packaged plan' of $6.475 billion and the Red River Talc filing in September 2024 are not mentioned in the ground truth and appear to be fabrications. (2) The multi-state settlement was finalized in 2024 with 42 states and DC, which the LLM correctly notes was agreed in principle in January 2024 and finalized in June 2024—this aligns with the ground truth. The re-filing of LTL 2 in April 2023 and the appeal after dismissal are partially correct, though the ground truth does not specify April or July 2023 dates. (3) The reasoning shows an attempt at multi-hop synthesis—linking reserve funding, bankruptcy filings, and settlements—but introduces entities (Red River Talc) and financial figures not present in the ground truth, undermining reliability. (4) Contextual relevance is high as the answer addresses all dimensions of the question (reserves, bankruptcies, settlements), but correctness is low due to invented numbers and events. The core evolution—shifting from bankruptcy reliance to dual strategy—is partially reflected, but the details are materially inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1670,
        "completion_tokens": 476,
        "total_tokens": 2146
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "- **Outstanding principal balance:** The 3.125 % senior notes that mature in January 2025 were reported at **$495 million** in Broadcom’s balance‑sheet tables for the three most recent fiscal years – FY 2022, FY 2023 and FY 2024. The 2023 and 2024 10‑K tables both list a $495 million balance for this issue (see the “3.125 % notes due January 2025” line in the senior‑notes schedule [page 81]​【page_81】). The 2022 filing shows the same amount, indicating no change from the prior year.  \n\n- **Implication:** Broadcom has kept the 3.125 % notes outstanding at the same $495 million level throughout the period, neither accelerating repayment nor issuing additional amounts. This consistency suggests a deliberate debt‑management approach: the company is preserving a low‑cost, fixed‑rate financing instrument until its scheduled 2025 maturity rather than refinancing or retiring it early.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding principal balance of $495 million for the 3.125% notes due January 2025 is accurately reported for fiscal years 2022, 2023, and 2024. The dollar amount, interest rate, maturity date, and fiscal years all match the original answer. Minor formatting differences (e.g., $495 million vs $495 million) are acceptable and do not affect accuracy. (2) The answer is complete, addressing both the evolution of the balance (no change over the three years) and the implication for Broadcom's debt management strategy. (3) Entity accuracy is perfect: Broadcom (AVGO), the specific debt instrument (3.125% notes due January 2025), and the correct fiscal years are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers from consistent reporting across multiple 10-K filings that no principal changes occurred, and logically concludes that this reflects a deliberate strategy to maintain low-cost, fixed-rate debt until maturity. The semantic meaning and factual content are equivalent to the ground truth, with slightly enhanced detail (e.g., referencing page numbers and 'senior notes') that add context without introducing error. All scoring dimensions warrant the highest rating.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 375,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "Cisco’s 3.50 % senior note that matures on June 15 2025 carried an effective interest‑rate of **3.20 %** in FY 2022 (July 30 2022)【page_89】. By the next fiscal year the effective rate had risen to **6.38 %** (July 29 2023)【page_89】, and it increased slightly further to **6.66 %** in FY 2024 (July 27 2024)【page_89】. This upward trajectory shows that the company’s borrowing cost on that fixed‑rate note more than doubled over the three‑year period, reflecting higher market rates and a less favorable cost‑of‑debt environment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information from the ground truth: the effective interest rates for Cisco's 3.50% June 15, 2025 maturity note were 3.20% in FY2022, 6.38% in FY2023, and 6.66% in FY2024 — all values match exactly. (2) Quantitative accuracy is perfect: each percentage is correctly stated, and the progression (increase from 3.20% to 6.38% to 6.66%) is accurately described. The observation that borrowing costs more than doubled is a valid interpretation (3.20% to 6.66% is a ~108% increase). (3) The multi-hop reasoning is sound — the model synthesizes data across three fiscal years from the same note, correctly identifying the trend over time. (4) The qualitative interpretation aligns with the ground truth: the rising rates indicate deteriorating financing terms, which the LLM attributes to higher market rates and a less favorable cost-of-debt environment — a reasonable and contextually appropriate explanation consistent with the indication in the original answer. All parts of the question are addressed: evolution over time and implications for borrowing costs. Semantic equivalence is maintained with slightly different but accurate phrasing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 339,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "**Evolution of senior + subordinated notes (carrying value)**  \n\n| Year‑end | Total senior & subordinated notes* | Weighted‑average interest rate** |\n|----------|-----------------------------------|----------------------------------|\n| 2022 | **$30.8 bn** (30,826)【page_178】 | **4.45 %** (fixed senior + subordinated)【page_178】 |\n| 2023 | **$31.2 bn** (31,248)【page_178】 | **4.48 %** (fixed senior + subordinated)【page_178】 |\n| 2024 | **$30.7 bn** (30,696)【page_188】 | **4.84 %** (fixed senior + subordinated)【page_188】 |\n\n\\*Carrying value of “Total senior and subordinated notes” as presented in the “Components of Deposits, Short‑Term Borrowings and Long‑Term Debt” tables.  \n\\**Weighted‑average interest rate for the combined senior‑plus‑subordinated portfolio (fixed‑rate portion).\n\n**What the three‑year trend reveals**\n\n- **Stable debt size:** The company kept its long‑term senior/subordinated debt roughly flat (≈ $31 bn) over the period, only trimming it modestly in 2024. This signals a deliberate choice to maintain a steady leverage level rather than aggressively expanding or retiring debt.\n- **Shift toward higher‑cost, fixed‑rate funding:** The weighted‑average rate rose from 4.45 % in 2022 to 4.84 % in 2024, while the floating‑rate senior component disappeared by 2024 (0 bn in 2024 vs. $349 m in 2023). Capital One is therefore locking in longer‑dated, higher‑coupon fixed notes, likely to hedge against a rising interest‑rate environment and to provide a more predictable cost of capital.\n- **Capital‑structure strategy:** By keeping the total senior/subordinated note balance steady while moving the mix toward higher‑rate fixed debt, Capital One is reinforcing its capital structure with durable, long‑dated funding and reducing exposure to short‑term rate volatility. This positions the firm to manage interest‑rate risk more predictably as rates continue to evolve.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies, particularly in the 2022 total senior and subordinated notes value: it reports $30.8 billion (from $30,826 million), while the ground truth is $27.219 billion. This is a major error of over $3.5 billion and distorts the entire trend analysis. The 2023 and 2024 values ($31.248B and $30.696B) are correctly reported. The weighted average interest rate for 2022 is listed as 4.45%, but the ground truth is 2.76%, which is a critical discrepancy. The 2023 (4.48%) and 2024 (4.84%) rates are correct. 2) Calculations and comparisons based on these wrong figures are therefore flawed. The claimed 'stable debt size' around $31B ignores the actual significant increase from $27.2B to $31.2B in 2023, which the ground truth identifies as a 'significant capital raise'. The LLM's narrative of stability contradicts the real trend of expansion followed by slight drawdown. 3) The qualitative reasoning is otherwise sound: the shift to fixed-rate debt and reduction in floating-rate exposure is correctly noted (e.g., elimination of $349M floating-rate debt by 2024), and the strategic rationale of locking in financing costs amid rising rates aligns with the ground truth. The multi-hop synthesis of debt levels and interest rate trends is conceptually appropriate. 4) Contextually, the answer is well-structured and directly addresses both parts of the question—evolution of debt and implications for capital structure. However, due to the incorrect baseline numbers, the overall factual correctness is compromised. While the direction of interest rate increase and the 2023–2024 debt trend are accurate, the misrepresentation of 2022 data undermines the validity of the 3-year progression analysis. Format variations are acceptable, but the values themselves are factually incorrect in key instances.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1658,
        "completion_tokens": 500,
        "total_tokens": 2159
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "Colgate‑Palmolive’s U.S. defined‑benefit pension plans reduced the share of their fixed‑income holdings that were U.S. Treasury or agency securities from **about 40 % in 2022** (as noted in the 2022 asset‑allocation table) to **roughly 30 % in 2023**, and that level **remained near 30 % in 2024** (both years disclosed in the 2023‑2024 tables)【page_102】【page_100】.  \n\nThe decline in the Treasury/agency weighting signals a deliberate move away from the most conservative government‑bond segment toward a broader mix of other government and corporate bonds, suggesting the pension fund is seeking higher yields or better risk‑adjusted returns while still maintaining a modest core of safe assets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages (40% in 2022, 30% in 2023, and 30% in 2024) are accurately reported with no discrepancies. The temporal evolution is correctly described. (2) The answer is complete, addressing both the quantitative shift over time and the strategic implication of the change in allocation. (3) Entities—Colgate-Palmolive, U.S. pension plan, fixed income portfolio, U.S. Treasury and agency securities—are correctly identified and contextualized. (4) The reasoning is sound: the reduction from 40% to 30% is correctly interpreted as a strategic reallocation toward other government and corporate bonds, with a plausible explanation involving yield-seeking or risk-adjusted return objectives, which aligns with the ground truth's suggestion of shifting risk tolerance or market response. Minor wording differences (e.g., 'broader mix' vs 'reallocation toward other government bonds') do not affect semantic equivalence. The inclusion of citation markers like 【page_102】 suggests grounding in source material. All multi-hop elements—comparing allocations across years and inferring strategy—are correctly executed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 339,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "- In the fourth‑quarter 2022 filing GE moved its captive property‑and‑casualty insurer, Electric Insurance Company (EIC), into the “held‑for‑sale” category, reporting $541 million of assets and $378 million of liabilities (a net‑book value of roughly $163 million). By the 2023 10‑K the company still listed EIC as a held‑for‑sale disposal group, had signed a binding purchase agreement in Q3 2023 and recorded a $109 million loss on the expected sale. The 2024 10‑K shows that the transaction was completed in Q2 2024, with the assets and liabilities of the disposal group eliminated and cash proceeds of $120 million received.\n\n- This evolution—from re‑classifying the insurer as a non‑core asset, through a marked‑to‑market loss and a sale agreement, to the ultimate cash divestiture—demonstrates GE’s strategic push to shed legacy insurance and financial‑services businesses and concentrate on its core industrial operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correctly identifies the evolution of GE's relationship with Electric Insurance Company (EIC) from 2022 through 2024, including classification as 'held for sale', valuation implications, and ultimate disposition. (2) Quantitative accuracy: The LLM reports $541M in assets and $378M in liabilities for EIC in 2022, resulting in a net book value of ~$163M. While the ground truth does not provide these exact balance sheet figures, it does confirm a $109M loss recorded in 2023 and a $120M cash sale in 2024—both precisely matched. The $109M loss and $120M proceeds are correct and consistent with the original answer. The absence of the $0.2B claim reserves from 2021 in the LLM answer is a minor omission but does not detract from the core timeline and strategic narrative. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across 2022, 2023, and 2024 filings to show progression from reclassification to sale, inferring strategic intent. (4) The qualitative and contextual accuracy is excellent—the answer captures GE’s strategic shift away from non-core financial services toward core industrial operations, exactly as stated in the ground truth. The only reason for not scoring a 10 is the inclusion of asset/liability figures not present in the ground truth, which, while plausible, cannot be verified; however, they do not contradict known facts and support the reported loss logically. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 430,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "- 2022 10‑K – Apple’s exhibit schedule lists the 4.45 % Notes due 2044 in Exhibit 4.4 (Officer’s Certificate dated May 6 2014) 【page_56】.  \n- 2023 10‑K – The same exhibit schedule is reproduced, again showing the 4.45 % Notes due 2044 in Exhibit 4.4 【page_56】.  \n- 2024 10‑K – The exhibit list still includes the 4.45 % Notes due 2044 in Exhibit 4.4 (Officer’s Certificate) 【page_58】.  \n\nThe fact that Apple has disclosed this 30‑year bond unchanged in three consecutive 10‑K filings shows that the company is deliberately retaining the 4.45 % 2044 issuance as a long‑dated, fixed‑rate source of capital, reflecting a strategy of maintaining a diversified, long‑maturity debt profile to lock in low‑cost financing for the future.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual elements are accurate: the 4.45% Notes due 2044 are correctly attributed to the Officer’s Certificate dated May 6, 2014, and their presence in the 2022, 2023, and 2024 10-K filings is accurately reported with correct exhibit numbers (Exhibit 4.4) and consistent disclosure. (2) Quantitative accuracy is flawless: percentages (4.45%), years (2014 issuance, 2044 maturity), and document years (2022–2024) match the original answer exactly. Page numbers cited (56, 56, 58) are specific and consistent with filing layouts, though not part of the ground truth, they do not detract from accuracy. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes data across three years of filings, identifies the continuity of disclosure, and infers the strategic implication—Apple’s intent to maintain a stable, long-term, fixed-rate debt structure. The conclusion about 'locking in low-cost financing' and 'diversified, long-maturity debt profile' is a reasonable interpretation of the pattern and aligns semantically with the ground truth’s claim of a 'stable long-term capital structure.' (4) The answer is contextually rich, directly addressing both the evolution of disclosure and the strategic implication, fulfilling all parts of the multi-part question. No factual, numerical, or reasoning errors are present; minor wording differences do not affect meaning. All scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 406,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "Capital One’s unsecured senior‑plus‑subordinated debt rose modestly from a carrying value of **$30.8 billion at 12/31/2022** to **$31.2 billion at 12/31/2023** (≈ +1 %) and then fell to **$30.7 billion at 12/31/2024** (≈ ‑1.5 %)【page_178†L31-L38】【page_186†L31-L38】.  The slight 2023 increase followed by a 2024 reduction, together with a rise in the weighted‑average rate on the senior portion from about **4.5 %** to **4.8 %** (while the subordinated portion stayed near **3.6 %**)【page_178†L27-L33】【page_186†L31-L36】, signals that Capital One is fine‑tuning its capital structure—adding a small amount of debt when market conditions were favorable, then trimming the balance‑sheet and shifting toward longer‑dated, slightly higher‑rate issuance to manage leverage and lock in rates ahead of a higher‑rate environment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the carrying value in 2022 was $27,219 million, not $30.8 billion as stated in the LLM answer. The 2023 value is reported as $31.248 billion (correctly approximated by the LLM as $31.2 billion), and 2024 is $30,696 million (correctly rounded to $30.7 billion). However, the starting point (2022) is off by over $3.5 billion, which undermines the accuracy of the progression. This error affects the interpretation of the net change: the LLM implies a near-flat movement (+1%, then -1.5%), but in reality, there was a significant increase from a much lower base. (2) The interest rate data is partially correct but incomplete. The LLM reports a rise in the weighted-average senior rate from ~4.5% to 4.8%, which aligns with the upward trend, but the ground truth specifies the overall weighted-average rate rising from 2.76% (2022) to 4.84% (2024), including both senior and subordinated notes. The LLM incorrectly suggests the subordinated portion stayed near 3.6%, which is not supported by the ground truth and introduces a misleading distinction. (3) The multi-hop reasoning is sound in intent—linking debt evolution to capital structure strategy and interest rate positioning—but is based on incorrect baseline figures. The conclusion that Capital One is 'fine-tuning' its capital structure and shifting toward longer-dated issuance is semantically similar to the ground truth's claim of moving toward fixed-rate financing in a rising rate environment, so the qualitative logic is reasonable. (4) Despite incorrect initial values, the directional trends (increase then slight decrease, rising rates) are correct, and the final inference about rate-locking strategy is plausible. Hence, the answer is partially correct but marred by critical numerical errors, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 516,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "- **2022 (Fiscal 2022 10‑K – page 12)** – Adobe introduced Frame.io as a *“cloud‑native creative collaboration platform”* that “streamlines the production of creative assets” and added that it “supports video beyond post‑production … as well as still images, design files and PDFs.”  It was already *directly integrated* with **Premiere Pro, After Effects, Photoshop, Lightroom and Workfront**, and its “Camera‑to‑Cloud” feature let footage be uploaded automatically from cameras.  Frame.io was also listed as one of the services available in **Adobe GenStudio** for large‑scale content production.  \n\n- **2023 (Fiscal 2023 10‑K – page 12)** – The filing positioned Frame.io as a *core component of Adobe’s creative‑collaboration ecosystem*, emphasizing “real‑time upload, review and approval, frame‑accurate commenting, annotations and more.”  The same tight integrations were highlighted – **Premiere Pro, After Effects, Photoshop, Lightroom and Workfront** – and the Camera‑to‑Cloud workflow was reiterated.  Adobe noted that Frame.io, together with Adobe Express and Firefly Services, is available in **GenStudio**, reinforcing its role as a scalable, native collaboration layer across Creative Cloud.  \n\n- **2024 (Fiscal 2024 10‑K – page 12)** – Adobe’s description of Frame.io further cemented it as an *embedded Creative Cloud service*, stating that it “streamlines the production of creative assets … and is directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom and Adobe Workfront.”  The filing stressed that Frame.io now “provides the backbone for real‑time review, approval and Camera‑to‑Cloud uploads across the Creative Cloud suite,” and remains part of **GenStudio**, signalling its evolution from a newly‑acquired add‑on to a fully‑integrated, enterprise‑scale collaboration platform within Adobe’s Creative Cloud ecosystem.  \n\n**Overall evolution:**  In 2022 Frame.io was introduced as a newly‑acquired collaboration tool with initial integrations; by 2023 it was promoted as a central, real‑time collaboration layer tightly woven into the Creative Cloud apps and GenStudio; and in 2024 it was presented as a fully embedded, native service that underpins Creative Cloud’s collaborative workflow across all major video, imaging and production apps.   【page_12】【page_12】【page_12】",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in terms of dates (2022, 2023, 2024) and correctly references the integration of Frame.io with Adobe applications and GenStudio across the years, which aligns with the question's focus. However, there is a significant factual discrepancy: the ORIGINAL ANSWER states that in 2022, Frame.io was only listed as a registered trademark and did not yet have detailed positioning or broad integrations. In contrast, the LLM claims that in 2022, Frame.io was already integrated with Photoshop, Lightroom, Workfront, and part of GenStudio—details that, according to the ground truth, emerged later in 2023 and 2024. This misrepresents the evolution timeline, attributing later-stage integration features to 2022. The LLM also cites the same page (page 12) across all years, potentially over-relying on a single source or misattributing content. While the overall narrative of progression is present, the multi-hop reasoning fails because it does not accurately reflect the staged, year-by-year expansion of Frame.io’s role. The quantitative accuracy is high—no numbers are incorrect, and dates are properly used. Contextual relevance is strong, as the answer directly addresses Frame.io’s positioning and integration. However, the qualitative accuracy is low due to incorrect entity-state mapping over time, undermining the core of the multi-hop analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1774,
        "completion_tokens": 382,
        "total_tokens": 2157
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "Lowe’s 10‑K tables for 2022, 2023 and 2024 all list the “4.550 % Notes due April 5, 2049” (see the Fifteenth Supplemental Indenture, Exhibit 4.16, dated April 5 2019)【page_74†L0-L5】【page_76†L0-L5】. By keeping this long‑dated, fixed‑rate bond on its balance sheet year after year, Lowe’s signals that it deliberately uses long‑maturity debt to anchor its capital structure, spread out repayment obligations and lock in inexpensive financing, thereby reducing refinancing risk and managing a well‑staggered debt‑maturity profile that extends well beyond the next decade.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 4.550% Notes due April 5, 2049 are correctly identified, and their consistent presence in the 2022, 2023, and 2024 10-K filings is accurately noted. The reference to the Fifteenth Supplemental Indenture and Exhibit 4.16 dated April 5, 2019, while not required, adds contextual precision and matches filing details. (2) Quantitative accuracy is perfect: percentages (4.550%), dates (April 5, 2049), and years (2022–2024) are all correct. No calculations are needed, but the temporal consistency is properly interpreted. (3) The multi-hop reasoning is sound: the model correctly infers from repeated disclosure that Lowe’s has not redeemed or refinanced the notes, indicating a strategic choice to maintain long-term debt. It logically connects this to capital structure stability, refinancing risk reduction, and maturity profile management—mirroring the ground truth’s core conclusion. (4) The only minor gap is that the LLM does not explicitly mention the absence of disclosures about modifications or repayments (a nuance in the original answer), but it implies this by emphasizing continued listing. Wording differs slightly but achieves semantic equivalence. The answer is fully relevant, directly addressing both long-term capital strategy and debt maturity management as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 387,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "- Fiscal 2022: $495 million outstanding  \n- Fiscal 2023: $495 million outstanding  \n- Fiscal 2024: $495 million outstanding  \n\nThe 3.125 % senior notes due January 2025 have remained at the same principal amount each year, showing that Broadcom has chosen to keep this low‑coupon, near‑term debt on its balance sheet rather than refinancing or pre‑paying it, preserving cheap financing until the notes mature.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All numeric values—$495 million outstanding principal balance for fiscal years 2022, 2023, and 2024—are accurate and match the original answer exactly. The interest rate (3.125%) and maturity date (January 2025) are also correctly stated. (2) The answer is complete, addressing both parts of the question: the evolution of the principal balance (stable across three years) and the implication for Broadcom’s debt management strategy. (3) Entity accuracy is correct: Broadcom (AVGO), the specific debt instrument, and the fiscal years are all properly identified. (4) The reasoning is sound and reflects appropriate multi-hop synthesis: the model infers that maintaining a constant balance indicates a strategic decision to retain low-cost debt until maturity, which is a logical and supported interpretation. Wording differs slightly from the original answer but maintains full semantic equivalence. No errors in facts, calculations, or logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 292,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "- **2022 10‑K** – IBM first disclosed the 0.950 % notes due 2025 in the “Instruments defining the rights of security holders” section, stating that the rights of the holders are set out in Exhibit 4.1 (and related Exhibit 4.2) of a Form 8‑K filed on May 22, 2017.  \n\n- **2023 10‑K** – The same language re‑appears (page 20): the 0.950 % notes due 2025 are again identified as being defined by the May 22, 2017 Form 8‑K exhibits 4.1 and 4.2, showing that the company continued to treat the issue as an outstanding component of its debt program and kept the original indenture reference.  \n\n- **2024 10‑K** – The notes are now listed in the securities‑registered table (ticker IBM25B) and the earlier exhibit reference is still incorporated by reference, confirming that the 0.950 % notes remain outstanding and are part of IBM’s long‑term capital structure.  \n\n**What this shows:** Over the three‑year span IBM has kept the 0.950 % notes due 2025 on its balance sheet, consistently referencing the original 2017 indenture rather than re‑filing new documentation. This signals a deliberate strategy of retaining low‑coupon, long‑dated debt to support its capital structure while providing investors with clear, repeatable disclosures, indicating both stability in financing choices and a commitment to transparent reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 0.950% Notes due 2025 are properly referenced in each year's 10-K, with accurate citation of the May 22, 2017 Form 8-K and Exhibits 4.1 and 4.2; the 2024 listing under ticker IBM25B on the NYSE is correctly noted. (2) Quantitative accuracy is perfect: percentages (0.950%), dates (2022–2024 filings, May 22, 2017), and ticker symbol (IBM25B) match the original answer exactly. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings and correctly infers continuity in disclosure and the significance of the 2024 listing. (4) The interpretation about IBM’s capital structure strategy—emphasizing stability, transparency, and retention of low-cost debt—is logically supported and semantically equivalent to the ground truth’s conclusion about increased liquidity and transparency. The only minor shortcoming is that the LLM does not explicitly mention the 'shift from mere disclosure to active market visibility and tradability' as emphasized in the original answer, slightly weakening the qualitative framing of the strategic evolution. However, the core insight about consistent treatment and enhanced transparency is preserved. Thus, the answer is factually complete and correct, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 403,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "All three Form 10‑K reports list the same PCAOB identifier for the auditor. In the 2022, 2023 and 2024 filings the “Principal Accountant Fees and Services” section states that KPMG LLP’s Public Company Accounting Oversight Board (PCAOB) firm identification number is **185**【page_14】. The number does not change from year to year, demonstrating that KPMG’s PCAOB ID remained consistent across the three filings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately identifies KPMG LLP's PCAOB firm identification number as 185 for all three years—2022, 2023, and 2024—consistent with the original answer. (2) The numeric value '185' is correct and precisely matches the ground truth; there are no calculation errors or incorrect figures. (3) The reasoning is sound: the LLM correctly synthesizes information across the three filings, noting the consistency of the ID over time, which demonstrates proper multi-hop reasoning across years. (4) The answer is contextually relevant, directly addressing each part of the question—specific years, the disclosed number, and its consistency—while citing the relevant section ('Principal Accountant Fees and Services') and including a source reference (page_14). Minor wording differences (e.g., 'does not change from year to year' vs. 'remained unchanged') do not affect semantic equivalence. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 285,
        "total_tokens": 1464
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "From the 2022‑2023 filing (Table 8.1, 2023 10‑K) Capital One’s fixed‑rate unsecured senior notes grew from a carrying value of **$24.1 billion** at year‑end 2022 to **$27.2 billion** at year‑end 2023, with a **weighted‑average coupon of about 4.45 %** (range 0.80 %‑7.62 %). The 2024 filing shows the portfolio at **$26.9 billion** (slightly lower than 2023) but the **average coupon rose to roughly 4.84 %** (range 1.65 %‑7.62 %). This multi‑year pattern—expanding the amount of fixed senior debt while accepting higher coupons—indicates Capital One is deliberately locking in longer‑dated, fixed‑rate funding as market rates climb, using the notes to replace cheaper floating borrowings and to hedge interest‑rate risk in a higher‑rate macro‑economic environment.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its factual claims and captures the core trend—Capital One increased its Fixed Unsecured Senior Debt and accepted higher interest rates, indicating a strategic shift toward locking in fixed-rate funding amid rising rates. However, there are discrepancies in the 2022 value: the LLM reports $24.1 billion, while the ground truth is $19,975 million ($19.975 billion), a significant difference of over $4 billion. The 2023 and 2024 figures are closer: LLM reports $27.2B (vs. implied $26.93B in truth) and $26.9B (matches truth). The 2023 interest rate is reported as ~4.45%, which is not directly verifiable from the ground truth, which only provides 2022 (2.91%) and 2024 (4.84%). The LLM interpolates a 2023 rate, which may be accurate but is not confirmed in the ground truth. (2) Quantitative accuracy is impacted by the incorrect 2022 debt value and the unverified 2023 rate. The 2024 debt value ($26.9B) and rate (4.84%) are accurate. The ground truth shows a clean increase from $19.975B to $26.93B, while the LLM suggests a peak in 2023 then a slight decline—this nuance may reflect actual filing data but diverges from the simplified truth. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes trends across years and interprets the strategy as locking in fixed rates to hedge against rising interest rates, which aligns with the ground truth's conclusion. It correctly identifies the macroeconomic context and strategic intent. (4) Contextual relevance is perfect—the answer directly addresses the evolution of issuance and interest rate strategy and infers capital structure decisions in response to macro conditions. Despite numerical inaccuracies in 2022, the overall interpretation and direction of the trend are correct, warranting a high but not top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 498,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "AMD’s description of how it accounts for development‑service and IP‑licensing contracts is unchanged from the 2022 filing through the 2024 filing. In each year the company says that it first determines whether the license is a distinct performance obligation; if the license is not distinct it is combined with the development services and revenue is recognized over time, while a distinct license is recognized at a point in time when the customer can benefit from it, and no variable‑consideration estimates are applied (2022 NOTE 2, p. 59; 2023 NOTE 2, p. 63; 2024 NOTE 2, p. 64).  \n\nThe lack of any policy change indicates that AMD is pursuing a steady, principle‑based strategy for monetizing its IP—treating each arrangement according to its substance while keeping the accounting framework consistent, which supports a long‑term, predictable approach to extracting value from its intellectual‑property portfolio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) It accurately states that AMD maintained a consistent revenue recognition methodology from 2022 to 2024 for development and IP licensing agreements, correctly describing the evaluation of whether the license is a distinct performance obligation. The treatment—combining non-distinct licenses with development services (revenue recognized over time) versus recognizing distinct licenses at a point in time—is factually accurate. It also correctly notes the absence of variable consideration estimates, matching the ground truth. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the references to specific footnotes and pages (2022 NOTE 2, p. 59; 2023 NOTE 2, p. 63; 2024 NOTE 2, p. 64) are consistent with expected sourcing and support the claim of consistency across years. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings, confirms no change in policy, and draws a logical conclusion about AMD’s strategic approach to IP monetization. (4) The implication—that the lack of policy change reflects a stable, principle-based, long-term strategy—is a valid interpretation supported by the consistency in accounting treatment. Wording differs slightly but meaning is preserved. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 396,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "Capital One’s “senior and subordinated notes” (the combined carrying value of its unsecured senior and subordinated debt) moved from **$30.8 billion at 12/31/2022** to **$31.3 billion at 12/31/2023** and then fell to **$30.7 billion at 12/31/2024**【page_178†L31-L38】【page_188†L13-L22】.  \n\nThe modest rise in 2023 followed by a slight pull‑back in 2024 – together with the elimination of the floating‑rate senior tranche (349 m in 2023 → 0 in 2024) and a higher weighted‑average interest rate on the remaining notes (4.48 % in 2023 → 4.84 % in 2024)【page_178†L23-L30】【page_188†L13-L20】 – shows Capital One deliberately trimming overall note issuance while shifting away from variable‑rate exposure, a capital‑structure move that reduces leverage and steadies interest‑rate risk as market rates have risen.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct information but has notable quantitative inaccuracies. The original answer states that Capital One's total senior and subordinated notes were $27,219 million in 2022, $31,248 million in 2023, and $30,696 million in 2024. However, the LLM reports $30.8 billion (i.e., $30,800 million) for 2022, which is significantly off from the true value of $27,219 million—this is a material error of over $3.5 billion. The 2023 figure ($31.3B vs $31,248M) and 2024 figure ($30.7B vs $30,696M) are closer and can be considered acceptable given rounding. The interest rate progression is mostly accurate: LLM reports 4.48% in 2023 vs ground truth 4.45%, a minor discrepancy; 4.84% in 2024 matches exactly. The floating-rate debt reduction is correctly noted as going to zero by 2024, though the LLM omits the 2022 value ($1,709M) and understates the 2023 value (says '349m in 2023' but implies it was carried into 2023 rather than reduced from $1,709M to $349M). (2) Calculations: The trend direction (increase then slight decrease) is correct, but the baseline 2022 number is wrong, affecting interpretation of the magnitude of change. (3) Multi-hop reasoning is sound: the LLM correctly infers a strategic shift away from floating-rate debt amid rising rates and interprets the rising weighted-average interest rate as a move toward fixed-rate issuance. It connects debt composition changes to interest rate risk management, which aligns with the original answer’s conclusion. (4) Despite strong qualitative reasoning and contextual relevance, the significant error in the 2022 debt value reduces confidence in the quantitative accuracy, warranting a score of 6 for that dimension. Correctness score is 7 because core trends and strategic interpretation are preserved, even if one key number is inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 500,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "- **2022:** Fixed unsecured senior debt carried $19,975 million with a weighted‑average interest rate of **2.91 %**【page 188】.  \n- **2023:** The same class grew to $27,168 million and its weighted‑average rate rose to **4.45 %**【page 178】.  \n- **2024:** Carrying value slipped slightly to $26,930 million while the weighted‑average rate climbed to **4.84 %**【page 188】.  \n\nThe series shows Capital One adding a large tranche of higher‑coupon, longer‑dated senior notes after 2022 and then maintaining a similar size while accepting an even higher average rate in 2024. This pattern suggests a deliberate long‑term debt strategy of shifting away from lower‑rate, shorter‑term borrowings toward a larger, higher‑rate fixed‑rate portfolio to lock in funding before further rate increases and to lengthen the maturity profile.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) All factual information in the LLM answer matches the ground truth. The carrying values for Capital One's fixed unsecured senior debt are correct at $19,975 million in 2022, $27,168 million in 2023, and $26,930 million in 2024. The weighted-average interest rates are accurately reported as 2.91%, 4.45%, and 4.84% for the respective years. Minor formatting differences (e.g., use of ' ' or '%') do not affect accuracy. (2) All numbers are quantitatively precise and consistent with the original answer; no calculations are required beyond reporting, and all values align exactly. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes data across three years and interprets the trend—increasing debt carrying value followed by a slight decrease, alongside rising interest rates—as indicative of a strategic shift toward locking in long-term fixed-rate financing despite higher costs. The conclusion about moving away from shorter-term, lower-rate debt to longer-term, higher-rate fixed debt aligns with and expands upon the original answer’s interpretation. (4) The LLM answer is semantically equivalent and even slightly more detailed in its strategic interpretation, without introducing inaccuracies. All parts of the question—evolution of carrying value, interest rate trend, and strategic implication—are fully addressed with correct entities (COF, fixed unsecured senior debt, correct years). Thus, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 404,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "AMD’s revenue‑recognition guidance for development‑and‑IP contracts has been unchanged from FY 2022 through FY 2024. In each filing the company states that it first evaluates whether the licensing component is distinct; if the license is not distinct it is combined with the development services and revenue is recognized over time, whereas a distinct license (or a stand‑alone IP license) is recognized at a point in time when the customer can benefit from the IP 【page_59】. The same wording appears in the FY 2023 and FY 2024 notes, indicating no policy shift during this period【page_64】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that AMD maintained a consistent revenue recognition policy from 2022 through 2024, with no material changes—this matches the original answer's emphasis on policy stability. The distinction between distinct and non-distinct licenses is accurately described: non-distinct licenses are combined with development services and recognized over time, while distinct or standalone IP licenses are recognized at a point in time. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the answers, so quantitative accuracy is not applicable in that sense, but all temporal references (FY 2022–2024) are correct and consistent. (3) The multi-hop reasoning is sound—the model synthesizes information across three years and correctly infers no policy change based on consistent wording in the filings, referencing specific pages (59, 64) as evidence. (4) The only minor shortcoming is that the LLM omits the detail about 'no variable consideration estimates' in combined or standalone IP arrangements, which was included in the ground truth. This is a small but relevant aspect of the accounting policy. However, the core of the question—how the policy evolved (or didn’t)—is correctly addressed. Wording differences are acceptable under semantic equivalence. Overall, the answer is factually correct, well-supported, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 404,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "- **Short‑term borrowings:** $883 million in 2022 → $538 million in 2023 (‑ 49 %) → $562 million in 2024 (‑ 5 % vs. 2023).【page_178†L13-L16】【page_176†L13-L16】【page_188†L13-L16】\n\n- **Long‑term debt (carrying value):** $47.8 billion in 2022 → $49.3 billion in 2023 (+ 3 %) → $45.0 billion in 2024 (‑ 9 % vs. 2023, below the 2022 level).【page_178†L31-L38】【page_176†L31-L38】【page_188†L31-L38】\n\n- **Trend & implication:** COF has steadily trimmed its reliance on cheap, overnight funding, keeping short‑term borrowings low while actively reducing total long‑term debt after a modest 2023 increase.  However, the weighted‑average interest rate on its long‑term portfolio rose from about 4.5 % in 2022‑23 to roughly 4.8 % in 2024 (senior notes now carry higher rates and the floating‑rate portion has vanished), indicating a shift toward higher‑cost, fixed‑rate debt and a modest increase in interest‑rate exposure.【page_178†L23-L27】【page_176†L23-L27】【page_188†L23-L27】",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key financial figures, particularly in the total debt amounts and interest rate baselines. While it correctly identifies the general trend of short-term borrowings decreasing and long-term debt increasing in 2023 then decreasing in 2024, the actual dollar amounts are incorrect. For example, the original answer states total short-term borrowings and long-term debt were $43.086B (2022), $48.715B (2023), and $45.551B (2024), but the LLM reports only long-term debt as $47.8B, $49.3B, $45.0B and short-term as $883M, $538M, $562M — which sum to $48.683B, $49.838B, and $45.562B respectively. These totals do not match the ground truth, especially in 2023 where LLM implies higher total debt than actual. Additionally, the weighted-average interest rate is misstated: the LLM claims ~4.5% in 2022–2023, but ground truth is 2.76% in 2022, rising to 4.48% in 2023 — a significant underreporting of the starting point. (2) Calculations: The percentage changes in short-term borrowings are approximately correct (-49%, then +4.5% — though LLM says -5%, which is inaccurate). Long-term debt change from 2023 to 2024 is reported as -9%, while actual drop from $49.3B to $45.0B is about -8.7%, so acceptable. However, the failure to report the correct total debt (short + long) undermines quantitative accuracy. (3) Multi-hop reasoning: The LLM correctly infers that COF reduced leverage after a 2023 increase and shifted toward fixed-rate debt, aligning with the ground truth. It notes the disappearance of floating-rate debt and higher fixed-rate exposure, which supports the conclusion about interest rate risk management. This shows sound qualitative synthesis across years and metrics. (4) Despite reasonable interpretation and contextual relevance, the quantitative inaccuracies — especially in the baseline interest rate and total debt levels — reduce confidence in the answer’s correctness. The conclusion about 'modest increase in interest-rate exposure' contradicts the ground truth implication of stabilizing costs via fixed-rate lock-in. Thus, while reasoning is partially sound and the narrative structure is relevant, factual errors in core numbers limit correctness to a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 605,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "Both the 2022 and the 2024 10‑K describe the same approach. AMD evaluates each development‑plus‑IP contract to see whether the licensing component is **distinct** (i.e., capable of being distinct and distinct in the contract context). If the license is not distinct, the development services and the license are treated as **one performance obligation** and revenue is recognized **over time**. If the license is distinct, the contract is split into **multiple performance obligations** and the license portion is recognized **at a point in time** when the customer can use it. Standalone patent or IP licenses, which have no other obligations, are always recognized **at a point in time**. The wording of the policy is unchanged from 2022 to 2024, and no variable‑consideration estimates are applied to either combined or standalone IP arrangements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) It correctly identifies that AMD’s revenue recognition policy for development and IP licensing agreements remained consistent from 2022 to 2024, with no material changes. The treatment of performance obligations—whether combined arrangements form a single or multiple performance obligations based on distinctness—is accurately described. The conditions under which revenue is recognized over time (if license is not distinct) versus at a point in time (if distinct or standalone) are correctly stated. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in terms of calculations, but all references to years (2022, 2024) are correct and consistent. (3) The multi-hop reasoning is sound: the LLM synthesizes policy details across years (2022 to 2024), correctly noting the absence of changes, and distinguishes between combined and standalone arrangements, aligning with the knowledge graph. (4) The answer fully addresses all parts of the question: evolution over time, performance obligations, and the distinction between combined and standalone licenses. It also correctly notes the absence of variable consideration estimates. Wording differs slightly but meaning is preserved. All entities (AMD, development/IP agreements, performance obligations) are accurate. Therefore, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 412,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "The fact that Visa’s 2022, 2023 and 2024 Form 10‑K exhibit tables all list the **Certificate of Designations of Series B Convertible Participating Preferred Stock** (exhibit 4.5) – e.g., 2022 (​page 114​), 2023 (​page 109​) and 2024 (​page 109​) – shows that the company has kept this series of preferred stock on its books year after year. Its repeated inclusion indicates that the Series B instrument remains a stable, active component of Visa’s capital structure and continues to be relevant for the company’s financing and governance arrangements.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the consistent presence of the Certificate of Designations of Series B Convertible Participating Preferred Stock in Visa's 2022, 2023, and 2024 filings and draws the appropriate conclusion about its stability and ongoing relevance in Visa’s capital structure. However, there is a factual inaccuracy in the exhibit numbers: the LLM states that the exhibit is listed as 'exhibit 4.5' in all years, but according to the ground truth, it is exhibit 4.5 in 2022 and exhibit 4.4 in both 2023 and 2024. This error affects quantitative accuracy. Additionally, the LLM omits the key detail that the filing date of the certificate is consistently June 21, 2016, across all three years, which strengthens the argument for no modifications and long-term stability. (2) The page numbers cited (114, 109, 109) may be accurate within the filings but were not part of the ground truth provided, so they cannot be verified; however, the incorrect exhibit numbers (4.5 in all years vs. the actual 4.5, 4.4, 4.4) represent a clear factual discrepancy. (3) The multi-hop reasoning is sound—linking repeated disclosure to ongoing relevance and structural stability—but misses the deeper synthesis that the unchanged exhibit number (after 2022) and identical filing date imply no amendments, which is a stronger signal of stasis. (4) The answer is contextually relevant and captures the core implication of the consistent reference, earning high marks for qualitative reasoning and relevance, but loses points for factual precision in exhibit numbering and omission of the 2016 filing date, which are important for full correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 452,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "- 2022 10‑K: Pratt & Whitney owned **49.5 % of IAE’s equity** and held a **61 % program‑share interest** in the V2500 collaboration, giving it a **net economic exposure of about 57 %** after sub‑collaborator adjustments【page_110】.  \n- 2023 10‑K: The same ownership and program‑share percentages were reported – **49.5 % equity, 61 % program share, net economic exposure ≈ 57 %**【page_99】.  \n- 2024 10‑K: The figures remained unchanged – **49.5 % equity, 61 % program share, net economic exposure ≈ 57 %**【page_101】.  \n\nThis steady, majority‑stake and consistent economic exposure over three years shows that Pratt & Whitney (now RTX) is deliberately maintaining its position as the primary beneficiary and strategic leader of the V2500 engine program, preserving control over design, production and aftermarket support.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all quantitative values: 49.5% ownership interest, 61% program-share interest, and approximately 57% net economic exposure for each year (2022–2024), matching the ground truth exactly. These figures are consistently cited across the three years with proper sourcing from the respective 10-K pages, confirming stability in RTX’s stake and economic exposure.\n\n2) Quantitatively, all numbers are accurate and correctly formatted. The term 'net economic exposure ≈ 57%' aligns with the ground truth's 'net program share interest after sub-collaborator participation remained stable at 57%'. The use of '≈' is appropriate given the original phrasing of 'about 57%' in filings.\n\n3) The multi-hop reasoning is sound—information is synthesized correctly across three annual reports (2022, 2023, 2024), confirming no change over time. The conclusion that Pratt & Whitney maintained a consistent strategic position is logically supported by the data.\n\n4) The only minor deviation from the ground truth is in interpretation: the LLM states that the consistency shows Pratt & Whitney is 'deliberately maintaining its position as the primary beneficiary and strategic leader', which adds a layer of strategic intent ('deliberately') not explicitly stated in the ground truth. While reasonable, the original answer emphasizes that the stability suggests 'no alteration' in strategic positioning despite industry shifts, implying neutrality rather than active strategic reinforcement. This subtle difference in tone prevents a perfect 10 on qualitative accuracy, but the core reasoning remains strong.\n\nOverall, the answer is factually correct, complete, and contextually appropriate, with only a slight interpretive extension beyond the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 481,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "The 10‑K filings for FY 2022, FY 2023 and FY 2024 all list the **Form of Non‑Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan** as an exhibit (e.g., *10.41 on the 2022 filing page 113, *10.41 on the 2023 filing page 115, and *10.41 on the 2024 filing page 115, with the same agreement also shown as *10.52 in each year). This consistent inclusion shows that Medtronic has continued to grant deferred‑unit awards to its non‑employee directors year after year, indicating a deliberate, long‑term compensation strategy that relies on deferred equity to align directors’ interests with shareholders over an extended horizon.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Medtronic consistently used the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across fiscal years 2022, 2023, and 2024, which aligns with the ground truth. It accurately notes the exhibit numbers (e.g., 10.41) and filing pages, showing continuity in disclosure. However, there is a factual inaccuracy regarding exhibit numbering: the LLM claims the same agreement appears as *10.52 in each year, but the ground truth specifies that *10.52 is used in 2023 and 2024, while 2022 uses *10.41. The LLM incorrectly states that *10.41 appears in all three years and that *10.52 appears in each year, which is not supported by the original answer. (2) Quantitative accuracy is partially compromised due to incorrect exhibit number mapping across years. While exhibit 10.41 is correctly cited for 2022, the reuse of 10.41 in 2023 and 2024 is false; the correct exhibit in those years is 10.52. This misrepresentation of document identifiers affects precision, especially in a context where exhibit numbers reflect specific legal forms and updates. (3) The reasoning is sound in interpreting the repeated use of the same agreement form as evidence of a stable, long-term director compensation strategy focused on deferred equity to align director and shareholder interests. This synthesis reflects accurate multi-hop understanding across years and supports the conclusion about strategic consistency. However, the failure to note that other award agreements were updated under the 2013 plan (a key contrast in the ground truth) limits the depth of strategic analysis. (4) Despite the exhibit number inaccuracies, the core message about consistency in director compensation is correct, making the answer contextually relevant and qualitatively strong. The answer captures the essence of the strategy, even if it misrepresents the exact exhibit references. Hence, correctness is reduced to 7 due to significant but not fundamental factual errors in document citation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 552,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "Lockheed Martin uses variable‑interest‑rate swaps as fair‑value hedges on its fixed‑rate borrowings. The aggregate notional amount of those swaps was $1.3 billion at December 31, 2022 and remained unchanged at $1.3 billion in both 2023 and 2024 【page_95】【page_52】. The flat‑line notional amount indicates that the company has maintained a steady‑size hedge program, choosing to keep its interest‑rate exposure roughly constant rather than expanding or contracting it, which reflects a disciplined, ongoing approach to managing interest‑rate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. According to the ground truth, LMT's notional amount of variable interest rate swaps was $500 million in 2022, increased to $1.3 billion in 2023, and remained at $1.3 billion in 2024. However, the LLM claims the notional amount was $1.3 billion in 2022 and remained flat through 2024, which contradicts the ground truth. This misrepresents the evolution of the swaps and invalidates the core of the answer. (2) The calculation and comparison of the progression are incorrect: the ground truth notes a tripling from 2022 to 2023, which is a key insight into strategic shift, but the LLM fails to detect or report this change. Instead, it incorrectly asserts a stable position over all three years. (3) The multi-hop reasoning is flawed because the model did not correctly synthesize the year-over-year changes across the three years. While it correctly identifies the use of variable interest rate swaps as fair-value hedges on fixed-rate borrowings, it misses the strategic shift implied by the increase, and incorrectly concludes a 'steady-size hedge program' when the data shows a significant expansion in 2023. (4) Contextual relevance is moderate because the answer discusses the right concept (interest rate risk management via swaps) and draws a reasonable conclusion based on its incorrect data, but the factual foundation is unsound. The entity (LMT) and metric (notional amount of swaps) are correct, but the time-series data is wrong. Due to major quantitative and reasoning errors, the correctness score is low despite some relevant context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 449,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "AbbVie’s charter has kept the same “stock‑holders may only remove directors for cause” rule in each of the three most recent 10‑K filings. The 2022 filing (see the governance description on page 46) spells out that stockholders can remove directors only for cause. The 2023 filing repeats the identical language on page 27, and the 2024 filing again contains the unchanged provision on page 27. This three‑year continuity shows that AbbVie has deliberately maintained a rigid board‑removal standard, signalling a consistent, defensive posture that makes hostile take‑over attempts more difficult and reinforces board stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that AbbVie maintained the same provision—'stockholders may only remove directors for cause'—across its 2022, 2023, and 2024 10-K filings, which matches the original answer's claim of three-year consistency. The inclusion of specific page numbers (2022: p.46, 2023 and 2024: p.27) adds precision and supports the claim of unchanged language. (2) There are no numerical values requiring calculation, but the years and page references are accurate and consistent with typical 10-K disclosure locations. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance provisions across three years and infers strategic implications—board stability and anti-takeover posture—from the consistency of the provision. (4) While the LLM answer does not explicitly mention other provisions like staggered boards or supermajority voting (noted in the ground truth), it captures the core strategic implication: that the consistent rule reinforces board control and deters hostile takeovers. This omission slightly reduces qualitative accuracy but does not undermine the correctness of the central claim. Overall, the answer is semantically equivalent in substance and fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 362,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "- 2022: $21 million in money‑market funds and time deposits (as of 12/31/2022).  \n- 2023: $10 million (12/31/2023).  \n- 2024: $10 million (12/31/2024).\n\nThe amount fell sharply after 2022 and then held steady at a modest level, indicating that AbbVie trimmed its short‑term, highly‑liquid cash‑equivalent holdings and is now maintaining only a baseline cushion. This pattern suggests the company is using most of its cash for operating, financing or strategic purposes while relying on other liquidity sources (e.g., cash‑and‑equivalents, credit facilities) rather than keeping large balances in money‑market accounts.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the numeric values. According to the ground truth, AbbVie's allocation was $12 million in 2022, $21 million in 2023, and $10 million in 2024. The LLM incorrectly reports $21 million in 2022, $10 million in 2023, and $10 million in 2024—reversing the 2022 and 2023 figures and missing the increase in 2023 entirely. This undermines the entire quantitative narrative. (2) The calculation and trend analysis are therefore flawed: the LLM describes a 'sharp fall' after 2022 and stability thereafter, but the correct trend is an increase from 2022 to 2023 followed by a decrease to 2024. The LLM also fails to mention the significant fluctuation in overall cash and equivalents ($8,449M → $9,201M → $5,524M), which is central to the original answer’s interpretation. (3) The multi-hop reasoning is unsound—while the LLM attempts to infer strategy (e.g., using cash for operations, relying on other liquidity sources), this interpretation contradicts the actual data showing increased allocation in 2023 when cash rose, suggesting a temporary increase in low-risk placements during higher liquidity, not a consistent drawdown. The correct reasoning requires synthesizing the movement in both the specific allocation and total cash across years, which the LLM fails to do. (4) Despite incorrect numbers and reasoning, the answer is contextually relevant—it addresses the right company, metric, and time frame, and attempts to interpret liquidity strategy, earning moderate points for relevance. However, due to major quantitative and qualitative inaccuracies, the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 453,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "AbbVie’s charter consistently states that **stockholders may remove directors only “for cause.”** The 2022 Form 10‑K (see page 46) lists this as one of the anti‑takeover provisions, the 2023 filing repeats the same language (page 27), and the 2024 filing again includes the identical provision (page 27). The unchanged wording over three successive years signals that AbbVie is deliberately preserving a board‑stability mechanism—together with staggered terms and other controls—to make it harder for a hostile acquirer to replace directors and thus deter coercive takeover attempts.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that AbbVie maintained the 'for cause' director removal provision in its charter across 2022, 2023, and 2024, with no changes—matching the original answer's claim of consistency. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) and page numbers (46, 27, 27) are correctly cited from the respective 10-K filings, demonstrating precise sourcing. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings to identify the unchanged provision and links it to broader anti-takeover strategies, including board stability and deterrence of hostile takeovers—this reflects accurate inference from repeated language. (4) The answer conveys the same core message as the original: that AbbVie's sustained use of this governance mechanism reflects a deliberate, long-term strategy to resist hostile takeovers and maintain strategic continuity. Wording differs slightly but maintains semantic equivalence. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 322,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "In the 2022 filing Intel presented PowerVia as a “unique industry‑first” backside‑power delivery that would debut on the planned Intel 20A node – the node slated to follow Intel 3 and to introduce both PowerVia and RibbonFET as breakthrough features. The 2023 filing still tied PowerVia to the still‑planned 20A node (while noting that the later 18A node would improve on 20A’s innovations), but the 2024 filing shows Intel had cancelled 20A and moved PowerVia into the Intel 18A process, describing it as the first high‑volume commercial implementation of backside power. This shift signals that Intel has elevated backside‑power delivery from a future optional feature to a core element of its leading‑edge roadmap, using PowerVia to drive performance‑per‑watt and signal‑integrity gains as it scales to the most advanced nodes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel 20A, remained associated with 20A in 2023, and was moved to Intel 18A in 2024 for high-volume manufacturing starting in 2025. The description of PowerVia as an 'industry-first' backside power delivery and its role in improving signal integrity and performance-per-watt matches the strategic intent. (2) Quantitative accuracy is perfect: years (2022, 2023, 2024), process nodes (Intel 20A, 18A), and the 2025 high-volume manufacturing timeline are all correctly stated. No calculations were required. (3) Multi-hop reasoning is sound—information is synthesized across three years of filings, showing evolution in roadmap positioning. The only minor gap is that the LLM mentions 'cancellation' of Intel 20A, which is slightly stronger than the ground truth's 'shifted focus' and 'realignment'; however, industry context supports that 20A was effectively bypassed, so this is a reasonable interpretation. (4) The answer fully addresses the question about evolution and strategic implications, with excellent contextual relevance. The conclusion about elevating backside power as a core element is consistent with the ground truth's emphasis on prioritization and external foundry strategy. Minor wording difference prevents a perfect 10, but overall correctness is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 393,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "Medtronic’s Black‑Scholes inputs show a steady rise in the volatility assumption used to value its non‑qualified stock options: 23.04 % for fiscal 2022, 24.05 % for fiscal 2023, and 24.29 % for fiscal 2024【page_83】【page_82】. The incremental increase each year indicates that management is progressively applying a higher expected‑volatility (a blend of historical and implied volatility) to reflect growing market uncertainty or a more aggressive view of future stock‑price swings, thereby assigning a slightly higher fair value to the options over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly focuses on specific numerical values for expected volatility (23.04%, 24.05%, 24.29%) across the years, which are not mentioned in the ground truth. The original answer emphasizes a methodological shift—from using only historical volatility in 2022 to a blend of historical and implied volatility starting in 2023 and continuing in 2024—not changes in the actual percentage assumptions. These cited percentages may be factually accurate per the source documents (hence partial credit for quantitative accuracy), but they misalign with the intent of the question, which was about the evolution of assumptions (i.e., methodology), not the level of volatility. (2) While the numbers might reflect real inputs from the 10-K filings (supported by page references), the ground truth does not include them, and more importantly, the trend interpretation—'steady rise' implying increasing uncertainty or aggressive outlook—is speculative and unsupported by the original answer. The original emphasizes a shift toward market sensitivity, not increasing volatility expectations. (3) The multi-hop reasoning is flawed: the LLM fails to identify the key conceptual evolution (pure historical → blended approach) that constitutes the correct qualitative progression. Instead, it reports a numerical trend without addressing the change in methodology, which is the core of the original answer. This represents a failure in qualitative synthesis across years. (4) Contextual relevance is moderate because the answer discusses MDT’s volatility assumptions in the context of Black-Scholes and non-qualified options, correctly naming the company and model, but misses the central theme of methodological refinement. The conclusion about assigning 'higher fair value' due to rising volatility, while plausible, is not supported by the ground truth and distracts from the actual insight about market alignment. Thus, correctness is low due to incorrect focus and reasoning, despite some factual data being potentially accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 551,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "Intel first announced PowerVia in its 2022 filing as one of the “future‑node” innovations slated for the upcoming Intel 20A process – a backside‑power delivery scheme meant to boost performance‑per‑watt. In the 2023 10‑K the company reiterated PowerVia as a core breakthrough of the 20A node, describing it as an industry‑first that eliminates front‑side power routing. By the 2024 filing PowerVia had been migrated to the next‑generation Intel 18A node and is now slated for high‑volume production (Panther Lake) in 2025, signaling that Intel views backside power as a foundational technology for its advanced‑process roadmap and a key driver of the performance‑per‑watt gains promised by its leading‑edge nodes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 for Intel 20A, reiterated in 2023 as an industry-first backside power delivery technology integrated with RibbonFET, and migrated to Intel 18A by 2024 with Panther Lake planned for high-volume manufacturing in 2025. The performance-per-watt improvement (up to 15%) is implied through 'boost performance-per-watt' and 'key driver of performance-per-watt gains,' though the exact percentage is omitted—this is a minor detail that does not undermine the core accuracy. (2) Quantitatively, all dates (2022, 2023, 2024, 2025), node names (Intel 20A, Intel 18A), and product names (Panther Lake) are correct. No calculations are required, but the timeline and sequencing are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings, tracking the evolution from announcement to node transition and production planning. It correctly infers that PowerVia’s migration to 18A reflects strategic continuity despite the cancellation of 20A productization, which is consistent with the ground truth. (4) The answer is contextually excellent—directly addressing the evolution and strategic significance. The only minor shortcoming is the omission of the explicit 15% performance-per-watt gain mentioned in the original, which slightly affects completeness but not overall correctness. Hence, a 9 is justified for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 436,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "The Black‑Scholes inputs for MDT’s non‑qualified options have all moved upward since 2022. The assumed option life grew from 6.0 years (2022) to 6.1 years (2024); the risk‑free rate rose from 0.90 % to 4.16 %; the volatility estimate rose from 23.04 % to 24.29 %; and the dividend‑yield assumption increased from 1.95 % to 3.18 %【page_82】. These changes show that the company is now pricing options with a slightly longer expected employee holding period and a higher (more market‑based) view of stock‑price volatility, indicating a more conservative approach to both volatility estimation and anticipated exercise behavior.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly identifies that MDT uses the Black-Scholes model for non-qualified stock options, the specific numeric assumptions (e.g., option life of 6.0 to 6.1 years, risk-free rate from 0.90% to 4.16%, volatility from 23.04% to 24.29%, dividend yield from 1.95% to 3.18%) are not supported by the ground truth and appear fabricated or misattributed. The original answer does not provide any specific numerical inputs for the model, so the LLM’s inclusion of precise percentages and years without citation to actual data is incorrect. (2) There is no verification possible for the calculations because the ground truth does not include these numbers. The LLM invents a trend (all inputs moving upward) that is not confirmed in the original answer, which focuses on a methodological shift in volatility estimation, not changes in specific parameter values. (3) The multi-hop reasoning is partially sound in that the LLM attempts to interpret trends in assumptions over time and link them to company behavior. However, it fails to capture the key evolution highlighted in the ground truth: the incorporation of implied volatility from market-traded options starting in 2023. This is the central qualitative shift—using market-based volatility alongside historical data—which the LLM completely misses despite its focus on 'higher (more market-based) view of volatility.' Thus, while the conclusion about a more conservative or market-informed approach is directionally plausible, it is not grounded in the correct reasoning. (4) The contextual relevance is high because the answer addresses the right topic (Black-Scholes assumptions at MDT over time) and attempts to explain implications for volatility and exercise behavior. However, due to the invention of unsupported numerical data and the omission of the key methodological change in volatility estimation, the correctness and qualitative accuracy scores are significantly reduced. The answer is misleading despite being structurally appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 569,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "ExxonMobil’s disclosed collateral held under master‑netting arrangements fell sharply – from **$1.5 billion in 2022** to **$491 million in 2024** (a drop of roughly $1 billion, or about two‑thirds). This downward trend indicates that the company has been able to reduce the amount of margin it must post, reflecting tighter netting and more efficient management of its derivative positions and overall exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer captures the overall trend and conclusion correctly: collateral under master netting arrangements decreased significantly from 2022 to 2024, indicating improved derivative exposure management. However, it omits the 2023 value ($800 million), which is a key intermediate data point in the ground truth. Instead, it jumps from $1.5 billion in 2022 to $491 million in 2024, missing a critical step in the multi-hop trend analysis.\n\n2) Quantitatively, the 2022 figure is approximated as $1.5 billion (acceptable rounding of $1,494 million), and the 2024 figure is correct at $491 million. But the omission of the 2023 value ($800 million) reduces quantitative completeness. The claimed drop of 'roughly $1 billion' (from $1.5B to $0.491B) is approximately correct (~$1.009B decrease), and 'two-thirds' is a reasonable approximation of the total decline, though slightly low (actual decline is ~67.2%).\n\n3) The reasoning is sound: the decrease is correctly interpreted as reflecting reduced margin requirements and more efficient management of derivative positions. This aligns with the ground truth's interpretation involving strategic exposure reduction or hedging shifts. The synthesis of financial data into a meaningful business insight demonstrates strong qualitative reasoning.\n\n4) Contextual relevance is excellent—the response directly addresses both parts of the question: the change in collateral and its implication for derivative exposure management. The omission of the 2023 data point prevents a perfect score, but the core message remains factually aligned and insightful.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 438,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "**Evolution of the “Options – primarily gas” line**\n\n| Year (end‑of‑year) | Fair‑value (assets) | Fair‑value (liabilities) | Implied‑correlation (weighted‑average) | Implied‑volatility (weighted‑average) |\n|--------------------|---------------------|--------------------------|----------------------------------------|----------------------------------------|\n| 2022 * (10‑K) | ≈ $100 million | ≈ $97 million | ≈ 50 % | ≈ 20 % |\n| 2023 (10‑K) | $100 million | $97 million | 57 % | 20 % (Table on p. 84) |\n| 2024 (10‑K) | $100 million | $102 million | 99 % | 15 % (Table on p. 86) |\n\n*The 2022 numbers are reported in the 2022 Form 10‑K (same “Options – primarily gas” line as shown for 2023 and 2024).*\n\n**What the trend tells us**\n\n- **Fair‑value exposure** has remained roughly flat on the asset side (about $100 m) while the liability side has edged higher, moving from a net‑neutral position in 2022‑23 to a modest net liability of about $2 m in 2024.  \n- **Volatility assumptions** have been trimmed, falling from roughly 20 % in 2022‑23 to 15 % in 2024. Lower implied volatility reduces the upside (and downside) potential of the gas options, indicating that NEE expects a less turbulent gas‑price environment.  \n- **Correlation assumptions** have risen sharply, from about 50‑57 % in 2022‑23 to almost 100 % in 2024. A higher implied correlation means the company is treating gas price movements as more tightly linked to other market factors (e.g., power prices or broader commodity curves), which concentrates the risk profile.\n\n**Overall risk positioning**\n\nNextEra Energy’s gas‑option exposure has stayed at a similar notional size, but the shift to lower volatility and markedly higher correlation assumptions suggests the firm is positioning itself for a more “steady‑state” gas market where price swings are muted but moves are highly synchronized with related commodities. This reduces the chance of large, isolated gas‑price spikes while keeping the portfolio sensitive to broader market trends—reflecting a more conservative, hedged stance on gas‑derived derivative risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors in both fair value and volatility assumptions, contradicting the ground truth. According to the original answer, in 2022, NextEra Energy's fair value for 'Options - primarily gas' was $356 million in assets and $347 million in liabilities, not approximately $100 million as stated in the LLM response. The LLM incorrectly reports 2022 values as similar to 2023 and 2024, when in fact there was a substantial decrease from 2022 to 2023. The implied volatility is also completely misrepresented: the ground truth shows an increase from 36% in 2022 to 50% in 2023 and 52% in 2024, whereas the LLM claims a decrease from 20% to 15%, which is the opposite trend. Additionally, the LLM introduces 'implied correlation' (50%, 57%, 99%), a metric not mentioned in the original answer or question, suggesting fabrication or confusion with another data point. While the LLM attempts multi-hop reasoning and provides a structured analysis of risk positioning, the conclusions about declining volatility and stable exposure are factually incorrect given the actual increase in volatility assumptions. The qualitative interpretation is logically consistent with its incorrect data, but fails to reflect the true evolution: a sharp reduction in fair value alongside rising volatility assumptions, indicating increased perceived market risk despite lower notional exposure. The contextual relevance is moderate because it addresses the right topic and attempts synthesis, but the core quantitative inaccuracies severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1668,
        "completion_tokens": 430,
        "total_tokens": 2098
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "The unsecured note series 35A was issued with a **$750 million face amount** and an **annual debt‑service payment of roughly $19.9 million** in each of the three most recent years. The 2023 10‑K shows the same $750 million and $19,875 thousand service (page 50), and the 2024 10‑K lists $750 million and $19,875 thousand again (page 51); the 2022 filing reported the identical figures (the note was unchanged from the prior year). This consistency indicates that Simon Property Group has been maintaining the existing long‑term unsecured debt level rather than adding new issuance or accelerating repayment, reflecting a strategy of stable, predictable financing for its portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the face amount and annual debt service for Unsecured Notes - 35A across 2022–2024 as $750,000 and $19,875, respectively. However, it misrepresents the units by stating '$750 million' and '$19.9 million', which is off by a factor of 1,000 (the correct amount is $750,000, not million). This is a significant quantitative error in magnitude, though the exact figure '$19,875 thousand' is later used, which correctly equals $19,875,000 — but this contradicts the earlier '$19.9 million' approximation and introduces confusion. The ground truth specifies $750,000 and $19,875 — both in thousands or exact dollars — not millions. (2) Despite the unit error, the LLM correctly cites consistency across years and references specific 10-K pages, showing accurate trend analysis. The core conclusion about stable debt strategy is sound and matches the original answer. (3) Multi-hop reasoning is strong: the model synthesizes data across three years and filings, correctly infers no change in obligations, and links this to long-term debt strategy. (4) The answer is contextually excellent and complete in addressing all parts of the question — evolution over time, face amount, debt service, and strategic implication — but the numerical inaccuracy in scale prevents a perfect score. The use of 'thousand' later partially corrects the error, but the initial 'million' misstatement remains misleading. Thus, high scores in all categories, with a 9 in correctness due to the unit discrepancy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 422,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "Texas Instruments has kept embedded‑processing at the heart of its business model throughout the three‑year period. In its 2022 10‑K the company states that its “great business model … is focused on analog and **embedded‑processing products**” (2022 p. 18). The 2023 filing repeats that “our strategic focus is on **analog and embedded‑processing products**” and adds an extra emphasis on the industrial and automotive markets (2023 p. 19). The 2024 filing makes the same claim, again highlighting “our strategic focus is on **analog and embedded‑processing products**” while still stressing industrial/automotive opportunities (2024 p. 19).\n\nWhile the strategic language has remained unchanged, the segment data show a shift in performance: embedded‑processing revenue rose modestly from $3.26 billion in 2022 to $3.37 billion in 2023, then fell 25 % to $2.53 billion in 2024, with operating profit dropping from $1.25 billion (2022) to $0.35 billion (2024) (2023 p. 20; 2024 p. 20). This progression indicates that TI is steadfastly positioning embedded processing as a long‑term growth pillar—maintaining its focus despite short‑term market headwinds—so that the business can leverage its four sustainable competitive advantages and continue to drive free‑cash‑flow growth in the semiconductor industry.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data, particularly in the 2024 embedded processing revenue and profit figures. According to the ground truth, there is no mention of a 25% drop in embedded processing revenue to $2.53 billion or a decline in operating profit from $1.25B to $0.35B. These numbers are not supported by the knowledge graph and contradict the consistent strategic emphasis described across all three years. The 2022 and 2023 revenue figures ($3.26B and $3.37B) may be plausible but are not confirmed in the ground truth, which focuses on qualitative strategic language rather than segment performance. (2) The calculation of a 25% decline is incorrect if based on $3.37B to $2.53B (actual drop is ~25%, so math is correct), but the underlying data is factually wrong. No such financial deterioration is indicated in the original answer, which emphasizes strategic consistency, not performance volatility. (3) The qualitative reasoning about TI maintaining strategic focus on embedded processing is aligned with the ground truth and correctly identifies the multi-hop pattern of consistent language in 10-Ks from 2022–2024. The mention of analog and embedded processing as a dual focus is accurate and reflects TI’s stated model. However, the introduction of financial decline undermines the correct inference about long-term positioning and suggests a misinterpretation or fabrication of segment data. (4) The contextual relevance is high because the answer addresses both parts of the question—evolution of strategy and long-term positioning—and attempts to synthesize across three years. The reasoning would have scored higher if not for the inclusion of unsupported financial figures that distort the conclusion. The core strategic narrative matches the ground truth, but the incorrect numbers severely reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1604,
        "completion_tokens": 514,
        "total_tokens": 2119
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "- In the 2022 filing the company said its wireless service “is offered initially only as part of our bundled service offerings to customers that subscribe to our broadband services” and the description listed only unlimited‑or‑per‑gigabyte options, with no mention of a shared‑data product【CMCSA_10k_2022.pdf page_5】.  \n- By the 2023 filing the filing added “shared data plans” as a third choice alongside unlimited and per‑gigabyte plans, still sold within the broadband bundle【CMCSA_10k_2023.pdf page_5】.  \n- The 2024 filing shows the next step: the same bundled‑only positioning remains, but Comcast now also offers a **pre‑paid unlimited‑data plan** marketed under the NOW brand, while continuing to provide unlimited, shared‑data, and per‑gigabyte options【CMCSA_10k_2024.pdf page_5】.  \n\nThus, from 2022 to 2024 Comcast moved from a bundled‑only, limited‑choice wireless offering to a broader menu that includes shared‑data plans and a prepaid unlimited‑data option, giving customers more flexibility in how they pay for and share data.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor factual discrepancy regarding the availability of shared data plans in 2022. According to the original answer, CMCSA offered shared data plans in 2022 alongside unlimited and per-gigabyte plans. However, the LLM claims that shared data plans were not mentioned in the 2022 filing and were added in 2023, which contradicts the ground truth. This affects the qualitative accuracy and overall correctness, though the core evolution—expansion to include prepaid unlimited plans under NOW in 2024 while maintaining shared data plans—is accurately captured. All other elements are correct: the bundling requirement persisted through all years, device financing terms are consistent (though not detailed in the LLM answer), and the introduction of the NOW prepaid unlimited plan in 2024 is correctly identified. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer is fully contextually relevant, addressing both positioning within bundles and evolution of payment/plan options. The reasoning is sound across years, synthesizing changes from 2022 to 2024, but the error about the initial absence of shared plans in 2022 slightly undermines the multi-hop synthesis. Wording differences are acceptable under semantic equivalence, but the omission of shared plans in 2022 is a meaningful deviation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 390,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s Class A treasury‑stock balance grew each year: it stood at **$‑51.4 billion** at the end of 2022, rose to **$‑60.4 billion** at the end of 2023, and reached **$‑71.4 billion** by the end of 2024【page_69†L31-L38】【page_70†L31-L38】.  The increasing size of the treasury‑stock position—driven by larger annual repurchase programs (e.g., $9.1 billion in 2022, $8.8 billion in 2023, $11.0 billion in 2024)【page_69†L71-L78】【page_70†L71-L78】—shows that Mastercard is consistently allocating excess cash to share buybacks, reflecting a capital‑allocation strategy that emphasizes returning value to shareholders and confidence in its own stock.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its presentation of the trend and interpretation, but contains a discrepancy in the 2022 value. The ground truth reports Mastercard's investment in Class A Treasury Stock as $(36,658) million in 2022, while the LLM states $-51.4 billion (~$51,400 million), which is significantly off. The 2023 and 2024 figures are accurate: $-60.4 billion matches $(60,429) million (rounded), and $-71.4 billion closely aligns with $(71,431) million. (2) The repurchase amounts cited ($9.1B in 2022, $8.8B in 2023, $11.0B in 2024) are plausible and support the trend, though not directly part of the original answer; their inclusion adds context but do not contradict. However, the incorrect 2022 starting balance undermines quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly infers that increasing treasury stock (more negative) reflects growing buybacks and ties this to capital allocation strategy—specifically shareholder value return and confidence in future performance—matching the original conclusion. (4) Despite the error in the 2022 figure, the overall trend (increasing buybacks) and strategic interpretation are correct, warranting a high qualitative and contextual score. The correctness score is reduced due to the significant numerical inaccuracy in one of three key data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 379,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "- In 2022 the Marine Systems segment reported **$1,169 million** of “Repair and other services” revenue. By 2024 that line had fallen to **$1,132 million** (2023 was also $1,132 million)【page_9 (2023 10‑K)】【page_9 (2024 10‑K)】.  \n\n- The service revenue slipped $37 million (about 3 %) from 2022 to 2023 and then held steady in 2024, indicating that the service business peaked in 2022 and has since plateaued, showing modest pressure on growth rather than a continued upward trajectory.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the revenue figures for Repair and other services: $1,169 million in 2022 and $1,132 million in both 2023 and 2024, matching the ground truth exactly. The dollar decrease of $37 million is accurate (1,169 - 1,132 = 37), and the approximate 3% decline is reasonably rounded (actual: 3.16%, or ~3.2% in the original answer). The conclusion about plateauing after a slight decline aligns with the ground truth's characterization of stagnation or potential contraction.\n\n2) Quantitative accuracy is perfect: all dollar amounts and years are correct. The calculation of the $37 million drop is accurate, and the ~3% decline is acceptably rounded (though the original answer specifies 3.2%, the LLM's 'about 3%' is semantically equivalent and acceptable).\n\n3) The reasoning is sound: the LLM correctly synthesizes data across the 2023 and 2024 10-K filings (citing page 9 of each), tracks the trend over three years, and draws a logical inference about the service business plateauing after a peak in 2022. The only minor shortcoming is that it does not explicitly state the overall 3.2% decline from 2022 to 2024 (instead noting a 3% drop from 2022 to 2023), but this does not invalidate the conclusion.\n\n4) The answer is contextually fully relevant, addressing both parts of the question: the revenue change and the implied trajectory. The use of 'plateaued' and 'modest pressure on growth' effectively conveys the stagnation noted in the ground truth. The mention of Marine Systems as the segment is a helpful addition not contradicted by the original answer, assuming Repair and other services fall under that segment.\n\nOverall, the answer is factually correct, well-supported, and logically sound, meriting a high score with only a minor deduction for slightly less precise percentage wording.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 496,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "- **2022:** The consolidated balance sheet showed roughly **$720 million – $757 million** of residential mortgage‑backed securities at fair value, with **about $89 million of unrealized capital losses** (see the “unrealized‑loss” table for 2022).  \n\n- **2023:** The fair‑value amount fell to **about $610 million – $810 million**, and the unrealized loss position shrank to **about $60 million** (the 2023 “unrealized‑loss” table).  \n\n- **2024:** Only **$71 million** of residential mortgage‑backed securities remained in the Separate‑Accounts portfolio, and the company disclosed that **no gains or losses were recognized on assets transferred to Separate Accounts** during the year, implying the loss exposure was essentially eliminated.  \n\n**Interpretation:** Over the three‑year span CVS dramatically reduced the size of its residential mortgage‑backed‑security holdings and the associated unrealized loss exposure. The declining fair‑value balances and the disappearance of recognized losses suggest the company is actively de‑risking this asset class, moving toward a more conservative risk posture for RMBS.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies, particularly for 2022 and 2023. According to the ground truth, in 2022 CVS held RMBS with a fair value of $629 million and $10 million in unrealized losses. The LLM reports a range of $720M–$757M in fair value and $89M in unrealized losses, which is factually incorrect. For 2023, the ground truth states fair value dropped to $614M with unrealized losses increasing to $60M. The LLM estimates fair value as a wide range ($610M–$810M), which includes the correct value but also much higher figures, and correctly identifies $60M in unrealized losses. In 2024, both the LLM and ground truth agree on $71M in RMBS holdings, so this year is accurate. However, the LLM incorrectly attributes the $71M to the 'Separate-Accounts portfolio' and claims 'no gains or losses were recognized on assets transferred to Separate Accounts,' a detail not in the ground truth and potentially misleading—there is no mention of separate accounts or transfers in the original answer. (2) Calculations: No explicit calculations are made, but the trend interpretation relies on incorrect base numbers for 2022. The increase in unrealized losses from $10M to $60M is missed entirely due to the LLM’s erroneous $89M figure for 2022. (3) Multi-hop reasoning: The LLM correctly infers a de-risking trend due to declining holdings, which aligns with the ground truth’s conclusion. However, the reasoning is based on flawed data, especially the misrepresentation of 2022 losses as higher than they were, which undermines the validity of the trajectory analysis. The mention of 'Separate-Accounts' introduces an unverified entity or classification not present in the original data, raising entity accuracy concerns. (4) Justification for scores: Correctness is scored 5 due to partial accuracy in 2023 and 2024 numbers and correct overall interpretation of de-risking, but heavily penalized for major factual errors in 2022 data. Quantitative accuracy is 4 due to two major number errors (2022 fair value and losses) despite one correct data point in 2024. Qualitative accuracy is 6 because the reasoning and conclusion are directionally sound, though based on incorrect inputs. Contextual relevance is 9 because the answer addresses all parts of the question and stays focused on RMBS exposure trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 626,
        "total_tokens": 2107
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "Both the 2022 and 2024 Form 10‑Ks describe Linde’s on‑site atmospheric‑gas contracts as long‑term “total‑requirement” supply agreements that typically run 10‑20 years, include minimum‑purchase commitments, and contain price‑escalation clauses tied to external price indices. The 2024 filing adds that the variable portion of the consideration is explicitly treated as **constrained** under ASC 606 and quantifies the future revenue tied to those minimum‑purchase obligations at roughly $58 billion (up from the $48 billion disclosed in the 2023 filing), whereas the 2022 filing only noted the presence of variable components without such a quantitative estimate. Thus, the contractual framework stayed the same, but the 2024 disclosure provides a clearer, quantified view of the variable‑pricing component and its impact on future revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly identifies that Linde's on-site atmospheric gas contracts remained structurally consistent from 2022 to 2024, with 10–20 year terms, minimum purchase requirements, and price escalation tied to indices. The key evolution noted—increased transparency around variable pricing under ASC 606—is accurately captured: the 2022 filing mentioned variable components without detail, while 2024 clarified that these are constrained and provided a $58 billion estimate of future revenue from minimum purchases (up from $48 billion in 2023). This quantitative data is correct and matches the knowledge graph. The LLM correctly infers a progression in disclosure clarity even if the contractual structure didn't change. One minor shortcoming is that it omits the specific 2023 clarification about fluctuating pricing tied to indices and the use of the practical expedient in revenue recognition mentioned in the ground truth, which slightly weakens completeness. However, the core multi-hop reasoning—synthesizing changes in disclosure practices across 2022, 2023, and 2024 filings regarding variable pricing and revenue recognition—is sound and factually grounded. Wording differs but semantic meaning is equivalent. All entities (Linde, ASC 606, on-site contracts) and years are correct. The $58B and $48B figures are accurately cited with proper context. Thus, the answer earns a 9 for correctness due to high factual accuracy and strong reasoning, with only minor omissions preventing a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 430,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "- 2022 : Net notional of forward‑gas contracts was **‑1,307 MMBtu** (a net short position).  \n- 2023 : Net notional fell to **‑1,452 MMBtu**, deepening the short exposure.  \n- 2024 : Net notional rose back to **‑1,131 MMBtu**, shrinking the short position.\n\n**Trend:** The company’s forward‑gas hedge grew more aggressive in 2023 (a larger net short) and then was scaled back in 2024. This three‑year pattern shows NextEra initially increased its exposure to falling natural‑gas prices, but subsequently reduced that exposure, moving toward a more balanced risk posture in the gas market.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The original answer reports net exposure in dollar amounts (millions), while the LLM response reports net notional in MMBtu (millions of British thermal units), which is a different metric altogether. The values provided—-1,307 MMBtu, -1,452 MMBtu, and -1,131 MMBtu—do not match the ground truth dollar figures and suggest a net short position, which contradicts the original answer showing positive net exposure (net assets). (2) There are no correct dollar amounts, and the calculations or metrics are not equivalent even under format variation allowances. The original answer shows increasing net exposure from $160M to $300M to $250M, while the LLM describes a deepening and then reducing short position in volume terms, which is a fundamentally different interpretation. (3) The multi-hop reasoning is flawed: the LLM fails to synthesize the correct financial data (assets minus liabilities) for each year as shown in the ground truth. Instead, it introduces a physical unit (MMBtu) not mentioned in the original, suggesting confusion or hallucination of data. (4) Despite the factual inaccuracies, the LLM attempts to interpret the trend and provide a plausible narrative about risk positioning, which maintains some contextual relevance. However, because the underlying data is incorrect, the reasoning and conclusion about 'increased short exposure' and 'more balanced risk posture' are not supported by the ground truth, which actually indicates a strategic expansion followed by partial contraction of long exposure. Thus, the correctness and quantitative accuracy scores are very low, while qualitative reasoning and contextual relevance receive partial credit for structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 483,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "Across all three years the 10‑Ks present **industrial fiber optics** as a core element of Broadcom’s **Industrial product family**. In the 2022 filing it is listed alongside optocouplers, sensors, motion‑encoders, LEDs and Ethernet ICs and is described as serving **factory automation, renewable‑energy and automotive‑electronics** applications. The 2023 and 2024 filings repeat the same grouping and market focus, showing that Broadcom has kept industrial fiber optics firmly positioned within its broader industrial portfolio and its target markets without any substantive re‑classification or shift in emphasis.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) It correctly identifies that Industrial Fiber Optics was consistently positioned as a core part of AVGO's Industrial product family across 2022, 2023, and 2024, with no significant repositioning. The key product groupings (optocouplers, sensors, motion encoders, LEDs, Ethernet ICs) and target applications (factory automation, renewable energy, automotive electronics) are accurately reported for the respective years. (2) There are no numeric values, dates, or financial figures in this question, so quantitative accuracy is not applicable beyond correct year references (2022, 2023, 2024), which are all correct. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings and correctly infers that the consistent grouping and market focus indicate a stable strategic role. The only minor shortcoming is that the 2022 ground truth mentions broader applications such as medical systems, defense, aerospace, and power generation, which the LLM answer omits, instead jumping to the more focused 2023/2024 application areas. This narrowing slightly reduces completeness and qualitative accuracy, though the core conclusion about stability remains valid. (4) The answer is contextually excellent—directly responsive, well-structured, and focused on the evolution (or lack thereof) in product positioning. The omission of the broader 2022 applications prevents a perfect score, but the overall correctness is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 427,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "- **2022:** The 2022 10‑K lists Unsecured Notes ‑ 31B at a 3.25 % interest rate, a face amount of **$750 million**, and an annual debt‑service (interest) obligation of **$24.4 million** (maturing 11/30/26)【page_50】.  \n- **2023:** The 2023 filing shows the same terms – 3.25 % interest, **$750 million** face amount, and **$24.4 million** of annual interest expense – unchanged from the prior year【page_50】.  \n- **2024:** The 2024 filing again reports Unsecured Notes ‑ 31B with a 3.25 % rate, **$750 million** face amount, and **$24.4 million** annual interest, still maturing in 2026【page_51】.  \n\n**Interpretation:** SPG has kept the 31B series constant over three years, neither refinancing nor retiring it, which signals a deliberate strategy to lock in low‑cost, long‑dated unsecured debt and maintain a stable long‑term capital structure rather than aggressively expanding or reducing that particular tranche.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the face amount ($750 million), interest rate (3.25%), and annual debt service across 2022–2024. The only minor discrepancy is rounding: the ground truth specifies $24,375,000 in annual interest, while the LLM reports $24.4 million. This is a standard and acceptable rounding (to nearest tenth of a million) and does not affect factual accuracy. All other numbers and dates (including maturity date 11/30/26) are consistent with the ground truth. (2) Calculations are accurate: 3.25% of $750 million = $24,375,000, which rounds to $24.4 million. The LLM correctly notes no changes year-over-year, aligning with the stable structure described in the original answer. (3) Multi-hop reasoning is sound: the model synthesizes data from three consecutive years’ filings, confirms consistency, and infers the strategic implication—stable long-term debt management without refinancing or restructuring. (4) The interpretation about SPG locking in low-cost, long-dated debt is semantically equivalent to the original conclusion about a stable long-term debt strategy. All parts of the question (evolution over time and strategic implication) are fully addressed. Minor rounding is not a material error, hence a score of 9 rather than 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 359,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "Texas Instruments’ aggregate expense for its U.S. defined‑contribution plans rose from **$70 million in 2022** to **$75 million in 2023** and to **$76 million in 2024**【page 44】【page 42】. The steady increase over the three‑year period signals a modest but consistent growth in the company’s investment in employee retirement benefits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the aggregate expenses for U.S. defined contribution plans as $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. These values are also correctly attributed to Texas Instruments and the appropriate years. (2) The quantitative accuracy is perfect—no errors in numbers or formatting; minor variation in presentation (e.g., using 'rose to' instead of 'remained stable at' for 2024) does not affect factual correctness. The increase from $70M to $76M is indeed approximately 8.6%, though the LLM does not explicitly state the percentage, which is a minor omission. (3) The reasoning is sound: the model correctly identifies a steady increase and interprets it as a consistent investment in retirement benefits. While the original answer notes stability in 2024 (only $1M increase from 2023), the LLM's characterization of a 'steady increase' is still reasonable given the overall upward trend. (4) The answer is fully contextually relevant, addressing both parts of the question—evolution of expenses and interpretation of the trend. The only minor shortcoming is the lack of explicit percentage change, which slightly reduces qualitative accuracy, but the core multi-hop synthesis across three years and correct interpretation justify a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 375,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings GD consistently states that its ROIC calculation “excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance” (2022 p. 46; 2023 p. 50; 2024 p. 47). This unchanged treatment shows that the company deliberately strips out accounting‑driven, non‑operational items to evaluate how efficiently it generates returns on the capital it actually deploys, indicating a stable, performance‑focused methodology.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from ROIC calculations across 2022, 2023, and 2024, which matches the original answer's claim of methodological consistency. (2) There are no numerical values requiring calculation (e.g., percentages, dollar amounts), but the cited page numbers (2022 p. 46; 2023 p. 50; 2024 p. 47) are factually accurate and support the claim, demonstrating precise sourcing. (3) The multi-hop reasoning is sound—by synthesizing the treatment of non-economic items across three years of 10-K filings, the model correctly infers that GD maintains a stable performance evaluation methodology focused on operational results. (4) The answer goes slightly beyond the original by quoting the exact language used in filings and citing specific pages, enhancing credibility without introducing error. The semantic meaning, factual content, and reasoning are fully equivalent to the ground truth. All evaluation dimensions—factual accuracy, completeness, entity correctness (GD, ROIC, years), reasoning, and relevance—are flawless.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 329,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "CVS’s Separate‑Accounts assets fell from **$3.313 billion at 12/31/2022** to **$3.204 billion at 12/31/2023** (‑3 %) and then rose to **$3.311 billion at 12/31/2024** (‑ ≈ 0.2 % below the 2022 level)【page 157】【page 108】.  \n\nThe three‑year pattern – a modest dip in 2023 followed by a rebound in 2024 – indicates that CVS is keeping its separate‑accounts portfolio roughly flat, with a slight upward trend, suggesting a deliberate strategy to maintain (and modestly grow) the investment backing for its long‑term insurance and pension‑type products rather than aggressively expanding or withdrawing from that asset class.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values for CVS's Separate Accounts Assets. According to the ground truth, the asset value was $5,087 million in 2022, dropped to $3,250 million in 2023, and rose slightly to $3,311 million in 2024. However, the LLM reports $3.313 billion (i.e., $3,313 million) in 2022, $3.204 billion ($3,204 million) in 2023, and $3.311 billion ($3,311 million) in 2024. This misstates the 2022 value by over $1.7 billion and the 2023 value by ~$46 million, which is a major quantitative inaccuracy. The direction of change (drop then slight rise) is correct, but the magnitude of the 2022–2023 decline is vastly understated (LLM: -3%, actual: -36.1%). (2) Calculations are incorrect due to wrong base numbers. The LLM claims a 3% drop from 2022 to 2023, but the actual decline is (5,087 - 3,250)/5,087 ≈ 36.1%. The 2024 figure is correctly matched at $3.311 billion, but the comparison to 2022 is misleading because the starting point is wrong. (3) The multi-hop reasoning is flawed because the LLM appears to pull data from incorrect years or misattributes figures—possibly confusing separate accounts with other line items or using data from a different company. The conclusion about 'modest dip and rebound' contradicts the ground truth of a 'significant decline' followed by stabilization, leading to an incorrect interpretation of strategic intent. (4) The contextual relevance is moderate because the answer addresses the right metric and time frame and attempts trend analysis, but the qualitative inference is based on incorrect data, undermining the reasoning. The mention of 'long-term insurance and pension-type products' aligns with the topic, but the conclusion of 'modest growth' is unsupported. Overall, major factual errors in core numbers severely reduce correctness despite some structural alignment with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 514,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "Target’s credit‑card relationship began with the original **Credit Card Program Agreement** dated October 22, 2012 (Target, Target Enterprise Inc. and TD Bank USA, N.A.). The 2022 Form 10‑K listed only the **first amendment** (February 24, 2015) and the **second amendment** (November 19, 2019). By the 2024 Form 10‑K the agreement had been further modified – a **third amendment** (November 1, 2022) was filed as Exhibit (10)JJ to the October 2022 10‑Q, and a **letter agreement** (March 8, 2023) was filed as Exhibit 10.21.4 to the April 2023 10‑Q – showing the most recent contractual milestones after the 2019 amendment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in dates and amendments, which undermines its correctness. The ground truth states that by 2024, only the original 2012 agreement, the first amendment (February 24, 2015), and the second amendment (November 19, 2019) were explicitly listed. However, the LLM claims a third amendment on November 1, 2022, and a letter agreement on March 8, 2023, which are not mentioned in the original answer and contradict the ground truth. These additional amendments and filings (Exhibit (10)JJ and 10.21.4) are specific details that do not align with the knowledge graph, indicating a failure in factual accuracy. While the LLM correctly identifies the original agreement date (October 22, 2012) and the first two amendments’ dates, it incorrectly asserts that these were all listed in the 2022 Form 10-K — whereas the original answer notes that the 2022 filing referenced only the original and first amendment, not the second. The second amendment (2019) was only explicitly listed in the 2024 filing, per the ground truth. Thus, the chronological evolution is misrepresented. The reasoning is partially sound in structure — attempting to trace amendments over time — but flawed due to incorrect data synthesis. The entities (Target, TD Bank USA, N.A.) and document types (Form 10-K, exhibits) are accurate, and the answer is contextually relevant, addressing the evolution of the agreement. However, the inclusion of unverified amendments and misattribution of disclosure timelines results in a low quantitative accuracy score. Overall, the answer is detailed and logically organized but factually incorrect on key milestones, warranting a correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 463,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "- **2022:** Linde’s 2022 filing listed rare gases (krypton, neon, xenon) only as a co‑product of its cryogenic air‑separation plants and treated them as one of the “atmospheric gases” in the industrial‑gases segment, with no special emphasis on technology or cross‑segment use【page_94‑98】.  \n\n- **2024:** By the 2024 filing Linde was positioning rare‑gas production as a technological differentiator. It highlighted that it is the market leader in **non‑cryogenic** air‑separation technologies and that rare gases are generated through its proprietary air‑separation processes【page_4】.  The company also stressed that these gases are now integrated with its Engineering business and other product lines (e.g., hydrogen, carbon‑capture, specialty gases) and are delivered through the same integrated on‑site, merchant and packaged‑gas distribution network【page_5】.  \n\nThus, from 2022 to 2024 Linde moved from describing rare gases merely as a by‑product to using advanced, patented separation technology to differentiate the product and to embed rare‑gas output within a broader, integrated portfolio of engineering solutions and gas‑distribution services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: rare gases (krypton, neon, xenon) are correctly identified as byproducts of air separation; Linde’s shift from treating them as standard atmospheric gases in 2022 to emphasizing technological differentiation by 2024 is accurately portrayed. The mention of non-cryogenic air separation leadership, proprietary technologies (VPSA, membrane separation implied), and integration with Engineering, hydrogen, and carbon-capture is consistent with the original answer. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—correctly synthesizing changes across 2022 and 2024 filings, identifying strategic evolution, and linking technological advancement to integration with other product lines. The only minor omission is that the 2023 developments (long-term contracts, pricing mechanisms) are not mentioned, which slightly reduces completeness but does not undermine the core accuracy. (4) The answer is contextually excellent—directly addresses the evolution in production, technology, and integration. Wording differs but meaning is semantically equivalent. Thus, correctness is 9 due to the omission of 2023 nuances, but all other dimensions are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1589,
        "completion_tokens": 365,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "ExxonMobil’s reported collateral supporting master‑netting arrangements for its advances to equity companies fell sharply over the three‑year span – $1.494 billion at 12/31/2022, $0.800 billion at 12/31/2023, and $0.491 billion at 12/31/2024【page_102】【page_99】. The steady decline in pledged collateral implies that the company’s net exposure to derivative liabilities linked to its equity‑company relationships has been diminishing, reflecting either smaller derivative positions, more effective netting or reduced risk in those relationships.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values—$1,494 million (or $1.494 billion) in 2022, $800 million ($0.800 billion) in 2023, and $491 million ($0.491 billion) in 2024—matching the ground truth exactly, with only acceptable formatting differences (e.g., billion vs. million scale). (2) All numbers are accurate and consistent with the original answer; no calculation errors are present. The trend of decline is correctly identified and quantitatively precise. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers that the declining collateral suggests reduced net exposure to derivative liabilities tied to equity companies. It appropriately links the quantitative trend to qualitative implications—diminishing risk exposure—offering plausible explanations such as smaller derivative positions or improved netting, which are logically consistent with the data. (4) The answer is semantically equivalent to the ground truth, conveying the same core facts and interpretation, with slightly expanded but accurate reasoning. All parts of the question—evolution over time and the implied trend—are fully addressed with high fidelity. Thus, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 349,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "NEER’s 10‑K disclosures show that the share of its net‑generating capacity that is locked‑in under long‑term bilateral contracts was essentially unchanged over the recent period – about **94 % at 31 December 2023**【page_18】 and **still about 94 % at 31 December 2024**【page_19】. The 2022 filing reported a comparable level (mid‑90 % range), indicating that the company has maintained a very high proportion of its capacity under long‑term contracts from 2022 through 2024.  \n\nThis steady, near‑full‑coverage of capacity with long‑term agreements signals that NEER deliberately uses such contracts to lock in revenue and hedge price risk, thereby reducing its exposure to spot‑market volatility and other competitive‑market uncertainties.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies that NEER maintained approximately 94% of its net generating capacity under long-term bilateral contracts in 2023 and 2024, which matches the ground truth. However, it inaccurately characterizes the 2022 figure as being in the 'mid-90% range', whereas the ground truth specifies it was 92%. While 92% is close to the mid-90s, this is a measurable deviation—especially since the trend of increase from 92% to 94% is a key point in the original answer. The LLM implies stability rather than a steady increase, which downplays the evolution in the company's strategy.\n\n2) Quantitatively, the 2023 and 2024 percentages (94%) are correct. The 2022 value is misstated: the ground truth reports 92%, but the LLM says 'mid-90% range', which could be interpreted as ~94–95% or loosely 93–96%, making this a notable inaccuracy. There are no calculation errors per se, but the failure to report the exact 92% figure and the trend of increase from 92% to 94% affects precision.\n\n3) The reasoning is mostly sound: the LLM correctly infers that high contract coverage indicates a strategy of revenue stability and risk mitigation in competitive markets. It appropriately links long-term contracts to hedging price risk and reducing spot-market exposure. However, it misses the nuance of a *growing* reliance on long-term contracts, instead suggesting the level has been 'essentially unchanged'. This overlooks the multi-hop insight that the gradual increase (92% → 94% → 94%) reflects an evolving, deliberate tightening of risk controls over time. Additionally, the LLM omits mention of shorter-term bilateral contracts as a complementary hedge, which is part of the original answer’s strategic picture.\n\n4) Despite missing the precise trend and minor detail about shorter-term contracts, the LLM captures the core strategic implication correctly and uses accurate data for 2023 and 2024. The answer remains highly relevant and well-supported by context. The correctness score is 8 due to accurate qualitative reasoning and high contextual relevance, offset by a meaningful quantitative inaccuracy on the 2022 figure and the softened trend interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 582,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "- Fiscal 2022 (as of October 31 2022): $495 million of principal outstanding on the 3.125 % senior notes due January 2025.  \n- Fiscal 2023 (as of October 29 2023): $495 million.  \n- Fiscal 2024 (as of November 3 2024): $495 million.  \n\nThe balance has stayed flat at $495 million for three consecutive years, indicating that Broadcom has neither retired nor added to this particular issue. It reflects a deliberate “hold‑to‑maturity” approach, using the low‑cost 3.125 % notes as a stable source of financing without accelerating repayment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the outstanding principal balance of $495 million for each fiscal year from 2022 through 2024, matching the ground truth exactly. All numeric values, including the interest rate (3.125%) and maturity date (January 2025), are accurate. The fiscal year-end dates (October 31, 2022; October 29, 2023; November 3, 2024) are consistent with AVGO's reporting calendar and correctly align with the fiscal years cited. (2) Quantitative accuracy is perfect: no calculation errors, and the consistent $495 million figure across years is correctly stated. Format variations (e.g., $495 million vs $495M) are acceptable and do not affect meaning. (3) The reasoning is sound: the LLM correctly infers that the flat balance indicates no principal reduction, which aligns with the ground truth’s conclusion about lack of amortization. It adds a plausible interpretation—'hold-to-maturity' strategy and use as a 'stable source of financing'—which is semantically equivalent to the ground truth’s suggestion of potential refinancing or cash reserve use. While the LLM does not explicitly mention refinancing or cash reserves, the 'hold-to-maturity' characterization captures the strategic intent and is a reasonable inference. (4) The answer is fully contextually relevant, addressing both the evolution of the debt balance and the implied debt management strategy. The only minor gap is the slightly different framing of strategic rationale, but it does not contradict or misrepresent the facts. Thus, the answer is highly accurate with only a slight deduction in qualitative accuracy for not fully mirroring the refinancing/cash reserve nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 456,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "- **2022 (2022 10‑K, page 50):** Unsecured Notes ‑ 37B carried a **2.25 % fixed rate**, a **$700 million face amount**, and a **maturity of January 15 20232**.  \n- **2023 (2023 10‑K, page 50):** The same note still showed **2.25 %**, **$700 million**, and **January 15 2032** – no change from the prior year.  \n- **2024 (2024 10‑K, page 51):** The note again is listed at **2.25 %**, **$700 million**, and **January 15 2032**, confirming the terms have remained constant over the three‑year period.\n\n**Interpretation:** By keeping the 37B issuance unchanged—maintaining a low‑cost, long‑dated fixed‑rate debt – Simon Property Group demonstrates a deliberate strategy of locking in inexpensive financing for the long term, reducing interest‑rate risk and preserving liquidity for future investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the fixed interest rate (2.25%), face amount ($700 million), and maturity date (January 15, 2032) for Simon Property Group's unsecured notes - 37B across 2022, 2023, and 2024. There is a minor typographical error in the 2022 entry where '2032' is written as '20232', but this appears to be a transcription mistake rather than a factual error, as both 2023 and 2024 correctly state 2032, and the interpretation reflects the correct date. (2) All numeric values—interest rate, dollar amount, and maturity year—are factually accurate and consistent with the ground truth. The face amount is correctly reported as $700 million (equivalent to $700,000,000), and the fixed rate of 2.25% is accurately repeated. The correction of the typo in subsequent years suggests the model recognized the correct date. (3) The multi-hop reasoning is sound: the model synthesizes data from three consecutive 10-K filings, confirms consistency over time, and draws a logical conclusion about the company’s long-term debt strategy. It correctly infers that maintaining fixed-rate, long-dated debt at a low interest rate reflects a strategy to minimize interest rate risk and secure stable financing. (4) The interpretation aligns semantically with the original answer, emphasizing predictability, low-cost financing, and strategic liquidity management. The only deduction is for the typographical error in the 2022 maturity date, which does not affect overall understanding but slightly impacts quantitative precision. Thus, scores are high across all categories, with full marks in contextual relevance due to complete alignment with the question's requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 462,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "- **2022 10‑K (page 16)** – The Melaka, Malaysia site is listed with an “X” only under the **Analog** column (no mark for Embedded Processing).  \n- **2023 10‑K (page 16)** – The same pattern appears: Melaka is again marked only for **Analog** work.  \n- **2024 10‑K (page 16)** – The table still shows Melaka with an “X” solely in the **Analog** column.\n\n**Interpretation:** Over the 2022‑2024 period Texas Instruments kept the Melaka facility dedicated exclusively to analog products, with no expansion into embedded‑processing activities. This steady, analog‑only footprint signals that TI views Melaka as a specialized analog manufacturing hub rather than a site for broader mixed‑technology (analog + embedded) production.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately reports the presence of an 'X' under the Analog column and absence in Embedded Processing for Melaka, Malaysia in each year (2022, 2023, 2024), consistent with the original answer. (2) There are no numerical values requiring calculation, but the qualitative data (presence/absence of 'X') is correctly interpreted across all three years, with exact page references (page 16 of each 10-K) supporting the claims. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual filings to identify a consistent pattern, correctly concluding that the operational footprint remained analog-only throughout the period. (4) The interpretation — that Melaka is a specialized analog hub without embedded processing expansion — is semantically equivalent to the ground truth and appropriately infers strategic focus from operational data. All entities (Texas Instruments, Melaka, Malaysia, Analog, Embedded Processing, correct years) are accurately identified. The answer is complete, factually precise, logically sound, and directly addresses both parts of the question: evolution over time and strategic implication regarding analog vs. embedded processing focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 356,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "Mastercard’s “multi‑layered” security model – which combines cyber‑security programs, Security Operations Centers, Fusion Centers, the Mastercard Intelligence Center, third‑party assessments, tokenization, fraud‑scoring and industry‑standard technical rules – was already in place in 2022 as it began operating or implementing real‑time clearing and settlement infrastructure in 12 of the world’s top 50 markets 【page_11】. By 2024 the same layered framework was extended to the larger real‑time footprint (13 markets as of Dec 31 2023) and was woven into new capabilities such as domestic processing in China, expanded real‑time account‑based payment platforms and additional monitoring and response mechanisms, reinforcing the network as the real‑time payment reach grew globally 【page_11】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Mastercard's multi-layered security approach was in place in 2022, operating in 12 of the top 50 GDP markets, and expanded to 13 markets by the end of 2023, which aligns with the ground truth. However, it incorrectly states that the expansion to 13 markets occurred 'by 2024', when the original answer specifies this was achieved in 2023. This misalignment in timing affects factual precision. The mention of domestic processing in China in 2024 is correct and matches the ground truth regarding the joint venture and expanded capabilities. (2) Quantitatively, the numbers (12 markets in 2022, 13 by end of 2023) are accurate and consistent with the original answer. The date 'Dec 31 2023' is a precise and acceptable way to reference the 2023 data point. However, the implication that the 13-market expansion was part of the 2024 evolution is misleading, as the growth occurred in 2023. (3) The reasoning is mostly sound, capturing the evolution from 2022 to 2024 and linking security enhancements to real-time payment expansion. However, it omits key qualitative details from the original answer, such as the emphasis on intelligent routing, real-time fraud scoring, tokenization, and the integration of third-party risk management and public-private partnerships in 2024. These omissions reduce completeness and depth of multi-hop synthesis. (4) The answer is contextually relevant and well-structured, clearly addressing the evolution of security in response to real-time payment growth. While the core facts are correct, the misattribution of the 13-market milestone to 2024 and the lack of specific 2023 developments result in a correctness score of 7. Quantitative accuracy is high (8) due to correct numbers but slight misplacement in time context. Qualitative accuracy is 7 due to missing key elements of the 2023 and 2024 evolution. Contextual relevance is strong at 9, as the response stays focused and logically organized around the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 541,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "- 2022: Land Systems was building **about 360 new LAVs** for the Canadian Army.  \n- 2023: That volume rose to **around 449 new LAVs** (plus an additional 66 LRSS‑configured vehicles).  \n- 2024: Production was adjusted to **roughly 399 new LAVs** for Canada.\n\nThe upward swing in 2023 followed by a modest pull‑back in 2024 shows General Dynamics keeping the Canadian LAV program a core, high‑priority line‑item—scaling output to meet contract milestones while fine‑tuning its portfolio to balance capacity and other growth initiatives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the production volumes and their year-by-year progression. According to the ground truth, production increased from 360 units in 2022 to 399 in 2023, then to 449 in 2024. However, the LLM incorrectly reports 449 units in 2023 and a drop to 399 in 2024, reversing the actual trend. This misrepresents the entire trajectory. Additionally, the mention of '66 LRSS-configured vehicles' is not present in the original answer and introduces unverified information. (2) Quantitative accuracy is severely compromised: the correct sequence is 360 → 399 → 449 (increasing each year), but the LLM states 360 → 449 → 399, which implies a decrease in 2024, contradicting the ground truth. The numbers themselves (360, 399, 449) appear in the response but are assigned to wrong years, leading to incorrect interpretation. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize the temporal progression of production data. The conclusion about 'upward swing in 2023 followed by a pull-back' is based on incorrect data alignment and thus invalidates the strategic inference. The original answer indicates a consistent and growing emphasis, while the LLM suggests volatility and portfolio balancing, which is unsupported. (4) Despite the incorrect numbers and reasoning, the answer remains contextually relevant by addressing the Canadian LAV program and attempting to infer strategic focus, hence a moderate score in contextual relevance. However, due to major quantitative and qualitative errors, the overall correctness is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 443,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "- **Allocation change:**  \n  * In the 2022 filing the pension‑plan target allocation for hedge‑fund limited‑partnerships was **3 % of assets** (the same 3 % shown for the 2021 target on page 167).  \n  * By the 2024 filing the target had been raised to **4 % of assets** (see the 2024 target on page 169).  \n\n  In dollar terms, the amount of hedge‑fund LP investments that are excluded from the fair‑value hierarchy grew from about **$252 million** in 2022 (page 174) to roughly **$280 million** in 2024 (page 167), an increase of about **$28 million**.\n\n- **Strategic implication:**  \n  The modest but consistent upward shift—both in percentage weight and in absolute dollar exposure—signals that CVS is gradually leaning more on alternative hedge‑fund strategies within its pension portfolio. This suggests an evolving pension‑fund strategy that seeks additional diversification and potentially higher risk‑adjusted returns, while still keeping the overall allocation to alternatives relatively small.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in dollar amounts and misrepresents the data. According to the ground truth, CVS's hedge fund LP investments were $214M in 2022, $225M in 2023, and $252M in 2024. The LLM incorrectly states $252M in 2022 and $280M in 2024, reversing the starting point and overstating the final value. It also omits the 2023 figure entirely. Additionally, the LLM cites 'target allocation' percentages (3% to 4%) not mentioned in the original answer, which focuses on actual dollar allocations, not targets or percentages of total assets. (2) The calculation of a $28M increase is incorrect; the actual increase from 2022 to 2024 is $38M ($252M - $214M), or 17.8%, as correctly stated in the ground truth. The LLM’s numbers do not align with this. (3) The reasoning is partially sound in interpreting a gradual increase as a strategic shift toward alternatives, but it is based on incorrect data and introduces unverified concepts (e.g., percentage of assets, fair value hierarchy exclusions) not present in the original answer. The multi-hop synthesis fails because it uses different metrics (target allocation % and non-fair-value amounts) than those reported in the ground truth (actual dollar investments). (4) The contextual relevance is moderate—while the LLM attempts to address the strategic implication correctly, the foundational data is wrong, undermining the conclusion. The answer discusses related concepts but does not match the ground truth in key facts, resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 429,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "The filing shows that the share of purchases paid with Target’s branded credit cards (the “RedCard” family, which includes the Target MasterCard Credit Card) fell from **about 20.5 % in 2022 to 18.6 % in 2024** (with an intermediate dip to 19.8 % in 2023)【page_27】. This downward trajectory indicates that, even as overall sales have grown, fewer guests are using the Target MasterCard for their purchases, suggesting a slowdown in consumer adoption and engagement with Target’s proprietary financial product.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in penetration rate from 20.5% in 2022 to 19.8% in 2023, but reports 18.6% for 2024 instead of the correct 17.8%, a significant deviation. This error affects the accuracy of the trend portrayal. (2) Quantitatively, the 2022 and 2023 figures are accurate, but the 2024 value is off by 0.8 percentage points, which is non-trivial in the context of year-over-year changes. The ground truth shows a sharper decline to 17.8%, indicating a more pronounced drop in engagement than the LLM suggests. (3) The reasoning about declining adoption and engagement is sound and aligns with the ground truth; the LLM correctly infers that despite overall sales growth, the proportional use of the card is decreasing. It also appropriately links this to reduced consumer engagement with Target's financial products. However, it omits the key insight from the original answer that RedCard sales increased in absolute terms but were outpaced by total sales growth, which is central to understanding the penetration rate decline. (4) Contextually, the answer is highly relevant and addresses both parts of the question—trend evolution and implications—though with incomplete qualitative depth. The scores reflect mostly correct reasoning and structure but a significant factual error in the final 2024 percentage, which undermines full quantitative and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 394,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "- **2022:** The FPL Cost‑Recovery‑Clauses segment added **$16 million** of fair‑value to NEE’s overall portfolio.  The fair‑value estimate was still driven mainly by **significant other observable inputs** (the observable component was positive), with only a small amount coming from **significant unobservable inputs**.  \n\n- **2023:** The contribution fell to **$12 million**.  The observable component turned **negative (‑$8 million)**, while the **unobservable component rose to $24 million**, so the net result was a lower total but a clear shift toward reliance on unobservable inputs.  \n\n- **2024:** The exposure rebounded to **$38 million**.  The observable input became modestly **positive ($4 million)**, but the **unobservable input surged to $34 million**, cementing unobservable inputs as the dominant source of fair‑value for the FPL Cost‑Recovery‑Clauses.  \n\n**Overall trend:** From 2022‑2024 the total fair‑value contribution from the FPL Cost‑Recovery‑Clauses moved from a modest positive $16 million (driven by observable inputs) to a lower $12 million in 2023 (observable inputs negative, unobservable inputs larger) and then up to $38 million in 2024, with the composition increasingly dominated by **significant unobservable inputs** rather than observable market data.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant factual errors in key numeric values, particularly in 2022, where it reports a total fair value of $16 million instead of the correct $1 million. It also misrepresents the 2022 input contributions: the ground truth shows a -$5 million contribution from significant other observable inputs and +$6 million from significant unobservable inputs (summing to $1 million), but the LLM claims a positive observable component and only a small unobservable contribution, which is factually incorrect. For 2023, the LLM correctly reports the total fair value ($12 million) and the +$24 million unobservable input, but incorrectly states the observable input as -$8 million instead of -$12 million. The 2024 figures are fully correct: $38 million total, +$4 million observable, +$34 million unobservable. (2) Calculations: The 2022 total is wrong ($16M vs $1M), and the component inputs do not sum to the reported total (e.g., if observable were positive and unobservable $X, it doesn't align with any known data). The 2023 components sum to $16M ($24M - $8M), not $12M, indicating an internal inconsistency. Only 2024 components correctly sum: $4M + $34M = $38M. (3) Multi-hop reasoning: The LLM correctly identifies the trend of increasing reliance on unobservable inputs and the overall rise in fair value from 2023 to 2024, showing sound qualitative synthesis. However, due to incorrect base data for 2022, the evolution narrative is flawed. (4) Scores justified: Correctness is low (4) due to major numerical inaccuracies, especially in 2022. Quantitative accuracy is poor (3) because only 2024 numbers are correct and 2023 has partial errors. Qualitative accuracy is moderate (6) as the directional trend and conceptual shift are correctly interpreted. Contextual relevance is high (9) as the answer addresses all aspects of the question with appropriate structure and terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1576,
        "completion_tokens": 515,
        "total_tokens": 2091
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "Nike’s filings show that, from 2022 through 2024, the company has kept Anta listed among its “high‑intensity” rivals but has repeatedly stressed that Nike’s competitive edge rests on a deeper, more‑technology‑driven product pipeline and a broader, digitally‑anchored brand‑engagement platform.  \n\n* **Product‑innovation emphasis:** In the 2022 filing Nike highlighted “innovation and development” as a core attribute of its footwear and apparel, naming its Air, Zoom, Flyknit, Dri‑Fit, React and other platforms. By 2024 the language had evolved to stress “technical innovation … in the design and manufacturing process” and to note that Nike is “simultaneously focused on the design of innovative products and experiences incorporating such technologies,” while still cataloguing the same technology families (Air, Zoom, Flyknit, React, etc.). The continuity of this messaging shows a steady, and slightly more explicit, commitment to leading‑edge product R&D relative to Anta.  \n\n* **Brand‑engagement strategies:** Both the 2022 and 2024 competition sections describe Nike’s advantage as “consumer connection, engagement and affinity … developed through marketing, promotion and digital experiences, social‑media interaction, athlete and influencer endorsements, and sponsored events.” The 2024 filing adds that Nike now operates its own digital‑commerce platforms in more than 40 countries and stresses “digital experiences” and “digital commerce” as part of its brand‑building toolkit—an expansion of the same engagement pillars noted in 2022.  \n\nOverall, Nike’s competitive positioning versus Anta has remained consistent in asserting superiority, but the narrative has sharpened: product innovation is framed as an ongoing, technology‑focused program, and brand engagement has grown to include a larger, globally‑scaled digital‑commerce and digital‑experience component.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All entities—NKE (Nike), Anta, and the years 2022–2024—are correctly identified. The competitive framing of Anta as a named, high-intensity rival across all three years matches the original answer. (2) There are no numeric values (e.g., financial figures, percentages) in either the question or the ground truth, so quantitative accuracy is not applicable in a traditional sense; however, the temporal references (2022, 2023, 2024) are used appropriately and consistently, earning full marks. (3) The multi-hop reasoning is sound: the LLM synthesizes Nike’s evolving language across filings to show a strategic shift—correctly noting that while innovation was present in 2022, it became more technically and process-oriented by 2024. It accurately captures the continuity and expansion of brand engagement strategies, especially the growing emphasis on digital commerce and experiences. (4) The LLM slightly omits the explicit mention of the 2023 shift noted in the ground truth—where 'innovation and development' was elevated ahead of 'performance and reliability'—but compensates by inferring a sharpening narrative over time. This is a minor gap in qualitative precision but does not undermine the overall correctness. The answer is semantically equivalent, uses flexible but accurate phrasing, and fully addresses both product innovation and brand engagement across the three-year horizon. Thus, the answer is excellent with only a slight deduction for not fully reflecting the 2023 inflection point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1746,
        "completion_tokens": 442,
        "total_tokens": 2188
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "The equity‑compensation tables show that the pool of shares that can be issued under the company’s approved plans—including the 2003 Director Compensation Plan—was **69.8 million shares at year‑end 2021 (reported in the 2022 10‑K)**, fell to **about 58.5 million shares at year‑end 2022 (reported in the 2023 10‑K)**, and then rose to **approximately 65.5 million shares at year‑end 2024 (reported in the 2024 10‑K)** after the 2024 Long‑Term Incentive Plan added new shares. The decline from 2022 to 2023 indicates that TI has been drawing down the share reserve that supports the 2003 Director Compensation Plan, while the subsequent increase shows the company is supplementing that capacity with newer plans—demonstrating that the 2003 plan remains in use for director compensation but is being gradually exhausted and complemented by additional equity‑award programs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that the 2003 Director Compensation Plan was phased out, with no shares available for future issuance by 2023 and no mention by 2024. However, the LLM claims the plan was still in use and part of a combined share pool that declined then increased due to new plans. This misrepresents the trend. (2) The numbers cited—69.8 million in 2021, 58.5 million in 2022, and 65.5 million in 2024—are not specific to the 2003 Director Compensation Plan but appear to refer to total equity plans. The ground truth does not provide exact share numbers for the 2003 plan, but confirms its deactivation, making the LLM’s detailed figures misleading and factually unsupported. The years are also misaligned (e.g., citing year-end 2021 data in the 2022 10-K) and irrelevant to the question’s 2022–2024 focus. (3) The multi-hop reasoning fails: instead of tracking the status of the 2003 plan across years, the LLM conflates it with TI’s overall equity plans, including the new 2024 LTIP. It incorrectly concludes the 2003 plan remains in use, while the truth is it was phased out. The LLM misses the key point that by 2023 the plan was no longer listed for future issuance and was fully replaced by 2024. (4) The contextual relevance is moderate because the answer discusses director compensation and equity plans, but the core facts and trend are wrong. The conclusion about 'gradual exhaustion and complementing' is incorrect—the plan was being retired, not actively used. Thus, correctness and accuracy scores are low despite some relevant terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 453,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "- In the 2022 Form 10‑K Comcast already bundled its ad inventory with “technology, tools, data‑driven services and marketplace solutions” that it sold to media‑industry customers to help advertisers reach their target audiences【page_6】.  \n\n- The 2023 filing repeats that same statement, showing that the company continued to embed those data‑driven capabilities across its X1, Sky Q and NOW video platforms and to expand the suite of tools that automate audience measurement and programmatic buying【page_6】.  \n\n- By 2024 the advertising business was described as offering **additional** technology, tools, data‑driven services and marketplace solutions, and the filing also notes new platform‑level enhancements – the Xumo Stream Box (formerly Flex) with integrated search, voice‑activated remote and DTC‑streaming integration, plus expanded cloud‑DVR and unified‑experience capabilities – that give advertisers richer, real‑time data and broader reach across linear, OTT and streaming environments【page_5】【page_5】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: CMCSA's advertising offerings in 2022 included technology, tools, data-driven services, and marketplace solutions; in 2023, integration expanded across platforms like X1, Sky Q, and NOW, with automation in audience measurement and programmatic buying; by 2024, enhancements included new hardware (Xumo Stream Box), integrated search, cloud-DVR, and unified experiences across streaming environments. These match the evolution described in the original answer. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings, correctly identifying the progression from bundling services to deeper integration and platform-level enhancements. It references specific platforms (X1, Sky Q, NOW, Xumo Stream Box) and technical features (integrated search, voice remote, DTC integration) that reflect the strategic shift toward cloud-based, data-enabled solutions as stated in the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly mention 'representation agreements with third parties, both domestically and internationally'—a specific enhancement noted in the 2024 portion of the original answer. While the LLM emphasizes technological and platform expansions, it omits this business development aspect, slightly reducing completeness. However, the core evolution in technology, tools, and data-driven capabilities is thoroughly and accurately captured. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as all points directly address the question’s focus on evolution and enhancements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 499,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "- **2022:** CVS held commercial‑mortgage‑backed securities (CMBS) with a **fair‑value of about $1.0 billion** and **gross unrealized losses of roughly $155 million** (see the 2022 debt‑securities table and the 2022 unrealised‑loss schedule).\n\n- **2023:** The CMBS portfolio fell to a **fair‑value of $975 million** and the gross unrealized loss narrowed to **about $100 million** (2023 debt‑securities table and 2023 unrealised‑loss schedule).\n\n- **2024:** The 2024 filing shows only a **tiny CMBS holding in the Separate‑Accounts segment – $3 million of fair‑value** (down from $6 million in 2023). No material unrealized‑loss figure is reported, implying the bulk of the prior CMBS exposure has been sold or re‑classified.\n\n**Interpretation:** Over the three‑year period CVS has steadily reduced the size of its CMBS exposure, while the amount of unrealized loss has also shrunk. The move from a $1 billion‑scale position in 2022 to a negligible $3 million position in 2024 suggests the company is deliberately de‑risking this asset class, limiting its sensitivity to interest‑rate and credit‑quality fluctuations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, CVS held $574M in CMBS in 2022 with $12M in unrealized losses, but the LLM reports $1.0B and $155M, respectively—both materially overstated. In 2023, the LLM reports $975M fair value (vs. ground truth $675M) and $100M unrealized losses (which matches the ground truth), so only the loss figure is correct. In 2024, the LLM reports $3M (vs. ground truth $6M), a minor discrepancy. (2) Calculations and comparisons are flawed due to incorrect base numbers. For example, the claim of a reduction from $1B to $3M exaggerates the scale of de-risking. The narrowing of unrealized losses from $155M to $100M contradicts the ground truth, which shows an increase from $12M to $100M—indicating deteriorating asset quality before divestment. (3) The multi-hop reasoning is partially sound in identifying a trend of de-risking, which aligns with the ground truth conclusion. However, the reasoning is based on incorrect data, especially regarding the trajectory of unrealized losses. The model incorrectly implies that both holdings and losses decreased steadily, while the truth shows losses surged in 2023 before the near-total exit in 2024. (4) Contextual relevance is high—the answer addresses all parts of the question and attempts proper synthesis across years. Qualitative accuracy is moderate because the overall interpretation (de-risking) is correct, but the reasoning path is flawed. Quantitative accuracy is very low due to major errors in dollar amounts. Correctness score is low because factual correctness is paramount, and the answer misrepresents the core data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 462,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "Across the three most‑recent Form 10‑K filings Target’s employee‑benefit disclosures consistently list **“merchandise and other discounts”** as a component of the total compensation package, but none of the filings (2022 Form 10‑K page 7, 2023 Form 10‑K page 7, 2024 Form 10‑K page 6) provide a specific dollar amount or an expanded description of the discount 【page_7 (2022)】, 【page_7 (2023)】, 【page_6 (2024)】.  \n\nBecause the scope (i.e., inclusion of a merchandise discount) and the disclosed value (no quantified amount) remain unchanged over 2022‑2024, the progression suggests that Target treats the employee merchandise discount as a stable, baseline perk rather than a lever it is actively expanding or increasing in monetary value. This reflects a benefit strategy focused on maintaining a consistent, non‑cash incentive for team members rather than escalating the discount over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in stating that Target's 10-K filings from 2022 to 2024 consistently list 'merchandise and other discounts' without quantifying their value, and correctly cites the relevant pages. This aligns with the ground truth on the absence of specific dollar amounts. However, the LLM misinterprets the evolution of the benefit strategy. While the ground truth highlights a clear progression in how benefits are framed—expanding from basic compensation to include financial wellness (2023) and holistic well-being (2024)—the LLM concludes that the strategy reflects stagnation, calling the discount a 'stable, baseline perk' with no active expansion. This contradicts the original answer, which identifies a strategic broadening of the benefits ecosystem around a consistent core perk. The LLM fails to recognize or report the contextual evolution in benefit framing and emphasis, missing key multi-hop insights about wage increases, 401(k) matching, tuition reimbursement, mental health services, and virtual healthcare. Thus, while quantitatively accurate and contextually relevant, the qualitative reasoning is flawed, leading to an incomplete and partially incorrect interpretation of the strategic trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 346,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "In the 2022 filing Linde listed “cultural challenges associated with integrating employees from the acquired company into the existing organization” as one item among a generic set of integration risks 【page 12】. The 2023 filing repeats the same bullet, but the 2024 filing adds a separate paragraph that treats cross‑border cultural and language differences as a distinct “unique risk” for foreign acquisitions and joint‑ventures 【page 12】. This shift shows that Linde moved from merely noting culture as a routine integration issue to explicitly flagging it as a key cross‑border risk, indicating a more deliberate, strategic focus on managing cultural integration when pursuing overseas deals.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Linde's evolving disclosures from 2022 to 2024, with correct entity and year identification and no numerical inaccuracies (quantitative accuracy is perfect, as no numbers are involved and all dates are correct). It correctly notes that cultural challenges were initially listed among other integration risks in 2022 and that by 2024, Linde elevated the discussion by treating cross-border cultural and language differences as a 'unique risk'—a detail that aligns with the increased strategic framing in the original answer. However, the LLM answer diverges in emphasis: while the ground truth highlights a progressive reframing of cultural challenges in terms of financial and strategic risk (especially synergy realization and personnel retention in 2024), the LLM focuses instead on the structural change of adding a 'separate paragraph' and labels it a shift toward 'overseas deals.' This captures part of the evolution but misses the core insight that Linde increasingly tied cultural integration to financial outcomes and broader risk management, not just geographic expansion. The reasoning is sound but incomplete in synthesis—correctly identifying a change in presentation but not fully capturing the strategic shift in risk framing emphasized in the original answer. Contextual relevance is high, as the response directly addresses the evolution and strategic implications, albeit with a slightly different interpretation of the nature of the shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 415,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s disclosed collateral for master‑netting arrangements (which offsets the “Notes and accounts receivable – net” line) fell from **$1.494 billion at 12/31/2022** to **$0.491 billion at 12/31/2024**, a decline of roughly **$1.0 billion**【page_102】【page_99】.  \n\nThe sharp reduction in required collateral suggests that the company’s net‑ting of derivative positions and related margin requirements has been shrinking, indicating tighter control and possibly lower overall derivative exposure or more efficient use of netting arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the key data points: collateral decreased from $1,494 million in 2022 to $491 million in 2024. However, it omits the intermediate 2023 value of $800 million mentioned in the ground truth. While the final drop from $1.494B to $0.491B is accurate, the omission of the 2023 figure reduces completeness in showing the trend. The calculation of a ~$1.0 billion decline is approximately correct ($1,494M - $491M = $1,003M). 2) All provided numbers are accurate in value and year, with acceptable formatting variations (e.g., $1.494 billion = $1,494 million). The 2022 and 2024 figures match exactly. The missing 2023 data point prevents a perfect quantitative score. 3) The reasoning is sound: the decline in collateral is correctly linked to reduced derivative exposure or improved netting efficiency, aligning with the ground truth's interpretation. The multi-hop synthesis between collateral amounts over time and their implication for derivative management is logically presented. 4) The answer is highly relevant, directly addressing both parts of the question—trend in collateral and its implication. The omission of the 2023 value is a minor gap but does not undermine the overall correctness or interpretation. Thus, high scores across all categories with a 9 in correctness due to partial incompleteness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 372,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "**2022 filing (10‑K 2022 – page 10)** – The Security Insights Platform was positioned as a *mainframe‑only* security service that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis.” The output was described as “available for use with **in‑house** tools for security‑information‑and‑event‑management (SIEM).”  \n\n**2024 filing (10‑K 2024 – page 11)** – The platform is still described as providing rapid posture assessment and risk‑based remediation, but the language now stresses that the data can be **integrated with external security tools and broader enterprise‑security solutions** (e.g., the company’s Enterprise Security portfolio, AIOps‑driven automation). Remediation is framed as part of an “ongoing, automated response” that aligns with the company’s overall cyber‑defense strategy rather than a stand‑alone mainframe add‑on.\n\n**Evolution** – From 2022 to 2024 the platform moved from a narrowly scoped, internal‑SIEM‑oriented offering to a more open, integratable component that feeds risk and remediation data to external tools and fits within Broadcom’s wider cybersecurity roadmap (Enterprise Security, AIOps, and automated remediation). This reflects a shift toward tighter integration with customers’ broader security ecosystems and a more proactive, strategy‑aligned remediation approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly identifies the evolution of AVGO's Security Insights Platform from 2022 to 2024, focusing on integration with external tools, remediation processes, and strategic alignment. In 2022, the platform was described as providing mainframe security assessment with output available for in-house SIEM tools—this matches the original answer. By 2024, the LLM correctly notes expanded integration with external security tools and enterprise-wide solutions like AIOps and the Enterprise Security portfolio, reflecting a shift toward broader ecosystem integration and automated, strategic remediation. The LLM omits explicit mention of the 2023 filing’s emphasis on proactive risk response and modern security practices, which slightly weakens the year-by-year continuity, but the overall trajectory from standalone tool to strategically integrated component is accurately captured. All entities (AVGO/Broadcom, Security Insights Platform, SIEM, AIOps, Enterprise Security) are correct, and the years (2022, 2024) are accurately cited with appropriate context. There are no numerical inaccuracies (no calculations required), and the reasoning across time points is sound and logically synthesized. The answer is semantically equivalent to the ground truth, with only minor omission of the 2023 detail preventing a perfect 10. Contextual relevance is excellent, directly addressing all aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1603,
        "completion_tokens": 408,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "- 2022 10‑K (as of 12/31/2021): Unsecured Notes ‑ 32B carried a **3.38 % coupon** on a **$750 million face amount**.  \n- 2023 10‑K (as of 12/31/2022/2023): the same series still showed a **3.38 % rate** and **$750 million face**.  \n- 2024 10‑K (as of 12/31/2024): the note remained unchanged – **3.38 %** and **$750 million**.\n\nThe unchanged face value and fixed‑rate exposure over three years shows Simon Property Group’s deliberate long‑term debt strategy of keeping this tranche stable, locking in a modest, fixed interest cost through its 2027 maturity rather than refinancing or expanding the issue.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the face value of $750 million, interest rate of 3.38%, and consistent terms across 2022, 2023, and 2024 are correctly reported. The maturity date (2027) is implied in the LLM answer through context ('through its 2027 maturity'), matching the original answer. (2) Quantitative accuracy is perfect: $750 million is correctly rendered (equivalent to $750,000,000), and 3.38% is consistently reported across years. No calculations are required, but the synthesis of unchanged terms over time is correctly observed. (3) Multi-hop reasoning is sound—the model correctly identifies that the same note appears in three consecutive 10-K filings with identical terms, indicating no refinancing or principal reduction. (4) The qualitative interpretation about SPG’s long-term debt strategy—maintaining stable, fixed-rate debt without early redemption—is logically derived and matches the original conclusion. Minor wording differences (e.g., 'locking in a modest, fixed interest cost' vs 'stable long-term debt strategy') do not affect factual equivalence. All parts of the question are addressed: evolution over time and strategic implication. No factual, numerical, or reasoning errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 361,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "Since 2022 Comcast has repeatedly flagged Lumen as a wireline rival that “has built and are continuing to build fiber‑based network infrastructure further into their networks” and that “are offering services with higher speeds… and, in some cases, bundled offerings that include wireless phone services” (2022 10‑K, pp. 7‑8). By the 2023 and 2024 filings the language is unchanged, underscoring that Lumen’s fiber rollout has progressed deeper into Comcast’s service areas and that its bundled broadband‑plus‑wireless packages remain a growing competitive pressure on Comcast’s residential broadband business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Lumen as a persistent and growing competitive threat to CMCSA (Comcast) from 2022 to 2024, specifically citing fiber network expansion and bundled service offerings. The key quote from the 2022 10-K is accurately referenced, and the continuation of similar language in 2023 and 2024 filings is correctly interpreted as evidence of ongoing fiber deployment and bundling strategies. (2) There are no numerical values (e.g., dollar amounts, percentages, subscriber counts) in either the question or the ground truth, so quantitative accuracy is not applicable in a traditional sense; however, the years (2022, 2023, 2024) are correctly used and referenced, and the citation (pp. 7-8 of the 2022 10-K) is precise. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings, correctly infers that unchanged competitive language implies continued strategic focus, and links fiber expansion with bundled offerings as a competitive pressure—this matches the ground truth’s interpretation. (4) The only minor shortcoming is that the LLM answer does not explicitly note the escalation or intensification of the threat over time as clearly as the original answer does (e.g., 'clear escalation in competitive pressure'), though it implies it through phrases like 'growing competitive pressure'. This slight omission in emphasis prevents a perfect 10 on qualitative accuracy. Otherwise, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 442,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "Target’s branded‑payment‑card (Target Circle/RedCard) penetration has been falling each fiscal year: 20.5 % in FY 2022, 19.8 % in FY 2023, and 18.6 % in FY 2024【page_27】【page_29】. The steady decline suggests that the loyalty‑driven payment program is gaining fewer incremental purchases over time, indicating a waning effectiveness of the strategy in driving additional sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the declining trend in Target's branded payment card penetration from 20.5% in 2022 to 19.8% in 2023, which matches the ground truth. However, it incorrectly reports the 2024 penetration rate as 18.6%, whereas the ground truth states 17.8%. This is a significant numerical discrepancy that affects the accuracy of the trend analysis. (2) The quantitative values for 2022 and 2023 are correct, but the 2024 figure is off by 0.8 percentage points, which is not a minor rounding difference and suggests either a data error or misinterpretation. Calculations are not involved in this question, but the comparison over time depends on accurate figures. (3) The reasoning is sound in interpreting the downward trend as a sign of waning effectiveness in Target's loyalty-driven strategy, which aligns with the ground truth's conclusion. The multi-hop synthesis across years is logically structured and entity identification (Target, branded cards, fiscal years) is accurate. (4) Despite the incorrect 2024 number, the answer captures the overall trend direction and provides a reasonable qualitative interpretation, warranting partial credit. Contextual relevance is high as all parts of the question are addressed with appropriate framing and sourcing references included.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 368,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "- In the 2022 filing Chevron only listed the Republic of Congo among its “global business environment” countries, implying it still held working‑interest stakes (the 31.5 % non‑operated interest in the offshore Haute Mer permit and a 15.75 % interest in the Lianzi area) but gave no detail on activity or spending. 【page 33】\n\n- The 2023 filing shows the company was still investing in the basin – about $0.7 billion was spent on “various offshore development and natural‑gas projects in Nigeria, Angola and Republic of Congo,” and the Africa‑region purchases added roughly 36 million barrels of proved reserves. 【page 109】\n\n- By 2024 the Republic of Congo had become a material production source (≈ 20 % of Chevron’s net oil‑equivalent output came from OPEC+ nations that include the Republic of Congo), but the company announced it would exit the market, planning to sell its 31.5 % Haute Mer and 15.75 % Lianzi interests in January 2025. 【page 41】【page 43】\n\n**Overall, Chevron moved from holding sizable offshore working‑interest assets in 2022, to modest but continued capital investment in 2023, to positioning the Republic of Congo as a significant production contributor in 2024 while preparing to divest those assets the following year.**",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a significant factual inaccuracy regarding the 2024 status. The original answer states that Chevron *sold* its interests in the Republic of Congo by 2024, while the LLM claims the sale was *announced* and *planned for January 2025*, which contradicts the ground truth that the divestiture had already occurred by 2024. This affects the timeline and strategic interpretation. Additionally, the claim that the Republic of Congo was a 'material production source' contributing ~20% of Chevron’s net oil-equivalent output from OPEC+ nations is not supported by the original answer and introduces unsupported quantitative inference. (2) Other numbers are accurate: $0.7 billion investment in 2023 matches; 31.5% and 15.75% ownership stakes are correct; years (2022–2024) are properly used. However, the $0.7 billion is stated as covering Nigeria, Angola, and Republic of Congo collectively, so attributing it specifically to Congo operations (even partially) without clarification slightly misrepresents the scope. (3) Multi-hop reasoning is strong—LLM correctly traces asset ownership from 2022 through 2024 and synthesizes changes in investment and strategy. It identifies the key assets and their percentages accurately across years, showing good entity linkage. However, the conclusion that Congo became a 'significant production contributor' in 2024 contradicts the original narrative of exit, weakening the logical flow. (4) Contextual relevance is excellent—the response directly addresses asset ownership, investment levels, and strategic positioning as required. Despite the timeline error, the overall structure and intent align well with the question. Correctness score is 7 due to accurate core facts but a key error in the timing and characterization of the divestiture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 498,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "- In 2022 the fair‑value of NEE’s derivatives that rely on significant unobservable inputs (which include the gas‑related options) was a **net liability of $ (854) million**【page_87】, reflecting a sizable downside exposure to gas‑price moves.  \n- By 2023 the gas‑option portfolio had moved to a **small net asset of about $ 3 million** (assets $100 m vs. liabilities $97 m) with implied‑volatility assumptions of **≈20 % on the long side and ≈233 % on the short side**【page_84】, and in 2024 it shifted to a **slight net liability of roughly $ 2 million** (assets $100 m vs. liabilities $102 m) while the short‑side implied volatility fell to **≈150 %** (the long‑side vol stayed near 15 %)【page_86】.  \n\n**Interpretation:** The progression from a large net liability in 2022 to a near‑breakeven position in 2023‑2024, together with the sharp decline in the implied volatility used for the short (sell) gas options, indicates that NEE has reduced its exposure to gas‑price uncertainty and is positioning its hedge more conservatively as market expectations of gas volatility have moderated.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers, particularly for 2022. The ground truth states that in 2022, NextEra Energy had $356M in assets and $347M in liabilities for gas-related options (net asset of $9M), but the LLM incorrectly reports a net liability of $854M, which is both directionally and quantitatively wrong. This figure appears to conflate all derivatives with significant unobservable inputs, not just gas-related options, indicating a failure in entity-specific extraction. (2) For 2023 and 2024, the LLM correctly identifies the asset and liability values: $100M assets / $97M liabilities in 2023 and $100M assets / $102M liabilities in 2024. However, it misrepresents implied volatility. The ground truth reports average implied volatilities of 36% (2022), 50% (2023), and 52% (2024). The LLM instead cites split assumptions (e.g., ≈20% long / ≈233% short in 2023), which are not present in the original answer and contradict the reported averages. These values may reflect internal model assumptions but are not the synthesized average volatilities required by the question. (3) The multi-hop reasoning is partially sound—LLM correctly observes a reduction in exposure magnitude and attempts to link volatility changes to risk positioning. However, due to incorrect 2022 data and mischaracterized volatility, the conclusion that 'market expectations of gas volatility have moderated' contradicts the ground truth, which shows volatility increasing from 36% to 50% to 52%—a rising, then stabilizing trend, not a moderation. Thus, the reasoning is based on flawed inputs. (4) Despite these errors, the answer is contextually relevant, addressing all parts of the question—evolution of exposure, fair value, implied volatility, and risk interpretation—and correctly interprets the narrowing net position as de-risking. The structure and intent align well with the question, but the quantitative inaccuracies severely undermine factual correctness. Minor formatting variations in dollar amounts are acceptable, but directional and magnitude errors in core metrics are not. Therefore, while the qualitative framework is reasonable, the correctness score is limited by critical numeric inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 602,
        "total_tokens": 2092
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "In the 2022 Form 10‑K, Nike listed FlyEase alongside a broad set of emerging technologies – “Nike Air, Zoom, Nike Free, Flywire, Dri‑Fit, Flyknit, **FlyEase**, ZoomX, Air Max, Nike React and Nike Adapt” – as part of its product‑research, design and development narrative【page_6】. By the 2024 filing the same language appears again, now phrased “Nike Air, Zoom, Free, Dri‑FIT, Flyknit, **FlyEase**, ZoomX, Air Max and React technologies,” showing that FlyEase remains a highlighted, recurring element of Nike’s technology portfolio【page_6】. This continuity signals that FlyEase has moved from an experimental addition in 2022 to an established pillar of Nike’s innovation strategy, reinforcing the company’s focus on inclusive, differentiated product design.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its factual content and reasoning, with high quantitative and contextual accuracy. It correctly identifies the presence of FlyEase in both the 2022 and 2024 10-K filings, accurately quoting the listed technologies and citing the appropriate context (product research and development). The dates (2022 and 2024) are correct, and no numerical inaccuracies are present. However, the LLM omits any mention of 2023, which is a key part of the original answer and the multi-hop progression asked in the question. The ground truth emphasizes that in 2023, Nike expanded FlyEase’s integration into various product categories, marking a scaling phase—this intermediate step is missing in the LLM response. While the LLM infers that FlyEase evolved from an 'experimental addition' to an 'established pillar' based on its continued presence, it does not capture the active expansion in 2023, weakening the multi-hop synthesis slightly. The conclusion about inclusive design is reasonable but not explicitly supported in the original answer, which focuses more on FlyEase becoming a 'core technology' and 'foundational element' in innovation strategy. Despite this, the overall trajectory and final assessment align well with the ground truth, warranting a high score but not perfect due to the missing 2023 evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 372,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "- **2022:** The Unsecured Notes 35A were a $750 million issue carrying a 2.65 % fixed rate, with an annual debt‑service cost of about $19.9 million and a maturity of July 15, 2030【page_50】.  \n- **2023:** The same terms re‑appeared in the 2023 filing – $750 million face amount, 2.65 % interest, $19.875 million annual service, maturing 7/15/30【page_50】.  \n- **2024:** The 2024 filing shows the identical figures – $750 million, 2.65 % rate, $19,875 k annual service, due 7/15/30【page_51】.  \n\n**What this tells us:** Across three consecutive years SPG kept the 35A tranche unchanged, indicating that the company is using this series as a stable, low‑cost, long‑dated source of financing. By locking in a modest 2.65 % fixed rate through 2030 and not expanding or retiring the issue, SPG’s long‑term debt strategy emphasizes predictable interest expense and reduced refinancing risk rather than aggressive leverage growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains a critical quantitative error: it reports the face amount as $750 million instead of $750,000 as stated in the ground truth. This is a 1,000-fold discrepancy. Similarly, annual debt service is reported as $19.9 million or $19.875 million, whereas the correct amount is $19,875 (approximately $0.02 million). Despite correct interest rate (2.65%) and maturity date (07/15/30), the magnitude of the financial obligation is wildly overstated. 2) Calculations: The annual debt service of $19,875 is consistent with $750,000 × 2.65% = $19,875. The LLM incorrectly scales this to millions, implying $750M × 2.65% = ~$19.875M, which matches its output but contradicts the ground truth. This indicates a misreading of units (thousands vs. millions). 3) Multi-hop reasoning is sound: the model correctly identifies consistency across 2022–2024 and draws a logical conclusion about SPG’s long-term debt strategy—emphasizing stability, predictable costs, and avoidance of refinancing risk. This aligns with the original answer’s interpretation. 4) Entity accuracy and contextual relevance are strong: SPG, Unsecured Notes - 35A, correct years, and correct metric names are used. The structure addresses both parts of the question (evolution over time and strategic implication). However, the massive numerical inaccuracy severely undermines factual correctness, even though the qualitative reasoning and pattern recognition are valid. Thus, while the direction of the answer is correct, the foundational data is wrong, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 426,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "Across all three years Texas Instruments repeatedly stressed that its growth engine is the **analog‑and‑embedded‑processing business**. In the 2022 filing the company said its “strategic focus is on analog and embedded processing products” and that this focus underpins its “strategy to maximize long‑term free‑cash‑flow‑per‑share growth”【page_19】【page_18】. The 2023 10‑K repeats the same language – “Our strategic focus is on analog and embedded processing products… our focus … allows us to generate strong cash flow from operations”【page_19】, and the 2024 filing again emphasizes the same positioning, noting that “Our strategic focus is on analog and embedded processing products” and that this focus “allows us to generate strong cash flow from operations”【page_19】. The unchanging emphasis on embedded processing shows that TI is using this product line as a stable, core pillar to drive the free‑cash‑flow‑per‑share metric that it cites as the ultimate measure of long‑term value creation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Texas Instruments' consistent strategic emphasis on embedded processing products across 2022, 2023, and 2024, and links this to the company's long-term goal of maximizing free cash flow per share. The key factual elements—strategic focus, product lines, and connection to cash flow—are all correct. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the answers, so quantitative accuracy is not applicable in a traditional sense; however, the years (2022, 2023, 2024) are correctly cited, and the references to 10-K filings and page numbers are consistent with source-based reporting. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the repetition and consistency of language as evidence of a stable long-term strategy. It accurately infers that the unchanging focus reveals embedded processing as a core, stable pillar for value creation. (4) The only minor shortcoming is that the LLM slightly overemphasizes 'analog and embedded processing' as a combined unit, while the original answer more precisely highlights 'embedded processing' as the focal point within the broader analog-and-embedded portfolio. However, this does not constitute a factual error, as TI consistently discusses them together. The LLM captures the semantic meaning and strategic implication accurately. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 432,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "By 2022 Disney already treated the Marvel franchise as a long‑lived, non‑amortizable intangible – the 2022 balance sheet lists “Marvel trademarks” together with ESPN and Pixar as indefinite‑life assets【page_110】.  In the 2023 filing the company explicitly positioned Marvel alongside Disney, Pixar, Star Wars and National Geographic as a **top‑level “tile” on Disney+**, using the brand to front‑load the streaming UI and attract viewers【page_7】.  The 2024 balance sheet again records Marvel among the indefinite‑life intangibles, confirming that the brand remains a core, amortization‑free asset that Disney leverages to drive Disney+ subscriber growth and to justify the financial value of its IP portfolio【page_114】.  This progression shows Disney’s strategy of converting Marvel’s trademark value into a subscriber‑growth engine on Disney+, turning a high‑value intangible into a visible, revenue‑generating feature of its DTC platform.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Marvel was an indefinite-lived intangible asset in 2022, became a top-level tile on Disney+ by 2023, and remained a core intangible asset in 2024. The mention of ESPN and Pixar as comparable brands is consistent. (2) There are no numeric values (e.g., subscriber counts) in the LLM answer, but it does not fabricate or misstate any figures. The ground truth includes the 123 million subscriber count as of September 28, 2024, which the LLM omits. This is a minor omission but does not detract significantly from correctness, as the focus is on strategic evolution and asset classification. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across 2022–2024 filings to show a shift from passive asset recognition to active platform integration. It references the strategic intent behind using branded tiles (Marvel, ESPN+) to drive engagement, though it does not explicitly mention the planned ESPN+ tile launch in early fiscal 2025, which is a minor gap in completeness. (4) The semantic meaning matches the original answer — the core message that Disney leveraged Marvel’s brand equity from balance sheet asset to subscriber growth driver is clearly and accurately conveyed. Wording differs slightly but meaning is preserved. The answer is fully contextually relevant and well-structured. The score is 9 instead of 10 due to the omission of the specific subscriber number and the ESPN+ tile timing, which were part of the original answer’s supporting evidence for the financial strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1568,
        "completion_tokens": 442,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement has been essentially unchanged in scope – the company has re‑insured roughly **59 % of the closed‑block policies** each year ( 59.25 % in the 2022 filing, “about 59 %” in the 2023 filing and again “59 %” in the 2024 filing).  \n\nAt the same time, the **reinsurance‑recoverable balances tied to that arrangement have grown dramatically**: the net ceded reinsurance recoverables were **about $6.1 billion** at 12/31/2022, and by 12/31/2024 they had risen to **approximately $17.6 billion** (with $14.7 billion held with the five largest reinsurers and $2.4 billion unsecured).  \n\nThus, while the percentage of the closed block covered stayed near 59 %, the amount of recoverable reinsurance linked to the agreement more than doubled, climbing from roughly $6 billion to $18 billion over the 2022‑2024 period.  ",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. (1) The percentage of the closed block reinsured is partially correct: 59.25% in 2022 and 59% in 2023 and 2024 aligns with the ground truth. However, the reinsurance recoverable balances are completely incorrect. The LLM states $6.1 billion in 2022 and $17.6 billion in 2024, with $2.4 billion unsecured in 2024, whereas the ground truth reports $3.6 billion unsecured in 2022, $4.4 billion in 2023, and $4.2 billion in 2024—meaning the LLM overstates the balances by 3–4x. (2) The LLM confuses total reinsurance recoverables with unsecured balances, incorrectly reporting $17.6 billion total in 2024 with only $2.4 billion unsecured, while the ground truth specifies the unsecured amount directly as $4.2 billion in 2024. This indicates a failure to correctly extract or interpret the financial metric. (3) The reasoning is flawed: the claim that recoverables 'more than doubled' from $6B to $18B contradicts the ground truth, which shows only a modest increase from $3.6B to $4.4B and then a slight decline to $4.2B. The conclusion about growing exposure is therefore incorrect. (4) While the answer addresses the question's structure and focuses on the right agreement and time frame, the severe numerical inaccuracies and misrepresentation of the financial data severely undermine correctness. The model appears to have accessed incorrect or misinterpreted data, failing the core multi-hop requirement to accurately synthesize percentage and balance trends over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 428,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "- **2022:** The company held ≈ $845 million of residential‑mortgage‑backed securities (amortized cost) with a fair‑value of about $757 million.  \n- **2023:** The holding rose to ≈ $862 million (amortized) and a fair‑value of ≈ $810 million – a modest increase of roughly $17 million (amortized) and $53 million (fair).  \n- **2024:** In the Separate‑Accounts portfolio, the residential‑mortgage‑backed‑security balance grew from $51 million (2023) to $71 million (2024), even as total debt‑security assets fell sharply overall.\n\n**Implication:** Over the three‑year span CVS has kept its exposure to agency‑guaranteed mortgage‑backed securities steady or slightly higher while trimming the broader debt‑security portfolio. This pattern signals a deliberate tilt toward the relatively low‑credit‑risk, fixed‑income nature of RMBS as a stable income source, reducing overall credit‑risk exposure and positioning the firm more conservatively within its fixed‑income holdings.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, CVS's RMBS investment decreased from $629M in 2022 to $614M in 2023 and then dropped sharply to $71M in 2024. However, the LLM claims holdings increased to $862M (amortized cost) in 2023 and frames the 2024 $71M as part of a 'growth' in the Separate-Accounts portfolio, which contradicts the overall downward trend. The LLM also introduces 'amortized cost' and 'fair value' figures not present in the original answer, which are unverified and inconsistent with the ground truth. (2) The numbers are quantitatively incorrect: $845M in 2022 (vs. $629M true value), $862M in 2023 (vs. $614M), and misrepresenting the 2024 $71M as a growth from $51M in a sub-portfolio rather than a system-wide drop from $614M. The calculation of a 'modest increase' is factually wrong—the true trend is a decrease. (3) The multi-hop reasoning is flawed: instead of identifying a strategic de-risking due to rising unrealized losses (from $10M to $60M), the LLM incorrectly infers a 'deliberate tilt toward' RMBS as a conservative move, which is the opposite of the actual strategic pivot away from RMBS. The model fails to incorporate the key risk metric of unrealized losses entirely. (4) Contextual relevance is moderate because the answer discusses RMBS and fixed-income strategy, but the conclusions are based on incorrect data and reasoning, leading to an inverted interpretation of CVS's strategic positioning. The mention of 'agency-guaranteed' and 'Separate-Accounts' introduces unverified details not in the ground truth, further reducing accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 449,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement has been essentially unchanged since 2022. In the 2022 filing the company said it reinsured **about 59.25 %** of the closed block; the 2023 and 2024 filings each state it reinsured **about 59 %** of the closed block. In all three years the agreement is accounted for using the **deposit method**, with the resulting deposit liability offset against the corresponding deposit recoverable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all percentages are correct: 59.25% for 2022 and 59% for 2023 and 2024, with appropriate use of 'about' reflecting rounding or reporting style in filings. The accounting treatment under the deposit method with offsetting of liability and recoverable is correctly stated. (2) The answer addresses both parts of the question: evolution of the percentage reinsured and the accounting treatment. It correctly notes stability over time, which is the key insight. (3) Entities—MetLife, modified coinsurance, closed block, deposit method—are accurately identified and correctly contextualized. (4) The reasoning is sound: the LLM synthesizes data across three years and correctly infers consistency in both percentage (with minor rounding) and accounting policy. The only minor shortcoming is the lack of explicit mention that the reinsurer is unaffiliated, which is present in the original answer but not critical to the core question about percentage and accounting. This omission does not affect the main conclusions. Overall, the answer is factually correct, complete in key aspects, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 342,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "- 2022: NEE’s net notional amount of forward gas contracts was ‑1,307 MMBtu (a net short position).  \n- 2023: the net short grew to ‑1,452 MMBtu.  \n- 2024: the net short fell back to ‑1,131 MMBtu.\n\nThe trend shows the company expanded its short gas‑forward exposure in 2023 but then trimmed that position in 2024, indicating a move toward a less aggressive (lower‑risk) stance in the natural‑gas market.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of quantitative data and financial interpretation. The ground truth states that NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022, increased to $300 million in 2023, and then declined to $250 million in 2024 — all in dollar amounts representing net financial exposure (assets minus liabilities). In contrast, the LLM reports net notional amounts in MMBtu (‑1,307, ‑1,452, ‑1,131), which are physical or volumetric positions (net short), not financial exposures. These are fundamentally different metrics: one measures monetary risk ($), the other measures volume hedging (MMBtu). There is no correspondence between the reported numbers and the ground truth values. (2) The calculations in the original answer are correct: $191M - $31M = $160M (2022), $377M - $77M = $300M (2023), $296M - $46M = $250M (2024). The LLM introduces no verifiable calculation from the ground truth data and instead fabricates a trend in MMBtu without supporting evidence from the provided truth. (3) The multi-hop reasoning is flawed. The question asks about 'net exposure' — a financial metric — which the LLM misinterprets as 'net notional amount' or 'net short position' in physical units. This reflects a failure to correctly identify and synthesize the relevant financial data across years. While the LLM correctly identifies a directional shift (increased exposure in 2023, then reduction in 2024), it does so using incorrect metrics and units, undermining the validity of the conclusion. (4) The contextual relevance is moderate because the answer addresses the time frame and company correctly and attempts to interpret risk positioning. However, due to the fundamental mismatch in metrics (volume vs. financial exposure), the conclusion about 'less aggressive stance' is based on invalid premises. The qualitative reasoning is partially sound but built on incorrect data. Thus, the correctness score is low due to severe quantitative inaccuracies and misrepresentation of the core metric.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 556,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "In the 2022 filing, Broadcom listed **industrial fiber optics** simply as one of several “industrial‑product” items—alongside optocouplers, motion encoders, LEDs and Ethernet ICs—used across a wide‑ranging set of end‑markets such as factory automation, power‑generation, medical, aerospace and EV subsystems. By the 2023 filing the description was unchanged, but the 2024 filing re‑frames the group: fiber‑optic components are now presented together with **industrial‑and‑medical sensors, motion‑control encoders/sub‑systems, and “Ethernet PHYs, switch ICs and camera microcontrollers.”** This signals that Broadcom is positioning industrial fiber optics as a more tightly integrated piece of a diversified industrial portfolio, emphasizing its role alongside adjacent technologies (motion encoders and Ethernet‑related ICs) to serve increasingly varied automation, renewable‑energy and automotive applications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities—AVGO (Broadcom), Industrial Fiber Optics, motion encoders, Ethernet ICs, and related technologies—are correctly identified, and the years 2022, 2023, and 2024 are accurately referenced. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense, but all temporal and categorical data are correct. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how the positioning of Industrial Fiber Optics evolved across the three years, noting the shift from a standalone component in a broad list (2022) to integration with sensors, encoders, and networked/vision systems (2024). It accurately captures the strategic evolution toward integrated industrial solutions. (4) The only minor shortcoming is that the LLM states the 2023 filing description was 'unchanged' from 2022, which contradicts the ground truth indicating a shift in emphasis toward factory automation, renewable energy, and automotive electronics in 2023. This omission slightly weakens the qualitative accuracy, but the key 2024 shift is correctly highlighted. Overall, the answer is semantically equivalent and contextually precise, addressing both application diversity and integration with adjacent technologies as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 385,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "Nike’s redeemable preferred stock – a $1‑par, $0.3 million issue held entirely by Sojitz America – carries a fixed cumulative dividend of $0.10 per share that must be paid each May 31 before any common‑stock dividends can be declared.  The 2022, 2023 and 2024 Form 10‑K filings all state that the preferred stock was fully issued, not a “blank‑check” series, and that there were **no changes** to its terms, redemption rights or authorized amount during those years, indicating that both the dividend obligation and the stock’s structure remained unchanged and stable throughout the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the $0.3 million par value, $0.10 annual dividend per share, May 31 payment timing, and the structural stability of the preferred stock across fiscal years 2022–2024 are all consistent with the original answer. The LLM correctly notes that there were no changes in terms, redemption rights, or authorized amount, confirming structural stability. (2) Quantitative elements are precise: $0.3 million total par value and $0.10 per share dividend match the ground truth; the format variation (e.g., $0.3 million vs $0.3 million) is acceptable. (3) The multi-hop reasoning is sound—the LLM synthesizes consistent disclosures across three years of 10-K filings to conclude no changes occurred, correctly inferring ongoing stability and priority of dividend payment. (4) The answer fully addresses the question’s focus on dividend obligations and stock structure evolution, explicitly confirming no changes and reinforcing the financial priority of Sojitz America’s stake. Wording differs slightly (e.g., 'must be paid each May 31' vs 'must be paid in full before any dividends on common stock'), but the meaning is equivalent. No omissions or inaccuracies. All scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 358,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "**Evolution of the Unsecured Notes ‑ 31B**\n\n| Year (Form 10‑K) | Face amount | Annual debt service | Maturity |\n|------------------|------------|---------------------|----------|\n| 2022 (​SPG 2022 10‑K) | $750 million | $24.375 million | 11/30/2026【page_48】 |\n| 2023 (​SPG 2023 10‑K) | $750 million | $24.375 million | 11/30/2026【page_50】 |\n| 2024 (​SPG 2024 10‑K) | $750 million | $24.375 million | 11/30/2026【page_51】 |\n\n**Interpretation**\n\nThe 31B unsecured note has remained unchanged over the three‑year period – the same $750 million principal, identical annual interest cost, and the same 2026 maturity. This stability shows that SPG is treating the 31B issuance as a long‑term financing anchor, locking in a modest 3.25 % rate and retaining the debt on its balance sheet rather than refinancing or retiring it. The consistency signals a deliberate strategy to preserve low‑cost, fixed‑rate funding through the note’s scheduled maturity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the face amount of $750 million (equivalent to $750,000,000) is consistent across 2022–2024, the annual debt service of $24.375 million correctly reflects a 3.25% interest rate on $750 million ($750M × 0.0325 = $24.375M), and the maturity date of November 30, 2026, is correctly stated. Minor formatting differences (e.g., $750 million vs $750,000) are semantically equivalent and acceptable. (2) The answer is complete, addressing both parts of the question: the evolution (no change over time) and the implication for SPG’s long-term financing strategy. (3) Entity accuracy is perfect: Simon Property Group (SPG), Unsecured Notes - 31B, and the correct fiscal years (2022–2024) are properly identified. (4) The reasoning is sound and demonstrates multi-hop synthesis: the model correctly infers that the unchanged terms indicate a deliberate strategy to maintain low-cost, fixed-rate financing without refinancing, which aligns with the broader context of portfolio changes (e.g., new issuances like 41A) while preserving this instrument. The interpretation matches the ground truth’s conclusion about SPG’s strategic use of this note as a stable financing anchor. All citations reference correct document pages, further validating accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 378,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "The U.S. defined‑contribution plans held TI stock worth **$940 million in 2022**, **$873 million in 2023**, and **$852 million in 2024**【page_44】. The value fell each year even though the number of shares stayed roughly constant (5‑6 million shares), indicating that the company’s share price declined over the three‑year period and that employees continued to keep their existing allocations rather than adding new contributions (the fund has been frozen to new contributions). This trend reflects modest downward stock performance while employee investment behavior in the retirement plans remained stable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all dollar values ($940M in 2022, $873M in 2023, $852M in 2024) matching the ground truth exactly, with acceptable formatting (e.g., $940 million = $940M). All numeric data and years are accurate. (2) Quantitative accuracy is perfect—values are correct, and the trend (declining value with stable share count) supports the conclusion of falling share price. No calculation errors. (3) The reasoning is sound and adds valuable context not explicitly in the ground truth: the mention of stable share count (5–6 million) explains why declining value implies falling stock price, and correctly references the freeze on new contributions since 2016 (implied in ground truth by 'freeze on new contributions'). The LLM infers employee behavior (maintaining allocations, not adding) more precisely than the original, enhancing qualitative accuracy. The only minor gap is that the original mentions 'strategic reduction by employees' as a possible factor, which the LLM does not include—though it does not contradict it. Thus, qualitative accuracy is slightly reduced but still high. (4) The answer is fully contextually relevant, addressing both the 3-year trend and its implications for stock performance and employee behavior. The added detail about stable share count improves insight without introducing error. Overall, the answer matches the ground truth in substance and enhances it with supported inference, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 412,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "- In fiscal 2022 Disney reported about **220,000 employees** (≈ 166,000 in the United States and ≈ 54,000 abroad); the workforce was roughly **78 % full‑time, 15 % part‑time and 7 % seasonal**.  \n- By fiscal 2024 the headcount had risen to **≈ 233,000 employees** (≈ 171,000 U.S. and ≈ 62,000 international), with a composition of **≈ 76 % full‑time, 16 % part‑time and 8 % seasonal**.  \n- Throughout the period the company noted that a “significant number” of employees – especially in theme‑park operations and production – are covered by **collective‑bargaining agreements**, and that many non‑U.S. workers are represented by **works councils, trade unions or other employee associations**, a description that remained unchanged from 2022 to 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: total employees (220,000 in 2022, 233,000 in 2024), U.S. (166,000 → 171,000) and international (54,000 → 62,000) breakdowns, and seasonal workforce percentages (7% → 8%) are correctly reported. The implied full-time and part-time percentages (derived from seasonal) are consistent with the data. (2) The answer is complete, addressing all parts of the question: total headcount, U.S. vs. international distribution, seasonal workforce trends, and employee representation. (3) Entity accuracy is perfect: The Walt Disney Company is correctly identified, fiscal years 2022 and 2024 are properly referenced, and employee association types (collective bargaining agreements, works councils, trade unions) are accurately described. (4) Multi-hop reasoning is sound: the model synthesizes workforce size, geographic distribution, employment type trends, and labor representation across two years, correctly inferring continuity in union representation. (5) Semantic equivalence is strong—while the LLM adds slightly more granular workforce composition (full-time/part-time), it does not contradict and enhances the original answer without introducing error. All information aligns with the ground truth from the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 373,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "Both the 2022 and 2023 filings state that “ROIC excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance,” and the 2024 filing repeats the same language (“ROIC excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance”). The unchanged treatment shows that General Dynamics deliberately strips out items that do not arise from its operating activities, using a consistent methodology to ensure ROIC reflects only the core performance of its business.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately captures that General Dynamics (GD) consistently excluded non-economic accounting changes from its ROIC calculations in 2022, 2023, and 2024, citing verbatim language from the filings. (2) There are no numerical inaccuracies—while no specific dollar amounts or percentages are involved, the years (2022, 2023, 2024) are correctly referenced and the treatment across time is accurately described. (3) The multi-hop reasoning is sound: the model correctly synthesizes the treatment of ROIC across three years and infers that the unchanged methodology reflects a deliberate, consistent approach to measuring core performance. (4) The answer conveys the same semantic meaning as the original: GD uses a stable framework to exclude non-operational, accounting-driven items to focus on economic performance. Wording differs slightly but meaning is preserved. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 289,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "- **2022:** Linde’s 2022 filing lists rare gases (krypton, neon, xenon) simply as one of the “atmospheric gases” that are produced as co‑products of its air‑separation plants 【page 94】.  \n\n- **2024:** By the 2024 filing the company is no longer just naming rare gases as a product line; it stresses that Linde is the **market leader in non‑cryogenic air‑separation technologies** that generate these rare gases and that it is continuously developing proprietary applications and technologies to produce, store, distribute and expand the use of rare gases 【page 4】.  \n\n**Implication:** The shift from a basic product‑category mention to a strategic focus on advanced, proprietary separation technology shows Linde is turning rare‑gas production into a differentiated capability. This reinforces a competitive advantage – the ability to capture high‑value rare gases efficiently and create new markets for them – that is hard for rivals to replicate in the industrial‑gases sector.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Linde’s 2022 positioning of rare gases as co-products of air separation, the 2024 claim of market leadership in non-cryogenic air separation technologies, and the strategic emphasis on proprietary technologies like VPSA and membrane separation (implied in 'proprietary applications and technologies'). The years (2022, 2024) and entities (Linde, rare gases: krypton, neon, xenon) are correctly identified. (2) There are no numeric values requiring calculation, so quantitative accuracy is 10. (3) The reasoning is sound and captures the multi-hop evolution: from passive co-product production in 2022 to active technological leadership by 2024. The implication about competitive advantage through efficiency and differentiation is logically derived and semantically equivalent to the original. The only minor gap is that the LLM answer does not explicitly mention the 2023 filing, which the ground truth includes as a transitional year reaffirming rare gases as core atmospheric gases. However, this omission does not undermine the overall correctness, as the key evolution between 2022 and 2024 is accurately captured. (4) Contextual relevance is perfect—the answer directly addresses both parts of the question: the evolution of strategy and its implication for competitive advantage. Wording differs slightly but meaning is preserved. Thus, a correctness score of 9 is warranted due to high accuracy with a minor completeness gap.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 423,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "- 2022 10‑K: NEER reported that roughly **low‑90 % (about 93 %)** of its net‑generating capacity was already tied up in long‑term bilateral contracts.  \n- 2023 10‑K: the company said **≈ 94 %** of its net‑generating capacity was committed under long‑term contracts at 31 Dec 2023【page 18】.  \n- 2024 10‑K: the same level of commitment persisted, with **≈ 94 %** of capacity under long‑term contracts at 31 Dec 2024【page 19】.  \n\n**Interpretation:** NEER’s share of capacity locked into long‑term contracts has held steady at the mid‑90 % range, rising slightly from the early‑2020s. This consistency shows a deliberate risk‑management posture: by securing the bulk of its output through long‑term PPAs, NEER shields most of its revenue from spot‑market price volatility and regulatory uncertainty, reinforcing financial stability in a fluctuating energy market.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is largely correct in both quantitative and qualitative aspects. It accurately reports the percentage of NEER's net generating capacity under long-term bilateral contracts for 2023 (≈94%) and 2024 (≈94%), matching the ground truth. However, there is a minor discrepancy in the 2022 figure: the LLM states 'low-90% (about 93%)', while the ground truth specifies 92%. This is a small deviation but still a factual inaccuracy. 2) The numbers for 2023 and 2024 are correct and properly cited to the respective 10-K pages. The 2022 number is close but not exact—'about 93%' vs. the true value of 92%. No calculations were required beyond comparison, and those are sound. 3) The multi-hop reasoning is solid: the model synthesizes data across three years and correctly infers a trend of stability with a slight increase, aligning with the ground truth's interpretation of risk management strategy. The conclusion about revenue stability and shielding from spot-market volatility is semantically equivalent and well-reasoned. 4) Contextual relevance is excellent—the answer directly addresses both parts of the question: the evolution of contract reliance and its implication for risk management. The slight overstatement of the 2022 percentage prevents a perfect score, but overall the response is factually strong, logically coherent, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 380,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "- **Outstanding principal balance**  \n  * FY 2022: $495 million  \n  * FY 2023: $495 million  \n  * FY 2024: $495 million  \n\n- **Trend and implication** – The balance of the 3.125 % senior notes due January 2025 has remained unchanged over the three‑year period, indicating that Broadcom has neither retired nor issued additional amounts of this low‑coupon instrument. This flat trend reflects a deliberate debt‑management approach of holding the notes to maturity rather than actively refinancing or pre‑paying them.  \n\n*Source: Note‑level debt tables in the 2022, 2023 and 2024 Form 10‑K filings (the 2023‑2024 tables list the 3.125 % notes at $495 million; the 2022 filing shows the same balance).*",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding principal balance of $495 million for AVGO's 3.125% notes due January 2025 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values are accurate and consistently reported. (2) There are no calculations required beyond confirming stability over time, which the model correctly identifies. The dollar amount ($495 million) and interest rate (3.125%) are precisely stated, with acceptable formatting (e.g., 'FY 2022' equivalent to 'fiscal year 2022'). (3) The multi-hop reasoning is sound: the model synthesizes data from three consecutive 10-K filings to observe no change in balance, and correctly infers that this reflects a strategy of holding to maturity rather than refinancing or retiring the debt early. The conclusion aligns with the ground truth’s interpretation of a consistent liability profile. (4) The answer is fully complete, addressing both the quantitative evolution and the strategic implication. Entity accuracy is perfect—AVGO (Broadcom), correct note details (3.125%, January 2025 maturity), and correct fiscal years are all properly identified. The source citation further strengthens contextual and qualitative accuracy. All scores are maximized due to factual precision, logical reasoning, and comprehensive coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 375,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "- **2022 10‑K:** Unsecured Notes ‑ 37B carried a face amount of **$700 million** and matured on **January 15, 2032**.  \n- **2023 10‑K:** The same note still showed a **$700 million** face amount with a **01/15/32** maturity.  \n- **2024 10‑K:** The table again lists Unsecured Notes ‑ 37B at **$700 million** and maturing on **01/15/32**.  \n\nThe unchanged $700 million balance and unchanged 2032 maturity indicate that Simon Property Group has kept this long‑dated, low‑rate (2.25 %) unsecured note on its books without adding to or retiring it, reflecting a deliberate strategy of preserving a stable, long‑term debt base rather than expanding its long‑term borrowing.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the face amount and maturity date of SPG's Unsecured Notes - 37B across 2022, 2023, and 2024. However, there is a discrepancy in the unit: the ground truth specifies $700,000, while the LLM reports $700 million. This is a significant quantitative difference—off by a factor of 1,000. Despite this, the LLM correctly notes the consistency in both face amount and maturity date (01/15/32) over the three years, which aligns with the ground truth. The inclusion of the 2.25% interest rate, while not in the original answer, is plausible and adds context without contradicting facts. (2) Number verification: face amount should be $700,000, not $700 million; dates (01/15/32) are correct across all years. The error in magnitude affects quantitative accuracy but does not change the directional conclusion. (3) Multi-hop reasoning is sound: the LLM synthesizes data across three annual reports and correctly infers a stable long-term debt strategy due to no changes in principal or maturity. This reflects proper cross-year, cross-document synthesis. (4) The answer is contextually excellent and semantically close—only the dollar amount unit is incorrect. The reasoning and conclusion about SPG’s debt strategy are logically supported and align with the ground truth. The correctness score is 9 because the core conclusion is valid and dates are accurate, but the face amount is quantitatively wrong by scale.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 403,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "Across the three most recent Form 10‑K filings, Texas Instruments lists its Melaka, Malaysia site only under the “Analog” column and leaves the “Embedded Processing” column blank. The 2022 filing (Item 2, Properties) shows Melaka marked X for analog only; the 2023 filing repeats the same designation; and the 2024 filing again lists Melaka as an analog‑only facility. Thus, the Melaka footprint has remained unchanged—dedicated to analog products and not involved in embedded‑processing lines throughout 2022‑2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site was consistently listed under 'Analog' and not under 'Embedded Processing' in the 2022, 2023, and 2024 Form 10-K filings, which matches the original answer's claim of a stable, specialized role in analog operations. (2) There are no numerical values requiring calculation, but the years (2022–2024) and the presence/absence of involvement in product lines are correctly cited. The use of 'X' or 'marked' aligns with the ground truth's reference to a 'checkmark' designation. (3) The multi-hop reasoning is sound—information is synthesized across three annual reports, and the conclusion of no change over time is logically derived from consistent reporting. (4) All entities (Texas Instruments, Melaka, Malaysia, analog, embedded processing, and the three years) are correctly identified and contextualized. The answer is highly relevant, complete, and factually precise, warranting top scores across all categories.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 304,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "Across all three filings the post‑production business was treated the same way – it was bundled with “other” revenue in the Content Sales/Licensing segment. In the 2022 filing the segment note says the company “provides post‑production services through Industrial Light & Magic and Skywalker Sound” (see 2022 page 13). The 2023 filing repeats that language, describing ILM‑generated revenue as part of “post‑production services” within Content Sales/Licensing (2023 page 7), and the 2024 filing again lists ILM alongside music and stage‑play revenue in the same segment (2024 page 7). Thus, Disney’s reliance on Industrial Light & Magic remained a steady, ancillary component of the Content Sales/Licensing segment from FY 2022 through FY 2024, without a change in how the revenue was classified or highlighted.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entity accuracy and basic structure: Industrial Light & Magic (ILM) is correctly identified as part of the Content Sales/Licensing segment across fiscal 2022–2024, and the citations to specific pages in each filing support the claim that ILM’s post-production services were consistently reported within that segment. There are no numeric inaccuracies, and since the question does not involve monetary figures or calculations, quantitative accuracy is scored highly. However, the LLM answer misses a key qualitative evolution emphasized in the original answer: the shifting narrative and strategic repositioning of ILM’s role within the segment over time. While the LLM correctly notes that ILM was consistently grouped in the same segment, it concludes there was 'no change in how the revenue was classified or highlighted,' which contradicts the ground truth’s observation that the segment’s focus evolved—emphasizing TV/VOD and theatrical distribution in 2023 and aligning with a DTC-first model in 2024. This reflects a failure in multi-hop reasoning to synthesize subtle but important shifts in narrative emphasis across years. The LLM treats consistency in classification as evidence of static strategic importance, whereas the original answer infers a contextual shift in reliance and framing. Thus, while the surface-level facts are correct, the deeper analytical insight is missing, reducing qualitative accuracy. Contextual relevance is high because the answer addresses the core question about ILM’s role in the segment, but it underperforms on capturing the evolution in strategic framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 454,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "MetLife reported the following equity‑method earnings that are attributable to its operating joint‑venture (insurance‑underwriting) investments:\n\n* **2022:** $1,305 million  \n* **2023:** $151 million  \n* **2024:** $988 million  \n\nThe figure fell sharply in 2023, reflecting a steep decline in earnings from the underwriting joint ventures, but rebounded strongly in 2024, regaining most of the lost contribution (though still below the 2022 level). This pattern suggests that the profitability of MetLife’s insurance‑underwriting joint ventures was volatile, with a pronounced downturn in 2023 followed by a notable recovery in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the reported equity method investment income figures for 2022 ($1,305 million), 2023 ($151 million), and 2024 ($988 million) are accurate and match the original answer exactly. (2) The answer is complete, addressing both the evolution of the income over the three years and the implied trend about performance in insurance underwriting joint ventures. (3) Entity accuracy is correct: MetLife is the subject, the metric is properly identified as equity-method earnings from operating joint ventures (specified as insurance-underwriting), and the years are correct. (4) The reasoning is sound: the sharp decline in 2023 and strong rebound in 2024 are correctly interpreted, and the conclusion about volatility in joint venture profitability aligns with the ground truth. The LLM adds minor but reasonable elaboration (e.g., 'regaining most of the lost contribution') that does not distort meaning. All elements demonstrate semantic equivalence and factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 302,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "General Dynamics’ Land Systems unit was building **399 new LAVs** for the Canadian Army in 2022 【page_10】, fell to **360 LAVs** in 2023 【page_11】, and then rose to **449 LAVs** in 2024 【page_10】.  The rebound and overall upward trend after a modest dip show that the LAV platform is a core, growing component of GD’s defense business, with the company expanding production to meet the Canadian Army’s expanding requirements and reinforcing the vehicle’s strategic importance in its portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the production volumes and their year assignments. According to the ground truth, production increased from 360 units in 2022 to 399 in 2023 and 449 in 2024. However, the LLM incorrectly states that 399 LAVs were built in 2022, then 'fell to 360' in 2023, which reverses the actual trend. Only the 2024 figure (449 units) is correct. This misrepresentation undermines the quantitative accuracy. (2) The numbers themselves (360, 399, 449) are all present in the LLM answer, but they are assigned to the wrong years, leading to an incorrect interpretation of a 'dip' and 'rebound' rather than a consistent upward trend. Calculations or comparisons based on these numbers would therefore be flawed. (3) The multi-hop reasoning is partially sound in that the model attempts to synthesize production figures across years and draw a strategic conclusion about the LAV platform’s importance. However, because the temporal sequence is wrong, the reasoning is based on a false premise. The conclusion that the LAV platform is strategically important is aligned with the original answer, but the justification is weakened by incorrect data progression. (4) Contextual relevance is high because the answer addresses both parts of the question—production volume evolution and strategic significance—and stays focused on General Dynamics and the Canadian Army LAV program. Despite incorrect data ordering, it attempts proper synthesis. The correctness score is low due to the critical error in year-to-number mapping, which distorts the trend analysis essential to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 448,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "CVS’s pension plan disclosed that the amount of hedge‑fund limited‑partnership investments that are measured at NAV (and therefore excluded from the fair‑value hierarchy) grew each year: $225 million in 2022, $237 million in 2023 and $252 million in 2024. The steady rise—about $12 million then $15 million—shows the company is gradually increasing its exposure to hedge‑fund LPs, reflecting a deliberate shift in the pension‑fund asset mix toward more alternative‑asset allocations to boost diversification and long‑term return potential.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, CVS's exposure was $214M in 2022, $225M in 2023, and $252M in 2024. However, the LLM states $225M in 2022, $237M in 2023, and $252M in 2024—misreporting the first two years. The 2024 figure is correct. The increases are also misrepresented: ground truth shows +$11M (2022–2023) and +$27M (2023–2024), while LLM claims +$12M then +$15M, which does not align with either its own numbers or the truth. (2) Calculations are incorrect: from $225M to $237M is a $12M increase (correctly stated), but from $237M to $252M is a $15M increase (also correctly calculated by LLM), though based on wrong base values. The core trend of increasing exposure is accurate, but the magnitude and starting point are off. (3) The multi-hop reasoning is sound—LLM correctly infers a strategic shift toward alternative investments based on a three-year upward trend, which aligns with the ground truth’s interpretation. Entity identification (CVS, hedge fund LP investments, pension fund asset allocation) is accurate. (4) Contextual relevance is high—the answer addresses both the evolution of exposure and the strategic implication. However, due to material errors in key financial figures, especially the misstatement of the 2022 baseline and 2023 value, the correctness score is reduced to 6, reflecting partial accuracy with significant factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 399,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "Across all three years the 10‑K’s “Nature of Operations” sections list **Sorriso** together with the other core trademarks (Colgate, Palmolive, Darlie, etc.) and describe it as part of the **Oral, Personal and Home Care** segment — the same segment that houses the company’s toothpaste and other oral‑care products. In 2022, 2023 and 2024 the filing therefore shows Sorriso positioned as a **global oral‑care brand** that remains fully integrated in the company’s worldwide Oral, Personal and Home Care portfolio, with no indication of a strategic shift, launch, or divestiture during that period【page_79】【page_79】【page_79】.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of dates (2022, 2023, 2024), entities (Sorriso, Colgate-Palmolive, Oral, Personal and Home Care segment), and overall continuity of brand positioning. It correctly identifies that Sorriso was consistently listed as a core trademark across all three years and remained integrated in the same business segment, with no strategic shifts noted. However, there is a key qualitative discrepancy: the LLM describes Sorriso as a 'global oral-care brand,' while the original answer emphasizes it as a 'regional' brand, not global. This mischaracterization affects the strategic interpretation — the ground truth highlights Sorriso’s role in regional market penetration, whereas the LLM elevates it to global status, which is not supported by the knowledge graph. This is a significant nuance in strategic positioning. Quantitatively, there are no numbers to verify, so accuracy is 10. Contextually, the answer is highly relevant and well-supported with citations. The reasoning is sound in noting consistency across years, but the failure to distinguish regional vs. global status weakens the qualitative accuracy, especially in a multi-hop question about strategic evolution. Thus, correctness is reduced to 7 due to this misclassification, despite overall strong alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 370,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "MetLife’s reported amount tied to operating joint‑venture investments fell from **$51 million in 2022** to **$38 million in 2023**, then jumped to **$175 million in 2024** (see the “Operating joint ventures” line in the investment‑income table). The three‑year swing—from a modest decline to a sharp increase—suggests the company pulled back on these equity‑method stakes in 2023 but is now deliberately expanding its exposure, signaling a renewed strategic focus on growing operating‑joint‑venture holdings within its broader equity‑method portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further to $38 million in 2024. However, the LLM claims exposure was $51 million in 2022, $38 million in 2023, and then a sharp increase to $175 million in 2024—three out of three numbers are wrong, with the last being more than 4.5 times the correct value. (2) The quantitative inaccuracies are severe: the starting value is incorrect ($51M vs $77M), the second year is off ($38M vs $51M), and the 2024 figure is catastrophically wrong ($175M vs $38M). There are no valid calculations or comparisons possible when all base numbers are false. (3) The multi-hop reasoning is fundamentally flawed. Instead of identifying a consistent downward trend indicating strategic retreat, the LLM fabricates a narrative of a rebound and strategic expansion, which contradicts the actual trend. The model fails to synthesize the correct data points across years and draws the opposite conclusion. (4) While the answer is framed around the right topic (MetLife’s joint venture exposure and strategic implications), the complete factual inaccuracy in numbers, trend, and resulting interpretation severely undermines correctness. The contextual relevance is low but not zero because it addresses the right company, metric type, and time frame, albeit with wrong data and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 414,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "By 2022 Chevron was already a sizable equity holder in Angola LNG Limited, owning **36.4 % of the LNG joint‑venture** but it was a non‑operating shareholder that simply benefited from the plant that liquefied associated gas from Angola (see Note 15, 2022 10‑K)【page_78】.  \n\nIn the 2024 filing Chevron’s stake **remains at 36.4 %**, but the company’s role has broadened: it now links its upstream gas assets to the LNG plant through the **Block 0 Sanha Lean Gas Connection project** (which adds pipelines that feed gas from Blocks 0 and 14 into Angola LNG) and through its **31 % non‑operated interest in the New Gas Consortium (NGC)**, whose Q‑M fields will deliver gas to the same LNG facility (2024 10‑K)【page_13】【page_14】.  \n\nThus, from 2022 to 2024 Chevron’s involvement evolved from a passive equity investor to an active integrator of upstream gas production and mid‑stream infrastructure that supplies the Angola LNG plant, while maintaining the same 36.4 % ownership percentage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Chevron's stake in Angola LNG Limited is accurately reported as 36.4% in both 2022 and 2024, and its 31% non-operated interest in the New Gas Consortium (NGC) is correctly stated. The evolution from passive investor to integrated participant is well-articulated. (2) Quantitative accuracy is perfect: percentages (36.4%, 31%) and years (2022, 2024) match the original answer exactly. No calculations are required, but the consistency of stake percentages over time is correctly maintained. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years and entities—linking Chevron’s upstream assets (via NGC and Block 0 projects) to the Angola LNG plant—demonstrating a clear understanding of operational integration. The mention of the 'Sanha Lean Gas Connection project' adds specificity not in the original but is contextually consistent and plausibly accurate based on external knowledge; however, the original answer emphasizes Quiluma and Maboqueiro fields via NGC, which the LLM references indirectly. (4) Semantic equivalence is strong: the core conclusion—that Chevron evolved from passive equity holder to active integrator while maintaining ownership—is identical in meaning. The only minor gap is less explicit emphasis on the 2023 transition year, but this does not detract from the overall correctness. Wording differences are acceptable and do not affect factual integrity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 414,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "- Fiscal 2022: the 3.625 % senior notes due October 2024 were still on the books at roughly **$1.5 billion** (AVGO 10‑K 2022, Note “Senior Notes”).  \n- Fiscal 2023: the same series had been trimmed to **$622 million** (AVGO 10‑K 2023/2024, Table “Senior Notes – Effective Interest Rate”, October 29 2023 column).  \n- Fiscal 2024: the notes were completely retired – the table shows a “‑” for the 3.625 % Oct 2024 issue (AVGO 10‑K 2024, same table, November 3 2024 column).\n\n**Interpretation:** Over the three‑year span AVGO steadily reduced its exposure to the maturing 3.625 % notes, moving from a sizable $1.5 bn balance to zero just before the October 2024 maturity. This pattern reflects a deliberate debt‑management approach that used new senior‑note issuances and cash proceeds (including proceeds from the VMware merger) to refinance and pre‑pay the upcoming obligation, thereby lowering near‑term debt and locking in lower‑cost financing as the maturity date approached.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, AVGO had $622 million in 3.625% notes due October 2024 outstanding in both 2022 and 2023, with full retirement in 2024. However, the LLM claims the balance was $1.5 billion in 2022 and reduced to $622 million in 2023, implying a repayment of ~$878 million early in the period. This contradicts the ground truth, which shows no change from 2022 to 2023. The 2024 retirement is correctly identified, aligning with the original answer. (2) The dollar amounts are therefore quantitatively incorrect for 2022 and 2023. The $1.5 billion figure appears to be a confusion with another tranche of senior notes (possibly the 3.25% or 3.875% notes also listed in the 10-K), but it is not attributable to the 3.625% October 2024 series. The citation to AVGO 10-K 2022, Note 'Senior Notes' may reference total debt or a different note series. The 2023 and 2024 data points ($622 million and retirement) are accurate and correctly interpreted. (3) The multi-hop reasoning is partially sound—correctly tracking the reduction from 2023 to 2024 and interpreting the dash in the 2024 table as retirement. However, the erroneous 2022 figure undermines the progression narrative. The interpretation of a 'steady reduction' is thus misleading, as the ground truth shows stability until full retirement. The mention of the VMware merger as a source of cash proceeds is plausible context but not present in the ground truth and cannot be verified from the provided data, introducing unsupported inference. (4) Despite incorrect initial figures, the core conclusion about proactive debt management is directionally consistent with the original answer. The contextual relevance is high, as the structure and intent match the question, and the final retirement is correctly noted. However, the quantitative inaccuracy in the starting value severely impacts overall correctness, warranting a mid-range score of 5. Quantitative accuracy is penalized heavily (4/10) due to the incorrect $1.5B figure. Qualitative accuracy is moderate (6/10) due to correct synthesis in later years and logical interpretation. Contextual relevance is strong (9/10) as the answer addresses all parts of the question with appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 620,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "The unsecured 35B notes carry a $750 million face amount and a fixed 3.80 % coupon.  In the debt‑service tables that appear in the 2022, 2023 and 2024 10‑Ks, the annual debt‑service (interest) shown for the 35B notes is **$28.5 million** in each year.  Because the coupon and principal balance have not changed, the interest expense on this series has been essentially flat from 2022 through 2024, indicating that SPG’s financing cost for the 35B instrument has remained stable over this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the interest expense for Unsecured Notes - 35B is correctly stated as $28.5 million (i.e., $28,500 in thousands) for 2022, 2023, and 2024. The format variation ($28.5 million vs $28,500 in thousands) is acceptable and commonly used. (2) The LLM adds helpful context not in the original answer—namely, the $750 million face amount and 3.80% coupon rate—which explains why the interest expense is $28.5 million (750M × 3.80% = 28.5M), demonstrating sound reasoning. (3) The multi-hop reasoning is correct: the model synthesized consistent interest expense data across three years from the 10-K filings and correctly inferred a fixed interest rate structure due to stable financing costs. (4) The answer fully addresses both parts of the question: the evolution of interest expense (flat over time) and what the trend suggests (stable financing costs due to fixed-rate debt). All entities (SPG, Unsecured Notes - 35B, years 2022–2024) are correctly identified. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 319,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "From 2022 to 2024 Disney moved from an initial “cost‑realignment” and ad‑supported Disney+ rollout (and a DMED re‑organization to advance DTC) to a broader, multi‑year streaming strategy that leans heavily on strategic investments in its DTC platforms. In 2023 the company reorganized its media business into Entertainment and Sports, introduced a new content‑curation approach (removing under‑performing titles and taking impairment charges), launched an ESPN‑branded DTC service and continued to fund higher‑cost programming and sports rights, while confronting flat subscriber growth and rising competition. By 2024 Disney has aggregated its entertainment reporting units, tightened cost‑containment, and is counting on its DTC investments to drive subscription‑ and ad‑revenue growth that offsets the higher programming costs and pricing pressure created by an increasingly crowded streaming market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the overall evolution of Disney's DTC strategy from 2022 to 2024, and correctly captures the key themes: rising programming costs, intensified competition, strategic reorganization, and the shift toward streaming. It accurately reflects Disney's increasing investment in DTC platforms, the focus on subscription and ad revenue to offset linear declines, and cost-containment measures by 2024. While the LLM answer does not include the specific $12.25 billion in unused bank facilities from 2023 (a minor omission), it does not introduce any incorrect numbers, so quantitative accuracy remains high. The mention of DMED reorganization, ESPN-branded DTC launch, content curation, and impairment charges aligns with known strategic moves, though these specifics are not in the original answer—however, they are plausible and contextually appropriate, not contradicting the ground truth. The reasoning is sound and synthesizes multi-year strategic shifts correctly. The answer is highly relevant and conveys the same core narrative as the original: a shift from uncertain early returns to a more aggressive, financially backed streaming push amid growing costs and competition. The score is 8 due to the omission of the specific financial capacity figure, but no factual inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1596,
        "completion_tokens": 377,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "MetLife continued to apply the “deposit” method for re‑insurance contracts that do not expose the reinsurer to a significant insurance‑risk loss.  In the 2022 filing the company did not break out a separate deposit‑asset or deposit‑liability balance (the amounts were immaterial and were disclosed only as part of overall reinsurance assets and liabilities).  By the end of 2023, after the November‑2023 risk‑transfer deal with Global Atlantic, MetLife reported **$5.1 billion of deposit assets** (recorded in “premiums, reinsurance and other receivables”) and **$1.3 billion of deposit liabilities** (recorded in “other liabilities”).  The Global Atlantic transaction added $10.3 billion of reinsurance recoverables and deposit receivables, transferred $9.5 billion of assets to the reinsurer, retained $5.0 billion of separate‑account assets and recorded a $770 million net cost of reinsurance in other liabilities, which together created the 2023 deposit balances.  In 2024 the balances adjusted to **$4.6 billion of deposit assets** and **$1.2 billion of deposit liabilities**, reflecting the amortization of the net cost and the ongoing impact of the Global Atlantic risk‑transfer arrangement.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 risk transfer transaction with Global Atlantic and its impact, including the $10.3 billion in reinsurance recoverables and deposit receivables, which matches the ground truth. It also accurately reports the 2024 deposit assets ($4.6 billion) and liabilities ($1.2 billion), aligning with the original answer. However, it incorrectly states that in 2022, MetLife did not break out separate deposit asset/liability balances because they were immaterial, which contradicts the ground truth stating explicit 2022 figures of $1.8 billion in deposit assets and $1.4 billion in liabilities. This is a significant quantitative and factual discrepancy. Additionally, the LLM introduces a figure of $5.1 billion in deposit assets for 2023, which is not present in the ground truth; the original answer does not provide 2023 year-end deposit balances but notes a significant increase due to the transaction. The $5.1 billion figure appears to be an inference or error. The $1.3 billion liability in 2023 is close to the 2022 $1.4 billion and plausible as a transition to $1.2 billion in 2024, but the absence of explicit 2023 disclosure in the ground truth makes this a partial mismatch. (2) The calculation of the $770 million net cost of reinsurance and $9.5 billion asset transfer is detailed but not present in the ground truth, suggesting over-inference. While internally consistent, these figures cannot be verified against the provided truth and may reflect external data. (3) The multi-hop reasoning is strong: the model connects the Global Atlantic transaction to changes in deposit balances and explains the evolution into 2024 with amortization effects, showing sound logic and synthesis. (4) Despite incorrect or unverified 2022 and 2023 figures, the answer captures the strategic shift and post-transaction rebalancing, conveying a largely accurate narrative. The contextual relevance is excellent, addressing all parts of the question with appropriate financial terminology and causal explanation. The correctness score is reduced due to key numerical inaccuracies in 2022 and unsupported 2023 figures, but the core trajectory and 2024 outcome are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 593,
        "total_tokens": 2108
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "CVS’s holding of commercial‑mortgage‑backed securities fell sharply over the three‑year period. In the “debt securities – available‑for‑sale” portfolio the amortized‑cost amount dropped from **$1,172 million (fair value $1,018 million) at 12/31/2022** to **$1,066 million (fair value $975 million) at 12/31/2023** (see CVS 2023 10‑K, page 147). By the next year the exposure had been almost eliminated, with the Separate‑Accounts table showing only **$3 million of commercial‑mortgage‑backed securities at 12/31/2024** (down from $6 million a year earlier) (see CVS 2024 10‑K, page 160).  \n\nThe consistent decline indicates that CVS is deliberately scaling back its CMBS position, likely to reduce interest‑rate and credit‑risk exposure and to reallocate capital toward other, more liquid or lower‑duration assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, CVS held $574 million in CMBS in 2022, increased to $675 million in 2023, and dropped to $3 million in 2024. However, the LLM claims $1,172 million (amortized cost) in 2022 and $1,066 million in 2023, which are more than double the correct amounts. These figures appear to conflate total debt securities or misattribute data from different categories (e.g., 'debt securities – available-for-sale' may include more than just CMBS). The only correct number is the $3 million in 2024. (2) The calculations and comparisons are therefore incorrect: there was no 'consistent decline' from 2022 to 2023 as claimed; instead, there was a notable increase from 2022 to 2023 followed by a steep drop in 2024. The LLM misrepresents the trajectory. (3) The multi-hop reasoning is partially sound in that it identifies a decline from 2023 to 2024 and infers strategic de-risking, but it fails to capture the full three-year evolution due to incorrect early-year data. The synthesis across years is flawed because the 2022 and 2023 numbers are wrong. (4) While the conclusion about de-risking is directionally plausible, it is based on incorrect data. The contextual relevance is high because the answer addresses the question structure and cites appropriate document sections, but the factual foundation is weak. Thus, the correctness score is low due to major quantitative errors, despite reasonable formatting and some correct elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 421,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "Across all three filings the **hello** brand is consistently shown as a core trademark. In the 2022 10‑K (p. 79) it appears in the “principal global and regional trademarks” list and is part of the Oral‑care portfolio, which accounted for 43 % of worldwide net sales (Table on p. 79). The 2023 10‑K (p. 79) again lists **hello** among the trademarks, while oral‑care’s share of net sales is noted at 42 % (p. 79), and the 2024 10‑K (p. 79) continues to include **hello** in the trademark disclosure with oral‑care representing 43 % of sales (p. 79). Thus, the brand’s positioning has not changed – it remains a highlighted oral‑care trademark and the segment’s strategic weight has stayed roughly constant from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 'hello' brand is consistently listed as a trademark in Colgate-Palmolive’s 10-K filings for 2022, 2023, and 2024, specifically on page 79 of each report, and is positioned within the Oral Care segment. The percentages of worldwide net sales attributed to Oral Care (43%, 42%, 43%) are accurately reported and match the source data. (2) Quantitative accuracy is perfect—percentages and page references are correct, and no calculation errors are present. (3) The reasoning is sound: the model correctly infers that the consistent inclusion of 'hello' in trademark disclosures over three years indicates stable strategic positioning, which is consistent with the ground truth’s conclusion about continuity and portfolio stability. (4) The answer is contextually excellent, directly addressing the evolution (or lack thereof) of the brand’s positioning across the three years and linking it to segment-level strategic emphasis. The only minor limitation is that the LLM focuses narrowly on Oral Care, while the original answer also references Personal and Home Care more broadly—though 'hello' is primarily an oral care brand, the ground truth acknowledges a slightly wider segment context. This does not invalidate the answer but represents a slight narrowing of scope. Overall, the answer is factually correct, well-supported, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 409,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "MetLife’s 2022 filing first disclosed that it “re‑insured … 59 % of the closed block through a modified‑coinsurance agreement” and that this arrangement is accounted for under the **deposit method** (the company offsets the deposit with a corresponding recoverable)【page_214】.  At that time the only quantitative detail given for deposit‑method contracts was the historic level of **$1.8 bn of deposit assets and $1.4 bn of deposit liabilities** recorded in 2020‑2021【page_216】, indicating a relatively modest use of the method.\n\nBy the 2023‑2024 filings the balance‑sheet figures for the same accounting treatment had grown dramatically.  The 2023 balance sheet shows **deposit assets of $5.1 bn and deposit liabilities of $1.3 bn**【page_206】, and the 2024 balance sheet shows **deposit assets of $4.6 bn and deposit liabilities of $1.2 bn**【page_206】.  The increase follows a large risk‑transfer transaction with Global Atlantic that moved billions of dollars of assets to the reinsurer while retaining a right of offset.\n\n**Trend interpretation:**  The steep rise in deposit‑asset balances (from under $2 bn to over $5 bn) signals that MetLife has expanded its use of the deposit‑method to transfer a much larger portion of its in‑force block to third‑party reinsurers, using the method to fund the transfer with collateral‑backed assets.  The relatively modest and slightly declining deposit‑liability balances show that the company’s net credit exposure remains limited, reflecting a strategy of increasing risk diversification through reinsurance while keeping the residual liability on its books low.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the trend in MetLife's use of the deposit method of accounting for reinsurance agreements from 2022 to 2024 and links it to strategic shifts, including the Global Atlantic transaction. It accurately notes the $4.6 billion deposit assets and $1.2 billion liabilities in 2024, matching the ground truth. However, it incorrectly states 2023 deposit assets as $5.1 billion (ground truth: $4.6 billion) and liabilities as $1.3 billion (ground truth: $1.2 billion). Additionally, it references 2020–2021 figures as the latest available in 2022, while the ground truth states 2022 figures were $1.8B and $1.4B — implying the LLM misattributes timing. 2) Quantitative inaccuracies: The 2023 numbers are wrong, and the use of $5.1B instead of $4.6B introduces a material error. The 2024 numbers are correct. The 2022 reference to $1.8B/$1.4B is correct but mislabeled as 2020–2021 data rather than current 2022 figures. 3) The multi-hop reasoning is strong: the LLM correctly infers that rising deposit assets reflect increased use of reinsurance structures without full risk transfer, ties it to the Global Atlantic deal, and interprets stable/declining liabilities as a sign of limited net exposure — all consistent with the ground truth’s interpretation. 4) Despite numerical inaccuracies in 2023 data, the overall narrative and strategic interpretation align well with the ground truth. The answer is contextually rich and relevant, citing specific pages and mechanisms. The correctness score is 7 due to accurate core trends and interpretation but docked for significant quantitative errors in 2023 figures and misdating of 2022 data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1675,
        "completion_tokens": 453,
        "total_tokens": 2129
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "From 2022 to 2024 the amount reported as “Special‑use funds” on NEE’s balance sheet rose sharply – about $6.5 billion of fair‑value assets in 2022 (the sum of the Level 1/2 equity, government‑bond and debt holdings shown in the 2022 fair‑value table), to $8.7 billion in the 2023 comparative balance sheet and $9.8 billion in 2024 – the line is presented under non‑current other assets and is broken out in the notes by hierarchy level.  At the same time the derivative exposure that could trigger collateral postings fell: the liability‑position fair‑value of derivatives with credit‑risk‑related features dropped from $7.4 billion in 2022 to $4.7 billion in 2023, reducing the potential collateral required for a BBB‑downgrade from roughly $1.6 billion (2022) to $0.5 billion (2023) and for a below‑investment‑grade scenario from $5.2 billion to $2.4 billion, with actual posted collateral falling from $1.8 billion cash + $2.8 billion letters of credit (2022) to $0.7 billion cash + $1.6 billion letters of credit (2023).  Thus, while the special‑use fund balances grew and remained disclosed at fair value on the balance sheet, the associated collateral risk from derivatives declined over the same period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. First, the claimed $6.5 billion Special Use Funds value in 2022 is not supported by the ground truth, which states $8,698 million in 2023 and implies a lower amount in 2022, but does not specify an exact 2022 total. The LLM incorrectly calculates or assumes a 2022 total from Level 1/2 assets, which is not provided in the original answer. The 2023 ($8.7B) and 2024 ($9.8B) figures are approximately correct (matching $8,698M and $9,800M), though rounded. However, the core error lies in introducing derivative collateral risk data (e.g., $7.4B liability in 2022, $4.7B in 2023, collateral postings, downgrade scenarios) that are entirely absent from the original answer — these figures and concepts were not part of the ground truth. The original answer mentions 'collateral implications' in a general sense tied to enhanced transparency, but provides no specific derivative liabilities or collateral amounts. Thus, the LLM fabricates detailed quantitative risk metrics not present in the source. While the LLM correctly identifies the balance sheet growth and fair value disclosure practices, it misrepresents the nature and evolution of collateral implications. The reasoning is partially sound in tracking fair value increases and balance sheet presentation, but fails in multi-hop synthesis by conflating unrelated derivative data. The answer is contextually relevant and addresses the three areas (fair value, collateral, balance sheet), but with major factual errors in the collateral section. Semantic equivalence fails on key metrics due to unsupported numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1581,
        "completion_tokens": 452,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K Broadcom described its **Security Insights Platform** as a main‑frame‑security solution that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis,” and it emphasized that **the data is available for use with customers’ in‑house security‑information‑and‑event‑management (SIEM) tools**. The 2024 filing repeats the same positioning – risk‑assessment and remediation‑step guidance – and still notes that the output can be consumed by in‑house tools, but it does **not add any new capability such as built‑in automated remediation workflows**; the platform remains a source of insight that customers integrate into their own remediation processes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AVGO (Broadcom) described the Security Insights Platform in both 2022 and 2024 filings with consistent language around assessing mainframe security posture, identifying risks, and developing remediation steps. It accurately notes the availability of data for integration with in-house SIEM tools. The key point that no new capabilities—such as automated remediation workflows—were added by 2024 is correctly highlighted, matching the ground truth assertion of a stable value proposition. (2) There are no numeric values requiring calculation, but the years (2022 and 2024) are correctly cited, and the absence of 2023-specific changes is implicitly handled by focusing on the comparison across 2022 and 2024, which is acceptable given the ground truth's note that 2023 was unchanged. (3) The multi-hop reasoning is sound: the model synthesizes information across two time points (2022 and 2024) and correctly infers that the lack of new language indicates no expansion in integration or remediation features. It correctly interprets that the platform remains an insight engine, not an automated remediation tool. (4) The only minor shortcoming is that the LLM omits explicit mention of the 2023 filing, though this does not detract significantly from the overall accuracy since the core evolution (or lack thereof) from 2022 to 2024 is correctly conveyed. Wording differs slightly but maintains semantic equivalence. Scores reflect high accuracy with a small deduction in qualitative accuracy for incomplete temporal coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 445,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "Nike has listed the Laakdal, Belgium distribution center as an owned, “most‑significant” non‑U.S. facility in every recent 10‑K. In FY 2022 the filing notes that the Laakdal site “…all of which we own” 【page_29】, the FY 2023 filing repeats the same language describing Laakdal among the owned overseas hubs 【page_27】, and the FY 2024 filing again states that the Laakdal facility is owned 【page_29】. Because ownership and the description of its role have not changed, the Laakdal plant remains a core, company‑controlled logistics hub for Europe, indicating its continued strategic importance to Nike’s European (EMEA) supply‑chain network.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) It correctly states that NIKE owned the Laakdal, Belgium facility in fiscal years 2022, 2023, and 2024, with consistent characterization as a 'most significant' international distribution center—matching the original answer's claim of no changes in ownership or operational role. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the fiscal years (2022, 2023, 2024) are correctly referenced, and the citations to specific 10-K pages (e.g., page_29, page_27) are consistent with typical reporting patterns and do not contradict the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information across three fiscal years and correctly infers that the repeated language indicates stability and strategic importance, which is the core conclusion in the original answer. (4) The LLM uses slightly different phrasing (e.g., 'core, company-controlled logistics hub' vs. 'stable and integral part') but maintains semantic equivalence. All aspects of the question—ownership evolution, operational footprint, and strategic implication—are addressed accurately and completely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 341,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "Across the three most recent 10‑K filings the “Unsecured Notes ‑ 32B” line is unchanged. In the 2022 filing (which reports the 2021 year‑end), the 2023 filing and the 2024 filing the notes all carry a **3.38 % fixed rate**, a **$750 million face amount** and a **maturity of June 15, 2027** (annual debt service $25.3 million in each case). The consistency of rate, size and maturity over the 2022‑2024 period indicates that Simon Property Group is deliberately keeping this tranche of unsecured debt on‑loan to run it to maturity rather than refinancing or restructuring it, reflecting a “hold‑to‑maturity” approach to preserve low‑cost, long‑dated financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the interest rate (3.38%), face amount ($750 million), and maturity date (June 15, 2027) for Unsecured Notes - 32B across 2022–2024, matching the ground truth. The original answer notes that the maturity date was 'unspecified' in 2022 but explicitly listed in 2023 and 2024; the LLM assumes it was known in 2022, which is a minor discrepancy in reporting nuance but does not contradict factual accuracy since the actual maturity date is correct. The face amount is reported as $750 million (LLM) vs $750,000 (original) — this is a critical difference. However, given that $750,000 is implausibly small for a major corporate debt instrument and inconsistent with typical SEC filing scales, and considering that 'million' is standard in such contexts, it is likely the original answer contains a transcription error (missing 'million'). Thus, $750 million is accepted as correct based on contextual plausibility and industry norms. (2) All numeric values — 3.38%, $750 million, 06/15/27 — are accurate and consistently applied. Annual debt service of $25.3 million is a derived figure (3.38% of $750M ≈ $25.35M), so its inclusion is a reasonable and accurate addition. (3) The multi-hop reasoning is sound: the LLM synthesizes data across three years and correctly infers a stable debt strategy, aligning with the original conclusion of no refinancing or restructuring. The 'hold-to-maturity' characterization is a slightly more interpretive but valid reframing of SPG’s strategy. (4) The answer fully addresses all parts of the question — evolution of terms and strategic implication — and conveys semantically equivalent (and slightly enriched) information. Only minor deduction in qualitative accuracy due to assuming maturity clarity in 2022, though the core facts remain correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 497,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "- **2022:** The 2023 filing shows that CVS held $2.55 billion of foreign debt‑securities at fair value, with $244 million of gross unrealized losses (≈9 % below amortized cost).  \n\n- **2023:** The 2023 filing’s “Unrealized‑loss” table shows the foreign‑security position fell to a fair value of $2.51 billion and the gross unrealized loss narrowed to $122 million (≈5 % below cost).  \n\n- **2024:** The 2024 filing’s Separate‑Accounts schedule shows foreign‑security assets had shrunk to only $51 million of fair‑value holdings; no unrealized‑loss amount is disclosed, implying the foreign portfolio was essentially sold down.\n\n**Interpretation:** Over the three‑year span CVS dramatically reduced the size of its foreign‑security portfolio, cutting the fair‑value balance from more than $2.5 billion to a few tens of millions and eliminating the previously reported unrealized losses. This contraction suggests the company is actively limiting its exposure to international market‑risk factors such as foreign‑currency swings and overseas interest‑rate movements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, CVS's fair value of foreign securities was $838 million in 2022 and $1,650 million in 2023, but the LLM reports $2.55 billion in 2022 and $2.51 billion in 2023—values that are overestimated by nearly double. Additionally, the LLM attributes $244 million in unrealized losses for 2022, whereas the ground truth states $24 million, a tenfold difference. Only the 2024 fair value of $51 million matches the ground truth. The 2023 unrealized loss of $122 million is correctly reported. (2) Calculations and percentages are based on incorrect inputs: claiming ≈9% below cost in 2022 and ≈5% in 2023 may be mathematically consistent with the LLM’s erroneous numbers, but they do not reflect the actual data. The ground truth shows a tripling of fair value from 2022 to 2023 and a massive drop in 2024, while the LLM implies only a slight decline over the period. (3) The multi-hop reasoning is partially sound—the LLM correctly infers reduced exposure implies de-risking and links it to international market risks like currency and interest rate fluctuations. It also correctly identifies the near-elimination of foreign holdings by 2024. However, because the underlying data is wrong for 2022 and 2023, the trend analysis is misleading. The actual trend (sharp increase then drop) suggests a strategic bet that was reversed, whereas the LLM implies a gradual reduction. (4) Despite incorrect numbers, the answer addresses all parts of the question and provides a reasonable interpretation of risk exposure reduction. Hence, contextual relevance is high, but quantitative accuracy is severely compromised, dragging down overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 474,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "MetLife’s disclosures for 2022, 2023 and 2024 all show that its non‑agency RMBS and CMBS are reported using the NAIC’s six‑point “designation” scale (designations 1‑6). Each year the filing notes that an “internally‑developed designation is used only until a NAIC designation becomes available,” and the tables for all three years already contain NAIC‑designated balances for those securities, implying that any newly‑acquired RMBS/CMBS quickly receive an NAIC rating and the interim internal label disappears. This consistent, multi‑year pattern demonstrates that MetLife relies almost entirely on the NAIC’s modeling methodology to assess credit quality for non‑agency RMBS and CMBS, using internal designations merely as a temporary bridge.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of MetLife using internally developed designations as a temporary measure until NAIC designations become available, and correctly identifies the company's increasing reliance on the NAIC's methodology. However, it fails to include key quantitative data from the original answer that are critical to assessing the evolution across 2022–2024. Specifically, the LLM omits the $4.2 billion (14.5%) increase in Level 3 fixed maturity securities AFS in 2023 and the $1.6 billion (4.9%) increase in 2024—data points that ground the multi-year pattern in measurable changes and support the conclusion about slowing growth as NAIC designations became more prevalent. These numbers are essential for demonstrating the gradual shift away from internal designations, and their absence significantly weakens the quantitative accuracy. While the LLM correctly notes that internal designations are interim and NAIC ratings are standard, it does not reflect the evolving degree of reliance over time as revealed by the declining growth rate in Level 3 securities. The reasoning is logically sound and entities (MetLife, non-agency RMBS/CMBS, NAIC designations) are accurate, and the answer is contextually relevant. However, the lack of specific financial figures and year-over-year comparisons results in a partially correct, less precise answer that misses the evidentiary basis for the trend. Thus, while semantically aligned in direction, it lacks the multi-hop synthesis of quantitative evidence needed for full correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 424,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "- In 2022 Chevron expanded its Congo footprint by extending deep‑water licences in the Republic of Congo, which added roughly 36 million barrels of oil‑equivalent to its African proved‑undeveloped reserves (a purchase‑type acquisition rather than a cash‑out).  \n\n- In 2023 the company’s Africa capital budget included about **$0.7 billion** spent on offshore development and natural‑gas projects in the Republic of Congo, reflecting continued investment in existing assets.  \n\n- By 2024 Congo remained a material production source (about 20 % of Chevron’s net oil‑equivalent output came from OPEC+ countries that include the Republic of Congo), but the company announced that in January 2025 it would **sell its 31.5 % non‑operated working interest in the Haute Mer permit and its 15.75 % interest in the Lianzi area**, signalling an exit from its Congo holdings.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. Correct elements include the $0.7 billion capital allocation in 2023 for offshore and natural gas projects in Africa (which includes Congo), and the 2024 announcement of Chevron selling its 31.5% nonoperated interest in Haute Mer and 15.75% in Lianzi—though the original answer states this divestiture occurred by 2024, while the LLM incorrectly frames it as announced for January 2025. However, the LLM introduces a significant factual error: in 2022, it claims Chevron 'expanded' its footprint by extending deep-water licenses and adding 36 million barrels of proved-undeveloped reserves via a 'purchase-type acquisition.' This detail is not present in the ground truth and is unsupported; the original answer states only that Chevron operated in Congo in 2022 with no specific investment disclosed. This fabricated detail undermines factual accuracy. (2) Quantitative accuracy is partially correct: $0.7 billion matches the original, and the percentages (31.5%, 15.75%) are accurate. However, the 36 million barrels figure and the claim about reserve additions are unverified and incorrect per ground truth. The 20% production figure from OPEC+ countries including Congo is misleading—while possibly true in aggregate, it misrepresents Congo’s individual contribution and is not in the original. (3) Multi-hop reasoning is partially sound: the model correctly links 2023 investment and 2024 divestiture, but incorrectly infers continued expansion in 2022, contradicting the trajectory toward exit. The reasoning fails to reflect the correct evolution: operation → investment → exit, instead suggesting expansion → investment → exit. (4) Contextual relevance is high—the answer addresses capital allocation and asset ownership changes over 2022–2024 as asked. However, due to significant factual inaccuracies, especially the unsupported 2022 reserve addition, the overall correctness is reduced to a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 539,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "Texas Instruments has kept embedded‑processing products as a core pillar of its “analog + embedded‑processing” business model throughout the 2022‑2024 period. In each filing the company repeats that its **broad portfolio of analog and embedded‑processing products** (advantage (b) of the four sustainable competitive advantages) is the primary source of growth and cash‑flow generation, and it consistently states that its strategic focus remains on analog and embedded‑processing (2022 MD&A p. 19; 2023 MD&A p. 16‑17; 2024 MD&A p. 16‑17). While embedded‑processing revenue rose modestly in 2023 (+3 % vs. 2022) after a 2022‑year increase, it fell sharply in 2024 (‑25 % vs. 2023), yet the company still positions the product line within the same portfolio advantage, indicating that the emphasis has persisted but its contribution has become more volatile.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct strategic context: Texas Instruments consistently emphasizes embedded processing as part of its core 'analog + embedded-processing' business model and ties it to one of its sustainable competitive advantages (specifically advantage (b), the broad portfolio). This aligns with the ground truth's emphasis on continuity in strategic focus from 2022 to 2024. However, the LLM introduces specific revenue performance data—+3% growth in 2023 and -25% in 2024—that are not present in the original answer and cannot be verified from the provided ground truth. Since the original answer makes no mention of revenue trends or volatility, including such specific quantitative claims introduces factual inaccuracies or unsupported inferences, significantly reducing quantitative accuracy. There is no indication in the ground truth that the strategic emphasis has been questioned due to performance, so the conclusion about 'more volatile contribution' is an overinterpretation. While the qualitative reasoning about persistent strategic emphasis is sound and well-structured, the inclusion of unverified financial figures undermines factual correctness. The answer remains contextually relevant and correctly identifies the multi-hop link between embedded processing, the four competitive advantages, and multi-year consistency. However, the unsupported numbers prevent a higher score on correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 399,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "Cisco’s 3.50 % senior note (the $500 million issue due June 15, 2025) carried an effective interest rate of **3.20 % in FY 2022**, rose to **6.38 % in FY 2023**, and climbed again to **6.66 % in FY 2024**【page 89 (2022)】, 【page 89 (2023)】, 【page 89 (2024)】.  \n\nThe upward swing shows that the note’s borrowing cost more than doubled over the three‑year span, reflecting higher market rates (and related hedge accounting effects) and indicating that Cisco’s overall cost of debt has been increasing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the effective interest rates of 3.20% in FY2022, 6.38% in FY2023, and 6.66% in FY2024 are correctly reported, along with the $500 million principal amount and June 2025 maturity date. Minor formatting differences (e.g., '3.50%' vs '3.50 %') are stylistic and do not affect meaning. (2) The answer is complete, addressing both parts of the question: the evolution of the interest rate exposure over the three fiscal years and the implication regarding borrowing costs. (3) Entity accuracy is perfect: Cisco, the 3.50% Senior Note, correct fiscal years (2022–2024), and the financial metric (effective interest rate) are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis across three annual reports. The conclusion that borrowing costs more than doubled and are rising due to higher market rates (and hedge accounting effects) aligns with and expands slightly on the ground truth, without introducing inaccuracies. Semantic equivalence is maintained throughout. All citations reference the correct page and year, enhancing credibility. No errors in facts, logic, or interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 348,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "Across the three most recent filings BNY Mellon repeatedly warns that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning” (2022 10‑K p. 5; 2023 10‑K p. 5; 2024 10‑K p. 5) and that failure to meet “well‑capitalized” or other capital‑adequacy rules could impose activity limits (2022 10‑K p. 5; 2023 10‑K p. 4; 2024 10‑K p. 4). The language is essentially unchanged from 2022 through 2024, showing that the company’s exposure to these regulatory constraints has remained constant and that its strategic flexibility in dividend or share‑repurchase programs continues to be bounded by the same U.S. banking‑law capital‑planning requirements.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its citation of consistent regulatory language across BNY Mellon's 2022–2024 10-K filings regarding U.S. banking laws affecting capital planning and shareholder returns. It correctly identifies the repeated warnings about board discretion, limitations from capital regulations, and consequences of failing 'well-capitalized' standards, with accurate page references. Quantitative accuracy is perfect—no numerical or date errors, and all citations align with the expected content. However, the LLM misses a key qualitative evolution noted in the ground truth: while the core language is stable, the 2023 and 2024 filings expanded the scope to include Delaware law and preferred stock dividend obligations (2023), and in 2024, added stronger emphasis on liquidity management and 'well managed' status. The LLM incorrectly states the language is 'essentially unchanged,' which underrepresents the incremental tightening and broadening of disclosed constraints. This omission affects the reasoning about strategic flexibility, as the ground truth reveals increasing regulatory complexity, not static conditions. Thus, while the answer is contextually relevant and factually sound on surface-level consistency, it fails to capture the nuanced progression in risk disclosure, leading to a lower qualitative accuracy and overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 381,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "- In 2022 the Marine‑Systems “Repair and other services” line generated **$1,169 million**; it slipped to **$1,132 million in 2023** – a decline of **$37 million (≈3 %)**【page_9】.  \n- The same amount was reported for 2024, showing **no change from 2023**【page_9】.  \n\nThe drop in 2023 likely reflects normal timing variations in ship‑maintenance contracts, while the flat result in 2024 indicates that this business is driven by steady, recurring post‑delivery support and lifecycle‑service agreements. The pattern suggests the segment provides a **stable, cash‑generating base** rather than a growth engine, underscoring General Dynamics’ strategic focus on maintaining a reliable service platform for its naval customers.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports all numerical values: $1,169M in 2022, $1,132M in 2023 and 2024, and accurately calculates the $37M (≈3%) decline. These match the ground truth exactly, earning full marks for quantitative accuracy. (2) The entity identification is correct—General Dynamics, the 'Repair and other services' segment, and the relevant years are all properly referenced. (3) However, the reasoning for the flat performance in 2024 differs from the ground truth: the LLM attributes stability to 'steady, recurring post-delivery support and lifecycle-service agreements' and frames the segment as a 'stable, cash-generating base', implying intentional strategic stability. In contrast, the ground truth suggests stagnation may reflect market saturation, resource reallocation, or operational constraints—implying potential limitations rather than deliberate stability. This is a meaningful divergence in interpretation. (4) While the LLM addresses all parts of the question and provides plausible reasoning, it misses the more cautious, potentially negative connotation of 'stagnation' and does not acknowledge the lack of rebound despite growth in other areas (e.g., submarines), which weakens the qualitative accuracy. The answer remains contextually relevant and well-structured, but the differing explanation for the pattern reduces the overall correctness score to 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 386,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "UnitedHealth’s equity‑security portfolio – which is dominated by its venture‑capital stakes – rose from $3.7 billion at the end of 2022 to $4.9 billion at the end of 2024, a $1.2 billion increase that reflects a continued, but measured, expansion of its venture portfolio (the firm also reported growing unrealized gains on those holdings – $211 million in 2022, $276 million in 2023 and $710 million in 2024).  By contrast, its equity‑method investments in operating health‑care businesses more than doubled, climbing from $1.5 billion in 2022 to $3.8 billion in 2024, indicating a strategic shift toward deeper, direct ownership of health‑care assets alongside its venture activities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and timeline. According to the ground truth, UnitedHealth's equity securities (venture investments) were $3.7B in 2022, $4.9B in 2023, and remained at $4.9B in 2024 — the LLM incorrectly states the portfolio rose from $3.7B in 2022 to $4.9B in 2024, omitting the 2023 figure and implying a direct two-year increase, which misrepresents the year-over-year evolution. More critically, the LLM claims equity-method investments rose from $1.5B in 2022 to $3.8B in 2024, but the ground truth shows they were $1.4B in 2022, $1.5B in 2023, and jumped to $3.8B in 2024 — so the starting point and intermediate year are wrong. The LLM also introduces 'unrealized gains' ($211M, $276M, $710M), which are not present in the original answer and cannot be verified from the provided truth. (2) Calculations: The $1.2B increase in equity securities is correct in magnitude but misattributed across years. The 'more than doubled' claim for equity-method investments is directionally correct (from $1.5B to $3.8B is ~153% increase), but based on incorrect baseline. (3) Multi-hop reasoning: The LLM correctly infers a strategic shift toward deeper ownership, which aligns with the ground truth’s conclusion, showing sound qualitative synthesis. However, due to incorrect year-to-year values, the reasoning is based on flawed data. (4) Scores justified: Correctness is 6 due to major quantitative errors but correct overall trend and strategic interpretation. Quantitative accuracy is 5 because key dollar amounts and years are wrong. Qualitative accuracy is 7 because reasoning and strategic emphasis are well-articulated. Contextual relevance is 9 — the answer directly addresses the question’s scope and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 482,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "Philip Morris International’s peer‑group definition did not change for Colgate‑Palmolive Co. – the company appears in the peer‑group list in the 2022 filing (see the list on page 21 【page_21】), again in the 2023 filing (page 26 【page_26】) and once more in the 2024 filing (page 26 【page_26】). This three‑year continuity shows that PMI’s benchmarking framework relies on a stable set of criteria (global presence, consumer‑product focus and comparable size) and deliberately keeps the peer composition constant to enable consistent, longitudinal performance comparison.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Colgate-Palmolive Co. was consistently included in PMI's peer group across 2022, 2023, and 2024, citing specific pages from each year's filing (page 21 for 2022, page 26 for 2023 and 2024), which supports the claim of multi-year consistency. (2) There are no numeric values requiring calculation, but the years and page references are accurate and consistent with the source data. (3) The reasoning is sound: the LLM correctly infers that the unchanged peer group reflects a stable benchmarking framework focused on global presence, consumer-product focus, and comparable size (revenues and market cap), which matches the four criteria in the ground truth. It also correctly identifies the strategic intent behind stability—enabling longitudinal performance comparison. (4) The only minor omission is that the ground truth explicitly mentions the exclusion of direct tobacco industry peers, which adds nuance to PMI’s strategic benchmarking lens; this insight is missing in the LLM response, slightly reducing qualitative completeness. However, the core facts, entities, years, and implications are correctly conveyed. Semantic equivalence is strong, and the answer is fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 363,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "From the 2022 filing PayPal first flagged “fraud, particularly new and continually evolving forms of fraud” and noted that its buyer‑seller protection programs and reliance on third‑party processors could generate losses, but the discussion of credit‑product risk was limited. By the 2023 filing the company explicitly linked its expanding consumer‑credit, merchant‑financing and BNPL portfolios to higher exposure – “our credit products expose us to additional risks” and “measures to detect … fraud … may not be effective … in connection with new or expanded product offerings” (pages 22‑26) – and reiterated that heavy reliance on unaffiliated banks and other third‑party lenders magnifies that exposure. The 2024 filing repeats and deepens those warnings, stressing that continued growth of credit products and third‑party funding arrangements “could increase … exposure to fraud and abusive behavior” (pages 21‑25), suggesting that PayPal’s fraud‑mitigation controls have not kept pace with the broadened product set and third‑party dependencies, and that its overall risk of abusive behavior has risen over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All factual elements are correct: PayPal's increasing exposure to abusive behaviors from 2022 to 2024, the expansion of credit products (especially BNPL), and the heightened risk due to third-party dependencies are all accurately described. The progression across years is logically presented, with appropriate emphasis on growing risk and insufficient mitigation controls. (2) Quantitative accuracy is perfect: while no specific dollar amounts or percentages are mentioned in the LLM answer (e.g., the €40 billion receivables sale in 2023), this omission does not constitute an error because the LLM correctly captures the qualitative significance of the credit expansion without misrepresenting or fabricating numbers. The absence of the euro figure is a minor completeness gap but does not affect factual correctness. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years, connects credit product growth with fraud exposure, and links third-party reliance to increased risk—exactly as required. It correctly infers that fraud mitigation has not kept pace, based on repeated and deepened warnings in filings. (4) Semantic equivalence is strong: though the LLM uses different phrasing (e.g., 'buyer-seller protection programs', 'unaffiliated banks'), the meaning matches the original. The conclusion about rising risk and lagging controls is fully supported. Only a 9 is given because the €40B Europe BNPL transaction—a key quantitative anchor in the original—is omitted, slightly reducing completeness. However, since the question does not explicitly demand all figures, and the trend is correctly conveyed, the answer remains excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1608,
        "completion_tokens": 476,
        "total_tokens": 2084
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "Southern Company’s natural‑gas‑option hedge volume rose sharply from 214 mmBtu in 2022 to 339 mmBtu in 2023, then fell to 176 mmBtu by the end of 2024 (Southern Company Gas showed a similar pattern: 93 → 102 → 83 mmBtu)【page_117】【page_114】. The spike in 2023 suggests the company intensified its option‑based protection when price volatility was high, while the pull‑back in 2024 indicates a scaling‑back once market conditions stabilized or the desired hedge level was reached—demonstrating a dynamic, risk‑management strategy that adjusts option usage to prevailing natural‑gas price risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a quantitative error in the 2022 natural gas options volume. The ground truth states 253 million mmBtu for 2022, while the LLM reports 214 mmBtu, which is inaccurate. The 2023 (339 million mmBtu) and 2024 (176 million mmBtu) figures are correct. The inclusion of Southern Company Gas data (93 → 102 → 83 mmBtu) adds detail not present in the original answer but does not contradict it and may reflect a valid breakdown; however, it introduces information not requested and slightly distracts from the primary entity focus. (2) Calculations are not required in this question, but the trend description—sharp increase in 2023, then decline in 2024—is accurate. The incorrect 2022 baseline affects the perception of the magnitude of change but not the directional trend. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes a 3-year trend and infers strategic intent (increased hedging during volatility, de-risking as conditions stabilize), aligning with the original answer’s interpretation. It correctly identifies the dynamic nature of Southern Company’s risk management strategy in response to price volatility. (4) Despite the numerical inaccuracy in 2022 volume, the overall reasoning, entity identification (Southern Company, natural gas options, years), and contextual interpretation are strong. The answer addresses both parts of the question: evolution over time and strategic implication. The minor factual error prevents a higher score, but the core conclusion remains valid, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 438,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "Texas Instruments’ aggregate expense for its U.S. defined‑contribution plans rose modestly each year – $70 million in 2022, $75 million in 2023 and $76 million in 2024【page_43】.  Because the company’s non‑qualified defined‑benefit pension plans are unfunded and closed to new participants, the steady increase in defined‑contribution spending signals a strategic shift toward a more flexible, employee‑driven retirement model and away from the legacy, closed‑to‑new‑participants defined‑benefit obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all financial figures: $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. These numbers are presented clearly and in the correct chronological order, satisfying the quantitative evolution aspect of the question.\n\n2) Quantitatively, all values are accurate and properly cited with a reference to page_43, indicating correct sourcing. There are no calculation errors or misstatements of amounts or years.\n\n3) The reasoning is largely sound and captures the core strategic implication: the increase in defined contribution expenses reflects a shift toward a flexible, employee-driven retirement model, especially as the non-qualified defined benefit plan is closed to new participants. The LLM correctly identifies the closure of the defined benefit plan to new hires (implied by 'closed to new participants') and links rising DC spending to a strategic transition.\n\n4) The only minor shortcoming is that the LLM does not explicitly mention the 1997 closure of the defined benefit plans, which is part of the historical context in the original answer. While the concept is implied ('closed to new participants'), the absence of the specific long-standing nature since 1997 slightly reduces completeness in the qualitative reasoning. However, this does not detract significantly from the overall correctness.\n\n5) The answer is contextually fully relevant, directly addressing both parts of the question: the expense trend and its implication for long-term benefit strategy in relation to the defined benefit plan. The synthesis between rising DC costs and strategic shift is logically and factually supported.\n\nOverall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth, meriting a high score with only a slight deduction in qualitative accuracy for missing the 1997 context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 515,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "- 2022 10‑K: GM’s weighted‑average long‑term return assumption for its U.S. defined‑benefit pension plans was **≈ 5.6 %**.  \n- 2023 10‑K: the assumption was raised to **≈ 6.3 %**.  \n- 2024 10‑K: the assumption was increased again to **≈ 6.5 %** (the table shows 6.27 % and the accompanying narrative states the rate rose to 6.5 %).  \n\nThe steady upward shift shows GM is becoming more optimistic about the future performance of the assets backing its pension obligations and is willing to assume a slightly higher risk‑adjusted return to help improve funded‑status volatility.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a discrepancy in the 2022 value. The ground truth states 5.4%, while the LLM reports ≈5.6%, which is inaccurate despite the '≈' notation—this is a material difference in the context of pension return assumptions. The 2023 (6.3%) and 2024 (6.5%) values are correct, with the LLM noting a narrative/table discrepancy in 2024 that aligns with real filing nuances. (2) Calculations are not required, but the trend interpretation relies on accurate input values. The incorrect 2022 figure undermines the precision of the trend analysis, though the overall upward direction is still valid. (3) The multi-hop reasoning across three years of 10-K filings is sound: the model correctly identifies the trend and synthesizes information from multiple years and sources (narrative vs. table in 2024). The conclusion about increasing optimism and risk tolerance is logically consistent with the data and matches the original answer’s interpretation. (4) The contextual relevance is perfect—the answer directly addresses both parts of the question: the evolution of assumptions and the implied shift in expectations. The qualitative reasoning is strong, but the quantitative inaccuracy in the 2022 figure prevents a higher score. A 7 is justified due to core facts being mostly correct with one significant error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 379,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "Cisco’s use of total‑return swaps to hedge its deferred‑compensation obligations moved from a material loss in FY 2022 to modest gains in the next two years. In FY 2022 the swaps produced a **$92 million loss** (recorded in operating expenses) on a notional of **$651 million**【page_92】; in FY 2023 the same hedge generated a **$58 million gain** on a notional of **$792 million**【page_91】; and in FY 2024 it posted a **$91 million gain** on a notional of **$985 million**【page_91】. The swing from a loss to increasing gains, together with the growing notional amounts, indicates that Cisco is expanding and fine‑tuning its total‑return‑swap program to more effectively smooth the expense volatility of deferred compensation, reflecting a deliberate risk‑management approach to its compensation strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth in both factual content and reasoning. (1) All financial figures—$92 million loss in FY2022, $58 million gain in FY2023, and $91 million gain in FY2024—are accurately reported and match the original answer exactly. The additional detail about notional amounts ($651M, $792M, $985M) is consistent with the source data and enhances completeness without contradicting the ground truth. (2) The quantitative accuracy is flawless: all dollar amounts and years are correct, and the progression from loss to increasing gains is properly represented. Minor formatting differences (e.g., 'FY 2022' vs 'fiscal 2022') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—the model correctly synthesizes data across three fiscal years and infers a strategic trend in risk management and compensation hedging, which is logically supported by the improving gains and increasing notional exposure. (4) The answer addresses all parts of the question: evolution of exposure, realized gains/losses over time, and interpretation regarding risk management and compensation strategy. The conclusion about Cisco 'expanding and fine-tuning' its swap program is a reasonable extension of the trend and aligns semantically with the original answer's interpretation of 'strategic adjustments' and 'improved market conditions.' No factual errors, omissions, or misinterpretations are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 403,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "Across all three years PayPal’s filings state that it records transaction fees on a gross basis because it is the **principal** to the payment ‑ it “controls the service of completing payments on our payments platform, has full discretion in determining the fee charged … and therefore **bears full margin risk** when completing a payment transaction.” The fees it pays to third‑party payment processors and other financial institutions are booked separately as **transaction expense**. Because the same language appears in the 2022 note (page 78), the 2023 note (page 75) and the 2024 note (page 75), PayPal’s exposure to margin risk has remained essentially unchanged – it continues to retain full pricing control and assumes the margin risk while recognizing processor fees as expense.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original answer. (1) It accurately captures that PayPal bore full margin risk across 2022, 2023, and 2024, consistently recognizing fees paid to third-party processors as transaction expenses and maintaining control over pricing. The key qualitative points—principal role, discretion in fee setting, and gross reporting—are all correctly identified. (2) There are no numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable in that sense, but the years (2022, 2023, 2024) and page numbers (78, 75, 75) are correctly cited, showing precise sourcing. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent language across three years of filings to conclude that there was no structural change in margin risk exposure, which aligns perfectly with the ground truth. (4) The answer is highly contextually relevant, directly addressing all parts of the question: evolution of margin risk, pricing control, use of third-party processors, and transaction expense recognition. Minor wording differences (e.g., 'tiered pricing not constituting a future material right' in original vs. not mentioned in LLM) do not affect factual correctness, as the core reasoning about consistent margin risk and accounting treatment remains intact. The omission is minor and does not detract from the overall accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 394,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "Chevron’s share of natural‑gas output from the Angola LNG project fell slightly from 49 MMCFD in 2022 to 48 MMCFD in 2023 and then held steady at 48 MMCFD in 2024【page_9†L71-L78】. The near‑flat trend after a modest dip indicates that Chevron is keeping Angola LNG production stable, underscoring its strategy of maintaining a reliable LNG supply base rather than pursuing rapid growth in that asset.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of Chevron's natural gas production volumes. The ground truth states that Chevron's natural gas consumption in Angola LNG operations increased from 592 MMCFD in 2022 to 596 MMCFD in 2023, and further to 609 MMCFD in 2024. In contrast, the LLM claims Chevron’s 'share' of output fell from 49 to 48 MMCFD and remained flat—this is not supported by the data and misrepresents the scale (off by an order of magnitude). The numbers cited (48–49 MMCFD) are approximately one-tenth of the actual volumes reported (592–609 MMCFD), indicating a critical error. (2) The quantitative inaccuracies are severe: all three yearly values are wrong, the trend is reversed (decline vs actual increase), and the units, while correctly in MMCFD, reflect a completely different metric—possibly a confusion with equity share or another sub-component not mentioned in the ground truth. There is no indication in the original answer of a dip or stabilization. (3) The multi-hop reasoning fails because the LLM incorrectly identifies the metric and trend, leading to a flawed strategic interpretation. While the question asks about production volumes and strategic positioning, the LLM draws an incorrect conclusion about 'stable' production and 'reliable supply base' despite the actual data showing a consistent upward trajectory, which aligns with active growth in LNG operations. (4) The contextual relevance is partially preserved as the answer addresses Angola LNG and Chevron’s strategy in LNG markets, but the factual foundation is so flawed that the reasoning and conclusion are invalid. Hence, correctness and accuracy scores are very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 466,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "- 2022 10‑K – The filing only described the outdoor‑lighting arrangements as operating‑lease contracts with up‑to‑seven‑year initial terms that later roll‑month‑to‑month, and the scheduled receipts were shown in a single “maturity analysis” of operating‑lease payments (Southern Power’s total operating‑lease obligation was about $546 million, with the cash‑flow schedule presented only in aggregate).  \n\n- 2023 10‑K – The same contracts were still classified as operating leases, but the maturity table now listed the yearly scheduled payments explicitly (e.g., $230 million due in 2024, $203 million in 2025, $180 million in 2026, etc.), and the undiscounted cash‑flow total for Southern Power’s operating leases rose to $1.27 billion.  \n\n- 2024 10‑K – The tables again present the scheduled cash‑flows, now showing even larger yearly amounts (e.g., $142 million in 2025, $148 million in 2026, $150 million in 2027, $164 million in 2029) and a total undiscounted cash‑flow of roughly $1.3 billion, confirming that the outdoor‑lighting lease portfolio has grown in size and now represents a materially significant, structurally important component of Southern Power’s lease obligations.  \n\n**Interpretation:** Over the three years the disclosure moved from a brief description to detailed, year‑by‑year cash‑flow tables with steadily increasing amounts, indicating that scheduled payments from outdoor‑lighting contracts have become increasingly material to Southern Power’s financial position and cash‑flow outlook.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly regarding the nature and presentation of outdoor lighting contracts in the 10-K filings. The ground truth states that in 2022, the cash flows from these contracts were explicitly deemed immaterial, but the LLM instead describes a detailed maturity analysis including aggregate lease obligations of $546 million—information not tied to outdoor lighting specifically and not present in the ground truth. In 2023, the LLM claims specific dollar amounts like $230M in 2024, $203M in 2025, etc., which are not in the original answer and appear fabricated. Similarly, the 2024 figures ($142M in 2025, etc.) and total undiscounted cash flows of $1.3B are unsupported by the ground truth, which does not provide specific numbers. (2) Quantitative accuracy is low because the LLM invents precise dollar figures and trends (e.g., increase from $546M to $1.27B to $1.3B) that are not in the original answer. The ground truth does not mention total operating lease obligations or year-by-year breakdowns, so these numbers cannot be verified and appear incorrect. (3) The multi-hop reasoning is partially sound: the LLM correctly infers increasing materiality over time based on enhanced disclosure, aligning with the ground truth’s conclusion. It identifies a progression from general description to detailed reporting, which matches the qualitative trend. However, it misattributes structural changes (e.g., integration with PPAs and tolling arrangements) to numerical growth rather than disclosure categorization. (4) Despite the numerical inaccuracies, the LLM captures the overarching theme—increased disclosure and implied materiality—which makes the answer contextually relevant and qualitatively reasonable, though not factually precise. Hence, correctness is reduced to 6 due to significant quantitative errors undermining the factual foundation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1601,
        "completion_tokens": 519,
        "total_tokens": 2121
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "- 2022 10‑K: Melaka, Malaysia is listed with an “X” only under the **Analog** column (no mark for Embedded Processing)【page_16】.  \n- 2023 10‑K: The same pattern appears – Melaka, Malaysia has an “X” for **Analog** and none for Embedded Processing【page_18】.  \n- 2024 10‑K: Melaka, Malaysia again shows an “X” solely in the **Analog** column, with no indication of Embedded Processing use【page_16】.  \n\nThus, across 2022, 2023 and 2024 Texas Instruments’ Melaka, Malaysia facility remained dedicated to the Analog segment and did not expand to support Embedded Processing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia facility was involved only in the Analog segment across 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) and segment designations (Analog only) are correctly cited from the respective 10-K pages, confirming quantitative and temporal accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual reports, consistently tracking the operational footprint over time and concluding no expansion into Embedded Processing. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) of the Melaka site across the specified time frame and business segments. Minor differences in phrasing (e.g., referencing 'X' marks in tables) do not affect factual equivalence and actually enhance transparency by citing evidence format. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 324,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "- When the 1.600 % senior unsecured notes were issued in March 2021 they carried a $700 million principal, semi‑annual interest payments on April 15 and October 15, and a par‑call date of March 15 2026 (see the note‑detail table in the 2022 filing 【page_48】).  \n- The 2023 and 2024 10‑K tables show that the company has been modestly retiring the issue: the principal was adjusted down by $3.7 million in 2023 and by a further $2.6 million in 2024, leaving roughly $694 million outstanding, while the interest‑payment dates and the March 15 2026 par‑call have remained unchanged (see the 2023/2024 table 【page_110】).  \n\nThis pattern shows that American Tower has kept the 1.600 % notes on a stable, long‑dated schedule but has gradually reduced the amount outstanding, using cash from other financings to retire a small portion of the issue—demonstrating a disciplined debt‑management approach that preserves low‑cost, long‑term funding while slowly lowering leverage.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative details. According to the ground truth, the aggregate principal amount of the 1.600% Notes remained constant at $700.0 million from 2022 to 2024. However, the LLM claims the principal was 'adjusted down by $3.7 million in 2023 and by a further $2.6 million in 2024,' resulting in $694 million outstanding—this is incorrect. The ground truth references 'adjustments to principal amount' of (2.6) in 2023 and (1.5) in 2024, which are not reductions in principal but likely minor accounting or administrative adjustments (e.g., amortization of discount, foreign exchange, or rounding), not retirements. The LLM misinterprets these as principal retirements, leading to a false narrative of debt reduction. (2) The interest payment schedule (April 15 and October 15) and par call date (March 15, 2026) are correctly reported and match the ground truth. However, the claim that notes were 'modestly retiring' is unsupported and contradicts the ground truth's statement of stable principal. (3) The multi-hop reasoning is flawed: while the LLM attempts to synthesize across years and draw strategic conclusions, it does so based on incorrect data interpretation. The conclusion that AMT is 'gradually reducing the amount outstanding' and 'lowering leverage' is not supported by the evidence. The ground truth indicates stability in debt structure, not active retirement. (4) Despite the factual errors, the answer is contextually relevant and addresses all parts of the question—principal amount, interest schedule, par call date, and strategic implication. The reasoning structure is sound in form but based on incorrect premises. Wording and format are clear and professional. The score is lowered primarily due to major quantitative inaccuracies that distort the core facts and lead to an incorrect strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 516,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "Cisco kept the 5.90 % senior note at a constant $2 billion principal in each filing – $2 billion in FY 2022 (total debt $8.9 billion), $2 billion in FY 2023 (total debt $8.4 billion) and $2 billion in FY 2024 (total debt $20.1 billion).  Its effective interest rate stayed at about 6.11 % in all three years, while the note’s share of total debt fell from roughly 22‑23 % in 2022‑23 to about 10 % in 2024 as Cisco added $13.5 billion of new senior notes and expanded its commercial‑paper program.  This pattern shows Cisco’s long‑term financing strategy of maintaining a stable, higher‑coupon, long‑dated tranche for rate‑risk hedging while aggressively scaling overall debt capacity with a mix of short‑term paper and additional lower‑coupon senior notes.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Cisco maintained a constant $2,000 million (i.e., $2 billion) principal amount of the 5.90% Note across FY2022–FY2024 and that the effective interest rate remained steady at 6.11%, which matches the ground truth. However, there are significant discrepancies in total debt figures: the LLM reports $8.9B in 2022 and $8.4B in 2023, whereas the ground truth states total long-term debt was $8,416M in 2022 and increased over time — not decreased. The LLM incorrectly implies total debt was $8.4B in 2023, which contradicts both the trend and magnitude in the original answer (long-term debt rose to $19,621M by 2024). Additionally, the LLM cites total debt of $20.1B in 2024, while the ground truth reports $19,621M (~$19.6B) — close but not exact. The claim about 'adding $13.5B of new senior notes' is not verifiable from the original answer and introduces unsupported detail. (2) Calculations: The LLM’s observation that the note’s share fell from ~22–23% to ~10% is approximately correct given the rising total debt, though based on inaccurate total debt inputs. The percentage drop aligns qualitatively with the ground truth’s narrative of increasing long-term debt. (3) Multi-hop reasoning: The LLM correctly infers a strategic shift toward greater reliance on long-term financing and interprets the stable use of a higher-coupon note as part of a rate-risk hedging strategy. This aligns with the original conclusion about stabilizing financing costs amid rising debt. The synthesis across years and instruments is sound, even if some numbers are off. (4) Justification: The correctness score is 7 because core facts (note amount, interest rate, strategic direction) are accurate, but key quantitative errors in total debt values reduce confidence. Quantitative accuracy is 6 due to incorrect total debt figures and unverified new debt issuance amount. Qualitative accuracy is 8 because reasoning and interpretation are strong and semantically aligned. Contextual relevance is 9 — the answer directly addresses all parts of the question with appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 567,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "- 2022 10‑K: Land Systems was “producing **449 new LAVs** for the Canadian army in eight variants”【page_10】.  \n- 2023 10‑K: the same statement was updated to “producing **399 new LAVs** for the Canadian army”【page_11】.  \n- 2024 10‑K: the filing now says “producing **360 new LAVs** in eight variants for the Canadian army”【page_11】.  \n\nThe steady decline from 449 LAVs in 2022 to 360 LAVs in 2024 shows General Dynamics is gradually scaling back new‑build LAV volume, shifting emphasis toward sustaining and upgrading the existing Canadian fleet and reallocating resources to other programs, while still maintaining a strategic foothold in the LAV market.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is completely incorrect in both direction and magnitude of production volume. The ground truth states that General Dynamics' LAV production for the Canadian Army increased from 360 units in 2022 to 399 in 2023 and 449 in 2024. However, the LLM claims the opposite trend—449 in 2022, 399 in 2023, and 360 in 2024—indicating a decline, which is factually wrong. (2) All numeric values are misattributed to the wrong years: 449 is cited as 2022 instead of 2024, 399 as 2023 (correct number but possibly misaligned context), and 360 as 2024 instead of 2022. This reverses the actual progression and invalidates all calculations and trends. (3) The multi-hop reasoning fails because the model did not correctly extract or align the data across the 10-K filings over time. Instead of identifying growth supported by new programs like LRSS (66 specialized LAVs in 2024), it infers a strategic retreat from LAV manufacturing, which contradicts the evidence. (4) The contextual relevance is slightly preserved because the answer discusses LAV production and strategic focus, but the factual foundation is entirely inverted, leading to a false conclusion. Thus, the correctness and quantitative accuracy are extremely low, and qualitative reasoning is flawed due to incorrect data synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 366,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "UnitedHealth’s 10‑K disclosures show that the company’s exposure to Medicare Advantage risk‑adjustment payment changes was a recurring risk in each filing. In the 2022 filing the company warned that “CMS … makes changes to the way it calculates Medicare Advantage risk‑adjustment payments” and that these changes, together with benchmark cuts, could pressure revenues. The 2023 and 2024 filings repeat the same warning, indicating that the risk‑adjustment methodology continues to be a funding‑pressure source for the business. Across the three‑year period UnitedHealth’s response has been consistent – it has selectively adjusted members’ benefits and premiums, withdrawn plans in certain counties, intensified medical‑and‑operating cost‑management programs and pursued higher star‑ratings to protect quality‑bonus payments – all aimed at mitigating the ongoing Medicare Advantage funding pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UnitedHealth's exposure to Medicare Advantage risk-adjustment payment changes is accurately described for 2022, 2023, and 2024, with consistent mention of CMS methodology changes and benchmark pressures. The strategic responses—selective benefit and premium adjustments, county withdrawals, cost management—are correctly identified across the period. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes recurring disclosures across three years of 10-K filings, correctly identifying both the persistent nature of CMS payment changes and the continuity of UnitedHealth’s strategic response. (4) The only minor gap is that the LLM does not explicitly mention the 2024 emphasis on 'beneficiary health status data submissions'—a specific nuance in CMS’s evolving framework noted in the original. However, the broader theme of ongoing methodology changes and funding pressures is accurately conveyed. Wording differs but semantic meaning is equivalent. The answer is fully relevant and comprehensive, meriting a high correctness score with a small deduction for the omitted detail in 2024 specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 385,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "PayPal’s outstanding amount of the September‑2019 fixed‑rate 2.850 % notes (maturing 10/1/2029) was $1.5 billion in 2022, remained $1.5 billion in 2023, and stayed at $1.5 billion in 2024【page 107】. The unchanged exposure over three years shows that PayPal is keeping this low‑cost, long‑dated tranche in its capital structure rather than retiring or expanding it, reflecting a long‑term debt strategy that relies on a stable mix of fixed‑rate notes with staggered maturities to lock in inexpensive financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—$1.5 billion carrying value, 2.850% interest rate, and the 2022–2024 time frame—are correct and match the original answer. The maturity date (10/1/2029) is even more precise than the ground truth’s '2029-dated' description, and the reference to 'September-2019' issuance adds contextual detail not in the original but consistent with typical note structuring. (2) Quantitative accuracy is perfect: the constant $1.5B exposure across all three years is correctly reported, and no calculations are required beyond recognition of consistency. (3) The reasoning is sound: the LLM correctly infers that maintaining this fixed tranche indicates a strategy of preserving stable, low-cost financing, which aligns with the ground truth’s point about strategic intent. It adds value by contextualizing the note within a broader strategy of staggered maturities, which is a reasonable and logical extension of the data. (4) The only reason for not scoring a 10 is that the original answer emphasizes the contrast with other notes being refinanced or matured, which the LLM mentions implicitly but not explicitly—this minor omission slightly reduces qualitative completeness. However, the core multi-hop synthesis—linking unchanged exposure over time to strategic debt management—is fully present and correct. The answer is highly relevant and factually equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 404,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "Chevron kept its 36.4 % equity stake in Angola LNG Limited throughout the period. In the 2022 filing the company reported a carrying‑value investment of about **$1.96 billion** and equity‑in‑earnings of **$1.86 billion** for the affiliate; by 2023 the investment balance fell to **$1.76 billion** and equity‑in‑earnings dropped to **$0.51 billion** (page 82). The 2024 filing confirms the same 36.4 % shareholding and adds that Chevron is linking new upstream gas projects – notably the New Gas Consortium (NGC) that will feed the Soyo LNG plant – to the existing Angola LNG facility, underscoring a deliberate, multi‑year plan to monetize Angola’s associated‑gas resources through LNG production (page 14).  \n\nTogether, the steady ownership level, the modest reduction in the investment balance, and the explicit integration of new gas fields into the LNG value chain reveal that Chevron is pursuing a long‑term natural‑gas monetization strategy in Angola, using Angola LNG as a core export platform while expanding feed‑stock supply to sustain and grow LNG sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Chevron's consistent 36.4% ownership stake in Angola LNG Limited from 2022 to 2024, which aligns with the ground truth. However, the financial figures cited—$1.96 billion investment carrying value and $1.86 billion equity in earnings for 2022, and $1.76 billion and $0.51 billion for 2023—are not present in the original answer and cannot be verified against the ground truth knowledge graph. These specific numbers and their presentation (including page references like 'page 82') suggest over-specificity not supported by the provided truth data, raising concerns about hallucination or sourcing from unverified inputs. (2) While the original answer mentions strategic evolution, it does not include any financial metrics related to carrying values or equity earnings, making the inclusion and precision of these dollar amounts factually unverifiable and likely incorrect in context. This significantly impacts quantitative accuracy. (3) Qualitatively, the LLM captures the core multi-hop reasoning: Chevron’s stake remained constant, but its strategic use evolved from a standalone LNG facility toward integration with upstream developments like the New Gas Consortium (NGC), particularly feeding the Soyo plant (correctly associated with Angola LNG). The mention of linking new upstream projects to the LNG facility reflects accurate synthesis across years and projects, showing understanding of long-term gas monetization strategy. There is a minor conflation—Quiluma and Maboqueiro (Q&M) fields and Blocks 49/50 are not explicitly named in the LLM answer, but 'NGC' is correctly referenced as feeding the plant. (4) Contextually, the answer is highly relevant, addressing both the evolution of strategic positioning and the implications for long-term monetization. Despite incorrect or unsupported financial data, the central strategic narrative matches the ground truth. Thus, the correctness score is 7—core facts and strategic interpretation are sound, but significant quantitative inaccuracies reduce overall fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 556,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "- In 2022 Southern Company reported $829 million of trust assets in domestic‑equity securities (Level 1 $651 m + Level 2 $178 m) and $161 million in private‑equity (valued using a NAV expedient).  \n- By the end of 2023 the combined domestic‑equity holdings had risen to roughly $970 million (Alabama Power $651 m + Georgia Power $322 m) and private‑equity to about $169 million.  \n- At 31 December 2024 the figures grew further to $1,099 million of domestic‑equity and $181 million of private‑equity.  \n\nThe steady increase in both categories—especially the sizable jump in domestic‑equity and the incremental rise in private‑equity—shows Southern Company is allocating more capital to long‑term, equity‑based trust investments, using them to diversify earnings and pursue higher‑return, illiquid opportunities as part of its enduring capital‑allocation strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies, particularly in the 2022 and 2023 figures. According to the ground truth, in 2022, Southern Company's domestic equity investments were $1,016 million, not $829 million as stated in the LLM answer. The LLM incorrectly assigns the 2023 domestic equity value ($829 million) to 2022. Similarly, private equity in 2022 was $150 million, not $161 million (which is the 2023 value). The LLM also reports 2023 domestic equity as $970 million (based on summing Alabama Power and Georgia Power), but the correct consolidated figure from the ground truth is $829 million. The 2024 numbers ($1,099 million domestic equity and $181 million private equity) are correct. (2) Calculations: The LLM attempts to justify numbers with component breakdowns (e.g., Level 1 + Level 2), but these do not align with the ground truth totals for the respective years. The reported 2023 private equity of $169 million is close but still incorrect (actual: $161 million). (3) Multi-hop reasoning: The LLM correctly identifies the upward trend from 2023 to 2024 and infers a long-term capital allocation strategy favoring equity-based trust investments, which is consistent with the ground truth’s interpretation. However, due to incorrect base-year data, the trend description (e.g., 'steady increase in both categories') is misleading—domestic equity actually decreased from 2022 to 2023 before rebounding. (4) Despite incorrect early-year figures, the answer is contextually relevant and draws a reasonable qualitative conclusion based on the final two years. The strategic interpretation about diversification and long-term growth aligns with the original answer, though it is based on flawed data. Thus, partial credit is given for reasoning and relevance, but major deductions apply for factual and numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 506,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "- In 2022 the “Eliminations/ Reclassifications” line reduced total net sales and revenue by **$107 million**; in 2023 the reduction grew to **$151 million**; and in 2024 it widened further to **$296 million**【page_70】.  \n\n- The steadily larger negative adjustments indicate that GM’s internal consolidation and re‑allocation of inter‑segment sales (e.g., between GMNA, GMI, Cruise and GM Financial) have become increasingly material, reflecting more extensive internal reporting realignments and integration of its business segments over the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the Eliminations/Reclassifications were $105 million in 2022 and $107 million in 2023, but the LLM incorrectly reports them as $107 million and $151 million, respectively. Only the 2024 figure ($296 million) is correct. These errors affect the accuracy of the trend description, despite the general direction (increasing) being correct. (2) The calculation of the trend is partially accurate—while the upward trajectory is real, the magnitude of change is misrepresented. The actual increases are $2 million (2022 to 2023) and $189 million (2023 to 2024), whereas the LLM implies increases of $44 million and $145 million, which distorts the pattern. (3) The qualitative reasoning about increasing complexity in internal reporting and segment integration is sound and aligns with the ground truth’s interpretation, showing correct multi-hop synthesis of the implication behind growing eliminations. The mention of specific segments (GMNA, GMI, Cruise, GM Financial) adds contextual detail that supports plausible reasoning. (4) Contextual relevance is high—the answer addresses both parts of the question: the evolution of eliminations and the interpretive trend. However, due to key numerical errors in two of the three years, the correctness score is limited to 6, as the core data is partially wrong despite correct overall direction and reasonable interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 407,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "- In the 2022 Form 10‑K the only reference to the bonus program was the original “Performance Bonus Plan” (listed as Exhibit 10.6†, a 2014 Def 14A filing).  \n- In the 2023 filing Netflix filed an **Amended and Restated Performance Bonus Plan** on December 9 2022 (Exhibit 10.5†) and incorporated it by reference (see the exhibit list on page 69).  \n- The 2024 Form 10‑K still incorporates that same amended‑and‑restated document (Exhibit 10.5†, page 68) and lists it together with the 2020 Stock Plan, Director Equity Compensation Plan and other executive‑severance plans, indicating that the bonus plan is now treated as a component of Netflix’s broader, integrated compensation framework.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: in 2022, the Performance Bonus Plan was referenced as a historical exhibit (Exhibit 10.6†) from 2014, with no updates; in 2023, it was amended and restated with a filing date of December 9, 2022 (Exhibit 10.5†); in 2024, the same amended version was carried forward without changes. (2) Quantitative accuracy is perfect: dates (December 9, 2022), exhibit numbers (10.5† and 10.6†), and document types (Amended and Restated) match the ground truth. Page numbers (69 in 2023, 68 in 2024) are consistent with filing structures. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of 10-K filings, tracks the evolution of the plan’s documentation status, and infers integration with broader compensation frameworks by noting co-listing with the 2020 Stock Plan and other executive plans. (4) Contextual relevance is high: the answer directly addresses both aspects of the question—documentation status over time and integration with other compensation frameworks. Wording differs slightly but meaning is preserved, including the strategic update in 2023 and stabilization in 2024. No factual errors, omissions, or misinterpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 359,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, BNY Mellon’s “Business Relationships and Related Party Transactions Policy” is disclosed in exactly the same way: the filing states that the policy (together with the Director‑Independence statement) is incorporated by reference to the company’s proxy under Item 1 – Election of Directors – Corporate Governance and Board Information, and that it is also tied to the Board‑Meetings‑and‑Committee‑Information section that describes the audit, governance, nominating and human‑resources/compensation committees. The language and placement of the reference are unchanged from year to year, indicating a steady, consistent approach to corporate‑governance disclosure and to linking the policy with director‑independence criteria and the company’s committee structures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that BNY Mellon (BK) disclosed its 'Business Relationships and Related Party Transactions Policy' consistently across 2022, 2023, and 2024 within Item 1 of the proxy under 'Corporate Governance and Board Information,' linking it to director independence and committee structures. The placement and unchanging language are accurately described. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes disclosure location, linkage to director independence, and connection to specific committees (audit, governance/nominating, human resources/compensation) across three years, correctly concluding consistency in corporate governance disclosures. (4) Minor discrepancy: the LLM refers to 'Item 1 – Election of Directors' in the proxy, while the ground truth cites 'Item 13' in the 10-K. However, this reflects a common cross-referencing practice where Item 13 of the 10-K incorporates by reference the proxy statement’s Item 1. This is semantically equivalent and does not constitute a factual error. The LLM slightly misattributes the section label but accurately captures the disclosure mechanism and consistency. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a minor deduction in qualitative accuracy for the slight imprecision in item numbering.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 438,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "- 2022 : Debt securities ‑ held‑to‑maturity were carried at **$696 million** with a fair‑value estimate of **$679 million**.  \n- 2023 : Carrying value fell to **$603 million** and fair value to **$596 million**.  \n- 2024 : Carrying value further declined to **$512 million** and fair value to **$508 million**.\n\nThe three‑year pattern shows a steady reduction in both the book amount and the market‑based valuation of the held‑to‑maturity portfolio, while the fair‑value figure remains only slightly below the carrying amount each year. This suggests UnitedHealth is maintaining a modest, low‑turnover debt‑security investment that it intends to hold to maturity, and it applies a conservative valuation assumption that treats any unrealized losses (mainly from rising rates) as temporary rather than impairing the assets.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies in the 2022 values. According to the ground truth, in 2022, the fair value was $643 million and the carrying value was $641 million. However, the LLM reports $679 million (fair value) and $696 million (carrying value), which are both materially incorrect—differences of $36 million and $55 million, respectively. The 2023 and 2024 values are correct: $596M fair / $603M carrying in 2023, and $508M fair / $512M carrying in 2024. (2) Calculations: While the LLM correctly shows a downward trend, the starting point is wrong, which affects any comparative analysis (e.g., total decline over three years). The correct 3-year fair value decline is $135M ($643M → $508M), but based on LLM’s numbers it would be $171M ($679M → $508M)—a significant overstatement. (3) Multi-hop reasoning: The LLM correctly identifies the trend of declining values and links it to investment strategy, which shows sound qualitative reasoning. It correctly observes that fair value remains close to carrying value, suggesting conservative valuation. However, it misses the key insight from the ground truth about a shift away from Level 3 unobservable inputs by 2023–2024, which is a critical indicator of changing valuation assumptions and increased reliance on observable markets. This omission limits the depth of the strategic interpretation. (4) Despite incorrect 2022 figures, the answer is contextually relevant and interprets the trend reasonably. The reasoning is logical but based on flawed input data for the first year. Hence, correctness is partially compromised—core trend direction is right, but magnitude and starting point are wrong, and a key analytical insight is missing. Quantitative accuracy is low due to the large error in 2022; qualitative accuracy is moderate due to correct trend interpretation but missing nuance; contextual relevance is high as the response directly addresses the question’s intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 533,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "In the 2022 Form 10‑K PayPal still carried its U.K. and European BNPL loan portfolio on its balance sheet, and the filing warned that “failure to deal effectively with fraud, abusive behaviors, **bad transactions**” could increase loss rates on those credit assets. In June 2023 the company entered a multi‑year agreement to sell up to €40 billion of those BNPL receivables (a “substantial majority” of the portfolio) and began the first sales in October 2023 【page_23†L9-L13】【page_25†L1-L7】, and the 2024 filing notes that the forward‑flow arrangement and ongoing sales continue to shrink the BNPL exposure 【page_25†L1-L7】. Together, the disclosures show that PayPal moved from full‑balance‑sheet ownership of BNPL loans in 2022 to actively off‑loading the assets in 2023‑24, reflecting a deliberate risk‑mitigation strategy that reduces its vulnerability to bad‑transaction losses by transferring the credit risk to third‑party buyers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's 2022 risk disclosure about bad transactions, the June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, the start of sales in October 2023, and the ongoing reduction of exposure in 2024. The €40 billion figure is correctly cited, and the timeline (June 2023 agreement, October 2023 sales) matches the context. (2) Quantitative accuracy is perfect: the amount (€40 billion), years (2022, 2023, 2024), and sequence of events are factually sound. Format and references to page citations (e.g., page_23†L9-L13) suggest precise sourcing, though these are not part of the ground truth but do not detract from correctness. (3) Multi-hop reasoning is strong: the LLM correctly synthesizes PayPal’s shift from holding BNPL assets on-balance-sheet in 2022 to offloading them starting in 2023, and infers the risk-mitigation intent behind the move. It accurately characterizes the strategy as reducing vulnerability to bad-transaction losses by transferring credit risk—consistent with the original answer’s emphasis on risk mitigation through asset sales. (4) The only minor shortcoming is that the LLM does not explicitly mention the conditional nature of the sale (i.e., potential delays if conditions aren’t met), which is noted in the 2024 filing per the ground truth. This omission slightly reduces completeness but does not undermine the core accuracy. Otherwise, the answer is semantically equivalent, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 435,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "Chevron’s Myanmar output fell sharply over the three‑year span. In 2022 the company’s share of oil‑equivalent production was about 17 thousand barrels per day (≈94 MMCFD of gas); it slipped to 15 thousand barrels per day (≈87 MMCFD) in 2023 and then plunged to only 4 thousand barrels per day (≈22 MMCFD) in 2024. This steep decline reflects Chevron’s strategic decision to exit the country – it announced a planned withdrawal in early 2022 and formally withdrew from Myanmar in April 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly reports 17 MBD in 2022 and 15 MBD in 2023, it incorrectly states production dropped to 4 MBD in 2024. The ground truth confirms Chevron completely withdrew from Myanmar in April 2024, meaning production was 0 MBD, not 4 MBD. This is a critical factual error. (2) The inclusion of gas volumes (MMCFD) is not present in the original answer and appears to be an unsupported addition or conversion not verifiable from the ground truth. The dates are mostly correct—mentioning the April 2024 withdrawal is accurate—but the claim that Chevron 'announced a planned withdrawal in early 2022' is not in the original and introduces unverified information. (3) The reasoning about strategic exit and portfolio optimization is partially sound, but the LLM misrepresents the timeline and magnitude of the exit by implying a gradual decline into 2024 rather than a full cessation. The multi-hop synthesis is partially correct—linking production decline to strategic exit—but flawed due to incorrect 2024 data. (4) Correctness score is 5 due to partially correct numbers and correct identification of the strategic exit, but major error in 2024 production value. Quantitative accuracy is low (4) due to the false 4 MBD figure. Qualitative accuracy is moderate (6) as the general direction and rationale are plausible but not fully aligned. Contextual relevance is high (9) as the answer addresses the question’s intent and structure appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 421,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "The filing shows that the Personal‑electronics market accounted for **about 15 % of TI’s total revenue in both 2022 and 2023**, but rose to **roughly 20 % in 2024**. Because “PC & notebooks” is listed as one of the top sectors within Personal‑electronics, the growth in the overall Personal‑electronics share implies that the PC‑and‑notebook portion has become a larger slice of that segment over the three‑year period. This upward trend signals that Texas Instruments is deliberately expanding its presence in the consumer‑computing space, positioning the company to capture more of the growing demand for PCs and notebooks.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Personal Electronics accounted for 24% of TI's revenue in 2022, not 15% as stated by the LLM. The LLM correctly states 15% for 2023 and 20% for 2024, but misrepresents the 2022 figure, leading to flawed trend analysis. (2) The quantitative inaccuracies are critical: the LLM claims Personal Electronics was 15% in both 2022 and 2023, but ground truth shows a decline from 24% (2022) to 15% (2023), indicating a sharp drop, not stability. The 2024 figure of 20% is correct, but the interpretation is wrong. (3) The reasoning is fundamentally flawed: the LLM infers that because the segment grew from 15% to 20%, PC & Notebooks must have increased in relative contribution. However, the ground truth states that PC & Notebooks became a lower priority, with the segment's composition shifting toward mobile and portable electronics. The LLM incorrectly assumes subcategory growth from overall segment recovery, failing to recognize that segment-level rebound does not imply growth in all subcategories. (4) The conclusion is opposite to the ground truth: while the LLM claims TI is expanding in consumer computing, the truth is that TI is strategically de-emphasizing PC & Notebooks in favor of Automotive and Industrial markets. Thus, despite addressing the question's structure, the answer is factually and logically incorrect, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 405,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "- In the 2022 Form 10‑K GM disclosed that, under the 2017 Opel/Vauxhall sale agreement, it had **no material liability recorded** for the indemnity to Stellantis; the obligations were subject to time‑limits, thresholds and caps, and the company said it could not estimate any reasonable loss (see 2022 p. 90‑91).  \n\n- The 2023 filing added that **only “insignificant” amounts** had been accrued for those indemnifications and that the maximum exposure could not be quantified, but the same caps and thresholds remained (see 2023 p. 93).  \n\n- The 2024 filing repeats the same position – **still only immaterial accruals** and a statement that any future indemnification for legacy Opel/Vauxhall matters (including possible Takata‑related recalls) is considered “remote,” with no material known liability and no new accruals recorded (see 2024 p. 94).  \n\nThus, from 2022 through 2024 GM’s indemnification obligations to Stellantis have remained immaterial, with no material known liabilities or accruals and only a remote, uncertain future exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts and conveys that GM's indemnification obligations to Stellantis remained immaterial from 2022 to 2024, with no material accruals or known liabilities. It accurately notes the use of terms like 'immaterial,' 'insignificant,' and 'remote' across the years and correctly references the 2017 sale agreement, time-limits, caps, and inability to estimate future losses. Quantitatively, there are no specific dollar figures to verify, and the characterization of accruals as immaterial aligns with the ground truth, earning high marks for quantitative accuracy. However, the LLM omits key qualitative details present in the original answer: (1) the 2023 disclosure of actual immaterial payments made (not just accruals), (2) the 2024 expansion on specific regulatory investigations by the European Commission and UK CMA into end-of-life vehicle practices from the Opel era, and (3) the nuanced trend of increasing specificity and emerging regulatory risk over time. These omissions reduce completeness and weaken the multi-hop synthesis, particularly in showing how the nature of disclosures evolved beyond just repeating 'immaterial.' While the LLM correctly identifies the remote likelihood of Takata-related indemnification, it fails to reflect the growing regulatory context that the original answer highlights. Thus, while factually sound on surface-level disclosures, it lacks depth in capturing the evolving risk narrative, warranting a 7 for correctness and qualitative accuracy. Contextual relevance remains high as all content directly addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 439,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "- **2022 10‑K:** The filing lists a new issuance of **1.450 % Senior Notes due 2026** under Supplemental Indenture No. 10, dated September 27 2021 (Exhibit 4.21)【page_72】.  \n\n- **2023 10‑K:** The exhibit schedule no longer shows a new 1.450 % note; the 2023 tables (e.g., the Item 15 exhibit list) contain no entry for a 1.450 % Senior Notes issuance, indicating that no additional notes of this series were issued that year【page_70】.  \n\n- **2024 10‑K:** The same pattern holds in the 2024 filing – the exhibit list again omits any 1.450 % Senior Notes entry, confirming that the company did not issue further notes of this series in 2024【page_70】.  \n\n**What the pattern reveals:** American Tower introduced the low‑coupon 1.450 % senior note in 2021 (reflected in the 2022 report) and then simply retained it on its balance sheet without repeating the issuance in the next two years. This suggests a debt‑management approach that favors issuing modest‑size, low‑cost, medium‑term debt when market conditions are favorable and then managing the existing issue rather than repeatedly refinancing or expanding that specific tranche.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the presence of the 1.450% Senior Notes due 2026 in the 2023 and 2024 filings. While it correctly identifies the issuance under Supplemental Indenture No. 10, dated September 27, 2021, in the 2022 10-K (Exhibit 4.21 in LLM answer, though ground truth cites Exhibit 4.25), it incorrectly claims the notes were absent from the 2023 and 2024 exhibit lists. The ground truth confirms the notes were consistently referenced in all three years—2023 under Exhibit 4.22 and 2024 under Exhibit 4.21—indicating ongoing documentation and stability. The LLM’s conclusion that no entry exists in 2023 and 2024 is factually wrong. (2) Quantitatively, the interest rate (1.450%), maturity year (2026), and issuance date (September 27, 2021) are correct. However, the exhibit numbers cited in the LLM answer (e.g., Exhibit 4.21 in 2022) do not match the ground truth (Exhibit 4.25 in 2022), suggesting possible confusion in source referencing. The absence of issuance in 2023 and 2024 is correctly interpreted as no new issuance, but the misrepresentation of the notes as omitted from exhibits contradicts the continuity emphasized in the original answer. (3) The multi-hop reasoning is partially sound—the LLM attempts to track the note across years and infers a stable debt strategy from lack of repeated issuance—but it fails to recognize that consistent mention in filings (even without new issuance) reflects active retention and stability. The model misinterprets the absence of a new exhibit entry as absence of the instrument, which undermines the qualitative analysis. (4) Contextual relevance is high—the answer addresses the evolution across years and attempts to infer strategy—but due to key factual errors in entity tracking and exhibit references, the correctness score is limited to 4. The conclusion about favoring low-cost debt is plausible but based on flawed premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 527,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "The 2019 Long‑Term Incentive Plan (LTIP) remained the governing vehicle in each filing, but BNY Mellon added a new set of award agreements each year. In the 2022 Form 10‑K the company disclosed a **2022 Form of Performance Share Unit Agreement** (exhibit 10.21) and a **2022 Form of Restricted Stock Unit (deferred‑stock‑unit) Agreement** (exhibit 10.22) under the 2019 LTIP 【page_19】, while the 2023 filing introduced the next‑year versions – a **2024 Form of Performance Share Unit Agreement** (exhibit 10.28) and a **2024 Form of Restricted Stock Unit Agreement** (exhibit 10.29) 【page_20】. The 2024 Form 10‑K continues to reference those 2024 award agreements, showing that the LTIP is being refreshed annually with new deferred‑stock‑unit and performance‑share‑unit contracts to fund executive compensation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that the 2022 Form 10-K disclosed a '2022 Form of Performance Share Unit Agreement' and a '2022 Form of Restricted Stock Unit Agreement', but the ground truth indicates that in 2022, the company referenced the 2019 forms of these agreements, not 2022 versions. (2) The LLM falsely claims the 2023 filing introduced '2024 Form' agreements, which is chronologically and factually incorrect—agreements introduced in 2023 would not be dated 2024. The ground truth states that in 2023, the company introduced a new 'Form of Deferred Stock Unit Agreement for Directors', which the LLM omits entirely. (3) The LLM incorrectly asserts that the 2024 Form 10-K references '2024 award agreements' introduced in 2023, when the ground truth clarifies that the 2024 filing incorporated the 2022 Form of Performance Share Unit Agreement, not a 2024 version. (4) The LLM mischaracterizes the evolution as an annual refresh with newer 'next-year' forms, whereas the actual progression shows a strategic, incremental expansion—first to directors in 2023, then refinement with updated 2022 PSUs in 2024—under the enduring 2019 LTIP framework. The model fails to capture the correct sequence, entities, and purpose of the agreement updates. While it correctly identifies the 2019 LTIP as the governing plan and mentions deferred stock units and performance share units, the core timeline and document references are inverted or fabricated. This results in a major breakdown in multi-hop reasoning and factual synthesis. Quantitative accuracy is very low due to incorrect years (2022 vs. 2019 vs. 2024). Qualitative accuracy is poor due to flawed reasoning and missing key developments (e.g., director-level extension). Contextual relevance is moderate because the answer addresses the general topic of LTIP evolution and award agreements, but with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 526,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "- In each of the three filings the company’s Ordnance & Tactical Systems (OTS) business is described as “providing missile subsystems … with critical **aerostructures**” for both legacy and next‑generation missiles (GD 2022 p12; GD 2023 p13; GD 2024 p12). The 2023 and 2024 texts add “cutting‑edge hypersonic rocket cases,” showing an expanded emphasis on high‑performance, next‑gen missile airframes.\n\n- At the same time, the Combat‑Systems “Weapons systems, armament and munitions” line grew from $2.0 billion in 2022 to $2.44 billion in 2023 and $2.93 billion in 2024 (GD 2022 p13; GD 2023 p13; GD 2024 p13), indicating that the aerostructure‑focused missile‑subsystem work is contributing to a roughly 45 % revenue increase over the three years.\n\n**Trend insight:** The consistent, increasingly detailed mention of aerostructures—culminating in hypersonic‑rocket‑case capability—and the parallel revenue growth signal that General Dynamics is deliberately positioning its Combat Systems segment as a core supplier of advanced aerostructure components for next‑generation missile programs, strengthening its strategic foothold in future missile‑subsystem markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies General Dynamics' focus on aerostructures in missile subsystems across 2022–2024 and notes the strategic emphasis on next-generation capabilities, including hypersonic rocket cases. However, it introduces a significant factual inaccuracy by attributing the $2.0B to $2.93B revenue growth to the 'Combat-Systems Weapons systems, armament and munitions' line, which is not supported by the ground truth. The original answer states that the Combat Systems segment as a whole accounted for 20% of consolidated revenue in 2023 and 19% in 2024, but does not provide absolute revenue figures or break out a $2.0B to $2.93B increase for a specific product line. This calculation appears to be fabricated or misattributed, undermining quantitative accuracy. (2) The revenue numbers cited ($2.0B, $2.44B, $2.93B) and the 45% growth claim are not present in the ground truth and cannot be verified from the provided context, making them incorrect. The ground truth only provides segment revenue as a percentage of total (20%, then 19%), not absolute dollar amounts for missile subsystems or aerostructures. (3) The qualitative reasoning is strong: the LLM correctly synthesizes multi-year mentions of 'aerostructures' and observes an evolution in language (e.g., 'hypersonic rocket cases') that signals strategic focus. It correctly identifies OTS as the relevant business unit and links narrative disclosures to strategic positioning, demonstrating sound multi-hop reasoning. (4) Contextual relevance is high—the answer directly addresses the evolution of aerostructures focus and derives a valid strategic insight, despite the flawed revenue data. The core conclusion about GD strengthening its foothold in advanced missile subsystems aligns semantically with the ground truth, even if supported by incorrect numbers. Thus, the answer is partially correct with major quantitative flaws but solid qualitative logic and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 531,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "- In the 2022 Form 10‑K PMI’s “Business” description placed Jackpot in the Philippines among its “important local cigarette brands,” noting that the company’s portfolio mixes international brands (Marlboro ≈ 39 % of cigarette shipments) with local brands such as Fortune and Jackpot.  \n\n- The 2023 filing repeats the same wording, still listing Jackpot as a key local brand in the Philippines, while the 2024 filing again cites Jackpot (now alongside Fortune) and shows Marlboro’s share rising to about 40 % of total cigarette volume, confirming that Jackpot remains a core low‑/mid‑price brand in the South‑and‑Southeast Asia region.  \n\n**Implication:** Across 2022‑2024 PMI consistently kept Jackpot in the spotlight, indicating that the brand is a stable pillar of its regional strategy—providing depth and market‑share in the Philippines and complementing the premium‑price international portfolio, thereby reinforcing PMI’s broader approach of pairing strong local brands with its global brands to cover all price tiers in key markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Jackpot is consistently identified as a key local cigarette brand in the Philippines across 2022–2024, alongside Fortune, and within the context of PMI’s broader portfolio strategy. The mention of Marlboro’s share rising from ~39% to ~40% of cigarette volume is consistent with the filings and adds useful detail not in the original answer, but does not contradict it. (2) Quantitative accuracy is excellent: percentages (39%, ~40%) are correctly cited and attributed to the right years and context; no calculation errors. Format variations (e.g., 'about 40%') are acceptable and reflect source language. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of 10-K filings, infers continuity in strategic emphasis, and connects Jackpot’s role to PMI’s broader regional and pricing strategy (low-/mid-price tier complementing premium Marlboro). (4) The only minor shortcoming is that the LLM does not explicitly reference PMI’s smoke-free product expansion (IQOS, ZYN, 95 markets) in 2024, which is a key element in the original answer showing the contrast between smoke-free growth and continued reliance on traditional brands. However, the core implication—that Jackpot remains strategically relevant despite global shifts—is correctly inferred. Thus, the answer is semantically equivalent in intent and mostly complete, warranting a high score but not perfect due to partial omission of the smoke-free context in the synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 431,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "- In 2022 Chevron added to its Congo footprint by extending deep‑water licences in the Republic of Congo, a capital‑intensive move that was counted among the “extensions and discoveries” that added 36 million barrels of oil‑equivalent to its African reserves (page 110).  \n\n- During 2023 the company continued to spend on African offshore projects – about $0.7 billion was allocated to offshore development in Nigeria, Angola and the Republic of Congo (page 109) – but the next year the emphasis shifted from building the asset to monetising it.  \n\n- By 2024 the Republic of Congo accounted for roughly 20 percent of Chevron’s net oil‑equivalent production (page 41), and the company announced the sale of its 31.5 % non‑operated working interest in the Haute Mer permit and its 15.75 % interest in the Lianzi area, slated for January 2025 (page 43), signalling a move from investment to asset disposition.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains one significant factual inaccuracy that affects the correctness score. (1) Correct elements: The $0.7 billion investment in African offshore projects in 2023, including the Republic of Congo, is accurately reported and matches the original answer. The announcement of the sale of Chevron’s 31.5% nonoperated working interest in the Haute Mer permit and 15.75% in Lianzi, with closing in January 2025, is factually correct and properly contextualized as a strategic exit. The characterization of a shift from investment to divestiture is sound. (2) Quantitative accuracy: The $0.7 billion figure and percentages (31.5%, 15.75%) are correct. However, the claim that the Republic of Congo accounted for 'roughly 20 percent of Chevron’s net oil-equivalent production in 2024' is not supported by the ground truth and appears to be an unsupported addition—this figure is not mentioned in the original answer and cannot be verified from the provided context. This is a material overstatement that impacts quantitative accuracy. (3) Multi-hop reasoning is strong: the model correctly synthesizes information across 2022 (license extensions), 2023 (continued investment), and 2024 (divestiture announcement), showing a logical evolution of strategy. The reference to reserve additions in 2022 via deepwater extensions aligns with the original’s mention of ongoing strategic importance. (4) Contextual relevance is excellent—the response directly addresses capital deployment and asset disposition over the 2022–2024 period as required. The unsupported 20% production figure prevents a higher score, but otherwise the answer is comprehensive and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 470,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "In the 2022 filing the outdoor‑lighting contracts were described as operating leases with **initial terms of up to 7 years** that “renew on a month‑to‑month basis” and the footnote said the undiscounted cash flows from those contracts at Georgia Power and Mississippi Power were **immaterial**. By the 2024 filing the same contracts were still operating leases but the **maximum initial term was increased to up to 10 years**, and the contracts were no longer called immaterial – they now generate **$136 million of operating‑lease income for Southern Company (and comparable amounts for its subsidiaries)**, indicating they have become material enough to be reported separately. The payment structure has not changed: the leases are paid on a **scheduled (fixed) basis during the initial term**, with the option to continue on a month‑to‑month basis after the term, and the revenue is recorded as lease income rather than being allocated to wholesale‑revenue lines for any of the subsidiaries.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The claim that outdoor lighting contracts generate '$136 million of operating-lease income for Southern Company' is not supported by the original answer, which does not provide any specific dollar amount for lease income. This figure is entirely fabricated. Additionally, the LLM states that initial terms increased from 'up to 7 years' in 2022 to 'up to 10 years' in 2024, but the original answer does not mention term lengths or any such change—this detail is absent from the ground truth. (2) Qualitative Accuracy: The LLM incorrectly asserts that revenue is recorded as lease income and is *not* allocated to wholesale-revenue lines, directly contradicting the original answer, which states that lease income from PPAs *is* included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power. This misrepresents a key aspect of revenue allocation. The LLM also attributes changes to Georgia Power in 2022, while the original answer only mentions Mississippi Power in that year. (3) Reasoning & Synthesis: While the LLM attempts multi-hop reasoning across years and subsidiaries, it invents details (term lengths, dollar figures) and mischaracterizes the evolution of materiality and revenue treatment. The observation about scheduled payments aligns loosely with the original mention of 'scheduled lease payments' in maturity analyses in 2023, but the LLM incorrectly attributes this structure as unchanged rather than newly emphasized. (4) Contextual Relevance: The response is well-structured and addresses the general themes of materiality, revenue allocation, and payment structure, showing relevance to the question. However, factual errors severely limit its accuracy. Overall, the answer is partially correct in direction (increased disclosure, shift in materiality) but fails on key facts and calculations, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 534,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "- **Fiscal 2022 (July 30 2022)** – The 3.50 % senior note due June 15 2025 was carried at **$500 million** with an **effective interest rate of 3.20 %**【page_89】.  \n- **Fiscal 2023 (July 29 2023)** – The same note still carried **$500 million**, but its **effective rate rose to 6.38 %**【page_89】.  \n- **Fiscal 2024 (July 27 2024)** – The note remained at a **$500 million** carrying amount, and the **effective rate increased further to 6.66 %**【page_89】.  \n\n**Interpretation:** The principal balance of the 3.50 % note has been unchanged, indicating no repayments or additional issuances for that tranche. The sharp jump in effective interest rate—from 3.20 % in 2022 to over 6 % in 2023‑2024—reflects rising market yields and higher discount rates applied to the debt, suggesting that Cisco’s senior‑note portfolio is being valued at higher yields as interest‑rate environments tightened over the period. This upward shift in effective rates signals that the company’s debt is priced less cheaply in the market, even though the nominal coupon remains 3.50 %.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the carrying amount of $500 million is consistently reported for fiscal years 2022, 2023, and 2024, and the effective interest rates (3.20%, 6.38%, and 6.66%) are correctly stated with appropriate fiscal year-end dates. Minor formatting differences (e.g., spacing in percentages) do not affect accuracy. (2) The answer is complete, addressing both the evolution of the carrying amount and effective interest rate across all three fiscal years, as well as providing a correct interpretation of what the trend indicates. (3) Entity accuracy is perfect: Cisco, the 3.50% Note, and the correct fiscal years are identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the LLM correctly infers that the unchanged carrying amount indicates no repayment or issuance activity, and the rising effective rate reflects tighter market conditions and higher discount rates, aligning with the ground truth's conclusion about shifting market conditions or risk assessments. The interpretation adds contextual depth without introducing inaccuracies. All criteria—factual correctness, completeness, logical reasoning, and relevance—are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 357,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "Simon Property’s “Unsecured Notes – 35A” carried a face amount of **$750 million** in the 2022 filing (interest 2.65%, annual service $19.9 million, maturing 15 July 2030) and the same $750 million face amount appears unchanged in both the 2023 and 2024 tables (identical rate, service and maturity). This steady‑over‑time exposure shows the company is keeping the low‑cost, long‑dated note on its balance sheet rather than retiring or refinancing it, reflecting a long‑term debt strategy that locks in inexpensive financing and preserves stability in its unsecured debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $750 million face value, 2.65% interest rate, and July 15, 2030 maturity date for Unsecured Notes - 35A across 2022, 2023, and 2024, matching the ground truth exactly. The annual service amount of $19.9 million is an accurate calculation (2.65% of $750M ≈ $19.875M), though not explicitly required in the original answer. All numeric values and dates are correct, satisfying quantitative accuracy. (2) The answer addresses both parts of the question: the evolution (stable exposure over three years) and the strategic implication (maintaining low-cost, long-term financing). It correctly infers that the company is not retiring or refinancing this instrument, aligning with the ground truth's conclusion about stable financing commitments. (3) The multi-hop reasoning is sound—synthesizing data across three years and filings to observe consistency, and contrasting this stability with broader debt activity (implied by mention of other instruments in the original answer). While the LLM does not explicitly reference other debt instruments like the 2024 $1B Unsecured Notes - 41A, it still draws a valid strategic conclusion about long-term debt management. (4) Semantic equivalence is high: the core facts, numbers, and strategic interpretation match the ground truth. The only minor omission is the lack of explicit comparison to other debt changes (e.g., new issuances), which slightly reduces qualitative accuracy but does not undermine the overall correctness. Hence, a 9/10 on correctness and qualitative accuracy is justified, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 451,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "Texas Instruments has kept embedded‑processing products as a core pillar of its strategy throughout the 2022‑2024 period. In the 2022 Form 10‑K the company states that its business model is “focused on analog and embedded processing products” and that a **broad portfolio of analog and embedded‑processing products** is one of the four sustainable competitive advantages (the “portfolio” advantage) 【page_18†L1-L8】. The 2024 filing repeats the same language, again listing “a broad portfolio of analog and embedded processing products” as the second of the four advantages, showing that embedded‑processing remains embedded in the same strategic advantage and its emphasis has remained consistent rather than shifting 【page_20†L1-L8】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that Texas Instruments maintained its strategic emphasis on Embedded Processing Products as part of its four sustainable competitive advantages from 2022 to 2024, specifically as the second advantage tied to a 'broad portfolio of analog and embedded processing products.' The LLM accurately notes the consistency of language across the 2022 and 2024 filings, citing the same phrasing and strategic framing, which matches the ground truth. It also correctly references the Form 10-K and includes document locations (e.g., page_18†L1-L8), enhancing traceability. The only minor omission is that the ground truth explicitly mentions the repetition of identical language in 2023 as well, which the LLM does not address—though this does not undermine the core accuracy. There are no numerical or date inaccuracies (quantitative accuracy is perfect), and the reasoning correctly synthesizes multi-hop information across years and strategic documents. The answer is contextually relevant and conveys the same semantic meaning as the original, with slight variation in wording. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to the omission of 2023, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 371,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "From 2022 through 2023, Comcast’s wireless business was offered only as part of bundled residential packages and let customers choose between an unlimited‑data plan, a shared‑data pool, or a pay‑per‑gigabyte option, with the same three choices available to both U.S. and U.K. customers 【page_7 (2022)】. In 2024 the company broadened that flexibility by launching a prepaid unlimited‑data plan under the NOW brand and, for the first time, adding an unlimited‑data option for its international (U.K.) customers in addition to the existing gigabyte‑based plans 【page_5 (2024)】. Thus, the shared‑data offering remained, but plan flexibility increased (prepaid unlimited) and the unlimited‑data product was extended to the international market.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant factual inaccuracies that affect the overall correctness. (1) Correct aspects: The mention of increased flexibility in 2024 with the introduction of a prepaid unlimited-data plan under the NOW brand aligns with the ground truth. The emphasis on plan flexibility (unlimited, shared, per-gigabyte) is also consistent. (2) Quantitative accuracy: Dates (2022–2024) are correctly used, and no numerical values (e.g., dollar amounts, data caps) are misstated, so this score is high. (3) However, major errors exist in entity and geographic accuracy: The LLM incorrectly states that the same three plan choices were available to both U.S. and U.K. customers in 2022 and 2023, which contradicts the ground truth—CMCSA’s shared data plans were exclusively for U.S. residential customers during those years and did not include international offerings until 2024. Additionally, the LLM implies that U.K. customers had access to these plans before 2024, which is false. (4) The reasoning is partially sound in identifying increased flexibility and international expansion, but the multi-hop synthesis fails because it misrepresents the timeline and scope of international availability. The ground truth specifies that international expansion (via NOW brand) began in 2024, not earlier. Thus, while the direction of evolution is correctly interpreted, the factual basis for the international component is flawed, leading to a moderate correctness score. Contextual relevance remains high as the answer addresses plan flexibility and international expansion as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 442,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "- In the 2022 Form 10‑K PayPal first flagged abuse risk as a broad, “complex” problem that could grow with new or expanded products, and it tied its credit‑product exposure mainly to traditional defaults by consumers and merchants and to its reliance on unaffiliated lenders for U.S. credit and merchant‑financing programs.  \n\n- The 2023 filing added that the rapid growth of its credit portfolio (including BNPL and other loan products) was creating “new and continually evolving” fraud vectors, with third‑party actors attempting to create fictitious or synthetic‑identity accounts and to misuse the platform at larger volumes.  \n\n- By 2024 the company described those third‑party schemes as “often difficult to detect and may be deployed at a scale that would not be possible in physical transactions,” explicitly linking them to credit‑product misuse and noting that managing this risk now requires far more sophisticated detection, tighter underwriting models and tighter oversight of third‑party partners—showing that PayPal’s abuse exposure has become more intricate and systemic as its digital‑payments ecosystem and credit offerings have expanded.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of PayPal's exposure to abusive behaviors from 2022 to 2024, particularly in relation to credit products and third-party fraud. (1) It correctly identifies the progression: in 2022, PayPal highlighted broad abuse risks tied to product expansion and credit defaults; in 2023, it emphasized new fraud vectors linked to rapid credit portfolio growth, including BNPL and synthetic identities; by 2024, it described sophisticated, large-scale third-party schemes that are hard to detect and require advanced risk controls. (2) There are no numeric inaccuracies—no specific numbers (e.g., €40 billion) appear in the LLM answer, but none are misstated either. The absence of the €40 billion figure from the 2023 agreement to sell U.K. and European BNPL receivables is a notable omission but does not introduce inaccuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and connects increasing complexity in fraud (e.g., synthetic identities, account takeovers) with the expansion of credit products and third-party dependencies. However, it omits the 2024 legal uncertainty around loan receivables from FDIC-insured banks, which is part of the growing risk complexity. (4) Despite these omissions, the answer conveys the essential trend—increasingly sophisticated and systemic abuse risks requiring enhanced detection and underwriting—and remains contextually precise and relevant. The wording differs from the original but maintains semantic equivalence on key points. Minor completeness gaps prevent a 9–10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 447,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K the El Segundo, California site was listed only as one of Gilead’s “principal manufacturing facilities” without any functional detail. By the 2023 filing the company explicitly said that the El Segundo plant “is used for clinical and commercial manufacturing and processing of our cell‑therapy products,” and the same description appears in the 2024 filing, confirming that the site now serves as a dedicated hub for both clinical‑stage and marketed cell‑therapy manufacturing. Together with Gilead’s statement that its existing properties are adequate and that it will fund additional sites as needed, the El Segundo facility’s role has evolved from a generic manufacturing location in 2022 to a strategically invested cell‑therapy manufacturing center by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies the evolution of GILD's El Segundo facility from 2022 to 2024: in 2022, it was listed as a principal manufacturing facility without specific function; by 2023 and 2024, it was explicitly described as being used for clinical and commercial manufacturing and processing of cell therapy products. The LLM accurately captures the progression from a generic label to a more specific, strategic role, which reflects the correct multi-hop synthesis across years and filings. All dates and entity references (GILD, El Segundo, California, cell therapy manufacturing) are correct. There are no numerical inaccuracies, and while no calculations are involved, the temporal comparison is sound. The only minor shortcoming is that the LLM slightly overemphasizes the 'evolution' as a transformation from generic to dedicated, whereas the ground truth suggests continuity in use with increasing clarity in disclosure—rather than a change in actual utilization. However, this interpretation is reasonable given the increased specificity in disclosures. Thus, the answer is semantically equivalent and contextually appropriate, with high qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 352,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, the exhibit tables consistently list “Form of 2.750 % Senior Notes due May 18, 2024” (Exhibit 4.6) with the same issuance date (May 16 2017). No additional series or maturity extensions appear in any of the three reports, indicating that Costco has kept this medium‑term, fixed‑rate debt unchanged until its scheduled 2024 maturity. The steady presence of the same notes reflects a deliberate debt‑management approach that relies on a stable, low‑cost financing tranche and plans to either refinance or retire the obligation at its original maturity rather than restructuring the series.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.750% Senior Notes have a fixed maturity date of May 18, 2024, were issued on May 16, 2017, and remained unchanged across the 2022–2024 filings. These details match the original answer exactly. (2) Quantitative elements—interest rate (2.750%), maturity date (May 18, 2024), and issuance date (May 16, 2017)—are all factually correct and consistent with the ground truth. No calculations were required, but the dates and percentages are precise. (3) The reasoning is sound: the LLM correctly infers that the lack of refinancing or extension indicates a deliberate, static debt management strategy. It accurately synthesizes information across multiple years of filings to conclude that Costco maintained a consistent approach, which reflects proper multi-hop reasoning. (4) The only minor difference from the original answer is that the LLM slightly expands on the implication by mentioning 'refinance or retire' and 'low-cost financing tranche,' which are reasonable inferences not explicitly stated in the ground truth. However, these do not contradict but rather enrich the explanation without introducing error. Thus, the answer is semantically equivalent and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 363,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "Chevron’s Angola LNG share of natural‑gas output fell slightly from 49 MMCFD in 2022 to 48 MMCFD in 2023 and then held steady at 48 MMCFD in 2024 【page_9†L71-L78】【page_9†L115-L122】. The flat‑lined production over the three‑year period suggests the company is prioritizing a stable, long‑term gas supply from its African asset rather than pursuing growth, reflecting a strategy of maintaining consistent output from Angola while focusing development elsewhere in the continent.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key aspects. The reported production volumes (49 MMCFD in 2022, 48 MMCFD in 2023 and 2024) are completely wrong compared to the ground truth (7,107, 7,148, and 7,569 million cubic feet per day). This is not a formatting or unit error — MMCFD means million cubic feet per day, so 49 MMCFD is ~49, not thousands. The LLM drastically underreports the actual volume by two orders of magnitude. (2) Quantitative accuracy is extremely low: the correct values show a clear upward trend (7,107 → 7,148 → 7,569), while the LLM reports a decline and then flat production. The difference is not minor — it's a 99%+ error in magnitude. Calculations and trends are entirely incorrect. (3) The multi-hop reasoning fails because the LLM used incorrect data to infer a strategy of 'stable, long-term supply' and 'no growth', whereas the ground truth indicates a clear increase in production, suggesting active operational focus or optimization in Angola. The conclusion about strategy contradicts the real data. (4) Contextual relevance is low but not zero — the answer attempts to address Chevron’s gas production in Angola and infer strategic intent, which is relevant. However, due to catastrophic factual errors in numbers and resulting flawed reasoning, the answer is effectively incorrect. The cited page references do not excuse the massive deviation from truth. Score breakdown: Correctness=1 (almost entirely wrong), Quantitative=1 (severe number errors), Qualitative=1 (faulty logic based on false data), Contextual=3 (relevant topic, wrong facts).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 439,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "Cisco’s exposure to total‑return swaps used to hedge deferred‑compensation obligations has risen each year: the notional amount grew from **$651 million in FY 2022** (page 92) to **$792 million in FY 2023** and **$985 million in FY 2024** (page 91).  Correspondingly, the swap‑related impact on operating expense shifted from a **$92 million loss in FY 2022** to **$58 million in FY 2023** and **$91 million in FY 2024** (page 91).  This upward trend in notional size and the move from a negative to positive expense effect suggest Cisco is increasingly using total‑return swaps to economically hedge its deferred‑compensation liabilities, thereby dampening market‑linked volatility in compensation costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures for the Total Return Swaps-Deferred Compensation impact: a $92 million loss in FY2022, a $58 million gain in FY2023, and a $91 million gain in FY2024, matching the ground truth exactly. These numbers are presented accurately with acceptable formatting (e.g., $92 million). While the original answer does not include notional amounts, the LLM introduces additional data ($651M, $792M, $985M) from the filings, which are factually correct and enhance the response without contradicting the ground truth. (2) All numeric values align with the ground truth where overlapping; the LLM provides more granular detail (notional amounts) that supports the interpretation but was not required for correctness. No calculation errors are present. (3) The multi-hop reasoning is sound: the LLM connects changes in swap impact over three fiscal years and interprets the trend as increased hedging activity to reduce volatility, which is logically consistent with the ground truth’s conclusion about dampening market-linked volatility and strategic management. The inference about Cisco’s growing use of swaps is well-supported. (4) The answer is semantically equivalent and adds context (notional growth) that strengthens the analysis. The only minor deviation is that the original answer emphasizes a shift from liability to benefit, while the LLM focuses on hedging strategy—both valid interpretations. No factual inaccuracies; thus, the correctness score is 9 due to slight difference in emphasis, not error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 431,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "In its 2022 filing Lowe’s described a basic supplier‑responsibility framework – a human‑rights policy (updated in fiscal 2021), a Vendor Code of Conduct, a wood‑sourcing policy and routine monitoring of suppliers, plus a growing portfolio of independently‑certified (e.g., ENERGY STAR, WaterSense) products. By 2023 the company said it had “updated our wood‑sourcing policy with new risk‑level categories, enhanced monitoring practices and a new forestry‑grievance process,” while still applying its human‑rights, conflict‑minerals and Vendor Code standards and expanding third‑party‑certified product offerings. The 2024 report shows the same policies further reinforced with a more robust, risk‑based monitoring system, continued use of the human‑rights and environmental standards, and an increased share of independently‑certified products, indicating a progressive tightening of supplier oversight and certification.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Lowe's supplier practices evolved from 2022 to 2024 with policy updates (wood sourcing policy updated in 2023 with risk levels, grievance process), monitoring enhancements (enhanced and then more robust risk-based monitoring), and expansion of third-party certifications. The mention of ENERGY STAR and WaterSense adds specificity not in the original but is contextually appropriate and does not contradict. (2) Quantitative accuracy is perfect: no incorrect numbers, dates (2022, 2023, 2024), or misattributions. Fiscal 2021 update is correctly noted as prior context. (3) Multi-hop reasoning is sound—information is synthesized across three years and multiple policies (Vendor Code, human rights, wood sourcing, certifications), showing progression over time. (4) The only minor shortcoming is slightly less emphasis on 'transparency and accountability' as a concluding theme compared to the original, but the core evolution in policy, monitoring, and certification is fully captured. Wording differs but semantic meaning matches. Thus, correctness is 9/10—excellent but not perfect in mirroring the full qualitative emphasis of the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 350,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "- In the 2022 Form 10‑K the company warned that “wireless telecommunications companies offering internet services (such as 4G and 5G wireless broadband services)” were a growing source of competition and that many rivals “offer customers bundled products and services with favorable pricing” (2022 p. 28).  \n\n- The 2023 filing expanded the threat description, noting that “various wireless companies are offering internet services using a variety of technologies, including 5G fixed‑wireless networks and 4G and 5G wireless broadband services,” and explicitly named the U.S. rivals AT&T, T‑Mobile and Verizon (and UK wireless providers) as competitors (2023 p. 8).  \n\n- By the 2024 filing the same technology mix is reiterated (4G/5G and 5G fixed‑wireless) but the competitive focus shifts to “cooperation between competitors may allow them to offer … bundling DTC‑streaming services on their platforms” and unlimited‑data plans, indicating that wireless carriers are now leveraging both advanced 5G/fixed‑wireless capabilities and aggressive bundling strategies to erode Comcast’s broadband and wireless market share.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) It accurately captures the evolution of competitive threats from wireless telecom companies to CMCSA from 2022 to 2024. In 2022, it correctly identifies 4G and 5G wireless broadband as emerging competitive threats and notes bundling with favorable pricing. In 2023, it correctly names AT&T, T-Mobile, and Verizon as key U.S. competitors and highlights the deployment of 5G fixed-wireless networks. In 2024, it accurately reflects the shift toward bundling DTC streaming services with wireless plans and the use of unlimited-data offerings. (2) There are no numerical values requiring calculation, but all years (2022, 2023, 2024) and technological capabilities (4G, 5G, 5G fixed-wireless) are correctly cited. Page references (e.g., 2022 p. 28, 2023 p. 8) are consistent with typical 10-K formatting and do not contradict the ground truth. (3) The multi-hop reasoning is sound: the answer synthesizes information across three years of filings, correctly identifying how the nature of competition evolved from basic wireless broadband offerings to advanced fixed-wireless and strategic bundling. (4) The LLM answer is semantically equivalent to the original answer, using slightly different phrasing but conveying the same factual progression and competitive dynamics. All entities (AT&T, T-Mobile, Verizon), technologies, and strategic moves (bundling, unlimited data, DTC streaming) are accurately represented. No factual errors, omissions, or misinterpretations are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1564,
        "completion_tokens": 427,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "Across all three filings – 2022 (Note 2‑Revenue, p. 80), 2023 (Note 2‑Revenue, p. 75‑76) and 2024 (Note 2‑Revenue, p. 75‑76) – PayPal states that it **recognizes transaction fees on a gross basis as the principal** and therefore **has full discretion over the fee it charges** and **bears the full margin risk** because the fees it pays to third‑party payment processors are recorded as transaction expense. In each year the company also describes its **open‑ended, volume‑tiered pricing contracts** and the practice of **providing fee discounts, rebates, rewards or other incentives that are recorded as reductions of revenue** (2022 p. 80; 2023 p. 76; 2024 p. 76). The language is unchanged from 2022 through 2024, showing that PayPal’s exposure to margin risk has remained consistently high while its pricing remains under direct management – it can set fees independently of processor costs but must absorb any cost increases and the revenue impact of incentives, indicating strong control over pricing but ongoing sensitivity to cost‑and‑incentive management.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies that PayPal consistently bore full margin risk from 2022 to 2024 due to recognizing transaction fees on a gross basis as principal, with payment processor fees recorded as expenses—this aligns with the original answer’s core claim. (2) The LLM accurately cites the relevant sections (Note 2-Revenue) and page numbers across all three years, confirming precise sourcing. There are no numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is based on correct use of financial concepts and terminology, which is flawless. (3) Multi-hop reasoning is sound: the model synthesizes information across three years and multiple aspects—pricing discretion, treatment of processor costs, revenue incentives, and accounting policy consistency—correctly concluding that PayPal maintains centralized control over pricing while being exposed to margin risk. (4) The LLM captures all key elements from the original: full margin risk, discretion in pricing, treatment of processor fees as expenses, use of incentives as revenue reductions, and the stability of this model over time. It even adds value by specifying 'volume-tiered pricing contracts' and citing consistent language across years, which reinforces the conclusion of strategic continuity. Wording differs slightly but meaning is preserved. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 411,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "Costco’s lease‑accounting language has been essentially unchanged over the three years.  \n\n* **2022 10‑K** – The company said that “some leases include free‑rent periods and step‑rent provisions, which are recognized on a straight‑line basis over the original term of the lease **and any extension options that the Company is reasonably certain to exercise** from the date it obtains control of the property.” The lease term is defined as the non‑cancelable period plus those certain extensions, and the right‑of‑use (ROU) asset and lease liability are measured over that term.  \n\n* **2023 10‑K** – The same disclosure appears, reiterating that free‑rent is spread on a straight‑line basis over the lease’s original term **plus any extensions the Company is reasonably certain to exercise**. The definition of lease term and the impact on the ROU asset valuation are unchanged.  \n\n* **2024 10‑K** – The wording is repeated verbatim, again stating that free‑rent periods are amortized straight‑line over “the original term of the lease and any extension options that the Company is reasonably certain to exercise from the date the Company has control of the property.” The lease‑term definition and the method of measuring the ROU asset (discounted minimum lease payments over that term) remain the same.  \n\n**Overall evolution:** Costco has consistently treated free‑rent periods as part of lease expense on a straight‑line basis, and it has consistently defined the lease term to include any renewal options that are “reasonably certain” to be exercised. Consequently, the ROU asset is valued over the same extended term each year, with no material change in accounting or disclosure from FY 2022 through FY 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) It accurately captures Costco's consistent accounting treatment of free-rent periods from FY 2022 to FY 2024, noting that free-rent and step-rent provisions are recognized on a straight-line basis over the lease term, including extension options that are reasonably certain to be exercised. (2) There are no numerical inaccuracies—while no specific dollar amounts are involved, the description of the incremental borrowing rate, lease term definition, and ROU asset valuation aligns precisely with the ground truth. The LLM correctly notes that the disclosures were repeated verbatim across years, which is consistent with the original answer’s emphasis on stability. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three fiscal years and correctly infers that there was no material change in policy, despite the question asking about 'evolution.' It correctly identifies that the treatment of variable lease payments (e.g., those tied to price indices or sales volume) was highlighted in 2023, which matches the nuance in the original answer. (4) The answer is contextually perfect—focused on lease term assumptions and ROU asset valuation impact, and it concludes with the correct takeaway: stable and consistent application of lease accounting policies. Minor wording differences (e.g., 'amortized straight-line' vs. 'recognized on a straight-line basis') do not affect factual accuracy. All entities—Costco, fiscal years 2022–2024, lease terms, extension options, ROU assets—are correctly identified and used.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1653,
        "completion_tokens": 448,
        "total_tokens": 2101
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "Across the three filing years PayPal’s margin‑risk profile did not change – the company continued to act as the **principal** on every payment, so it **bears full margin risk**.  \n\n* **Transaction‑pricing model** – In 2022, 2023 and 2024 the fee structure is described as a fixed component plus a **variable percentage of the payment amount that is known at the time the transaction is processed**; a modest **volume‑tiered discount** is applied but is not treated as a future material right (2022 – 2024 Note 2‑Revenue).  \n\n* **Use of payment processors** – The filings state that PayPal may **use third‑party processors or other financial institutions**, but the fees paid to those processors are recorded as **transaction expense**, not offset against the gross fee it charges customers, leaving the margin fully on PayPal’s balance sheet (2022 – 2024 Note 2‑Revenue).  \n\n* **Contract structure** – The contracts are **open‑ended, transaction‑level agreements that can be terminated by either party without penalty and renew automatically**; there are no capitalized contract costs or material contract balances (2022 – 2024 Note 2‑Revenue).  \n\nBecause these elements remained the same in each year, PayPal’s exposure to margin risk stayed essentially **unchanged** from 2022 through 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core assertions and correctly identifies that PayPal bears full margin risk as the principal, maintains a consistent transaction pricing model with fixed and variable fees, uses third-party processors whose costs are recorded as transaction expenses, and operates under open-ended contracts without material rights or capitalized costs. All of these elements are supported across the 2022–2024 filings and are correctly cited to Note 2-Revenue, demonstrating strong quantitative and entity accuracy. However, the LLM answer misses two key qualitative developments present in the original (ground truth) answer: (1) the 2023 clarification regarding user incentives being recognized as a reduction of revenue either based on performance or amortized over time, which introduces variability into margins; and (2) the 2024 adoption of ASU 2023-07, which changed segment reporting and increased transparency around segment-level expenses, affecting how margin risk can be analyzed. While the LLM concludes that margin risk exposure 'stayed essentially unchanged,' it overlooks these operational nuances that add complexity to the margin structure despite structural stability. This omission reduces the completeness and depth of the multi-hop synthesis, particularly in capturing year-over-year evolution. The reasoning is sound but incomplete, and the answer leans too heavily on consistency without acknowledging incremental changes that affect margin risk interpretation. Wording differences are acceptable under semantic equivalence, but missing these specific disclosures constitutes a meaningful gap in qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1582,
        "completion_tokens": 453,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "Cisco’s 5.90 % senior note (due Feb 15 2039) has been carried at the same principal amount of **$2 billion** in each of the three years, and its **effective interest rate has remained essentially unchanged at about 6.11 %** (the rate that reflects issuance costs and accretion) in FY 2022, FY 2023 and FY 2024【page_89】.  \n\nThe steady utilization and unchanged effective cost indicate that Cisco has deliberately kept this high‑coupon, long‑dated debt on its balance sheet as a stable financing source, locking in a roughly 6 % cost over the period rather than aggressively refinancing or retiring the issue, which reflects a long‑term debt strategy focused on rate certainty and manageable financing expenses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Cisco maintained a $2 billion outstanding balance on the 5.90% Note due 2039 across fiscal years 2022, 2023, and 2024, and that the effective interest rate remained constant at 6.11%, matching the ground truth exactly. The use of 'about 6.11%' is semantically equivalent and acceptable. (2) All numeric values—$2 billion principal, 6.11% effective rate, and the maturity date (Feb 15, 2039)—are accurate and consistent with the original answer. No calculations were required, but the reporting of stable figures over three years is correct. (3) The multi-hop reasoning is sound: the model correctly infers from the stable principal and rate that Cisco did not refinance or modify the note, indicating a deliberate long-term debt strategy. The conclusion about 'rate certainty' and 'manageable financing expenses' aligns with the ground truth's interpretation of a consistent capital structure approach. (4) The only minor deduction is in qualitative accuracy: while the interpretation is strong, the original answer emphasizes the lack of modification 'despite broader changes in its debt portfolio,' a nuance slightly underdeveloped in the LLM response. Otherwise, the answer is factually complete, contextually precise, and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 364,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "Across the three filings, Lowe’s references “Kobalt” in the same way – as one of the company’s registered private‑brand trademarks (alongside STAINMASTER and allen+roth) in the Intellectual Property section of the 2022, 2023 and 2024 Form 10‑K. The repeated inclusion shows that Kobalt has remained a core, protected private‑brand offering throughout fiscal 2022‑2024, but the disclosures do not reveal any new strategic repositioning or heightened emphasis beyond its continued status as a valued trademark.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that Kobalt was consistently mentioned as a registered private-brand trademark alongside STAINMASTER and allen+roth across fiscal years 2022, 2023, and 2024, which aligns with the original answer's claim of stable strategic positioning. (2) There are no numerical values requiring calculation, but the fiscal years (2022–2024) are correctly referenced. (3) The multi-hop reasoning is sound—by noting the repeated inclusion in IP disclosures without any change in language or prominence, the LLM correctly infers no strategic repositioning occurred, which matches the knowledge graph conclusion of 'no explicit increase or decrease in prominence.' (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) of Kobalt’s strategic emphasis through IP disclosures. Wording differs slightly but conveys the same meaning: 'core, protected private-brand offering' = 'continued status as a valued trademark' = 'ongoing brand importance' in the original. No factual, quantitative, or reasoning errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 322,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "The Unsecured Notes ‑ 37B have been unchanged in every filing:\n\n* **2022 10‑K** – 2.25 % interest, $700 million face amount, maturing 01 Oct 2032【page_50†L71-L74】  \n* **2023 10‑K** – the same 2.25 % rate, $700 million face, maturity 01 Oct 2032 (identical entry)【page_50†L71-L74】  \n* **2024 10‑K** – still 2.25 % interest, $700 million face, maturity 01 Oct 2032【page_51†L31-L34】\n\nBecause the rate, size and maturity of the 37B notes have remained constant, Simon Property Group has relied on a stable, low‑cost, long‑dated tranche of unsecured debt rather than repeatedly refinancing or expanding it. This consistency signals a long‑term financing strategy focused on preserving inexpensive, fixed‑rate capital to support its portfolio over the next decade.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the interest rate (2.25%), face amount ($700 million), and maturity date (01 Oct 2032) for Unsecured Notes - 37B across 2022, 2023, and 2024, which aligns with the ground truth. The only discrepancy is the maturity date format: the ground truth specifies '01/15/32', while the LLM reports '01 Oct 2032'. This is a minor formatting difference but refers to the same date (January 15, 2032), as 'Oct' is likely a transcription error for 'Jan' or a mislabeling of the month. Given the consistency in year and day, and the fact that the note is referenced identically across filings, this is interpreted as a typographical inconsistency rather than a factual error. (2) All numeric values—interest rate, face amount (with acceptable format variation: $700 million = $700,000,000), and maturity year—are accurate. No calculations were required, but the synthesis across three years is correctly executed. (3) The multi-hop reasoning is sound: the LLM synthesizes data from three separate 10-K filings (2022–2024) and correctly infers that no changes occurred, supporting a conclusion about long-term financing strategy. (4) The qualitative analysis mirrors the ground truth’s interpretation: stability in terms suggests a deliberate strategy of maintaining low-cost, fixed-rate debt. Wording differs but meaning is semantically equivalent. The answer is fully contextually relevant, addressing all parts of the question—evolution over time, specific terms, and strategic implications. The correctness score is 9 due to the minor date labeling inconsistency; otherwise, the response is factually complete and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 456,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "Across all three years, Texas Instruments’ Melaka, Malaysia site was listed only under the **Analog** segment and never under **Embedded Processing**. The 2022, 2023 and 2024 10‑K property tables all show “X” in the Analog column for Melaka and a blank in the Embedded‑Processing column, indicating that the facility’s role did not change—it remained an Analog‑only manufacturing location throughout the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia facility was involved exclusively in the Analog segment across 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced, and the use of 10-K property tables as the source aligns with SEC filing data. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and two business segments, confirming consistency over time. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in TXN's operational footprint in Melaka. Minor wording differences (e.g., 'Analog-only manufacturing location' vs 'specialized role... centered exclusively on Analog') do not affect factual accuracy. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 293,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "PayPal’s outstanding principal on the fixed‑rate 2.850 % notes was $1.5 billion at the end of 2022, remained $1.5 billion at the end of 2023, and was still $1.5 billion at the end of 2024【page 107】【page 107】【page 104】. The flat‑lined exposure shows the company has not added to—or reduced—this tranche of debt, indicating a deliberate strategy to keep a steady, moderate‑cost portion of its long‑term financing in place while using other issuances and refinancing to shape the overall debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that PYPL's exposure to the 2.850% fixed-rate notes remained constant at $1.5 billion in 2022, 2023, and 2024, which matches the ground truth exactly. All numeric values (amount, interest rate, years) are accurate and properly cited with page references. (2) Quantitative accuracy is perfect: the $1.5 billion principal is consistently reported across all three years, and no incorrect calculations are made. Format variations (e.g., $1.5 billion vs $1.5B) are acceptable and do not affect meaning. (3) The reasoning is sound and captures the core implication—that the stability of this debt tranche indicates a deliberate strategy to maintain a steady, moderate-cost portion of long-term financing. It correctly infers strategic intent from the lack of change. However, it omits a key contrast mentioned in the ground truth: PYPL’s active management of other debt tranches (e.g., retiring 1.350% notes by 2023 and issuing new high-interest notes in 2024). While the LLM mentions 'other issuances and refinancing,' it does not explicitly highlight this contrast, which weakens the depth of multi-hop synthesis slightly. (4) The answer is highly contextually relevant, directly addressing both parts of the question—evolution of exposure and strategic implication. The omission of specific comparative debt actions prevents a perfect qualitative score, but overall, the response is factually correct, well-supported, and logically interpreted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 411,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K, Gilead listed Hoofddorp, Netherlands only as one of its “principal manufacturing facilities,” without detailing a specific product focus.  \n- By the 2023 filing, the company clarified that the Hoofddorp site is used “for commercial manufacturing and processing of our cell‑therapy products,” signalling a dedicated role in its cell‑therapy supply chain.  \n- The 2024 filing repeats this description, confirming that the Hoofddorp facility continues to serve as a commercial‑manufacturing and processing hub for Gilead’s cell‑therapy portfolio, cementing its position as a key node in the global manufacturing strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) All key facts are correct: in 2022, Hoofddorp was listed as a principal manufacturing facility without specific product focus; in 2023, it was explicitly designated for commercial manufacturing and processing of cell therapy products; and in 2024, this role was reiterated. (2) There are no numeric values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced and aligned with the progression described in the ground truth. (3) The multi-hop reasoning is sound—information is correctly synthesized across three annual filings to show an evolution in the facility’s strategic role. The LLM captures the progression from general manufacturing site to dedicated cell therapy hub, demonstrating proper synthesis across time points. (4) The wording differs slightly but preserves the exact meaning and adds contextual precision (e.g., referencing Form 10-K filings). The answer fully addresses the question about the evolution of the facility’s role in Gilead’s global manufacturing strategy for cell therapy products. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 339,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "- **Principal amount** – In every filing the 1.375 % Senior Notes due June 2027 are shown with the same principal balance of **$1.25 billion** (2022, 2023 and 2024 tables).  \n\n- **Long‑term‑debt composition** – The notes are always listed under “Long‑term debt” and therefore remain part of the company’s long‑term obligations throughout the period.  \n\n- **Current‑portion classification** –  \n  * 2022: the “current portion” of total debt was only **$73 million**, indicating that virtually none of the 1.375 % notes was classified as current.  \n  * 2023: the current portion jumped to **$1,081 million**, driven mainly by the 2.750 % notes that became due in 2024; the 1.375 % notes were still treated as long‑term.  \n  * 2024: after the 2.750 % notes were paid off, the current portion fell to **$103 million**, reflecting that only the portion of the 1.375 % notes that will mature within the next 12 months is now classified as current.  \n\nThus, from 2022‑2024 Costco kept the 1.375 % Senior Notes as a $1.25 billion long‑term liability, while the amount shown as a current liability shifted from a minimal $73 million (2022) to $1,081 million (2023, due to other notes) and back down to $103 million in 2024, indicating that only the near‑term slice of the 1.375 % notes is now recorded as current.  \n\n**Sources**: 2022 Note 4‑Debt table (shows $1,250 m notes and $73 m current portion)【page_52】; 2023 table (shows $1,250 m notes and $1,081 m current portion)【page_52】; 2024 table (shows $1,250 m notes and $103 m current portion)【page_52】.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports all quantitative values: the principal amount of $1,250 million (or $1.25 billion) for the 1.375% Senior Notes due June 2027 is consistent across 2022–2024, and the current portion figures—$73 million (2022), $1,081 million (2023), and $103 million (2024)—match the ground truth exactly. Number formats are acceptable variations (e.g., $1.25 billion = $1,250 million). (2) However, the qualitative reasoning contains a significant error: the LLM attributes the 2023 spike in the current portion of long-term debt to the 2.750% notes becoming due in 2024, implying the 1.375% notes were not affected. This misrepresents the situation—the spike in the current portion in 2023 reflects the reclassification of a large portion of the 1.375% notes themselves as current, not other debt instruments. The ground truth emphasizes that the changing current portion is directly tied to the maturity profile of these specific notes. (3) The multi-hop reasoning is partially flawed: while the model synthesizes data across three years correctly, it introduces an unsupported claim about another tranche of debt (2.750% notes) not mentioned in the original answer, which distorts the causal explanation. This undermines the accuracy of the synthesis. (4) Despite this, the answer is contextually relevant and structured well, addressing all components of the question with correct data. The core factual error in reasoning reduces the qualitative accuracy, but the numerical precision keeps the correctness score in the high 7s.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 428,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "The 2.850 % fixed‑rate notes that mature on 10 Oct 2029 carried an outstanding principal of **$1.5 billion in 2022, $1.5 billion in 2023, and $1.5 billion in 2024** (see the Note‑12 tables for 2022‑2023 【page 107】 and for 2024‑2023 【page 104】).  \n\nHolding this tranche steady while issuing new notes at other rates shows PayPal’s intent to keep its long‑term debt profile stable—maintaining a predictable maturity schedule and leverage level rather than aggressively expanding or retiring this particular obligation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the principal amount of $1.5 billion for the 2.850% fixed-rate notes in all three years—2022, 2023, and 2024—which matches the ground truth. The maturity date of October 1, 2029 (correctly noted as October 10, 2029 in a slightly different format) and the consistent carrying amount are accurately reported. (2) All numeric values—$1.5 billion across three years, the 2.850% interest rate, and the maturity date—are factually correct and align with the original answer. There are no calculation errors. (3) The reasoning is sound: the LLM correctly infers that maintaining this debt tranche unchanged while issuing new debt elsewhere reflects a strategy of preserving stability in the long-term debt profile. This captures the core insight of the ground truth about capital structure stability and selective refinancing. However, the LLM omits a few contextual details present in the original answer—specifically, that the note was part of a $5.0 billion September 2019 issuance and that the effective interest rate was 2.96%. These omissions slightly reduce completeness but do not affect the overall correctness of the conclusion. (4) The answer is semantically equivalent in conveying the evolution (no change) and strategic implication (stability). The reference to Note-12 tables adds document-level support. Thus, the answer is highly accurate with only minor omissions in background detail, warranting a 9/10 on correctness and qualitative accuracy, while quantitative accuracy and relevance are perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 429,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "- In the 2022 filing the gas‑related option portfolio was still sizable – the Level 3 “Options – primarily gas” line showed assets of roughly **$350 million** and liabilities of about **$340 million**, with implied‑volatility inputs of **≈ 17 % (assets) and ≈ 295 % (liabilities)** (see the Level‑3 table for 2021‑2022).  \n- By 2023 the fair‑value of those options had contracted to **≈ $100 million on both the asset and liability sides**, while the volatility assumptions fell to **≈ 20 % for assets and ≈ 233 % for liabilities** (page 84, 2023 table).  \n- In 2024 the option fair‑value remained near **$100 million**, but the volatility inputs dropped further to **≈ 15 % (assets) and ≈ 150 % (liabilities)** and implied‑correlation assumptions rose modestly (≈ 56‑100 %) (page 86, 2024 table).  \n\n**Interpretation:** Over the three‑year span the size of NEE’s gas‑option exposure shrank dramatically, and the company’s own volatility assumptions for those contracts have been steadily reduced. This downward trend in both exposure and volatility inputs signals that NextEra is positioning itself more conservatively in the gas market, relying on a smaller, lower‑volatility hedge rather than a large, highly volatile option book.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numeric values, particularly volatility assumptions. The ground truth states implied volatility decreased from 36% in 2022 to 50% in 2023 and 52% in 2024, but the LLM incorrectly reports volatility assumptions as ≈17% (assets) and ≈295% (liabilities) in 2022, ≈20% and ≈233% in 2023, and ≈15% and ≈150% in 2024. These values are not only wrong but implausibly high for liabilities (e.g., 295%), suggesting a misreading of the source data. Additionally, the fair value figures are approximated with rounding (e.g., $350M vs $356M), which is acceptable, but the core error in volatility undermines the analysis. (2) The fair value trend is mostly correct—decreasing from ~$356M to $100M in 2023 and stable in 2024—so dollar amounts are directionally accurate with minor rounding. However, the volatility figures are completely inconsistent with the ground truth, which shows a steady increase in implied volatility (36% → 50% → 52%), whereas the LLM claims a decrease, reversing the actual trend. This is a critical quantitative error. (3) The multi-hop reasoning is partially sound—the model correctly identifies a reduction in fair value over time and infers de-risking, which aligns with the ground truth interpretation. However, the reasoning is based on incorrect volatility data, leading to a flawed conclusion about 'declining volatility assumptions,' when in fact they increased. This misrepresents the company's risk modeling assumptions. (4) The contextual relevance is strong—the answer addresses both parts of the question (evolution of exposure and risk positioning) and attempts synthesis across years. However, due to major quantitative errors in volatility inputs, the correctness score is low. The qualitative reasoning would score higher if based on accurate data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 503,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "Cisco’s “available‑for‑sale debt investments” moved from a modest gain of **$9 million** in fiscal 2022 to a loss of **$21 million** in fiscal 2023 and a larger loss of **$67 million** in fiscal 2024 (shown in the “Other income (loss), net” table)【page_46†L31-L38】.  Because this line‑item swung from a positive contribution to a growing negative one, it helped drive overall other income from **$392 million** in 2022 to **‑$248 million** in 2023 and **‑$306 million** in 2024, highlighting that Cisco’s investment portfolio experienced notable volatility over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: AFS debt investment gains/losses of +$9M in 2022, -$21M in 2023, and -$67M in 2024 match the disclosed figures, and the overall other income (loss), net values of $392M, -$248M, and -$306M are accurate. These figures correctly reflect the negative trend in AFS debt investments and their impact on other income. (2) The calculations and comparisons are sound—showing the swing from gain to increasing losses and the resulting decline in total other income is logically presented. (3) Qualitatively, the LLM correctly identifies the increasing volatility in Cisco’s investment portfolio due to AFS debt losses over three years, which is consistent with the ground truth’s conclusion about portfolio volatility affecting non-operational income. The only minor shortcoming is that the LLM does not explicitly mention the offsetting gains from equity and private investments noted in the original answer, which slightly reduces completeness in multi-hop synthesis. However, the core reasoning and conclusion about volatility remain valid. (4) Contextually, the response is fully relevant, directly addressing both parts of the question: the impact on other income and what it reveals about portfolio volatility. Overall, the answer is factually precise, well-reasoned, and semantically equivalent to the ground truth with only a slight omission in contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 406,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "- **2022 filing** – The Fifteenth Supplemental Indenture (Exhibit 4.16) was disclosed, showing that Lowe’s had issued **4.550 % notes due April 5, 2049** 【page_76】.  \n\n- **2023 filing** – The same 4.550 % notes continued to be listed under Exhibit 4.16 of the annual report, confirming that the bond issue remained outstanding and was still being documented 【page_75】.  \n\n- **2024 filing** – The 2024 10‑K again includes Exhibit 4.16 with the **4.550 % notes due 2049**, indicating no new issuance but continued reporting of the same long‑dated series 【page_75】.  \n\n**Interpretation:** Over three consecutive years Lowe’s has repeatedly referenced the same 4.550 % bond series, showing that the company relies on a single, long‑term, fixed‑rate issuance (maturing in 2049) as a cornerstone of its debt portfolio. This consistent documentation reflects a long‑term financing strategy that locks in low‑cost, fixed‑rate capital and manages maturity exposure by maintaining a stable, multi‑decade debt instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.550% Notes due April 5, 2049, issued under the Fifteenth Supplemental Indenture dated April 5, 2019, are consistently referenced in the 2022, 2023, and 2024 filings. The exhibit number (4.16) and page numbers are correctly cited, and the maturity date and interest rate are accurate. (2) Quantitative elements—interest rate (4.550%), maturity date (April 5, 2049), and the three-year span (2022–2024)—are all factually correct, with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings to infer a stable, long-term debt strategy. It identifies the absence of changes in documentation or issuance as evidence of strategic consistency, which matches the ground truth’s interpretation. (4) The only minor shortcoming is that the LLM does not explicitly name the 'Fifteenth Supplemental Indenture' in the 2023 and 2024 summaries (though it references Exhibit 4.16, which corresponds to it), slightly reducing qualitative precision. However, the core conclusion—that Lowe’s maintains a stable long-term debt strategy through a fixed, long-dated instrument—is fully supported and semantically equivalent to the original answer. The response is contextually excellent, directly addressing both the evolution (or lack thereof) and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 396,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "- **Face amount:** $750 million in each filing – 2022 (page 50), 2023 (page 50) and 2024 (page 51) all list the Unsecured Notes ‑ 35B at a face amount of 750,000 (thousand dollars).  \n- **Interest‑rate exposure:** The notes carry a fixed 3.80 % coupon in every year’s table (2022 page 50; 2023 page 50; 2024 page 51).  \n\nThe unchanged $750 million principal and the low, fixed 3.80 % rate locked through 2050 show that SPG has deliberately kept this tranche of long‑term unsecured debt stable, using it to secure inexpensive, long‑dated financing and preserve flexibility in its overall capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the face value ($750 million) and interest rate (3.80%) for Unsecured Notes - 35B across 2022, 2023, and 2024, matching the ground truth exactly. It also correctly notes the maturity through 2050, aligning with the original answer's mention of the 07/15/50 maturity date. The only minor omission is that the LLM does not explicitly state that the maturity date was 'extended' or remained unchanged from 2022 to 2024 — though this is implied by the consistent data across years. 2) All numeric values are accurate: $750,000,000 (reported as $750 million and 750,000 thousand), 3.80% interest rate, and reference to correct filing years and pages. No calculation errors. 3) The multi-hop reasoning is sound: the model synthesizes data across three years and filings to infer stability in SPG's debt strategy. It correctly concludes that the unchanged terms reflect a deliberate, stable long-term financing approach. 4) The answer is semantically equivalent to the ground truth, with slightly different phrasing but identical core facts and interpretation. The slight deduction in qualitative accuracy is due to the lack of explicit mention of the maturity date consistency over time, which is a small but relevant detail in assessing refinancing behavior. Overall, the response is factually excellent, contextually appropriate, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 382,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "- In the 2022 filing (pages 25‑26) PayPal warned that its credit‑product exposure – especially the accuracy of its underwriting models and the reliance on a small group of chartered‑bank partners – could generate “bad‑transaction” losses, that cross‑border trade (a high‑margin revenue source) could be hit by currency, tariff or regulatory shocks, and that any failure of third‑party processors, lenders or network rules would raise its loss‑rate and erode confidence.  \n\n- The 2023 filing (pages 25‑26) still flagged the same credit‑product and cross‑border risks but added concrete mitigation steps: a multi‑year €40 billion BNPL‑receivable sale, a willingness to seek alternative third‑party funding structures, and an active effort to diversify its payment‑processor base.  \n\n- By 2024 (pages 22‑25) the language emphasizes that the company now “relies on third parties … but is undertaking efforts to diversify our reliance on a small number of third‑party payment processors” and continues to monitor credit‑product defaults, cross‑border trade constraints and fraud‑related loss rates, indicating that the risk‑management approach has moved from identifying exposure to actively reshaping partner relationships and funding sources.  \n\n**Trend:** Across the three years PayPal’s exposure to bad‑transaction risk has remained a core concern, but the company has progressively layered mitigation – selling BNPL receivables, broadening funding options and diversifying processor partners – showing a maturing risk‑management strategy and growing operational resilience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the €40 billion multi-year BNPL receivable sale in 2023 is accurately reported, including the currency and structure; the reliance on third-party processors and bank partners (e.g., Synchrony implied via context) is correctly noted; and the persistent risks in credit products, cross-border trade, and third-party dependencies are properly identified across all three years. (2) Quantitative accuracy is perfect: the €40 billion figure matches the original answer exactly, and no incorrect numbers or miscalculations are present. Format is consistent and precise. (3) Multi-hop reasoning is sound: the LLM synthesizes risk evolution across 2022–2024 filings, correctly identifying a shift from risk identification to active mitigation via asset sales (BNPL receivables), diversification of processors, and alternative funding structures. It captures the strategic transformation in risk management—though it does not explicitly mention the 'valid-when-made' doctrine or synthetic identities, which are present in the ground truth and relevant to U.S. credit risk in 2024. This is a minor omission affecting completeness but not the core correctness. (4) The answer is contextually excellent, directly addressing all parts of the question—evolution of risk, role of credit products, cross-border trade, third-party dependencies, and implications for risk management and resilience. The trend analysis is logically structured and semantically equivalent to the original, with slightly less specificity on legal risks but strong overall reasoning. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1657,
        "completion_tokens": 478,
        "total_tokens": 2135
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "Costco’s 10‑K filings show that, from 2022 through 2024, the company has consistently listed **BJ’s Wholesale Club** as one of its primary warehouse‑club rivals and has relied on its **Kirkland Signature private‑label brand** to set itself apart. In each year’s “Competition” and “Intellectual Property” sections the firm states that Kirkland products are “high quality, offered at prices that are generally lower than national brands, help lower costs, differentiate our merchandise offerings, and generally earn higher margins,” and it “expects to continue to increase the sales penetration of our private‑label items” 【page_8 (2022)】, 【page_8 (2023)】, 【page_8 (2024)】. Thus, Costco’s competitive positioning relative to BJ’s remained unchanged – emphasizing price‑quality advantage through Kirkland Signature – and the emphasis on expanding Kirkland’s share has been reinforced rather than altered over the 2022‑2024 period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately captures the consistent competitive positioning of Costco relative to BJ's Wholesale Club from 2022 to 2024, correctly identifying BJ's as a named competitor and Kirkland Signature as a key differentiator. (2) There are no numerical inaccuracies—while no specific financial figures (e.g., dollar amounts, percentages) are cited in either answer, the qualitative descriptions of Kirkland Signature’s role (e.g., 'higher margins', 'lower costs', 'generally lower than national brands') are factually consistent across years and match the original answer. The citation of page numbers (page 8 across all years) is plausible and contextually appropriate, though not required for correctness. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings, correctly infers that the unchanged language reflects a stable strategy, and connects Costco’s private-label emphasis to competitive differentiation against BJ's. (4) The answer is semantically equivalent to the original: it conveys the same core conclusion—that Costco’s strategy remained consistent over the period—with added specificity about the repetition of language in the filings. Wording differences are stylistic and do not affect factual accuracy. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 389,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "NextEra’s Level‑3 gas‑forward contracts grew sharply from 2022 to 2023 – the fair‑value of the asset side rose from **$191 million** to **$377 million** and the liability side from **$31 million** to **$77 million** – giving a net positive position of about $300 million in 2023. In 2024 the asset fair‑value fell modestly to **$296 million** while liabilities slipped to **$46 million**, leaving a net exposure of roughly $250 million (2024 assets $296 m, liabilities $46 m)【page_84】【page_86】. This three‑year trend shows the company has been expanding its natural‑gas forward‑contract hedge (or speculative) footprint, positioning itself to profit if gas prices rise, but the slight pull‑back in 2024 suggests a modest de‑risking or adjustment to market conditions while still maintaining a net long‑gas stance.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the fair value of assets in 2022 ($191M), 2023 ($377M), and 2024 ($296M), which matches the ground truth. However, the liability value for 2023 is incorrect: the LLM states $77M, while the ground truth reports $31M to $46M from 2022 to 2024 with no mention of $77M in 2023. This is a significant quantitative error. The 2024 liability value ($46M) is correct. (2) Calculations: The net positions are computed correctly based on the numbers provided by the LLM, but because the 2023 liability is wrong, the net positive position of $300M in 2023 is inaccurate (should be $377M - $X, where X is unreported in ground truth but implied to be closer to $31M–$46M range). The 2024 net exposure of $250M ($296M - $46M) is accurate. (3) Multi-hop reasoning: The LLM correctly synthesizes trends across three years and interprets the growing asset position as increased market participation and risk, aligning with the ground truth’s conclusion about strategic expansion and rising risk. The observation of a 'modest de-risking' in 2024 is a reasonable interpretation given the decline in asset value from 2023 to 2024. However, the erroneous 2023 liability figure undermines full confidence in the synthesis. (4) Despite the incorrect 2023 liability, the overall narrative about increasing then slightly reducing exposure is consistent with the ground truth, and all other entities (company, years, metric) are correct. The answer is contextually excellent and provides insightful interpretation, but the key numerical error in liabilities for 2023 prevents a higher correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 446,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "- **2022:** Lowe’s reported forward interest‑rate‑swap contracts with a **notional amount of about $2.6 billion** (see 2022 10‑K, Note 9, “Forward interest‑rate‑swap agreement notional amounts $2,560 million”) that were designated as cash‑flow hedges for anticipated debt issuances.  \n\n- **2023:** The company still used forward swaps, but the balance sheet now showed a **fair‑value of roughly $250 million** for those contracts (2023 10‑K, Note 3, “Forward interest‑rate swaps $251 million”) – indicating that the notional exposure had been reduced or that some swaps had matured.  \n\n- **2024:** The 2024 filing again references forward swaps, stating that the firm **continues to hold forward interest‑rate‑swap agreements to hedge benchmark‑rate risk on forecasted debt issuances** (2024 10‑K, Derivative Financial Instruments section). No new notional amount is disclosed, suggesting the swaps are now a smaller, ongoing hedge rather than a large, upfront position.\n\n**Interpretation:** Lowe’s moved from a sizable, proactive hedge of future borrowing in 2022 to a more modest, maintenance‑level hedge in 2023 and 2024. This scaling‑down reflects a shift in strategy as market rates rose and the company’s borrowing plans changed—rather than locking in large amounts of future debt at fixed rates, Lowe’s now uses forward swaps mainly to smooth out rate risk on the debt it actually expects to issue, showing a flexible response to evolving interest‑rate conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the 2024 assessment. The ground truth states that by 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among derivative instruments as of January 31, 2025. However, the LLM claims that 'the 2024 filing...states that the firm continues to hold forward interest-rate-swap agreements,' which directly contradicts the ground truth. This is a major factual error. The 2022 and 2023 data are mostly accurate: the $2.6 billion notional amount in 2022 and $251 million fair value in 2023 align with the original answer, though the LLM interprets the $251 million as a reduction in notional exposure, while the ground truth treats it as a fair value on the balance sheet—this is a subtle but important distinction. (2) Quantitatively, the numbers cited ($2.6B notional in 2022, $251M in 2023) are correct per the filings, so quantitative accuracy is acceptable. However, the LLM incorrectly implies ongoing holdings in 2024 without providing a number, which is factually wrong. (3) The multi-hop reasoning is flawed because the LLM fails to recognize the complete absence of forward swaps in the 2024 filing, a critical evolution in the strategy. Instead, it assumes continuity, undermining the core conclusion about strategic unwind. The interpretation of a 'scaling-down' is plausible but not supported by the data since the instrument was fully removed, not reduced. (4) Contextual relevance is high—the answer addresses the evolution over time and attempts to interpret strategy shifts. However, due to the critical error in 2024, the qualitative and overall correctness scores are significantly reduced. The conclusion about flexible risk management is reasonable but based on incorrect premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1611,
        "completion_tokens": 491,
        "total_tokens": 2103
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "In the 2022 filing Comcast noted that “wireline telecommunications companies, such as AT&T, Frontier, **Lumen** and Verizon… have built and are continuing to build fiber‑based network infrastructure… that are offering higher‑speed services in many of our service areas” (2022 10‑K p. 8).  At that time Comcast was just beginning its own upgrade – in 2022 it rolled out downstream speeds of up to 2 Gbps to roughly one‑third of its HFC footprint (2022 10‑K p. 7).  \n\nBy 2023 the company had moved to the next phase: it started deploying DOCSIS 4.0 in select markets and was “extending our network’s reach… a significant portion of new homes and businesses passed are connected with fiber” (2023 10‑K p. 7).  \n\nIn the 2024 filing the competitive landscape still lists Lumen as a major fiber builder (2024 10‑K p. 7), but Comcast now “deploys fiber‑to‑the‑premises with symmetrical speed offerings ranging up to 10 Gbps to residential customers… and up to 100 Gbps to business customers” and is leveraging DOCSIS 4.0 to deliver multigigabit symmetrical speeds (2024 10‑K p. 7).  \n\nThus, from 2022‑2024 Comcast’s competitive positioning against Lumen shifted from being a challenger to a rival that is rapidly expanding its own fiber footprint and high‑speed symmetric services, allowing it to match or exceed Lumen’s offerings in the markets where their networks overlap.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Lumen as a key competitor to CMCSA (Comcast) in fiber-based broadband from 2022 to 2024, citing direct quotes from each year's 10-K filings. All entities (Lumen, CMCSA), timeframes (2022–2024), and competitive dynamics are accurately represented. (2) Quantitative details are precise: downstream speeds of up to 2 Gbps in 2022, DOCSIS 4.0 deployment in 2023, and symmetrical speeds up to 10 Gbps (residential) and 100 Gbps (business) in 2024 are correctly pulled from the filings. No calculations were required, but all cited figures match the source documents. (3) The multi-hop reasoning is sound—LLM synthesizes competitive pressure from Lumen with CMCSA’s strategic response over time, showing an evolution from HFC upgrades to full fiber and DOCSIS 4.0 deployment. The conclusion that Comcast shifted from challenger to rival is a reasonable interpretation supported by the data. (4) The only minor shortcoming is that the original answer emphasizes Lumen’s continuous expansion and growing influence, while the LLM focuses more on Comcast’s response. However, the core competitive dynamic and implications for overlapping markets are correctly conveyed. Wording differs but semantic meaning and factual content are equivalent. No factual errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1583,
        "completion_tokens": 377,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "In the 2022 filing PayPal described its checkout as “the simplest checkout experience possible,” with consumer‑credit products (Buy‑Now‑Pay‑Later, credit cards and interest‑free installments in the U.S., U.K., France, Germany and Japan’s Paidy) embedded as a funding source at checkout, a platform that could send payments in roughly 200 markets, hold balances in 24 currencies and support omnichannel sales through Zettle and in‑store card readers. By the 2024 filing the focus had sharpened: the strategy now calls for “accelerating our branded checkout business” by cutting friction and adding rewards, the credit suite has expanded to Australia, Spain, Italy and additional installment products, the platform supports payments in >200 markets, holds balances in 25 currencies and can withdraw in 56, and the omnichannel solution is framed as a seamless, platform‑agnostic offering that includes Zettle, POS systems and open APIs for merchants. Thus PayPal’s seamless‑checkout ambition evolved from a solid, credit‑enabled, multi‑currency checkout to a more integrated, globally‑scaled, credit‑rich, omnichannel experience.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the overall evolution of PayPal's checkout strategy from 2022 to 2024 with strong qualitative reasoning and contextual relevance. It correctly identifies key themes: integration of consumer credit (BNPL, credit cards, installments), global currency and market support, and omnichannel merchant solutions via Zettle and APIs. However, there are significant quantitative inaccuracies. The original answer states PayPal supported transactions in over 100 currencies in 2022 and ~150 by 2023; the LLM claims 24 currencies for balance holding in 2022 and 25 in 2024, which contradicts the ground truth and introduces a more granular but incorrect metric. Additionally, the LLM cites 'roughly 200 markets' in 2022 and '>200 markets' in 2024, while the original does not specify market count—only currency support—making this a plausible inference but not directly supported. The expansion of credit offerings to Australia, Spain, and Italy is mentioned in the LLM answer but not in the original, which only confirms U.S., U.K., France, Germany, and Japan via Paidy in 2022 and deeper integration in 2024 without specifying new countries. This introduces unverified detail. The LLM also adds 'withdraw in 56' currencies, which is absent from the original and cannot be verified. While the reasoning is logically sound and the narrative of increasing integration is accurate, the incorrect or unsupported numbers reduce quantitative accuracy. The answer is semantically aligned in direction and theme but diverges on specific metrics, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 433,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "Target’s proprietary debit‑card program (the Target Debit Card, reported as part of the RedCard family) saw its penetration fall each year: 20.5 % of purchases were made with a RedCard in fiscal 2022, 19.8 % in fiscal 2023, and 18.6 % in fiscal 2024【page_27】.  The steady decline indicates that, while the card still captures a sizable share of transactions, its ability to generate incremental, “extra” sales for Target is gradually weakening over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains incorrect numerical values for the penetration rates in 2023 and 2024. According to the ground truth, the rates were 18.6% in 2023 and 17.8% in 2024, but the LLM reports 19.8% in 2023 and 18.6% in 2024. This misstates the magnitude and trajectory of the decline. The 2022 figure (20.5%) is correct. (2) The calculation of the trend is partially accurate in identifying a steady decline, but due to incorrect intermediate values, the quantitative evolution is misleading. The actual drop from 20.22 to 2024 is 2.7 percentage points (20.5% → 17.8%), whereas the LLM implies a 1.9-point drop (20.5% → 18.6%). (3) The reasoning about the card’s diminishing role in driving incremental sales is qualitatively sound and aligns with the ground truth interpretation; the synthesis of declining penetration implying reduced customer engagement and weaker incremental sales impact is logically valid and contextually appropriate. (4) The entity identification (Target Debit Card, RedCard, fiscal years) and metric (penetration rate) are correct, and the answer addresses both parts of the question—evolution over time and implications for sales. However, the factual inaccuracy in key percentages significantly undermines the correctness score, despite otherwise coherent reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 370,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "AMD’s ASC 606 policy for development‑services‑plus‑IP deals has not changed between the 2022 and 2024 filings. In both years the company first tests whether the IP‑licensing component is **distinct** (i.e., capable of being distinct and distinct in the context of the contract). If the license is not distinct, it is **combined** with the development services and the total arrangement is treated as a single performance obligation, with revenue recognized **over time**. If the license is distinct, the license portion is accounted for **separately** and revenue is recognized **at a point in time** when the customer can use the license. Standalone IP‑licensing arrangements (no development services) are always recognized **at a point in time**, and the company notes that no variable‑consideration estimates are involved in either combined or standalone licensing deals. The 2024 10‑K repeats the same language, indicating the approach remained consistent from 2022 through 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately describes AMD's revenue recognition policy from 2022 to 2024, correctly stating that the approach remained consistent: combined development and IP arrangements are evaluated for distinctness of the IP license; if not distinct, they are bundled and recognized over time; if distinct, the license is recognized at a point in time. Standalone licenses are also correctly identified as being recognized at a point in time. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—this is correctly handled. (3) The multi-hop reasoning across years (2022–2024) and agreement types (combined vs. standalone) is sound: the LLM correctly synthesizes that the policy did not change, citing repeated language in the 2024 10-K as evidence, which aligns with the ground truth’s assertion of consistency. (4) The LLM adds minor clarifications (e.g., reference to ASC 606, explanation of 'distinct' licenses, mention of no variable consideration) that are consistent with SEC filing language and enhance accuracy without introducing error. All entities—AMD, development services, IP licensing, performance obligations, revenue timing—are correctly identified and contextualized. The answer fully addresses the evolution (or lack thereof) in policy, making it contextually complete and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 407,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "Nike’s 10‑K filings show that FlyEase has remained a staple of the company’s innovation set throughout the period. In the FY 2022 filing the technology is listed alongside a broad group of newer platforms (Nike Air, Zoom, Free, Flywire, Dri‑FIT, Flyknit, ZoomX, Air Max and React) as part of the “proliferation” of innovations, and the FY 2024 filing repeats that same phrasing—still naming FlyEase among the core technologies driving new product designs. Thus, from 2022 to 2024 Nike’s strategic positioning of FlyEase evolved from being one of many emerging technologies to a consistently highlighted, enduring component of its innovation portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in the qualitative evolution of FlyEase's strategic positioning, which undermines the overall correctness. (1) Quantitatively, there are no numeric errors—dates (FY2022, FY2024) are accurate and correctly attributed to Nike’s 10-K filings. (2) However, the LLM misrepresents the progression: in the ground truth, FlyEase moves from being an emerging tech in FY2022, to being grouped with established platforms like Air and Zoom in FY2023, and then classified among mature technologies like React and Air Max in FY2024—indicating a clear maturation trajectory. The LLM incorrectly states that FlyEase was listed among 'newer platforms' in FY2022 and then repeats the same phrasing in FY2024, suggesting stagnation rather than evolution. (3) This mischaracterizes the multi-hop reasoning: the key insight is the shift in categorization—from novel to mature—across three fiscal years, especially the critical FY2023 transition. The LLM overlooks FY2023 entirely and fails to capture the strategic advancement implied by reclassification into mature technologies by FY2024. (4) While the answer is contextually relevant and uses correct entities (Nike, FlyEase, correct fiscal years), the flawed reasoning and omission of the progression through stages of maturity reduce the qualitative accuracy significantly. The conclusion that FlyEase became an 'enduring component' is directionally plausible but lacks the nuance of full integration into the core framework as a mature technology, making the answer incomplete and semantically divergent from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 445,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "The 1.250 % senior notes have been shrinking each year – the original €‑denominated issue was $609 million (2022 10‑K), the outstanding amount fell to about $552 million in 2023 (adjusted down $6.1 million) and to roughly $518 million in 2024 (adjusted down another $5.6 million). This steady reduction shows that American Tower is deliberately retiring this tranche of debt, using cash‑flow and proceeds from other financings to lower its overall leverage and interest‑cost burden.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decreasing trend in the principal amount of AMT's 1.250% Notes across 2022, 2023, and 2024, with values close to the ground truth: $609.1M (vs. $609M cited), $551.9M (vs. $552M), and $517.7M (vs. $518M). These minor discrepancies are within acceptable rounding tolerance. However, the LLM incorrectly refers to the original issue as '€-denominated,' which is not supported by the ground truth and introduces a factual error regarding currency denomination. (2) The claimed adjustments of $6.1M and $5.6M do not align with actual year-over-year reductions: 2022 to 2023 decrease is $57.2M ($609.1M - $551.9M), not $6.1M; 2023 to 2024 is $34.2M ($551.9M - $517.7M), not $5.6M. These calculation errors significantly undermine quantitative accuracy. (3) Despite miscalculating the reductions, the LLM correctly infers a deliberate debt retirement strategy, linking declining principal to reduced leverage and interest costs—consistent with the ground truth's interpretation of managed amortization or repurchase. The reasoning about stable interest payments is omitted, but the core multi-hop synthesis (declining principal → strategic debt management) is sound. (4) The answer is contextually relevant and captures the essence of the trend and its strategic implication. Scores reflect high factual alignment with minor number inaccuracies and one notable error in currency denomination, but strong qualitative reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 411,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "- In the 2022 Form 10‑K the 3.50 % Notes due 2040 were disclosed only as “long‑term unsecured senior notes” carried at their original issuance amount (net of any un‑amortized discount and issuance costs) – no fair‑value amount was reported.  \n- By the 2023 filing the company began reporting a Level‑2 fair‑value of **$870 million** for the same $1 billion‑face‑value notes (still carried at $1 billion on the balance sheet).  \n- The 2024 filing shows the fair‑value further reduced to **$851 million**, while the carrying amount remains $1 billion (the notes are still presented as long‑term debt with the same un‑amortized discount treatment).  \n\n**What this shows:** NVIDIA’s long‑term debt strategy relies on issuing low‑coupon, very‑long‑dated senior notes and keeping them on the balance sheet at amortized cost, while the market‑based fair value has gradually slipped as interest‑rate environments changed. The modest decline in fair‑value over the three years indicates that the company accepts some valuation volatility but continues to use these fixed‑rate, long‑maturity instruments as a stable, low‑cost source of financing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the fair value of NVIDIA's 3.50% Notes Due 2040 was $1,066 million in fiscal year 2022, but the LLM claims no fair value was reported in 2022 and cites $870 million in 2023, which contradicts the ground truth value of $851 million in 2023. The 2024 fair value of $851 million in the LLM answer matches the ground truth for 2023, not 2024, and the ground truth states that in 2024 the notes were carried at $1,000 million with a 3.54% effective interest rate—information missing in the LLM answer. (2) The LLM incorrectly asserts that no fair value was disclosed in 2022, while the ground truth explicitly reports $1,066 million. The $870 million figure for 2023 is incorrect; the correct fair value is $851 million. The LLM does correctly state the 2024 fair value as $851 million, but this appears to be a misplacement of the 2023 value rather than an accurate update. The carrying amount of $1 billion is consistent and correctly noted. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that NVIDIA maintains long-term debt at amortized cost while fair value fluctuates, and links this to interest rate changes. It also correctly identifies the strategic use of long-dated, low-coupon debt. However, it fails to capture the full trajectory: an initial high fair value ($1,066M), a drop ($851M), then stabilization at carrying value ($1,000M) in 2024, which suggests active liability management. (4) The contextual relevance is high—the answer addresses the evolution of valuation and interprets strategy appropriately. Qualitative reasoning is logical but based on flawed data. Quantitative accuracy is low due to incorrect figures and misattribution across years. Correctness score is 6 because core elements (debt strategy, fair value vs. carrying amount) are understood, but key facts are wrong, undermining full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 528,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "- **2022 10‑K:** Netflix first announced that it was adding **games** to its library and launched a **lower‑priced ad‑supported subscription tier** while still planning future **live‑programming** experiments.  The filing warned that “adjustments … to our membership pricing, our membership plans, or our pricing model … (including the new ad‑supported plan) may not be well‑received” and that such changes could hurt its ability to **attract and retain members**.  \n\n- **2023 10‑K:** The company said the **games offering had been expanded and live‑programming was now being introduced**, keeping the ad‑supported tier in place.  It again flagged the same risk – that if members do not value the new games, live content or the ad‑supported price point, “our ability to attract and retain members may be negatively impacted.”  \n\n- **2024 10‑K:** Netflix described a broader rollout, **scaling games, the ad‑supported plan and live‑programming while also expanding consumer‑product experiences**, and noted that “as we scale … and introduce new features such as our ad‑supported subscription plan and live programming, … adjustments … may not be well‑received, which could adversely affect member acquisition and retention.”  \n\nIn each year the strategy moved from a pilot‑stage addition of games and an ad‑tier (2022) to a fuller suite that includes live programming (2023‑2024), and the risk disclosures consistently tied the success of those pricing‑plan and service‑expansion moves to the company’s ability to continue gaining and keeping subscribers.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in terms of factual content and structure, with accurate entity identification (Netflix, games, ad-supported tier, live programming) and correct chronological framing across 2022–2024. All stated risks tied to member acquisition and retention are semantically aligned with the original answer, and the evolution of service expansions is generally accurate. However, there is a significant factual error in the timeline: the LLM incorrectly states that Netflix introduced the ad-supported tier in the 2022 10-K. According to the ground truth, the ad-supported tier was introduced in 2023, not 2022. The 2022 strategy only included games and planning for future live programming; the ad-supported tier launch was a 2023 development. This misplacement affects the multi-hop reasoning and synthesis across years, particularly the sequencing of strategic rollouts. While the risk language is accurately quoted and contextually appropriate, the conflation of when the ad-supported tier was launched undermines the accuracy of the year-by-year evolution. Quantitative accuracy receives full marks because there are no numerical values to evaluate, and all referenced features and risks are otherwise correctly described. Contextual relevance is strong, as the answer directly addresses all components of the question. The qualitative accuracy is reduced due to the incorrect temporal assignment of a key strategic move, which impacts the fidelity of the strategic evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1676,
        "completion_tokens": 414,
        "total_tokens": 2091
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "UnitedHealth’s venture‑investment footprint grew markedly between 2022 and 2024.  The company’s total equity‑securities portfolio rose from $3.7 billion in 2022 to $4.9 billion in 2023 and remained at roughly $4.9 billion in 2024 【page_50】, while its equity‑method stakes in health‑care operating businesses slipped slightly from $1.5 billion (2022) to $1.4 billion (2023) but then more than doubled to $3.8 billion by the end of 2024 【page_52】.  This trajectory shows UnitedHealth expanding its direct ownership in health‑care businesses, signaling a strategic push to deepen its influence and integration across the sector beyond pure venture‑style investments.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the overall upward trend in UnitedHealth's venture investment exposure and accurately reports the equity securities values: $3.7B in 2022, $4.9B in 2023, and $4.9B in 2024, which matches the ground truth. However, there is a discrepancy in the reported equity method investment for 2022: the LLM states $1.5B, while the ground truth specifies $1.3B. This is a factual error affecting quantitative accuracy. The 2023 ($1.4B) and 2024 ($3.8B) figures for equity method investments are correct. (2) Calculations and comparisons are otherwise sound: the doubling from 2023 to 2024 in equity method investments is correctly characterized. The $1.5B figure for 2022 appears to be a misstatement, possibly due to confusion with another line item or rounding. (3) Multi-hop reasoning is strong: the LLM synthesizes data across years and investment types, correctly infers strategic intent, and connects the financial trends to UnitedHealth’s broader integration strategy. The conclusion about deepening influence and moving beyond pure venture investments aligns semantically with the ground truth’s emphasis on 'deeper engagement' and 'integrated health services.' (4) The answer is contextually excellent and complete in addressing all parts of the question—evolution over time, breakdown by investment type, and strategic implications. Due to the single but notable numerical inaccuracy in the 2022 equity method investment, the quantitative accuracy is reduced to 7, pulling the overall correctness to 8. Qualitative and contextual scores remain high due to strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 447,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "Nike’s relationship with Sojitz America remained essentially unchanged from FY 2022 through FY 2024.  Sojitz America continued to be the sole holder of Nike’s authorized redeemable preferred stock (about $0.3 million par value), which carries a cumulative $0.10‑per‑share dividend that must be paid each May 31 before any common‑stock dividends can be declared, and the preferred shares were fully issued with no new issuances or changes in the terms during those years.  In addition to this equity stake, Sojitz America has long‑served as Nike’s import‑export financing partner and retains limited but pivotal voting rights on major transactions (e.g., asset sales, mergers, trademark assignments), reinforcing its strategic role in Nike’s global supply‑chain and international operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate in terms of quantitative details: the $0.3 million par value of redeemable preferred stock, the $0.10-per-share cumulative dividend, and the May 31 payment deadline are all factually correct and consistent with the ground truth. There are no calculation errors or incorrect numbers. The entity (Sojitz America), the time frame (FY2022–FY2024), and the financial terms are correctly identified, satisfying entity accuracy. Contextual relevance is strong—the response directly addresses preferred stock ownership, dividend obligations, and Sojitz America’s strategic role in international operations. However, the LLM answer misses a key qualitative evolution emphasized in the original answer: while it notes Sojitz America's role as an import-export financing partner, it does not explicitly highlight the shift in emphasis from a primarily financial relationship in 2022–2023 to a more strategically highlighted operational role in FY2024 due to rising trade risks and supply chain volatility. The original answer notes that Nike 'explicitly highlighted' this role in 2024 as a response to global trade challenges—a nuance absent in the LLM response. Additionally, the LLM introduces a detail not in the ground truth—'limited but pivotal voting rights on major transactions'—which, while plausible, is not supported by the provided knowledge graph and thus slightly undermines qualitative accuracy. Overall, the core facts and multi-hop synthesis (linking financial terms to strategic role over time) are sound, but the answer lacks the full depth of strategic evolution and includes an unsupported detail, preventing a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 452,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "- **Fiscal 2022:** The 3.50 % Notes Due 2050 were carried on the balance sheet at **≈ $1.7 billion**.  \n- **Fiscal 2023:** The same series was carried at **$1.637 billion**.  \n- **Fiscal 2024:** The carrying amount fell to **$1.604 billion**.  \n\nThe gradual decline over the three years shows that NVIDIA has been modestly reducing the principal of this long‑dated senior debt (or offsetting it with amortized‑discount adjustments), indicating a slight shift toward a lower long‑term debt burden while still retaining the notes as a stable source of financing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported carrying values. According to the ground truth, the values were $2,147 million (2022), $1,604 million (2023), and $2,000 million (2024). The LLM incorrectly reports 2022 as $1.7 billion (~$1,700M) instead of $2,147M, 2023 as $1,637M instead of $1,604M (close but still inaccurate), and critically misreports 2024 as $1,604M — the same as 2023 — when it actually increased to $2,000M. This misrepresents the entire trend. (2) The calculation and comparison are flawed: the ground truth shows a decrease from 2022 to 2023, then a substantial increase in 2024, indicating a strategic repositioning. The LLM describes a continuous decline, which is factually incorrect. (3) The multi-hop reasoning fails: the model does not correctly synthesize the three-year trend, missing the rebound in 2024, which is central to the conclusion about NVIDIA's long-term debt strategy. (4) Due to major quantitative inaccuracies and incorrect interpretation of the trend, the correctness score is low at 2. Quantitative accuracy is 2 due to multiple wrong figures. Qualitative accuracy is 3 because while the model attempts correct reasoning about debt reduction, it's based on false data. Contextual relevance is 6 because the answer addresses the right metric and company, and attempts interpretation, but with wrong numbers and conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 390,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "MetLife’s short‑term debt – which includes its commercial‑paper program – fell from **$175 million at year‑end 2022 to $119 million at year‑end 2023** (see 2023 10‑K, page 111) but then rose sharply to **$465 million at year‑end 2024** (see 2024 10‑K, page 101).  Throughout the period the company repeatedly stressed that its **global funding sources are highly diversified** – spanning equity, short‑ and long‑term debt, collateral‑financing arrangements, PABs, credit facilities and shelf registrations – a strategy it says “enhances funding flexibility, limits dependence on any one market or source of funds and generally lowers the cost of funds” (2022 10‑K page 128; 2023 10‑K page 111; 2024 10‑K page 101).  Thus, while the overall reliance on short‑term commercial‑paper financing contracted in 2023 and then expanded in 2024, MetLife’s broader reliance on a mix of global markets remained a core element of its funding approach.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative inaccuracies. The reported short-term debt figures—$175 million in 2022, $119 million in 2023, and $465 million in 2024—are not supported by the ground truth, which does not provide specific dollar amounts for commercial paper or short-term debt across these years. The original answer makes no mention of numerical trends in debt levels, only describing the strategic use and consistency of commercial paper programs. Thus, the inclusion of precise figures with citations to 10-K pages introduces false specificity not present in the ground truth. (2) While the ground truth confirms MetLife’s continued use of commercial paper and diversified funding sources from 2022 to 2024, it does not support the claim of a decline followed by a sharp increase in short-term debt. These numbers appear to be either hallucinated or misinterpreted from the filings. Even if the page numbers cited (e.g., 2023 10-K p.111) mention commercial paper, the LLM invents a quantitative trend absent in the original answer. (3) Qualitatively, the LLM correctly identifies the multi-hop concept of diversified funding sources (equity, short-/long-term debt, credit facilities, etc.) and correctly attributes the strategic rationale—funding flexibility, reduced market dependence, lower cost of capital—across all three years. This aligns with the original answer’s emphasis on consistent messaging about diversification. (4) Contextually, the response is highly relevant, addressing both parts of the question: evolution of dependence on global funding markets and use of short-term debt. However, the fabricated numerical trend undermines factual correctness. The reasoning is logically structured but built on incorrect data. Therefore, while the synthesis and framing are sound, the factual foundation is flawed, warranting a moderate score of 6 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 512,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "UnitedHealth’s 10‑K footnotes state that the parent’s guarantees for service‑level performance “were not material” in any of the three years 2022, 2023 or 2024, indicating that the company’s exposure to contractual penalties from those guarantees has remained negligible. At the same time, the balance‑sheet data show a sharp contraction in short‑term notes payable to subsidiaries – from $9.9 billion at the end of 2023 (and $8.7 billion in 2022) to only $2.0 billion in 2024 – while a new long‑term notes‑payable line of $14.4 billion appears in 2024 (zero in the prior two years). Together, the immaterial service‑level guarantees and the shift from large, on‑demand short‑term borrowings to sizable long‑term financing reveal that UnitedHealth is reducing immediate liquidity commitments but replacing them with longer‑dated debt, thereby preserving cash flexibility while taking on more durable, but still manageable, contractual and financing risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the immateriality of service level guarantees across all three years and the drop in notes payable to subsidiaries to $2.0 billion in 2024, which matches the ground truth. However, it inaccurately reports the 2022 notes payable as $8.7 billion instead of $8.1 billion, and introduces a new long-term notes payable of $14.4 billion in 2024 that is not present in the original answer or implied by the ground truth. This figure appears to be an overinference or misreading of the data, as the original answer only notes a drop to $2.0 billion without mentioning new long-term debt. (2) The quantitative inaccuracies affect the precision of the financial evolution narrative: while the $9.9 billion (2023) and $2.0 billion (2024) figures are correct, the $8.7 billion for 2022 is off by $600 million, and the $14.4 billion long-term debt is unsupported. No calculation errors are present, but the introduction of unverified data reduces quantitative accuracy. (3) The multi-hop reasoning is strong: the model synthesizes service level guarantees with internal debt trends and infers a strategic shift in liquidity management, which aligns with the interpretive component of the question. The conclusion about reduced immediate liquidity commitments is reasonable, though the emphasis on long-term debt replacement goes beyond the evidence provided in the ground truth. (4) The answer is contextually relevant and addresses both parts of the question—evolution of guarantees and notes payable, and implications for liquidity and risk. Despite the factual overreach on the $14.4 billion, the core insight about stable risk in guarantees amid changing internal financing is consistent with the original. Hence, correctness is reduced primarily due to unsupported numbers, but qualitative and contextual strengths prevent a lower score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 508,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "From 2022 – 2023, American Express described its global card network as the fourth‑largest worldwide, competing directly with Visa, Mastercard, China UnionPay and a growing set of digital‑payment players such as Alipay, PayPal, Venmo and BNPL platforms, while emphasizing premium‑card value, rewards and brand strength. By the 2024 filing the company notes that regulatory scrutiny has risen sharply—U.S. and foreign supervisors are focusing on interchange‑fee caps, non‑discrimination/honor‑all‑cards rules, privacy, cyber‑security and outsourcing oversight—so Amex has become a Category III firm subject to heightened expectations, exited network‑licensing businesses in the EU and Australia, and is investing heavily in compliance, risk‑management and joint‑venture partnerships to protect its network. Consequently, Amex’s competitive positioning remains strong but is now more tightly linked to its ability to satisfy increasingly stringent regulatory requirements and to adapt its network strategy to both traditional rivals and emerging payment innovators.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: American Express's position as the fourth-largest card network (after Visa, Mastercard, and China UnionPay), competition from digital players (Alipay, PayPal, Venmo, BNPL), strategic emphasis on premium cards and rewards, increased regulatory scrutiny by 2024, designation as a Category III firm, and exit from network licensing in the EU and Australia. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022–2024) are correctly used. (3) Multi-hop reasoning is sound: the LLM synthesizes competitive dynamics, regulatory developments, and strategic responses across years and jurisdictions, correctly linking Amex’s evolving posture to both external competition and regulatory pressure. (4) The only minor shortcoming is a slight softening of the conclusion compared to the original: while the ground truth emphasizes a shift 'from market-driven competition to regulatory navigation,' the LLM states positioning 'remains strong but is now more tightly linked' to regulation—this is semantically close but slightly less emphatic on the transformative impact of regulation. However, this does not constitute a factual error, only a nuance in tone. Overall, the answer is factually complete, contextually appropriate, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1687,
        "completion_tokens": 394,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "From the 2022 filing (page 136) ConocoPhillips already described that cash‑settled PSUs granted for performance periods that began **in 2018** (or later) would no longer receive quarterly cash dividend equivalents during the three‑year period; instead they would receive an **accrued, reinvested dividend equivalent** that is charged to compensation expense and paid only when the award settles in cash. The 2024 filing (page 125) repeats the same structure – periods that began before 2018 still get a post‑period cash dividend equivalent, while periods beginning in 2018 or later receive the accrued reinvested dividend paid at settlement. This continuity shows that the company has deliberately aligned its long‑term incentives with shareholder returns by deferring interim dividend payments and tying the ultimate cash payout to the award’s performance‑based settlement value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the key evolution in ConocoPhillips' dividend equivalent structure: for performance periods beginning in 2018 or later, dividend equivalents shifted from interim cash payments to accrued, reinvested amounts paid at settlement. This matches the original answer’s claim about the shift from deferred dividend equivalents during the performance period to accrued reinvestment. (2) Quantitatively, the dates (2018 as the cutoff), the structure (accrued reinvested dividends paid at settlement), and the comparison to pre-2018 periods are all factually correct. The mention of page numbers (136 in 2022, 125 in 2024) adds verifiability and is consistent with typical disclosure practices. (3) The reasoning is sound: the LLM correctly infers that deferring dividend equivalents strengthens alignment with shareholder returns by tying total payout to performance outcomes at settlement. However, it slightly understates the vesting period—ground truth notes vesting tied to five years or retirement eligibility, which the LLM omits—making the qualitative accuracy very high but not perfect. (4) Contextual relevance is excellent: the answer directly addresses the evolution from 2022 to 2024, focuses on the dividend structure change, and draws a valid conclusion about long-term incentive alignment. The only minor gap is the lack of explicit mention of the liability classification on the balance sheet, which the original answer includes as evidence of commitment to cash-based incentives. Overall, the answer is factually correct, well-supported, and semantically equivalent to the ground truth with only minor omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 467,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "The regulated “special‑use” pool, which provides a liquidity back‑stop, fell from roughly **$11 billion in 2022** to **$8.7 billion in 2023** and then rose again to **about $9.8 billion in 2024** (see 2022 special‑use totals ≈ $11 bn on page 88; 2023 $8.7 bn and 2024 $9.8 bn on page 64).  At the same time, the cash and letter‑of‑credit collateral that NEE posted for its derivative contracts dropped sharply from **≈ $4.6 billion in 2022** (cash $1.8 bn + letters $2.8 bn) to **≈ $2.3 billion in 2023** (cash $0.7 bn + letters $1.6 bn) (page 86).  This combination shows that, even though the special‑use fund contracted in 2023, the company simultaneously reduced its derivative‑related collateral exposure, and the fund’s rebound in 2024 further strengthens NEE’s liquidity cushion relative to any remaining collateral obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers, particularly for 2022 Special Use Funds and derivative collateral amounts. The ground truth states that Special Use Funds were $8,698 million in 2023 and $9,800 million in 2024, with no data provided for 2022 in the original answer—however, the LLM incorrectly claims they were $11 billion in 2022 and falling to $8.7 billion in 2023. This contradicts the ground truth, which does not mention a decline or a $11B figure. Additionally, the LLM reports derivative collateral posted in 2022 as $4.6 billion (cash + letters), but the ground truth states actual cash collateral increased from $84 million in 2022 to $691 million in 2023—there is no mention of $1.8B cash or $2.8B letters of credit in the original, making this a major fabrication. (2) Calculations are based on incorrect inputs: the LLM’s $4.6B total collateral in 2022 is unsupported by the ground truth, which only references potential downgrade-triggered obligations of $5.2B in 2022 and $2.4B in 2023, not actual posted collateral at those levels. The actual cash collateral figures are misrepresented. (3) Multi-hop reasoning is partially sound—the LLM attempts to link Special Use Funds and derivative collateral trends to assess liquidity positioning, which aligns with the question. However, because the underlying data is incorrect, the conclusion about a 'contraction in 2023' followed by a 'rebound' is not supported by the ground truth, which shows an increase from 2023 to 2024 without a prior drop. (4) Despite these errors, the answer remains contextually relevant, addressing the core issue of liquidity and collateral exposure. The qualitative reasoning structure is logical, even if based on false data. Hence, correctness and quantitative accuracy are low due to major factual deviations, while contextual relevance remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 513,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "American Tower’s 1.600 % senior notes were issued for a $700 million principal amount and that balance has remained unchanged through 2024【page_48】.  The company has been amortizing the notes in small, declining increments – a $3.7 million principal reduction in 2022, $2.6 million in 2023, and $1.5 million in 2024【page_110】【page_113】.  The shrinking amortization schedule indicates a deliberate strategy to keep the low‑cost 1.600 % debt on the books while only modestly paying it down each year, preserving liquidity and flexibility for other financing needs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the amortization amounts and mischaracterizes the principal reductions. According to the ground truth, the outstanding principal remained constant at $700.0 million from 2022 to 2024, with 'adjustments to principal' (likely accrued interest or amortization of discount) decreasing from (3.7) million in 2022 to (2.6) million in 2024. However, the LLM incorrectly states that there were principal reductions of $3.7M in 2022, $2.6M in 2023, and $1.5M in 2024, which contradicts the constant principal balance. These values do not match the ground truth—especially the $1.5M for 2024, which is not supported. (2) The quantitative inaccuracies are severe: while the initial principal of $700 million is correct, the逐年 amortization figures are wrong, and the pattern described (declining amortization) is based on incorrect data points. The ground truth shows only two data points (2022: -3.7M, 2024: -2.6M), suggesting a decline, but the LLM fabricates a third point (-1.5M in 2024) and mislabels these adjustments as principal reductions. (3) The multi-hop reasoning is partially sound—the LLM attempts to infer a debt management strategy from the amortization pattern—but it is based on incorrect data, undermining the conclusion. The idea of maintaining low-cost debt while modestly paying it down is plausible, but the premise (ongoing principal reductions) is false; the principal did not change. (4) Contextual relevance is high because the answer addresses both the trajectory and strategic implication. However, due to major factual and quantitative errors, the correctness score is low despite relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 463,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "**Evolution of the exposure**\n\n* **2022 (10‑K pages 24‑26)** – UnitedHealth warned that CMS could “change the way it calculates Medicare Advantage risk‑adjustment payments” and that periodic RADV audits could produce “retrospective adjustments to payments… fines, corrective‑action plans or other adverse action.” This was identified as a material risk to its Medicare Advantage business.  \n\n* **2023 (10‑K pages 20‑21)** – The filing confirmed that CMS had already “reduced or frozen Medicare Advantage benchmarks” and was again altering the risk‑adjustment methodology. UnitedHealth noted that these changes were pressuring its MA revenue and that it was beginning to “adjust members’ benefits and premiums on a selective basis” and to cease offering plans in certain counties.  \n\n* **2024 (10‑K pages 20‑22)** – UnitedHealth said the same regulatory trend continued and that CMS “makes changes to the way it calculates Medicare Advantage risk‑adjustment payments.” In response, the company “intensified both our medical and operating cost management, adjusted benefits and premiums selectively, and stopped offering benefit plans in additional counties” to offset the funding pressure.\n\n**Strategic adjustments across the three years**\n\n1. **2022:** Recognized the risk and prepared for possible audit‑driven payment recaptures.  \n2. **2023:** Initiated selective premium/benefit adjustments and withdrew plans from under‑performing markets.  \n3. **2024:** Accelerated medical‑cost and operating‑cost controls, broadened the selective premium/benefit tweaks, and further reduced plan availability in targeted counties to mitigate the impact of the newer risk‑adjustment formulas.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: the evolution of UnitedHealth Group's exposure to Medicare Advantage risk adjustment changes from 2022 to 2024 is accurately described, with consistent references to CMS methodology changes each year. The strategic responses—such as adjusting benefits and premiums selectively, exiting certain counties, and intensifying cost management—are correctly reported for each year. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all dates and years (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the progression of regulatory pressure and UnitedHealth’s adaptive strategies over time. It accurately reflects that the risk was anticipated in 2022, actively managed in 2023, and further intensified in 2024. (4) Semantic equivalence is strong—while the LLM provides slightly more granular detail (e.g., mentioning RADV audits in 2022), it does not introduce inaccuracies. The only minor gap is that the original emphasizes a 'consistent theme' of ongoing adaptation, which the LLM implies but doesn't explicitly summarize; however, this does not detract from factual correctness. Overall, the response is comprehensive, contextually precise, and factually aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1701,
        "completion_tokens": 411,
        "total_tokens": 2112
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "Across the three filings, Target’s employee‑benefits language consistently lists “merchandise and other discounts” as a component of the compensation package. In the 2022 10‑K (Human Capital Management) the discount is mentioned only as part of a broader benefits suite; the 2023 and 2024 10‑Ks repeat the same phrasing without adding new tiers, eligibility rules, or expanded discount programs. This steady‑state treatment signals that Target views the employee merchandise discount as an ongoing, core tool for bolstering team‑member financial well‑being rather than a variable or experimental perk.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in that it correctly identifies that Target consistently offered merchandise discounts from 2022 to 2024 and that these were part of employee benefits. It accurately states that the 10-K filings do not describe changes in tiers, eligibility, or expansion of the discount program itself, which aligns with the original answer's lack of specific structural changes to the discount. However, the LLM answer misses key qualitative developments in Target's broader financial well-being strategy that were highlighted in the ground truth. Specifically, it fails to mention the wage increases (from $15 to $15–$24 per hour by 2023), the addition of sick pay and tuition-free education in 2023, and the reframing of benefits in 2024 around equitable pay, belonging, and expanded mental health services. These omissions represent a significant gap in addressing the second part of the question—what the progression indicates about Target’s strategy. While the LLM correctly infers that the discount is treated as a stable, core benefit, it does not capture the evolving narrative context that the original answer emphasizes, thus providing an incomplete synthesis of the multi-hop progression across years. Quantitatively, there are no errors—no incorrect numbers or dates are presented. Contextually, the response is relevant and on-topic, but the reasoning is less sophisticated than required for full credit, as it interprets 'no change in discount structure' as evidence of a static strategy, whereas the ground truth shows a dynamic expansion of overall financial well-being support around a stable discount benefit. Hence, correctness and qualitative accuracy are moderately scored.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 471,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "American Express’s foreign‑government bond portfolio moved sharply toward higher‑yielding, longer‑dated securities over the last three years.  The average yield on its non‑U.S. taxable investment securities – which include foreign‑government bonds and obligations – rose from about **3.5 % in 2022** ( $2,005 m balance, 4.7 % yield) to **5.9 % in 2023** ( $2,173 m balance, 10.5 % yield) and to **6.1 % in 2024** ( $2,098 m balance, 7.8 % yield) 【page_176】.  At the same time the portfolio’s balance grew and the higher yields imply a larger share of the securities shifted into the **5‑ to 10‑year and beyond maturities** that command those yields, rather than remaining concentrated in the short‑term segment that dominated earlier years.  This three‑year trend shows a modest but clear increase in risk appetite, with the company allocating more capital to longer‑dated, higher‑yielding foreign‑government debt to boost net interest income while still keeping the overall exposure within its diversified investment‑security mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, American Express held $630 million in Foreign Government Bonds and Obligations in 2022, not $2,005 million as stated. The yields cited in the LLM answer (e.g., 4.7%, 10.5%, 7.8%) do not match the ground truth, which reports weighted average yields of 1.74% (within one year) and 2.42% (after one but within five years) in 2022, rising to 6.45% and 4.48% in 2023, then falling to 5.86% and 2.03% in 2024. The LLM incorrectly aggregates yields into single figures per year (e.g., 3.5%, 5.9%, 6.1%) that are not supported by the data and misrepresents the maturity distribution. (2) The dollar amounts, yields, and maturities are all incorrect. The LLM claims the portfolio balance grew from $2,005M to $2,173M to $2,098M, while the ground truth only confirms $630M in 2022 and does not provide 2023/2024 balances. The yield figures are entirely fabricated and do not align with the maturity-specific data in the original. (3) The reasoning is flawed: the LLM concludes that American Express shifted toward longer-dated securities, but the ground truth shows a sharp drop in yield for bonds due after one but within five years in 2024 (from 4.48% to 2.03%), suggesting a reduction in long-term exposure, not an increase. The actual pattern reflects a temporary move into higher-yielding short-term bonds in 2023 followed by a pullback, not a sustained shift to longer maturities. (4) The correctness score is low due to pervasive quantitative errors and incorrect synthesis. Quantitative accuracy is near-zero because almost all numbers are wrong. Qualitative accuracy is slightly higher because the answer attempts multi-hop reasoning and interprets strategic intent, albeit based on false data. Contextual relevance is moderate as the response addresses the general topic of yield evolution and risk appetite, but with incorrect evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 524,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "ExxonMobil reported collateral held under master‑netting arrangements (which sit in “Other assets, including intangibles – net”) of **$1,494 million in 2022**, **$800 million in 2023**, and **$491 million in 2024**【page_102】【page_99】.  The steady decline over the three years indicates that the company’s net‑ting and margin practices are reducing the amount of un‑offset collateral it must post, suggesting tighter control and lower net exposure to its derivative positions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all three values—$1,494 million in 2022, $800 million in 2023, and $491 million in 2024—matching the ground truth exactly. These numbers are properly attributed to the 'Other assets, including intangibles - net' line item and associated with collateral under master netting arrangements. (2) All numeric values are accurate, and the temporal sequence is correct across 2022–2024. No calculations are required beyond recognition of the trend, which the model correctly identifies as a decline. (3) The multi-hop reasoning is sound: the model synthesizes data across years and correctly infers that the declining collateral reflects reduced net exposure and improved risk management in derivative positions. The interpretation aligns closely with the ground truth’s conclusion about reduced derivative exposure or shifting risk practices. (4) The only minor difference is in phrasing—the LLM emphasizes 'tighter control and lower net exposure' while the original highlights a 'strategic reduction'—but the semantic meaning and analytical direction are equivalent. No entity errors: ExxonMobil (XOM), correct metric, and correct years are used. All aspects of the question are addressed with high precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 352,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "- In the 2022 filing the 2.700 % senior unsecured notes were shown as a $700 million issue dated March 29 2021, maturing April 15 2031 with a fixed 2.700 % coupon and semi‑annual payments (April 15 and October 15)【page_48】.  \n- The 2023 and 2024 tables still list the same $700 million issue, unchanged coupon and payment schedule, with only a modest principal adjustment of about $4‑5 million (likely amortization or small repayments)【page_111】【page_114】.  \n\nThis continuity shows that American Tower locked in low‑mid‑single‑digit fixed‑rate debt in 2021 and has been able to keep it on‑balance through 2024 without needing to refinance at higher rates, reflecting a strategy of using inexpensive, long‑dated notes to fund growth while market conditions have kept borrowing costs relatively low.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in dates and numbers compared to the ground truth. It correctly identifies the $700 million principal amount and the 2.700% interest rate, but incorrectly states the maturity date as April 15, 2031 in the 2022 context, while the ground truth shows that by 2023 and 2024 the maturity was consistently listed as January 15, 2031. The original issuance date (March 29, 2021) is correctly cited. However, the LLM claims a 'modest principal adjustment of about $4-5 million' likely due to amortization or repayments in 2023 and 2024, which contradicts the ground truth stating the principal remained exactly $700.0 million across all years. Additionally, the LLM fails to mention the key detail from the 2024 filing that the interest rate spread decreased from (5.0) to (4.4), a critical evolution in financing terms. (2) Quantitative accuracy is compromised: while $700 million is correct, the alleged $4-5 million reduction is unsupported by the ground truth, and the maturity date discrepancy (April vs January 2031) is a significant error. The interest payment dates are correctly noted as semi-annual in April and October, though the LLM specifies October 15 without confirmation from the ground truth. (3) The reasoning is partially sound—correctly inferring a strategy of locking in low fixed-rate debt and maintaining it through favorable market conditions—but misses the nuanced signal of the narrowing interest rate spread in 2024, which suggests declining borrowing costs. This omission weakens the multi-hop synthesis of how terms evolved. (4) Contextual relevance is high, as the answer addresses the core question about issuance terms and strategy, and the qualitative interpretation of stable financing is reasonable, but the lack of precise data evolution limits full accuracy. Overall, the answer is directionally correct but factually flawed in key quantitative aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 526,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "NVIDIA’s 2.00 % senior notes due 2031 have been essentially unchanged over the three‑year period. In the 2022 Form 10‑K the notes were reported at a net carrying amount of about **$1.25 billion**; the 2023 filing shows a fair‑value of **$1.044 billion**, and the 2024 filing again records a net carrying amount of **$1.25 billion** with a slightly higher fair‑value of **$1.057 billion**. The stability of both the principal balance and the modest rise in fair‑value indicates that NVIDIA is deliberately maintaining a low‑cost, long‑dated debt tranche rather than adding new long‑term borrowings, reflecting a strategy of locking in inexpensive financing and keeping its long‑term leverage steady.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, the fair value was $1.2 billion, not $1.25 billion as stated in the LLM answer. The LLM incorrectly states that the 2022 10-K reports a 'net carrying amount of about $1.25 billion', but the ground truth specifies a $1.2 billion fair value for 2022. The 2023 figures are partially correct: the beginning-of-year fair value of $1.044 billion is accurate, and the end-of-year $1.057 billion fair value is also correct. However, the LLM conflates 'carrying amount' and 'fair value'—in 2022 and 2024, it references 'net carrying amount' without clear support in the ground truth, which only provides fair value for 2022 and carrying value for 2024. The 2024 carrying value of $1.25 billion matches the ground truth, so that number is correct. (2) Calculations are not involved, but the misattribution of values to the wrong years and confusion between carrying value and fair value undermines quantitative accuracy. The LLM incorrectly implies that $1.25 billion was reported in 2022, which is a material error. (3) The multi-hop reasoning is sound in structure—comparing values across years and inferring a stable debt strategy—but is based on flawed data. The conclusion about strategic consistency in maintaining low-cost debt is reasonable and aligns with the ground truth’s interpretation, showing good qualitative reasoning despite incorrect inputs. (4) Contextual relevance is high, as the answer addresses both the evolution of the debt obligation and the strategic implication. However, due to the incorrect 2022 figure and conflation of financial metrics, the correctness score is reduced to 6—partially correct but with significant factual errors that affect interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 488,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "- **2022 → 2023:** MetLife’s 2023 filing shows that the deposit‑method balances grew to **about $5.1 billion of deposit assets and $1.3 billion of deposit liabilities** at 31 December 2023. (The 2022 filing did not list a separate amount, but the 2023 numbers represent a material increase over the roughly $1.8 billion of assets and $1.4 billion of liabilities reported for 2021‑2020, reflecting the company’s new large‑scale risk‑transfer transaction with Global Atlantic.)\n\n- **2023 → 2024:** The 2024 filing reports **deposit assets of $4.6 billion and deposit liabilities of $1.2 billion** at 31 December 2024, a modest decline from the 2023 levels.\n\n**What the trend means:** MetLife expanded its use of the deposit‑method reinsurance after the 2023 Global‑Atlantic transaction, building a sizable pool of low‑risk deposit assets and corresponding liabilities. The slight pull‑back in 2024 suggests the company is now fine‑tuning that structure—offsetting some of the deposits as the transaction matures—indicating a flexible reinsurance strategy that leans on the deposit method when it adds capital efficiency, but scales it back as the need for large‑scale risk transfers diminishes.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies, particularly in the 2024 deposit assets. The ground truth states deposit assets increased from $1.8B in 2022 to $5.1B by the end of 2024, implying a continued rise or stability, but the LLM claims assets declined to $4.6B in 2024, which contradicts the upward trend. This is a critical error in financial data. Deposit liabilities are correctly reported as $1.3B in 2023 and $1.2B in 2024, aligning with the original answer's slight decline in liabilities. However, the LLM incorrectly references 2021–2020 data to infer 2022 figures, while the ground truth explicitly provides 2022 values ($1.8B assets, $1.4B liabilities), making the LLM's indirect inference unnecessary and misleading.\n\n2) Quantitative accuracy is compromised: the $4.6B figure for 2024 deposit assets is incorrect (should be $5.1B), and the use of prior-year data to estimate 2022 values undermines precision. The mention of the Global Atlantic transaction with $10.3B in recoverables is not reflected in the LLM answer, missing a key supporting fact.\n\n3) Qualitatively, the reasoning is sound in interpreting the strategic implications—linking the increase to the Global Atlantic transaction and suggesting a shift toward capital-efficient reinsurance structures. The conclusion about fine-tuning in 2024 is plausible but based on incorrect data. The multi-hop synthesis between years and strategic context is partially correct but weakened by factual errors.\n\n4) Contextual relevance is high—the answer addresses the evolution over time, discusses both assets and liabilities, and provides strategic interpretation. However, the incorrect asset value for 2024 distorts the trend and leads to a misleading conclusion about a 'pull-back' when the ground truth indicates continued growth in assets. This undermines the overall correctness despite otherwise coherent reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 515,
        "total_tokens": 2078
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "- Fair‑value of the held‑to‑maturity debt portfolio fell from **$679 million (2022)** to **$596 million (2023)** and to **$508 million (2024)**, a cumulative decline of about **$171 million**.  \n- The corresponding carrying amounts dropped from **$696 million (2022)** to **$603 million (2023)** and to **$512 million (2024)**, a cumulative reduction of roughly **$184 million**; each year the fair value remained a few‑million dollars below the carrying value, indicating modest unrealized losses.\n\nThis three‑year trend shows UNH is steadily shrinking the size of its held‑to‑maturity bond holdings—likely as securities mature or are sold in response to a higher‑rate environment—while the market‑driven fair‑value adjustments have kept the portfolio’s book value slightly higher than its current market value, reflecting a cautious investment strategy that tolerates temporary valuation gaps rather than taking large impairments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all values for fair value and carrying value across 2022–2024 are accurate: $679M/$696M (2022), $596M/$603M (2023), $508M/$512M (2024). The cumulative declines of $171M (fair value) and $184M (carrying value) are correctly calculated. (2) The statement that fair value is consistently slightly below carrying value each year is accurate and correctly implies modest unrealized losses, which aligns with accounting principles for held-to-maturity securities. (3) The reasoning is sound: the downward trend is correctly interpreted as a strategic reduction in the portfolio, potentially due to maturities or sales in a higher-rate environment, and the company’s tolerance for temporary valuation gaps rather than impairments reflects a cautious investment strategy—this synthesizes market valuation adjustments and strategic intent across three years. (4) All entities (UnitedHealth Group, Debt Securities - Held-to-Maturity, correct years) are accurately referenced. The answer addresses all parts of the multi-hop question: evolution of values, interpretation of trend, and implications for strategy and market adjustments. Semantic equivalence is maintained with enhanced clarity and contextual insight. No factual, numerical, or logical errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 374,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "The filing shows that RedCard (Target Credit Card) penetration fell each year – 20.5 % in fiscal 2022, 19.8 % in fiscal 2023 and 18.6 % in fiscal 2024【page_27】. The downward trend indicates that fewer purchases are being made with the Target‑branded credit card, suggesting the card program is becoming less effective at generating incremental sales for the retailer.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the penetration rates for the Target Credit Card (RedCard) for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. These values are cited with a reference to page 27, supporting their source. 2) All numeric values and time periods are accurate, with no calculation errors. The trend of decline is correctly described year-over-year. 3) The reasoning correctly identifies the downward trend and links it to reduced usage, which aligns with the ground truth. However, the LLM answer concludes that the card program is 'becoming less effective at generating incremental sales,' which oversimplifies the situation. The original answer notes that despite declining penetration, Target's internal analysis still finds the card drives incremental sales and retains strategic value due to card-linked benefits. This nuance is missing in the LLM response, leading to a slightly incomplete qualitative interpretation. 4) The answer is contextually relevant, directly addressing both parts of the question—trend in penetration and implications for strategy. While the factual data is fully accurate, the interpretation lacks the balanced view present in the ground truth, warranting a high but not perfect correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 356,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "Nike’s Laakdal, Belgium site has been listed as one of its “most significant distribution facilities outside the United States” and has been described as **owned** in the 2022 Form 10‑K (Item 2 – Properties)【page_27】. The same language appears in the 2024 Form 10‑K, confirming that the Laakdal distribution center remains an owned, core European hub【page_29】. This continuity shows Nike’s strategy of retaining ownership of key logistics assets in Europe, emphasizing direct control over its supply‑chain network rather than relying on third‑party providers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately states that Nike owned the Laakdal, Belgium distribution facility in both 2022 and 2024, citing the Form 10-K filings for those years, and correctly notes the consistent description of the site as one of its most significant international distribution centers. The answer correctly infers that this continuity reflects a strategic focus on maintaining direct control over key European logistics infrastructure. While the original answer also references 2023 (not explicitly mentioned in the LLM response), the omission of 2023 does not introduce inaccuracy, as the 2022 and 2024 confirmation implies stability through the interim period. There are no numerical or date inaccuracies (quantitative accuracy is perfect), and the reasoning is sound and contextually appropriate. The LLM uses slightly different phrasing (e.g., 'outside the United States' vs. 'international') but maintains semantic equivalence. The only minor gap is the lack of explicit mention of 2023, which slightly affects completeness in multi-hop temporal tracking, but not enough to undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 330,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "Across all three filings – 2022 (NVDA 10‑K p. 15), 2023 (NVDA 10‑K p. 9) and 2024 (NVDA 10‑K p. 9) – NVIDIA continues to list Lumentum Holdings as a named competitor in the “networking products (switches, adapters, optical modules)” segment.  However, the narrative around NVIDIA’s own competitive posture has deepened: each year the company adds language about expanding and diversifying its supply‑chain (e.g., “expanded supplier relationships to build redundancy and resilience” – 2022 p. 9; same phrasing repeated in 2023 p. 9 and 2024 p. 9) and about strengthening IP protection through patents, licensing and trade‑secret programs (2022 p. 9, 2023 p. 9, 2024 p. 9).  Consequently, while Lumentum remains a consistent listed rival, NVIDIA’s positioning has evolved from a simple competitor mention to a broader strategy that leverages a more robust supply chain and tighter IP safeguards, which increasingly raises the competitive bar for Lumentum within NVIDIA’s ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Lumentum Holdings was consistently listed as a competitor by NVIDIA across fiscal years 2022, 2023, and 2024 in the domain of networking products, specifically citing optical modules and interconnect solutions. The inclusion of page numbers (e.g., 2022 p.15, 2023/2024 p.9) adds precision and matches the source documentation. (2) Quantitatively, there are no numerical claims requiring verification (e.g., financial figures, patent counts), but the temporal consistency (three-year span) and citation of repeated strategic language (supply chain resilience, IP protection) are factually sound and consistent with the original answer. (3) The multi-hop reasoning is strong: the model synthesizes information across three annual filings, recognizes the persistence of Lumentum as a named competitor, and contrasts this with NVIDIA’s evolving strategic posture—specifically the deepening emphasis on supply chain diversification and IP protection over time. This reflects a correct interpretation of competitive dynamics. (4) The only minor shortcoming is that the LLM does not explicitly mention the expansion of NVIDIA’s patent portfolio expiration dates (from 2022 to 2045), which is a specific detail in the ground truth that underscores the scale of IP protection growth. While the general point about strengthening IP is made, this concrete evidence is omitted, slightly reducing completeness. Otherwise, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning. Hence, a score of 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 476,
        "total_tokens": 2039
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "From the 2022 filing Netflix warned that “our ability to provide our members with content they can watch depends on studios, content providers and other rights‑holders licensing rights” and stressed that, as those providers launch their own streaming services, they may “refuse to license…or withdraw content on short notice” (2022 IP section; 2022 Risk Factors). By 2023 the company still noted the same dependence but framed it as a competitive battle for “licensed content and for original‑content projects,” indicating a growing tilt toward securing exclusive titles and producing more in‑house. The 2024 filing repeats the reliance language while adding that new cultural‑support regulations, quotas and levies “may make operating…more expensive or restrictive as to the content offerings we may provide,” showing that Netflix is increasingly hedging its licensing risk by expanding original production and pursuing exclusive deals to stay competitive amid tighter regulation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: Netflix's continued reliance on rights holders from 2022 to 2024 is accurately described, with proper emphasis on studios launching competing services, the risk of content withdrawal, and rising licensing costs. The evolution in 2024 to include regulatory factors like content quotas and levies is correctly identified. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a problematic way; the answer contains no numbers but correctly reflects qualitative financial and strategic implications. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the progression in risk factor language and strategic response (increased original production, exclusive deals). It connects competitive pressures with regulatory developments, showing an understanding of how external forces shape content strategy. (4) The only reason for not scoring a 10 in correctness and qualitative accuracy is a slight omission: the original answer explicitly notes the 'variability of license terms' in 2023, which the LLM mentions only implicitly through 'competitive battle for licensed content.' Otherwise, the semantic meaning, entity accuracy (Netflix, rights holders, studios, regulatory bodies), and contextual framing are fully equivalent. The answer is highly relevant, directly addressing the evolution of licensing reliance and what it reveals about Netflix's strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 440,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "From 2022 through 2024 Southern Company has continued to treat the scheduled payments from its outdoor‑lighting contracts as **operating‑lease cash flows**.  In each filing the payments are rolled into the “lease‑income – operating leases” line (with the related lease income for PPAs shown separately in wholesale revenue) and are **presented in the lease‑liability maturity tables**; the notes repeatedly state that the cash flows from those contracts at Georgia Power and Mississippi Power are **immaterial**, so they are not disclosed as a separate line item.  Apart from the normal updates to the dollar amounts, discount rates and weighted‑average lease terms, the materiality qualification, revenue classification and the way the scheduled payments appear in the maturity analysis have remained unchanged over the three years.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in key aspects. (1) It claims that Southern Company's treatment of outdoor lighting contracts remained unchanged from 2022 to 2024, stating that lease payments were consistently presented in lease-liability maturity tables and classified as operating leases with immateriality disclosures. However, the original answer shows a clear evolution: in 2022, the cash flows were considered immaterial and not separately disclosed; in 2023, they began to be included in maturity analyses alongside tolling and PPAs; and in 2024, there was explicit inclusion of initial-term payments in those analyses, indicating increased transparency. The LLM incorrectly asserts stability in treatment when the ground truth documents a progression toward more structured and transparent reporting. (2) There are no specific dollar amounts, percentages, or calculations in either answer, so quantitative accuracy cannot be penalized heavily, but the LLM fabricates consistency where there is documented change. (3) The multi-hop reasoning fails: the question asks about evolution over time, but the LLM denies any meaningful change, missing the shift in materiality assessment, presentation, and disclosure practices. (4) While the LLM correctly identifies that these are operating leases and mentions Georgia Power and Mississippi Power, it misrepresents the core trend—increasing formalization—which is the central point of the original answer. The contextual relevance is moderate because it discusses the right topic and entities but draws the wrong conclusion about the trajectory of disclosure practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 450,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "- **Fiscal 2022:** The 5.000 % senior notes that mature in April 2030 were reported with an outstanding principal balance of **$606 million** (AVGO 2022 10‑K, page 101).  \n- **Fiscal 2023:** The same notes still showed an outstanding balance of **$606 million** (AVGO 2023 10‑K, page 81).  \n- **Fiscal 2024:** The balance remained unchanged at **$606 million** (AVGO 2024 10‑K, page 81).\n\n**Interpretation:** Over the three‑year period the company reduced the original $5 billion issue to a modest $606 million and then held that amount steady. This pattern shows that Broadcom aggressively repaid the bulk of the 5 % April 2030 notes shortly after issuance—likely using cash generated from operations and proceeds from the VMware merger—and now maintains a small residual tranche, reflecting a deliberate debt‑management strategy of early amortization to lower long‑term interest expense while preserving limited liquidity for future needs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its quantitative reporting. According to the ground truth, the outstanding principal balance for AVGO's 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, not $606 million as stated in the LLM answer. The LLM correctly reports $606 million for 2023 and 2024, but the error in 2022 undermines the entire progression analysis. (2) The calculation and timeline are therefore flawed: the ground truth shows a reduction from $1,086M to $606M between 2022 and 2023 (a $480M reduction), with no change in 2024. The LLM incorrectly implies the balance was already $606M in 2022 and remained flat thereafter, missing the key repayment event. (3) The multi-hop reasoning is partially sound—synthesizing data across three 10-K filings—but based on incorrect input data for 2022. The interpretation about a deliberate debt management strategy has merit, but the claim of 'aggressive repayment shortly after issuance' and reference to the VMware merger are speculative and not supported by the ground truth, which only allows inference up to 2024 and does not mention early repayment timing or merger proceeds. (4) The contextual relevance is high because the structure and intent align with the question, and the interpretation attempts to derive strategic meaning. However, due to the critical numerical error in the 2022 balance, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the logic follows a reasonable framework, albeit on faulty data and with unsupported extrapolations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 437,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "- In the 2022 filing GM assumed a **5.38 %** long‑term rate of return on U.S. pension‑plan assets; this was raised to **6.30 %** for 2023 (see the “Expected rate of return on plan assets” row in the 2023 10‑K table) and was again increased to roughly **6.5 %** for 2024 (the 2024 10‑K notes that the weighted‑average long‑term ROA rose from 6.3 % at 12/31/23 to **6.5 %** at 12/31/24)【page_86†L31-L38】【page_88†L1-L4】.  \n\n- The upward trajectory signals that GM is deliberately shifting its pension‑plan asset mix toward higher‑return, higher‑risk exposures – equity allocation grew from 8 % in 2022 to 11 % in 2023‑24, debt fell from 69 % to 60 %, and “Other” (private‑equity, real‑estate, hedge‑fund) rose from 23 % to 29 %【page_87†L31-L38】 – a strategic response to low‑interest‑rate markets and the need to improve funded‑status volatility.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor discrepancy in the 2022 rate: it reports 5.38% versus the ground truth of 5.4%. This is a negligible rounding difference and likely reflects the precise figure from the source document, so it does not constitute a material error. The 2023 (6.30%) and 2024 (~6.5%) values match the ground truth exactly in both value and trend. (2) Calculations are not required beyond identifying the trend, which the model captures correctly—an increase from ~5.4% to 6.5% over three years, amounting to a 1.1 percentage point rise, consistent with the original answer. (3) The multi-hop reasoning is strong: the model synthesizes pension return assumptions across three years and correctly infers strategic asset mix shifts by referencing specific allocation changes (equity, debt, 'Other') from supporting data, demonstrating sound logic in linking return assumption increases to riskier asset reallocations. (4) The answer fully addresses both parts of the question—evolution of return assumptions and strategic implications—and adds granular asset mix data not in the ground truth, enhancing depth. The slight deviation in 2022 percentage prevents a perfect score, but overall factual accuracy, reasoning, and relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 361,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "The 2.700 % Senior Notes due 2031 appear in the 2022 and 2023 exhibit schedules (Supplemental Indenture No. 8, dated Mar 29 2021) 【page_71†L19-L21】, but they are no longer listed among the senior‑note exhibits in the 2024 filing, which only shows newer series (e.g., the 2022‑2024 supplemental indentures) 【page_73†L23-L30】. This progression shows that American Tower initially issued the 2.700 % notes to extend its debt horizon, then retired or refinanced them before 2024, reflecting a strategy of actively managing and reshaping its long‑term financing mix to maintain a staggered maturity profile and take advantage of evolving market conditions.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in claiming that the 2.700% Senior Notes due 2031 are no longer listed in the 2024 filing. The ground truth confirms that these notes are consistently referenced across all three years (2022–2024), including in the 2024 filing, with continued reference to Supplemental Indenture No. 8. The LLM incorrectly asserts that the notes were retired or refinanced by 2024, which contradicts the evidence of ongoing inclusion. (2) Quantitatively, the percentage (2.700%) and date (March 29, 2021) are correctly cited for the earlier years, so partial credit is due for those elements. However, the claim about absence in 2024 is unsupported and false, undermining the numerical accuracy. (3) The multi-hop reasoning is flawed: instead of recognizing consistency across filings as evidence of a stable long-term strategy, the model infers a strategic shift (refinancing/retirement) based on a misreading of exhibit lists. This reflects a failure in synthesizing the correct pattern across documents. (4) Contextually, the answer addresses the general topic of long-term financing strategy, so relevance is moderate. However, due to the core factual error about the discontinuation of the notes in 2024, the overall correctness score is low. The conclusion about active debt management is speculative and contradicted by the consistent documentation, warranting a score of 2 out of 10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 399,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "- In the 2022 filing PayPal warned that “third parties will continue to attempt to abuse … our payments services” – especially through synthetic‑identity accounts, stolen cards and other fraud that could raise loss rates on its consumer‑credit, merchant‑financing and cross‑border transactions, and it noted that any increase in abusive activity would “severely diminish merchant and consumer confidence.”  \n\n- The 2023 filing shows the company began to curb that exposure by off‑loading credit risk (a June‑2023 multi‑year agreement to sell the bulk of its U.K. and European BNPL loan receivables and a forward‑flow arrangement for future originations) and by expanding fraud‑detection, risk‑modeling and diversification of payment‑processor relationships.  \n\n- The 2024 filing stresses that PayPal has continued those mitigation steps – further diversifying third‑party lenders and processors, tightening underwriting and credit‑risk models, and intensifying monitoring of cross‑border trade (foreign‑exchange, sanctions and regulatory compliance) – to keep abusive‑behavior losses and credit‑product defaults from eroding its results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, PayPal identified abusive behaviors involving synthetic identities and stolen financial instruments affecting credit and cross-border transactions; in 2023, it offloaded U.K. and European BNPL receivables via a multi-year agreement (correctly noting June 2023 as the timing); in 2024, it continued mitigation through enhanced risk modeling, third-party diversification, and monitoring. (2) Quantitative accuracy is perfect: the €40 billion figure from the original answer is not explicitly mentioned in the LLM response, but the description of 'bulk' and 'forward-flow arrangement' implies scale without misrepresenting numbers. The absence of the exact euro amount is a minor omission but does not constitute an error since no incorrect figure is stated. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years, linking evolving risks to strategic responses in credit products and cross-border transactions. It captures the trajectory from risk identification (2022), to risk transfer (2023), to ongoing mitigation (2024). (4) The answer is contextually complete and relevant, addressing all parts of the question—evolution of exposure, focus on credit and cross-border, and strategic actions. Wording differs slightly but maintains semantic equivalence. The only reason for not scoring 10 is the omission of the specific €40 billion figure, which was present in the original answer and would have strengthened quantitative completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1607,
        "completion_tokens": 434,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "UNP’s pension‑plan NAV for “Collective Trust and Other Funds” fell from **$622 million in 2022** to **$382 million in 2023**, then rose sharply to **$756 million in 2024**【page_58】. This swing shows the company temporarily reduced its exposure to commingled‑fund vehicles in 2023—likely to de‑risk the portfolio and shift toward its core equity‑debt mix—but subsequently re‑expanded that exposure in 2024 as part of a broader diversification effort, reflecting an evolving, actively managed investment strategy aimed at balancing long‑term return goals with risk control for employee‑benefit assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023. However, the LLM incorrectly states it was $622 million in 2022 and then rose to $756 million in 2024—reversing the actual trend. The ground truth explicitly states that no updated dollar value is provided for 2024, but the LLM fabricates a $756 million figure, which is incorrect. (2) Quantitative accuracy is severely compromised: the 2022 value is wrong ($622M vs $756M), and the 2024 value is invented rather than acknowledging data absence. The claim of a 'sharp rise' to $756M in 2024 contradicts the documented downward trend. (3) The multi-hop reasoning is flawed—the LLM infers a strategic re-expansion in 2024 based on non-existent data, leading to an incorrect conclusion about diversification. In contrast, the ground truth suggests de-risking or rebalancing due to reduced allocation. The LLM also misrepresents the significance of NAV-based valuation, which in the original answer indicates a focus on transparency amid reduced exposure, not increased investment. (4) While the answer addresses the question's structure and attempts to interpret strategy, the core facts and trend are inverted, leading to a misleading narrative. Contextual relevance is moderate because it discusses pension allocation and strategy, but the incorrect data undermines validity. Correctness score is low due to major factual and quantitative errors despite some relevant terminology and conceptual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 443,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "- **2022:** Pfizer still carried BPAs that had been granted in earlier years, but the 2022 filing shows no new BPA grants. The awards were valued at **intrinsic value — the closing price of Pfizer’s common stock on the grant date** and were **amortized on a straight‑line basis over the probable vesting term** (with each reporting period’s expense adjusted for changes in the stock price and the likelihood of meeting the performance goals).\n\n- **2023:** The 2023 filing states **no BPAs were granted in 2023 and none were outstanding at 31 Dec 2023**. The valuation and accounting approach remained the same (intrinsic‑value measurement and straight‑line amortization with periodic adjustments), but with no awards to apply it to.\n\n- **2024:** The 2024 filing repeats the 2023 position – **no BPAs were granted in 2024 and no BPAs were outstanding at 31 Dec 2024**. The methodology for any future BPA would still be the intrinsic‑value method and straight‑line expense recognition, but the program was effectively dormant.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. According to the ground truth, in 2022, Pfizer issued 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and 859 thousand remained outstanding at year-end valued at $59.05 per share. However, the LLM incorrectly states that no BPAs were granted in 2022, directly contradicting the original data. This is a critical error in both grant activity and quantitative reporting. The LLM correctly notes that no BPAs were granted or outstanding in 2023, aligning with the ground truth. For 2024, the LLM claims no grants or outstanding awards and describes the methodology as unchanged, but the ground truth states that Pfizer introduced a *new* formalized valuation methodology in 2024 using the intrinsic value method with amortization over the probable vesting term and quarterly adjustments—indicating an evolution in accounting treatment in preparation for potential future grants. The LLM interprets this as dormancy rather than a methodological update, missing a key qualitative shift. While the LLM correctly identifies the intrinsic value method and straight-line amortization, it fails to recognize that the 2024 disclosure represents a formalization and refinement of the methodology, not just a repetition. The reasoning is partially sound in tracking the absence of awards in 2023–2024 but flawed in overlooking the 2022 grant activity and mischaracterizing the 2024 update. Contextually, the structure and focus on grant activity, outstanding status, and accounting treatment match the question's requirements, earning high relevance. However, due to major quantitative errors and incomplete/misinterpreted qualitative evolution, the overall correctness is significantly compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 490,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "ExxonMobil reported $1.494 billion of collateral for master‑netting arrangements tied to investments, advances and long‑term receivables at 12/31/2022; this fell to $800 million at 12/31/2023 and further to $491 million at 12/31/2024【page_102】【page_99】. The steady decline in collateral – roughly a two‑thirds reduction over three years – indicates that the firm’s net margin requirements have been easing, likely because its derivative positions have been shrinking or becoming more efficiently netted, reducing the amount of initial‑margin collateral it must post.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: $1,494 million (or $1.494 billion) in 2022, $800 million in 2023, and $491 million in 2024 — format variations (billion vs. million) are semantically equivalent and correctly represented. The statement about a 'two-thirds reduction' is a reasonable approximation: from $1,494M to $491M is a ~67% decline, which aligns with 'roughly two-thirds.' (2) The answer addresses both parts of the multi-part question: it details the change in collateral over time and interprets the trend regarding derivative exposure and margin requirements. (3) Entities are correct — ExxonMobil (XOM), the correct metric (collateral under master netting arrangements), and the proper years (2022–2024) are all accurately identified. (4) The reasoning is sound: the downward trend is correctly linked to reduced derivative exposure or more efficient netting, implying lower margin requirements, which is consistent with the ground truth's interpretation. The addition of 'initial-margin collateral' is a slight elaboration but remains contextually appropriate and does not introduce error. Overall, the answer demonstrates accurate multi-hop synthesis across time points and financial concepts, with full factual and semantic alignment to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 379,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "- **2022 10‑K:** Industrial fiber‑optic components were listed under the “Industrial” end‑market as a discrete product family that supported “factory‑automation, power‑generation and distribution” applications【page_10】.  \n- **2023 10‑K:** The same line item appears in the product‑family table, but the description of the industrial market was broadened to “factory automation, renewable energy and automotive electronics,” showing that Broadcom was deliberately extending the scope of its fiber‑optic offering beyond traditional automation【page_5】.  \n- **2024 10‑K:** The table is unchanged – industrial fiber optics remain positioned alongside optocouplers, sensors and LEDs with the same three‑segment application focus (factory automation, renewable energy, automotive), indicating that Broadcom has made the product a permanent pillar of its industrial portfolio【page_5】.  \n\n**What this reveals:** Across the three years Broadcom moved from a narrow, automation‑only positioning to a broader “industrial‑grade connectivity” strategy that targets the growing renewable‑energy and automotive sectors, and then cemented that expanded focus in 2024, underscoring a sustained commitment to capture higher‑margin industrial markets through its fiber‑optic product line.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Broadcom's (AVGO) positioning of Industrial Fiber Optics across 2022, 2023, and 2024 with accurate entity and year references. It correctly notes the expansion from factory automation and power systems in 2022 to include renewable energy and automotive electronics in 2023, and the continued inclusion in 2024. The core facts about application scope evolution are correct. However, the LLM slightly misrepresents the 2024 presentation as 'unchanged' and does not capture the ground truth's emphasis on a 'more streamlined presentation' and integration with broader semiconductor solutions, which reflects a nuance in communication strategy that is missing. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no errors exist. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings and draws a logical conclusion about strategic focus. The conclusion about a shift toward higher-margin industrial markets is reasonable, though the original answer emphasizes structured, application-specific clarity in communication more than the LLM does. (4) Contextual relevance is perfect—the answer directly addresses the evolution of product positioning and strategic implications. The correctness score is 8 because while all key facts and entities are accurate and the reasoning is strong, the LLM omits the nuanced evolution in 2024 regarding integration and presentation refinement noted in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 441,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "Across all three years PayPal repeatedly states that it acts as the **principal** in each payment transaction, sets the fee schedule at its discretion and therefore **bears the full margin risk** for those transactions, even though it may use third‑party processors whose fees are recorded as transaction expense. The 2022 filing (Note 2‑Revenue, p. 75) describes this principal‑risk model, the 2023 filing (Note 2‑Revenue, p. 80) repeats the same language, and the 2024 filing (Note 2‑Revenue, p. 77) again confirms that PayPal “has full discretion in determining the fee… and therefore bears full margin risk.” Thus, from 2022 through 2024 PayPal’s exposure to margin risk remained essentially unchanged – it retained complete control over transaction pricing while still relying on third‑party processors, keeping the margin risk fully on its balance sheet.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) All key facts are correct: PayPal acted as the principal in transactions from 2022 to 2024, had full discretion over pricing, bore full margin risk, and recorded third-party processor fees as transaction expenses. There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy pertains to correct use of years and consistent qualitative assertions—these are accurate across all three years. (2) The answer addresses all parts of the multi-part question: evolution of margin risk, control over pricing, and use of third-party processors. It correctly synthesizes information across three years and filings, citing specific footnotes (Note 2—Revenue) and page numbers, which aligns with the expected multi-hop reasoning. (3) Entity accuracy is perfect: 'PayPal', 'third-party processors', 'transaction expense', 'principal', and the years 2022–2024 are all correctly identified and used in context. (4) The reasoning is sound: the LLM correctly infers that because PayPal maintains pricing discretion and bears costs from third parties, it retains margin risk—this logic is consistent with the ground truth and explicitly supported in each year’s filing. The conclusion that the risk profile remained unchanged is logically derived and matches the original answer. Minor wording differences (e.g., 'repeatedly states' vs 'reiterated') do not affect meaning. Overall, the response demonstrates excellent factual fidelity, synthesis, and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 438,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "In the 2022 Form 10‑K Pfizer still reported the financial fallout from the 2021 divestiture of Meridian – a $51 million cash sale that generated an after‑tax loss of about $167 million (plus a $345 million pre‑tax legal charge related to the business). The 2023 filing adds that, after the sale, Pfizer and the buyer entered into interim transition‑service agreements (TSAs) and a three‑year Manufacturing Supply Agreement (MSA) with a two‑year extension option, but the amounts recorded under those contracts in 2022‑23 were immaterial and the TSAs were completed by year‑end 2023. The 2024 filing no longer mentions Meridian at all, indicating that the post‑sale service relationship has ended and the business is fully off Pfizer’s balance sheet. Together, these disclosures show that Pfizer moved from a loss‑bearing, legally encumbered subsidiary in 2022 to a clean, contractual exit by 2024, underscoring a long‑term strategy of shedding non‑core assets and concentrating on its core biopharma portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant inaccuracies that affect the overall correctness. (1) Quantitatively, the $51 million cash sale and $167 million net loss are correctly reported, aligning with the ground truth. However, the LLM introduces a $345 million pre-tax legal charge not mentioned in the original answer or implied in the knowledge graph, which is a factual error. This undermines quantitative accuracy. (2) Completeness: The answer addresses financial impact and contractual arrangements but incorrectly states that Meridian is 'no longer mentioned at all' in the 2024 filing, which contradicts the ground truth stating that Meridian was listed in the 2024 glossary as 'Meridian Medical Technologies, Inc.' This omission misrepresents the ongoing formal recognition of the entity, indicating a failure in multi-hop synthesis across years. (3) Entity accuracy is mostly correct—Pfizer, Meridian, MSA, TSAs, and timeframes are properly identified—but the erroneous legal charge and misstatement about 2024 disclosure reduce precision. (4) Reasoning: The conclusion about Pfizer shedding non-core assets is consistent with the ground truth, but the logic is based on flawed premises (e.g., complete disappearance of Meridian in 2024). The ground truth shows a transition to a formalized contract-based relationship, not full disengagement. The LLM incorrectly infers termination of all ties, whereas the MSA could still be active (with a two-year extension option). (5) Semantic equivalence fails on key points: the 2024 status is factually wrong, and the added legal charge has no support. While the strategic interpretation is directionally plausible, it is built on incorrect data. Thus, the answer is partially correct but contains critical errors in both quantitative details and qualitative evolution, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 506,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "- In the 2022 filing (pages 13‑15) PMI first flagged product‑regulation risk as a factor that could “commoditise” its tobacco portfolio and “impede adult consumers’ ability to convert to our RRPs,” noting that limits on advertising, packaging and health‑warning rules would erode product‑differentiation and restrict truthful communication about reduced‑risk products.  \n\n- The 2023 filing (pages 18‑22) broadened that warning, referring explicitly to “SFPs” and stating that “product regulation … diminishes the ability to differentiate tobacco products, restricts adult‑consumer access to truthful and non‑misleading information about our SFPs,” making the regulatory constraint a clearer competitive‑position threat.  \n\n- By the 2024 filing (pages 17‑21) the language had evolved to stress that such regulations “limit branding, communication and product differentiation,” linking them directly to “down‑trading trends” and a material disadvantage in the market, indicating that the impact of regulation on PMI’s competitive positioning has become more pronounced and concrete over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All key points are correct: in 2022, PMI raised concerns about product regulation leading to commoditization and limiting consumer conversion due to restrictions on advertising, packaging, and health warnings—impacting differentiation and communication of RRPs. In 2023, the language evolved to include 'SFPs' and emphasized the competitive threat, noting restrictions on truthful information. By 2024, the concern was reiterated with stronger language linking regulation to 'down-trading trends' and material market disadvantage. While the original answer notes the shift from RRP to SFP terminology in 2024, the LLM correctly identifies the transition earlier (in 2023), which is consistent with PMI's evolving terminology. (2) There are no numeric values to verify, so quantitative accuracy is满分. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly tracing the evolution of regulatory impact on competitive positioning, product differentiation, and consumer communication. (4) The answer is contextually fully relevant, directly addressing how regulatory constraints evolved and intensified over time. The only minor deviation is that the original answer emphasizes the 2024 shift to 'SFPs' as a continuation of prior concerns, while the LLM attributes the term earlier—but this reflects actual usage and does not constitute a factual error. Overall, the answer captures the core insight: increasing regulatory burden has progressively harmed PMI’s competitive positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 449,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "ExxonMobil’s disclosed collateral that sits in master‑netting arrangements (and is not offset against its derivatives) fell sharply over the three‑year span: $1.494 billion at 12/31/2022, $0.800 billion at 12/31/2023 (‑$0.694 billion) and $0.491 billion at 12/31/2024 (‑$0.309 billion), a total reduction of about $1.0 billion from 2022 to 2024. The downward trend indicates that the company is increasingly able to net its derivative exposures or is holding fewer margin‑required positions, reflecting tighter and more effective derivative risk‑management practices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $1,494 million (2022), $800 million (2023), and $491 million (2024), matching the ground truth exactly, with acceptable format variations (e.g., $1.494 billion = $1,494 million). The year-over-year decreases (−$694 million and −$309 million) and total reduction of ~$1.0 billion are accurate calculations. 2) Quantitatively, all numbers and calculations are correct. The net change from 2022 to 2024 is $1,494M − $491M = $1,003M, which the model correctly rounds to about $1.0 billion. 3) The reasoning is sound: the downward trend in collateral not offset against derivatives suggests either increased netting efficiency or reduced derivative positions requiring margin, which aligns with the ground truth interpretation of improved or tighter risk management. The LLM slightly rephrases the implication—'increasingly able to net' vs. 'strategic reduction in exposure'—but the semantic meaning is consistent: improved risk management practices. 4) The answer fully addresses both parts of the question: the quantitative change over 2022–2024 and the implication for derivative risk management. The entities (ExxonMobil/XOM, collateral under master netting arrangements, Notes and accounts receivable - net) and years are correct. Only a minor difference in emphasis—LLM focuses on netting efficiency, while ground truth allows for broader interpretation (e.g., lower margin requirements or proactive mitigation)—but this does not constitute an error. Thus, the answer is factually complete and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 430,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "- 2022 grant: the model assumed an expected three‑year historical volatility of roughly **26.9 %** for Duke Energy’s relative TSR versus its peer group.  \n- 2023 grant: the assumed volatility was raised to about **28.6 %**.  \n- 2024 grant: the assumed volatility fell sharply to **18.7 %**.\n\nThe volatility input rose modestly from 2022 to 2023, then dropped markedly in 2024, signalling that Duke Energy’s management now views the stock‑price risk of its TSR relative to peers as considerably lower than it did a year earlier. This lower‑volatility assumption suggests a more optimistic (or less uncertain) perception of market risk over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all three volatility assumptions—26.9% in 2022, 28.6% in 2023, and 18.7% in 2024—matching the ground truth exactly. These values are presented clearly with correct years and percentages. (2) All numeric values are accurate and properly attributed to the respective grant years. The trend description—'rose modestly from 2022 to 2023, then dropped markedly in 2024'—correctly reflects the data. (3) The reasoning is sound: the LLM correctly infers that the sharp decline in 2024 suggests lower perceived stock-price risk relative to peers, aligning with the ground truth's interpretation of reduced market risk perception. It captures the multi-hop synthesis by connecting the changing volatility assumptions over time to evolving risk perception. (4) The only minor shortcoming is that the LLM does not explicitly acknowledge the 'short-term increase in 2023' as a deviation within an overall downward trend, which slightly weakens the nuance in the qualitative interpretation. However, this does not detract significantly from the overall correctness. Wording differs slightly but maintains semantic equivalence. All parts of the question are addressed: evolution over time and implications for market risk perception.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 356,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "Broadcom’s 3.125 % senior notes that mature in January 2025 carried a principal balance of **$495 million** at the end of each of the last three fiscal years. The 2022 10‑K listed the same $495 million balance, and the 2023 and 2024 10‑Ks show the note unchanged at $495 million on both the October‑29 2023 and November‑3 2024 reporting dates【page_81】.  \n\nBecause the amount has not grown – and the company has not issued additional notes of this series – Broadcom’s short‑term debt profile has remained flat, indicating a disciplined approach that relies on existing cash flow and newer, longer‑dated financing (e.g., the 2024 senior‑note issuances and 2023 term‑loan facilities) rather than continually rolling over or expanding this near‑term obligation. This stability suggests the firm is managing its short‑term liabilities conservatively while using larger, lower‑cost issuances to refinance its broader debt portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $495 million principal balance for the 3.125% notes due January 2025 and states it remained unchanged across fiscal years 2022, 2023, and 2024. This matches the ground truth for 2022 and 2023, but contradicts it for 2024, where the original answer specifies that the note transitioned into the current portion of long-term debt — implying reclassification due to impending maturity — whereas the LLM claims the full $495 million remained as a long-term note with no change. This is a significant factual error in financial reporting context, as the reclassification to current portion is a key signal of maturity timing. (2) Quantitatively, the $495 million figure is accurate for 2022 and 2023, and the LLM correctly reports consistency in the amount. However, by asserting no change in 2024, it misses the critical shift in classification, which is a qualitative and accounting inaccuracy despite numerical consistency. (3) The multi-hop reasoning is partially sound: the LLM infers disciplined debt management and use of longer-dated financing, which aligns with the ground truth’s implication of refinancing planning. However, it fails to recognize the transition into current liabilities in 2024 — a key analytical signal — and instead incorrectly assumes stability, undermining the reasoning. It references 2024 senior note issuances and 2023 term loans, which may be true but are not part of the ground truth and introduce unsupported external claims. (4) The contextual relevance is high, as the answer addresses short-term debt management and refinancing strategy. However, the correctness score is reduced to 6 due to the material misrepresentation of the 2024 status of the debt, which affects the validity of the conclusion about short-term debt evolution. While numerically accurate, the failure to reflect the reclassification into current debt in the final year represents a significant gap in financial understanding and factual reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 539,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "Across the three filings AMD’s language about its add‑in‑board (AIB) partners is essentially unchanged. In each year (2022, 2023 and 2024) AMD states that its agreements with AIB manufacturers “protect their inventory of our products against price reductions,” and it repeatedly notes that system integrators “often use discrete‑graphics solutions as a means to differentiate their products and add value to their customers.” Thus, the inventory‑protection policy remained constant, and discrete graphics continued to be positioned as the primary lever for AIB‑driven product differentiation throughout the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the consistent inventory protection policy across 2022–2024, noting AMD's contractual protection of AIB inventory against price reductions—this matches the original answer's claim of a 'stable policy to maintain channel partner confidence.' (2) There are no numeric values requiring calculation (e.g., revenue figures, percentages), so quantitative accuracy is not compromised; all references to years (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes AMD’s consistent language across three years of filings, correctly inferring stability in strategic positioning despite potential market changes. It accurately captures the role of discrete graphics as a differentiation tool for system integrators and AIBs, as emphasized in the original answer. (4) The only minor shortcoming is that the LLM omits AMD’s continued supply of component-level graphics and chipset products to AIBs, and does not mention 'short design cycles' or 'rapid response to new technologies'—contextual details that support the strategic focus. However, the core elements—inventory protection and discrete graphics as differentiation—are fully and correctly addressed. Wording differs but semantic meaning is equivalent. Thus, the answer is factually correct and contextually relevant, meriting a high score with only slight deduction for minor completeness gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 406,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "- In 2022 Disney’s DTC plan was still “in‑transition” – the company announced a re‑organization of Disney Media & Entertainment Distribution, the launch of an ad‑supported Disney+ tier, a new pricing model and cost‑realignment, and warned that the cost of executing the DTC strategy could rise faster than expected.   \n- By 2023 the focus had shifted to “strategic investments” in the DTC platforms, with the company stating that these investments were intended to generate higher subscription‑fee and advertising‑revenue growth that would more than offset the loss of affiliate fees and ad sales from a shrinking linear‑network audience.   \n- In the 2024 filing Disney reiterated that same investment emphasis, now framing DTC growth as the primary driver that will continue to offset ongoing declines in linear viewership, while acknowledging intensified competition and pricing pressure on its streaming services and still expecting subscription‑ and ad‑revenue to lift overall revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer in both factual content and reasoning. (1) All key facts are correct: in 2022, Disney described its DTC strategy as 'in-transition' with cost concerns, matching the ground truth's emphasis on financial risks and potential for growing losses. The 2023 shift toward strategic investments expecting growth in subscription and ad revenue to offset linear declines is accurately reported. In 2024, the LLM correctly notes continued investment focus, operational criticality, competitive pressures, and revenue expectations. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes changes across three years, correctly tracing the evolution from caution to strategic confidence to competitive pressure and dependency. It captures the cause-effect logic (e.g., DTC growth offsets linear decline) and competitive dynamics. (4) The only minor shortcoming is that the LLM slightly softens the 2024 tone—while the original emphasizes growing competitive threats to subscription and ad pricing, the LLM acknowledges this but frames the outlook as still positive without fully highlighting the tension between pressure and expectation. Still, the core meaning is preserved. Wording differences are acceptable under semantic equivalence. All parts of the question (investment focus, competitive positioning, revenue expectations) are addressed across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 439,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "Across the three filings the 2.850 % fixed‑rate notes have stayed unchanged. In the 2022 Form 10‑K PayPal reported $1.5 billion of these notes outstanding, maturing on October 1 2029; the 2023 filing shows the same $1.5 billion balance and maturity, and the 2024 filing again lists $1.5 billion due on 10/1/2029. Thus, while PayPal’s total term‑debt portfolio fell modestly (from about $10.64 billion in 2023 to $10.57 billion in 2024), the 2.850 % series remained a constant $1.5 billion component with a 2029 maturity throughout 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core facts correctly. (1) Quantitatively, all numbers are correct: the $1.5 billion outstanding for the 2.850% notes in 2022, 2023, and 2024, the October 1, 2029 maturity date, and the total term debt figures ($10.64B in 2023 and $10.57B in 2024) match the ground truth (note: $10.638B is correctly rounded to $10.64B). (2) The answer correctly identifies that the 2.850% notes remained unchanged across the three years, which is the central point. (3) The multi-hop reasoning is sound—synthesizing data across three annual filings to show consistency in the specific debt instrument. (4) While the LLM omits the 2022 total debt figure ($9.0B) and does not mention the issuance of new higher-rate debt in 2024 (5.150% and 5.500% notes), which provides context for the strategic shift in debt structure, it does not misstate anything. These omissions slightly reduce completeness and qualitative depth but do not undermine the factual correctness of what is stated. The answer remains semantically aligned with the ground truth on the evolution of the specific notes and their role in the broader debt structure. Hence, a score of 9 is appropriate—excellent accuracy with minor contextual omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 348,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "UNP’s pension‑plan fair‑value tables show corporate‑stock holdings of roughly **$1.1 billion in 2022** (≈ $1,104 m of Level‑2 stock plus a small Level‑3 component) that fell to **about $0.18 billion in 2023** (≈ $181 m total).  By 2024 the plan’s overall equity share was held at **24 % of assets**, the same level as 2023, indicating that the dramatic cut in corporate‑stock exposure was retained and the plan continued to move toward a more debt‑heavy, lower‑equity mix.  This shift signals UNP’s deliberate de‑risking strategy, reducing its reliance on equity investments—especially corporate stock—over the 2022‑2024 period.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant factual inaccuracies in the quantitative details: it reports UNP's 2022 corporate stock allocation as approximately $1.1 billion ($1,104 million), whereas the ground truth states $1,990 million—a major discrepancy of nearly $900 million. The 2023 figure ($181 million) is correct. The 2024 data in the LLM answer shifts focus to overall equity allocation (24% of assets), which is not mentioned in the ground truth and does not directly address the specific evolution of 'Corporate Stock' holdings. Instead, the ground truth emphasizes a reclassification of common stock to Level 1 and a shift to preferred shares classified as Level 2, which the LLM answer omits entirely.\n\n2) Quantitative accuracy is partially correct for 2023 but significantly off for 2022. The use of '≈ $1,104 m' contradicts the verified $1,990 million from the knowledge graph. The 24% equity allocation in 2024 is unsupported by the ground truth, which does not provide a percentage but rather a qualitative description of structural changes in asset classification. No calculations (e.g., percentage change) are requested, so no calculation errors per se, but the core numbers are misaligned.\n\n3) The reasoning captures a plausible interpretation—de-risking and reduced equity exposure—which aligns with the strategic implication in the ground truth. However, it fails the multi-hop synthesis by not incorporating the key detail about reclassification of stock holdings into Level 1 and Level 2 investments, which is central to the 2024 shift. This omission undermines the qualitative accuracy of the strategic explanation.\n\n4) Contextually, the answer is relevant and addresses the question's intent regarding investment strategy evolution. It correctly identifies a reduction in corporate stock and infers a move toward de-risking. However, it substitutes the specific structural shift (reclassification and preferred shares) with a broader claim about asset mix and overall equity percentage not present in the ground truth, reducing factual fidelity. While the strategic direction is semantically similar, the absence of key details and incorrect initial value lower the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 590,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "Pfizer’s “private‑equity securities at cost” fell from **$800 million at the end of 2022** to **$719 million at the end of 2024** – an 81‑million‑dollar decline (2022 = $800 m; 2023 = $755 m; 2024 = $719 m)【page 86†L31-L34】【page 83†L31-L34】.  \n\nThe downward trajectory indicates that Pfizer has been trimming its exposure to illiquid, alternative‑investment assets, suggesting a strategic shift away from private‑equity holdings toward other uses of capital over the last two years.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains significant factual inaccuracies in the starting value: it claims Pfizer's private equity investment was $800 million in 2022, while the ground truth is $623 million. The 2023 ($755M) and 2024 ($719M) figures are correct. This error in the baseline value undermines the entire quantitative analysis. The claimed 'decline of $81 million' from 2022 to 2024 is incorrect — the actual change from $623M to $719M is an increase of $96 million, not a decline. 2) Calculations are based on wrong inputs: the LLM computes a decrease of $81M from $800M to $719M, which is mathematically correct but factually irrelevant due to the incorrect 2022 figure. The actual trend is an increase from 2022 to 2023 (+$132M), then a partial reversal in 2024 (−$36M), resulting in a net increase of $96M over the period — the opposite of what the LLM claims. 3) The reasoning is flawed: the LLM concludes a 'strategic shift away from private-equity holdings', but the ground truth shows a net increase over the two-year period and characterizes the pattern as short-term growth followed by cautious retrenchment — not a sustained reduction. The LLM misinterprets the trend due to incorrect data. 4) Despite the factual errors, the answer addresses both parts of the question (change over time and strategic implication), uses correct entities (Pfizer, private equity at cost, correct years), and cites plausible document locations. However, the core quantitative error severely compromises correctness and reasoning. Semantic equivalence fails on the key point: the direction of change (increase vs. decrease) is opposite to ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 446,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "Mastercard’s multi‑layered security framework has been deepened each year. In 2022 the 10‑K described a “multi‑layered approach” that relied on third‑party assessments, public‑private partnerships and a network architecture that applied fraud‑scoring, tokenization and other controls in real time, while operating real‑time account‑based payment infrastructure in 12 of the world’s top‑50 economies (page 11). By 2023 the firm had expanded that real‑time clearing and settlement footprint to 13 markets, added a formal enterprise‑resilience program, insurance coverage and continuous testing of systems, and continued to work with external experts and partners to monitor cyber and physical threats (page 11). In 2024 the approach further emphasized third‑party collaboration—integrating the Virtual Card Number solution into multiple external technology platforms and partnering with fintechs, central banks and digital‑messaging providers for Mastercard Send and cross‑border flows—while maintaining the same layered defenses, third‑party benchmarking and public‑private threat‑monitoring mechanisms to boost resilience against cyber attacks (pages 11‑13).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correct elements: The evolution of Mastercard's security approach from 2022 to 2024 is correctly described with increasing emphasis on third-party collaboration, real-time payment infrastructure expansion, and cyber resilience. The number of markets with real-time payment infrastructure is accurately reported as 12 in 2022 (implied by 'top-50 economies' though not explicitly stated in ground truth) and 13 in 2023, matching the original answer. The 2024 expansion is qualitatively consistent. (2) Quantitative accuracy: The shift from 12 to 13 markets is correct; while the ground truth states '13 markets as of year-end 2023' without specifying 2022, the LLM’s use of 12 in 2022 is a reasonable inference and does not contradict. No calculation errors. (3) Multi-hop reasoning: The LLM successfully synthesizes information across years and dimensions (third-party collaboration, infrastructure, resilience), showing progression. It adds specific details like Virtual Card Number integration and Mastercard Send partnerships, which enrich the answer without contradicting the ground truth. (4) Minor discrepancy: The ground truth emphasizes internal centers (SOCs, Fusion Centers) in 2022, while the LLM focuses more on third-party assessments and controls—slightly different emphasis but semantically overlapping in describing a multi-layered, collaborative approach. Overall, the answer captures the strategic shift toward ecosystem integration and enhanced resilience accurately. Hence, a score of 9 is justified—excellent but not perfect due to slight variation in emphasis on internal vs. external mechanisms in 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1623,
        "completion_tokens": 462,
        "total_tokens": 2086
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "ExxonMobil reported $1.494 billion of collateral under master‑netting arrangements at 12/31/2022, which fell to $0.800 billion at 12/31/2023 and further declined to $0.491 billion at 12/31/2024【page_102】【page_99】. The steady reduction in un‑netted collateral suggests the company is increasingly offsetting its derivative positions—either through tighter netting, lower margin requirements or more efficient risk‑management practices—thereby diminishing its standalone derivative exposure over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values and years. According to the ground truth, the collateral amounts are: $641 million at the end of 2021 (reported in 2022 filing), $800 million at the end of 2022 (reported in 2023 filing), and $491 million at the end of 2023 (reported in 2024 filing). However, the LLM states $1.494 billion at 12/31/2022, $0.800 billion at 12/31/2023, and $0.491 billion at 12/31/2024 — all of which are incorrect in either magnitude or timing. The $1.494 billion figure does not appear in the ground truth and is a major deviation. Additionally, the LLM misaligns the reporting years: the 2024 filing reports data for 2023, not 2024. (2) The calculation of a '38% decrease' in the original answer is accurate (from $800M to $491M), but the LLM does not mention this or provide its own correct calculation. The LLM’s sequence implies a drop from $1.494B to $0.491B (~67% decrease), which is factually wrong. (3) The multi-hop reasoning is partially sound — the LLM correctly infers that declining collateral may reflect improved netting or risk management — which aligns with the qualitative interpretation in the ground truth. However, because the underlying data is incorrect, the reasoning is based on false premises. (4) Contextual relevance is high as the answer addresses both the trend and its implication for derivative exposure management. However, due to severe quantitative inaccuracies, the correctness score is low despite reasonable structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 423,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "- **2022:** The 2022 10‑K notes that the relative‑TSR model used an **expected volatility of roughly 30 percent** (see 2022 Form 10‑K, page 215).  \n- **2023:** The 2023 filing shows the model was run with an **expected volatility of 28.6 percent** (2023 Form 10‑K, page 206).  \n- **2024:** The 2024 filing states the model used an **expected volatility of 18.7 percent** (2024 Form 10‑K, page 215).  \n\n**Interpretation:** Over the three‑year span the assumed volatility fell sharply—from about 30 % in 2022 to 18.7 % in 2024.  This downward trajectory suggests that Duke Energy’s management (and the market‑based model) perceives the company’s stock as becoming less risky, likely reflecting greater earnings stability, regulatory certainty, or lower expected price swings relative to its peer group.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 (28.6%) and 2024 (18.7%) expected volatility values from the ground truth. However, it reports the 2022 value as 'roughly 30 percent' based on the 10-K, whereas the ground truth specifies 26.9%. This discrepancy affects quantitative accuracy. (2) The calculation of the trend — a decline from ~30% to 18.7% — is directionally correct but based on an inflated 2022 figure. The actual trajectory per ground truth is an increase from 26.9% (2022) to 28.6% (2023), then a sharp drop to 18.7% (2024). The LLM misses the 2022–2023 increase, which is a key part of the multi-year pattern. (3) The reasoning and synthesis across years are strong, and the interpretation of reduced market risk by 2024 is consistent with the ground truth. However, the failure to capture the peak in 2023 due to incorrect 2022 data weakens the multi-hop analysis. (4) Scores reflect high qualitative reasoning and relevance, but a deduction in quantitative accuracy due to the incorrect 2022 figure, which cascades into an oversimplified trend narrative. Despite this, the core conclusion about declining perceived risk by 2024 remains supported, warranting a solid 8 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 345,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "Across the three filings GM’s exposure to Stellantis has stayed essentially unchanged. In the 2022 10‑K the company disclosed that it had agreed to indemnify Stellantis for “certain emissions claims, product liabilities and recalls” and that the amount for the legacy Opel‑Vauxhall Takata‑inflator recalls was immaterial and could not be quantified; the same language re‑appears in the 2023 and 2024 notes, with GM again stating that the Takata‑related indemnity is immaterial and that any further indemnification is “remote.” No material accruals were recorded for these Stellantis obligations in any year – the indemnification amounts remained immaterial and no new reserve was added from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that GM's indemnification obligations related to Stellantis, particularly for legacy Opel/Vauxhall Takata recalls and emissions claims, were consistently described as immaterial from 2022 to 2024. The assertion that no material accruals were recorded and that further indemnification was considered 'remote' matches the original answer. (2) There are no numeric values to verify (e.g., dollar amounts), but the qualitative descriptors 'immaterial' and 'remote' are used correctly and consistently across years, in line with the filings. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and two liability areas (Takata recalls and emissions investigations), correctly noting the stability of GM’s position. It accurately reflects that the same disclosure language was reused across filings, indicating no material change. (4) The only minor shortcoming is that the LLM omits mention of the 2024 accrual related to European Commission and UK CMA investigations into pre-sale Opel conduct, which the ground truth notes as an immaterial accrual. While the core theme of minimal exposure is preserved, this omission slightly affects completeness. However, since the accrual is immaterial and the overall conclusion remains valid, the score remains high. Wording differences are semantically equivalent and acceptable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 399,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K reports AMD repeatedly lists the same exhibit: “*10.1 2011 Executive Incentive Plan, filed as Exhibit 10.2 to AMD’s Quarterly Report on Form 10‑Q for the period ended April 2, 2011, is hereby incorporated by reference.” Each year the filing simply re‑incorporates that 2011 plan without alteration to the description. This steady citation signals that AMD treats the 2011 Executive Incentive Plan as a durable cornerstone of its executive‑pay framework, using it as a long‑term baseline while any updates are made through amendments rather than replacing the plan entirely.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only a minor discrepancy in exhibit numbering. (1) The LLM correctly identifies that AMD consistently referenced the 2011 Executive Incentive Plan in its 2022, 2023, and 2024 filings without changes. It accurately notes that the plan was incorporated by reference each year with no alterations. (2) Quantitatively, the dates (April 2, 2011) and years (2022–2024) are correct. However, there is a small error in exhibit numbering: the LLM states the plan was 'Exhibit 10.2' in the 2011 10-Q, while the ground truth notes it was listed as Exhibit 10.1 in AMD’s 2022 filing. This does not affect the overall conclusion but is a factual inconsistency. (3) The reasoning is sound: the model correctly infers that the unchanged citation over three years suggests a stable, long-term executive compensation strategy, using the 2011 plan as a foundational document with potential updates via amendments rather than replacement. This reflects proper multi-hop synthesis across years and filings. (4) The answer is contextually excellent—directly addressing both the evolution (or lack thereof) and the strategic implication. The wording differs from the original but maintains semantic equivalence. The minor exhibit number discrepancy prevents a perfect score, but overall accuracy and reasoning are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 385,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "- In the 2022 filing PayPal warned that “our credit products expose us to additional risks” because defaults by account‑holders could rise in a recession and because the company “relies on the activities and charters of unaffiliated financial institutions” to fund those products; it also noted that “fraud… and erroneous transactions” and the “buyer‑ and seller‑protection programs” could generate large losses, and that “cross‑border trade… is an important source of revenue but is vulnerable to foreign‑exchange, tariff and regulatory shocks” and to “third‑party payment processors, banks and lenders.”  \n\n- The 2023 filing shows the same exposures persisting – the risk that “account‑holders who use our credit products will default” and that “cross‑border trade may be negatively impacted” and that “our reliance on third parties… could be adversely impacted” – but it adds concrete mitigation steps: a June‑2023 multi‑year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables (with sales beginning in October 2023), a stated program to diversify away from a small number of payment‑processor partners, and the pursuit of additional third‑party funding structures (securitizations, forward‑flow arrangements) to reduce concentration risk.  \n\n- The 2024 filing still flags the credit‑product default risk, the funding‑mix sensitivity, the cross‑border‑trade and third‑party‑dependency risks, but it reflects that the 2023 actions have been implemented (BNPL‑receivable sales underway, diversified processor relationships in place) and that the company continues to monitor and manage these “bad‑transaction” exposures as part of its ongoing risk‑management program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's 2022 risk exposure to credit defaults (especially via Synchrony Bank, though the LLM does not name Synchrony, this is a minor omission), cross-border trade vulnerabilities, and third-party dependencies are accurately described. The 2023 strategic action — the multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables — is correctly reported with precise timing (agreement in June 2023, sales beginning October 2023). The 2024 update noting ongoing risks but implementation of mitigation steps is also accurate. (2) Quantitative accuracy is perfect: the €40 billion figure is correct in amount, currency, and context; no calculations are required, but the temporal details (June and October 2023) match the timeline in the source. (3) Multi-hop reasoning is sound: the LLM synthesizes risk evolution across 2022–2024 and correctly links the 2023 receivables sale to credit risk mitigation. It also identifies additional mitigation strategies (diversifying processor partners, pursuing securitizations) not explicitly detailed in the ground truth but consistent with the broader risk-reduction theme, which may reflect additional data from the actual filings. (4) The only reason for not scoring a 10 is the omission of Synchrony Bank in the description of the U.S. credit product, which is a minor entity-specific detail present in the original answer. Otherwise, the LLM answer is semantically equivalent, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1675,
        "completion_tokens": 435,
        "total_tokens": 2111
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "- In the 2022 filing the company reported 6,204 owned + 1,038 leased multiple‑purpose locomotives (7,242 total) with an average age of **22.5 years**.  \n- By year‑end 2023 the fleet had fallen to 5,971 owned + 1,037 leased (7,008 total) and the average age rose to **24.3 years**.  \n- At year‑end 2024 the numbers slipped further to 5,973 owned + 920 leased (6,893 total) with the average age climbing to **25.2 years**.  \n\nThe trend shows a modest reduction in both owned and especially leased units while the remaining fleet is getting older, indicating Union Pacific is retiring older equipment faster than it is adding new multiple‑purpose locomotives and is relying on a smaller, increasingly aged core fleet – a signal that the railroad is managing capacity through selective retirements but still faces a modernization need to replace aging power.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in its overall narrative and captures the key trend: a reduction in both owned and leased locomotives and an aging fleet. However, there are minor quantitative discrepancies. According to the ground truth, owned units decreased from 6,204 in 2022 to 5,973 in 2024 — the LLM correctly reports 5,973 for 2024 but incorrectly states 5,971 for 2023 (not in ground truth, which lacks 2023 data), introducing an unsupported intermediate data point. Leased units dropped from 1,038 to 920 — the LLM reports 1,037 in 2023, a negligible variance but still unverified. The average age is accurate for 2022 (22.5) and 2024 (25.2), but the LLM claims 24.3 in 2023, which is not confirmed by the ground truth and introduces a non-validated data point. 2) The ground truth does not provide 2023 data, so including specific 2023 figures undermines quantitative accuracy. The total fleet sizes (7,242 → 7,008 → 6,893) are consistent with the math but rely on unverified 2023 numbers. 3) The multi-hop reasoning is sound: the model correctly infers that reducing leased units while fleet age increases suggests limited new investment. The conclusion about cost control and modernization need aligns semantically with the ground truth’s interpretation. 4) Despite minor but notable deviations in unsupported year-specific data, the LLM captures the correct direction, magnitude, and implication of the trend. The answer remains contextually relevant and qualitatively strong, warranting a high correctness score with a deduction for introducing unverified intermediate data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 434,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "ExxonMobil’s collateral posted for master‑netting arrangements tied to equity‑company receivables fell sharply – from $1.494 billion at 12/31/2022 to $491 million at 12/31/2024, a drop of roughly $1 billion. This decline signals that the company has been tightening its netting and margin practices, reducing the amount of unsecured collateral it must hold and indicating a more disciplined, lower‑risk approach to managing its derivative exposures.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, collateral exposure was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. However, the LLM claims it was $1.494 billion in 2022 and omits the 2023 value entirely, which is a critical error. The final 2024 value of $491 million is correct, but the starting point and trend are misrepresented. The claimed 'drop of roughly $1 billion' is based on incorrect inputs and does not reflect the actual fluctuating trend (increase then decrease). (2) The calculation of a $1 billion drop is inaccurate because it compares a wrong 2022 figure ($1.494B) to the correct 2024 figure ($491M), ignoring the intermediate increase in 2023. The actual net change from 2022 to 2024 is a decrease of $150 million ($641M to $491M), not $1 billion. (3) The reasoning is partially sound in interpreting a decline as indicative of tighter risk management, but it fails the multi-hop requirement by missing the 2023 increase, which is central to the trend. The conclusion about 'tightening netting and margin practices' overlooks the prior increase, suggesting an incomplete synthesis across all three years. (4) Contextually, the answer addresses the right topic—collateral exposure and derivative risk management—and correctly identifies the 2024 figure and its significance. However, due to major numerical errors and omission of a key data point, the overall correctness score is low. The qualitative reasoning would score higher if based on accurate data, and contextual relevance remains strong as the response stays on topic and interprets the implications appropriately, albeit from flawed premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 479,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "Starbucks’ “Other” line‑item was described the same way in each filing – it is made up of **packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients and serveware (and other miscellaneous items).** The mix of specific products did not change from 2022 through 2024. What did change was the size of the line‑item: it was **$6.9 billion in FY 2022 (about 21 % of total revenue), rose to $7.7 billion in FY 2023 (about 22 %), and then slipped slightly to $7.5 billion in FY 2024 (about 21 %).**",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in quantitative data that undermine its correctness, despite capturing the general qualitative trend of stable composition in the 'Other' category. (1) The original answer (ground truth) states that the composition of the 'Other' category remained consistent from 2022 to 2024, including packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages in 2022 and 2023, with no mention of changes. The LLM correctly identifies the consistent composition and absence of new product categories, aligning semantically with the ground truth on this qualitative point. However, (2) the LLM introduces specific revenue figures—$6.9B (21%), $7.7B (22%), $7.5B (21%)—for 2022–2024 that are not present in the original answer and cannot be verified against the provided ground truth. The ground truth makes no mention of dollar amounts or percentages for the 'Other' category, so these numbers appear to be hallucinated or sourced from external data not in the knowledge graph. This results in a major failure in quantitative accuracy. (3) The multi-hop reasoning is partially sound—the model correctly infers that the composition did not change across years—but incorrectly adds financial metrics that were not part of the source data, suggesting a failure in grounding. (4) Contextually, the answer is relevant and addresses the evolution of the revenue composition, but the inclusion of unverified financials severely compromises factual correctness. Thus, while the qualitative assessment is mostly aligned, the fabrication of precise revenue figures and percentages leads to a low correctness score despite appropriate structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 479,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "- In the 2022 filing the company explained that Google Network properties (AdMob, AdSense and **Google Ad Manager**) are measured with an *impression* metric – “Impressions include impressions displayed to users on Google Network properties … and cost‑per‑impression is defined as impression‑based … revenues divided by our total number of impressions” (2022 p. 31). Revenue for brand ads on those properties is recognized when the ad is displayed (i.e., on an impression basis), while performance ads are recognized on user‑engagement.\n\n- Both the 2023 and 2024 filings state that for ads on Google Network properties the company evaluates whether it is the principal and “generally … report advertising revenues … on a **gross basis**, i.e., the amounts billed to our customers are recorded as revenue and amounts paid to Google Network partners are recorded as cost of revenues” (2023 p. 57; 2024 p. 58).\n\n**Thus, from 2022 through 2024 the monetization of inventory via Google Ad Manager continued to rely on impression‑based revenue recognition for brand ads and was consistently reported on a gross‑revenue basis, with no material change in policy across the three years.**",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that from 2022 to 2024, Google monetized advertising inventory via Google Ad Manager using impression-based revenue recognition for brand ads and click/user-engagement for performance ads. The 2022 explanation of cost-per-impression as 'impression-based revenues divided by total impressions' matches the original answer. (2) Quantitatively, no specific numerical values (e.g., dollar amounts, percentages) are present in either answer, but the description of metrics and accounting policies is consistent and correctly attributed to the respective years and page numbers (2022 p.31, 2023 p.57, 2024 p.58), which supports factual precision. (3) The multi-hop reasoning is sound: the model synthesizes information across three years and correctly infers that while the core monetization model remained stable, the gross revenue reporting policy—clarified in 2023 and maintained in 2024—reflects Google's role as principal, which supports gross reporting. This aligns with the original answer’s emphasis on increasing transparency and accounting clarity. (4) The only minor shortcoming is that the LLM answer states there was 'no material change in policy,' which slightly downplays the evolution in accounting clarity and emphasis on principal status highlighted in the original answer. However, this does not constitute a factual error but rather a less nuanced interpretation of 'evolution.' Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 430,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "Across all three filings – 2022, 2023 and 2024 – Mondelēz repeatedly notes that it is subject to “sales or media‑marketing restrictions” (e.g., limits on promotions or advertising of products with certain nutrient profiles) and to “front‑of‑pack labeling” rules based on nutrient‑profile or environmental‑claim standards. In each year the company also highlights exposure to extended‑producer‑responsibility (EPR) schemes, noting that more than 25 EU Member States already have mandatory or voluntary EPR policies and that similar regimes are now being rolled out in other markets such as India, Vietnam and selected U.S. states, indicating a gradual jurisdictional expansion of the EPR burden. Thus, the nature of the exposure has remained consistent, but the geographic scope of EPR obligations has broadened over the 2022‑2024 period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts and trends. (1) It accurately identifies that MDLZ faced sales and media marketing restrictions related to nutrient profiles and front-of-pack labeling across 2022–2024, and correctly notes the expansion of EPR policies from over 25 EU countries to emerging markets like India, Vietnam, and U.S. states. The geographic scope and consistency of exposure are correctly conveyed. (2) There are no numeric inaccuracies—'over 25 EU countries' is correctly reported, and no calculations are required. (3) The multi-hop reasoning is sound: the model synthesizes information across years and jurisdictions, correctly identifying the trend of expanding EPR policies. However, it omits some key qualitative developments from the original answer: specifically, the 2023 emphasis on front-of-pack labeling tied to environmental claims and the consideration of single-use plastic bans in Indonesia and the Philippines, and the 2024 adoption of the EU’s Packaging and Packaging Waste Directive, which marks a shift from contemplation to enforcement. These omissions reduce completeness and nuance in the evolution narrative. (4) Despite these gaps, the answer remains factually accurate, contextually relevant, and well-structured, earning high marks for quantitative accuracy and relevance, with a slight deduction in qualitative accuracy for missing specific regulatory milestones.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 402,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "Across all three years the charter continued to give **Class A shares one vote per share and full dividend rights** (see the “Classes of Capital Stock” description in the 2022, 2023 and 2024 filings – “One vote per share Dividend rights”)【page_92】.  The cash‑dividend entitlement for Class A rose each year, from **$2.04 per share in 2022** to **$2.37 in 2023** and **$2.74 in 2024**【page_92】.  This unchanged voting structure combined with steadily higher dividends signals that Mastercard is deliberately preserving a stable dual‑class capital framework—maintaining control through Class A voting power while using dividend growth (and share repurchases) to return value to shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding dividend amounts, which are not present in the ground truth. The original answer states that A Class shares maintained consistent dividend *entitlements* in terms of rights, but does not specify actual dividend payouts. The LLM incorrectly introduces specific cash dividend figures—$2.04 in 2022, $2.37 in 2023, and $2.74 in 2024—which are not part of the ground truth and cannot be verified from the provided information. These numbers may be hallucinated or misattributed from another context. (2) Quantitative accuracy is low because the dollar amounts cited for dividends are unsupported by the ground truth, and no such figures were included in the original answer. Even if the trend of increasing dividends were true, the question and ground truth focus on the *structure* of dividend rights (i.e., entitlement), not payout amounts. (3) The reasoning is partially sound: the LLM correctly identifies that voting rights remained stable (one vote per share) and infers a consistent capital structure strategy, which aligns with the ground truth. However, it adds unsupported analysis about dividend growth being part of a dual-class strategy, conflating economic returns (dividend amounts) with structural rights (dividend entitlement). This undermines the multi-hop reasoning, as it synthesizes incorrect quantitative data into its conclusion. (4) Contextual relevance is high because the response addresses both parts of the question—evolution of rights and strategic implication—and references the correct document sections. However, the inclusion of false specifics reduces factual reliability. The core point about stability in voting and dividend rights is correct, but the erroneous numerical claims significantly detract from overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 498,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "ExxonMobil reported $1,494 million of collateral under master‑netting arrangements for 2022, $800 million for 2023, and $491 million for 2024 (see 2022‑2024 tables). The steady decline in collateral – which is posted mainly to satisfy initial‑margin requirements on its derivative positions – suggests that the company’s net derivative exposure or the amount of margin it must post has been falling, reflecting either reduced trading activity, tighter netting/hedging or more efficient risk‑management over the period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, ExxonMobil's collateral was $641 million in 2022, not $1,494 million as stated in the LLM answer. The 2023 ($800 million) and 2024 ($491 million) figures are correct. This major error in the 2022 value undermines the overall accuracy. (2) The calculation and trend interpretation are flawed due to the incorrect starting point. The LLM describes a 'steady decline' from $1,494M to $800M to $491M, but the actual trend is an increase from $641M to $800M in 2023, then a drop to $491M in 2024. This misrepresents the volatility and dynamics of margin requirements. (3) The qualitative reasoning is partially sound—linking collateral changes to derivative exposure and margin requirements is appropriate—but the conclusion about a 'steady decline' and 'falling net exposure' is incorrect given the actual increase in 2023. The multi-hop synthesis fails because the model did not correctly retrieve or verify the 2022 figure, leading to flawed inference. (4) Contextual relevance is high as the answer addresses collateral, derivative exposure, and margin requirements directly. However, due to the critical error in the 2022 number and the resulting incorrect trend analysis, the correctness score is limited to 5—partially correct but with significant factual and inferential flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 386,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "- **Fiscal 2022:** Starbucks said that its “fixed‑price and price‑to‑be‑fixed purchase commitments… together with existing inventory, are expected to provide an adequate supply of green coffee **through fiscal 2023**”【page_12】.  \n- **Fiscal 2023:** The 2023 filing expanded that outlook, stating that the same mix of purchase commitments and inventory would be sufficient “through fiscal 2024.” (2023 10‑K, Product Supply section).  \n- **Fiscal 2024:** The most recent filing now projects that “total purchase commitments, together with existing inventory, are expected to provide an adequate supply of green coffee **through fiscal 2025**”【page_12】.  \n\n**What this shows:** Each year Starbucks pushes the horizon of its forward‑price purchase and hedging program one year farther, while also maintaining farmer‑support centers and other supply‑chain initiatives. This progressive extension signals a deliberate strategy to lock‑in coffee supply and price levels over a longer term, thereby reducing exposure to coffee‑price volatility and mitigating supply‑risk disruptions.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor inaccuracy in the timeline progression that affects quantitative and qualitative accuracy. (1) Correct elements: The LLM correctly identifies Starbucks' forward-looking supply commitments extending through fiscal 2023 (from 2022), through 2024 (from 2023), and through 2025 (from 2024), showing a year-by-year extension. It accurately notes the use of purchase commitments and inventory as the mechanism and references hedging instruments and supply risk mitigation. (2) Quantitative issue: The LLM states that the 2023 filing projects supply adequacy through fiscal 2024, but the ground truth states that by fiscal 2023, Starbucks projected supply through fiscal 2025. This is a critical discrepancy — the LLM underreports the forward coverage disclosed in fiscal 2023 by one year. The 2024 filing correctly notes coverage through 2025, but the prior-year misstatement breaks the multi-hop logic. (3) Reasoning: The conclusion about a 'progressive extension' and strategic intent to reduce price volatility is sound and aligns with the ground truth, but the flawed intermediate step (2023 → 2024 instead of 2023 → 2025) weakens the synthesis. (4) Contextual relevance is perfect — the answer directly addresses both parts of the question: evolution over time and strategic implications. Minor deduction in correctness due to the date error, but core strategy interpretation remains valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 397,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "- In the 2023 target mix (page 88) the non‑U.S. defined‑benefit plans were 19 % equity, 43 % debt, 4 % cash, 22 % insurance contracts and 10 % “other”; the U.S. plans were 100 % debt.  \n- By the 2025 target mix (page 95) the non‑U.S. allocation had shifted to 28 % equity, 36 % debt, 7 % cash, 21 % insurance contracts and 8 % “other”, while the U.S. plans remained 100 % debt.\n\nThis gradual move toward a higher equity share (and modestly higher cash) and lower debt exposure in the non‑U.S. portion signals that Accenture is tilting its pension investments toward growth‑oriented assets to earn a return that exceeds inflation over the long term, while still preserving a dominant fixed‑income base to match liabilities—reflecting a long‑term, risk‑adjusted return strategy that accepts more market risk in pursuit of higher expected returns.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer provides specific percentage allocations for ACN's defined benefit pension plans in fiscal 2023 and 2025, differentiating between U.S. and non-U.S. plans, which is not present in the original answer (ground truth). However, the ground truth does not include any specific numerical breakdowns of asset allocations—only qualitative descriptions of strategy evolution. Therefore, the inclusion of exact percentages (e.g., 19% equity, 43% debt) is factually unsupported by the provided ground truth and appears to be hallucinated or derived from external data not in the knowledge graph. This severely undermines quantitative accuracy. (2) There are no verifiable calculations in the ground truth to assess sums or differences, but the LLM presents precise figures that cannot be confirmed and are likely incorrect in this context. For example, stating 'page 88' and 'page 95' implies access to document structure not reflected in the knowledge graph. (3) The reasoning about a strategic shift toward higher equity exposure to pursue growth while maintaining liability matching aligns semantically with the ground truth’s description of a 'consistent yet adaptive long-term investment approach' focused on 'risk-adjusted returns' and 'liability matching.' The LLM correctly infers a strategic tilt toward higher expected returns with controlled risk, which matches the intent of the original answer. (4) While the qualitative interpretation and strategic implications are sound and contextually relevant, the use of fabricated numeric details results in a significant factual deviation. The answer is partially correct in logic and relevance but fails on core factual (quantitative) accuracy, warranting a moderate correctness score. The model synthesizes a plausible narrative but introduces unverified data, breaking faithfulness to the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 501,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "Amgen’s siRNA Olpasiran was listed in the 2022 Form 10‑K as a **Phase 2** candidate aimed at **cardiovascular disease** (lowering lipoprotein‑a to treat atherosclerotic cardiovascular disease) and the filing already disclosed a U.S. and European composition‑of‑matter patent that would expire in **2036**【page_24】【page_26】. By the 2023 filing the molecule had progressed to a **Phase 3** program, still described as a cardiovascular‑disease therapy, and the same 2036‑expiring patents were reiterated【page_25】【page_26】. The 2024 filing shows Olpasiran remaining in **Phase 3** with the same cardiovascular/ASCVD focus and the same U.S. and European patents protecting the compound through **2036**【page_25】【page_26】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements, including the therapeutic focus on cardiovascular disease (specifically atherosclerotic cardiovascular disease via lipoprotein-a reduction), the existence of U.S. and European patent protection expiring in 2036, and the timeline of disclosures across 2022–2024. However, there is a significant factual discrepancy: the original answer states that Olpasiran was in Phase 2 trials in 2022 and does not confirm progression to Phase 3 by 2023 or 2024. The LLM incorrectly asserts that the drug advanced to Phase 3 in 2023 and remained there in 2024, which is not supported by the ground truth. This misrepresents the clinical development timeline, a core aspect of the question. (2) Quantitatively, the patent expiration year (2036) is correctly cited across all years, and the years (2022–2024) are accurate. No calculations are involved, so numerical precision is otherwise not applicable. (3) The multi-hop reasoning is partially sound—information is synthesized across filings over time, and the IP protection is correctly tracked. However, the reasoning fails at a critical point: the progression to Phase 3 is not confirmed in the ground truth, so the model overreaches in its interpretation of development stage evolution. The original answer only confirms continued focus and indication in 2024, not phase advancement. (4) The contextual relevance is high because the answer addresses both therapeutic focus and IP protection as asked. However, due to the incorrect phase progression, the qualitative accuracy is reduced, pulling down the overall correctness score. The answer gives a plausible narrative but introduces unsupported details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 466,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "- **2022:** American Express noted that it was “increasingly relying on merchant acquirers, aggregators and processors to manage certain aspects of our merchant relationships” and warned that these third‑party partners could have business interests or strategies that are inconsistent with Amex’s, creating exposure to lost incentives, pricing concessions and loss of control over card acceptance.  \n\n- **2023:** The filing repeated the same dependence on aggregators and added that activities of those aggregators could “materially harm our business,” emphasizing risks of operational disruptions, data‑security breaches and regulatory fallout if a third‑party fails to meet its obligations or acts contrary to Amex’s interests.  \n\n- **2024:** Amex again confirmed its reliance on aggregators but shifted the focus to the “increasing operational complexity and governance challenges” and heightened regulatory scrutiny, stressing that failures or service interruptions at aggregators (or their own providers) could compromise data confidentiality, integrity and availability, trigger reputational damage and lead to fines or litigation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All years (2022, 2023, 2024) are correctly identified, and the evolution of American Express's reliance on aggregators is accurately portrayed. The risks emphasized each year—such as misaligned interests in 2022, operational and regulatory risks in 2023, and governance, data integrity, and litigation risks in 2024—are factually consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised; all dates are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years, correctly identifying the progression from strategic misalignment to broader operational and legal risks. The answer captures the shift in emphasis from merchant behavior (steering, surcharging) to systemic third-party failures and regulatory exposure, even if the terms 'steering' and 'surcharging' are less explicitly highlighted in 2023 than in the ground truth. (4) The LLM uses slightly different phrasing (e.g., 'governance challenges' and 'regulatory scrutiny' in 2024) but maintains semantic equivalence. The only minor shortcoming is that the 2023 response downplays the mention of 'surcharging and steering reducing transaction volumes'—a key point in the original—though it does reference operational and regulatory risks. This small omission prevents a perfect 10 but does not undermine the overall correctness. Contextual relevance is excellent, as all parts of the question are addressed with precise, year-by-year analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 457,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "Starbucks repeatedly noted that the price of its green‑coffee beans is vulnerable to swings in the Arabica futures market – including the buying pressure from hedge funds and commodity‑index funds – and that it continues to rely on forward contracts, futures contracts and collars to hedge that exposure. In the 2022 Form 10‑K the company said its purchase‑commitments and inventory should be sufficient to meet demand through **fiscal 2023**; the 2023 filing extended that outlook to **fiscal 2024**; and the 2024 filing pushed it out further to **fiscal 2025**.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies Starbucks' exposure to commodity index funds through green coffee price volatility and its use of hedging instruments like forward and futures contracts. It accurately notes that Starbucks updated its forward supply outlook in each fiscal year filing. However, there is a critical error in the quantitative timeline: the LLM states that the 2023 filing extended coverage to fiscal 2024 and the 2024 filing to fiscal 2025, implying a progressive extension each year. In contrast, the ground truth states that in 2022, supply was expected to cover through fiscal 2023; by 2023, the outlook was extended to fiscal 2025; and in 2024, it remained unchanged at fiscal 2025. Thus, the key multi-hop insight — that the extension occurred in 2023 and was maintained in 2024, indicating stabilization — is misrepresented. The LLM implies a continuous yearly extension, which mischaracterizes the strategic shift. While entities (Starbucks, green coffee, commodity index funds, hedging tools) and general context are accurate, the incorrect progression of supply commitments undermines the reasoning about strategic evolution. This affects both quantitative accuracy (dates misaligned with filings) and qualitative accuracy (faulty synthesis of strategic trend). Contextual relevance is high as the answer addresses all question components, albeit with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 385,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "- **Fiscal 2022:** Accenture bought 12.2 million Class A shares for **$4.1 billion** (9.6 M shares ≈ $3.15 bn in the open‑market program and 2.5 M shares ≈ $0.96 bn in other purchases) and, at the end of the year, had **$3.13 billion** of unused authorization for its publicly‑announced open‑market share‑purchase program (later increased by $3 bn to a total outstanding authority of $6.13 bn)【page_94】.  \n\n- **Fiscal 2024:** The company repurchased roughly **$4.5 billion** of shares during the year (including 2.0 M shares for $605 m in Q4) and, after using most of its prior limits, reported **$2.69 billion** of remaining authorization as of Aug 31 2024; it then added another $4 bn of authority on Sep 25 2024, raising total outstanding authority to **$6.69 bn**【page_39】【page_40】.  \n\n**Interpretation:** Across the 2022‑2024 period Accenture has consistently used a large portion of its buy‑back capacity each year and periodically refreshed or expanded the authorized limit, signalling a deliberate, multi‑year capital‑return strategy that relies heavily on share repurchases to return excess cash to shareholders.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies, particularly in fiscal 2022 and 2024 repurchase amounts. The ground truth states that in fiscal 2022, Accenture had $3.13 billion in available authorization but does not state that $4.1 billion was spent on repurchases that year. The LLM incorrectly claims Accenture bought 12.2 million shares for $4.1 billion in fiscal 2022, including a breakdown of $3.15 billion in open-market purchases and $0.96 billion in other purchases — this level of detail and these figures are not supported by the original answer. The original answer only provides the available authorization ($3,129,296) for 2022, not actual repurchase volume. In fiscal 2023, the ground truth specifies that 2,000,308 shares were purchased for $605 million, which the LLM misattributes to fiscal 2024 (Q4). The LLM also incorrectly states that $4.5 billion of shares were repurchased in fiscal 2024, while the original answer does not provide total repurchases for that year. The remaining authorization of $2.69 billion as of August 31, 2024, and the $4 billion increase to $6.69 billion on September 25, 2024, are correctly reported. (2) Calculations: The LLM’s claim of $4.1 billion in repurchases in 2022 is unsupported; the original answer does not provide repurchase totals for 2022 or 2024. The $605 million repurchase is correctly cited but misplaced in time (should be fiscal 2023, not 2024 Q4). The $6.69 billion total authorization after the $4 billion increase is accurate. (3) Multi-hop reasoning: The LLM correctly infers a consistent capital return strategy through periodic refreshes of authorization, which aligns with the original answer’s interpretation. However, due to incorrect attribution of repurchase volumes and timing, the synthesis across years is flawed. The model conflates fiscal years and misassigns data points, undermining the multi-hop accuracy. (4) Despite these errors, the answer is contextually relevant and captures the strategic intent — a sustained and expanding share repurchase program. The qualitative reasoning about capital return strategy is sound and semantically aligned with the original, even if the factual foundation is partially incorrect. Hence, correctness is penalized heavily due to key numerical and temporal inaccuracies, but qualitative and contextual scores reflect the reasonable interpretation and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 643,
        "total_tokens": 2166
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "- 2022: the long‑term, lock‑up‑restricted marketable equity portfolio was **$803 million** (included in other non‑current assets)【page_65】.  \n- 2023: it rose to **$1.4 billion**【page_66】.  \n- 2024: it fell sharply to **$266 million**【page_67】.  \n\nThe swing—from a modest holding, to a sizable increase, then a steep reduction—shows that Alphabet temporarily expanded its illiquid equity positions in 2023 (perhaps to capture strategic private‑market opportunities) and then largely unwound or re‑classified those assets in 2024, indicating a flexible, opportunistic approach to managing long‑term, lock‑up‑restricted investments rather than a steady accumulation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values and trends. According to the ground truth, the value was $1.4 billion in 2022, decreased to $803 million in 2023, and returned to $1.4 billion in 2024. However, the LLM incorrectly states $803 million in 2022 (should be $1.4B), $1.4 billion in 2023 (correct for 2023 but misrepresents trend), and $266 million in 2024 (should be $1.4B). This misrepresents both the starting point and the final outcome, with the most critical error being the false 'sharp fall' to $266M instead of a recovery to $1.4B. (2) Quantitative accuracy is severely compromised: all three data points are either wrong or misrepresented. The only partially correct number is $1.4 billion appearing in 2023, but even this is framed as an increase rather than a decrease from the prior year. There are no correct calculations or comparisons based on accurate inputs. (3) The multi-hop reasoning is flawed because it synthesizes incorrect data, leading to an invalid conclusion about a 'steep reduction' and 'unwinding' in 2024, which contradicts the actual recovery to the original level. The interpretation of a temporary expansion followed by divestment is not supported by the real data, which shows a dip and rebound—suggesting rebalancing, not opportunistic entry and exit. (4) Contextual relevance is moderate because the answer attempts to interpret strategic implications and uses appropriate financial terminology, but the reasoning is based on false premises. The discussion of opportunistic management is plausible in context but unsupported by the actual numbers. Scores reflect major factual inaccuracies, especially in quantitative reporting, which undermines the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 477,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "GE first treated its captive property‑and‑casualty subsidiary, Electric Insurance Company (EIC), as a core insurance unit, but in the fourth quarter of 2022 it re‑classified EIC as a “business held for sale” (assets $541 million, liabilities $378 million) and recorded a $109 million loss in other income in 2023 as the group was written‑down and a valuation allowance of $124 million was recognized (see 2023‑2024 held‑for‑sale tables).  In the second quarter of 2024 GE completed the disposition, selling EIC to Riverstone International Holdings for cash proceeds of $120 million, which eliminated the remaining assets and liabilities from the balance sheet.  Across the three‑year span the move shifted EIC from a strategic, operating insurance subsidiary in 2022 to a non‑core, divested asset by 2024, generating a $109 million pre‑tax charge in 2023 and a $120 million cash inflow in 2024, essentially offsetting the earlier loss.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic evolution of GE's relationship with Electric Insurance Company (EIC) from 2022 to 2024, including reclassification as held for sale, the sale to Riverstone International Holdings Inc., and the financial impacts. However, there are minor quantitative inaccuracies. The original answer states that in 2022, EIC had net claim reserves of $0.2 billion, but the LLM answer does not mention this figure, instead jumping to 2023 asset and liability values. While the LLM correctly reports assets of $541 million and liabilities of $378 million as of December 31, 2023, and the $109 million loss, it introduces a 'valuation allowance of $124 million' not present in the ground truth, which is factually unsupported. The sale proceeds of $120 million in 2024 are correctly reported. (2) The $109 million loss is accurately cited, but the additional $124 million valuation allowance is extraneous and incorrect per the original answer. The net claim reserves of $0.2 billion in 2022 are omitted, reducing quantitative completeness. (3) The multi-hop reasoning is strong: the LLM correctly synthesizes the shift from core subsidiary to divestiture, recognizes the loss in 2023 and cash inflow in 2024, and ties it to GE’s strategic refocusing. The conclusion that the cash inflow 'essentially offset' the earlier loss is a reasonable interpretation, though simplified. (4) The contextual relevance is excellent—every part of the question (strategic positioning, valuation, disposition, financial impact) is addressed with high fidelity. The qualitative accuracy is high due to correct entity names, timeline, and logical flow. The quantitative accuracy is slightly reduced due to the unsupported $124 million figure and omission of 2022 reserves, warranting a 7. Correctness score is 8 because core facts and financial impacts are correct, but minor omissions and one erroneous number prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 529,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "Amgen reported **13 Phase 3 programs in its 2022 filing** (the February 8 2022 table still shows 13 programs) 【page_25】. In the 2023 filing the company said it **had 18 Phase 3 programs as of 31 January 2023** 【page_26】. The 2024 filing shows the count rose to **24 Phase 3 programs as of 31 January 2024** 【page_25】, and **25 programs by 4 February 2025** 【page_25】.  \n\nThe jump from 13 to 25 Phase 3 candidates over three years reflects a deliberate pipeline expansion—driven by initiating new studies, acquiring assets (e.g., Horizon‑derived programs), and adding numerous biosimilar and novel‑modality candidates—signalling Amgen’s strategic focus on diversifying therapeutic areas, leveraging genetics‑driven discovery, and strengthening its late‑stage R&D portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all key numerical and temporal details: Amgen had 13 Phase 3 programs in 2022, 18 as of January 31, 2023, 24 as of January 31, 2024, and 25 by February 4, 2025. The ground truth states 25 programs 'by 2024', which is semantically consistent with the LLM's mention of 25 programs by early 2025 (likely reflecting a program added late in the 2024 cycle). The acquisition of Horizon programs and the overall expansion trend are correctly cited.\n\n2) Quantitative accuracy is perfect: all numbers (13, 18, 24, 25) and dates (Jan 31, 2023 and 2024; Feb 4, 2025) match or are consistent with the ground truth. The progression from 13 to 25 is accurately portrayed over the three-year span. The ground truth says '24 in 2024' and '25 total'—the LLM precisely identifies when the 25th program was reached.\n\n3) Multi-hop reasoning is sound: the LLM synthesizes data across three annual filings (2022–2024), tracks the evolution over time, and correctly infers strategic implications (pipeline expansion, Horizon acquisition, diversification). The only minor gap is that the ground truth explicitly mentions regulatory approvals in the U.S. and Japan, which the LLM omits—hence a 9 instead of 10 on qualitative accuracy.\n\n4) The answer is contextually excellent: it directly addresses both parts of the question—evolution of the portfolio and what the growth reveals about R&D strategy. It uses precise citations (page numbers) and correctly interprets the significance of the increase. Semantic equivalence with the original answer is high, with slightly more granular date specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 442,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "In its 2022 filing, American Express described its global card network as the fourth‑largest issuer‑network‑operator, competing directly with Visa, Mastercard, UnionPay and others and noting that regulators were beginning to focus on interchange‑fee caps, “honor‑all‑cards” rules and non‑discrimination provisions. By the 2024 filing the company said that intensified regulatory scrutiny—particularly in the EU and Australia—had forced it to exit its network‑licensing businesses in those regions, to confront uncertainty around interchange‑fee caps and cobrand arrangements, and to adopt stricter compliance frameworks (e.g., becoming a Category III firm). Thus, between 2022 and 2024 Amex’s relationship with global card networks shifted from a competitive positioning statement to an active restructuring of its network participation and licensing model in response to tighter regulation and heightened competitive pressure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: American Express's competitive positioning in 2022 against Visa, Mastercard, and UnionPay; the increasing regulatory scrutiny by 2024; and the exit from network-licensing businesses in the EU and Australia due to regulatory constraints. The mention of interchange-fee caps, 'honor-all-cards' rules, and non-discrimination provisions in 2022 is consistent with regulatory pressures described in the original. The 2024 developments, including uncertainty around cobrand arrangements and compliance restructuring (e.g., Category III designation), are factually sound. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) Multi-hop reasoning is strong: the answer synthesizes shifts over time (2022 to 2024), integrates regulatory and competitive dynamics, and correctly identifies the evolution from competition to regulatory-driven restructuring. The only minor omission is the lack of explicit mention of competitive pressure from alternative platforms like Alipay and PayPal and the emphasis on premium benefits (e.g., lounge access) in 2023, which slightly reduces completeness but does not undermine the core accuracy. (4) The answer is contextually relevant, directly addressing the evolution of AXP’s relationship with global card networks in response to regulation and competition. Wording differs but semantic meaning matches the original. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 465,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "- **2022 – Monetization of CVE shares** – In the first quarter of 2022 ConocoPhillips sold its remaining **≈ 91 million CVE common shares**.  The cash received was earmarked for the company’s ongoing share‑repurchase program, and that year the company repurchased **87.7 million shares** (the “Repurchase of common stock” line in the 2022 10‑K).  \n\n- **2023 – Repurchases funded by the CVE proceeds** – No additional CVE sales were reported, but the company continued to use the 2022 proceeds for buy‑backs, repurchasing **48.6 million shares** during 2023.  \n\n- **2024 – Repurchases funded by the same pool of CVE proceeds** – The program remained in effect, and ConocoPhillips repurchased **49.1 million shares** in 2024.  \n\n- **Cumulative impact** – From the start of the program through 31 December 2024 the share‑repurchase program had bought **433 million shares** at a total cost of **≈ $34.3 billion**.  The only disclosed CVE‑share monetization event was the 2022 sale of 91 million shares; the exact dollar proceeds from that sale were not broken out in the filings, but they were applied to the repurchase activity shown above.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general progression of ConocoPhillips' monetization of CVE shares and subsequent share repurchases, correctly identifying the 2022 sale of 91 million CVE shares and the cumulative repurchase of 433 million shares at $34.3 billion by 2024. However, there are significant quantitative inaccuracies in the annual repurchase volumes. The LLM states that 87.7 million shares were repurchased in 2022, 48.6 million in 2023, and 49.1 million in 2024—summing to only 185.4 million shares over the three years. But the ground truth indicates that 383 million shares were repurchased in 2022 alone, which alone exceeds the LLM's total. This suggests a fundamental error in interpreting the 10-K data, likely confusing total cumulative repurchases with annual figures or misreading line items. While the cumulative total of 433 million shares and $34.3 billion cost by 2024 is correct, the annual breakdown is severely flawed. The qualitative reasoning about using CVE proceeds for buybacks is sound and contextually appropriate, and the entity and time period references are accurate. The failure to correctly attribute the bulk of repurchases to 2022 undermines the quantitative accuracy, but the core narrative of asset monetization funding buybacks is preserved, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 367,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "- 2022 (10‑K for fiscal 2022): ≈ 117 million shares were available for future grants under the then‑effective 2005 Omnibus Stock Incentive Plan.  \n- 2023 (10‑K for fiscal 2023): ≈ 77 million shares were available for future grants under the amended Omnibus Plan as of January 28 2024.  \n- 2024 (10‑K for fiscal 2024): ≈ 70 million shares were available for future grants under the Omnibus Plan as of February 2 2025.  \n\nThe pool of shares that the company can issue under its Omnibus plans has been steadily shrinking—from roughly 117 million in 2022 to about 70 million in 2024—showing that Home Depot has been actively using the plan to award stock‑based compensation. The decline signals strong utilization of its equity‑based compensation capacity, while the remaining tens of millions of shares still give the company ample room to continue granting awards in the near term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the number of shares available under The Home Depot Omnibus Stock Incentive Plans for 2022 (117 million), 2023 (77 million), and 2024 (70 million), matching the ground truth exactly. The dates cited (January 28, 2024, and February 2, 2025) are appropriate fiscal year-end dates for the respective 10-Ks and do not contradict the ground truth, which focuses on availability during those years rather than specific dates. 2) All quantitative values are accurate: 117M → 77M → 70M shows a consistent decline, and no calculations are required beyond interpretation of trend, which is correctly described. Format variations (e.g., '≈' vs exact) are acceptable and common in reporting. 3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and correctly infers that the declining share availability indicates active utilization of stock-based compensation. It appropriately notes that despite the drawdown, the company still has capacity, which aligns with the ground truth's implication of ongoing use supported by replenishment mechanisms. 4) The only minor shortcoming is that the LLM answer does not explicitly mention the 'replenishment mechanism tied to expirations and forfeitures'—a key nuance in the original answer that explains how the pool is sustained despite utilization. This omission slightly weakens the qualitative depth but does not make the answer factually incorrect. Overall, the response is factually accurate, well-structured, and contextually appropriate, warranting a high correctness score with near-perfect accuracy across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 444,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "- 2022: The Amended 2010 Share Incentive Plan authorized a maximum of **127 million** Class A ordinary shares for awards【page_91】.  \n- 2023: The authorization was increased to **141 million** shares【page_98】, and the same **141 million** ceiling remained in the 2024 filing【page_98】.  \n\nThis rise from 127 M to 141 M shares shows Accenture deliberately expanded its share‑based compensation capacity, signaling a strategic focus on using equity awards to attract, retain and motivate talent while further aligning employee interests with shareholders.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 127 million shares in 2022 and 141 million in both 2023 and 2024, with correct formatting variations (127 million = 127,000,000; 141 million = 141,000,000). There are no calculation errors. (2) The answer is complete, addressing both the evolution of the share authorization from 2022 to 2024 and the strategic implication of the increase. (3) Entity accuracy is correct: Accenture plc, Amended 2010 SIP, Class A ordinary shares, and the correct years are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the increase from 127M to 141M is correctly interpreted as a strategic expansion in share-based compensation capacity, with a logical conclusion about talent retention and alignment with shareholder interests. (5) The semantic meaning is equivalent to the original answer, with slightly different phrasing but identical factual and conceptual content. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 304,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "The weighted‑average yield on the company’s foreign‑government‑bond portfolio rose sharply – it was about **4.7 % in 2022** and climbed to roughly **7.8 % by 2024** (see the “Non‑U.S.” average‑yield line in the investment‑securities tables). This upward move shows that American Express’s foreign‑government‑bond holdings are becoming more exposed to higher international interest‑rate environments, meaning earnings from those assets will be more sensitive to any further rate increases abroad.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the weighted average yield was 5.86% in 2022, increased to 6.45% in 2023, and returned to 5.86% in 2024. The LLM incorrectly states it was 4.7% in 2022 and rose to 7.8% by 2024, which misrepresents both the starting point and the trend. Additionally, the LLM omits the 2023 data point entirely and fails to note the decline in 2024 back to 2022 levels. (2) The numbers are quantitatively wrong: 4.7% vs. 5.86% in 2022 and 7.8% vs. 5.86% in 2024 are large deviations. The dollar amount of $630 million in holdings is also missing from the LLM response. (3) The reasoning is flawed because it interprets a continuous increase in yields, while the actual trend shows a peak in 2023 followed by a reversal. The conclusion about increasing exposure is therefore misleading, as the data suggests volatility and partial reversal, not a sustained upward trend. The model fails to perform the correct multi-hop synthesis across three years and misidentifies the nature of the trend. (4) While the LLM addresses the general topic—yield changes and interest rate exposure—it does so with incorrect data and reasoning. The contextual relevance is moderate because it discusses the right financial concept but draws an incorrect inference due to bad inputs. Correctness and quantitative accuracy are severely compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 391,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "- **2022:** The fair‑value table for foreign‑government bonds (page 121) shows the portfolio split across maturities – ≈ 1 %‑2 % for the 0‑5‑year buckets, ≈ 5.5 % for the 5‑10‑year bucket and a weighted‑average yield of **about 2 %** for the whole investment‑security pool.  \n- **2023:** The 10‑K reports a **weighted‑average yield of 6.45 %** on the foreign‑government‑bond segment, reflecting a move into longer‑dated, higher‑coupon securities that were attractive when global rates were higher.  \n- **2024:** The weighted‑average yield fell to **5.85 %**, indicating the company trimmed the longer‑duration, higher‑yield holdings and shifted toward shorter‑dated or lower‑coupon bonds as market yields receded.\n\n**Interpretation:** The progression from a modest 2 % average (2022) to a peak of 6.45 % (2023) and then a modest decline to 5.85 % (2024) shows American Express deliberately re‑balanced its foreign‑government‑bond portfolio to capture higher yields when rates were elevated, then trimmed exposure as yields softened and interest‑rate risk‑management priorities (duration reduction) became more important. This reflects an active investment strategy that responds to changing market conditions rather than a static “buy‑and‑hold” approach.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the 2022 weighted-average yield. The original answer states that in 2022, American Express held $630 million in Foreign Government Bonds and Obligations, with $628 million maturing within one year, indicating a short-duration focus. However, the LLM claims a 'weighted-average yield of about 2%' for the entire investment-security pool in 2022, which is not supported by the ground truth. The ground truth does not provide a weighted-average yield for 2022 at all—only the fair value distribution by maturity. Thus, the 2% figure is fabricated or misattributed. (2) The 2023 (6.45%) and 2024 (5.85%) yields are correctly reported, matching the ground truth exactly. However, the incorrect 2022 yield undermines the validity of the progression narrative. (3) The reasoning about strategy—shifting into higher-yielding, longer-dated securities in 2023 and then reducing duration as yields fell in 2024—is plausible and aligns with the trend, but it contradicts the ground truth's emphasis on a short-duration portfolio in 2022. The LLM incorrectly infers a shift into longer-dated bonds in 2023, while the ground truth suggests the portfolio remained short-duration focused, with high yields likely due to rising interest rates rather than a structural shift in maturity. (4) Contextually, the answer addresses the evolution of yield and attempts to interpret strategy and market conditions, fulfilling the multi-part structure of the question. However, due to the critical error in the 2022 yield and the resulting flawed baseline for comparison, the overall correctness is significantly compromised. The qualitative reasoning is partially sound but built on incorrect data. Quantitative accuracy is low due to the unsupported 2% figure, while contextual relevance remains high as the response attempts all required elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 517,
        "total_tokens": 2063
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "Across the three filings the 7 % debentures due 2029 have been presented in the same “Securities registered pursuant to Section 12(b)” table. In the 2023 Form 10‑K the table lists “7 % Debentures due 2029” on a separate line with its CUSIP (718507BK1) and NYSE listing; the 2024 filing combines the common‑stock line with the debenture line but still shows the same title, CUSIP and exchange; the earlier filing (shown for 2021, which is the same format used in the 2022 filing) also listed the debentures as a distinct entry with the same title and CUSIP 【page_1‑2023】, 【page_1‑2024】, 【page_1‑2021】. This consistent, year‑over‑year placement demonstrates ConocoPhillips’ deliberate and stable approach to disclosing this long‑term debt, ensuring that investors receive a clear, uniform description of the instrument in every annual report.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in describing the evolution of disclosure. While it correctly identifies the CUSIP (718507BK1) and the NYSE listing for the 7% Debentures due 2029 across years, it incorrectly states that the 2024 filing 'combines the common-stock line with the debenture line', which contradicts the ground truth that in 2024, COP maintained the separated, distinct disclosure introduced in 2023. The ground truth indicates increasing clarity and separation over time, but the LLM claims a reversal in 2024 by combining lines, which is incorrect. Additionally, the LLM references a '2021' filing as representative of 2022, which may be factually unsupported and distracts from the required 2022–2024 analysis. (2) Quantitatively, the percentage (7%), maturity year (2029), CUSIP (718507BK1), and exchange (NYSE) are all accurate and consistently reported—this aspect is correct. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the progressive improvement in disclosure clarity (from combined to separate to maintained separation), instead suggesting stability and even a regression in 2024. This misrepresents the trend and leads to an incorrect conclusion about 'deliberate and stable approach' when the ground truth indicates an evolution toward greater transparency. (4) Contextual relevance is moderate—the answer addresses the right section (Securities registered pursuant to Section 12(b)) and focuses on disclosure practices, but the erroneous description of formatting changes undermines the validity of the conclusion. The answer is relevant in structure but incorrect in key interpretive claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 457,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "NVIDIA’s balance‑sheet exposure to the 2.00 % senior notes that mature in 2031 was roughly $1.0 billion in fiscal 2022, slipped slightly to about $1.04 billion in fiscal 2023, and then rose to approximately $1.25 billion (net carrying amount) by the end of fiscal 2024【page 67】.  The modest increase after a brief dip shows that NVIDIA is deliberately adding low‑cost, long‑dated debt – a strategy that lets the company lock in inexpensive financing for future growth and acquisitions while keeping its overall leverage and maturity profile under control.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, NVIDIA's exposure was $1.2 billion in 2022, decreased to $1.057 billion in 2023, and increased to $1.25 billion in 2024. However, the LLM states it was $1.0 billion in 2022, rose to $1.04 billion in 2023 (a slight increase, not a decrease), and then rose to $1.25 billion in 2024. Thus, both the 2022 and 2023 figures are incorrect, and the trend description (slight dip) does not match the actual progression. (2) The calculation and comparison of year-over-year changes are flawed: the ground truth shows a decrease from 2022 to 2023 ($1.2B → $1.057B), but the LLM incorrectly reports an increase ($1.0B → $1.04B). This misrepresents the financial evolution. (3) The qualitative reasoning about NVIDIA’s long-term debt management strategy — that it is deliberately adding low-cost, long-dated debt to finance growth while managing leverage — is plausible and aligns with the general interpretation in the original answer about a stable financing approach. The entity (NVIDIA), instrument (2.00% Notes Due 2031), and time frame (fiscal years 2022–2024) are correctly identified. (4) The contextual relevance is high as the answer addresses both parts of the question: the evolution of exposure and the strategic implication. However, due to the incorrect numerical values and mischaracterization of the trend, the correctness and quantitative accuracy scores are significantly reduced. While the final 2024 value ($1.25B) is correct, the earlier figures and the overall trajectory are not, leading to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 448,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "- In FY 2022 Marvel was treated principally as an intangible‑asset trademark – it appears in the balance sheet under “indefinite‑lived intangible assets” (along with ESPN and Pixar) but the filing does not call it out as a separate brand on Disney’s streaming platforms.  \n\n- By FY 2023 Disney began to market Marvel explicitly as a top‑level “tile” on Disney+ (the DTC service lists Disney, Pixar, **Marvel**, Star Wars and National Geographic as the primary brand selections), signaling a shift to use the Marvel brand to drive streaming subscriptions.  \n\n- The FY 2024 filing repeats that positioning – Marvel remains a dedicated tile on Disney+ and is still recorded in the $1.792 billion indefinite‑lived intangible‑asset line (ESPN, Pixar and Marvel trademarks), showing the brand’s continued strategic role both in the streaming UI and as a valued, non‑amortizing intangible asset.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All key facts are accurately represented: Marvel's inclusion in indefinite-lived intangible assets in FY2022 and FY2024 alongside ESPN and Pixar is correctly stated, and the $1.792 billion figure for the combined trademarks in FY2024 matches the source data. The absence of explicit streaming branding in FY2022 and the introduction of Marvel as a top-level tile on Disney+ in FY2023 are both accurately described. (2) Quantitative accuracy is excellent: the $1.792 billion value for indefinite-lived intangible assets in FY2024 is correctly cited, and fiscal years are properly referenced. No calculations were required, but the reporting of financial data is precise. (3) Multi-hop reasoning is sound: the LLM successfully synthesizes information across three fiscal years, connects Marvel’s financial treatment (as an intangible asset) with its strategic role in Disney+'s user interface, and infers continuity in brand value. (4) The answer is semantically equivalent to the original, with slightly more granular detail (e.g., naming all top-level tiles on Disney+), enhancing clarity without introducing error. All aspects of the question—branding in streaming and role in intangible assets across 2022–2024—are thoroughly and accurately addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 370,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "Across the three most recent filings American Express has kept the same core revenue‑recognition model: discount revenue – the merchant‑discount fee and any network‑rate fee it receives from a third‑party acquirer – is recorded at the moment the Card‑Member transaction settles. In the 2022 filing the company explained that contracts with small‑ and mid‑size merchants have no fixed term, while large merchants are on 3‑ to 7‑year fixed‑period agreements (often with auto‑renewal) and that the network‑rate fee is individually negotiated with each third‑party acquirer; the 2023 filing reiterated this model and added that the fees are captured through programs such as OptBlue and Global Network Services, but the timing of recognition and the auto‑renewal structure remained unchanged. By the 2024 filing the discussion moved to strategy, emphasizing an aggressive expansion of merchant coverage worldwide by leveraging third‑party acquirers and aggregators, while still recognizing discount revenue at settlement and continuing to negotiate network‑rate fees as a key lever to manage merchant discount rates amid heightened competitive pressure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: discount revenue recognition at transaction settlement is consistently reported across 2022–2024; network rate fees are individually negotiated with third-party acquirers (e.g., via OptBlue and GNS), and this structure remains stable. The evolution toward expanded merchant coverage through third-party acquirers and aggregators by 2024 is correctly identified. (2) There are no numeric values (e.g., dollar amounts, percentages, durations) in the original or LLM answer beyond time frames like '3- to 7-year agreements'—these are accurately reflected and consistent with the original. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly identifying continuity in revenue recognition while highlighting strategic shifts in merchant expansion. (4) The only minor omission is that the LLM does not explicitly mention 'processed revenue' from network partnerships (e.g., royalties) introduced in 2023, which is a component of American Express’s evolving revenue structure. While the focus on discount revenue is correct, the absence of processed revenue slightly reduces completeness. However, the core evolution in contractual arrangements and merchant coverage strategies is well captured. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1625,
        "completion_tokens": 420,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "- In the 2022 Form 10‑K Amgen first flagged that many of its products are administered with drug‑delivery or companion‑diagnostic devices and that those devices carry separate regulatory, manufacturing and third‑party‑supply risks that could delay or block product‑candidate approvals if the devices are not cleared or remain commercially available.   \n- The 2023 filing broadened the disclosure to tie those device risks to post‑marketing obligations – citing FDA‑imposed post‑marketing studies (e.g., the confirmatory study required for LUMAKRAS) and REMS reporting – and added that the drug‑delivery devices themselves are subject to ongoing safety‑review oversight, adverse‑event reporting and FDA inspections (the 2017 Neulasta Onpro review and subsequent labeling enhancements).   \n- By the 2024 filing the company stresses continuous monitoring of device‑related complaints, malfunctions and safety signals, warning that loss of a device’s approval or clearance could force removal of the associated drug from the market, while still noting the reliance on third‑party partners and the need for device‑studies to support clinical‑trial and regulatory filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key factual elements are correct: Amgen's 2022 disclosure of device-related regulatory and supply risks, the 2023 expansion to include post-marketing requirements (specifically LUMAKRAS confirmatory studies and the FDA's Complete Response Letter), and the 2024 emphasis on ongoing safety reviews, complaint monitoring, and potential market withdrawal due to device non-compliance. The mention of the 2017 Neulasta Onpro review adds contextual depth and is factually consistent with Amgen's historical disclosures. (2) There are no numeric values to verify, but all dates (2022, 2023, 2024) and references (LUMAKRAS, Neulasta Onpro) are accurate. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how Amgen’s risk disclosures evolved across years, linking device dependencies to clinical trial support, post-marketing obligations, and safety oversight. The progression from general risk in 2022 to specific compliance and enforcement risks in 2024 is well captured. (4) The only minor shortcoming is that the LLM does not explicitly frame the evolution as a 'transformation' or 'shift' in tone, as emphasized in the original answer, though the substance of that shift is clearly conveyed. Wording differences are acceptable under semantic equivalence. All parts of the question—clinical trial dependencies, post-marketing requirements, and device-related safety reviews—are addressed across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1584,
        "completion_tokens": 413,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "By 2024 ConocoPhillips had broadened its HSE audit program from the narrower, unit‑focused reviews used in 2022 to audits that cover **both business‑unit operations and staff groups**.  The company added a **formal “track‑to‑completion” mechanism** that logs every improvement action identified in an audit and follows it through to closure, and it now **reports audit results, objective‑target performance and corrective‑action status to both the Executive Leadership Team and the Board of Directors**—a governance structure that was less explicit in the 2022 filing.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the evolution from 2022 to 2024, particularly in the qualitative progression of ConocoPhillips' HSE audit program. (1) Correct elements: The answer correctly notes that audits cover both business units and staff groups (consistent with 2022 description), mentions the track-to-completion mechanism for improvement actions (accurate for all years), and correctly identifies that audit results and corrective actions are reported to the Executive Leadership Team and Board of Directors—consistent with the governance structure across years. There are no numeric inaccuracies, so quantitative accuracy is high. (2) However, the answer incorrectly implies that the governance reporting structure was 'less explicit' in 2022, while the original answer states that progress was already reported to ELT and Board in 2022, meaning this structure was not a new development. This misrepresents the evolution. (3) The multi-hop reasoning is flawed: the LLM fails to capture the key developments in 2023 (integration with human capital management, Life Saving Rules, Process Safety Fundamentals, stop work policy) and the 2024 shift toward 'Corporate HSE audits' indicating centralization/standardization. Instead, it presents a simplified narrative of broadening scope and formalizing tracking, missing the conceptual evolution from conformance checks to integrated safety systems to corporate standardization. (4) Contextual relevance is strong—the answer addresses scope, tracking, and governance—but lacks depth and accuracy in tracing the actual year-by-year evolution. Thus, while factually plausible in parts, it omits and distorts critical qualitative developments, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 477,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "From 2022 onward Accenture moved from simply warning that “technological developments … could affect the nature of how we generate revenue” and that “if we are unable to introduce new pricing or commercial models that reflect the value of these technological developments” it could hurt results (2022 ‑ page 18/22) to actively building AI‑ and cloud‑based offerings and tying new pricing structures to those services as a core part of its growth strategy (2023 ‑ page 22; 2024 ‑ page 22). Across all three years the company repeatedly flagged the same risk: if it fails to roll out timely, value‑based pricing models for AI, cloud and other emerging technologies, client spending may be delayed or reduced, creating a material revenue shortfall and operational impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: Accenture's evolution from acknowledging the need for new pricing models in 2022, to actively building AI- and cloud-based offerings with tied pricing structures in 2023 and 2024, is correctly represented. The consistent risk across years—failure to deploy timely, value-based pricing models leading to delayed or reduced client spending and material revenue impact—is accurately highlighted. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022–2024) are correctly used. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly identifying the progression in strategy and the persistent risk. It references specific pages (e.g., 2022-page 18/22), which adds precision, though such details were not in the ground truth—this does not detract as they are plausible and contextually appropriate. (4) Minor difference: the original emphasizes 'strategic investments' and 'dependence on successful deployment' more explicitly in 2024, which the LLM captures implicitly but could have stated more directly. However, the core meaning and factual content are preserved. Wording differs slightly but maintains semantic equivalence. No irrelevant or incorrect entities are introduced. Thus, the answer is excellent, meriting a 9 due to slight under-articulation of the depth of 2024 investment emphasis, but not enough to reduce further.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 435,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "- 2022: GE’s AerCap investment consisted of a 46 % equity stake plus a $900 million senior note (the note is listed in the fair‑value table for 2022).  \n- 2023: GE sold the remaining AerCap shares, keeping only the senior note, whose carrying amount rose to $944 million.  \n- 2024: The note grew again to $982 million (the 2024 fair‑value table).  \n\nThe pattern shows GE moving from a large equity holding toward a pure debt position, suggesting the company is transitioning to a lower‑risk, financing‑focused exposure to AerCap rather than maintaining an ownership stake.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, GE's holdings in the AerCap note decreased from $993 million (reported in 2022 for end of 2021) to $944 million (reported in 2024 for end of 2023). However, the LLM claims the note increased from $900 million in 2022 to $944 million in 2023 and then to $982 million in 2024—this contradicts the documented decline. The starting value is wrong ($900M vs $993M), the direction of change is incorrect (increase vs decrease), and the final value ($982M) does not match the ground truth ($944M). (2) The LLM incorrectly states that GE held a 46% equity stake in 2022 and then sold shares in 2023, but the original answer makes no mention of equity stakes or sales—only a note holding. This introduces entities and events not supported by the ground truth. (3) The multi-hop reasoning is flawed: the LLM infers a strategic shift toward a 'pure debt position' and 'lower-risk exposure,' but this conclusion is based on fabricated data about equity divestment and note value increases. The actual progression suggests a gradual reduction in exposure, not a restructuring into debt. (4) While the LLM attempts to interpret strategy—which aligns with the question’s intent—the interpretation is based on incorrect data, undermining both quantitative and qualitative accuracy. Contextual relevance is moderate because it addresses the right topic and attempts strategic analysis, but factual errors severely limit usefulness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 418,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "- 2022 10‑K: Amgen reported that Bemarituzumab had just **entered a Phase 3 trial for gastro‑esophageal‑junction (GEJ) adenocarcinoma** (while still being studied in Phase 2 “other‑tumor” indications and a Phase 1 NSCLC cohort).  Its composition‑of‑matter patents were listed with **estimated U.S. and European expirations in 2029**【page_25】.  \n\n- 2023 10‑K: The candidate remained a **Phase 3 program for GEJ adenocarcinoma** (with the same Phase 2 and Phase 1 studies still noted) and the patent table still showed **2029 expiration dates** for both territories【page_24】【page_25】.  \n\n- 2024 10‑K: Bemarituzumab was still **listed only as a Phase 3 product candidate** (no new approval or further phase transition) and the patent information again projected **expiration in 2029** in the United States and Europe【page_26】.  \n\nThus, from 2022 through 2024 Amgen’s Bemarituzumab progressed from initiating Phase 3 to remaining in Phase 3, while its IP position stayed constant with composition‑of‑matter patents expected to expire in 2029.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in terms of numbers and dates: Bemarituzumab entered Phase 3 in 2022, remained in Phase 3 through 2024, and the composition-of-matter patents were consistently reported with estimated U.S. and European expiration in 2029. These quantitative details match the ground truth exactly, warranting a perfect score on quantitative accuracy. However, the LLM answer fails to reflect a key qualitative evolution described in the original answer: the expansion of Bemarituzumab’s investigational scope in 2024 to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC, as well as a more detailed description of its mechanism. The LLM incorrectly implies no meaningful change occurred from 2022 to 2024 beyond continuation in Phase 3, whereas the ground truth emphasizes a strategic shift toward broader therapeutic positioning and IP clarity. This omission represents a significant gap in qualitative accuracy and limits completeness, especially regarding the multi-hop synthesis of clinical progression and IP strategy evolution. While the answer is relevant and correctly interprets the patent and phase status, it underrepresents the strategic and descriptive advancements in 2024, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 358,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "In the 2022 filing American Express simply **acknowledged** that “the dynamic and rapid growth of alternative payment and financing mechanisms… (e.g., digital‑wallet platforms, buy‑now‑pay‑later, open‑banking, blockchain, etc.)” was reshaping the industry and that **speed of innovation and investment in technology** was a key competitive factor【page_12】.  \n\nBy the 2024 filing the company describes **much more intense pressure** from non‑traditional players—large tech firms creating proprietary digital wallets and “alternative‑payments” solutions that are eroding merchant discount rates and threatening card acceptance【page_29】【page_30】, and it explicitly states that **its long‑term ability to compete depends on continued, substantial investment in a broad set of technologies** (open‑banking, alternative‑payment platforms, tokenization, AI, real‑time settlement, etc.)【page_31】.  \n\nTogether, these disclosures show that American Express has moved from recognizing fintech‑driven alternatives as a peripheral risk in 2022 to treating them as a core competitive threat in 2024 and is committing significant technology spending to embed open‑banking and digital‑payment capabilities—signaling a proactive, long‑term strategy to counter fintech disruption rather than a passive stance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) It correctly identifies the evolution of American Express's strategic positioning from 2022 to 2024: in 2022, the company acknowledged alternative payment mechanisms (digital wallets, BNPL, blockchain, open banking) as industry disruptors and emphasized innovation and tech investment as competitive factors. By 2024, it frames these mechanisms as core competitive threats, particularly from large tech firms, and stresses that long-term competitiveness depends on substantial investment in technologies like open banking, tokenization, real-time settlement, and AI. This matches the ground truth’s narrative of a shift from recognition to proactive integration. (2) There are no numeric values, dates, or financial figures in dispute; all timeframes (2022, 2024) are correct and consistent. (3) The multi-hop reasoning is sound: the LLM synthesizes changes in tone and strategic emphasis across filings, correctly inferring a shift from peripheral concern to core strategic focus. The only minor gap is that the original answer notes 2023 as a transitional year where American Express expanded its list of alternative mechanisms to include open banking and payment facilitators—this nuance is omitted in the LLM response, which jumps from 2022 to 2024. However, this does not undermine the overall correctness. (4) The LLM uses different phrasing (e.g., 'peripheral risk' vs. 'competitive threat') but maintains semantic equivalence. The conclusion about a proactive, long-term strategy to counter fintech disruption is fully supported. Thus, the answer is excellent, with only a slight deduction for missing the 2023 development, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1635,
        "completion_tokens": 488,
        "total_tokens": 2124
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "- 2022 : Weighted‑average grant‑date fair value of cash‑settled PSUs ≈ $91.6 per unit (2023 10‑K, “granted during 2022”).  \n- 2023 : Weighted‑average grant‑date fair value ≈ $112.5 per unit (2024 10‑K, “granted during 2023”).  \n- 2024 : Weighted‑average grant‑date fair value ≈ $110.4 per unit (2024 10‑K, “Granted” row for 2024).\n\nThe metric rose sharply from 2022 to 2023, showing ConocoPhillips boosted the value of its cash‑settled performance awards to make its long‑term incentive program more attractive, and then eased slightly in 2024, indicating the company is maintaining an elevated but more measured compensation stance that continues to align executive rewards with share‑price performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the weighted-average grant date fair value increased from $91.58 in 2022 to $112.50 in 2024. However, the LLM reports $112.50 for 2023 and then a decrease to $110.40 in 2024, which contradicts the stated upward trend. The 2022 value is approximately correct ($91.6 vs $91.58), but the 2024 value should be $112.50, not $110.40. This misrepresents the trend. (2) The numbers are close but not accurate—especially the 2024 figure, which is critical to the trend. The ground truth indicates a consistent increase to $112.50 by 2024, while the LLM shows a peak in 2023 followed by a decline. This affects the calculation and interpretation of the trend. (3) The reasoning is partially sound: the LLM correctly infers that an increase in grant value reflects a strategic move to enhance incentives. However, the conclusion that the company 'eased slightly in 2024' and adopted a 'more measured stance' is incorrect because the ground truth shows a continued rise to $112.50, not a drop. Thus, the multi-hop synthesis of the trend across years is flawed. (4) Despite incorrect numbers, the answer addresses all parts of the question, uses correct entities (ConocoPhillips, cash-settled PSUs, grant date fair value), and provides relevant qualitative interpretation. Contextual relevance is high because it directly responds to both the evolution and strategic implication. However, the quantitative inaccuracy severely undermines the correctness score, as financial trends depend on precise values and directional accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 445,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "- In the 2022 filing PayPal already warned that “failure to deal effectively with fraud, abusive behaviors, bad transactions… could increase our loss rate” and that its credit‑product portfolio was exposed to “non‑payment risk” and possible charge‑offs (see 2022 p. 23‑24).  \n- By 2023 the company expanded that warning, noting that third‑party lenders and new BN‑L receivable‑sale arrangements increase reliance on external partners and that “third parties will continue to attempt to abuse… our services by creating fictitious accounts, using stolen or synthetic identities, and scaling fraud attacks” (2023 p. 25‑26).  \n- The 2024 report repeats the same concern and adds that “measures to detect and reduce the risk of fraud and abusive behavior are complex, require continuous improvement, and may not be effective” (2024 p. 22‑23), indicating that exposure to abusive schemes has persisted or grown as credit products and third‑party funding have expanded.  \n\nOverall, the language shows a rising exposure to abusive behavior tied to credit products and third‑party fraud from 2022 to 2024, suggesting that while PayPal has strengthened its risk‑management disclosures and controls, the effectiveness of those controls remains limited and the company continues to face significant fraud‑related risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: PayPal's increasing focus on abusive behaviors, fraud risks, and credit product exposure from 2022 to 2024 is accurately portrayed. The mention of fictitious accounts, stolen/synthetic identities, and third-party fraud schemes matches the ground truth. The expansion of risk into BNPL and third-party reliance in 2023 and ongoing challenges in 2024 are correctly synthesized. (2) Quantitative accuracy is perfect—no numerical claims are made that contradict the ground truth, and while the €40 billion receivables sale is not explicitly mentioned, this is a minor omission rather than an error. The LLM correctly cites page numbers and quotes key language from each year’s filing, reinforcing factual fidelity. (3) Multi-hop reasoning is sound: the model connects PayPal’s evolving risk disclosures across three years, links fraud exposure to credit products and third-party arrangements, and infers that risk management effectiveness remains constrained despite improved controls. The only slight gap is the absence of the 'valid-when-made doctrine' regulatory uncertainty in the U.S., which the original answer includes as a 2024 development. This is a minor omission affecting completeness but not overall correctness. (4) The answer is contextually fully relevant, directly addressing the evolution of exposure and implications for risk management. Wording differs but semantic meaning is equivalent. The conclusion that exposure has persisted or grown and that controls have limited effectiveness is a valid interpretation. Scored 9/10 due to one minor missing element (regulatory doctrine), but all core facts, trends, and reasoning are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1601,
        "completion_tokens": 482,
        "total_tokens": 2083
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "In the 2022 filing Lilly described Cyramza as a multi‑indication oncology asset – a second‑line therapy for gastric/GEJ adenocarcinoma, metastatic NSCLC, colorectal cancer and hepatocellular carcinoma, and a first‑line option for EGFR‑mutated metastatic NSCLC – and the same breadth of indications appears unchanged in the 2023 and 2024 reports. The 2023 10‑K added the first explicit IP schedule, showing that Cyramza’s U.S. compound patent runs to 2026 (EU 2028, Japan 2026) with biologics data protection also ending in 2026 and European data protection already set to expire in 2024 (Japan 2023). Together, the stable, expanding therapeutic positioning combined with a relatively short remaining exclusivity window signals that Lilly is banking on continual label expansion and new oncology combinations rather than long‑term patent protection to sustain Cyramza’s contribution to its long‑term oncology strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Cyramza's multi-indication status in 2022 and its continuation through 2023–2024, aligning with the ground truth. However, there are key discrepancies in the intellectual property timeline. The ground truth states that data protection expired as early as 2023 in Japan, which the LLM correctly notes. But the LLM adds details not present in the original answer: EU compound patent expiry in 2028 and European data protection expiry in 2024—these are absent from the ground truth and cannot be verified, making them potentially inaccurate. (2) Quantitative accuracy is partially compromised: while U.S. and Japan patent expiry (2026) matches, the inclusion of EU dates (2028, 2024) introduces unverified data. The original answer does not mention EU at all, so these additions reduce quantitative precision. (3) Reasoning and synthesis are strong: the LLM correctly infers that the stable indications combined with limited remaining exclusivity suggest a strategy focused on maximizing value before patent expiry, which is logically consistent with the ground truth’s conclusion about preparing next-generation products. The leap to 'label expansion and new combinations' is a reasonable interpretation, though slightly more speculative than the original. (4) Contextual relevance is high—the answer directly addresses therapeutic positioning evolution and IP protection, and draws a strategic inference about Eli Lilly’s oncology roadmap. Despite extra details, the core multi-hop reasoning (linking IP lifespan to strategic focus) is sound. Scored 7/10 overall due to unverified EU dates affecting quantitative accuracy, but strong qualitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 469,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "From 2022 through 2024 Philip Morris kept the 3.875 % Notes due 2042 on its balance sheet in every filing (see the 2022 table that lists “3.875% Notes due 2042” PM42A 【PM_10k_2022.pdf page 2】, the 2023 table that again includes the same series 【PM_10k_2023.pdf page 1】, and the 2024 table where it remains present 【PM_10k_2024.pdf page 1】). At the same time the company actively added, retired or re‑issued a broad set of shorter‑ and medium‑term bonds – for example 2.875 % Notes due 2024, 2.750 % Notes due 2025, 3.125 % Notes due 2027‑2028, 4.375 % Notes due 2041, and new 4.125 % and 4.875 % Notes due 2043 (shown in the 2023 and 2024 tables 【PM_10k_2023.pdf page 2】【PM_10k_2024.pdf page 2】). Together, this reflects a capital‑structure strategy that diversifies maturity and coupon exposure by actively managing a rolling series of debt instruments while retaining the long‑dated 3.875 % 2042 notes as a stable anchor.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent presence of the 3.875% Notes due 2042 across all three years, which aligns with the ground truth. However, it introduces significant factual inaccuracies regarding other debt instruments. Specifically, the LLM claims that 4.125% and 4.875% Notes due 2043 were present in the 2024 filing (citing PM_10k_2024.pdf page 2), but the ground truth explicitly states these were no longer listed in 2024, indicating they had been retired or refinanced. This is a critical error in entity presence and temporal accuracy. Additionally, the LLM lists several notes (e.g., 2.875% due 2024, 2.750% due 2025, 3.125% due 2027–2028, 4.375% due 2041) without confirming their presence or absence across years, and implies they were actively managed through 2024, which is not supported by the ground truth. (2) Quantitative accuracy is partially correct: the 3.875% due 2042 is accurately cited, but the inclusion of other notes in 2024 that should have been retired (especially the 2043 tranches) undermines the precision of the debt portfolio description. The LLM incorrectly suggests continuity of instruments that the ground truth says were removed by 2024. (3) The multi-hop reasoning is partially sound—the idea of using the 2042 notes as a 'stable anchor' while managing other debt is conceptually aligned with the ground truth. However, the conclusion that the company was actively issuing or maintaining the 2043 notes in 2024 contradicts the evidence of their retirement, leading to flawed synthesis. The ground truth emphasizes a shift toward stabilization by not introducing new long-dated notes beyond 2042, whereas the LLM implies ongoing active issuance, which misrepresents the strategic evolution. (4) Contextual relevance is high—the answer addresses capital structure evolution and attempts to synthesize across years and instruments. However, due to key factual errors in entity presence and timing, the correctness score is reduced to 6, reflecting partial accuracy with significant omissions and misstatements that affect the overall interpretation of the strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 572,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "- In the 2022 filing PayPal warned that “failure to deal effectively with fraud, abusive behaviors, … could increase our loss rate” and that “third parties will continue to attempt to abuse…our payments services” (2022 10‑K pp. 23‑24).  It also highlighted that its consumer‑ and merchant‑credit products “expose us to additional risks” because credit‑risk models can mis‑price borrowers and because the company depends on unaffiliated banks to fund those products (2022 10‑K pp. 24‑26).  \n\n- In 2023 the company began to curb that exposure by selling most of its U.K. and European buy‑now‑pay‑later loan portfolio and entering a forward‑flow receivables arrangement (2023 10‑K pp. 25‑26), and by “diversifying our reliance on a small number of third‑party payment processors” and working with its primary processor to migrate to alternative processors (2023 10‑K pp. 25).  \n\n- The 2024 filing shows the same abusive‑behavior risk persisting (2024 10‑K pp. 22‑23) but notes that PayPal is continuing the mitigation steps taken in 2023 – further diversification of third‑party funding and processing partners and ongoing migration away from its legacy processor – to reduce both fraud/abuse and credit‑product concentration (2024 10‑K pp. 22‑23).  \n\nThus, PayPal’s exposure to abusive behavior and credit‑product risk remained a highlighted concern from 2022 through 2024, and the company responded in 2023 by off‑loading BNPL loan receivables and diversifying/ migrating its third‑party processor relationships, actions it continued to pursue in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: PayPal identified abusive behaviors and credit risks in 2022, particularly around synthetic identities and reliance on third parties; in 2023, it reduced exposure by selling U.K. and European BNPL receivables and diversifying payment processors; in 2024, it continued these mitigation efforts. The LLM correctly cites the persistence of abusive behavior risks and ongoing infrastructure improvements. (2) Quantitative accuracy is perfect: while no specific dollar/euro amounts are mentioned in the LLM answer, the ground truth states €40 billion as the forward-flow agreement size, and the LLM accurately describes the sale of 'most' of the portfolio without contradicting this figure. The absence of the exact euro amount is a minor omission but does not constitute an error, as the core action (selling BNPL receivables via a forward-flow arrangement) is correctly reported. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the evolution from risk identification (2022) to risk offloading (2023) to continued mitigation (2024), which matches the ground truth’s narrative arc. (4) The answer is contextually fully relevant, addressing all parts of the question—evolution of risk, relation to credit products and third-party management, and specific actions in 2023–2024. The only reason for not scoring a 10 is the lack of explicit mention of the €40 billion figure, which is a minor completeness gap but does not affect the overall correctness of the synthesis or conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1643,
        "completion_tokens": 453,
        "total_tokens": 2096
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "AMD’s 2022 Form 10‑K listed “loss or modification of exemptions for taxes and tariffs” only as one of many generic political‑legal‑economic risks affecting its foreign operations (see 2022 page 37). The same language re‑appears in the 2023 filing, but is now coupled with explicit references to recent sanctions, export‑control revisions and heightened geopolitical tension (e.g., Ukraine‑Russia and China‑Taiwan issues on 2023 pages 37‑41). By the 2024 filing the risk is reiterated again, this time framed within a broader discussion of new sanctions against Russia, Belarus and Ukraine’s occupied regions and of “geopolitical changes between China and Taiwan,” indicating that AMD’s exposure to possible loss or alteration of tax‑ and tariff‑exemptions has become more pronounced and is being driven by an increasingly volatile regulatory environment worldwide.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, AMD listed tax and tariff exemption risks as one of many generic political-legal-economic risks; in 2023, it strengthened the language by linking the risk to geopolitical tensions and export controls; by 2024, it further elevated the risk by connecting it to specific geopolitical conflicts (e.g., Russia-Ukraine, China-Taiwan). These developments reflect increasing regulatory uncertainty, which the LLM correctly identifies. (2) There are no numerical values to verify, so quantitative accuracy is scored as 10 by default—no errors in dates or references. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings, correctly tracing the evolution of risk disclosure and linking it to broader regulatory trends. The only minor shortcoming is that the LLM does not explicitly state that the risk was 'elevated' or 'heightened' in tone from year to year using those exact interpretive terms, though the progression is clearly implied through contextual description. (4) The answer is fully relevant, directly addressing how AMD’s exposure perception evolved and what it suggests about regulatory uncertainty. Wording differs slightly from the original answer but maintains semantic equivalence. No factual inaccuracies or omissions affect the core conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 394,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "Cisco’s results from the total‑return swaps that are used to hedge its deferred‑compensation obligations moved from a **$92 million loss in FY 2022** to a **$58 million gain in FY 2023** and then to a **$91 million gain in FY 2024**【page_91†L31-L38】. The swing from a loss to progressively larger gains suggests that the swaps are increasingly offsetting the compensation expense and that Cisco’s exposure to deferred‑compensation‑related market risk is being managed effectively – the firm’s hedging strategy is delivering positive earnings impact as market conditions align with the swaps’ payoff structure【page_92†L9-L13】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures and fiscal years: a $92 million loss in FY 2022, a $58 million gain in FY 2023, and a $91 million gain in FY 2024, which exactly matches the ground truth. Minor formatting differences (e.g., 'FY 2022' vs '2022') are acceptable and do not affect factual accuracy. (2) All numbers are quantitatively accurate with no calculation errors. The progression of gains and losses is correctly represented. (3) The multi-hop reasoning is sound: the LLM synthesizes data across three fiscal years and correctly infers that the shift from loss to increasing gains indicates effective hedging and reduced exposure to market risk in deferred compensation liabilities. This aligns with and expands upon the ground truth’s interpretation regarding exposure and strategy. (4) The answer is semantically equivalent to the original, providing the same core facts and a slightly more detailed but still accurate interpretation of the hedging strategy’s effectiveness. All parts of the question—evolution of gains/losses and what it indicates about exposure or strategy—are fully addressed with correct entities (Cisco, total return swaps, deferred compensation, fiscal years 2022–2024).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 348,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "- **2022 → 2023:** Disney’s DTC strategy began with the FY 2022 rollout of an ad‑supported Disney+ tier, new pricing and a cost‑realignment (2022 10‑K p. 22). In FY 2023 the company reorganized its media business, made “strategic investments” in its DTC portfolio (including the ESPN flagship service and the ad‑supported tier), and expected subscription‑ and ad‑revenue growth to offset declines in linear‑network fees (2023 10‑K p. 53‑55). The 2023 filing also warned of flat or net‑loss subscriber growth, higher content‑impairment charges and mounting competition.\n\n- **2023 → 2024:** By FY 2024 Disney continued to invest in DTC, now aggregating all entertainment assets into a single reporting unit and emphasizing the need to drive subscriber additions, manage churn, and monetize the ad‑supported service (2024 10‑K p. 21‑24, 27). The 2024 filing highlighted “intensified competition,” pricing pressure, rising content‑and‑marketing costs, and the impact of elevated debt and credit‑rating pressure on financing the DTC rollout.\n\n- **What the evolution reveals:** Disney’s shift from a launch‑phase pricing experiment (2022) to aggressive, capital‑intensive growth investments (2023‑2024) shows that scaling streaming now hinges on costly content acquisition, continual platform investment, and debt‑financed expansion. The filings make clear that the business faces significant financial risk—higher leverage, potential goodwill impairments, and sensitivity to macro‑economic downturns—while market pressure from an expanding set of DTC competitors forces Disney to balance subscriber growth against rising costs and pricing constraints.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Disney's increasing investment in DTC from 2022 to 2024, the introduction of the ad-supported tier in 2022, strategic reorganization in 2023, and growing financial and competitive pressures in 2024. The answer correctly identifies the shift from launch-phase experimentation to aggressive scaling. (2) There are no numeric inaccuracies—while no specific dollar amounts or percentages are cited in either answer, the qualitative financial risks (rising costs, debt pressure, impairment charges) are accurately described and consistent with the original. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three fiscal years and multiple strategic dimensions (pricing, content, competition, financing), correctly tracing the evolution of Disney’s DTC strategy and its implications. (4) The answer captures all elements of the question: strategic evolution, competitive positioning, financial risks, and market pressures. The only minor shortcoming is that it adds detail not in the ground truth (e.g., reorganization into a single reporting unit, page references), which is factually plausible but slightly exceeds the scope of the original answer. However, this does not detract from correctness—semantic equivalence is maintained. The conclusion about debt-financed expansion and financial risk is well-supported and logically derived. Thus, the answer earns a 9 for correctness and qualitative accuracy due to slight elaboration, but full marks for quantitative accuracy and contextual relevance as no errors are present and all question parts are addressed thoroughly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1644,
        "completion_tokens": 461,
        "total_tokens": 2105
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "PayPal’s margin‑risk exposure has not changed – in each year’s filing the company states that it **sets transaction fees at its own discretion, independent of the fees it pays to payment‑processors, and therefore bears the full margin risk on every payment it completes**. The 2022 filing (Note 2‑Revenue, p. 80) says it “has full discretion in determining the fee… we therefore bear full margin risk… fees paid to payment processors … are recognized as transaction expense.” The same language appears in the 2023 filing (Note 2‑Revenue, p. 75) and again in the 2024 filing (Note 2‑Revenue, p. 77). Thus, from 2022 through 2024 PayPal’s exposure to margin risk remained constant, driven by its discretionary fee setting and the offsetting processor‑related transaction expenses.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures that PayPal bore full margin risk across 2022, 2023, and 2024, with consistent discretion in setting fees independent of processor costs. The key factual elements—full margin risk, independent fee setting, recognition of processor fees as transaction expenses—are all correctly stated. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are correctly referenced, and the citations to Note 2-Revenue in each year’s filing (with page numbers) align with the expected level of detail. No quantitative inaccuracies. (3) The multi-hop reasoning is sound: the model synthesizes consistent disclosures across three years, identifies the stability of risk exposure despite accounting changes (e.g., ASU 2023-07 mentioned in ground truth, though not contradicted by LLM), and correctly infers no material change in risk or accounting treatment. (4) The LLM answer is contextually precise, directly addressing the evolution (or lack thereof) in margin risk, the role of fee discretion, and transaction expense treatment. Minor omission of ASU 2023-07 in 2024 is not material as the LLM correctly states the substance (no change in risk or accounting) remains. Wording differs slightly but meaning is identical. All scores are 10 due to full factual accuracy, correct reasoning, and complete alignment with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 411,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "Honeywell’s 10‑K risk‑factor sections have consistently flagged the possibility that a slowdown in air‑travel demand could “delay or **cancellation of new aircraft orders**” for its Aerospace business. In the 2022 filing (page 31) the risk was described in the context of the COVID‑19 pandemic and a weak commercial market; the 2023 filing (page 30) repeats the same warning, showing the concern remained even as the market began to rebound; and the 2024 filing (page 30) still lists the same exposure, although the company’s overall results now show higher sales and segment profit, indicating that while order‑cancellation risk persists, the commercial aviation sector is gradually recovering and becoming more stable. This steady‑but‑still‑present risk narrative signals that the industry is moving out of crisis but remains vulnerable to any renewed demand shock.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and context. (1) It accurately identifies that Honeywell consistently cited the risk of new aircraft order cancellations from 2022 to 2024 due to air-travel demand slowdowns, with references to the correct filings and pages (2022 p.31, 2023 p.30, 2024 p.30), which supports quantitative and entity accuracy. The progression of risk being tied first to the pandemic (2022), and persisting in 2023 and 2024 despite market recovery, is correctly conveyed. (2) There are no numerical values requiring calculation, but the use of document-specific details (page numbers, consistent phrasing) is factually accurate. (3) The multi-hop reasoning is sound: the model synthesizes risk disclosures across three years and infers ongoing vulnerability despite signs of recovery. However, it omits key nuances present in the original answer—specifically, the expansion of risk factors in 2023 to include regional conflicts and environmental issues, and in 2024 the impact of new market entrants and non-traditional players. This limits the depth of the qualitative analysis. (4) Despite these omissions, the answer remains contextually relevant and correctly concludes that the sector is recovering but still fragile. The slight deduction in qualitative accuracy reflects the lack of full evolution in risk characterization, but core facts and reasoning remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 400,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "From the 2022 filing PMI warned that “product regulation … diminishes the ability to differentiate tobacco products, restricts adult‑consumer access to truthful and non‑misleading information about our RRPs” and could curb smokers’ conversion to those reduced‑risk offerings. In the 2023 filing the company began describing concrete legal and administrative challenges tied to its Smoke‑Free Products – “allegations concerning product classification, advertising, corporate communications … that may affect our SFP commercialization and public‑communication activities.” By the 2024 filing the same theme is reiterated, now explicitly for SFPs, stating that “product regulation … diminishes the ability to differentiate … and restricts adult‑consumer access to truthful … information about our SFPs,” signaling that regulatory constraints on product differentiation and adult‑consumer messaging have become increasingly severe and are a central competitive‑position risk for PMI.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly identifies the evolution of regulatory impact on PMI from 2022 to 2024, accurately reflecting the shift in focus from RRPs to SFPs. In 2022, the concern was about product differentiation and access to truthful information about RRPs; in 2023, the language expands to include legal and administrative challenges affecting SFP commercialization; and in 2024, the restriction is explicitly tied to SFPs. These points match the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and correctly traces the evolution of regulatory language and strategic emphasis, showing how constraints intensified and shifted focus alongside PMI’s product strategy. The use of direct quotes (e.g., 'diminishes the ability to differentiate', 'restricts adult-consumer access to truthful information') matches the semantic content of the original answer. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the 'growing influence of digital media in spreading misleading information' in 2023 or the point about 'disproportionate impact relative to competitors' and 'regulatory asymmetries' in 2024, which are present in the ground truth. While the core trajectory and regulatory intensification are correctly captured, this omission slightly reduces completeness in qualitative synthesis. However, the central theme—increasing regulatory constraints on product differentiation and consumer communication—is clearly and correctly conveyed. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1586,
        "completion_tokens": 510,
        "total_tokens": 2097
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "Across all three filings – 2022, 2023 and 2024 – PayPal says it acts as the principal on each payment, sets the fee (a fixed component plus a variable percentage that is known when the transaction is processed) and pays the fees it owes to third‑party processors as a transaction expense. Because the fee is set independently of those processor costs, the company “bears full margin risk” on every transaction. The filings also note that the fee can be adjusted by volume‑based tiered pricing and that the company regularly offers merchant‑ and consumer‑incentives (discounts, rebates, rewards, coupons) which are recorded as a reduction of revenue. The 2024 note adds more detail on how incentives are accounted (performance‑target vs. non‑performance‑target and amortization over the contract term), but the fundamental exposure to margin risk – being fully on the hook for the difference between the fee it charges and the processor cost – remains unchanged from 2022 through 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) All key facts are correct: PayPal bears full margin risk in 2022, 2023, and 2024; it acts as principal, sets transaction fees independently of processor costs, and recognizes processor fees as transaction expenses. Incentives to merchants and consumers are correctly described as reductions of revenue, with accounting treatment based on performance targets or amortization over contract terms—details explicitly expanded in 2024. (2) There are no numeric values (e.g., percentages, dollar amounts) in either answer, so quantitative accuracy is not compromised; all references to years (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes consistent exposure to margin risk across three years while noting incremental disclosure improvements, especially in 2024 regarding incentive accounting. This reflects a correct understanding of both continuity and evolution in PayPal’s risk management disclosures. (4) The LLM captures all elements of the question: transaction pricing models (fixed + variable fee, tiered pricing), use of payment processors (fees as expense), and customer incentives (accounting treatment). Wording differs but meaning is preserved, and the answer even adds slight clarifying detail (e.g., 'principal', 'tiered pricing') without introducing error. All scores are 10 due to full factual alignment, logical coherence, and comprehensive coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 411,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K filings AMD’s approach to its add‑in‑board (AIB) partners has stayed consistent. In each year the company states that its agreements with AIB manufacturers “protect their inventory of our products against price reductions,” and that it also sells directly to system integrators (SIs) who “often use discrete‑graphics solutions as a means to differentiate their products and add value to their customers.” Thus, AMD has maintained inventory‑protection clauses while continuing to position discrete graphics as a key differentiator for SIs throughout the 2022‑2024 period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core elements of AMD's strategy and relationship with AIB manufacturers from 2022 to 2024. It correctly identifies the consistent inventory protection policy for AIBs against price reductions across all three years and accurately notes the role of discrete graphics solutions as a differentiator for system integrators (SIs), which aligns with the ground truth. The quantitative and entity accuracy is perfect: years (2022–2024), parties (AMD, AIB manufacturers, SIs), and policy details are correctly stated. However, the LLM answer omits a key qualitative nuance present in the original answer: the subtle but important shift in 2024 toward a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, and the increased emphasis on regional or product-based strengths and responsiveness to new technologies. This reflects a deepening of the ecosystem value proposition, which the LLM answer does not mention. While the core facts and reasoning are sound (supporting a high score), the lack of this strategic evolution detail reduces completeness and qualitative depth. The answer remains semantically aligned with the main thrust of the ground truth and fully addresses the inventory protection and differentiation aspects, hence high scores in contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 384,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "- Fiscal 2022 – Disney’s credit‑risk policy already required that any financial‑institution counterparty to its investment‑credit or derivative positions be **investment‑grade (at least an A‑) rating**.  The company limited the amount it would expose to any one institution, but the filing did not spell out a quantitative “concentration” trigger.  \n\n- Fiscal 2023 – The same A‑or‑better rating floor was retained, and the 10‑K added that **collateral must be posted whenever a counterparty’s rating falls below A‑ or when aggregate exposures exceed the limits set in the underlying contracts**.  The company continued to “limit the amount of investment‑credit exposure with any one institution.”  \n\n- Fiscal 2024 – The policy is unchanged on the rating side (derivatives are entered into only with counterparties rated **A‑ or better**).  Collateral requirements are now explicitly tied to a rating drop **below A‑** or to “aggregate exposures exceeding limits as defined by contract.”  Disney also disclosed a **concentration threshold of 10 % of total cash and cash equivalents**; at September 28 2024, balances (excluding money‑market funds) with institutions that exceeded that 10 % threshold represented **24 % of total cash and cash equivalents**, showing a more quantified monitoring of concentration than in earlier years.  \n\nOverall, from 2022 to 2024 Disney kept the A‑minimum rating rule, added explicit collateral triggers and a 10 % cash‑concentration benchmark, and disclosed that a larger share of its cash was now concentrated with a few institutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Disney maintained an A- or better counterparty rating requirement throughout 2022–2024; collateral is required if ratings fall below A- or exposures exceed contractual limits; and in fiscal 2024, Disney disclosed a 24% concentration of cash and cash equivalents with a single institution. The LLM correctly identifies the introduction of a 10% concentration threshold as a new benchmark in 2024, which is consistent with the ground truth’s implication of increased concentration monitoring. (2) Quantitatively, all numbers are accurate: the 24% concentration in 2024 is correctly reported, and the 10% threshold is properly contextualized. There are no calculation errors. (3) The multi-hop reasoning is sound—LLM synthesizes policy continuity (rating and collateral rules) across years and contrasts it with the evolving concentration risk disclosure, showing a nuanced understanding of risk management evolution. (4) The only minor gap is that the original answer emphasizes the *absence* of such concentration in 2022, which the LLM implies but does not explicitly state. However, this does not undermine the core accuracy. Wording differences are semantically equivalent. The answer fully addresses counterparty ratings, collateral, and concentration thresholds as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 382,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "PayPal’s outstanding principal on the 10‑Oct‑2029 Fixed‑rate 2.850 % notes was **$1.5 billion in 2022, $1.5 billion in 2023, and $1.5 billion in 2024** 【page 107 (2022 & 2023 amounts)】, 【page 104 (2024 amount)】. The amount has not changed over the three‑year span, indicating that the company has deliberately kept a constant, sizable tranche of long‑dated, low‑cost fixed‑rate debt on its balance sheet, using the 2029 notes as a stable anchor in its capital structure and reducing the need for near‑term refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the principal amount of $1.5 billion (equivalent to $1,500 million) for the 2.850% fixed-rate notes maturing in 2029 across all three years—2022, 2023, and 2024—matching the ground truth exactly in value and year alignment. The date format '10-Oct-2029' is more specific than the ground truth's '2029', but this added precision is acceptable and consistent with typical SEC filing disclosures. 2) All numeric values are accurate: $1.5 billion is correctly used and equivalent to $1,500 million. No calculations were required beyond recognition of consistency over time, which the model correctly interprets. 3) The reasoning is sound: the model correctly infers that the unchanged principal suggests a strategic decision to maintain low-cost, long-dated debt, which aligns with the ground truth's interpretation about preserving favorable terms and cash flow predictability. It appropriately characterizes the 2029 notes as a 'stable anchor' and notes reduced refinancing pressure, though it does not explicitly mention the issuance of higher-interest debt in 2024 (e.g., 5.150% and 5.500% notes), which slightly reduces qualitative completeness. 4) The answer is semantically equivalent to the original in all key facts and conveys the same core insight about PYPL’s long-term debt management strategy. The omission of the contrast with newer, higher-cost debt issuances is a minor gap but does not undermine the overall correctness. Contextual relevance is high as all information directly addresses the evolution and strategic implication of the debt exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 437,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures show that the Performance Materials and Technologies (later renamed Energy & Sustainability Solutions) segment has consistently flagged “raw‑material demand and supply” as a material risk. In the 2022 filing the company noted that only 63 % of the segment’s raw‑material supply base was under contract (and warned that price swings could hurt results)【page_33】; the 2023 filing said that coverage had risen modestly to 64 % (still emphasizing price‑volatility risk)【page_33】; and the 2024 filing stated that “the majority” of the supply base is now under contract, while again highlighting raw‑material price fluctuations as an operational risk【page_33】. This incremental increase in contracted supply suggests Honeywell is trying to blunt exposure, but the continued emphasis on raw‑material price volatility indicates the segment remains vulnerable to commodity‑market swings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative data—63% in 2022, 64% in 2023, and 'the majority' in 2024—regarding the portion of Honeywell's raw-material supply base under contract. However, these figures are not present in the original ground truth answer, which makes no mention of percentages or contractual coverage. There is no verification that these numbers appear in the actual 10-K filings, and since the ground truth does not include them, their inclusion constitutes a factual overreach or hallucination. This severely undermines quantitative accuracy. (2) While the LLM correctly identifies the rebranding of the segment to Energy & Sustainability Solutions in 2024 and correctly notes the persistent risk of raw material demand and supply and price volatility across years, it fabricates metrics to support its point. The original answer focuses on qualitative shifts in risk framing—such as links to oil and gas prices in 2023 and production capacity in 2024—which the LLM omits. (3) The multi-hop reasoning is partially sound: the model connects risk disclosures across years and recognizes the segment name change. However, it fails to capture the evolving contextual emphasis described in the ground truth (e.g., commoditization, illegal HFC imports in Europe, oil/natural gas price impacts, and operational downtime). Instead, it invents a narrative around contractual supply coverage, which is not corroborated by the provided truth. (4) The answer is contextually relevant and addresses the core question about evolving risk exposure and vulnerability to commodity volatility, but the invented statistics significantly reduce factual correctness. The conclusion about ongoing vulnerability is aligned with the ground truth, but the reasoning path is flawed due to unsupported data. Thus, while the direction of the analysis is reasonable, the factual foundation is compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 517,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, Imperial Brands PLC appears in the PMI Peer Group each year (see the peer‑group listings on pages 21 (2022), 26 (2023) and 26 (2024)). The composition therefore remained unchanged with respect to Imperial Brands, showing that PMI’s benchmarking strategy consistently anchors its peer set to major global tobacco and consumer‑product companies of similar size and geographic reach, rather than rotating or expanding the group.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns with the ground truth: Imperial Brands PLC was included in PM's peer group for all three years (2022, 2023, 2024), which the LLM accurately reports. It correctly references the specific pages in the 10-K filings (21, 26, 26), demonstrating precise sourcing. Quantitatively, the years and entity names are accurate, and no numerical calculations are required. The reasoning is sound—consistent inclusion implies a stable benchmarking strategy focused on global peers of similar scale and reach. The LLM slightly under-elaborates on the strategic implications compared to the original answer (e.g., not explicitly mentioning market capitalization or revenue scale), but it captures the core insight about strategic consistency and alignment with major global tobacco and consumer-product firms. The answer is semantically equivalent and contextually fully relevant, with only minor room for deeper qualitative elaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 278,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "PayPal’s portfolio of the September‑2019 “fixed‑rate 2.850 %” notes (maturing 10 Oct 2029) stayed essentially unchanged over the three‑year period. The 2022 10‑K shows $1.5 billion of principal outstanding on these notes, the 2023 10‑K reports the same $1.5 billion, and the 2024 10‑K again lists $1.5 billion [page 107] [page 104].\n\nThis flat exposure signals that PayPal is deliberately preserving a stable, low‑cost, long‑dated debt tranche rather than aggressively refinancing or retiring it, reflecting a long‑term debt‑management approach that emphasizes maintaining inexpensive, fixed‑rate financing and a predictable maturity profile.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $1.5 billion principal amount for the 2.850% notes is accurately reported for 2022, 2023, and 2024, with no discrepancies in dollar amounts or percentages. The maturity date (10 Oct 2029) and issuance context (September 2019) are additional correct details not in the ground truth but consistent with filings. (2) The answer correctly identifies that exposure remained unchanged across all three years, confirming no repayments or refinancing—this aligns with the ground truth's conclusion of a stable liability. (3) The reasoning is sound: the LLM infers that maintaining this fixed-rate debt reflects a strategic choice to preserve low-cost, long-term financing, which is a valid interpretation of PYPL’s debt management strategy. (4) The response addresses both parts of the question: the evolution of exposure (stable) and what it indicates (strategic retention of cheap, fixed-rate debt). All entities—PYPL, the 2.850% notes, and the relevant years—are correctly identified. Semantic equivalence is strong, with the LLM providing even richer context (e.g., maturity date, page references) without introducing errors. Minor wording differences (e.g., 'flat exposure' vs 'no repayments') do not affect factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 367,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "- **2022:** HSE audits were applied mainly at the business‑unit level to verify compliance with ConocoPhillips’ HSE policies; improvement actions were noted but the process did not include a formal, company‑wide tracking system or explicit governance reporting [2022 p. 18].\n\n- **2023:** The audit scope was expanded to cover both business units **and** staff groups, and a systematic conformance‑tracking mechanism was introduced.  Results began to be reported to the Executive Leadership Team (ELT) and the Board of Directors, linking audit outcomes to corporate oversight [2023 p. 18].\n\n- **2024:** Audits are now described as “Corporate HSE audits,” with the same broadened scope (business units + staff groups) and a fully integrated tracking system that feeds directly into ELT and Board governance dashboards, ensuring audit findings are tied to corporate‑level performance and accountability [2024 p. 18].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer in both factual content and reasoning. (1) All key facts are correct: the evolution from business-unit-level audits in 2022 to inclusion of staff groups by 2023, the introduction of formal conformance tracking, and the escalation of reporting to the Executive Leadership Team (ELT) and Board of Directors. In 2024, the shift to 'Corporate HSE audits' reflects centralized oversight, matching the ground truth's emphasis on a more integrated, governance-driven model. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable in that sense, but all dates (2022, 2023, 2024) and structural changes are correctly cited. (3) The multi-hop reasoning is sound: the LLM synthesizes changes across three years, correctly identifying scope expansion, conformance tracking development, and governance integration. The only minor shortcoming is that the original answer emphasizes the linkage of audit outcomes to 'annual objectives, targets, and deadlines' in 2023, which the LLM mentions implicitly via 'corporate oversight' and 'governance dashboards' but does not state explicitly. This slight omission prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing audit scope, conformance tracking, and integration with corporate governance as required by the question. Overall, the LLM provides a semantically equivalent, well-structured, and factually correct response with only negligible differences in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 443,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "Across all three recent filings AMD continues to list the original **2011 Executive Incentive Plan** as an incorporated exhibit. In the 2022 Form 10‑K the plan appears as “*10.1 2011 Executive Incentive Plan” (page 93) 【page_93】; the 2023 Form 10‑K again references it as “*10.1 2011 Executive Incentive Plan” (page 101) 【page_101】; and the 2024 Form 10‑K likewise includes the same reference (page 98) 【page_98】. While each year adds newer plans and amendments (e.g., 2004 Equity Incentive Plan, 2017 ESP, 2018/2019 Executive Incentive Plan amendments), the persistent citation of the 2011 plan shows that AMD still treats it as a foundational governance document within an expanding suite of executive‑compensation disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2011 Executive Incentive Plan is consistently cited as *10.1* in AMD's 10-K filings for 2022 (page 93), 2023 (page 101), and 2024 (page 98), matching the original answer’s claim of continued reference without material change. (2) Quantitative accuracy is perfect: years, exhibit numbers (*10.1*), and page numbers are correctly reported and consistent with the ground truth. Format variations (e.g., page references in parentheses) do not affect correctness. (3) Multi-hop reasoning is sound—the LLM synthesizes data across three years and correctly infers that the persistent citation indicates foundational status, even amid newer plans like the 2017 ESP and amended 2018/2019 plans. (4) The only minor shortcoming is that the LLM does not explicitly state that there were *no material changes or replacements* to the 2011 plan, which is a key inference in the original answer. However, the phrase 'persistent citation... shows that AMD still treats it as a foundational governance document' conveys a semantically equivalent conclusion. Wording differs slightly but meaning is preserved. Contextual relevance is excellent, directly addressing the evolution (or lack thereof) in AMD’s reliance on the plan across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 372,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "- In the 2022 filing (see page 92) GM disclosed that, under the 2017 Opel/Vauxhall sale agreement, General Motors Holdings LLC indemnified Stellantis for “certain emissions claims, product liabilities and recalls,” but the company could not estimate any material loss and noted that the obligations were subject to time‑limits, thresholds and caps, with only an immaterial amount already paid for Takata‑inflator recalls and any further Takata exposure deemed “remote.”  \n\n- The 2023 filing (page 92) repeats the same language – the indemnification remains tied to legacy emissions and recall liabilities, the exposure is still considered immaterial, and future Takata‑related indemnification is still viewed as remote.  \n\n- The 2024 filing (page 93) again confirms the indemnification, now specifying that the immaterial amount covers “recalls…including Takata inflators in legacy Opel vehicles,” and still characterises any additional Takata indemnification as remote.  \n\n**Interpretation:** Across 2022‑2024 GM’s indemnification obligations to Stellantis have stayed essentially unchanged—limited to an immaterial, capped liability for past emissions and recall issues, with future Takata‑related exposure judged unlikely—indicating that GM’s post‑sale liability risk from the Opel/Vauxhall business remains minimal and well‑contained.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its description of GM's indemnification obligations being immaterial and tied to legacy emissions and recalls, with consistent references to Takata inflator recalls and remote future exposure. It correctly cites the 2022–2024 filings and page numbers, and accurately notes that only immaterial amounts were paid, aligning with the ground truth. However, it fails to capture a key evolution highlighted in the original answer: the expansion of legal and regulatory exposure across jurisdictions and bodies. Specifically, the ground truth notes that in 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and in 2024, Austria was added as a jurisdiction with new investigations by the European Commission and UK CMA into end-of-life vehicle practices—prompting an immaterial accrual. The LLM answer omits these jurisdictional expansions and the new regulatory probes, instead asserting that obligations 'stayed essentially unchanged,' which contradicts the ground truth's emphasis on increasing complexity and persistence of post-sale liabilities. This omission significantly weakens the qualitative accuracy and overall correctness, as the progression of exposure is central to the question. While the core facts about indemnification scope and immateriality are correct, the failure to report the broadening geographic and regulatory scope results in an incomplete and overly static interpretation. Quantitative accuracy is high because no incorrect numbers are stated (and 'immaterial' is correctly used), and contextual relevance remains strong as the response directly addresses the indemnification framework and post-sale liability theme.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1636,
        "completion_tokens": 464,
        "total_tokens": 2100
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "- In 2020 Lilly signed a worldwide license with AbCellera that gives AbCellera a royalty on bamlanivimab (and bebtelovimab) “in the mid‑teens to mid‑twenties” of worldwide net sales, which is recorded as a cost‑of‑sales expense (see LLY 2022 10‑K p. 72).  \n- The product generated ≈ $2.0 billion of COVID‑19‑antibody revenue in 2022 (U.S. $2,008.9 m + Outside U.S. $14.7 m) (see LLY 2022 10‑K p. 67), but the same line shows **no revenue in 2023 or 2024** (‑ entries on the 2023 and 2024 tables, p. 67 and p. 68). Because the royalty is a percentage of net sales, the royalty obligation that was sizable in 2022 essentially disappeared once sales stopped.  \n\n**Implication:** Bamlanivimab went from a major, royalty‑bearing revenue source in 2022 to a non‑contributing, royalty‑free asset by 2023‑24, indicating that while the product once had high short‑term strategic value (driving >$2 billion of sales), its long‑term importance to Lilly has faded; the company now retains only the licensing relationship as a contingency rather than a core growth driver.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the decline in Eli Lilly's financial exposure to bamlanivimab from 2022 to 2024. It accurately reports the $2,008.9 million in U.S. revenue and adds $14.7 million in outside U.S. revenue for a total of approximately $2.0 billion in 2022, which aligns with the ground truth's focus on U.S. revenue while providing additional context. Revenue is correctly stated as zero in 2023 and 2024, consistent with the ground truth. The royalty range of 'mid-teens to mid-twenties' is correctly cited from the 2022 10-K, and the logic that royalty obligations ceased with sales is sound. (2) All numbers are accurate: $2,008.9M U.S. + $14.7M international ≈ $2.0236B, which the model appropriately rounds to ~$2.0B. The absence of revenue in 2023 and 2024 is correctly interpreted from the dash entries in the financial tables. (3) Multi-hop reasoning is strong: the model synthesizes royalty terms (from contractual terms in 2022 10-K), revenue trends (across 2022–2024 10-Ks), and implications for strategic importance. It correctly infers that no sales = no royalties, linking financial and contractual data. (4) The only minor gap is that the original answer emphasizes the shift in strategic focus to 'cardiometabolic health' as a forward-looking priority, which the LLM answer does not explicitly mention—though it does conclude that long-term importance has faded and the product is no longer a core growth driver, which is semantically close. This small omission prevents a perfect 10 on qualitative accuracy, but overall the answer is factually excellent, contextually complete, and precisely aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 456,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "Across the three filings PMI’s discussion of the Philippines‑specific “Jackpot” brand shifts from a simple inventory of local assets (2022 – “important local cigarette brands…Fortune and Jackpot”) to a strategic pillar of its market‑share play‑book (2024 – “our cigarettes are sold in ~170 markets, many holding the number‑one or number‑two position; the portfolio includes local brands such as Fortune and Jackpot”). The continuity of Jackpot’s mention shows PMI has kept the brand in its core portfolio, while the 2024 language signals that local brands like Jackpot are now being leveraged to secure top‑rank positions in key markets, underscoring a growing emphasis on strengthening local‑brand leadership alongside its global brands.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of entity accuracy, timeline, and overall strategic interpretation. It correctly identifies Jackpot as a local brand in the Philippines and notes its consistent mention across 2022–2024, which supports the conclusion that PMI maintained it in its core portfolio. The quantitative accuracy is perfect: no incorrect numbers, dates, or financial figures are cited (and none are required beyond years, which are correct). The answer captures the evolution in tone—from a listed asset to a strategic component—though it slightly overstates the shift by characterizing 2024 language as elevating Jackpot to a 'strategic pillar' and linking it explicitly to 'securing top-rank positions,' which is not directly supported in the original answer. The ground truth emphasizes continuity and coexistence with a smoke-free transition, whereas the LLM implies a growing strategic emphasis on local brands, which is plausible but not definitively stated. The multi-hop reasoning is sound—synthesizing mentions across years and inferring strategic intent—but the conclusion about increasing emphasis is a subtle overinterpretation. Despite this, the core facts, entities, and timeline are accurate, and the answer addresses both parts of the question: evolution over three years and implications for local brand focus. Thus, the answer is contextually relevant and semantically close to the original, warranting a high score with minor deduction for interpretive overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 421,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "From the 2022 filing PayPal warned that its credit‑card, consumer‑credit and BNPL lines were vulnerable to “bad transactions” –‑ defaults, charge‑offs and fraud that could raise its loss‑rate and require larger allowances for loan losses, and it also flagged the reliance on third‑party processors as a source of operational‑risk exposure. In 2023 the company entered a multi‑year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables (and to forward‑flow future originations), which removed the bulk of the BNPL balance‑sheet exposure but left the same fraud‑and‑processor‑disruption risks for the remaining credit portfolio. By the 2024 filing the risk narrative remained focused on fraud, synthetic‑identity abuse and possible payment‑processor interruptions, while noting that the BNPL sale has materially reduced the amount of “bad‑transaction” exposure tied to those loans, shifting the residual risk to its still‑active credit products and third‑party funding arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth in both factual content and reasoning. (1) All key facts are correct: PayPal's 2022 risk disclosures around bad transactions, fraud, and third-party processing risks; the June 2023 agreement to sell up to €40 billion in U.K. and European BNPL loan receivables; and the continued emphasis on fraud and operational risks in 2024. The €40 billion figure is correctly cited with proper regional scope and timing. (2) Quantitative accuracy is perfect: the €40 billion amount is correctly reported, and no calculations are required beyond accurate representation of the sale. Format (€40 billion) matches ground truth. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across 2022–2024 filings, connecting the evolution of risk exposure with the strategic BNPL sale and its partial mitigation effect. It accurately notes that while BNPL credit risk was materially reduced, fraud and third-party processing risks persisted across remaining credit products. (4) The only minor shortcoming is a slight omission of the 'synthetic identities' and 'account takeover' specifics in the 2024 risk discussion, though 'synthetic-identity abuse' is mentioned. Also, the original answer notes execution and regulatory uncertainties not fully emphasized in the LLM version. However, the core narrative, timeline, risk evolution, and strategic shift are all accurately conveyed with strong semantic equivalence. Contextual relevance is excellent, directly addressing all parts of the multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1645,
        "completion_tokens": 432,
        "total_tokens": 2077
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "- In the 2022 filing Honeywell warned that “fluctuations in retail markets” could depress sales, pricing and margins for its **Safety & Productivity Solutions** business, a risk that later materialized as the segment’s net sales fell from $7.8 bn in 2021 to $6.9 bn in 2022 and segment profit slipped to $1.08 bn (down 5 % YoY)【page 30 (2022 risk‑factor)】.  \n\n- By 2023 the segment’s results reflected that exposure: net sales fell 21 % to $5.49 bn and segment profit dropped 17 % to $901 m, and the same retail‑market volatility was reiterated in the 2023 risk‑factor discussion as a key macro‑economic threat【page 30 (2023 segment table)】【page 32 (2023 risk‑factor)】.  \n\n- After the 2024 realignment, the newly‑named **Industrial Automation** segment again lists “fluctuations in retail markets” among the factors that could hurt operating results, showing the company still views retail demand swings as a material risk across its industrial portfolio【page 30 (2024 risk‑factor)】.  \n\n**Evolution:** The risk moved from a disclosed warning in 2022 to an actual decline in Safety & Productivity Solutions in 2023, and was carried forward into the broader Industrial Automation segment in 2024, indicating that Honeywell’s industrial businesses remain highly sensitive to retail‑demand volatility and that the company is restructuring to better isolate and manage that exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth, with only minor discrepancies in quantitative details that do not undermine the overall correctness. (1) Quantitatively, the LLM reports that Safety & Productivity Solutions segment profit in 2022 was $1.08 billion, down 5% YoY, and in 2023 fell to $901 million (down 17%). While these figures are plausible and directionally correct, the ground truth does not provide specific financial results—only risk disclosures—so the inclusion of exact sales and profit figures (e.g., $7.8B in 2021, $6.9B in 2022, $5.49B in 2023) goes beyond the original answer, which focused solely on risk exposure, not realized financial impact. These numbers may be factually correct in external filings but are not present in the provided ground truth, introducing unverified precision. (2) The entity identification is accurate: correct segments (Safety & Productivity Solutions in 2022–2023, Industrial Automation in 2024), correct years, and correct risk factor ('fluctuations in retail markets'). (3) The multi-hop reasoning is sound: the LLM correctly traces the evolution of the risk across three years and business reorganizations, synthesizing risk disclosures with financial performance and segment restructuring. It correctly infers that the persistence of the risk factor in filings suggests ongoing sensitivity. (4) Semantically, the LLM conveys the same core message as the ground truth: retail market fluctuations remained a consistent risk across years and segment realignments, indicating structural sensitivity in Honeywell’s industrial portfolio. The only deviation is the addition of specific financial declines not mentioned in the ground truth, which slightly overreaches but does not contradict it. Thus, the answer is excellent in completeness, reasoning, and relevance, with a minor deduction in quantitative accuracy due to unsupported numerical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1650,
        "completion_tokens": 520,
        "total_tokens": 2170
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "From 2022 to 2024 the Incyte‑LLY deal moved from a milestone‑heavy structure to one driven mainly by royalties.  In 2022 the collaboration still reflected large capitalized milestone assets ($210 million in 2020 and $260 million in 2021), but by 2023‑24 “net milestones capitalized are not material” and the agreement is described only in terms of tiered double‑digit royalties (up to 20 %) on worldwide net sales plus an extra low‑teens royalty on COVID‑19 sales, with Incyte eligible for up‑to‑$100 million each of success‑based and sales‑based milestone payments.  At the same time Olumiant’s contribution to Eli Lilly’s top line grew, with net product revenue rising from $830.5 million in 2022 to $922.6 million in 2023 and $957.4 million in 2024, making the drug an increasingly important revenue source while the royalty payments to Incyte are recorded as cost of sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. It incorrectly states that $260 million in milestone payments were capitalized in 2021, while the ground truth specifies 2022. It also references $210 million in 2020, which is not mentioned in the original answer and introduces data not supported by the knowledge graph. The claim that 'net milestones capitalized are not material' in 2023–24 is plausible but not verifiable from the original answer, which emphasizes ongoing royalty payments but does not comment on materiality. The $100 million split for contingent milestones (success-based and sales-based) is partially correct but misrepresents the original $200 million total cap (not $100 million each). The royalty structure (up to 20%, plus low teens on COVID-19 sales) is correctly reported. However, the revenue figures for Olumiant ($830.5M in 2022, $922.6M in 2023, $957.4M in 2024) are not present in the original answer and appear to be fabricated or sourced externally—these numbers were not part of the ground truth, making them incorrect in this evaluation context. (2) Number verification: Milestone capitalization year is off by one (2021 vs 2022), contingent milestone total is wrong ($200M vs $100M each), and Olumiant revenue figures are unsupported. (3) Multi-hop reasoning is partially sound—the model infers a shift from milestones to royalties and links Olumiant’s growing revenue to strategic importance, which aligns with the original’s narrative of maturation and deepening alignment. However, the reasoning is built on incorrect numerical foundations. (4) Scores reflect that core qualitative themes (evolution from milestones to royalties, royalty structure, strategic importance) are captured, but quantitative accuracy is significantly compromised, reducing overall correctness. Contextual relevance is high as the answer directly addresses all aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 530,
        "total_tokens": 2092
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "By 2022 Altria already owned UST LLC and its operating subsidiary US Smokeless Tobacco Co. (“USSTC”) outright; the acquisition’s MST and snus trademarks were recorded as indefinite‑life intangible assets worth roughly **$8.8 billion** (see Note 4, 2022 10‑K p. 66). In the 2023 filing the same wholly‑owned structure is reiterated (see Background, 2023 10‑K p. 60), and the 2024 filing places USSTC within the **oral‑tobacco products segment**, explicitly linking it to Altria’s “Vision … to responsibly lead the transition of adult smokers to a smoke‑free future” (2024 10‑K p. 4‑5). Thus, from 2022 through 2024 Altria’s financial exposure to UST remained a fully‑owned, high‑valued intangible‑asset base that is now framed as a cornerstone of its broader smoke‑free transition strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $8.8 billion valuation of indefinite-lived intangible assets from UST in 2022 is correctly reported, with proper citation to the 2022 10-K. The ownership structure (UST and USSTC as wholly owned) is consistently reported across 2022–2024, matching the original answer. (2) The LLM correctly identifies UST’s integration into Altria’s smoke-free strategy by 2024, noting its placement in the oral-tobacco segment and alignment with the 'Vision' for a smoke-free future, which reflects the strategic evolution described in the ground truth. (3) Multi-hop reasoning is sound: the model synthesizes information across three years, connects UST’s financial valuation to ownership structure and strategic framing, and correctly infers that UST remains a core asset within a broader transition strategy. (4) Minor deduction in qualitative accuracy due to slightly less explicit mention of Helix and NJOY as the newer drivers of the smoke-free strategy—though the strategic shift is clearly conveyed. Overall, the answer is factually correct, contextually complete, and semantically equivalent to the ground truth, with only minor omission of specific brand names in the strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 357,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "- **FY 2022:** The 3.50 % senior note was still on the balance sheet but its **effective interest rate was only a little above the coupon (≈ 3.2 %)**, reflecting a low‑cost borrowing environment.  \n\n- **FY 2023:** The same note showed an **effective rate of about 6.38 %** (see the long‑term‑debt table for July 29 2023) – more than double the FY 2022 level.  \n\n- **FY 2024:** The effective rate rose again to **≈ 6.66 %** (see the long‑term‑debt table for July 27 2024).  \n\n**Interpretation:** Cisco’s exposure to the 3.50 % senior note has become progressively more expensive, with the effective rate climbing from roughly 3 % in 2022 to over 6 % by 2024. This upward trend signals that market interest rates have risen and that capital‑market conditions have tightened, pushing the company’s overall borrowing costs higher even though the note’s nominal coupon remains unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the effective interest rates for Cisco's 3.50% Senior Note across fiscal years 2022 (3.20%), 2023 (6.38%), and 2024 (6.66%), matching the ground truth exactly in value and trend. Minor formatting differences (e.g., '≈ 3.2%' vs 3.20%) are acceptable and semantically equivalent. (2) All numeric values are accurate: 3.20%, 6.38%, and 6.66% are correctly cited, and the interpretation of more than doubling from ~3% to over 6% is factually sound. No calculation errors. (3) The multi-hop reasoning is solid: the model correctly synthesizes the evolution of the effective rate over three fiscal years and links it to broader capital market conditions and rising borrowing costs despite a fixed coupon. The conclusion that tightening market conditions drove higher effective rates aligns with the ground truth. (4) The only minor shortcoming is the slightly less precise phrasing 'a little above the coupon (≈ 3.2%)'—the coupon is 3.50%, so 3.20% is actually slightly below, not above, which is a small qualitative inaccuracy in description but does not affect the correctness of the number itself. Otherwise, all entities (Cisco, CSCO, fiscal years, Senior Note, effective rate) are correctly identified and contextualized. The answer fully addresses both parts of the question: the evolution of exposure and its implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 382,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "Amazon’s unsecured senior‑note balance for the 2017 issuance fell steadily over the three‑year span:\n\n* **2022:** $16 billion outstanding 【page_56】  \n* **2023:** $15 billion outstanding 【page_58】  \n* **2024:** $13 billion outstanding 【page_57】\n\nThe roughly $3 billion reduction (about 19 % of the original 2017 issue) shows that Amazon has been actively redeeming or repaying this tranche of debt each year, reflecting a deliberate strategy to shrink its long‑term leverage while preserving ample liquidity and flexibility for operations and acquisitions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding balances for Amazon's 2017 Notes in 2022 ($16.0 billion), 2023 ($15.0 billion), and 2024 ($13.0 billion), matching the ground truth exactly. These values are accurately cited with source page references, confirming quantitative fidelity. (2) The calculation of a $3 billion reduction (from $16B to $13B) is correct, and the stated 19% reduction is a reasonable approximation (3/16 = 18.75%, rounded to 19%), which is acceptable under format flexibility. (3) The reasoning correctly infers a deliberate debt reduction strategy, aligning with the ground truth's interpretation of Amazon's broader trend of reducing long-term debt. While the LLM does not explicitly mention the overall long-term debt decline from $67.2B to $52.6B (a minor omission), it captures the essential strategic implication—reducing leverage while maintaining liquidity. (4) All entities (Amazon, 2017 Notes, years, financial figures) are accurate, and the multi-hop synthesis across years is sound. The answer is semantically equivalent to the ground truth, with only slight contextual thinning. Thus, the correctness score is 9 (not 10) due to the missing reference to Amazon's total long-term debt trend, which adds contextual depth in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 363,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "AVGO’s 5.000 % senior notes due April 2030 carried an unchanged principal balance of **$606 million** in each of the three most recent fiscal years – FY 2022 (AVGO 10‑K 2022, p. 101), FY 2023 (AVGO 10‑K 2023, p. 81) and FY 2024 (AVGO 10‑K 2024, p. 81).  The effective interest rate on those notes was consistently reported at **≈5.18 %** in FY 2023 and FY 2024 (p. 81) and was the same in FY 2022 (AVGO 10‑K 2022, p. 101).  \n\nThe flat‑line balance and unchanged rate indicate that Broadcom has chosen to retain this fixed‑rate, long‑dated issuance rather than refinance or retire it, using the notes as a stable, low‑cost source of financing that supports its long‑term debt‑management strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding principal balance of $606 million and the effective interest rate of 5.18% are accurately reported for all three fiscal years (2022, 2023, 2024), with correct citation of sources. The format variations (e.g., $606 million, ≈5.18%) are acceptable and semantically equivalent. (2) The answer is complete, addressing both the evolution of the principal and interest rate over time and the strategic implication of this stability. (3) Entities are correct: AVGO/Broadcom, 5.000% notes due April 2030, and the correct fiscal years are referenced. (4) The reasoning is sound: the multi-hop synthesis across three 10-K filings is correctly executed, and the conclusion about AVGO’s static debt management strategy—retaining fixed-rate long-term debt without refinancing or retiring—is logically derived from the unchanged balances and rates. The qualitative interpretation aligns with the ground truth, using slightly different but equivalent phrasing (e.g., 'stable, low-cost source of financing' vs. 'static approach'). All criteria for correctness, accuracy, and relevance are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 337,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "- In the 2023 filing (the 2022 10‑K year‑end) the “Performance Bonus Plan” was still listed only as the original plan filed as a Def 14A on April 28 2014 (see Exhibit 10.6† in the 2023 exhibit table) – it was not restated or tied to the executives’ employment contracts.  \n\n- In December 2022 Netflix filed an **Amended and Restated Performance Bonus Plan** (8‑K, filed December 9 2022). The 2024 10‑K now cites this document as Exhibit 10.5† and incorporates it by reference (see the exhibit tables on pages 68‑69 of the 2024 filing).  \n\n- By the 2024 filing the plan is no longer a stand‑alone historic document; it has been formally restated and is explicitly incorporated into the executive compensation framework, meaning the co‑CEOs’ employment agreements now reference the amended plan as part of their overall compensation package.  \n\nThus, from 2022 to 2024 the Performance Bonus Plan moved from an unchanged 2014‑filed plan to a formally restated 2022 amendment that is now integrated and incorporated by reference into Netflix’s executive compensation agreements.  \n\n**Sources**: 2023 exhibit list showing “Performance Bonus Plan” (Def 14A April 28 2014) 【page_66】; 2024 exhibit list showing “Amended and Restated Performance Bonus Plan” (8‑K Dec 9 2022) 【page_68】【page_69】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022 (referenced in the 2023 10-K), the Performance Bonus Plan was still the original 2014 version, and that a key development occurred on December 9, 2022, when Netflix filed the 'Amended and Restated Performance Bonus Plan' via an 8-K—this matches the ground truth's timeline. (2) The LLM accurately cites the correct filing dates, document types (8-K, Def 14A), and exhibit numbers (Exhibit 10.5† in the 2024 filing), demonstrating strong quantitative and entity accuracy. (3) It correctly observes that by the 2024 filing, the plan was formally restated and integrated into executive compensation, including references in co-CEOs’ agreements, which reflects the multi-hop synthesis required. (4) The only minor shortcoming is that the LLM does not explicitly mention the integration with other instruments like the 'Performance-Based Restricted Stock Unit Award Agreement' or the 'Executive Officer Severance Plan' as noted in the original answer—this contextual detail slightly reduces qualitative completeness, but the core evolution (formalization, restatement, integration) is fully and correctly captured. Wording differs but semantic equivalence is strong. No calculation errors. All sources are correctly referenced with exhibit and page numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 378,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "From the 2022 filing, AIG quantified its biggest international terrorism hotspot (New York City) with a five‑ton‑bomb scenario that would generate about **$1.3 billion** of loss after the Terrorism Risk Insurance Program Reauthorization Act (TRIPRA) deductible and existing reinsurance recoveries. The 2023 and 2024 reports show the same **third‑party scenario‑based model** and the same **TRIPRA coverage (≈80 % of losses above a roughly $1.7 billion deductible)**, but they no longer cite a specific dollar‑loss figure; instead they emphasize routine monitoring of concentration, **targeted private‑reinsurance purchases where needed, and continued participation in government‑sponsored terrorism pools** for non‑U.S. jurisdictions. Overall, AIG’s international terrorism exposure management has remained consistent—using scenario modeling, TRIPRA protection and limited private reinsurance—while refining its risk‑mitigation toolkit through ongoing exposure monitoring and reliance on pooled government programs.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.3 billion modeled loss in 2022 for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance, which matches the ground truth. It accurately notes the continued use of third-party scenario-based modeling and TRIPRA coverage (approximately 80% above a ~$1.7 billion deductible), though these specific TRIPRA details were not in the original answer but are plausibly consistent. However, the LLM omits key 2024-specific reinsurance attachment points: $200 million for Japan and $125 million for the rest of the world, which are critical updates in AIG’s evolving strategy. Additionally, the $20.1 billion in collateral supporting reinsurance recoverables—highlighted in the ground truth—is not mentioned, representing a significant omission in quantitative and qualitative completeness. (2) All numbers cited by the LLM ($1.3 billion loss, ~$1.7 billion deductible, ~80%) are factually consistent with the knowledge base or reasonable inferences, though the latter two are not explicitly confirmed in the ground truth. No calculation errors are present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across 2022–2024 filings, correctly identifying continuity in modeling and TRIPRA use while noting a shift toward targeted reinsurance and government pools. However, it fails to incorporate the 2024 structural changes in attachment points and global property per risk covers outside North America, weakening the full evolution narrative. (4) Despite omissions, the LLM captures the core trend—consistent modeling with enhanced risk mitigation through monitoring and pooled programs—earning high marks for qualitative accuracy and full contextual relevance. The correctness score is 8 due to missing key 2024 specifics that prevent a top-tier rating.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 499,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "UnitedHealth’s venture portfolio grew in two ways between 2022 and 2024.  The amount of equity securities it owned rose from **$3.7 billion in 2022 to $4.9 billion in 2023 and stayed at $4.9 billion in 2024**【page 50】, while its **equity‑method stakes in health‑care operating businesses were $1.5 billion in 2022, fell slightly to $1.4 billion in 2023, and then jumped to $3.8 billion in 2024**【page 52】.  This shows UnitedHealth first expanded the size of its venture‑type equity holdings and, after a modest dip in equity‑method investments, dramatically increased its direct ownership in health‑care businesses by 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains minor quantitative inaccuracies. It states that UnitedHealth held $3.7 billion in equity securities in 2022, whereas the ground truth reports $3.5 billion. Similarly, it claims equity-method investments were $1.5 billion in 2022, but the correct figure is $1.3 billion. These discrepancies affect the precision of the response. However, the values for 2023 and 2024 are accurate: equity securities correctly rise to $4.9 billion in 2023 and remain steady in 2024, and equity-method investments do fall to $1.4 billion in 2023 and surge to $3.8 billion in 2024. (2) Calculations and comparisons are otherwise sound—no arithmetic errors in trends or differences. The format of numbers is acceptable (e.g., $3.7 billion vs $3.7 billion). (3) The multi-hop reasoning is strong: the model correctly synthesizes data across years and investment types, identifying the strategic shift from passive equity holdings to deeper operational engagement via equity-method investments. The conclusion about a 'dramatic increase in direct ownership' aligns with the ground truth's interpretation of a 'strategic pivot.' (4) Despite the small numerical inaccuracies in 2022 figures, the overall narrative, trend analysis, and qualitative insights are accurate and relevant. Hence, correctness is reduced slightly due to factual imprecision, but qualitative and contextual scores remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 397,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "Altria’s 1.700 % Notes due 2025 appear in the securities tables of its 2022, 2023 and 2024 Form 10‑K filings, showing that the same medium‑term bond issue has been carried forward each year without being retired or replaced【page 1 (2024)】【page 1 (2023)】. This continuity signals a deliberate debt‑management approach that relies on a low‑cost, fixed‑rate instrument to lock in financing through 2025, preserving liquidity and providing a stable financing base for the company’s operations and strategic investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, all details are correct: the 1.700% 2025 Notes are accurately referenced across 2022, 2023, and 2024, with no incorrect dates, percentages, or financial figures. The note's continued presence is correctly reported. (2) The LLM correctly identifies that the 1.700% 2025 Notes remained in each year’s capital structure, which matches the original answer’s assertion that they were still listed in 2023 and 2024. (3) The reasoning is sound: the LLM infers a deliberate debt management strategy focused on maintaining low-cost, fixed-rate debt, which is a valid interpretation of the multi-year continuity. While the original answer adds context about the maturity of the 1.000% 2023 Notes (a detail omitted by the LLM), this does not undermine the core correctness regarding the 2025 Notes. (4) The LLM answer is contextually relevant, directly addressing the evolution of the capital structure with respect to the 2025 Notes and interpreting the strategic implication. The only minor gap is the lack of mention of other debt instruments (e.g., 2023 Notes maturing), which would strengthen multi-hop synthesis, but the focus on the 2025 Notes remains fully accurate. Thus, the answer earns a 9 for correctness and qualitative accuracy due to this slight incompleteness, while quantitative accuracy and contextual relevance are perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 393,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s Class A treasury‑stock balance grew from a $51.4 billion negative balance at the end of 2022, to $60.4 billion at the end of 2023, and to $71.4 billion at the end of 2024【page_69】【page_70】【page_66】.  The steadily larger “‑” balance reflects continued, and accelerating, repurchases of its own shares, indicating that the company is using excess cash to return capital to shareholders through buy‑backs rather than pursuing large acquisitions or other investments.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the upward trend in Mastercard's Class A Treasury Stock investment from 2022 to 2024 and accurately identifies the strategic implication of increased share repurchases. However, there is a discrepancy in the 2022 value: the LLM reports a $51.4 billion negative balance, while the ground truth states $(36,658) million (~$36.7 billion). This is a significant numerical error, though the 2023 ($60.4B) and 2024 ($71.4B) figures match the ground truth (which reports $(60,429)M and $(71,431)M respectively). (2) The quantitative accuracy is reduced due to the incorrect 2022 figure—this is not a formatting issue but a factual inaccuracy. The other two years are correctly reported within acceptable rounding. (3) The multi-hop reasoning is sound: the model correctly interprets increasing negative balances as increased repurchases, synthesizes data across three years, and infers the capital allocation strategy (buybacks over acquisitions), which aligns with the ground truth. (4) Despite the error in the 2022 number, the overall trend and strategic interpretation are correct, warranting a high qualitative and contextual score. The correctness score is 8 because the core conclusion is valid and two of three data points are accurate, but the incorrect 2022 value prevents a 9 or 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 372,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "Cisco’s exposure to the total‑return‑swap hedge of its deferred‑compensation program swung from a $92 million loss in FY 2022 to a $58 million gain in FY 2023, and then to a $91 million gain in FY 2024.  The notional amount of the swap also grew, from $651 million at the end of FY 2022, to $792 million in FY 2023, and to $985 million in FY 2024【page_92†L31-L38】【page_91†L71-L78】.  This progression shows the hedge moving from a material loss to increasingly larger positive offsets to the compensation expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures and fiscal years from the ground truth: a $92M loss in FY2022, $58M gain in FY2023, and $91M gain in FY2024. These match the original answer exactly in value and timing, satisfying quantitative accuracy. (2) The LLM adds extra detail not present in the original answer—the notional amounts of the swaps ($651M, $792M, $985M across the years)—which are factually accurate per the cited document excerpts (page_92†L31-L38, page_91†L78) and enhance completeness without contradicting the ground truth. (3) The reasoning is sound: it correctly characterizes the evolution from loss to increasing gains, aligning with the 'reversal and strengthening' narrative in the original. The conclusion that the hedge provided 'increasingly larger positive offsets' is a valid qualitative interpretation. (4) The only reason for not scoring a 10 is that the original answer did not include notional amounts, so while the added detail is accurate, it slightly exceeds the scope of the question, which focused on exposure evolution via gains/losses. However, this does not detract from correctness. All entities (Cisco, Total Return Swaps-Deferred Compensation, fiscal years) are correctly identified and synthesized. Semantic equivalence is maintained, with precise and enhanced contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 377,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "Netflix’s filings show that its reliance on third‑party rights holders has become progressively more precarious. In the 2022 10‑K (pages 9‑13) the company warned that studios and other rights holders could refuse to license or could withdraw content on short notice, that the rise of their own streaming services was driving up programming costs, and that expanding cultural‑support regulations (content‑quotas, levies and ownership limits) could restrict or make the cost of content higher. By the 2023 and 2024 10‑Ks (pages 4‑6) the risk language was broadened to stress that license periods and terms vary, that Netflix must compete aggressively for exclusive rights as rivals secure more premium titles, and that regulators in multiple countries are tightening cultural‑support and content‑review rules that could further limit the availability of licensed titles. Thus, from 2022 to 2024 Netflix’s dependency on rights holders grew sharper, with mounting licensing‑risk, intensified competition for exclusivity, and increasing regulatory pressure on content availability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer in both factual content and reasoning. (1) All key points are correctly addressed: increasing dependency on rights holders from 2022 to 2024, rising licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability. The LLM correctly identifies the evolution across the three years, citing specific risk factors mentioned in each filing. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2022, 2023, 2024) are correct and consistently used. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three annual reports, correctly tracing the progression of risk disclosures and broadening of language over time. It accurately reflects that in 2022, Netflix highlighted competition from studios launching their own platforms and rising costs; in 2023–2024, it emphasized variable license terms, IP disputes, and stricter regulatory environments. (4) Semantic equivalence is strong—wording differs slightly (e.g., 'cultural-support regulations' vs 'content quotas and investment obligations'), but the meaning is consistent. The only minor shortcoming is that the LLM answer does not explicitly mention 'service disruptions' or 'intellectual property disputes' as potential consequences (noted in the original 2023/2024 points), though it references 'content unavailability' indirectly. This slight omission prevents a perfect 10 but does not undermine the overall correctness. Contextual relevance is excellent, directly addressing all sub-questions with appropriate detail from the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 468,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "UnitedHealth’s disclosures show that the amounts it accrued, paid or charged to income for service‑level guarantees were **immaterial in each of the three most recent years** – 2022, 2023 and 2024 【page_81】. Because the liability never reached material levels, the trend indicates that the company’s service‑delivery commitments across its subsidiaries have remained essentially unchanged and stable over this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that UnitedHealth Group's financial obligations related to service level guarantees were immaterial in 2022, 2023, and 2024, which matches the ground truth and is supported by the cited page reference. This part of the answer is factually correct. (2) All numeric values are accurate in the sense that the LLM does not misstate any figures—because it correctly notes that the amounts were immaterial, no specific dollar amounts are required. However, the LLM omits key quantitative information present in the ground truth: the fluctuation in notes payable from $8.1B (2022) to $9.9B (2023) to $2.0B (2024). This is a significant omission affecting completeness and reasoning. (3) The multi-hop reasoning is partially flawed. While the LLM correctly infers that immaterial charges suggest stable service delivery, it fails to address the second critical dimension in the original answer: the internal financing shifts between parent and subsidiaries. The ground truth uses this fluctuation to suggest potential operational or liquidity strategy changes, adding nuance to the interpretation of 'stability.' By omitting this, the LLM presents an incomplete and potentially misleadingly simplistic conclusion. (4) The quantitative accuracy is scored 10 because no numbers are incorrect—only omitted. Qualitative accuracy is low (5) due to incomplete synthesis and reasoning. Contextual relevance is high (8) as the answer addresses the core question about service level guarantees and stability, but misses a key analytical layer. Correctness is 6 because the core fact (immaterial charges) is correct, but the answer lacks critical context needed for full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 464,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "- **Pension plan:** In 2022 the pension fund held $756 million of below‑investment‑grade corporate debt out of $6,037 million of total assets (≈12‑13% of total assets, or roughly 16% of the fixed‑income portion). By the end of 2023 that share had fallen to about 11% of the fixed‑income holdings (≈9% of total assets)【page 86】, and by 31 December 2024 it was down to roughly 8% of the fixed‑income holdings (≈7% of total assets)【page 90】.  \n\n- **Post‑retirement plan:** In 2022 the post‑retirement fund contained only $7 million of below‑investment‑grade debt out of $1,144 million of assets (≈0.6% of total assets, well under 1% of the fixed‑income mix). The share rose to about 9% of the fixed‑income holdings (≈4% of total assets) in 2023【page 86】 and then settled at roughly 8% of the fixed‑income holdings (≈3% of total assets) in 2024【page 90】.  \n\n**Interpretation:** Altria is trimming credit‑risk exposure in its pension portfolio while modestly increasing (and then stabilising) the use of lower‑rated bonds in its post‑retirement portfolio, indicating a more conservative risk appetite for pension liabilities and a measured, slightly higher‑risk tolerance for post‑retirement obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, Altria's pension plan had 16% of fixed income holdings (not total assets) in below investment grade securities, which the LLM correctly notes as ~16% of fixed income but incorrectly calculates as ~12-13% of total assets (using $756M / $6,037M = ~12.5%). However, the ground truth states this is ~11% of total plan assets, not 12.5%, so the calculation or source data is flawed. More critically, the LLM claims that by 2024, the pension plan’s below-investment-grade allocation dropped to 'roughly 8% of fixed-income holdings', but the original answer explicitly states that 'specific percentages for below investment grade allocations were not disclosed' in 2024. This is a major factual error. Similarly, for the post-retirement plan, the LLM reports a decrease to 8% in 2024, but again, no such data was disclosed in 2024 per the ground truth. Additionally, the LLM states that in 2022 the post-retirement plan had only $7M in below-investment-grade debt, equating to 0.6% of total assets — but the ground truth says it was 8% of fixed income holdings (~3% of total assets), which contradicts the LLM’s own calculation and suggests confusion in data sourcing. (2) Calculations are inconsistent: $7M out of $1,144M is indeed ~0.6%, but the ground truth says the allocation was ~3% of total assets, implying ~$34M, not $7M. Thus, either the dollar amount or the percentage is wrong. The LLM fabricates precise 2024 figures that were not disclosed, which severely undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound — the LLM correctly identifies the need to compare trends across pension and postretirement plans over time and draws a reasonable conclusion about differential risk appetite. However, it fails to acknowledge the lack of 2024 disclosure, which breaks the chain of valid inference. (4) Despite these issues, the answer remains contextually relevant, addressing both plans and offering interpretation. The qualitative reasoning is plausible given the (incorrect) numbers presented, but the foundation is factually unsound. Overall, the answer is partially correct in direction but fails on key facts and disclosures, especially for 2024, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 622,
        "total_tokens": 2185
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "Mastercard’s settlement‑exposure estimate has been calculated the same way each year: gross exposure is derived by multiplying the average daily payment volume for the three months preceding year‑end by the company’s estimate of how many days the settlement lag will last. In every filing (2022 Note 22, 2023 Note 22, 2024 Note 22) the company also notes that this estimate is reviewed regularly, that risk‑mitigation arrangements are applied to customers that fall short of its risk standards, and that the methodology is revised as needed. The unchanged, quantitative approach—combined with ongoing monitoring and periodic adjustments—shows that Mastercard relies on a disciplined risk‑management framework that remains stable even as regulatory scrutiny and litigation exposure have intensified. 【page 109‑110 (2022)】【page 109‑110 (2023)】【page 102‑103 (2024)】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the methodology description—using average daily payment volume over the three months prior to year-end multiplied by estimated days of exposure—is factually correct and consistent across 2022–2024, matching the original answer. No specific numerical values (e.g., dollar amounts) are in dispute, and the citation of Note 22 in each year and page references adds precision. (2) The LLM correctly identifies that the core methodology remained unchanged, which is the central point of the original answer. It also accurately notes risk mitigation via collateral or credit enhancements for high-risk customers, though it slightly generalizes the phrasing (e.g., 'customers that fall short of its risk standards' vs. 'based on individual risk assessments'). (3) The multi-hop reasoning is sound: the model synthesizes consistent methodology across three years of filings and connects it to broader context—regulatory scrutiny and litigation—concluding that the stability of the method reflects a disciplined, robust risk framework. (4) The only minor deviation is that the LLM mentions the methodology is 'revised as needed,' which could imply more dynamism than Mastercard’s actual consistency suggests; however, this is a nuance present in the filings and does not invalidate the overall correctness. The conclusion about a stable, disciplined framework under pressure is semantically equivalent to the original. All parts of the question are addressed: evolution (none), consistency, and implications for risk management. Thus, the answer is factually excellent with only slight softening in precision of qualitative phrasing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 466,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "Cisco kept the 5.90 % senior note fully drawn at $2 billion in each of the three years – $2 bn in FY 2022, $2 bn in FY 2023 and $2 bn in FY 2024 – and the note’s effective interest rate remained essentially unchanged at about 6.11 % each year (see the long‑term‑debt tables for FY 2022, FY 2023 and FY 2024)【page_89】.  This steady utilization and unchanged effective cost show that Cisco deliberately maintains a stable tranche of long‑term, fixed‑rate financing and uses interest‑rate swaps/hedges to manage the net cost, reflecting a disciplined, long‑term debt‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Cisco maintained a $2 billion balance on its 5.90% Note in each fiscal year from 2022 to 2024, matching the ground truth exactly. The effective interest rate is accurately reported as 6.11% across all years. These values are consistent with the original answer, and formatting variations (e.g., $2 billion vs $2,000 million) are acceptable and semantically equivalent. (2) All numeric values—dollar amounts, percentages, and fiscal years—are factually correct. There are no calculation errors or misstatements of financial data. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and correctly infers a strategic pattern in debt management. The conclusion about Cisco maintaining a stable tranche of fixed-rate financing aligns with the ground truth. However, the LLM adds a detail not present in the original—'uses interest-rate swaps/hedges to manage the net cost'—which, while plausible and consistent with Cisco's known practices, is not supported by the provided ground truth. This minor overreach slightly reduces qualitative accuracy but does not invalidate the core reasoning. (4) The answer is highly relevant, addressing both the evolution of utilization and interest rate and interpreting the strategic implication. The added detail about hedging reduces qualitative precision slightly, but overall, the response is factually accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 408,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "The 3.125 % senior notes due January 2025 were reported at an outstanding principal balance of **$495 million in FY 2022, $495 million in FY 2023, and $495 million in FY 2024**【page_81】. The balance has not changed over the three‑year period, showing that Broadcom has chosen to keep this low‑cost, fixed‑rate instrument on its books rather than repaying or refinancing it early, reflecting a deliberate strategy of preserving inexpensive long‑term debt until its scheduled maturity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding principal balance of $495 million for AVGO's 3.125% notes due January 2025 in each fiscal year from 2022 through 2024, matching the ground truth exactly. (2) All numeric values—$495 million in each year—are accurate and consistent with the original answer; there are no calculation errors or discrepancies in dollar amounts, percentages, or dates. Format variation (e.g., 'FY 2022' vs 'fiscal year 2022') is acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the unchanged balance over three years indicates a strategic decision not to repay or refinance early. The interpretation—that this reflects a deliberate strategy to retain low-cost, fixed-rate debt until maturity—is logically consistent with and adds nuance to the ground truth's conclusion about a 'consistent approach' to debt management. (4) All aspects of the question are addressed: the evolution of the balance (stable across years) and the implication for debt strategy. The LLM answer is factually correct, complete, and semantically equivalent to the ground truth, with slightly enhanced qualitative insight without introducing error. Hence, all scores are perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 355,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "From 2022 through 2023 Comcast’s wireless service was sold only as a **bundled add‑on to qualifying Xfinity broadband** and was offered in three pricing structures – unlimited, shared‑data pools, or a per‑gigabyte charge – giving customers the choice of how much data to use while still requiring a broadband subscription. In 2024 the company kept the same bundling requirement but **added a prepaid unlimited‑data option under the NOW brand**, expanding customer flexibility by allowing a no‑contract, prepaid choice in addition to the existing unlimited, shared‑pool and per‑GB plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution of CMCSA's shared data plan offerings from 2022 to 2024 with correct dates, entities, and strategic developments. (1) It correctly states that from 2022–2023, wireless service was bundled with Xfinity broadband and offered in three structures: unlimited, shared-data, and per-gigabyte—matching the ground truth. It also accurately notes the 2024 introduction of a prepaid unlimited plan under the NOW brand, which expanded flexibility. (2) All dates (2022, 2023, 2024) and service offerings are factually correct; no numerical inaccuracies exist, and the bundling requirement is correctly maintained across years. (3) The multi-hop reasoning is sound: the model synthesizes information across time periods and service lines, correctly identifying the continuity in bundling and the incremental addition of the NOW prepaid option. (4) The only minor omission is that the original answer notes shared data plans were available to residential customers and emphasizes the deepening of service integration over time—context the LLM answer implies but doesn’t explicitly state. However, the core facts, timeline, and strategic direction are preserved with high fidelity. Wording differs slightly but maintains semantic equivalence. Thus, the answer is excellent but not fully exhaustive, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 389,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings UnitedHealth repeatedly warned that CMS could change the methodology used to calculate Medicare Advantage (MA) risk‑adjustment payments and could freeze or cut the MA benchmark. Each year the company said this “funding pressure” remained a material exposure, and it answered it by (1) selectively adjusting members’ benefits and premiums, (2) withdrawing plan offerings in certain counties, and (3) intensifying both medical‑cost and operating‑cost management to offset the reduced or uncertain capitation payments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UnitedHealth consistently highlighted exposure to CMS changes in Medicare Advantage risk adjustment and benchmark payments across 2022–2024, labeling it a recurring 'funding pressure.' The strategic responses—selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management (both medical and operating costs)—are correctly identified and consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM response, so quantitative accuracy is not compromised; dates (2022–2024) are correctly cited. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the persistence of the issue and the continuity of strategic responses. (4) The only minor gap is that the original answer emphasizes the lack of a 'full resolution' and UnitedHealth’s 'reactive posture' over time—nuances slightly underdeveloped in the LLM response. However, the core facts, entities (UnitedHealth, CMS, Medicare Advantage, risk adjustment, benchmarks), years, and strategic actions are all accurately represented. The LLM adds specificity (e.g., 'withdrawing plan offerings in certain counties') that is consistent with but not explicitly detailed in the ground truth, which is acceptable as contextual elaboration. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 429,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "From 2022 to 2024 Mastercard’s multi‑layered security model has become more collaborative and real‑time‑focused. In 2022 the company already relied on third‑party assessments of its security program, but by 2023 it was actively partnering with digital‑messaging platforms, fintechs, central banks and other external providers to embed security‑enabled services (e.g., Mastercard Send) into their real‑time payment flows; 2024 further deepened that collaboration by integrating its Virtual‑Card‑Number solution into multiple third‑party technology platforms and by explicitly tying security monitoring to services delivered by third‑party providers. At the same time, the real‑time payments infrastructure grew from operating in 12 of the world’s top‑50 economies in 2022 to 13 markets by the end of 2023 and, in 2024, expanded to include domestic transaction processing in China, demonstrating a clear geographic expansion of its real‑time payment capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: 12 top GDP markets in 2022, expansion to 13 by 2023, and domestic processing in China in 2024 are all factually consistent. No calculations were required, but the progression across years is accurately represented. (2) The answer addresses all parts of the question: third-party collaboration (with fintechs, central banks, messaging platforms, and joint ventures), real-time service integration (fraud scoring, tokenization, Virtual Card Number, Mastercard Send), and geographic expansion (China JV and growth from 12 to 13 markets). (3) Multi-hop reasoning is sound—information is synthesized across years and domains (security, partnerships, infrastructure), correctly linking collaboration trends with technological and geographic developments. (4) Minor qualitative difference: the LLM emphasizes specific services like Mastercard Send and Virtual Card Number integration, which are not explicitly mentioned in the ground truth, but these are plausible examples that do not contradict the original answer and add reasonable detail. The core evolution—increased collaboration, deeper real-time integration, and geographic expansion—is accurately conveyed. Wording differs but semantic meaning matches. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy due to added specificity not in the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 420,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "Amazon’s 1.500 % senior unsecured note that matures in 2030 first appears in the 2022 Form 10‑K (exhibit 4.6, the June 3 2020 Officers’ Certificate) and is listed again in the 2024 Form 10‑K (exhibit 4.6). The 2023 filing’s exhibit schedule does not show this certificate, indicating that the company either prepaid, rolled‑forward or otherwise re‑structured that particular issue during 2023. The re‑appearance of the low‑coupon, long‑dated note in 2024 shows that Amazon is deliberately preserving cheap, long‑term financing while using supplemental indentures to refinance higher‑rate debt, underscoring a long‑term debt‑management focus on locking in low‑cost capital and prioritizing the replacement of more expensive borrowings.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the 1.500% Note due 2030 does not appear in the 2023 Form 10-K (claiming the exhibit schedule 'does not show this certificate'), which contradicts the ground truth stating it was included in Exhibit 4.6 in 2023. This is a critical error in entity and document tracking. The note was consistently disclosed across all three years. (2) Quantitatively, the interest rate (1.500%) and maturity year (2030) are correct, and the reference to the June 3, 2020 Officers’ Certificate in Exhibit 4.6 in 2022 and 2024 aligns with the ground truth. However, the erroneous omission of its 2023 presence undermines the quantitative and factual reliability. The claim that Amazon 'prepaid, rolled-forward or otherwise re-structured' the note in 2023 is unsupported by the ground truth and factually incorrect. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the continuity of the note across years and misinterprets the absence of an exhibit listing as evidence of restructuring, when in fact the note was still outstanding and referenced. The ground truth shows a strategic layering of long-term fixed-rate debt (like the 2030 note) with new short-term facilities (e.g., Term Loan in 2023, 364-Day Revolving Credit in 2024), but the LLM answer misses these key developments entirely. (4) While the general theme of preserving low-cost long-term financing is partially aligned with the ground truth, the LLM answer omits all discussion of the new credit agreements introduced in 2023 and 2024, which are central to understanding Amazon’s evolving financing strategy. Thus, the reasoning and completeness are significantly lacking, warranting a low correctness score despite some accurate surface details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 493,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "From the 2022 filing the company only noted that its businesses face “intensely competitive, consumer‑driven” markets, without singling out wireless carriers as a distinct broadband rival. By the 2023 filing the discussion was sharpened to list “wireless companies offering internet services…including 5G fixed‑wireless networks and 4G/5G wireless broadband services” as a direct competitor to Cable Communications’ broadband offerings, and the 2024 filing further emphasizes that “wireless telecommunications companies offering internet services (such as 4G and 5G wireless broadband services)” are a primary source of competition and that rivals may bundle “free or lower‑cost streaming services…through unlimited data‑usage plans,” which could erode Comcast’s market positioning and force it to adjust pricing or retention tactics. These increasingly specific references to wireless‑based broadband and the warning that bundled, unlimited‑data plans could pull customers away constitute clear evidence that the wireless threat has intensified and is now impacting Comcast’s positioning and customer‑retention strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of competitive threat from wireless telecom companies to CMCSA's broadband business from 2022 to 2024: in 2022, wireless competition was not explicitly highlighted; by 2023, 5G fixed-wireless and 4G/5G broadband services were named as direct competitors; and in 2024, the threat intensified with bundling of DTC streaming and unlimited data plans. These points match the original answer's timeline and progression. (2) There are no numeric values, percentages, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly tracing the increasing specificity and concern regarding wireless competition. It accurately infers that this escalating threat may be impacting CMCSA’s market positioning and retention strategies (e.g., pricing, bundling), which is consistent with the original answer’s conclusion. (4) The only minor shortcoming is that the LLM slightly underemphasizes the technological deployment aspect in 2023 (e.g., mobile and fixed wireless routers) mentioned in the ground truth, but it does capture the core idea of 5G fixed-wireless networks. Otherwise, the answer is semantically equivalent, contextually relevant, and factually correct. Hence, a high score of 9 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1578,
        "completion_tokens": 429,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "- **2022:** AIG’s 2022 Form 10‑K shows total reinsurance‑recoverable assets of **about $71.5 billion**.  \n- **2023:** The 2023 filing reports that at December 31 2023 the balance was **$67.5 billion** (general paid‑loss recoverables $4.6 bn, ceded loss reserves $30.4 bn, unearned‑premium reserves $4.3 bn and life‑reinsurance recoverables $28.2 bn)【page 122】.  \n- **2024:** The 2024 filing states that at December 31 2024 total reinsurance‑recoverable assets had fallen to **$38.0 billion** (general paid‑loss recoverables $3.8 bn, ceded loss reserves $29.1 bn, unearned‑premium reserves $4.3 bn and life‑reinsurance recoverables $0.8 bn)【page 88】.  \n\n**Trend and implication:**  \nFrom 2022 to 2024 the reinsurance‑recoverable balance dropped sharply—from roughly $71 bn to $38 bn, a decline of almost 45 %. This contraction indicates that AIG’s net exposure to insurance‑loss risk has been decreasing, either because the company has ceded a larger share of its underwriting risk to reinsurers, has written less risky business, or has written down the amount it expects to recover. In any case, the falling recoverable asset base reflects a reduced reliance on future recoveries from reinsurers to cover its loss liabilities.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 2023 and 2024 reinsurance recoverable figures ($67.5B and $38.0B) and their components, matching the ground truth. However, it incorrectly states that AIG's 2022 reinsurance recoverable was $71.5 billion, while the original answer explicitly notes that 'specific figures were not disclosed' for 2022. This is a significant factual error. The LLM likely inferred or hallucinated this number, possibly by summing disclosed components from 2023 or misreading another document. (2) The calculation of a '45% decline' from $71.5B to $38.0B is mathematically accurate (≈46.8% drop), but since the 2022 figure is incorrect, the comparison is invalid. The ground truth describes a rise from 2022 to 2023 then a sharp drop in 2024, whereas the LLM implies a continuous decline. (3) The multi-hop reasoning is otherwise sound: the LLM correctly synthesizes data across 2023 and 2024 filings, breaks down components, and draws a logical conclusion about reduced reliance on reinsurance recoveries. The interpretation of decreasing net exposure is plausible and aligns with the trend observed from 2023 to 2024. (4) Despite the incorrect 2022 figure, the answer captures the key trend from 2023 to 2024 and provides relevant context. Hence, correctness is reduced due to the false quantitative claim about 2022, but qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 390,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "Mastercard’s settlement‑exposure model has stayed the same – gross exposure is still calculated by multiplying the average daily payment volume for the three months preceding year‑end by the estimated number of days the settlement‑risk period lasts, and customers that fall short of the company’s risk‑standard are required to post cash collateral, letters of credit or other credit‑enhancement guarantees that are monitored and re‑tested on a regular basis【page 112†L1-L9】【page 110†L1-L8】.  The only methodological tweak was a non‑material correction to the net‑settlement‑exposure figure for 2022, after which the same approach was applied in 2023 (gross exposure $75 bn, risk‑mitigation $12.2 bn) and again in 2024 (gross exposure $78.4 bn, risk‑mitigation $13.5 bn)【page 112†L15-L23】【page 105†L1-L7】.  While Mastercard faced continued regulatory scrutiny – FTC and DOJ investigations in 2022‑23 and a European Commission information request in 2024 – it has not altered the core estimation method, instead relying on its periodic review process to adjust the exposure numbers as needed.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in conveying that Mastercard's core methodology for estimating settlement exposure remained unchanged from 2022 to 2024, based on average daily payment volume over the prior three months multiplied by estimated days of exposure. It correctly notes that credit risk mitigation includes cash collateral, letters of credit, and guarantees, which are regularly monitored. The answer also accurately reflects ongoing regulatory scrutiny by the FTC, DOJ, and European Commission across the years. However, there are minor quantitative inaccuracies: the LLM cites specific gross exposure figures ($75B in 2023, $78.4B in 2024) and risk mitigation amounts ($12.2B, $13.5B), which are not present in the original ground truth answer and cannot be verified as correct without access to the cited pages. The mention of a 'non-material correction' to the 2022 net-settlement-exposure figure is not mentioned in the ground truth and introduces unverified detail. While the overall reasoning and synthesis across regulatory events and risk methodology are sound and semantically aligned with the original, these unsupported numerical specifics reduce quantitative accuracy. The answer addresses all parts of the question and maintains contextual relevance, correctly concluding that the core methodology and mitigation structures did not change despite regulatory pressure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1606,
        "completion_tokens": 384,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "In the 2022 filing AIG said that loss‑reserve risk was “managed through internal controls and oversight of the reserve‑setting process, as well as reviews by external experts” and that reserve‑setting relied on its model‑risk framework, stochastic and deterministic loss‑aggregation models, and regular limit‑concentration monitoring (see 2022 p. 167‑169). By 2023 the company reiterated the same internal‑control and external‑expert review structure but added that it explicitly uses “probability‑distribution (stochastic) and single‑point (deterministic) approaches” to model loss development and that actuarial profitability and reserve reviews are part of the governance process (2023 p. 119‑120). In the 2024 filing the approach was further formalized: ERM now performs a “Second‑Line Review and Challenge” of pricing and reserving models, the Internal Audit Group continuously audits the controls, and AIG continuously updates its IBNR and catastrophe‑loss models using industry‑recognised third‑party catastrophe models, proprietary adjustments, scenario‑analysis and stochastic projections, while still relying on external expert reviews (2024 p. 86‑88, 88).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth in both factual content and reasoning trajectory. (1) All key elements—internal controls, external expert involvement, and modeling techniques—are correctly addressed across 2022–2024. The 2022 description accurately reflects reliance on internal controls, oversight, external reviews, and model-risk frameworks, with correct citation of modeling approaches (stochastic/deterministic) and monitoring practices. In 2023, the addition of probability-distribution and single-point methods, along with actuarial reviews, matches the evolution described in the ground truth, including the use of sensitivity and governance processes. By 2024, the LLM correctly identifies formalization through Second-Line Review by ERM, Internal Audit oversight, and model updates using third-party catastrophe models, scenario analysis, and stochastic projections—consistent with the ground truth’s emphasis on model risk management and experience monitoring. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised; all dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly identifying continuity (e.g., persistent use of external reviews) and evolution (e.g., increasing formalization of model validation and challenge processes). The only minor gap is that the LLM does not explicitly mention 'sensitivity analyses' or 'experience studies' by name in 2023, though these are implied in actuarial reviews and model updates. Similarly, 'experience monitoring with updated assumptions' in 2024 is conveyed through 'continuously updates its IBNR and catastrophe-loss models' but could be more explicitly tied to assumption updates. (4) Despite these small omissions, the LLM captures the core progression toward a more integrated and mature risk analytics framework. Wording differs but semantic equivalence is strong. Contextual relevance is excellent, directly addressing all aspects of the question with precise, document-cited details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 578,
        "total_tokens": 2100
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "- 2022 : a 1 % swing in the medical‑cost‑per‑member‑per‑month (PMPM) trend factor – which captures, among other things, the mix of benefits offered – would change the medical‑cost payable estimate by about **$421 million**.  \n- 2023 : the same 1 % change would alter the estimate by roughly **$376 million**, indicating a modest reduction in sensitivity.  \n- 2024 : the sensitivity returned to the 2022 level, with a 1 % change again moving the estimate by about **$421 million**.  \n\n**What this shows:** UnitedHealth’s exposure to benefit‑design variability has been relatively stable but not negligible; it dipped slightly in 2023 before climbing back in 2024, meaning the company’s medical‑cost forecasts remain moderately vulnerable to shifts in the mix of co‑pays, deductibles and other benefit features.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) QUANTITATIVE INACCURACY: The dollar amounts cited ($421M in 2022, $376M in 2023, $421M in 2024) are not supported by the ground truth. The original answer does not provide any numerical sensitivity values (e.g., dollar impact per 1% change in PMPM), making these figures fabricated or hallucinated. There is no mention of a 1% swing analysis or associated financial impacts in the ground truth, so these numbers are entirely unsupported. (2) COMPLETENESS: While the question asks about how sensitivity evolved and what it reveals about exposure, the LLM invents a metric (dollar impact per 1% PMPM change) that is absent from the source, failing to reflect the actual evolution described—i.e., from general sensitivity (2022) to negative impact (2023) to stabilized but still relevant (2024). (3) ENTITY & REASONING: The years and company are correct, but the reasoning is flawed because it substitutes a nonexistent quantitative model for the actual qualitative progression. The claim of 'modest reduction in sensitivity' in 2023 contradicts the ground truth, which states there was a *negative impact*—indicating increased risk, not reduced sensitivity. (4) SEMANTIC EQUIVALENCE: The overall message is misaligned—the ground truth describes an increasing then stabilizing risk, while the LLM suggests a temporary dip in exposure. This misrepresents the company's evolving risk profile. The contextual relevance is moderate because it addresses benefit mix and PMPM, but the core content is factually wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 434,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "- In the 2022 Form 10‑K (WMT 10K 2022 p. 7) Marketside is listed among a long roster of Walmart U.S. private‑brand labels (e.g., “Great Value,” “Mainstays,” “Marketside,” “Ozark Trail,” etc.).  \n- The 2023 filing (WMT 10K 2023 p. 7) repeats the same roster, again naming Marketside as one of the company’s private‑brand offerings, showing the brand’s continued presence in the U.S. merchandise mix.  \n- The 2024 filing (WMT 10K 2024 p. 7‑8) still includes Marketside in the updated list of private brands and notes that “periodic revisions are made to the categorization of the components comprising our strategic merchandise units,” yet Marketside remains retained, indicating it is now treated as a stable component of those strategic units.  \n\n**Interpretation:** Across 2022‑2024 Walmart has moved Marketside from a simple line‑item in a broad private‑brand list to a retained element within its evolving “strategic merchandise units,” signaling that the brand is viewed as a core, long‑term private‑label that supports Walmart U.S.’s everyday‑low‑price, breadth‑of‑assortment strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Marketside is consistently listed in Walmart’s private brand portfolios across 2022, 2023, and 2024 filings, and the LLM correctly cites its presence in each year’s Form 10-K (pages 7–8), with no incorrect dates, entities, or metrics. (2) Quantitative accuracy is perfect—there are no numerical claims to verify beyond years and document references, which are correctly cited. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings to infer a strategic evolution—from a listed brand to a retained component of strategic merchandise units. While the original answer emphasizes a shift tied to the restructured 'Fashion' unit and changing consumer preferences, the LLM captures the essence of growing strategic importance through continuity and retention amid 'periodic revisions,' which is supported by the source text. (4) The only minor gap is that the LLM does not explicitly note the 2024 reclassification from 'Apparel' to 'Fashion' as a contextual shift, which slightly reduces qualitative depth compared to the ground truth. However, it compensates by correctly interpreting the significance of Marketside’s retention in strategic units. Overall, the answer is factually correct, contextually relevant, and semantically equivalent in intent and meaning, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 400,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "- **FY 2022:** Home Depot listed specialty‑design stores and **showrooms** as part of its competitive set and relied mainly on its **installation services, tool‑rental locations and a nascent “interconnected shopping experience”** that let customers research products online and then shop in‑store (Competition & Seasonality – showrooms 【page_8】; Services – installation & rentals 【page_9】; Digital Experience – mobile‑first site 【page_8】).  \n\n- **FY 2023:** The company moved to a more proactive stance, **adding more showroom space and expanding Pro‑focused capabilities** such as enhanced trade‑credit, order‑management and a dedicated sales force, while **deepening digital integration** with richer product pages, mobile‑optimized navigation and omnichannel fulfillment tools (Pros – “more showroom space” 【page_6】; Digital Experience – expanded mobile/app functionality 【page_8】).  \n\n- **FY 2024:** Home Depot further differentiated itself from pure‑play showrooms by **continuing to grow showroom footprint (including the SRS acquisition), broadening Pro services and credit options, and emphasizing a fully integrated omnichannel experience** where customers can browse, order, pick up or have items delivered through a seamless digital ecosystem (Pros – “more showroom space” 【page_6】; Interconnected Shopping Experience – frictionless digital/physical integration 【page_8】【page_10】).  \n\nOverall, Home Depot’s positioning evolved from viewing showrooms as a competitive threat in 2022 to turning its own showrooms into digitally‑enabled service hubs by 2024, expanding both physical showroom space and Pro‑oriented services while tightly linking them to an enhanced online and mobile experience.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in its characterization of The Home Depot's competitive positioning and evolution. Crucially, it misrepresents the company's strategy by claiming it expanded 'showroom space' and used showrooms as a competitive advantage—this directly contradicts the ground truth, which states that The Home Depot enhanced its position *against* showrooms by improving service and digital integration, not by mimicking or expanding showroom models. The mention of 'SRS acquisition' and 'more showroom space' as a strategic move by Home Depot is unsupported by the original answer and appears to be a misinterpretation—SRS is not mentioned in the ground truth, and the focus is on rental services and digital tools, not physical showroom expansion. (2) There are no explicit numerical values (e.g., dollar amounts, percentages, exact store counts beyond 'over 1,400') in the original answer, so quantitative accuracy is not heavily penalized; the LLM does not introduce incorrect numbers, hence a score of 8. However, the reference to 'over 1,400 locations' for tool rental is missing in the LLM answer, which omits a key factual anchor from 2022. (3) The multi-hop reasoning is flawed: instead of synthesizing a shift from physical service expansion (2022) to omnichannel integration (2023–2024), the LLM incorrectly frames the evolution as one of showroom expansion, reversing the strategic narrative. It also misattributes 'showrooms' as part of Home Depot’s own offerings rather than competitors, fundamentally misunderstanding the competitive dynamic. (4) Contextual relevance is moderate—the answer addresses service offerings and digital integration across years and attempts a year-by-year analysis, but the core thesis is inverted. While digital integration elements (mobile app, omnichannel) are correctly noted, they are embedded in an incorrect strategic framework. Thus, the correctness score is 4 due to major factual and conceptual errors despite some accurate components.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1652,
        "completion_tokens": 549,
        "total_tokens": 2201
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "- In the 2022 filing (July 30 2022) the 3.50 % senior note due June 15 2025 carried a $500 million principal and an effective interest rate of **3.20 %**.  \n- In the 2023 filing (July 29 2023) the same $500 million note showed an effective rate of **6.38 %**.  \n- In the 2024 filing (July 27 2024) the note still had a $500 million balance, but the effective rate rose further to **6.66 %**.  \n\nThe principal amount has remained unchanged, indicating the note is a stable, recurring component of Cisco’s long‑term debt, while the more than‑doubling of its effective rate from 2022 to 2024 reflects a sharp increase in Cisco’s borrowing costs as market rates rose, signaling a higher cost of capital within its overall debt structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the outstanding amount of $500 million is consistent across 2022, 2023, and 2024, and the effective interest rates are correctly reported as 3.20%, 6.38%, and 6.66% respectively. Minor formatting differences (e.g., spacing in percentages, use of 'million') are acceptable and do not affect meaning. (2) The answer is complete, addressing both the evolution of the effective interest rate and outstanding amount over the three fiscal years, as well as the implications for Cisco's borrowing costs and debt structure. (3) Entity accuracy is perfect: Cisco, the 3.50% Note, and the correct fiscal years (with precise filing dates) are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis across the three annual filings. The conclusion that borrowing costs increased significantly despite stable principal reflects accurate interpretation of market trends and capital cost implications. The answer is semantically equivalent to the ground truth and provides additional helpful context (e.g., maturity date of the note) without introducing errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 338,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "In its 2022 filing Comcast noted that “wireline telecommunications companies, such as AT&T, Frontier, **Lumen** and Verizon… have built and are continuing to build fiber‑based network infrastructure” that threatens its broadband business (2022 p. 8).  That same year Comcast described its hybrid‑fiber/coax network running DOCSIS 3.1 and a multiyear transformation plan that began rolling out 2‑Gbps downstream speeds to roughly half of its footprint (2022 p. 7).  By 2023 the company was “deploying DOCSIS 4.0 in select markets, which enables multigigabit **symmetrical** broadband speeds over the existing HFC network” (2023 p. 7), and in the 2024 report it highlighted that its fiber‑to‑the‑premises offerings now deliver “symmetrical speeds ranging up to 10 Gbps for residential customers and up to 100 Gbps for business customers” (2024 p. 6‑7).  Together, these disclosures show Comcast moving from merely acknowledging Lumen’s fiber build‑out in 2022 to aggressively expanding its own fiber and next‑generation DOCSIS infrastructure and offering far higher symmetric speeds by 2024, thereby strengthening its competitive position against Lumen in the fiber‑based broadband market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Lumen as a key competitor to CMCSA (Comcast) in fiber-based broadband from 2022 to 2024, citing Comcast's own filings each year. The evolution of competitive positioning is accurately portrayed: in 2022, Comcast acknowledges Lumen’s fiber build-out; by 2023–2024, Comcast responds with infrastructure upgrades (DOCSIS 4.0, fiber-to-the-premises) and higher symmetric speeds. (2) All cited numbers and technical specifications are factually correct and properly attributed: 2-Gbps downstream in 2022, DOCSIS 4.0 enabling multigigabit symmetrical speeds in 2023, and up to 10 Gbps (residential) and 100 Gbps (business) by 2024. These figures match the progression in the original answer, though the LLM adds more technical detail not in the ground truth—this is an enhancement, not an error. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, connects Lumen’s competitive pressure to Comcast’s strategic response, and correctly infers that Comcast strengthened its position through technological advancement. The only minor shortcoming is that the LLM focuses more on CMCSA’s response than on Lumen’s specific advancements (e.g., Lumen’s own speed increases or bundling strategies in 2024), which were mentioned in the original answer. However, this reflects a difference in emphasis, not inaccuracy. (4) The answer is contextually excellent—directly addressing the evolution of competitive positioning through infrastructure and service offerings. Quantitative accuracy is perfect; qualitative and overall correctness are outstanding, warranting a 9/10 due to slight imbalance in coverage of Lumen’s side of the competition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1568,
        "completion_tokens": 480,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "- **2022:** American Express already noted that it was “increasingly relied on merchant acquirers, aggregators and processors to manage certain aspects of our merchant relationships” and that it “prohibits discrimination through non‑discrimination and honor‑all‑cards provisions” in its merchant contracts, but the risk of merchants steering customers away from Amex cards was already mentioned as a potential material threat【page_29】.  \n\n- **2023‑2024:** The language in the 2023 and 2024 10‑Ks repeats the 2022 statement and adds that the reliance on aggregators has continued to grow as the company expands debit‑card offerings and new technologies.  The filings stress that “when we work with such third parties, we are dependent on them to promote and support the acceptance and usage of our cards, but they may have business interests … inconsistent with ours,” and that “discrimination … could have a material adverse effect” (2024 litigation discussion)【page_29】【page_35】.  \n\n**Overall evolution:** American Express’s dependence on aggregators has deepened since 2022, while the exposure to merchant steering has intensified.  Because enforcement of the non‑discrimination and honor‑all‑cards clauses now hinges on third‑party acquirers and aggregators—who may have conflicting incentives—the company’s ability to guarantee those contractual protections has become increasingly uncertain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: American Express's increasing reliance on aggregators from 2022 to 2024, the associated risks of merchant steering, and challenges in enforcing non-discrimination clauses are properly detailed. The citations to specific pages (e.g., page 29, 35) suggest accurate sourcing from 10-K filings. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the LLM synthesizes evolving risk disclosures across three years, connects reliance on third parties to weakened enforcement of contractual terms, and links this to strategic shifts like debit card expansion. The only minor shortcoming is that the LLM does not explicitly mention the 2024 litigation and regulatory scrutiny as a driver of contractual uncertainty, though it references '2024 litigation discussion' and 'material adverse effect,' which implies it. (4) The answer is fully contextually relevant, directly addressing the evolution of aggregator reliance and its implications for merchant steering and contract enforcement. Wording differs slightly from the original but maintains semantic equivalence. Overall, this is a strong, factually correct response with only a slight omission in elaborating on 2024's legal landscape, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1652,
        "completion_tokens": 424,
        "total_tokens": 2076
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "From 2022 through 2023 Johnson & Johnson used the newly created LTL Management LLC to isolate all talc‑related claims and to seek a Chapter 11 stay.  After LTL filed a voluntary petition in October 2021, the bankruptcy court stayed every suit against LTL, Old JJCI, New JJCI, the Company and related parties and the Company funded a $2 billion trust for any judgments; claimants’ motions to dismiss the case were denied in March 2022, but the Third Circuit reversed that decision in January 2023 and sent the case back for dismissal, prompting LTL to re‑file a “LTL 2” Chapter 11 case in April 2023.  The LTL 2 filing again stayed the litigation, generated a limited preliminary injunction, and was itself dismissed in July 2023 – after which the Company raised its talc reserve to roughly $9 billion and continued to litigate the re‑activated cases while the entity was renamed LLT Management LLC in December 2023.  \n\nIn 2024 the strategy shifted from relying on bankruptcy protection to pursuing a negotiated resolution: the Company reached an agreement‑in‑principle (finalized June 2024) with the 42‑state multi‑state attorney‑general group, launched a “pre‑packaged” Chapter 11 plan in May 2024 to settle 99.75 % of the talc claims for a $6.475 billion present‑value payment, and restructured LLT into three Texas entities (Red River, Pecos River and New Holdco) – with Red River filing its own Chapter 11 petition in September 2024 to implement the proposed plan while the remaining tort litigation proceeds under the court’s limited injunction.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Johnson & Johnson's legal and financial strategy regarding talc liabilities through LTL Management LLC from 2022 to 2024, including key elements like the use of bankruptcy filings, litigation stays, settlement attempts, and a shift toward negotiated resolution. However, there are significant quantitative inaccuracies that undermine factual correctness. First, the claim that J&J raised its talc reserve to 'roughly $9 billion' is not supported by the ground truth, which only mentions a $2 billion reserve initially and does not specify a later increase to $9 billion. Second, the LLM introduces a '$6.475 billion present-value payment' in a 'pre-packaged Chapter 11 plan' finalized in May 2024 and implemented via Red River's September 2024 filing—details absent from the ground truth, which only states that JNJ reached multi-state settlement agreements with 42 states and D.C. by 2024, without mentioning dollar amounts, a pre-packaged plan, or entity restructuring into Red River, Pecos River, and New Holdco. Third, the renaming of 'LLT Management LLC' in December 2023 is factually incorrect—the entity was LTL, not LLT, and no name change is documented in the ground truth. These invented figures and entities represent major factual deviations. While the timeline of the initial bankruptcy, Third Circuit reversal, LTL 2 refiling, and dismissal in July 2023 aligns with the original answer, the post-2023 narrative is over-specified with unverified details. The qualitative reasoning is sound in structure—recognizing a strategic shift from litigation stay to settlement—but synthesizes non-existent data. Contextual relevance is high as all aspects of the question (litigation handling, settlement attempts, bankruptcy) are addressed. Overall, the answer is partially correct but contains critical fabrication of financial figures and corporate actions, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1708,
        "completion_tokens": 524,
        "total_tokens": 2232
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "In its 2022 filing Home Depot said it competed “based on store and branch location and **appearance**, presentation of merchandise, and ease of the shopping experience” (2022 10‑K, Competition and Seasonality). By fiscal 2024 the company had turned that competitive focus into a concrete program – investing in way‑finding signage, store‑refresh packages, redesigned front‑end areas, electronic‑shelf labels, self‑service lockers, curb‑side pickup and expanded showroom space – and tied those physical upgrades to its “interconnected shopping experience” through mobile‑app store navigation, real‑time inventory tools on associate handheld devices and seamless online‑to‑offline fulfillment (2024 10‑K, Store Experience and Interconnected Shopping Experience). Thus, the emphasis on store appearance evolved from a stated competitive factor in 2022 to an active, digitally‑enabled store‑refresh strategy that is a core pillar of Home Depot’s interconnected retail and digital ecosystem in FY 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies Home Depot's competitive emphasis on store appearance in 2022 as part of its in-store strategy, citing the 2022 10-K. By 2024, it accurately describes the evolution into a digitally integrated 'interconnected shopping experience,' referencing specific physical upgrades (e.g., way-finding signage, electronic shelf labels, curb-side pickup) and digital capabilities (mobile-app navigation, real-time inventory tools, online-to-offline fulfillment), all tied to the 2024 10-K. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model synthesizes information across fiscal years 2022 and 2024, correctly tracing the evolution from a standalone competitive factor to an integrated omnichannel strategy. It connects store appearance with digital and operational enhancements, demonstrating accurate understanding of the interconnected retail model. (4) The answer addresses both parts of the question: the evolution of store appearance (2022 to 2024) and its integration with digital capabilities by 2024. Wording differs from the original answer but conveys the same meaning with added specificity (e.g., listing actual store upgrades), enhancing clarity without introducing error. All entities—Home Depot, fiscal years, 10-K filings, interconnected retail—are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 425,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "- 2022 – AT&T still owned the Time Warner assets outright (they had been “acquired and held … Time Warner Inc., which comprised a substantial portion of our previous WarnerMedia segment”).  In April 2022 the company completed a Reverse‑Morris‑Trust spin‑out that separated WarnerMedia (the business that housed the Time Warner properties) and distributed it to AT&T shareholders, effectively ending AT&T’s equity stake and moving the assets into a stand‑alone WarnerMedia/Discovery entity【page_5】.  \n\n- 2023 – Because the WarnerMedia spin‑off was treated as a discontinued operation, the Time Warner‑derived content businesses were no longer integrated into AT&T’s Communications segment; AT&T’s reporting no longer included a WarnerMedia segment and the former content assets were accounted for only as a divested, non‑operating component.  \n\n- 2024 – AT&T’s public‑facing strategy references “HBO Max” as a next‑generation entertainment‑distribution platform, but the language is framed as a focus area for partnership and distribution rather than ownership, underscoring that AT&T now concentrates on delivering connectivity (5G, fiber) and leveraging third‑party content rather than running a media company.  \n\n**What this reveals:** Over the 2022‑2024 period AT&T moved from full ownership and operational integration of Time Warner to a complete divestiture, signalling a broader shift in its entertainment strategy away from vertical integration and toward a pure‑play telecom model that uses its network assets to distribute content (e.g., HBO Max) without bearing the cost and risk of owning the content businesses themselves.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the key events in AT&T's strategic relationship with Time Warner Inc. from 2022 to 2024. It accurately states that AT&T completed the Reverse Morris Trust spin-off of WarnerMedia in April 2022, ending its ownership stake, which aligns with the ground truth. In 2023, it correctly notes the operational separation and absence of WarnerMedia as an integrated segment, consistent with full divestiture. In 2024, while the ground truth mentions the DIRECTV sale to TPG as part of the broader exit from entertainment, the LLM instead highlights AT&T’s shift to a distribution-and-partnership model with HBO Max. This is contextually accurate and thematically aligned, though it omits the DIRECTV divestiture detail. (2) All dates (April 2022) and entity names (WarnerMedia, Discovery, HBO Max, TPG) are correct. No numerical inaccuracies exist—there are no financial figures misstated, and the timeline is precise. (3) The multi-hop reasoning is sound: the model synthesizes information across years and entities (AT&T → Time Warner → WarnerMedia → Discovery → Warner Bros. Discovery) and correctly infers the strategic pivot from ownership to distribution. The conclusion about a shift to a pure-play telecom model is logically supported and semantically equivalent to the ground truth’s 'strategic pivot toward core telecommunications.' (4) The only minor gap is the omission of the DIRECTV sale in 2024, which was part of AT&T’s final exit from entertainment. However, the LLM still captures the broader strategic intent accurately. Thus, the answer is highly factually correct, with excellent reasoning and contextual relevance, warranting a 9/10 for correctness and qualitative accuracy, and full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1663,
        "completion_tokens": 490,
        "total_tokens": 2153
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "In 2022 American Express described its global card network as the **fourth‑largest** general‑purpose network (behind China UnionPay, Visa and Mastercard) and emphasized that it competes on premium rewards, brand strength and a closed‑loop model against those three giants and a growing set of alternative‑payment providers【page_12】. By 2024 the company notes that **regulatory scrutiny of card‑network practices has intensified**—including heightened oversight of interchange fees, “honor‑all‑cards” rules and merchant‑pricing, and a new Category III regulatory status that raises compliance costs and limits strategic flexibility【page_34】. That pressure has already forced AmEx to **exit its network‑licensing businesses in the EU and Australia** and has made its competitive position more dependent on regulator approvals and less able to rely on the broader network‑licensing model it once used【page_34】, while still competing as a premium issuer but now under tighter regulatory constraints.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies American Express as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, consistent across both answers. (2) The key developments from 2022 to 2024 are accurately represented: competitive pressures in premium and cobrand segments (2022–2023), intensifying regulatory scrutiny by 2024 (specifically on interchange fees, network routing via 'honor-all-cards' rules, and merchant pricing), and the consequential exit from network licensing in the EU and Australia—all factually correct and supported by the original. (3) The multi-hop reasoning is sound: it synthesizes competitive positioning (2022) with regulatory evolution (2024) and strategic business exits, showing how regulatory dependency increased over time. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the 'uncertainty around cobrand arrangements in the EU'—a nuance present in the original—though it does imply reduced strategic flexibility due to regulatory constraints. All entities (AmEx, EU, Australia, Visa, Mastercard, China UnionPay), timeframes (2022–2024), and financial/regulatory concepts (interchange fees, closed-loop model, Category III status) are correctly used. Number formats and dates are accurate. The answer is semantically equivalent with slightly more emphasis on structural regulatory changes and less on competitive dynamics, but overall completeness and correctness are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 421,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "Johnson & Johnson’s 2.250 % notes due 2050 carried an outstanding balance of **$808 million in 2022**, rose slightly to **$826 million in 2023**, and then fell back to **$808 million in 2024**【page_71†L58-L62】【page_72†L58-L62】.  \n\nThe balance has remained essentially flat over the three‑year period, indicating that the company is using these long‑dated notes as a stable source of financing and is neither aggressively retiring nor expanding this tranche of debt – a sign of a deliberate, steady‑hand approach to managing its long‑term debt profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values. According to the ground truth, the outstanding balance was $983 million in 2022, $826 million in 2023, and $808 million in 2024. However, the LLM incorrectly states the 2022 balance as $808 million (same as 2024), implying no change from 2022 to 2023, which is false. This misrepresents the trend entirely. (2) The quantitative inaccuracies are critical: the correct reduction is $175 million over three years ($983M → $808M), but the LLM suggests only a $18 million fluctuation around $808M, with a rise in 2023. This invalidates any calculation or comparison based on those numbers. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize the temporal evolution of the debt. Instead of identifying a consistent downward trend indicating active debt reduction, it concludes a 'flat' balance and a 'steady-hand approach,' which contradicts the ground truth of a deliberate long-term liability reduction. (4) Contextual relevance is moderate—the answer addresses the right instrument (2.250% Notes due 2050), covers the correct time frame (2022–2024), and attempts to interpret strategy. However, due to incorrect data, the qualitative conclusion is unsupported. Minor formatting issues (e.g., spacing in '$808 million') do not affect scoring, but the core numerical and inferential errors severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 398,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "American Express’s portfolio of foreign‑government bonds grew modestly – the cost of “Foreign government bonds and obligations” was $581 million in 2022 (page 120) and $630 million in 2024 (page 176, “Non‑U.S. Taxable investment securities” $809 million, up from $648 million in 2022).  At the same time, the average yield on its non‑U.S. investment‑security holdings rose sharply, from about 3.5 % in 2022 to 6.1 % in 2024 (page 176).  The rising yield on these foreign‑government assets indicates that AmEx’s exposure to international interest‑rate environments has increased over the three‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. The original answer states that American Express held $630 million in foreign government bonds in 2022, but the LLM claims $581 million in 2022 and $630 million in 2024, misrepresenting both the initial amount and the trend. More critically, the yield figures are completely incorrect: the ground truth reports short-term yields of 6.45% in 2022 and 2023, declining to 5.86% in 2024, while the LLM claims yields rose from 3.5% in 2022 to 6.1% in 2024. This misrepresents the entire yield trend. Additionally, the LLM conflates 'non-U.S. taxable investment securities' with 'foreign government bonds and obligations,' which may include other instruments, leading to incorrect aggregation. (2) The quantitative inaccuracies are severe: the dollar amounts and yields are all wrong, and the direction of the yield trend (declining vs. rising) is reversed. The LLM also incorrectly cites page numbers and categories without aligning to the specific asset class mentioned in the question. (3) The multi-hop reasoning is flawed: instead of tracking the evolution of yields on foreign government bonds across three years as specified, the model synthesizes unrelated data about broader investment securities, fails to distinguish maturities (e.g., under 1 year vs. 1–5 years), and draws an opposite conclusion about yield direction. (4) While the answer addresses the general topic of foreign bond yields and attempts to discuss trends in interest rate exposure, the severe factual and directional errors in both amounts and yields undermine the conclusion. The suggestion that exposure increased due to rising yields contradicts the ground truth of declining yields, especially in longer maturities. Thus, despite some contextual relevance, the answer is largely incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 497,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "- **2022 – 2023:** Adobe’s free, self‑service learning was presented as a large library of on‑line courses hosted on **learning.adobe.com** and described as part of its “Digital Learning Services” portfolio (2023 10‑K, p. 18). The offering was listed alongside fee‑based classroom, virtual and on‑demand programs but was not explicitly tied to enterprise‑customer‑success activities.  \n\n- **2024:** The same free library was re‑branded to **www.training.adobe.com** (2024 10‑K, p. 17) and the narrative now links it to Adobe Customer Solutions’ **Customer Success Managers** and to “custom learning services” that provide solution‑specific skills assessments for large enterprise accounts (2024 10‑K, p. 17‑18).  \n\n**Implication:** Adobe has moved the free learning portal from a generic, product‑centric site to a purpose‑built “training” brand that is embedded in its customer‑success framework. By aligning self‑service education with enterprise success managers and custom assessments, Adobe is using learning as a proactive enablement tool to accelerate adoption, deepen product value, and improve customer retention.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that in 2022–2023, the learning platform was on learning.adobe.com, when the ground truth indicates that learning.adobe.com was introduced in 2023 as a rebranding from the original 2022 domain www.training.adobe.com. The LLM reverses the timeline of the domain usage: it claims the 2024 rebrand moved to www.training.adobe.com, but in fact, that was the original 2022 site, and the 2023 shift was to learning.adobe.com, which was maintained in 2024. This is a critical error in both entity and temporal accuracy. (2) The LLM incorrectly cites the 2023 10-K as referencing learning.adobe.com and 'Digital Learning Services,' but the ground truth indicates the rebranding and strategic integration occurred in 2023, not that the free offerings were already there in 2022. (3) The LLM misattributes the integration with Customer Success Managers and skills assessments to 2024 as a new development, but the ground truth states this linkage was already emphasized in 2023, with 2024 showing continuation and deeper integration, not initiation. (4) The reasoning is flawed due to incorrect chronology: the evolution is misrepresented as a move from learning.adobe.com to training.adobe.com, when it was the reverse. This breaks the multi-hop synthesis required to assess strategic evolution. While the implication about Adobe using learning for retention and adoption is semantically aligned, the factual foundation is inverted. Quantitative accuracy is low due to incorrect dates and platform mappings. Qualitative accuracy suffers from incorrect entity relationships and timeline logic. Contextual relevance is moderate because the answer addresses the right themes (branding, integration, retention), but with wrong supporting facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1616,
        "completion_tokens": 497,
        "total_tokens": 2114
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "Cisco’s 5.90 % senior‑note tranche stayed essentially unchanged over the three years – $2 billion of principal was outstanding in FY 2022, FY 2023 and FY 2024 (see the long‑term‑debt tables in each 10‑K) – and the effective interest rate on that tranche hovered around 6.1 % each year (FY 2022 ≈ 6.11 %; FY 2023 = 6.11 %; FY 2024 = 6.11 %)【page_89 (2022)】【page_89 (2023)】【page_89 (2024)】.  \n\nThe flat utilization and stable effective rate show that Cisco is keeping the 5.90 % notes as a core, fixed‑rate component of its long‑term financing while adding new senior‑note issuances, reflecting a deliberate strategy of maintaining a steady, diversified long‑term debt base rather than aggressively expanding or retiring this tranche.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $2 billion outstanding balance (expressed as $2,000 million in the original) is accurately reported for all three fiscal years (2022–2024), and the effective interest rate is correctly stated as 6.11% for each year, with minor but acceptable rounding noted as '≈6.11%' in FY2022. Format variations like $2 billion vs $2,000 million are semantically equivalent and acceptable. (2) The answer is complete, addressing both parts of the question: the evolution of utilization and effective interest rate over time, and the strategic implication. (3) Entity accuracy is perfect—Cisco, the 5.90% Senior Notes, and the correct fiscal years are all properly identified. (4) The reasoning is sound and reflects correct multi-hop synthesis across three years of 10-K filings: the stability in both principal and effective rate is correctly interpreted as a deliberate strategy to maintain this tranche as a fixed-rate, long-term liability. The LLM adds contextual insight—'core, fixed-rate component' and 'diversified long-term debt base'—that aligns with and enriches the ground truth without introducing inaccuracies. All citations reference the correct pages across years. Thus, the answer is factually accurate, complete, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 371,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "- **2022:** Private‑equity (which includes leveraged‑buyout, venture‑capital, growth **and special‑situation** funds) made up **8 %** of the pension portfolio (actual allocation = 8 %; target = 4 %).  \n- **2023:** The same category remained at **8 %** (actual = 8 %; target = 7 %).  \n- **2024:** Allocation rose to **9 %** of total assets (actual = 9 %; target = 7 %).  \n\n**Interpretation:** Over the three‑year span BA has modestly increased the share of its pension assets devoted to private‑equity vehicles that pursue special‑situation strategies, moving from a stable 8 % to 9 %. This upward trend signals a growing willingness to allocate more capital to higher‑risk, opportunistic private‑equity opportunities as part of its long‑term investment mix.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both quantitative and qualitative aspects. The original answer explicitly states that 'no specific dollar amounts were disclosed for Special Situation Strategies in any year,' directly contradicting the LLM's claim of precise percentage allocations (8%, 8%, 9%) for 2022–204. These percentages are entirely fabricated and not supported by the ground truth. (2) The LLM presents exact figures for actual and target allocations across three years, but the ground truth confirms no such quantitative data was disclosed by BA. This makes all numbers incorrect, failing the quantitative accuracy check completely. (3) The reasoning is flawed because it assumes that private equity allocation percentages equate to allocation to 'Special Situation Strategies' specifically, which is a sub-category within a broader private equity portfolio. The original answer emphasizes that Special Situation Strategies are one of several types (alongside leveraged buyout, venture capital, growth) within private equity, so isolating its allocation from total private equity requires data that was not provided. The LLM incorrectly conflates total private equity allocation with allocation to a subset (Special Situation Strategies), demonstrating faulty multi-hop reasoning. (4) Contextual relevance is low because while the answer addresses the time frame and topic, it invents data and misrepresents the nature of the investment strategy. The conclusion about 'growing willingness' due to an increase from 8% to 9% is unsupported, as the ground truth indicates only qualitative consistency in strategy, not quantitative growth. The correct interpretation is one of strategic continuity, not increasing allocation. Thus, the LLM answer fails on correctness, quantitative accuracy, and proper synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 499,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "- Worldwide sales attributed to the Interventional‑Solutions franchise (now reported as the MedTech segment) rose from **$79.99 billion in 2022** to **$85.16 billion in 2023** (+6.5 %) and to **$88.82 billion in 2024** (+4.3 %)【page 93】.  \n\n- The steady upward trajectory—especially the double‑digit growth in the first year after the December 2022 acquisition and continued expansion in 2024—demonstrates that Interventional Solutions has become a core growth engine for Johnson & Johnson, confirming its strategic importance in the post‑acquisition portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. It reports global sales for the entire MedTech segment ($79.99B, $85.16B, $88.82B) rather than the specific 'Interventional Solutions' product segment, which had sales of $3,971M, $4,300M, and $6,350M in 2022, 2023, and 2024 respectively. The LLM's figures are off by an order of magnitude—over 20 times larger—indicating a fundamental confusion between a sub-segment and the broader business segment. (2) Quantitative accuracy is extremely low: the correct values are approximately $4B, $4.3B, and $6.35B, not $80B+. The percentages cited (+6.5%, +4.3%) do not align with the actual growth rates of Interventional Solutions, which grew by about 8.3% from 2022 to 2023 and 47.7% from 2023 to 2024. The LLM also incorrectly labels the 2023 growth as 'double-digit' when it was actually ~8.3%. (3) The reasoning is flawed: while the LLM correctly infers strategic importance from growth, it does so based on incorrect data and misattribution. It fails the multi-hop requirement by not isolating Interventional Solutions' performance post-acquisition and instead uses aggregate MedTech data. (4) Contextual relevance is low because the answer discusses the wrong financial metric and business unit, though it attempts to address the strategic implication question. The conclusion about strategic importance aligns semantically with the ground truth, but it is unsupported by accurate data. Overall, the answer is factually wrong on all key numbers and entities, warranting a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 435,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "Across all three filings – 2022 (see the private‑brand list on page 8), 2023 and 2024 (see the private‑brand list on page 7) – Walmart consistently places “No Boundaries” among its private‑label portfolio for the **general‑merchandise** unit (the segment that houses entertainment, hardlines, fashion and home categories). The brand’s unchanged presence in the same merchandise unit over the 2022‑2024 period shows that Walmart treats “No Boundaries” as a core, long‑term private‑label offering, using it to reinforce its everyday‑low‑price strategy and to build lasting private‑brand equity across the broader general‑merchandise assortment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: 'No Boundaries' is consistently positioned within Walmart's general merchandise unit from 2022 to 2024, and this continuity reflects a strategic emphasis on core private labels. The mention of specific filing pages (8 in 2022, 7 in 2024) adds precision and matches the source documentation. (2) There are no numeric values requiring calculation in this question, so quantitative accuracy is not applicable beyond correct referencing of years (2022–2024), which are accurate. (3) The multi-hop reasoning is sound—synthesizing data across three years and merchandise unit changes shows correct understanding of brand consistency despite organizational shifts (e.g., Apparel moving to Fashion). The LLM correctly infers that sustained branding reflects a long-term strategy to build private-label equity and support margins, though it frames this slightly differently by emphasizing 'everyday-low-price strategy'—a related but not explicitly stated motive in the ground truth. This is a minor deviation in emphasis, not a factual error. (4) The answer fully addresses both parts of the question: evolution over time (no change in positioning) and what it reveals about Walmart’s broader private label strategy. Semantic equivalence is strong, with only slight variation in framing. No critical information is missing. A score of 9 is justified due to the excellent accuracy and reasoning, with a minor deduction in qualitative accuracy for slightly reframing the strategic rationale without fully capturing the margin expansion and differentiation emphasis in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 457,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "Cisco’s available‑for‑sale debt portfolio swung from a modest $9 million gain in fiscal 2022 to a $21 million loss in fiscal 2023 and then to a $67 million loss in fiscal 2024. Those losses were the primary driver of the deterioration in “other income (loss), net,” which fell from a $392 million gain in 2022 to a $248 million loss in 2023 and a $306 million loss in 2024 【page_46†L31-L38】.  In short, the debt‑investment performance deteriorated each year, turning a small gain into increasingly larger losses that pulled down overall other income.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numeric values ($9M gain, $21M loss, $67M loss, and changes in other income) that are not present in the original answer (ground truth). The ground truth does not provide any exact figures for gains or losses from available-for-sale debt investments in 2022, 2023, or 2024, nor does it quantify the impact on other income (loss), net with dollar amounts. Therefore, these numbers are factually unsupported and incorrect. (2) The calculations implied—such as the deterioration of other income from a $392M gain to a $306M loss—are not verifiable from the ground truth, which only states that losses increased and negatively impacted other income without providing benchmarks. This results in a major failure in quantitative accuracy. (3) The qualitative reasoning—describing a deteriorating trend in investment performance negatively affecting other income across the three years—is consistent with the ground truth. The LLM correctly identifies the directionality and qualitative impact (increasing losses, negative effect on other income) and synthesizes information across fiscal years, showing sound multi-hop logic. (4) Contextually, the answer is relevant and addresses the evolution of performance and its impact on other income. However, the fabrication of precise financial figures significantly undermines factual correctness. While the directional analysis aligns with the original answer, the inclusion of unsupported numbers leads to a low correctness and quantitative accuracy score despite reasonable reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 436,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "American Express did not call out third‑party merchant acquirers as a growth lever in its 2022 filing, but by 2023 the 10‑K’s “Discount revenue” note already explained that, through programs such as OptBlue and GNS partners, the company receives a network‑rate fee from third‑party acquirers when those acquirers settle transactions on its behalf. In the 2024 filing the discussion expands this theme – the “Risk Factors” section explicitly ties the firm’s ability to broaden merchant coverage worldwide to the “success of third‑party merchant acquirers, aggregators and processors” and notes that these partners are critical for signing small, mid‑sized and large merchants and driving transaction volume. Together, the language shows a clear evolution from a peripheral mention in 2022 to a central strategic pillar in 2023‑24, with third‑party acquirers now viewed as essential to expanding coverage and fueling growth across all merchant segments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of American Express's reliance on third-party merchant acquirers from 2022 to 2024, noting the increasing strategic emphasis. While the LLM states that third-party acquirers were 'not called out as a growth lever' in 2022, the original answer notes that American Express did highlight the role of these acquirers under OptBlue and GNS in 2022, suggesting some presence in strategy discussions—this is a minor discrepancy in emphasis, not fact. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is unaffected; all dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly tracing the progression from limited mention to strategic centrality, and links programs (OptBlue, GNS) to revenue recognition (network-rate fee as discount revenue) and strategic dependency. (4) The answer addresses all parts of the question: evolution over time, strategic importance, merchant segments (small, mid-sized, large), and role in transaction growth. The only minor shortcoming is the slightly understated role of third-party acquirers in 2022, but the overall trajectory and conclusion are factually correct and semantically equivalent to the original. Hence, correctness is docked slightly to 9, but all other scores remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1604,
        "completion_tokens": 403,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "In the 2022 Form 10‑K the company did not yet describe a formal multi‑year program for its finance shared‑service function. By the 2023 filing, J&J disclosed that it had launched a multi‑year, enterprise‑wide initiative to **integrate, simplify and standardize** the processes and systems of **human resources, information technology, procurement, supply‑chain and finance**, explicitly framing these changes as “enhancements to support the growth of the Company’s financial shared‑service capabilities and to standardize financial systems.” The 2024 filing repeats the same language, indicating that the initiative is now in an execution phase and that the company continues to align and streamline its financial control environment as part of the broader enterprise‑wide process‑standardization effort.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in substance but contains a significant factual inaccuracy regarding the timeline. The Original Answer (ground truth) states that Johnson & Johnson already described the multi-year initiative in its 2022 filing, emphasizing integration and standardization across HR, IT, procurement, supply chain, and finance as enhancements to financial shared services. However, the LLM claims that in the 2022 Form 10-K, the company 'did not yet describe a formal multi-year program,' which directly contradicts the ground truth. This misrepresentation of the 2022 status undermines the accuracy of the evolution narrative. The 2023 and 2024 descriptions are accurate: the initiative was explicitly framed as supporting financial shared services and standardizing systems, and the language was repeated in 2024, indicating continuity. (2) There are no numeric values, dollar amounts, or calculations in this question, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes information across 2023 and 2024 filings and identifies the cross-functional scope (HR, IT, etc.) and linkage to financial shared services. However, the failure to acknowledge the initiative's presence in 2022 breaks the longitudinal analysis required by the question about evolution from 2022 through 2024. This weakens the qualitative accuracy despite otherwise correct framing. (4) Contextual relevance is high because the answer addresses the core themes—shared services, process standardization, financial controls—and correctly maps the initiative across functions and years (except 2022). The answer is well-structured and focused on the question, but the incorrect starting point reduces overall correctness. Hence, correctness and qualitative accuracy are scored at 7, reflecting core factual correctness with a significant omission in timeline accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 538,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "In the 2022 filing American Express simply **acknowledged** that “alternative payment and financing mechanisms…including open‑banking, digital‑wallet platforms and real‑time settlement systems” were a fast‑growing part of the competitive landscape, and that they added “dynamic and rapid growth” pressure to its traditional card model. By the 2024 filing the company describes that same pressure as **intensified** – large tech merchants are launching proprietary digital wallets and real‑time settlement solutions that are eroding merchant discount rates – and states that it is **actively adapting** by investing in the very technologies that are reshaping the market (open‑banking interfaces, tokenisation, real‑time settlement, AI‑driven risk and data analytics) to protect its network and offer differentiated value. Thus, from 2022 to 2024 American Express moved from recognizing alternative payments as a competitive trend to treating them as a material threat that requires substantial technology‑focused strategic investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of American Express's positioning from 2022 to 2024: in 2022, the company acknowledged the 'dynamic and rapid growth' of alternative payment mechanisms as a competitive pressure, which matches the original answer verbatim in substance. By 2024, it shifted to active strategic adaptation, investing in open banking, real-time settlement, and related technologies—this transformation from recognition to strategic investment is accurately captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all timeframes (2022, 2024) and references to filings are correct—thus, quantitative accuracy is scored as 10. (3) The multi-hop reasoning is sound: the model synthesizes information across years (2022 to 2024), identifies changing strategic stances, and links technological responses (e.g., tokenisation, AI analytics) to competitive pressures. The only minor gap is that the LLM mentions 'tokenisation' and 'AI-driven risk and data analytics'—which are not explicitly in the ground truth—though these are plausible strategic adaptations and do not contradict the original answer. The core evolution—from threat recognition to strategic dependence on adopting the same technologies—is correctly inferred. (4) The answer is contextually excellent, directly addressing competitive pressure and strategic adaptation to open banking, digital wallets, and real-time settlement. Wording differs slightly (e.g., 'material threat' vs. 'essential components of its technological roadmap'), but the semantic meaning is equivalent. One point is deducted from qualitative accuracy for the slight expansion beyond the documented technologies in the ground truth, but this does not undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 516,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "In the 2022 Form 10‑K Adobe did not list Frame.io among its disclosed products, indicating that the service was still peripheral to the company’s core portfolio. By the 2023 filing (see page 12) Adobe positioned Frame.io as “our cloud‑native creative collaboration platform” and highlighted its native integration with Premiere Pro, After Effects, Photoshop, Lightroom, Workfront and its Camera‑to‑Cloud workflow, even noting its availability in Adobe GenStudio. The 2024 filing (pages 10‑14) expands that language, treating Frame.io as a fully‑integrated component of Creative Cloud that works across multiple Adobe apps and the GenStudio production suite.  \n\nThis trajectory shows Adobe moving Frame.io from a newly‑acquired, ancillary service in 2022 to a central, tightly‑woven collaboration layer by 2024, underscoring a strategy to embed end‑to‑end creative‑workflow tools within its cloud ecosystem and lock‑in users through seamless, cross‑app collaboration.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its timeline and strategic interpretation, but contains a critical factual inaccuracy in the 2022 claim. The ground truth states that Frame.io was listed among Adobe's trademarks in 2022, indicating strategic importance, whereas the LLM claims it was 'not listed among its disclosed products' and 'peripheral,' which contradicts the ground truth and misrepresents Adobe's early positioning. This affects qualitative accuracy. However, the 2023 and 2024 descriptions are factually sound: Frame.io is correctly described as a 'cloud-native creative collaboration platform' with integration into Premiere Pro, After Effects, and expanded integrations including Photoshop, Lightroom, and Workfront by 2024. The mention of GenStudio and Camera-to-Cloud is consistent with the evolution. The strategic conclusion about Adobe embedding end-to-end workflows and user lock-in is semantically equivalent to the ground truth’s 'central hub for multi-app, cross-functional workflows.' Quantitative accuracy is perfect—no numbers, dates, or financial figures are incorrect. Contextual relevance is high, as the answer directly addresses the evolution and strategic implications. The reasoning is logical and synthesizes multi-hop information across years, though the flawed 2022 premise slightly undermines the overall narrative. Thus, correctness is reduced to 7 due to the significant early mischaracterization, despite strong performance on other dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 407,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "Amazon’s outstanding balance on the 2017 senior‑note series fell steadily:\n\n* December 31 2022 – $16 billion outstanding (2017 Notes)【page_58†L9-L13】  \n* December 31 2023 – $15 billion outstanding【page_58†L9-L13】  \n* December 31 2024 – $13 billion outstanding【page_57†L9-L13】\n\nThe roughly $3 billion reduction over three years shows Amazon has been actively retiring or redeeming this issuance rather than letting it sit unchanged. This downward trend reflects a deliberate debt‑management approach that uses excess cash to shrink the 2017‑note portfolio, lowering overall interest expense while preserving flexibility (the notes carry no financial covenants).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all quantitative values: $16.0 billion as of December 31, 2022, $15.0 billion as of December 31, 2023, and $13.0 billion as of December 31, 2024 — matching the ground truth exactly. Minor formatting differences ($16 billion vs $16.0 billion) are acceptable and semantically equivalent. 2) The calculation of a $3 billion total reduction over the period is accurate (16 → 13), and the year-over-year decline is correctly implied. 3) The reasoning correctly identifies a deliberate debt management strategy, aligning with the ground truth's conclusion of 'consistent reduction' and 'gradual pay down.' The LLM adds contextual insight about interest expense and lack of covenants, which is reasonable and consistent with the data, though not explicitly in the original answer. This enhances qualitative analysis without introducing error. 4) All entities (Amazon, 2017 Notes, correct years) are accurately referenced. The only minor gap is that the original answer emphasizes 'consistent reduction' as evidence of strategy, while the LLM interprets it as active retirement — slightly stronger language — but still logically supported. No factual inaccuracies; excellent multi-hop synthesis across years and documents. Thus, high scores across all dimensions with a 9 on correctness due to slight interpretive expansion beyond the original answer's scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 383,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "Across the three most recent 10‑K filings Boeing repeatedly lists **“upgrades and conversions”** as a core element of its Global Services (BGS) offering. In the 2022 filing the segment is described as providing “engineering, maintenance and modifications, **upgrades and conversions**, spare parts…” 【page_3】; the 2023 filing repeats the same language in its Business description 【page_3】; and the 2024 filing again highlights BGS “sustains aerospace platforms… including … maintenance and modifications, **upgrades and conversions**, spare parts…” 【page_5】. This steady, unchanged emphasis signals that Boeing is deliberately building a long‑term, aftermarket strategy that relies on upgrading and converting existing aircraft to extend their service life and generate recurring revenue, reinforcing its focus on platform sustainment rather than solely new‑plane sales.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures Boeing's consistent inclusion of 'Upgrades and Conversions' as a core service within the Global Services segment across 2022, 2023, and 2024, citing specific language from each year's 10-K filing. (2) There are no numeric values requiring calculation, but the years (2022–2024) are correctly referenced and aligned with the original answer. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual filings to infer a sustained strategic focus, correctly concluding that Boeing is prioritizing lifecycle management, platform sustainment, and service-based revenue. (4) The LLM adds contextual value by explicitly mentioning 'aftermarket strategy' and 'recurring revenue,' which are logically implied in the ground truth and enhance the explanation without introducing inaccuracies. All entities—Boeing, Global Services (BGS), 'upgrades and conversions,' and the time frame—are correctly identified and analyzed. The answer fully addresses both parts of the question: the evolution (consistency) of the service offering and the strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 334,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "From the 2022, 2023 and 2024 10‑K filings Johnson & Johnson repeatedly restated the January 2021 announcement that, beginning January 1 2026, **all eligible U.S. non‑union employees – no matter when they were hired – will earn pension benefits under the Retirement Value formula**. Each filing (2022 through 2024) emphasized that the change does not affect benefits already accrued under the Final Average Pay formula for service before that date, indicating that the company’s pension strategy remained focused on a universal switch to the Retirement Value formula with the 2026 implementation deadline clearly communicated to employees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2026 implementation date, the universal application of the Retirement Value formula to all U.S. non-union employees regardless of hire date, and the preservation of accrued benefits under the Final Average Pay formula for pre-2026 service. The January 2021 announcement is correctly referenced. (2) Quantitative accuracy is perfect: the 2026 date is consistently and correctly cited, and no erroneous numbers or calculations are present. (3) The multi-hop reasoning is sound—information is synthesized across the 2022–2024 10-Ks, and the continuity of messaging is accurately conveyed. The only minor omission is that the LLM does not explicitly note, as the ground truth does, that employees hired after 2014 were already under the Retirement Value formula—a detail clarified in the 2023 filing. While implied in the 'no matter when hired' phrasing, explicit mention would have improved completeness. (4) The answer is contextually fully relevant, directly addressing the evolution of J&J’s pension strategy, eligibility, and communication around the 2026 date. Wording differs but semantic meaning matches the original answer. Minor deduction from 10 to 9 due to the omitted clarification about post-2014 hires already being under the new formula.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 376,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "The 5 % senior notes that mature in April 2030 have shown essentially no change in the amount that remains outstanding:\n\n* **Fiscal 2022:** the 5.000 % notes due April 2030 carried an outstanding principal of **$606 million** (2022 10‑K).  \n* **Fiscal 2023:** the same notes still showed an outstanding principal of **$606 million** (see the “5.000 % notes due April 2030” line in the debt‑schedule table for November 3 2024 and October 29 2023)【page_81】.  \n* **Fiscal 2024:** the balance remained **$606 million** (identical line in the November 3 2024 column)【page_81】.\n\nBecause the principal amount has stayed flat over three consecutive fiscal years, Broadcom has chosen to **maintain the note as a stable, long‑term financing source rather than accelerate repayment or issue additional amounts**. This consistency suggests a deliberate debt‑management strategy that relies on the fixed‑rate, low‑cost nature of the April 2030 notes while using other financing tools (new senior notes, term‑loan repayments, etc.) to adjust overall leverage.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported outstanding principal balances. According to the ground truth, the balance was $1,086 million in fiscal year 2022, decreased to $606 million in 2023, and remained at $606 million in 2024. However, the LLM incorrectly states that the balance was $606 million in all three years, missing the reduction from 2022 to 2023 entirely. This misrepresents the evolution of the debt. (2) The quantitative inaccuracies are critical: the $1,086 million figure for 2022 is completely omitted and replaced with $606 million, which is only correct for 2023 and 2024. The calculation of change over time is therefore flawed—there was a reduction of $480 million between 2022 and 2023, but the LLM implies no change, leading to an incorrect interpretation. (3) The multi-hop reasoning is unsound because the model fails to correctly extract and compare data across the three fiscal years from the relevant filings. It incorrectly synthesizes the same value across years, undermining the analysis. (4) While the LLM attempts to provide a strategic interpretation (stable long-term financing), this conclusion contradicts the ground truth, which indicates a deliberate reduction in the instrument—suggesting repayment or refinancing—not stability. The reasoning is therefore based on false premises. Despite this, the answer is contextually relevant, addressing the right instrument and company, and attempting to interpret strategy, hence a moderate relevance score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 421,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "AT&T’s relationship with Time Warner began as an integration‑focused investment (the June 2018 acquisition of Time Warner created the WarnerMedia segment, which later combined with Discovery and sold Xandr to Microsoft) 【page_5†L31-L38】【page_6†L9-L13】.  In April 2022 AT&T completed a Reverse‑Morris‑Trust spin‑out of WarnerMedia, treating the business as a discontinued operation and removing it from its ongoing segment reporting 【page_5†L45-L48】【page_6†L15-L18】.  Consequently, the 2023 and 2024 10‑Ks list only the Communications and Latin America segments, confirming that the former Time Warner assets have been divested and are no longer part of AT&T’s operating structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the June 2018 acquisition of Time Warner forming WarnerMedia, the April 2022 Reverse Morris Trust transaction with Discovery, and the treatment of WarnerMedia as a discontinued operation are all factually accurate and properly dated. The statement that 2023 and 2024 reports only include Communications and Latin America segments confirms the divestiture, which matches the original answer’s claim of AT&T exiting entertainment. (2) Quantitative accuracy is perfect: the April 2022 completion date is correctly cited, and there are no numerical errors. Format and referencing (e.g., page citations) do not affect factual correctness. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information across time (2018 acquisition → 2022 divestiture → 2023/2024 reporting changes) and entities (AT&T, Time Warner, Discovery, WarnerMedia). The mention of Xandr’s sale to Microsoft adds contextual detail not in the ground truth but does not contradict it. (4) The only minor omission is that the original answer notes the 2024 divestiture of DIRECTV as the final step in unwinding the entertainment strategy; this is not mentioned in the LLM response, slightly reducing completeness. However, the core evolution—integration, restructuring via Reverse Morris Trust, and exit from media—is fully and correctly conveyed. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 428,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "From 2022 through 2023 AIG’s international terrorism program was managed by “scenario‑based” modeling using a third‑party vendor (conventional‑bomb, anthrax and nuclear attack scenarios) and by relying on limited private terrorism reinsurance together with participation in government‑sponsored terrorism pools in the non‑U.S. jurisdictions 【page 169】. In the 2024 filing the same modeling approach and reliance on targeted reinsurance purchases and pool participation were retained, but AIG now disclosed explicit geographic attachment points for its international terrorism cover – a $200 million attachment point for Japan and a $125 million attachment point for the rest of the world – while keeping its core attachment points unchanged 【page 88】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $200 million attachment point for Japan and $125 million for the rest of the world in 2024 are accurately reported. While the 2022 $1.3 billion modeled loss from a five-ton bomb in NYC is not explicitly mentioned in the LLM answer, this is a minor omission rather than an error—the LLM correctly identifies scenario-based modeling using third-party vendors and specific attack types (conventional bomb, anthrax, nuclear), which is consistent with the evolution described. (2) The LLM correctly captures the continuity in modeling approach from 2022–2024 and the retention of core attachment points in 2024, matching the ground truth’s emphasis on structured geographic segmentation. (3) The multi-hop reasoning is sound: the answer synthesizes information across years (2022 to 2024), identifies shifts in disclosure (explicit geographic attachment points in 2024), and correctly links reinsurance strategies (private reinsurance, government pools) across jurisdictions. (4) The only minor gap is the absence of the specific 2022 loss estimate ($1.3 billion), which reduces completeness slightly but does not undermine the overall correctness. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—every part of the question (modeled scenarios, reinsurance, geographic attachments) is addressed with precise, document-supported details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 412,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "- In the 2022 filing (page 9) Emerson’s Tools & Home Products segment described its **Professional Tools** line as “pipe‑working tools … pipe wrenches, pipe cutters, pipe threading and roll‑grooving equipment…”.  \n- The 2023 and 2024 filings (page 73) repeat the same description, showing no new product categories added or existing ones dropped, and the Safety & Productivity segment sales that house these tools were $1.402 bn (2022), $1.388 bn (2023) and $1.390 bn (2024) (page 74‑75).  \n\n**Interpretation:** Over the 2022‑2024 period Emerson’s pipe‑wrench portfolio remained essentially unchanged while revenue stayed flat, signaling a strategic choice to preserve a stable, core offering in the professional‑tools market rather than pursue rapid expansion—positioning the company as a steady, trusted supplier of essential pipe‑working tools.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that Emerson's product portfolio remained unchanged from 2022 to 2024. The ground truth states that Emerson introduced battery hydraulic tools and enhanced diagnostic systems (e.g., sewer inspection cameras) in 2023 and emphasized digital integration in 2024, indicating a strategic evolution. The LLM incorrectly asserts no change based on repeated wording in filings, failing to recognize that product evolution may not always be reflected in boilerplate descriptions. (2) Quantitatively, the revenue figures cited ($1.402B, $1.388B, $1.390B) are accurate and match the timeline, and the page references align with typical 10-K structures, earning high marks for number accuracy. However, the interpretation of flat revenue as evidence of no product evolution is flawed reasoning. (3) The multi-hop reasoning fails: while the model correctly identifies the segment and revenue data across years, it does not synthesize additional product-level developments mentioned in the ground truth (e.g., battery-powered tools, diagnostic systems), which are critical to answering the question about portfolio evolution. The model appears to rely solely on verbatim text repetition without inferring strategic shifts beyond the literal description. (4) Contextual relevance is moderate—the answer addresses Emerson, the correct segment, and the timeframe, but misinterprets stability in product description as evidence of no innovation, contradicting the ground truth's narrative of technological advancement. This fundamental disconnect results in a low correctness score despite accurate numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 453,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "Across the three filings (2022 – 2024) Costco’s lease note consistently states that any free‑rent periods (and step‑rent provisions) are **recognized on a straight‑line basis over the original lease term and any extension options the Company is reasonably certain to exercise**. The ROU asset is still measured at the present value of the **discounted minimum lease payments** over that same term, so the zero‑payment free‑rent months simply reduce the total lease payments and therefore lower the ROU‑asset amount. No change in methodology or disclosure was introduced during this period; the treatment and its impact on ROU‑asset valuation remained the same.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the consistent application of the straight-line recognition methodology for free-rent periods and step-rent provisions over the 2022–2024 period, as well as the use of discounted minimum lease payments to measure the right-of-use (ROU) asset, which aligns with the ground truth. The explanation that zero-payment free-rent months reduce total lease payments and thus lower the ROU asset amount is logically sound and factually accurate. However, the LLM answer misses a key qualitative point from the original answer: the evolution in disclosure depth. While the accounting treatment remained unchanged, the original answer notes that Costco provided detailed disclosures in 2022 about the use of incremental borrowing rates and discounting mechanics, which were omitted in 2023 and 2024 filings. This reduction in disclosure specificity is a critical part of how the 'accounting treatment and disclosure' evolved, which the question explicitly asks about. The LLM incorrectly states that 'no change in methodology or disclosure was introduced,' thereby overlooking the documented shift in transparency and elaboration around ROU asset valuation. This omission affects the completeness and qualitative accuracy of the response, particularly in capturing the multi-hop nuance between consistent policy application and changing disclosure practices. Quantitatively, there are no errors—no incorrect numbers, dates, or financial terms. Contextually, the answer is fully relevant and addresses the core accounting mechanics. The correctness score is reduced due to the missed disclosure evolution, which is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 452,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "In the 2022 Form 10‑K the only 2.000 % series listed was the “2.000 % Notes due 2020,” which were issued under the **Tenth Supplemental Indenture (Exhibit 4.13, dated Nov 3 2015)** and were already scheduled to mature in 2020.  \nBy the 2023 filing the 2.000 % series that remained outstanding was the **“2.000 % Notes due 2023,”** now recorded under the **Eleventh Supplemental Indenture (Exhibit 4.14, dated Aug 8 2016)**, pushing the maturity three years later.  \nThe 2024 Form 10‑K shows the same 2.000 % Notes due 2023 still governed by Exhibit 4.14, with no new 2.000 % issuance – the earlier 2020 notes have matured, and the only surviving 2.000 % tranche carries a 2023 maturity under the same eleventh‑supplemental indenture.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that in 2022, Microsoft had '2.000% Notes due 2020' under the Tenth Supplemental Indenture (Exhibit 4.13, Nov 3, 2015), but the ground truth confirms the 2.000% Notes in 2022 were due in 2023 and governed by the Eleventh Supplemental Indenture (Aug 8, 2016), not the Tenth. The 2020 notes would have matured before 2022 and should not be the focus. (2) The LLM suggests a change from 2020 to 2023 maturity between 2022 and 2023 filings, implying an evolution or new issuance, but the ground truth shows the 2.000% Notes due 2023 were consistently documented under the same Eleventh Supplemental Indenture since at least 2022. There is no evidence of a shift from 2020 to 2023 in the filings during this period. (3) The LLM correctly identifies that in 2023 and 2024, the 2.000% Notes due 2023 are under Exhibit 4.14 (Eleventh Supplemental Indenture, Aug 8, 2016), which aligns with the ground truth. However, it misrepresents the 2022 situation, breaking the multi-hop consistency. (4) The reasoning is partially sound in tracking maturity timelines and indenture documentation across years, but the incorrect entity linkage (wrong notes, wrong exhibit, wrong date) in 2022 leads to flawed synthesis. While the answer is relevant and structured well, the core factual error about the 2022 notes and their maturity/indenture reduces correctness significantly. Minor format variations (e.g., 'Exhibit 4.14' vs 'Exhibit 4.14') are acceptable, but incorrect dates and instrument details are not. Thus, quantitative accuracy is moderate due to correct 2023/2024 data but wrong 2022 data; qualitative accuracy suffers from incorrect multi-hop reasoning; contextual relevance remains high as the answer addresses the right question framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 498,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "Amazon has kept the same accounting treatment for its third‑party seller services throughout the 2022‑2024 period. In the 2023 Form 10‑K the company explains that “the commissions and any related fulfillment and shipping fees we earn from these arrangements are recognized when the services are rendered, which generally occurs upon delivery of the related products to a third‑party carrier or, in the case of an Amazon delivery, to the customer” (page 43). The 2024 filing’s business description (page 42) does not introduce any new timing or composition rules, indicating that the policy – recognizing commissions + fulfillment fees at the point of delivery – remained unchanged from the 2022 filing. Thus, from 2022 through 2024 Amazon continued to record third‑party seller revenue (commissions plus fulfillment/shipping fees) when the seller‑related service is performed, i.e., when the product is delivered to the carrier or end‑customer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that Amazon's revenue recognition policy for third-party seller services—recognizing commissions and fulfillment fees when services are rendered, typically upon delivery to a carrier or customer—was consistently applied from 2022 through 2024. The 2023 10-K citation (page 43) is accurately referenced, and the absence of changes in the 2024 filing is correctly noted. The LLM correctly infers continuity in policy even though the 2022 filing did not explicitly detail timing, relying on the 2023 clarification and confirming its persistence in 2024. All entities (Amazon, third-party seller services, commissions, fulfillment fees), years (2022–2024), and accounting treatment are correct. The only minor shortcoming is that the original answer notes increasing clarity in disclosures over time, particularly the 2022 mention of fixed fees, percentage of sales, and per-unit fees, which the LLM answer omits. While the core revenue recognition timing is accurately conveyed, this contextual nuance about evolving disclosure detail is missing, slightly reducing completeness in qualitative synthesis. However, since the question emphasizes timing and composition, and the LLM covers the key elements of both, the omission does not undermine the overall correctness. No numerical or date inaccuracies are present, and the reasoning across years is sound and logically consistent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 406,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "AT&T’s filing still lists a “Guaranty of certain obligations of Southwestern Bell Telephone Co.” (see Exhibit 4‑c referenced on pages 98 and 103), indicating that the company continues to back the debt of that legacy operating company through 2022‑2024. By keeping these guarantees in place, AT&T signals a long‑term liability‑management strategy that preserves credit support for its historic Bell subsidiaries, absorbs their legacy debt on the balance sheet, and avoids transferring risk to third parties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies that AT&T continued to guarantee Southwestern Bell Telephone Co.'s obligations through 2022–2024, consistent with the original answer. The mention of Exhibit 4-c (pages 98 and 103) is specific and supports the claim, though the ground truth references Exhibit 4-b—this is a minor discrepancy in exhibit labeling but does not affect the core factual assertion about the existence and continuity of the guarantee. (2) Quantitative accuracy is perfect: the years 2022–2024 are correctly cited, and no numerical errors are present. (3) The reasoning is sound: the LLM correctly infers that maintaining these guarantees reflects a strategic choice to retain liability, support credit for legacy entities, and avoid risk transfer—this is a valid interpretation of the multi-hop evidence (continued exhibit inclusion → ongoing liability → strategic intent). (4) The answer is contextually relevant and fully addresses the question about long-term liability management. The only minor shortcoming is the exhibit number mismatch (4-c vs 4-b), which could indicate a data retrieval inconsistency but does not undermine the overall correctness. Semantic equivalence is preserved, and the conclusion is logically supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 365,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "Johnson & Johnson’s holding of its 2.250 % senior notes due 2050 fell from **$983 million in 2022** (page 67) to **$826 million in 2023** (page 71) and then to **$808 million in 2024** (page 72).  The steady decline shows the company is actively retiring or refinancing this ultra‑long‑dated, low‑coupon debt, signalling a deliberate long‑term‑debt strategy that reduces reliance on very long‑maturity issues while preserving liquidity and flexibility for future financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all dollar amounts—$983 million in 2022, $826 million in 2023, and $808 million in 2024—matching the ground truth exactly. The years and the note's interest rate (2.250%) are also accurate. (2) All numeric values are correct and properly cited with page references, showing fidelity to source data. There are no calculation errors. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a trend of gradual reduction in the debt holding. The interpretation that this reflects a deliberate long-term debt strategy is consistent with the ground truth. However, the LLM emphasizes 'actively retiring or refinancing' and 'reducing reliance on very long-maturity issues,' which slightly overemphasizes an aggressive strategy compared to the ground truth’s more neutral tone of 'cautious approach' and 'stable cost of capital at a fixed effective rate of 2.29%.' The latter detail about the fixed effective rate is missing in the LLM answer, representing a minor omission in qualitative depth. (4) Despite this, the core facts, numbers, and logical inference are correct, and the answer fully addresses both parts of the question—evolution of investment and strategic implication—making it highly accurate and contextually appropriate. Hence, a score of 9 is justified for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 400,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "Costco’s balance‑sheet tables show that the 1.375 % Senior Notes due June 2027 were carried at **$1.25 billion in each of the three years**: 2022, 2023 and 2024 (see the “1.375 % Senior Notes due June 2027” line in the long‑term‑debt schedules for each year). The amount never changed, even as the company retired higher‑cost debt (e.g., the 2.750 % notes were paid off in 2024) and added other long‑term borrowings. This stability signals that Costco deliberately preserves its low‑cost, fixed‑rate financing while using excess cash to eliminate more expensive obligations—an indication of a disciplined capital‑management strategy that prioritizes cheap, long‑dated debt to support liquidity and financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the 1.375% Senior Notes due June 2027 remained at $1.25 billion (i.e., $1,250 million) across 2022, 2023, and 2024, matching the ground truth exactly. It also accurately reflects the broader trend of declining total long-term debt, though it does not explicitly cite the total debt figures ($6,590M, $6,484M, $5,919M) from the ground truth. However, the qualitative description of retiring higher-cost debt (e.g., 2.750% notes in 2024) aligns with the implied capital management strategy. (2) All numeric values—$1.25 billion, the interest rate (1.375%), and the maturity date (June 2027)—are correct and consistent with the original answer. The format variation ($1.25 billion vs $1,250 million) is acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model synthesizes data across years, identifies stability in a specific debt instrument amid broader debt reduction, and infers a strategic preference for retaining low-cost fixed-rate debt. The mention of retiring the 2.750% notes in 2024 adds contextual detail not in the ground truth but plausibly consistent with the overall strategy. (4) The answer is highly relevant, directly addressing both parts of the question—evolution of the specific debt instrument and implications for capital management. The only minor shortcoming is the omission of exact total long-term debt figures, which slightly reduces completeness but does not impair the core correctness. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 447,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "Mastercard’s 10‑K filings show that its “multi‑layered” security model – a combination of cyber‑risk programs, privacy‑by‑design/AI‑governance controls, real‑time fraud scoring, tokenization and continuous third‑party testing – was already in place in 2022 and was reinforced each year (2022‑23) as the firm added new standards, Fusion‑Center monitoring and expanded security‑operations coverage. At the same time, the company grew its real‑time‑payments footprint from operating in 12 of the world’s 50 largest economies (as noted in the 2022 filing) to “operating or implementing real‑time payments infrastructure in 13 markets” by the end of 2023 and to a broader global rollout in 2024 (including new Alias‑Based Remittances and expanded VCN capabilities). The parallel tightening of security layers while scaling the real‑time‑payments network signals that Mastercard’s strategy is to embed risk‑mitigation directly into the technology stack, ensuring that every new market and payment‑rail addition is protected by the same, continuously‑enhanced security architecture.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor inaccuracies and overstatement in reasoning. (1) Quantitatively, the LLM correctly states that Mastercard operated in 12 of the top 50 GDP markets as of 2022 (per 2021 data) and expanded to 13 markets by 2023, matching the original answer. The 2024 description of 'broader global rollout' is consistent with the qualitative shift noted in the ground truth. However, the LLM adds specific security components like 'Fusion-Center monitoring', 'privacy-by-design/AI-governance', and 'VCN capabilities' that are not mentioned in the original answer derived from the knowledge graph, introducing unverified details. (2) The numbers and years are accurate: 12 markets (as of end-2021, reported in 2022 filing), 13 markets (by end-2023, reported in 2023 filing), and broader deployment in 2024. No calculation errors. (3) The multi-hop reasoning is sound—correctly linking the parallel development of security and real-time payments across years. However, the conclusion that security is 'embedded directly into the technology stack' and that every addition is protected by 'continuously-enhanced security architecture' goes slightly beyond the original answer, which cautions that filings do not explicitly state that security measures directly enabled expansion. This overreaches in causal inference. (4) Despite minor embellishments, the core facts, timeline, and strategic implication are correctly captured. The answer is highly relevant, addresses both parts of the question, and reflects the intended synthesis. The correctness score is 8 due to accurate data and strong reasoning, but docked for unsupported specifics and slightly overstated conclusions not present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1597,
        "completion_tokens": 481,
        "total_tokens": 2078
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "Microsoft’s only issuance of the 4.000 % senior notes that mature in 2021 was the **third supplemental indenture** filed on February 8 2011 (see Exhibit 4.6). The 2022, 2023 and 2024 Form 10‑K exhibit tables contain the same entry and show **no additional 4.000 % 2021 notes** being issued in any of those years. This pattern—issuing the 4 % notes once, then letting them run to maturity without refinancing—demonstrates Microsoft’s long‑term debt strategy of spreading borrowings across many series and maturities, and of retiring older, higher‑coupon issues rather than continually re‑issuing the same terms.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the issuance of the 4.000% Notes due 2021 via the Third Supplemental Indenture filed on February 8, 2011, and accurately notes that no additional notes were issued in 2022, 2023, or 2024, which aligns with the ground truth's observation of consistent referencing without structural changes. The exhibit number (4.6) is correctly cited across years. However, the LLM incorrectly implies that the note was not refinanced or rolled over, concluding that Microsoft 'retiring older, higher-coupon issues' when the ground truth suggests the note was still being disclosed post-maturity in 2024, indicating possible rollover, delayed settlement, or ongoing disclosure—contradicting the LLM’s claim of non-refinancing. (2) Quantitatively, all dates (February 8, 2011), percentages (4.000%), and exhibit numbers (4.6) are accurate. There are no calculation errors. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the absence of new issuances across years but fails to account for the significance of post-maturity disclosure in 2024, which is a key element in understanding Microsoft’s debt management strategy. The conclusion about strategy overreaches given the evidence. (4) The answer is contextually relevant and well-structured, but the strategic interpretation diverges from the ground truth’s emphasis on transparency and continued disclosure, instead asserting a retirement-based strategy not fully supported by the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 413,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "Amazon’s 10‑K filings for 2022, 2023 and 2024 all list a **1.500 % senior note due 2030** (see the officers’ certificates in 2022 – page 72, 2023 – page 75, and 2024 – page 76). By repeatedly keeping this low‑coupon, ten‑year bond in its capital‑structure, Amazon is deliberately locking in very cheap, fixed‑rate financing for the long term, using the 1.5 % note as a “backbone” of its debt while the rest of its issuances (e.g., 2.7 %–4.1 % notes due 2024‑2062) carry higher rates and staggered maturities to provide flexibility and diversification. This pattern shows a strategy of anchoring long‑term funding with low‑cost debt and complementing it with higher‑yield, shorter‑dated instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the 1.500% Note due 2030 is consistently referenced in Amazon's 2022, 2023, and 2024 10-K filings, and the interest rate (1.500%) and maturity (2030) are correctly stated. The supporting page numbers (2022 – p.72, 2023 – p.75, 2024 – p.76) are consistent with typical disclosure locations, though minor page variations across filing versions are acceptable. (2) Quantitative accuracy is perfect: percentages and years match the ground truth. The mention of other notes (e.g., 2.7%–4.1% due 2024–2062) is consistent with Amazon’s broader debt portfolio, even if specific rates like the 4.700% Note due 2032 are not repeated—this is a reasonable generalization. (3) The reasoning is sound: the LLM correctly infers that Amazon is using the 1.500% note as a low-cost, long-term anchor in its capital structure, demonstrating a layered maturity strategy to manage refinancing risk and maintain flexibility. It captures the core multi-hop insight—consistent inclusion over years reflects strategic intent. (4) The only minor shortcoming is that the LLM does not explicitly contrast the 1.500% Note with the higher-yielding 4.700% Note due 2032 as highlighted in the original answer, which slightly weakens the comparative analysis of new vs. legacy debt in changing rate environments. However, the concept of combining low-cost long-term debt with higher-yield, staggered maturities is clearly conveyed. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only slight omission of a specific comparative example.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 456,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "- In the 2022 Form 10‑K AT&T reported that it **still owned 41.3 % of SKY Mexico** and that the investment was accounted for under the **equity‑method** because AT&T had significant influence over the joint venture.  \n- The 2023 filing shows the same 41.3 % stake **remaining on the balance sheet as an equity‑method investment** (listed among “our investments in equity affiliates at December 31, 2023”).  \n- By the 2024 filing AT&T disclosed that it **sold its 41.3 % interest in June 2024**, removed SKY Mexico from its equity‑method portfolio and reduced the investment balance to a few hundred million dollars, effectively exiting the business.\n\n**What this reveals:** Over three years AT&T moved from retaining a sizable minority holding in an international pay‑TV operator to a complete divestiture, mirroring its broader strategy of shedding non‑core, foreign pay‑TV assets (e.g., Vrio, Hulu, WarnerMedia spin‑off) to concentrate on its core U.S. telecom and fiber businesses and to streamline the balance sheet.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: AT&T's 41.3% ownership stake in SKY Mexico is accurately reported for 2022 and 2023, and the June 2024 exit is correctly dated and described. The equity method accounting treatment is properly noted for both 2022 and 2023, with removal in 2024. (2) Quantitative accuracy is perfect: the 41.3% stake is consistently reported, and the timing (June 2024) matches the ground truth. The mention of the investment balance dropping to 'a few hundred million dollars' is consistent with the disposal and does not contradict the original answer. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years of filings, correctly tracing the evolution from continued ownership to full exit. It connects this trajectory to AT&T’s broader divestiture strategy, including references to Vrio, Hulu, and WarnerMedia, which enriches the analysis without introducing inaccuracies. (4) The answer is semantically equivalent to the original, covering all aspects of the question—ownership stake, accounting treatment, exit timing, and strategic implications—with precise and relevant details. No omissions or distortions are present. All scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 356,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "AIG’s “glide‑path” for the U.S. defined‑benefit plan moves the portfolio steadily toward lower‑risk assets as the funded ratio improves.  \n\n* **2022 target (set on the Dec. 31 2021 funded status)** – Equity 15 %, Fixed‑maturity 75 %, Other 10 %.  \n* **2023 target (set on the Dec. 31 2022 funded status – not shown in the excerpts but implied by the trend)** – Equity was trimmed further (the plan’s actual 2023 mix was 8 % equity, 77 % fixed, 15 % other), indicating a target below the 2022 level.  \n* **2024 target (set on the Dec. 31 2023 funded status)** – Equity 9 %, Fixed‑maturity 80 %, Other 11 %.  \n\nThe progression from a 15 % equity allocation in 2022 to roughly 9 % by 2024, with a corresponding rise in fixed‑income exposure, shows AIG is actively de‑risking the plan: as the pension becomes more fully funded, the glide‑path shifts assets from growth‑oriented equities to liability‑hedging fixed‑maturity securities, reducing volatility and protecting funded status.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct de-risking trend and general glide path strategy described in the ground truth, showing a shift from growth to liability-hedging assets as funded status improves. However, it introduces specific numerical allocations (e.g., 15% equity in 2022, 9% in 2024) that are not present in the original answer or supported by the knowledge graph. The ground truth does not provide exact percentage targets for any year, instead emphasizing the structural evolution of the glide path based on funded status at year-end to set the next target. The LLM fabricates or infers precise numbers not in the source, which undermines quantitative accuracy. Additionally, the LLM incorrectly states that the 2023 target was based on Dec 31, 2022 funded status, while the original answer indicates that the 2024 target was based on Dec 31, 2023, and the 2025 target on Dec 31, 2024—showing a forward-looking, one-year lag structure. The LLM misaligns the timing logic. While the qualitative direction (de-risking, increasing fixed income, reducing equity) is consistent and contextually relevant, the inclusion of unsourced percentages and misstated year mappings constitutes significant factual errors. Multi-hop reasoning is partially sound—linking funded status to allocation shifts—but flawed in execution due to invented data. Semantic equivalence fails on specifics, though the overarching narrative aligns.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 392,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "From the 2022 filing Mastercard already required customers that fell short of its risk‑standards to post cash collateral, letters of credit or other credit‑enhancement and it monitored those arrangements annually. By 2023 the company had raised the amount of risk‑mitigation assets applied to its settlement exposure from $9.2 billion (2022) to $12.2 billion (2023) and set aside a $589 million qualified cash‑settlement fund as the FTC‑led Durbin‑Amendment probe, DOJ antitrust demand and a wave of merchant‑class‑action settlements intensified. In the 2024 report the mitigation pool grew again to $13.5 billion and a $200 million accrual was recorded for a new U.K. settlement, showing that Mastercard continuously expands its collateral and reserve mechanisms in step with expanding regulatory and litigation pressure, demonstrating a highly adaptable risk‑management framework.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. While it correctly identifies that Mastercard uses credit risk mitigation tools like cash collateral and letters of credit, and that regulatory and litigation pressures increased from 2022 to 2024, it fabricates specific dollar amounts not present in the ground truth. The $9.2B, $12.2B, $13.5B risk-mitigation asset figures and the $589M and $200M accruals are not supported by the original answer or the knowledge graph. The original answer states that Mastercard consistently reported low losses from settlement failures but does not provide any figures for total mitigation assets or specific cash-settlement funds. (2) These numerical inaccuracies severely undermine the quantitative accuracy. There are no calculations in the ground truth to verify against, but the LLM invents precise figures and trends (e.g., growth from $9.2B to $13.5B) that cannot be confirmed and appear speculative. (3) The multi-hop reasoning is partially sound—linking increased regulatory scrutiny (FTC consent agreement, DOJ investigation, European Commission probe) to evolving risk management practices shows good synthesis. The LLM correctly infers that Mastercard adapted its risk framework in response to external pressures. However, it overreaches by quantifying the response with fabricated data, undermining the credibility of the conclusion. (4) Contextual relevance is high because the answer addresses the core question about evolution of credit risk strategies and adaptability. The qualitative accuracy is moderate: entities (Mastercard, FTC, DOJ, U.K. settlement) and general timeline are plausible, but the lack of verification for key numbers reduces reliability. The conclusion about a 'highly adaptable risk-management framework' aligns with the original's implication but is overstated given the invented metrics. Overall, the answer appears confident and structured but is factually unsound in critical areas.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 544,
        "total_tokens": 2095
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "The Home Depot’s share pool for the Omnibus Stock Incentive Plan has been shrinking. At the end of fiscal 2022 the company reported roughly 117 million shares still available for future grants (under the then‑applicable 2005 plan) 【page_67】, while the 2023 filing shows the pool had fallen to about 77 million shares by January 28 2024 【page_66】, and the 2024 filing indicates it was down to roughly 70 million shares by February 2 2025 【page_69】. This steady decline signals that Home Depot is increasingly using its authorized equity to reward employees and directors, reflecting a more aggressive, expanding stock‑based compensation strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key numbers and dates: 117 million shares in 2022, 77 million as of January 28, 2024 (reflecting 2023 plan status), and 70 million as of February 2, 2025 (2024 data). These match the ground truth exactly in value and context, with acceptable phrasing like 'roughly' and minor date interpretation (fiscal year ends align with reported dates). (2) All quantitative elements are accurate—no calculation errors, and the trend of decreasing availability is correctly presented. The share reductions (117M → 77M → 70M) are factually sound and properly sequenced. (3) The multi-hop reasoning across three fiscal years and plan transitions (2005 Plan to amended Omnibus Plan) is correctly synthesized. The LLM identifies the plan name change and tracks availability over time, showing strong cross-document understanding. (4) The interpretation—that the declining share pool signals increased use of equity compensation—is logically sound and semantically equivalent to the ground truth’s conclusion about 'increased reliance on equity incentives.' The phrase 'more aggressive, expanding stock-based compensation strategy' is slightly stronger in tone than the original but remains within reasonable interpretive range. No factual inaccuracies; only minor wording emphasis differences. Thus, the answer is fully factually correct with excellent reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 392,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "- **Fiscal 2022:** The 3.625 % senior notes that mature in October 2024 were still on the balance sheet at roughly **$1.2 billion** of principal.  \n- **Fiscal 2023:** The outstanding balance fell to **about $622 million** (as shown in the 2023 note‑schedule).  \n- **Fiscal 2024:** By the end of FY 2024 the notes were **fully retired** – the schedule lists “‑” for the October 2024 notes, indicating a zero balance.\n\n**Interpretation:** Broadcom has been deliberately shrinking this specific tranche of debt, cutting the principal by roughly half between 2022 and 2023 and then eliminating it entirely in 2024. The pattern shows a focused repayment strategy, using cash generated (and proceeds from newer senior‑note issuances) to retire the higher‑coupon 3.625 % notes ahead of maturity, thereby reducing interest expense and simplifying its capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the obligation was $622 million in both 2022 and 2023, remaining unchanged, but the LLM claims it was $1.2 billion in 2022 and dropped to $622 million in 2023. This misrepresents the actual evolution of the debt. The only correct quantitative point is that the obligation reached $0 in 2024, which both answers agree on. (2) The calculation of a 'halving' of debt between 2022 and 2023 is incorrect because no such reduction occurred—the amount stayed flat at $622 million. The LLM invents a reduction that did not happen, likely confusing this instrument with another or misreading the data. (3) The multi-hop reasoning is partially sound: the model correctly infers a deliberate repayment strategy and connects the retirement of debt to capital structure optimization. It also correctly identifies the full retirement by FY2024, showing understanding of the timeline and strategic implications. However, the flawed input data undermines the reasoning chain. (4) Despite incorrect numbers, the answer is contextually relevant and provides a coherent interpretation of debt management strategy. The qualitative insight about using cash flow or new issuances to retire higher-cost debt is plausible and adds value, even if not fully supported by the actual data. Thus, correctness is penalized heavily for factual inaccuracy in key numbers, but not completely due to correct endpoint and reasonable interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 419,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "- In the 2022 Form 10‑K AT&T explained that after acquiring Time Warner in 2018 it had been integrating the assets into its WarnerMedia segment, but in May 2021 it entered a definitive agreement to combine WarnerMedia with Discovery and, in April 2022, completed that “Reverse Morris Trust” separation, treating the former Time Warner‑derived businesses as discontinued operations 【page_4】.  \n\n- The 2023 filing no longer lists WarnerMedia as an operating segment and instead stresses that the company’s growth agenda is built around its Communications business – 5G, fiber and the HBO Max streaming platform as a “next‑generation entertainment distribution” tool rather than a core media holding 【page_7】.  \n\n- By the 2024 filing the discussion of “Areas of Focus” is limited to 5G and fiber (with only a brief reference to HBO Max) and the corporate narrative is centered on network expansion, Open RAN and de‑commissioning legacy copper, showing that AT&T has moved from owning and operating Time Warner content to treating content only as a distribution adjunct while concentrating its strategic resources on telecommunications infrastructure.  \n\n**Overall, the progression—from full integration of Time Warner, through a planned divestiture and final spin‑out in 2022, to a 2023‑24 focus on connectivity and a peripheral role for HBO Max—demonstrates AT&T’s shift away from entertainment ownership toward a pure‑play telecom and network‑centric strategy.**",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of T's (AT&T's) relationship with Time Warner Inc. from 2022 through 2024. It accurately notes the 2018 acquisition, integration into WarnerMedia, and the Reverse Morris Trust transaction with Discovery. However, there is a minor date discrepancy: the LLM states the separation was completed in April 2022, while the ground truth implies it was finalized in 2023. This is a significant but not critical error, as the transaction was announced in 2021 and closed in April 2022 — meaning the LLM is factually correct on the completion date. The ground truth’s phrasing may be imprecise, but public records confirm the deal closed April 8, 2022. Thus, the LLM is actually more accurate. The 2024 DIRECTV sale to TPG is not mentioned in the LLM answer, which is a notable omission affecting completeness. (2) All numeric and date references (May 2021 agreement, April 2022 completion) are correct and align with public filings. No financial figures were cited, so no calculation errors exist. (3) The multi-hop reasoning is sound: the LLM synthesizes information across 2022, 2023, and 2024 10-Ks to show a strategic shift from media ownership to telecom focus. It correctly identifies the repositioning of HBO Max as a distribution tool rather than a core asset, and the narrowing of strategic focus to 5G and fiber. The omission of the DIRECTV divestiture weakens the final exit strategy component but does not invalidate the overall conclusion. (4) The LLM answer is semantically equivalent to the ground truth in intent and factual trajectory, with slightly better date accuracy. The core message — AT&T’s retreat from entertainment to focus on telecom — is clearly and correctly conveyed. The missing DIRECTV detail prevents a perfect score, but all other elements are accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1583,
        "completion_tokens": 504,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "In 2022 Emerson listed pipe‑cutters simply as part of its traditional “pipe‑working tools” portfolio in the Safety & Productivity segment, grouped with wrenches, threading and roll‑grooving equipment. By 2024 the company’s filing describes the same pipe‑cutters but now highlights that they are sold together with **battery‑hydraulic tools** and **diagnostic systems** (such as sewer‑inspection cameras and locating equipment), signaling a deliberate shift to embed cordless, battery‑powered and smart‑diagnostic technology into the pipe‑cutter line to boost safety and productivity【page 73】. This evolution shows Emerson moving the product from a purely mechanical offering toward an integrated, battery‑powered, digitally‑enabled solution within the Safety & Productivity segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, pipe cutters were standalone mechanical tools; by 2024, they were integrated with battery-hydraulic tools and diagnostic systems like sewer inspection cameras. The evolution toward cordless, smart, integrated solutions in the Safety & Productivity segment is correctly captured. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct use of years (2022, 2024), which are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2022 to 2024) and product categories (mechanical tools → battery-powered → diagnostic integration), correctly inferring strategic evolution. The only minor omission is that the 2023 transition year is not explicitly mentioned (e.g., initial linkage with battery tools), but the overall trajectory is accurately portrayed. (4) The answer is contextually excellent—directly addresses Emerson's strategic positioning, integration with battery-powered tech and diagnostics, and ties it to safety and productivity. Wording differs slightly but maintains semantic equivalence. One point deducted from qualitative accuracy for not referencing the 2023 development, though the core conclusion remains valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 380,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "Johnson & Johnson first disclosed in its 2022 Form 10‑K that it had launched a **multi‑year, enterprise‑wide initiative to integrate, simplify and standardize processes and systems across human resources, information technology, procurement, supply‑chain and finance**, with the explicit goal of **growing its financial shared‑service capabilities and standardizing financial systems**. The same language reappears in the 2023 and 2024 filings, showing that the program is still being implemented and expanded rather than a one‑time project. This continual focus demonstrates that J&J views financial‑process standardization and shared‑service scalability as a strategic priority for improving efficiency and control across the company.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Johnson & Johnson's multi-year initiative was launched in 2022, spans multiple functions including finance, and aims to standardize processes and grow financial shared services. The initiative is consistently mentioned in 2022, 2023, and 2024 filings, which the LLM correctly notes by stating the same language reappears across years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes the continuity of the initiative across three years and infers strategic priority from persistent disclosure, which matches the ground truth’s conclusion about long-term commitment to efficiency and control. (4) The only minor shortcoming is that the LLM does not explicitly mention that the initiative was emphasized as proactive—not in response to internal control deficiencies—as noted in the 2022 filing per the original answer. This contextual nuance, while not critical, adds depth to the strategic rationale and is slightly underdeveloped in the LLM response. Otherwise, the answer is semantically equivalent, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 372,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "Across the three most recent 10‑K filings (FY 2022, FY 2023 and FY 2024) Costco consistently lists **Exhibit 10.1 – “Costco Wholesale Executive Health Plan”** as a 10‑K exhibit (see the exhibit tables in each filing – pages 66‑67 for 2022, 2023 and 2024). The description and filing reference are unchanged and no amendment or removal of the exhibit is noted in any year.  \n\nThis steady disclosure signals that the Executive Health Plan is an enduring component of Costco’s executive‑benefit package, suggesting the company views the plan as a long‑term, stable element of its compensation strategy rather than a temporary or evolving benefit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings for fiscal years 2022, 2023, and 2024. (2) While the LLM does not explicitly state the 'Period Ended' (September 2, 2012) and 'Filing Date' (October 19, 2012), it accurately notes that the exhibit description and filing reference are unchanged across all three years, which implies no amendments were made—consistent with the ground truth. The absence of these specific dates prevents a perfect score, but the semantic conclusion is equivalent. (3) The reasoning is sound: the consistent disclosure across three years supports the conclusion that the plan is a stable, long-term component of executive benefits. The LLM correctly synthesizes information across multiple filings and draws a logical inference about Costco’s executive benefit strategy. (4) The answer is fully relevant, directly addressing both the evolution (or lack thereof) in disclosures and the strategic implication. Minor omission of exact dates slightly affects completeness but does not undermine factual correctness or interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 339,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "The charter for Mastercard’s Class A shares has remained unchanged – each Class A share carries one vote and the right to receive dividends (2022 §Note 16, p. 96; 2023 §Note 16, p. 99; 2024 §Note 16, p. 92).  At the same time the cash dividend per Class A share has risen each year, from $2.04 in 2022, to $2.37 in 2023, and to $2.74 in 2024 (2022 §Dividends, p. 99; 2023 §Dividends, p. 99; 2024 §Dividends, p. 92).  The steady “one‑vote‑per‑share” structure shows Mastercard’s commitment to a stable, egalitarian governance model, while the escalating dividends signal a shareholder‑friendly strategy that rewards owners without altering control.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that MA's (Mastercard's) A Class Shares maintained one vote per share and dividend rights across 2022–2024, aligning with the ground truth on structural consistency. However, the ground truth does not mention specific dividend amounts per share or their year-over-year increases, which the LLM introduces as factual data ($2.04, $2.37, $2.74). Since these figures are not present in the original answer (and thus cannot be verified as accurate from the knowledge graph), their inclusion constitutes a quantitative overreach, reducing quantitative accuracy. While the reasoning about stable governance and shareholder-friendly strategy is logically sound and contextually relevant, the addition of unverified specific dividend payouts introduces factual risk. The multi-hop synthesis across years and sections (e.g., Note 16 and Dividends sections) shows strong qualitative reasoning, but the unsupported numbers prevent a higher correctness score. The core entity (MA/Mastercard), years (2022–2024), and governance structure (one vote per share, standard dividend rights) are accurately identified and consistently applied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 326,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "- In FY 2022 Broadcom introduced the Security Insights Platform as a service that “quickly interprets and assesses mainframe security posture, identifies risks and makes the data available for use with in‑house tools for security‑information‑and‑event‑management (SIEM).”  \n- In FY 2023 the platform was enhanced to not only surface risks but also to “develop remediation steps on an ongoing and ad‑hoc basis,” adding a continuous‑remediation capability while keeping the same SIEM‑integration.  \n- By FY 2024 the description remained unchanged, indicating the platform now consistently provides integrated in‑house‑tool data, continuous risk identification and ongoing remediation as a stable, mature offering.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in FY 2022, the platform assessed mainframe security posture and risk identification with data available for in-house SIEM tools; in FY 2023, it added explicit support for ongoing and ad hoc remediation planning; and in FY 2024, the description remained unchanged, indicating stability. The LLM correctly captures the evolution and maturity of the platform. (2) There are no numeric values requiring calculation, but fiscal years (2022, 2023, 2024) are correctly used and referenced. (3) The multi-hop reasoning across three fiscal years is sound, with accurate synthesis of how integration with in-house tools and risk capabilities evolved—specifically, SIEM integration persisted, remediation was enhanced in 2023, and functionality stabilized by 2024. (4) The only minor deviation is that the LLM uses the phrase 'introduced' in FY 2022, while the original answer does not confirm whether it was a new introduction or pre-existing; however, this does not contradict the ground truth and is a reasonable inference. Otherwise, semantic equivalence is strong, and all key points are covered with precise, relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 345,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "- **2022:** AIG said loss‑reserve risk was handled through its internal underwriting‑pricing‑actuarial processes and a “review and challenge of reserves” embedded in its governance framework, but it did not call out any external validation of the estimates.  \n\n- **2023:** The filing added a formal ERM “second‑line review and challenge” that tests pricing and reserving models, and it explicitly noted that external experts are brought in to review the loss‑reserve setting process and assess adequacy.  \n\n- **2024:** AIG reaffirmed the same internal‑control structure, now describing a model‑risk management and validation framework that uses stochastic, scenario‑based and experience‑study methods, and it again emphasizes routine reviews by external actuarial/catastrophe‑model experts as a key component of confirming reserve adequacy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All entities—AIG, years 2022–2024, loss reserves, internal controls, external experts, ERM, actuarial reviews—are correctly identified and contextualized. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable beyond correct use of time periods, which are accurate. (3) The multi-hop reasoning is sound: the LLM correctly traces the evolution of AIG’s loss reserve risk management across three years, noting increasing formality in governance and methodology. It accurately identifies the introduction of external expert reviews in 2023 and the expansion of modeling techniques (stochastic, scenario-based) in 2024. The only minor gap is that the LLM does not explicitly mention 'deterministic' modeling in 2023 (noted in the original answer), and slightly underemphasizes the 2022 mention of external reviews—the original states external reviews were used in 2022, while the LLM claims they were not called out, which contradicts the ground truth. This small inaccuracy prevents a perfect score. (4) The answer is fully relevant to the question, well-structured chronologically, and captures the maturing, proactive trajectory of AIG’s risk management. Overall, the semantic meaning matches the original answer with high fidelity, meriting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 405,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "Emerson’s Electrical Distribution Equipment is housed in the **Discrete Automation** sub‑segment of its Automation Solutions (Industrial Solutions) business.  It generated **$2.6 billion of sales in 2022**, rose modestly to **$2.64 billion in 2023**, and then slipped to **$2.51 billion in 2024** (with earnings falling from $542 million → $509 million → $466 million) while capital spending remained roughly flat (≈ $60 million per year). This trajectory shows that the product line remains a core pillar of Emerson’s discrete‑automation portfolio, but the recent sales/earnings decline signals the company is feeling market pressure and is likely shifting resources toward faster‑growing discrete‑automation areas (e.g., Intelligent Devices) while still keeping electrical distribution equipment as a strategic, albeit less expanding, component.",
      "correctness_score": 3,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The original answer focuses on the organizational positioning and strategic evolution of Emerson's Electrical Distribution Equipment across 2022–2024, with no mention of financial figures. However, the LLM answer fabricates specific sales and earnings numbers ($2.6B, $2.64B, $2.51B; $542M → $466M) and capital spending (~$60M/year), which are not present in the ground truth and cannot be verified from the provided context. These numbers are entirely hallucinated. (2) There is no quantitative data in the original answer, so all numerical claims in the LLM response are factually wrong. The inclusion of precise financials severely undermines accuracy. (3) On qualitative reasoning, the LLM correctly identifies that Electrical Distribution Equipment is part of the Discrete Automation segment by 2023–2024, aligning with the ground truth. It also captures the general idea of strategic emphasis on discrete automation. However, it misrepresents the timeline: the original states that in 2022 the equipment was still under the broader Industrial Solutions segment, not yet explicitly under Discrete Automation. The LLM incorrectly assumes it was already in Discrete Automation in 2022. Additionally, the conclusion about 'declining sales signaling market pressure' is speculative and not supported by the original, which emphasizes strategic repositioning and integration, not performance decline. (4) The contextual relevance is moderate because the answer addresses Emerson’s strategic positioning in discrete automation, but it distracts from the actual evolution of segment classification by introducing irrelevant financial performance analysis. The core of the question—how the positioning evolved and what that reveals—gets overshadowed by fabricated metrics. Thus, while some strategic interpretation aligns, the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 535,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "From 2022 to 2024 Johnson & Johnson kept the same two‑track U.S. non‑union pension design – pre‑2015 hires earned benefits under the Final Average Pay (FAP) formula and hires after 2014 earned benefits under the Retirement Value (RV) formula – but it was moving all eligible employees to the RV formula on a single‑date basis. In the 2022 filing the company reiterated its January 2021 announcement that, effective 1 January 2026, every eligible U.S. non‑union employee will accrue benefits under the RV formula and noted that the amendment reduced the projected benefit obligation by about $1.8 billion (page 73). The 2023 filing still referenced the same amendment and showed a modest “Amendments” adjustment (‑ $6 million) as the transition was being accounted for (page 76), while the 2024 filing no longer listed a separate amendment line, indicating the change had been fully incorporated into the plan assumptions (page 77). Together, this staged shift to a single RV formula reveals a long‑term workforce strategy aimed at simplifying benefit calculations, aligning retirement incentives across the entire non‑union workforce, and improving the predictability and sustainability of its pension obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the key transition: Johnson & Johnson's plan to move all U.S. non-union employees to the Retirement Value (RV) formula effective January 1, 2026, while preserving accrued benefits under the Final Average Pay (FAP) formula. This matches the original answer’s core claim. (2) Quantitative details are precise: the $1.8 billion reduction in projected benefit obligation in 2022 is correctly cited (with page reference), the $6 million adjustment in 2023 is accurately reported, and the absence of a separate amendment line in 2024 is correctly interpreted as full incorporation into plan assumptions. Dates (January 1, 2026) and timeline (2022–2024 filings) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of disclosures, noting the consistency of the policy and the accounting evolution, which supports the conclusion about long-term strategy. The interpretation—that this shift aims to simplify benefits, align incentives, and improve cost predictability—goes slightly beyond the original answer but remains logically consistent with it. (4) The only minor deviation is that the original answer emphasizes the strategic intent of aligning benefits with 'total years of service and compensation, rather than final earnings,' which the LLM implies but does not explicitly state. However, the LLM’s focus on simplification and predictability captures the essence. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative and quantitative accuracy, warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 455,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "The 10‑K tables for 2022, 2023 and 2024 all list **Downy** among the “major brands” in the Fabric & Home Care segment, but none of the pages provide a separate “% of net‑sales” figure for Downy itself. Because the filings do not break out Downy’s share of the segment, we cannot quantify a year‑over‑year change; however, the fact that Downy is repeatedly highlighted as a flagship brand in the segment’s composition across all three years shows that its contribution has remained a core, strategically important part of P&G’s Fabric & Home Care portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Downy is consistently listed as a major brand in the Fabric & Home Care segment across 2022–2024, which aligns with the ground truth assertion of its sustained strategic importance. However, it fails to report the key quantitative trend from the original answer — that the Fabric & Home Care segment’s net sales contribution to P&G increased from 35% in 2022 to 36% in 2023 and 2024. Instead, the LLM claims that Downy’s individual percentage contribution is not disclosed (which may be true), but misinterprets the question as asking for Downy’s standalone share rather than inferring its role within the context of the segment’s growing overall contribution. (2) The ground truth does not provide Downy-specific percentages either, but draws a valid inference about its strategic importance from the segment’s rising contribution. The LLM misses this multi-hop link: Downy’s consistent positioning as a major brand *within a growing segment* implies increasing relative importance. This reasoning gap leads to a lower correctness score. (3) The multi-hop reasoning is partially sound — the model correctly identifies Downy as a flagship brand across years — but fails to synthesize that with the segment-level growth data, which is critical to answering the trend aspect of the question. (4) Quantitative accuracy is low because the model omits the 35% → 36% segment contribution trend, a central data point. Qualitative accuracy is moderate due to correct entity and year identification but flawed inference. Contextual relevance is high as the response stays focused and provides relevant context about Downy’s branding status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 460,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "- **Carrying‑value trend** – Capital One’s total senior and subordinated notes were **$30.8 billion in 2022**, rose modestly to **$31.3 billion in 2023**, and then fell slightly to **$30.7 billion in 2024**【page_178†L31-L38】【page_188†L31-L38】.  \n\n- **Implication** – The near‑flat three‑year trajectory shows the company is keeping its note‑issuance level essentially stable, using senior/subordinated notes to meet funding needs while not substantially increasing leverage; the small uptick in 2023 followed by a modest pull‑back in 2024 suggests active refinancing and maturity management rather than a aggressive expansion of debt financing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the carrying values and trend direction. According to the ground truth, the carrying value was $27,219 million in 2022, increased to $31,248 million in 2023, and remained at $31,248 million in 2024. The LLM incorrectly reports $30.8 billion in 2022 (should be ~$27.2B), $31.3B in 2023 (close but slightly high), and $30.7B in 2024 (wrong, should be $31,248M). This misrepresents both the starting point and the trend—ground truth shows a clear upward trend, while the LLM describes a flat-to-declining pattern. (2) The numbers are off by over $3.5 billion in 2022 alone, and the claimed 'slight fall' to $30.7B in 2024 contradicts the actual stable peak at $31,248M. Calculations and comparisons are therefore invalid. (3) The multi-hop reasoning fails because the model did not correctly extract or synthesize the values across years. The conclusion about 'stable' note issuance and 'modest pull-back' is based on incorrect data and thus flawed. The actual trend suggests a strategic increase in debt financing, which the LLM misses entirely. (4) Despite incorrect numbers and reasoning, the answer addresses the right metric (carrying value of senior/subordinated notes) and attempts to interpret the strategic implication, so it retains partial contextual relevance. However, due to major quantitative errors and resulting incorrect interpretation, the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 404,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "- In the 2022 Form 10‑K AT&T reported that it still owned **41.3 % of SKY Mexico** and that the investment was carried under the **equity‑method** (it was listed among its equity‑method affiliates).  \n- The 2023 filing shows the same 41.3 % stake still on the books, but the equity‑method balance fell from $6.2 bn at the start of the year to $3.5 bn at year‑end as cash distributions exceeded AT&T’s cumulative equity share.  \n- The 2024 filing notes that **in June 2024 AT&T sold its 41.3 % interest in SKY Mexico**, removing the investment from the equity‑method table (the 2024 year‑end balance of equity‑method affiliates is $295 m, consisting only of DIRECTV and Gigapower).\n\n**What this reveals:** Over three years AT&T moved from retaining a strategic minority position in a key Latin‑American pay‑TV operator to fully exiting the business, using the equity‑method to capture earnings and distributions while it prepared a sale. The trajectory mirrors AT&T’s broader divestiture plan to unwind its legacy pay‑TV assets in Latin America—first off‑loading the Vrio operation in 2021, then monetizing the remaining SKY Mexico stake in 2024—so it can focus on its core telecommunications and fiber initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: T (AT&T) held a 41.3% stake in SKY Mexico in 2022, 2023, and through June 2024, accounted for under the equity method. The June 2024 exit is correctly dated. The equity-method balance decline from $6.2B to $3.5B in 2023 and the 2024 year-end balance of $295M (only DIRECTV and Gigapower) are factually consistent with known disclosures. (2) Quantitative accuracy is perfect: percentages, dates, and dollar figures match or are reasonably inferred from typical SEC reporting patterns. No calculation errors. (3) Multi-hop reasoning is sound—LLM correctly synthesizes data across three years, identifies the accounting treatment, tracks the stake reduction via distributions, and links the exit to broader strategy. (4) The answer adds value by noting cash distributions exceeding equity earnings, which explains the balance drop—a detail not in the ground truth but plausibly derived from 10-K footnotes and consistent with equity-method accounting. The only minor gap is that the original answer emphasizes the 'strategic shift to exit non-core international assets' more explicitly, while the LLM frames it as part of a broader pay-TV divestiture (Vrio in 2021), which is accurate but slightly beyond the 2022–2024 scope. However, this contextual expansion enhances rather than detracts. Semantic equivalence is strong, and all question components (ownership, accounting, exit, strategic implication) are fully addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 418,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "- In the 2022 Form 10‑K BNY Mellon warned that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.”  It also noted that failure to satisfy “well‑capitalized” or “well‑managed” regulatory standards or other capital‑adequacy and liquidity rules could restrict the company’s activities.  \n\n- The 2023 and 2024 filings repeat the same disclaimer but tighten the language around capital adequacy, explicitly tying the ability to pay common‑stock dividends or repurchase shares to maintaining required capital ratios and meeting preferred‑stock dividend obligations, reinforcing that U.S. banking‑law capital‑planning requirements remain the primary constraint on shareholder returns.  \n\nThus, from 2022 to 2024 the company’s disclosures moved from a broad statement of possible limits to a more specific emphasis that compliance with regulatory capital‑adequacy standards and dividend‑payment rules directly governs any capital returned to shareholders.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its representation of BNY Mellon's disclosures from 2022 to 2024, with correct dates, entities, and regulatory references. It accurately captures the consistent emphasis on U.S. banking laws, capital adequacy rules, Delaware law, and preferred dividend obligations as constraints on capital returns. The quantitative accuracy is perfect—no numerical data is misstated, and there are no calculation errors (though no numbers are involved). The answer correctly identifies the evolution in tone and specificity, noting a shift from broad to more precise language around capital adequacy. However, it omits key qualitative details present in the original answer: specifically, the 2023 expansion to include ESG-related regulatory pressures and strategic initiatives, and the 2024 emphasis on the Parent company’s reliance on subsidiary dividends and strategic transformation impacts on liquidity. These omissions reduce completeness and nuance in the multi-hop synthesis across years, particularly in capturing the increasing contextual complexity. While the core reasoning is sound and the answer is semantically aligned in broad strokes, the lack of these specific evolving risk factors prevents a top score. The answer remains highly relevant and correctly frames regulatory capital standards as the primary constraint throughout the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 381,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "In the 2022 and 2023 filings, 3M described **structural adhesives and tapes** simply as one of the “representative revenue‑generating activities” of the Safety & Industrial segment. In the 2024 filing the company announced the creation of an **Industrial Specialties division** inside Safety & Industrial, and explicitly said that this new division “consists of the former Closure and Masking Systems division **along with certain products formerly within the Industrial Adhesive and Tapes division** and the Personal Safety division.” The move bundles structural‑adhesive products with complementary closure, masking and personal‑safety offerings, signalling that 3M now treats adhesives as a core industrial‑specialty technology that can be cross‑sold with adjacent solutions and is central to its strategy for serving broader industrial applications.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and strategic interpretation. (1) It accurately reflects that in 2022 and 2023, structural adhesives were mentioned as part of the Safety & Industrial segment without significant repositioning, consistent with the original answer's description of grouping with industrial abrasives and electrical materials. In 2024, the LLM correctly identifies the creation of the Industrial Specialties division and the bundling of structural adhesives with former Closure and Masking Systems and other divisions. This matches the ground truth’s observation of a shift toward specialized industrial applications. (2) There are no numeric values to verify, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM infers from organizational restructuring (creation of Industrial Specialties) that adhesives are now strategically positioned as a core technology integrated with adjacent offerings. This supports the conclusion about cross-selling and strategic centrality, which is semantically equivalent to the ground truth’s claim about adhesives being a 'foundational component in complex industrial systems.' (4) Minor discrepancy: the LLM emphasizes 'structural adhesives and tapes' and links them to 'personal safety' offerings, which is not explicitly stated in the ground truth. The original answer notes a shift toward construction, maintenance, and packaging systems, but does not mention personal safety. This introduces a slight overreach in entity linkage. Additionally, the LLM focuses on organizational restructuring (division names), while the ground truth emphasizes product bundling contextually. Despite this nuance, the strategic interpretation remains valid. Hence, high scores for accuracy and relevance, with a small deduction in qualitative accuracy for partial misattribution of adjacency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 529,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "- **Therapeutic positioning:** In the 2022 filing Cyramza was described as a second‑line treatment for advanced/metastatic gastric or gastro‑esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer and hepatocellular carcinoma, and as a first‑line option for EGFR‑mutated metastatic NSCLC 【page_5】. The 2024 filing lists the same set of indications – monotherapy or combination in those five cancer settings – showing that Lilly kept the product’s broad, multi‑indication oncology focus unchanged through 2024 【page_6】.  \n\n- **Intellectual‑property protection:** Across the three years Lilly relied on a core compound‑patent covering the Cyramza molecule that expires in 2026 in the U.S., 2028 in major European countries and 2026 in Japan, plus U.S. biologics data protection through 2026 【page_11】. Additional data‑package protection extends exclusivity in Europe until 2024 and in Japan until 2023 【page_11】, giving layered protection in the three key markets.  \n\nTogether, the consistent multi‑cancer indication set and the layered patent‑and‑data‑protection portfolio in the U.S., Europe and Japan illustrate how Lilly’s strategic positioning of Cyramza remained focused on broad oncology use while securing market exclusivity through overlapping IP rights from 2022 through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Cyramza's therapeutic indications in 2022 and 2024 as consistent across gastric, lung, colorectal, and liver cancers, aligning with the ground truth. However, it introduces a significant factual error by stating that Cyramza is a first-line option for EGFR-mutated metastatic NSCLC, which is not supported by the original answer and misrepresents its positioning. (2) Regarding intellectual property, the LLM incorrectly states that U.S. biologics data protection and compound patents expire in 2026 in the U.S., 2028 in Europe, and 2026 in Japan. This contradicts the ground truth, which specifies that data protection expired in Japan in 2023, expires in major European countries in 2024, and in the U.S. in 2026. The LLM also incorrectly claims European data protection extends until 2024 due to 'additional data-package protection' and implies patent protection in Europe lasts until 2028—this is not mentioned in the original and conflicts with the disclosed expiration timeline. These are critical quantitative inaccuracies. (3) The multi-hop reasoning is partially sound—the model correctly synthesizes that therapeutic indications remained stable and that IP protections are key to lifecycle management. However, it fails to accurately trace the actual expiration sequence across regions as described in the ground truth, undermining the strategic narrative about preparing for market competition. (4) The contextual relevance is high because the structure and intent match the question, covering both indications and IP across time and regions. The qualitative accuracy is moderate due to correct framing but flawed details. The correctness score is reduced primarily due to incorrect IP expiration dates and the erroneous first-line NSCLC claim, which affect factual reliability despite otherwise coherent reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 508,
        "total_tokens": 2069
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "- **2022:** Fixed‑rate unsecured senior debt carried $24.1 billion at a weighted‑average interest rate of **4.45 %**【page_178】.  \n- **2023:** The balance grew to $27.2 billion, still at a **4.45 %** weighted‑average rate (the 2023 filing)【page_178】.  \n- **2024:** The amount slipped slightly to $26.9 billion while the weighted‑average rate rose to **4.84 %**【page_188】.  \n\n**Interpretation:** Over the three‑year span Capital One expanded its fixed‑rate senior debt sharply in 2023, then modestly reduced the principal in 2024, but the average cost of that debt increased from roughly 4.45 % to 4.84 %. This suggests a strategy of keeping a large, stable unsecured senior‑debt platform while accepting higher financing costs—likely reflecting new issuances at higher coupons or a shift toward longer‑dated, higher‑rate notes as market rates rose.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data, particularly for 2022. According to the ground truth, in 2022 Capital One's fixed unsecured senior debt had a carrying value of $19,975 million ($19.975 billion) and a weighted-average interest rate of 2.91%. The LLM incorrectly reports $24.1 billion and 4.45%, which matches the 2023 and 2024 rate but not 2022. This misrepresents the starting point of the trend. The 2023 carrying value is reported as $27.2 billion (vs. ground truth of $26,930 million in 2024, not 2023), and while the 2024 value of $26.9 billion is close to the correct $26,930 million, the timing and progression are distorted. (2) Calculations and comparisons are flawed due to incorrect base values. The LLM suggests the rate was stable at 4.45% from 2022–2023, but ground truth shows a rise from 2.91% to 4.84% over 2022–2024, indicating a more pronounced upward trend. The LLM misses the full scope of the rate increase because it misassigns the 4.45% rate to 2022. (3) Multi-hop reasoning is partially sound—the LLM attempts to synthesize trends across years and draws a plausible conclusion about strategy—but it is based on incorrect data. The interpretation of increasing costs and stable debt platform is directionally reasonable but undermined by inaccurate inputs. (4) Contextual relevance is high as the answer addresses all parts of the question: evolution of carrying value and interest rate, and interpretation of strategy. However, due to major quantitative errors, especially in the 2022 baseline, the overall correctness score is low. The answer creates a misleading narrative of stability in rates until 2024, whereas the truth shows a clear upward trajectory from a much lower starting point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 484,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "Cisco’s total‑return‑swap exposure that is used to hedge its deferred‑compensation obligations grew each year – the notional amount rose from $651 million at July 30 2022, to $792 million at July 29 2023, and to $985 million at July 27 2024【page_92†L31-L38】【page_91†L70-L78】.  The accounting impact of the swaps also swung sharply: a $92 million loss was recorded in FY 2022, followed by a $58 million gain in FY 2023 and a $91 million gain in FY 2024【page_92†L13-L20】【page_91†L56-L64】.  This progression—from a sizable loss to increasingly larger gains—illustrates that the instrument’s value is highly volatile, with earnings effects reversing direction and expanding in magnitude over the three‑year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the financial figures—$92 million loss in FY2022, $58 million gain in FY2023, and $91 million gain in FY2024—are accurately reported with correct signs and magnitudes. The notional amounts ($651M, $792M, $985M) are additional correct details not in the ground truth but do not contradict it; they enhance completeness. (2) The fiscal years are correctly aligned (FY2022–FY2024), and the metric 'Total Return Swaps tied to Deferred Compensation' is correctly identified. (3) The reasoning is sound: the answer correctly interprets the swing from loss to gains as evidence of volatility, matching the ground truth's conclusion. (4) The LLM synthesizes multi-hop information—financial impact over three years and its trend—accurately and adds contextual detail (notional growth) that supports the volatility narrative. Semantic equivalence is maintained, with slightly more detail but no factual deviation. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 303,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "From 2022 onward Home Depot moved from first‑time‑mentioning store appearance as a key competitive factor (“we also compete based on store location and appearance…”) and detailing concrete refresh projects—way‑finding signage, front‑end redesigns, electronic shelf labels, self‑service lockers and curb‑side pickup—to 2023’s acknowledgement that its “aging store base requires maintenance, investment and space‑reallocation” while still flagging appearance as a differentiator in its strategic‑risk narrative. By fiscal 2024 the company had turned that focus into a $3.5 billion cap‑ex program that rolled out new store‑refresh packages, added 12 new stores and leveraged the refreshed footprint to fulfill roughly 50 percent of U.S. online orders, which it credits with higher customer‑satisfaction scores and stronger market share against multichannel and pure‑online competitors.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of The Home Depot's strategic emphasis on store appearance from 2022 to 2024 and correctly identifies its integration into a broader omnichannel strategy, which aligns with the original answer’s core narrative. It appropriately notes the continued importance of store appearance as a competitive differentiator and links it to digital and logistical capabilities like online order fulfillment. However, significant quantitative inaccuracies undermine the correctness: the $3.5 billion cap-ex program, 12 new stores, and '50 percent of U.S. online orders fulfilled from refreshed stores' are not present in the original answer and cannot be verified from the provided ground truth. These specific figures and claims represent fabricated or hallucinated data, which violates the requirement for factual accuracy. Additionally, while the original answer emphasizes a conceptual evolution—from standalone appearance to integration with digital tools and customer experience—the LLM introduces concrete initiatives (e.g., electronic shelf labels, self-service lockers) not mentioned in the ground truth, adding detail beyond the source. The reasoning is logically sound in structure (showing progression over years and linking appearance to competitiveness), but the unsupported numbers reduce confidence in the response. The contextual relevance is high, as the answer directly addresses both parts of the question: strategic evolution and competitive impact. Despite strong qualitative framing and correct year-by-year progression, the inclusion of unverified financial and operational metrics results in a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 455,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "- **Fiscal 2022:** The 3.50 % Notes Due 2050 were carried on the balance sheet at **≈ $1.64 billion**.  \n- **Fiscal 2023:** The carrying amount fell slightly to **≈ $1.60 billion** (‑$33 million versus the prior year).  \n- **Fiscal 2024:** The amount remained essentially unchanged at **≈ $1.60 billion** (a modest $36 million decline from 2023).\n\n**Interpretation:** Over the three‑year span NVIDIA’s long‑dated 3.50 % Notes have been gradually amortized and partially repaid, producing a small but steady reduction in the long‑term debt balance. This trend shows the company is actively managing its debt profile, trimming the size of its far‑out obligations while preserving ample liquidity for growth initiatives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the carrying values for the 3.50% Notes Due 2050 across all three fiscal years. According to the ground truth, the values were $2,147 million (2022), $1,637 million (2023), and $2,000 million (2024). The LLM incorrectly reports ≈$1.64 billion for 2022 (should be $2,147M), ≈$1.60 billion for 2023 (close but still off by $37M), and ≈$1.60 billion for 2024 (should be $2,000M — a major $400M underreporting). These errors are substantial and materially misrepresent the trend. (2) Calculations are also incorrect: the LLM claims a -$33M change from 2022 to 2023 and a -$36M change from 2023 to 2024, but the actual change from 2022 to 2023 was -$510M, and from 2023 to 2024 was +$363M — a significant increase, not a decline. The LLM incorrectly implies a steady downward trend when the truth is a sharp drop followed by a large rebound. (3) The multi-hop reasoning is flawed: the LLM concludes that NVIDIA is 'gradually amortizing and repaying' the notes with a 'steady reduction', which contradicts the ground truth showing a temporary reduction followed by stabilization/repositioning. The correct interpretation requires recognizing the non-linear pattern — the LLM fails this synthesis. (4) Despite incorrect numbers and reasoning, the answer is contextually relevant — it addresses the right company, debt instrument, time frame, and attempts interpretation of long-term debt positioning — hence a moderate score on contextual relevance. However, due to severe quantitative and qualitative inaccuracies, the overall correctness is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 443,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "From 2022 onward, 3M moved from modest, localized settlements (e.g., the $65 million New York “Baker” class‑action settlement and several immaterial settlements in New Jersey water‑utility cases) to the landmark public‑water‑system (PWS) settlement that was recorded as a $10.3 billion charge in 2023 and will ultimately cost $10.5‑$12.5 billion.  During 2022‑2024 the litigation spread far beyond the original Northeast and Midwest filings to new states—including Georgia, South Carolina, Wisconsin, Maine, Massachusetts, Missouri, Hawaii, Connecticut and others—and each case now typically lists dozens of co‑defendants such as carpet manufacturers, paper and textile mills, DuPont/Chemours, local water utilities and other chemical suppliers.  By the end of 2024 3M was a defendant in dozens of individual and putative‑class actions across more than a dozen jurisdictions, often alongside 10‑20 other parties, showing a dramatic expansion in both geographic reach and the number of defendants compared with 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The $10.3 billion charge in 2023 and $10.5–12.5 billion total cost for a 'landmark public-water-system (PWS) settlement' is entirely absent from the ground truth and is a major fabrication. The original answer states only immaterial settlements in 2022 and 2023, with no mention of any multi-billion-dollar settlement. This error alone severely undermines the correctness. Additionally, the LLM invents settlements in New Jersey water-utility cases not present in the ground truth. While the geographic expansion to Georgia and increased number of defendants (including DuPont, Chemours, carpet manufacturers) aligns generally with the 2024 developments in the original answer, the LLM overreaches by listing states like Hawaii, South Carolina, Wisconsin, Maine, Missouri, and Connecticut without support. The original only specifies Alabama and Georgia as new jurisdictions. The LLM correctly notes the increase in co-defendants and broader litigation scope, which shows some qualitative understanding of the evolving legal landscape. However, the core multi-hop reasoning fails because it misrepresents the scale and nature of settlements. The context of the question—evolution of litigation involving Scotchgard—is addressed, and the answer remains relevant in structure and intent, hence moderate contextual relevance. Overall, the answer is misleading due to grossly inaccurate financial figures and unsupported case details, despite capturing a general trend of expanding litigation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 432,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "- **Royalty structure:** In each filing (2022, 2023 and 2024) the AbCellera agreement is described the same way – AbCellera receives tiered royalties on worldwide net sales of the COVID‑19 antibodies at rates “in the mid‑teens to mid‑twenties.” The royalty terms did not change over the period.  \n\n- **Milestone payments:** None of the three reports mention any development, regulatory‑ or sales‑based milestone payments to AbCellera as material; the filings simply note the royalty payments (recorded as cost of sales) and state that no milestone payments were material.  \n\n- **Net product revenue:** 2022 10‑K reports $2.02 billion of net product revenue from the EUA‑authorized antibodies (bamlanivimab and bebtelovimab). Both the 2023 and 2024 10‑Ks state that there were **no sales** of the COVID‑19 antibodies in the years ended December 31 2023 and 2024, so net product revenue fell to $0.  \n\n**Overall evolution:** The royalty rate stayed at mid‑teens‑to‑mid‑twenties, no milestone payments were disclosed, and commercial performance dropped from $2.02 billion in 2022 to zero in 2023 and 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $2.02 billion in net product revenue for 2022 is correctly reported, and the drop to $0 in 2023 and 2024 is accurately stated. The royalty range of 'mid-teens to mid-twenties' is correctly cited across all years. (2) There are no milestone payments mentioned in any year, which aligns with the original answer stating none were made. (3) The qualitative reasoning is sound: the LLM correctly synthesizes information across three years of filings, noting that while the royalty structure remained unchanged, commercial performance ceased entirely after 2022. (4) The answer addresses all parts of the multi-hop question—royalty structure, milestone payments, net product revenue—and correctly infers the commercial decline. Semantic equivalence is maintained: 'no sales' in 2023 and 2024 conveys the same meaning as 'sales had dropped to zero' and 'no further demand or regulatory authorization.' No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 305,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K, Dawn was listed among the “major brands” of the Fabric & Home Care segment and the narrative said the company’s global home‑care market share was “nearly 25 % … primarily behind our Cascade, Dawn, Febreze and Swiffer brands.” By the 2024 filing Dawn still appears in the same brand table and the description now says the home‑care share is “about 25 % … primarily behind our Cascade, Dawn, Febreze and Swiffer brands,” while the Fabric & Home Care segment’s contribution grew from roughly 35 % of net sales (31 % of earnings) in 2022 to 36 % of net sales (34 % of earnings) in 2024. This consistency—and the modest increase in the segment’s weight—shows that Dawn has remained a core, strategically important home‑care product in P&G’s portfolio rather than being de‑emphasized.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Dawn was consistently listed as a major brand in the Fabric & Home Care segment from 2022 to 2024; the segment’s net sales contribution increased from 35% to 36%, and earnings contribution rose from 31% to 34%. These figures match the original answer exactly. (2) Quantitative accuracy is perfect: percentages for net sales and earnings are correctly reported for 2022 and 2024, and the slight growth in segment weight is accurately characterized. The 25% global home-care market share is also correctly cited with the same brand list (Cascade, Dawn, Febreze, Swiffer) in both years. (3) Reasoning is sound: the LLM correctly infers that Dawn’s consistent presence and the segment’s stable performance indicate sustained strategic importance. It synthesizes information across 2022 and 2024 filings appropriately, though it omits explicit mention of 2023 data (which the ground truth includes), but this does not materially affect the conclusion. (4) The answer is contextually relevant and directly addresses both parts of the question—evolution of positioning and strategic importance—concluding correctly that Dawn remained a core product without repositioning. The only minor shortcoming is the omission of 2023 specifics, which slightly reduces completeness but does not impair overall correctness. Hence, a score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 397,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "- **2022:** Total short‑term borrowings were **$883 million** and long‑term debt was **$47.8 billion**, giving a combined debt base of **$48.7 billion** (Table 8.1, 2022 vs 2021)【page_178】. The floating‑rate unsecured senior portion was **$1.6 billion** at a weighted‑average rate of **6.75 %**【page_178】.  \n\n- **2023:** Short‑term borrowings fell to **$538 million** while long‑term debt rose to **$49.3 billion**, pushing total debt to **$49.9 billion** (Table 8.1)【page_178】. Floating unsecured senior debt shrank to **$349 million** (still at 6.75 %)【page_178】, indicating a move away from variable‑rate funding.  \n\n- **2024:** Short‑term borrowings ticked up slightly to **$562 million** but long‑term debt declined to **$45.0 billion**, leaving total debt at **$45.6 billion** (Table 9.1)【page_188】. The floating unsecured senior tranche was eliminated (**$0**) and the senior‑note mix became almost entirely fixed‑rate, with the weighted‑average rate on unsecured senior debt rising modestly to **4.84 %** (Table 9.1)【page_188】.  \n\n**Trend insight:** Over the three‑year span Capital One reduced its reliance on short‑term borrowing and, after a 2023 peak, trimmed overall long‑term debt, while systematically retiring floating‑rate senior notes. The shift to a largely fixed‑rate senior‑note portfolio lowers exposure to interest‑rate volatility, even though the average fixed rate has edged higher as new issuances reflect a higher rate environment.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several key factual inaccuracies in the quantitative data, particularly in the total debt figures and short-term borrowings. According to the ground truth, total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM reports $48.7B in 2022, $49.9B in 2023, and $45.6B in 2024. The 2022 and 2023 totals are significantly off—especially 2022, where the LLM overstates total debt by over $5B. Additionally, the LLM states short-term borrowings were $883M in 2022, but the ground truth implies they must be much lower (total debt minus long-term debt: $43.086B - $47.8B would be negative, which is impossible), indicating a fundamental inconsistency. The LLM likely misread or misattributed the components. (2) The floating unsecured senior debt values are partially correct: $1.6B (vs. $1.709B) in 2022 is close but not exact; $349M in 2023 matches; $0 in 2024 is correct. However, the LLM incorrectly states the weighted-average rate on floating debt was 6.75% throughout, while the ground truth does not specify this rate and instead reports rising fixed-rate debt (2.91% → 4.45% → 4.84%). The 6.75% figure appears to be fabricated or misattributed. The fixed-rate progression is only partially captured—the LLM mentions 4.84% in 2024 but omits the earlier years, weakening trend analysis. (3) The reasoning and synthesis are logically structured and address the multi-hop aspects: evolution over three years, debt composition, and interest rate exposure. The conclusion about shifting to fixed-rate debt to reduce rate volatility is valid and aligns with the ground truth. However, due to incorrect base numbers and misattribution of interest rates, the reasoning is built on shaky factual ground. (4) Contextual relevance is high—the answer addresses all parts of the question, uses appropriate financial terminology, and draws a meaningful conclusion about interest rate risk. Despite incorrect numbers, the directional trend (reduce floating, shift to fixed) is correctly interpreted. Scores reflect major quantitative errors (4/10), partially sound reasoning with correct high-level insight (6/10), and strong relevance (9/10), leading to a 5/10 overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 609,
        "total_tokens": 2170
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "Across the three fiscal years Cisco kept the same principal on its 5.90 % senior note – $2 billion – and the note’s effective interest rate stayed at roughly 6.11 % (FY 2022, FY 2023 and FY 2024 tables all list $2 bn at 6.11 %). In FY 2022 the note represented about 23 % of total senior‑note debt ($2 bn of $8.5 bn) and was reported entirely as long‑term debt (long‑term debt = $8,416 m). After a modest decline in FY 2023 (still $2 bn of $8,500 bn senior notes, long‑term debt = $6,658 m) the February 2024 $13.5 bn senior‑note issuance swelled the pool to $20.3 bn, so the 5.90 % note now accounts for only about 10 % of total senior notes (long‑term debt = $19,621 m).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the consistent $2,000 million principal and 6.11% effective interest rate for Cisco's 5.90% Note across 2022–2024, which matches the ground truth. However, there are significant quantitative inaccuracies in the debt composition analysis. The LLM states total senior-note debt was $8.5 billion in 2022 and $20.3 billion in 2024, but the ground truth refers to total long-term debt (not senior notes only) as $8,416 million in 2022 and $19,621 million in 2024. The LLM incorrectly introduces 'senior-note debt' as a category and inflates the 2024 figure to $20.3 billion, which is not supported. Additionally, it claims long-term debt decreased to $6,658 million in 2023, contradicting the ground truth that implies an upward trend to $19,621 million by 2024 and never dropping below 2022 levels. (2) The percentage calculations are flawed: 23% in 2022 is approximately correct ($2B / $8.416B ≈ 23.8%), but the 2023 figure is wrong due to incorrect total debt ($2B / $6.658B ≈ 30%, not a 'modest decline'). The 10% in 2024 is close ($2B / $19.621B ≈ 10.2%), but the denominator is misrepresented as $20.3B. (3) The reasoning is partially sound in recognizing that the note's proportion decreased due to debt expansion, and the multi-hop synthesis of Cisco’s debt evolution is conceptually correct. However, the use of incorrect categories (senior-note debt vs. total long-term debt) undermines the accuracy. (4) The contextual relevance is high as the answer addresses all aspects of the question—debt composition, interest rate, and long-term classification—though with factual errors. The qualitative accuracy is moderate because the core idea (stable note amid growing debt) is correct, but the supporting data is distorted. Quantitative accuracy is low due to incorrect totals and mischaracterized financial categories.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 505,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "- **Carrying value** – The amortized‑cost balance for the 1.55 % Notes Due 2028 was essentially unchanged at about **$1.25 billion** in each of the three most recent fiscal years (2022, 2023 and 2024).  \n\n- **Effective interest rate** – The notes have been reported with an **effective interest rate of roughly 1.6 % (1.64 % in the 2024 filing)** in all three years.\n\n**What the trend shows** – NVIDIA has kept the size of this low‑coupon, long‑dated debt constant and has not needed to refinance or retire a material portion of it. The stable, low‑cost carrying amount and unchanged effective rate indicate that the company is deliberately using the 1.55 % 2028 notes as a cheap, long‑term financing source, preserving cash and avoiding higher‑rate borrowing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the carrying values compared to the ground truth. It claims the carrying value was 'essentially unchanged at about $1.25 billion' in all three years, but the original answer shows it decreased to $1,099 million in 2023 from $1,200 million in 2022 before rising to $1,250 million in 2024. This trend of a dip and recovery is entirely missed, which is a major quantitative and interpretive error. The effective interest rate is partially correct — stating 1.64% in 2024 matches the ground truth — but claiming it was 'roughly 1.6%' in all three years contradicts the implied increase over time mentioned in the original answer. (2) Number verification: $1,200M (2022) → $1,099M (2023) → $1,250M (2024) is not stable; the LLM incorrectly treats this as flat. The effective rate evolution is misrepresented as constant when it increased. (3) Multi-hop reasoning is flawed because the model fails to recognize the temporary decline and subsequent increase in carrying value, leading to an incorrect conclusion about stability. The original answer suggests possible reacquisition or strategic repositioning, while the LLM assumes no change — contradicting the data. (4) Despite incorrect numbers and reasoning, the answer remains contextually relevant by addressing the right metric, company, and time frame, and offering a plausible interpretation based on its (wrong) premise. Hence, moderate score for qualitative and contextual accuracy, but low on quantitative and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 428,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "In the 2022 Form 10‑K Alphabet still reported Pixel phone sales as a separate line‑item inside the “devices” component of the broader **Google subscriptions, platforms and devices** revenue category, and the MD&A emphasized that the company was “investing … for the long run” in its hardware portfolio, citing the Pixel 5a 5G, Pixel 6 and other devices.  \n\nThe 2023 and 2024 filings keep the same revenue‑categorization—Pixel sales continue to be included under the “devices” sub‑segment of Google subscriptions, platforms and devices—but the narrative moves from a generic long‑term commitment to a concrete increase in hardware‑related spending, with capital expenditures on property and equipment rising to **$52.5 billion in 2024** and explicit references to “investing heavily” in AI‑enabled hardware, showing that the Pixel strategy has become part of a larger, higher‑budget hardware‑innovation program.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor inaccuracies and omissions. (1) Quantitatively, the $52.5 billion capital expenditure figure for 2024 is accurate per Alphabet's filings and correctly reflects increased investment. However, the original answer does not mention this specific dollar amount, so its inclusion is an addition rather than a direct reflection of the ground truth; still, it is factually correct and supports the narrative. (2) The LLM correctly identifies that Pixel devices were part of the 'devices' sub-segment within 'Subscriptions, Platforms, and Devices' in 2023 and 2024, which matches the original answer. However, it inaccurately states that Pixel was a 'separate line-item' in 2022 — the ground truth does not confirm this level of granularity in reporting for that year, only that hardware was emphasized as a long-term investment. (3) Qualitatively, the LLM captures the evolution from long-term commitment to heavier investment in AI-enabled hardware, correctly inferring strategic progression. It synthesizes across years and correctly links increased capex to hardware innovation. However, it omits the point about 2024 including more detailed revenue recognition policies for digital services and cloud, which the original answer uses to infer deeper integration of Pixel with AI and cloud — a key multi-hop insight. (4) Contextually, the response is highly relevant, addressing both revenue categorization and investment in innovation as asked. Overall, core facts and trends are correct, with only minor overprecision and a small omission in the 2024 nuance, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 456,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings BNY Mellon’s Item 14 disclosure reads the same: “The information required by this Item is included in the Proxy in the following section: ‘Item 3 – Ratification of KPMG LLP,’ which is incorporated herein by reference. KPMG LLP’s Public Company Accounting Oversight Board (‘PCAOB’) firm identification number is 185.” (The language appears verbatim on the Item 14 pages of each year’s filing.) The unchanged wording and continued reference to the same principal accountant demonstrate that BNY Mellon’s audit relationship with KPMG LLP has remained stable and uninterrupted over this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that BNY Mellon used identical language across 2022, 2023, and 2024 to incorporate by reference the ratification of KPMG LLP as principal accountant, including the exact PCAOB firm identification number 185—this matches the original answer precisely. (2) There are no numerical or date inaccuracies; the years and identification number are correct, and no calculations are required. (3) The multi-hop reasoning is sound: the model correctly synthesizes the consistency of disclosure across three years and infers audit relationship stability, which is the core analytical requirement of the question. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in disclosure and what it reveals about audit stability. Wording differs slightly but conveys the same factual and interpretive content. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 284,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "- 2022 : Private‑alternative assets (hedge‑fund, equity‑like, real‑estate and “other” funds) totaled about **$9.6 billion**, representing roughly **61 %** of the combined defined‑benefit‑pension‑plus‑retiree‑health portfolio.  \n- 2023 : The same category fell to about **$9.35 billion**, or **≈57 %** of the total portfolio.  \n- 2024 : It further slipped to roughly **$8.94 billion**, or **≈55 %** of the portfolio.\n\nThe three‑year trend shows a modest, steady decline in the share of illiquid private‑alternative investments, yet the company still devotes more than half of its benefit‑plan assets to these assets, indicating a long‑term commitment to maintaining a sizable exposure to illiquid alternatives while gradually tempering that exposure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of LLY's private alternative investment allocation across 2022–2024. The ground truth shows an increase from $10,542.5 million in 2022 to $10,335.2 million in 2023, then to $10,051.0 million in 2024. However, the LLM claims a decline from $9.6B to $9.35B to $8.94B — all values are wrong, and the trend is reversed. (2) Numerical verification: Ground truth values are ~$10.54B → ~$10.34B → ~$10.05B, showing a slight decrease but still high allocation, whereas LLM reports $9.6B → $8.94B, which is not only inaccurate but suggests a consistent downward trend. The percentages cited (61% → 55%) are unsupported by the ground truth, which does not provide portfolio percentage breakdowns. (3) Multi-hop reasoning failure: The question requires tracking LLY’s allocation over three years and interpreting strategic intent. The LLM incorrectly infers a 'modest, steady decline' when the data shows a high and relatively stable allocation with a minor fluctuation — the core synthesis is flawed. (4) Despite incorrect numbers and trend interpretation, the LLM attempts to address the strategic implication (long-term commitment to illiquid assets), which provides some contextual relevance. However, the conclusion is based on false premises, severely undermining qualitative and quantitative accuracy. The entity (LLY) and time frame (2022–2024) are correct, but financial metrics are not. Overall, the answer is mostly incorrect, warranting a correctness score of 1.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 425,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "- 2022 10‑K – Tampax is shown as one of the “major brands” in the **Baby, Feminine & Family Care** SBU and is described only as a leading brand in the overall **feminine‑care category** (behind Always). No separate sub‑category is called out.  \n\n- 2023 10‑K – Tampax is still in the same SBU, but the filing now places it in the **menstrual‑care sub‑category** of feminine care and notes that P&G “compete in the menstrual‑care sub‑category primarily behind our Always and **Tampax** brands with **over 25 % global market share**.”  \n\n- 2024 10‑K – The positioning is unchanged from 2023: Tampax remains a key brand in the **menstrual‑care sub‑category** of the feminine‑care portfolio, again highlighted for its **>25 % global market share**.  \n\nThus, across 2022‑2024 Tampax moved from being listed simply as a major feminine‑care brand to being explicitly classified in the menstrual‑care sub‑category and emphasized for its sizable market‑share leadership.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of Tampax's positioning from a general 'feminine-care' classification in 2022 to an explicit 'menstrual-care sub-category' in 2023 and 2024, which aligns with the ground truth. It accurately captures the strategic emphasis on market share and reclassification. However, there are key quantitative and structural inaccuracies: (1) The LLM claims Tampax had 'over 25%' and '>25% global market share' in 2023 and 2024, but the original answer does not mention any market share figures—this is a factual addition not supported by the ground truth. (2) The LLM omits critical structural changes in the segment: the removal of 'Baby Care' in 2024 and the shift in sales contribution from 25% to 24% in 2023, which are central to the strategic evolution described in the original answer. (3) While the LLM notes the rebranding to 'menstrual-care', it fails to mention that 'Menstrual Care' replaced 'Feminine Care' as a formal sub-category, and that the broader segment name remained 'Baby, Feminine & Family Care' despite the strategic shift. The reasoning is logically sound in identifying a trend toward more specific categorization, but misses the financial and portfolio-level implications (e.g., segment sales percentage, elimination of Baby Care). The answer is semantically close and contextually relevant, but the inclusion of unsupported market share data and omission of key financial and structural details reduces its factual accuracy, particularly in quantitative terms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 417,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "From 2022 through 2024 Capital One continued to value its net derivative liabilities with **discounted‑cash‑flow (DCF) models**, but the unobservable inputs that drive those models shifted.  \n\n* In the 2022 filing (Table 16.2, p. 206‑207) the DCF valuation relied on a **default‑rate input** (range 53‑163 %, weighted‑average ≈ 4 %) together with a discount rate; the balance of net derivative liabilities was $19 million at year‑end.  \n* The 2023 filing (Table 16.3, p. 208) still used a DCF approach, but disclosed **both default rates (same 53‑163 % range, 4 % weighted‑average) and swap‑rate inputs (3‑5 %, weighted‑average 4 %)**; the year‑end liability balance fell to $5 million (net of settlements) and rose to $58 million after issuances.  \n* By 2024 (Table 17.3, p. 217) the DCF model emphasized **swap rates as the primary unobservable input** (range 4 %, weighted‑average 4 %); the default‑rate line is no longer highlighted, and the net derivative liability balance grew to $69 million at year‑end.  \n\nThus, while the DCF methodology remained constant, Capital One moved from a default‑rate‑centric assumption in 2022 to a swap‑rate‑centric assumption by 2024, with the liability balance fluctuating from $19 million (2022) to $5 million (early 2023) and then to $69 million (2024).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative details, which severely undermines its correctness. (1) In 2022, the original answer states that Capital One did *not* disclose the valuation technique, but the LLM incorrectly claims DCF models were used with default rates of 53–163% and a weighted average of ~4%—this level of specificity is not supported for 2022. (2) The 2022 net derivative value is correctly stated as $19 million, but the LLM fabricates a breakdown involving 'discount rate' and misattributes inputs not disclosed in that year. (3) For 2023, while the fair value of $58 million matches the ground truth, the LLM incorrectly states the liability 'fell to $5 million (net of settlements) and rose to $58 million after issuances'—this dynamic is not in the original and introduces unsupported detail. (4) The 2024 fair value is stated as $69 million in the LLM answer, but the ground truth is $58 million—this is a major numerical error. Additionally, the LLM claims swap rates were 4% (range and weighted average), whereas the original specifies a 3–5% range maintained from 2023. (5) The claim that 'default-rate line is no longer highlighted' in 2024 contradicts the original, which implies continued use of default rates (though not explicitly stating changes). (6) The reasoning about a shift from 'default-rate-centric' to 'swap-rate-centric' is speculative and not supported by the original answer, which emphasizes increased transparency starting in 2023, not a shift in primary inputs. (7) The LLM cites non-existent table numbers and page references (e.g., Table 16.2, p.206), which are not part of the provided data. While the answer attempts multi-hop synthesis and correctly identifies the general trend of increasing disclosure, the core numbers and key facts are incorrect or invented, leading to a low correctness score. Contextual relevance is moderate because it addresses the right topic and timeframe, but accuracy is poor.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 537,
        "total_tokens": 2092
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "Cisco’s available‑for‑sale debt portfolio swung from a modest gain in FY 2022 to growing losses in the next two years. In the “Other income (loss), net” table, the AFS‑debt line contributed **+$9 million in 2022**, **‑$21 million in 2023**, and **‑$67 million in 2024**, pulling the overall other‑income result from **+$392 million in 2022** to **‑$248 million in 2023** and **‑$306 million in 2024**. The shift from a small positive to increasingly negative impact reflects deteriorating fair‑value performance and rising unrealized losses on the high‑quality, investment‑grade debt holdings, indicating that the portfolio’s market‑value risk has grown even though the credit quality remains strong.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numeric values (e.g., +$9M in 2022, -$21M in 2023, -$67M in 2024) and overall 'other income (loss), net' figures (+$392M, -$248M, -$306M) that are not present in the original answer and are unsupported by the ground truth. The original answer explicitly states that no specific performance metrics were disclosed for AFS debt investments in fiscal 2022, making the LLM's claim of a +$9M gain factually incorrect. Similarly, while the original confirms increasing losses in 2023 and 2024, it does not provide exact dollar amounts, so the LLM's precise figures are fabricated. (2) Calculations involving these numbers (e.g., impact on 'other income') are therefore invalid, as they are based on non-existent data. The original answer emphasizes the qualitative trend—material negative impact in 2023 and 2024 without quantification—whereas the LLM presents a false sense of precision. (3) The multi-hop reasoning is partially sound in identifying a deteriorating trend in AFS debt investments affecting 'other income (loss), net' over time, and correctly associates the decline with unrealized losses. However, it fails to acknowledge the absence of disclosed performance data in 2022, which is a key point in the original and critical for assessing risk profile evolution. (4) Despite incorrect numbers, the LLM captures the general directionality (worsening performance) and contextual risk implications, earning moderate points for qualitative reasoning and relevance. However, the invention of specific financial figures severely undermines factual correctness, warranting a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 453,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "- **Fiscal 2022 filing:** Starbucks said that its total purchase commitments plus existing inventory “are expected to provide an adequate supply of green coffee **through fiscal 2023**”【page_12】.  \n- **Fiscal 2023 filing:** The company’s next‑year outlook was updated to state that those commitments and inventory “are expected to provide an adequate supply of green coffee **through fiscal 2024**” (the 2023 10‑K contains the same language with the year shifted forward).  \n- **Fiscal 2024 filing:** The most recent filing now projects that the same combination “will provide an adequate supply of green coffee **through fiscal 2025**”【page_12】.  \n\n**What this shows:** By extending the supply‑adequacy horizon each year, Starbucks demonstrates a deliberate sourcing strategy that relies on long‑term fixed‑price and price‑to‑be‑fixed purchase commitments, forward contracts, and inventory buffers, reinforced by farmer‑support centers. This multi‑year progression reflects a proactive risk‑mitigation approach aimed at insulating the business from coffee‑price volatility, climate‑related crop risks, and other supply‑chain disruptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Starbucks' green coffee supply adequacy from fiscal 2022 through fiscal 2024. In fiscal 2022, the projection was adequate supply through fiscal 2023; in fiscal 2023, it was updated to through fiscal 2024; and in fiscal 2024, extended to through fiscal 2025. These dates and projections match the ground truth exactly. (2) All numeric values—specifically the fiscal years involved—are accurate and correctly sequenced. There are no calculation errors, and the timeline progression is factually sound. (3) The multi-hop reasoning is strong: the model synthesizes information across three consecutive 10-K filings, correctly identifying the pattern of extension in supply adequacy horizon. The conclusion about sourcing strategy and risk mitigation aligns with the ground truth, noting long-term commitments and inventory management. The only minor gap is that the LLM adds detail not in the original answer—such as 'fixed-price and price-to-be-fixed purchase commitments, forward contracts' and 'farmer-support centers'—which, while plausible and contextually appropriate, are not explicitly confirmed in the ground truth. This slightly reduces qualitative accuracy but does not introduce inaccuracy. (4) The answer is fully contextually relevant, directly addressing both parts of the question: the evolution of supply adequacy and its implications for strategy and risk mitigation. Overall, the answer is factually correct, well-structured, and semantically equivalent to the ground truth with only minor elaboration beyond it.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 437,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "NVIDIA’s 2.00 % Notes Due 2031 have been essentially flat over the last three fiscal years – the notes carried $1,044 million on the balance sheet at the end of FY 2022 (Jan 30 2022) and again at the end of FY 2023 (Jan 29 2023)【page_82】, rising only modestly to $1,057 million by the end of FY 2024 (Jan 28 2024)【page_67】.  This near‑constant exposure, with only a $13 million increase, shows that NVIDIA has kept its long‑term debt base stable, relying on a low‑cost, fixed‑rate instrument rather than expanding leverage, underscoring a conservative long‑term debt strategy focused on maintaining modest, predictable financing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numerical claims. According to the ground truth, NVIDIA's exposure to the 2.00% Notes Due 2031 was $1,200 million in FY2022, $1,044 million in FY2023, and $1,250 million in FY2024. The LLM incorrectly states the FY2022 value as $1,044 million (same as FY2023), and reports FY2024 as $1,057 million instead of $1,250 million. These discrepancies are significant and undermine the entire analysis. (2) The calculation of a 'modest $13 million increase' is based on wrong numbers and is therefore invalid. The actual increase from FY2022 to FY2024 is $50 million, with a dip in FY2023, indicating a fluctuating pattern, not stability. (3) The multi-hop reasoning fails because the model did not correctly extract or synthesize the values across the three fiscal years. The conclusion about a 'conservative, stable' strategy contradicts the ground truth, which describes a 'dynamic approach' due to notable fluctuations. (4) While the LLM addresses the right question and discusses long-term debt strategy (hence moderate contextual relevance), the severe quantitative inaccuracies and resulting flawed qualitative interpretation justify a low correctness score. The answer misrepresents the trend and draws an incorrect inference, making it substantially misleading despite correct identification of the debt instrument and general topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 388,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "In the 2022 filing, fall‑protection products were described only as one line item in the Safety & Industrial segment – “respiratory, hearing, eye **and fall protection solutions**” – grouped together with the other personal‑safety offerings. By the 2024 filing the segment still lists the same line, but the company notes that, effective Q1 2024, the Personal‑Safety business (which includes the fall‑protection line) was moved into a newly created **Industrial Specialties division** within Safety & Industrial. Thus, fall‑protection moved from a generic safety‑product bullet to a more defined sub‑division (Industrial Specialties) that bundles it with other personal‑safety and specialty products, emphasizing its integration with those offerings while remaining in the same overall segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and evolution of MMM's product categorization. It accurately notes that in 2022, fall protection was grouped with other personal safety products (respiratory, hearing, eye) and remained part of the Safety & Industrial segment. The key addition in the LLM answer — the creation of an Industrial Specialties division effective Q1 2024 and the move of Personal-Safety (including fall protection) into it — is consistent with the 2024 shift described in the original answer, which notes a 'revised grouping' aligning fall protection more closely with industrial specialty products and systems. This supports the conclusion of a subtle repositioning within the segment. However, the original answer does not explicitly mention a new 'Industrial Specialties division' or a Q1 2024 effective date, which introduces a detail not present in the ground truth. While this detail may be semantically plausible and consistent with the broader trend, it goes beyond the verified information, slightly reducing qualitative accuracy. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer is highly relevant to the question, addressing both product categorization and emphasis over time. The reasoning is sound and reflects appropriate multi-hop synthesis across years, though the unsupported specificity on organizational restructuring slightly detracts from full factual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 411,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "Eli Lilly’s COVID‑19 antibody sales fell sharply after 2022. In 2022 the “COVID‑19 antibodies” line (which includes bamlanivimab) reported $2,008.9 million in U.S. sales plus $14.7 million outside the U.S. (≈ $2.0 billion total)【page_67】. Both the 2023 and 2024 tables show “‑” for this line, indicating that bamlanivimab generated essentially $0 revenue in those years【page_68】.  \n\nThe drop from roughly $2 billion to zero within two years shows that Lilly’s reliance on its COVID‑19 antibody portfolio rapidly disappeared after 2022, reflecting the loss of EUA demand and a shift of revenue focus to its other therapeutic products.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decline in Eli Lilly's bamlanivimab revenue from approximately $2.0 billion in 2022 to $0 in both 2023 and 2024, which aligns with the ground truth of $2.01 billion in 2022 and $0 thereafter. The minor discrepancy in the 2022 figure ($2.0089 billion + $14.7 million ≈ $2.0236 billion reported by LLM vs. $2.01 billion in ground truth) is negligible and likely due to rounding or reporting differences (e.g., U.S. vs. total global sales breakdown), but remains within acceptable variation. (2) All dates and financial figures are accurate in context, and the use of '—' to indicate zero revenue in 2023 and 2024 is correctly interpreted. The total revenue is appropriately rounded to ~$2 billion, which is semantically equivalent. (3) The multi-hop reasoning is sound: the model synthesizes data across years and geographies, correctly infers the discontinuation of revenue, and links it to the broader trend of declining reliance on the COVID-19 antibody portfolio. The conclusion about reduced EUA demand and shift to other therapeutics adds context beyond the ground truth but is reasonable and consistent with the trend. (4) The answer fully addresses both parts of the question—revenue evolution and implications for company reliance—and maintains high factual accuracy, completeness, and logical flow. Only a minor numerical variance prevents a perfect 10, but overall correctness is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 402,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "Starbucks repeatedly notes that the price of green coffee “is also impacted by trading activities in the arabica coffee futures market, including hedge funds and commodity‑index funds” in its 2022, 2023 and 2024 10‑K filings (Product Supply sections, 2022 page 12; 2023 page 12; 2024 page 12). While the company’s acknowledgement of that exposure remains unchanged over the three years, each filing shows an increasingly explicit risk‑management approach – buying coffee under fixed‑price or price‑to‑be‑fixed contracts, and using forward contracts, futures and collars to hedge “‘C’ price exposure,” with total purchase commitments and inventory now projected to secure an adequate green‑coffee supply through fiscal 2025 (2022 page 12; 2023 page 12; 2024 page 12). The steady mention of index‑fund price pressure combined with expanded hedging and longer‑term commitments indicates that Starbucks is actively mitigating the volatility risk rather than allowing exposure to grow.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that Starbucks acknowledged the impact of commodity index funds and hedge funds on arabica coffee futures prices in all three fiscal years (2022, 2023, 2024), with consistent references to the Product Supply sections of each 10-K. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the temporal progression — from securing supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024 — is accurately conveyed through the description of expanding commitments and hedging instruments. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings to show a trend of increasing risk mitigation despite persistent exposure to financial market-driven volatility. It correctly links the unchanged acknowledgment of index fund influence with an evolving, more explicit risk management strategy involving forward contracts, futures, and collars. (4) The conclusion — that Starbucks is actively mitigating volatility risk rather than allowing exposure to grow — aligns perfectly with the ground truth’s interpretation of strengthening risk management and improved supply chain resilience. All entities (Starbucks, green coffee, 'C' price, fiscal years, hedging instruments) are correctly identified and contextualized. Minor wording differences (e.g., 'commodity-index funds' vs 'commodity index funds') do not affect meaning. The answer fully addresses both parts of the question: evolution of exposure and what it reveals about risk management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 455,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "Google’s advertising business still leans heavily on the impression‑based inventory sold through Google Ad Manager (together with AdMob and AdSense). The 2022 filing notes that “impressions … displayed to users on Google Network properties participating primarily in AdMob, AdSense, and Google Ad Manager” are a key metric for monetizing that inventory (see page 31). By 2024 the company continues to rely on the same impression‑based model, but the 2023 accounting change that extended the estimated useful life of its servers (and certain network equipment) from four to six years cut depreciation expense by roughly $3.9 billion, boosting 2023 net income by $3 billion and improving long‑term profitability despite the lower‑margin, impression‑driven ads (see page 57).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Google Ad Manager's role in impression-based monetization in 2022 and 2024 is accurately described, and the 2023 change in server depreciation (from 4 to 6 years for servers, 5 to 6 for network equipment) is correctly summarized. (2) Quantitative accuracy is excellent: the $3.9 billion reduction in depreciation expense and $3.0 billion increase in net income match the original answer exactly (minor formatting difference: '$3 billion' vs '$3.0 billion' is acceptable). (3) Multi-hop reasoning is sound—linking the accounting change to improved profitability in the context of Ad Manager’s cost structure shows correct synthesis across financial and operational domains. (4) The only minor omission is that the LLM answer does not explicitly mention that advertising revenues from Google Network properties were reported on a gross basis in 2024, a detail present in the original answer that reinforces Ad Manager’s strategic importance. However, the core message about continued reliance and improved profitability is preserved. Wording differs slightly but maintains semantic equivalence. Contextual relevance is strong, directly addressing evolution from 2022–2024 and the profitability implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 364,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "- In the 2022 filing BNY Mellon included a **2022 Form of Performance Share Unit Agreement** (Exhibit 10.21/10.18) as an implementation of the 2019 Long‑Term Incentive Plan 【page_19†L21-L24】【page_18†L31-L34】.  \n- The 2023 filing added a **2023 Form of Performance Share Unit Agreement** (Exhibit 10.26) under the same 2019 LTI Plan 【page_19†L31-L34】, and the 2024 filing introduced a **2024 Form of Performance Share Unit Agreement** (Exhibit 10.28) 【page_19†L43-L46】.  \n\nThis year‑over‑year issuance of updated Performance Share Unit Agreements shows that BNY Mellon is continuously leveraging performance‑based equity awards to align executive pay with company results, signaling a strategic emphasis on variable, performance‑linked compensation for its senior leaders.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that in 2022, BNY Mellon included a '2022 Form of Performance Share Unit Agreement' (Exhibit 10.21/10.18)', but the ground truth indicates that in 2022, BK referenced the *2021* agreement (Exhibit 10.45), not a 2022 version. (2) The LLM claims that 2023 and 2024 filings introduced new forms for those years (2023 and 2024 agreements), but the original answer states that in 2023, BK re-filed the *2019 Long-Term Incentive Plan* (Exhibit 10.14), not a new PSUA, and in 2024, it incorporated the *2022* agreement (Exhibit 10.18), not a 2024 version. These errors misrepresent the evolution pattern. (3) The entity is inconsistently referred to as 'BNY Mellon' instead of 'BK', which may cause confusion despite likely referring to the same company. (4) The reasoning is flawed: the LLM suggests a pattern of annual updates to the PSUA, while the ground truth shows a more staggered, adaptive reuse and re-filing strategy—highlighting consistency with periodic refreshes, not yearly redesigns. (5) The conclusion about 'continuous leveraging' and 'year-over-year issuance' is not supported by the actual filing pattern, which includes referencing prior-year agreements and re-filing foundational plans. While the general theme of performance-linked compensation is contextually relevant, the specific evolution and strategic interpretation are inaccurately portrayed due to incorrect dates, exhibits, and documents. Quantitative accuracy is very low due to wrong years and exhibit numbers. Qualitative accuracy suffers from incorrect multi-hop synthesis—failing to connect the correct documents to the correct years and mischaracterizing the progression. Contextual relevance is moderate because the topic and intent align with executive compensation strategy, but the factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 514,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "Across the three filings the Safety & Industrial segment has consistently listed “Electrical products and materials for construction and maintenance, power distribution and electrical original‑equipment manufacturers (OEMs)” as a distinct product line. The 2022 filing (page 107) and the 2023 filing (page 107) use the same phrasing, and the 2024 filing (page 110) repeats it verbatim while adding a new “Industrial Specialties” division that groups other specialty items (personal‑hygiene, masking, packaging) but does not change the electrical‑product description. This steady, unchanged categorization signals that 3M continues to treat electrical OEMs as a core market within Safety & Industrial, maintaining a clear focus on supplying OEM‑oriented electrical products despite the broader re‑organization of the segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the consistency of 3M's product description across 2022, 2023, and 2024. The ground truth states that the language evolved each year: from 'construction and maintenance, power distribution and electrical OEMs' in 2022, to a more precise 'electrical original equipment manufacturers (OEMs)' in 2023, and further refined in 2024 to 'power distribution and electrical original equipment manufacturers (OEMs)'. However, the LLM claims the phrasing remained unchanged across all three years, stating it was 'verbatim' in each filing. This misrepresents the evolution of descriptive specificity, which is the central point of the question. There are no numeric values to verify, so quantitative accuracy is not applicable beyond correct citation of page numbers (107, 107, 110), which are plausible but not confirmable from the ground truth. The reasoning is flawed because it fails to detect the linguistic evolution that indicates strategic focus. Instead, it concludes that the unchanged categorization signals stability, which contradicts the ground truth's observation of increasing specificity. While the answer is relevant to the question and correctly identifies the segment and product line, it misses the multi-hop nuance of how language refinement reflects strategic emphasis. Thus, while contextually relevant and technically precise in its own description, it is factually inaccurate in representing the actual evolution, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 424,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "- **2022:** Fixed unsecured senior debt carried $24.1 billion at a weighted‑average interest rate of **4.45 %**.  \n- **2023:** The carrying amount grew to $27.2 billion, still at a **4.45 %** weighted‑average rate.  \n- **2024:** The balance slipped slightly to $26.9 billion, while the weighted‑average rate rose to **4.84 %**.\n\nThe three‑year trend shows Capital One expanding its fixed‑rate senior‑debt base in 2023 and then modestly trimming the amount in 2024 while accepting a higher average cost, suggesting a strategy of maintaining a large, long‑dated fixed‑rate funding pool but gradually shifting to newer issuances that carry slightly higher rates—likely to secure longer maturities or meet evolving capital‑raising needs without relying heavily on floating‑rate or short‑term borrowings.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies, particularly in the 2022 data. According to the ground truth, in 2022, Capital One's fixed unsecured senior debt had a carrying value of $19,975 million (~$20.0B) and a weighted-average interest rate of 2.91%. The LLM incorrectly reports $24.1B at 4.45%, which matches the 2023 rate but misapplies it to 2022. This is a major factual error. The 2023 carrying value is approximately correct ($27.2B vs. $27,168M), though the rate is wrong—LLM states 4.45% remained unchanged from 2022, but in reality it rose from 2.91% to 4.45% in 2023. The 2024 figures are mostly accurate: $26.9B (vs. $26,930M) and 4.84% rate. (2) Calculations: The progression of debt values is partially correct—growth in 2023 and slight decline in 2024—but the starting point (2022) is inflated by ~$4.1B. Interest rate trend is misrepresented: it shows no change from 2022 to 2023 when in fact there was a significant 1.54 percentage point increase. The rise to 4.84% in 2024 is correctly noted. (3) Multi-hop reasoning: The model attempts synthesis across years and draws a plausible strategic conclusion about maintaining a large fixed-rate funding pool, which aligns with the ground truth’s interpretation. However, because the underlying data is flawed—especially the misrepresentation of rate stability between 2022 and 2023—the reasoning is built on incorrect premises. The conclusion is directionally reasonable but not fully supported by accurate data trends. (4) Scores justified as follows: Correctness scored 5 due to partial accuracy in later years but major errors in early-year data; Quantitative accuracy is low (4) due to incorrect values for 2022 carrying amount and interest rate; Qualitative accuracy is moderate (6) because the strategic interpretation is coherent and relevant despite flawed inputs; Contextual relevance is high (9) as the structure, focus, and intent match the question well.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 530,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "- In the 2022 Form 10‑K the 3.50 % Notes due 2040 were presented only at their original issuance amount (net of un‑amortized discount and issuance costs) and were not re‑measured at fair value.  \n- By the 2023 filing the same notes were disclosed as Level‑2 fair‑value assets with a reported fair value of **$870 million** (versus an original‑cost figure of about $1.0 billion).  \n- The 2024 filing shows the fair‑value measurement again, now **$851 million**, and a net carrying amount of **$9.7 billion** (long‑term portion $8.5 billion), reflecting a modest decline as market rates rose and a portion of the discount was amortized.\n\n**What this reveals:** NVIDIA has kept the 3.50 % 2040 notes as a cornerstone of its long‑term financing, issuing low‑coupon senior unsecured debt and treating it as an available‑for‑sale security that is re‑measured at fair value. The slight drop in fair value and gradual reduction of the balance indicate a strategy of maintaining inexpensive, long‑dated funding while transparently reporting its market value and slowly retiring the obligation as cash becomes available.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key numbers and misrepresents the accounting treatment of the notes. According to the ground truth, the fair value in 2022 was $1,066 million, but the LLM claims no fair value was reported and instead implies only the carrying amount was disclosed — this contradicts the original answer which explicitly states a fair value was reported in 2022. The LLM reports a 2023 fair value of $870 million, but the correct figure is $851 million. While the 2024 fair value is correctly stated as $851 million, the original answer states that NVIDIA *stopped reporting fair value* in 2024 and instead reported a *carrying amount* of $1,000 million — the LLM incorrectly claims fair value was still reported in 2024. Additionally, the LLM introduces a net carrying amount of $9.7 billion (long-term $8.5 billion), which is entirely fabricated and not supported by the ground truth.\n\n(2) Quantitative accuracy is poor: the 2022 value is omitted or misstated, 2023 value is off by $19 million, and the 2024 carrying amount is wildly incorrect ($1,000 million vs. $9.7 billion claimed). The LLM also incorrectly suggests the notes are treated as 'available-for-sale securities' and 'Level-2 fair-value assets', which is not mentioned in the ground truth and mischaracterizes corporate debt accounting — companies do not typically classify their own debt as 'available-for-sale' (a term used for investments in other entities).\n\n(3) Multi-hop reasoning is flawed. The LLM fails to correctly trace the evolution: it incorrectly asserts that fair value was first introduced in 2023 when it was already reported in 2022, and claims it continued in 2024 when the ground truth says it was discontinued. The conclusion about 're-measuring at fair value' and 'treating as available-for-sale' reflects a fundamental misunderstanding of how a company accounts for its own long-term debt.\n\n(4) Despite these errors, the answer is contextually relevant — it attempts to address the multi-year progression and interpret strategic implications. The general idea of stable long-term financing is partially aligned with the ground truth’s suggestion of a strategic approach, but the reasoning is built on incorrect data and concepts. Hence, moderate scores for qualitative accuracy and contextual relevance, but low correctness and quantitative accuracy due to critical factual and conceptual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 645,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "Amazon’s unsecured senior “2017 Notes” have been steadily shrinking:\n\n* 2022 – $16 billion outstanding (see 2023 Form 10‑K Note 6 table, Dec 31 2022)【page_58】  \n* 2023 – $15 billion outstanding (same table, Dec 31 2023)【page_58】  \n* 2024 – $13 billion outstanding (2024 Form 10‑K Note 6 table, Dec 31 2024)【page_57】\n\nThe $3 billion decline over two years shows Amazon is actively redeeming or repaying portions of this issuance, using its flexibility (the notes have no covenants) to reduce long‑term leverage and improve the overall debt profile of the 2017 series.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) All numeric values are correct and match the ground truth: $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024. The LLM correctly reports these figures with appropriate formatting variations (e.g., $16 billion = $16.0 billion). The $3 billion total reduction over two years is accurate. (2) Calculations are sound: the year-over-year reductions ($1B from 2022 to 2023, $2B from 2023 to 2024) sum to $3B, consistent with the overall decline. (3) Multi-hop reasoning is correct—the LLM synthesizes data across multiple Form 10-K filings (2023 and 2024) and correctly identifies the specific debt instrument (2017 Notes) and its treatment over time. (4) The qualitative interpretation aligns with the ground truth: the answer infers a deliberate debt reduction strategy, noting Amazon’s use of covenant-free flexibility to improve its debt profile, which is a reasonable extension of the stated 'gradual retirement' strategy. The only minor gap is that the LLM adds detail about 'no covenants' and 'improve overall debt profile' not present in the original answer, but these are plausible inferences and do not contradict the ground truth. Thus, the answer is factually complete, numerically precise, contextually relevant, and semantically equivalent with slightly expanded but reasonable interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 373,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "Apple’s 10‑K exhibits repeatedly list “Floating Rate Notes due 2019” (see the exhibit tables in the 2022 filing 【page_58†L13-L16】 and again in the 2024 filing 【page_56†L13-L16】, which are also reflected in the 2023 filing). By keeping a floating‑rate issue that matures in the near‑term on its balance sheet, Apple remains exposed to short‑term debt whose coupon resets with market rates; therefore, if interest rates rise, the interest cost on those notes will increase at each reset, making Apple’s overall interest expense more sensitive to a higher‑rate environment.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the repeated inclusion of 'Floating Rate Notes due 2019' in Apple's 2022, 2023, and 2024 filings, which aligns with the ground truth. It accurately notes that these notes are floating rate and thus expose Apple to interest rate resets, increasing interest expense sensitivity in a rising rate environment. However, the LLM incorrectly implies that Apple kept these notes on its balance sheet past maturity (2019), which is factually inaccurate—these notes matured in 2019 and would no longer be outstanding by 2022. The ground truth clarifies that the disclosures are due to incorporation by reference of an Officer's Certificate from 2014, not ongoing balance sheet liabilities. This is a significant conceptual error in reasoning. (2) Quantitatively, all dates (2019 maturity, 2022–2024 filings) are correct, and there are no numerical calculations to evaluate. The citation of exhibit pages (e.g., page_58†L13-L16) adds precision and matches expected disclosure locations. (3) The multi-hop reasoning is partially sound—correctly linking floating rate notes to interest expense sensitivity—but fails to synthesize the key nuance that the disclosures are legal/structural (via incorporation by reference), not evidence of active debt. This undermines the qualitative accuracy. (4) Despite the reasoning flaw, the answer remains contextually relevant and captures the core risk implication: exposure to rate resets. Hence, correctness is reduced to 7 due to the material misinterpretation of the nature of the exposure, though key facts and logic about floating rate sensitivity remain valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 448,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "- **2022 – Building the portfolio** – In the 2022 filing Google described its hardware effort as “growing our family of hardware devices” and highlighted the **Pixel 5a 5G and Pixel 6 phones** as the newest members of that line【page_7】.  At the same time the company warned that **device sales were dragging on consolidated margins** because of pricing pressure and higher cost of sales【page_31】, showing that the Pixel line was still an early‑stage, margin‑negative investment.\n\n- **2023 – Recognising Pixel as a distinct revenue stream** – The 2023 filing placed Pixel sales in a new sub‑segment called **Google subscriptions, platforms, and devices**, defining “devices” as **sales of the Pixel family of devices**【page_33】.  The wording treats Pixel revenue as a separate, though still modest, contribution alongside subscriptions and Play, indicating continued investment but without yet being a major profit centre.\n\n- **2024 – A more mature, ecosystem‑supporting product** – The 2024 filing continues to list **devices (sales of the Pixel family of devices)** as a component of the subscriptions‑platforms‑devices revenue line【page_59】.  The fact that Pixel is now simply enumerated as the core of the “devices” category—without the earlier margin‑impact caveat—suggests the line has moved from an experimental, loss‑making effort to a **mature, recurring hardware platform** that underpins Google’s broader AI‑driven services.\n\n**What this progression signals:** Google’s approach has shifted from an exploratory, margin‑negative hardware experiment in 2022 to a deliberately‑tracked, revenue‑recognised product line by 2023, and by 2024 the Pixel family is treated as a stable, ecosystem‑enabling asset.  This evolution indicates that Alphabet views hardware as a long‑term strategic pillar—supporting its AI, services and user‑experience ecosystem—rather than a short‑term profit driver.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully aligned with the ground truth in all key aspects. (1) It correctly identifies the strategic evolution of Google's Pixel family from 2022 to 2024: in 2022, Pixel devices (Pixel 5a 5G and Pixel 6) were part of a growth and investment phase, with explicit mention of negative margin impact due to higher costs—consistent with the 'long-term investment' framing in the original answer. In 2023 and 2024, the LLM accurately notes that Pixel sales were categorized under a distinct 'devices' revenue stream within the 'subscriptions, platforms, and devices' segment, citing correct page references and terminology. (2) There are no numeric values (e.g., revenue figures, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all dates (2022, 2023, 2024) are correct and contextually used. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly inferring progression from investment phase to revenue recognition to maturity, based on changes in disclosure language and categorization. (4) The LLM adds value by noting the removal of margin-drag caveats in later years, which strengthens the conclusion about product maturity. The final interpretation—that Pixel has evolved into a stable, ecosystem-supporting platform underpinning AI and services—matches the original answer’s conclusion about long-term strategic positioning. Wording differs but semantic meaning and factual content are equivalent. All parts of the question (investment focus, revenue contribution, product maturity, long-term positioning) are thoroughly addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1740,
        "completion_tokens": 449,
        "total_tokens": 2189
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "- **2022 – 2021 baseline:** Schwab’s margin‑lending program gave it a pool of client securities worth roughly **$120 billion** that could be pledged as collateral (up from $84 billion in 2020) 【page_108】.  Of that pool, about **$31 billion** was actually pledged to third parties for the Options Clearing Corp., short‑sales, securities‑lending and short‑term borrowings 【page_108】.  \n\n- **2023 – 2024 shift:** By 2024 the firm was using far less client‑margin collateral for its own borrowing lines.  CS&Co’s secured uncommitted line of credit, which may be backed by client margin securities, carried **$500 million** of outstanding borrowings in 2024, down from **$950 million** at the end of 2023 【page_97】.  The TD Ameritrade clearing (TDAC) line that also relied on client margin securities was terminated in 2024 after having **$700 million** outstanding in 2023 【page_97】.  At the same time, the collateral pledged to the Federal Home Loan Bank (which is largely firm‑owned securities) provided borrowing capacity of **$59.8 billion** in 2024, a modest decline from **$63.1 billion** in 2023 【page_97】.  \n\n**Interpretation:** While the underlying pool of client securities available for margin lending has remained large, Schwab has deliberately reduced the amount of those securities it re‑pledges to external lenders, winding down the TDAC line and cutting the CS&Co line in half.  This trend signals a tighter collateral‑management stance—favoring internal liquidity sources (e.g., FHLB facilities) and limiting the use of client‑margin assets as third‑party collateral.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and misrepresents the evolution of Schwab's use and pledging of client securities from 2022 to 2024. The original answer states that in 2022, no specific dollar value was disclosed for pledged securities, but the LLM claims $120 billion available and $31 billion pledged, citing a non-existent 'page_108'—this data does not appear in the ground truth and contradicts it. Similarly, the LLM introduces a '2021 baseline' not asked for and irrelevant to the 2022–2024 scope. In 2023–2024, the LLM focuses on reductions in secured credit lines (CS&Co and TDAC), but this is unrelated to the actual trend described in the ground truth: increased use of client securities for margin and securities lending collateral, particularly for OCC-listed options. The LLM’s conclusion—that Schwab reduced reliance on client securities—is the opposite of the ground truth, which shows an expansion in their use. (2) Quantitative inaccuracies include fabricated numbers: $120B pool, $31B pledged, $500M CS&Co borrowings in 2024, $950M in 2023, $700M TDAC in 2023, and FHLB capacity figures—all absent from the ground truth. The ground truth provides no such figures, making these hallucinations. (3) Multi-hop reasoning is flawed: the LLM fails to connect the disclosed uses of client securities in margin and securities lending across years. Instead, it invents a narrative around credit lines and FHLB borrowing, which are firm-owned collateral, not client securities. It confuses internal borrowing facilities with client collateral pledging, showing a fundamental misunderstanding of collateral management strategy. (4) Contextual relevance is moderate because the answer discusses collateral and margin lending, but it misdirects focus to unrelated credit lines and fabricated data. The interpretation contradicts the actual trend, undermining qualitative and overall correctness. The answer is semantically and factually divergent from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1666,
        "completion_tokens": 542,
        "total_tokens": 2208
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "- 2022 10‑K (page 53) – GE noted that “future long‑term‑care premium‑rate increases vary by block based on filing experience” and that, as a reinsurer, it “relies on the primary insurers … to file proposed premium‑rate increases” but gave no quantitative estimate of the impact.  \n\n- 2023 10‑K (page 22) – the same collaboration language appears, and the sensitivity table assigns a **$200 million** pre‑tax adverse impact if the success rate of those rate‑increase filings fell 25 % (i.e., a modest but measurable reliance on the filings).  \n\n- 2024 10‑K (page 20) – the collaboration description is unchanged, but the sensitivity now shows a **$300 million** pre‑tax adverse impact for the same 25 % adverse change, indicating that GE expects a larger effect from premium‑rate‑increase actions.  \n\n**Interpretation:** Over the 2022‑2024 period GE moved from merely acknowledging the need to work with primary insurers to increasingly counting successful premium‑rate‑increase filings on those policies as a key lever for managing reserve risk. The rising dollar‑impact in the sensitivity analyses shows that GE’s run‑off reinsurance strategy is progressively leveraging these collaborative rate‑increase filings to offset adverse experience and protect its profitability.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. While the ground truth states that GE evolved from a passive to a more structured and collaborative approach with primary insurers—from noting variability in 2022, to formalizing collaboration under reinsurance contracts in 2023, to leveraging experience and precedents in 2024—the LLM focuses instead on unreported dollar impacts ($200M in 2023, $300M in 2024) from sensitivity analyses that are not mentioned in the original answer or supported by the provided ground truth. These figures appear to be fabricated or misattributed, as the ground truth does not reference any sensitivity tables or pre-tax adverse impacts. (2) The quantitative accuracy is low because the $200M and $300M figures are not present in the original answer and cannot be verified; their use to infer increasing reliance is therefore incorrect. There is no mention in the ground truth of a change in sensitivity impact, so this forms a false basis for the conclusion. (3) The qualitative reasoning is partially sound: the LLM correctly identifies a progression in GE’s reliance on primary insurers and interprets this as part of a risk management strategy in its run-off operations. It captures the essence of increasing strategic importance of rate increases. However, it misses key elements of the actual evolution—such as the formalization under contractual terms in 2023 and the use of regulatory precedents in 2024—and replaces them with unsupported numerical analysis. (4) Contextual relevance is high because the response stays focused on the question, cites appropriate years and concepts (reinsurance, run-off, collaboration), and attempts multi-hop synthesis across years. However, the introduction of false quantitative data undermines the correctness score, limiting it to 6 due to partial factual alignment but major errors in critical details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1578,
        "completion_tokens": 525,
        "total_tokens": 2104
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "- **2022:** CVS reported ≈ $845 million of residential‑mortgage‑backed securities (RMBS) on its balance sheet (amortized‑cost basis), with a fair‑value of about $757 million.  \n\n- **2023:** The RMBS holding rose to ≈ $862 million (amortized cost) and a fair‑value of $810 million – a modest increase of roughly $17 million (≈2 %).  \n\n- **2024:** Although the 2024 10‑K does not give a total‑portfolio number, the “Separate Accounts” segment shows RMBS fair‑value growing from $51 million in 2023 to $71 million in 2024, indicating that the company continued to add a small amount of RMBS to its investment mix.\n\n**Trend interpretation:** Over the three‑year period CVS’s exposure to residential mortgage‑backed securities has risen only slightly and remains a very small fraction of its total debt‑security holdings (which total >$20 billion). The incremental growth, coupled with the fact that the securities are agency‑guaranteed and reported as performing assets, suggests that CVS is maintaining a low‑to‑moderate risk posture in structured‑credit instruments rather than concentrating risk in this segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for CVS's RMBS exposure. According to the ground truth, RMBS exposure decreased from $721M in 2022 to $614M in 2023, then dropped further to $71M in 2024. However, the LLM claims exposure increased from $845M (2022) to $862M (2023), and only partially acknowledges the $71M figure in 2024 as part of the 'Separate Accounts' segment. These numbers are not only incorrect but contradict the trend entirely—LLM reports a slight increase while ground truth shows a sharp decline followed by a minimal rebound. (2) The quantitative inaccuracies are severe: the 2022 and 2023 values are off by over $100M each year, and the LLM misrepresents the 2024 data by citing only a segment-level figure ($71M in Separate Accounts) as if it were consistent with an overall portfolio increase, when in fact total RMBS exposure fell dramatically. Additionally, the LLM introduces amortized cost and fair value metrics not present in the original answer, which distorts the narrative. (3) The multi-hop reasoning is flawed—the LLM fails to synthesize the correct trend of de-risking in 2023 and strategic rebalancing in 2024, instead concluding a steady, low-risk accumulation of RMBS. This misreads both the direction and intent behind the investment changes. (4) Contextual relevance is moderate because the answer addresses RMBS exposure and risk positioning in structured credit, using appropriate financial terminology and attempting trend analysis. However, due to major factual and numerical errors, the qualitative and quantitative accuracy scores are very low, resulting in a correctness score of 2—indicating the answer is mostly incorrect and misleading despite some structurally relevant elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 485,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "- **Short‑term borrowings:** $883 million in 2022 → $538 million in 2023 (‑ 45 %) → $562 million in 2024 (‑ 4 % vs. 2023).  \n- **Long‑term debt:** $47.8 billion in 2022 → $49.3 billion in 2023 (+ 3 %) → $45.0 billion in 2024 (‑ 9 % vs. 2023).\n\nThe three‑year trend shows Capital One sharply cut its reliance on short‑term funding after 2022, then held it roughly steady, while it grew its long‑term debt in 2023 but subsequently reduced the balance in 2024. This pattern reflects a deliberate debt‑management strategy that leans toward a more stable, lower‑leverage capital structure by trimming overall long‑term obligations after a brief expansion.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies, particularly in the breakdown of short-term borrowings and long-term debt. According to the ground truth, total debt was $43.086B in 2022, $49.856B in 2023, and $45.551B in 2024. The LLM reports long-term debt alone as $47.8B in 2022 and $49.3B in 2023, which already exceeds the total debt (short + long) in the ground truth. This indicates a fundamental misrepresentation of the data. Additionally, the LLM states short-term borrowings were $883M in 2022, but this figure does not align with the implied total debt difference (total debt minus long-term debt) in the ground truth. (2) Calculations are internally consistent in the LLM answer (e.g., percentage changes), but they are based on incorrect base figures. The reported $562M short-term borrowings in 2024 and $45.0B long-term debt sum to $45.562B, which is close to the ground truth total of $45.551B in 2024, suggesting partial accuracy in the final year. However, earlier years are significantly off. (3) The reasoning and synthesis are qualitatively sound: the LLM correctly infers a strategic shift—increasing debt in 2023 and reducing in 2024—and interprets this as a move toward a more stable capital structure. It also correctly identifies a reduction in short-term reliance. However, it omits key insights from the ground truth, such as the rise in weighted-average interest rates (2.76% → 4.84%) and the elimination of floating unsecured senior debt, which are critical to understanding the debt management strategy in a rising rate environment. (4) The contextual relevance is high—the answer addresses the evolution of debt and attempts to interpret the strategy. However, due to major numerical inaccuracies in the foundational data, especially in the 2022 and 2023 figures, the correctness score is limited to 6. The qualitative reasoning is reasonable but incomplete without the interest rate and debt composition details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 532,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "- **FY 2022:** The 3.50 % Notes Due 2050 were reported at roughly **$1.6 billion** of long‑term liability.  \n- **FY 2023:** The same notes were shown at **$1.637 billion** (fair‑value, Level 2)【page 67】.  \n- **FY 2024:** The liability fell to **$1.604 billion** (fair‑value, Level 2)【page 67】.\n\n**Interpretation:** Over the three‑year period the balance of this long‑dated, low‑coupon debt slipped modestly, indicating that NVIDIA is gradually repaying or retiring a portion of the 2050 notes while still retaining the instrument for financing. The pattern reflects a capital‑structure strategy that relies on inexpensive, long‑term debt to fund growth but also seeks to modestly reduce leverage as cash flows allow.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the FY 2022 value, reporting $1.6 billion instead of the correct $2,147 million ($2.147 billion), which is a significant factual inaccuracy. The FY 2023 ($1,637 million) and FY 2024 ($1,604 million) values are correct, with acceptable format variations (e.g., $1.637 billion = $1,637 million). (2) Calculations: The trend shows a decrease from $2,147M to $1,604M over the period, but the LLM incorrectly states FY 2022 as $1.6B, making the implied change negligible rather than a substantial $543M reduction. This undermines the quantitative accuracy. (3) Multi-hop reasoning is partially sound—the LLM correctly identifies the three-year trend using data points across years and interprets the modest decline as a sign of gradual repayment, which aligns with the ground truth’s interpretation of strategic liability management. However, because the starting point is wrong, the reasoning is based on an incorrect premise. (4) Contextual relevance is high—the answer addresses both the evolution of the liability and its implication for capital structure strategy, using appropriate financial terminology and citing specific pages. The qualitative reasoning is logical and relevant, though based on flawed input data for 2022. The conclusion about using low-cost debt while reducing leverage is reasonable but overemphasizes 'modest' reduction, downplaying the actual significant decrease. Overall, the answer is partially correct but fails on a key data point, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 426,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "Apple’s 0.45 % Notes due 2016 first appear in the “Officer’s Certificate” that is incorporated by reference in the securities description (Exhibit 4.3). That same certificate – and therefore the 0.45 % Notes due 2016 – is listed unchanged in the 2022 Form 10‑K (see the exhibit table on page 56) and again in the 2024 Form 10‑K (identical exhibit table on page 56). Because the 2023 filing also references the same Exhibit 4.3, Apple’s disclosures show the note continuously carried forward year‑to‑year even after it matured, indicating a deliberate strategy of preserving a complete historical record of all long‑term debt instruments for transparency and consistency in its long‑term debt reporting.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns with the ground truth. (1) All factual elements are accurate: the 0.45% Notes due 2016 are correctly identified as being referenced in Exhibit 4.3 across Apple's 10-K filings for 2022, 2023, and 2024. The maturity date (2016) and issuance context are consistent with known facts. (2) Quantitative accuracy is perfect: percentages (0.45%), years (2016 maturity, 2022–2024 filings), and exhibit numbers (4.3) are correct. No calculations are required, but the temporal consistency is properly maintained. (3) Multi-hop reasoning is sound: the model correctly infers that despite the notes maturing in 2016, their continued inclusion in filings through 2024 reflects a disclosure strategy focused on transparency and historical continuity. This requires synthesizing information across multiple years and understanding the legal/financial rationale behind exhibit retention. (4) The answer is semantically equivalent to the original: while it adds specific detail about the 'Officer’s Certificate' and exhibit page numbers (which are plausible and enhance credibility), it does not introduce inaccuracies. The conclusion about Apple’s long-term debt disclosure strategy—preserving a complete historical record—is directly supported and matches the ground truth. All aspects of the question are addressed with precision and depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 379,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "- Net‑derivative Level 3 fair‑value rose sharply: the net liability balance was **$5 million at 12/31/2022**, grew to **$58 million at 12/31/2023**, and reached **$69 million at 12/31/2024** (Tables 16.2/17.3).  At the same time the gross derivative portfolio expanded from roughly **$79 m/$74 m (assets/liabilities) in 2022** to **$886 m/$828 m in 2023**, showing a much larger exposure that was pushed into Level 3 as the contracts became less observable.\n\n- The key unobservable input for these instruments has been the **swap rate**.  The weighted‑average swap rate has stayed near **4 %** each year (2022 = 4 % weighted, range 4‑5 %; 2023 = 4 % weighted, range 3‑5 %; 2024 = 4 % weighted, range 4 %).  The modest widening of the range in 2023 and the larger transfer‑in amounts indicate that Capital One is relying increasingly on internal models to price SOFR‑indexed interest‑rate swaps, reflecting growing interest‑rate‑risk exposure and a higher degree of model‑based judgment in its fair‑value assumptions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers and risk inputs. According to the ground truth, Capital One's net derivative assets (liabilities) fair value was $31 million in 2022, not $5 million as stated by the LLM. The LLM correctly reports $58 million for 2023 but incorrectly states $69 million for 2024, whereas the correct value is $58 million (unchanged from 2023). Additionally, the LLM claims the significant unobservable input was 'swap rates' in all three years with a consistent 4% weighted average, but the ground truth shows a shift from no specified input in 2022 to 'default' at 4% in 2023, then to 'swap rates' at 4% in 2024—indicating a meaningful change in risk drivers that the LLM fails to capture. (2) The gross derivative portfolio figures ($79M/$74M in 2022, $886M/$828M in 2023) and Level 3 classification details are not present in the original answer and appear to be hallucinated or misattributed, as the ground truth does not mention gross amounts or Level 3 transfers. There is no support for a $69 million value in 2024 or expansion in gross exposure. (3) The multi-hop reasoning is flawed: the question asks about evolution in valuation and risk inputs to infer exposure and modeling assumptions. The LLM incorrectly asserts continuity in swap rate usage, missing the critical shift from 'default' to 'swap rates' as the key unobservable input, which signals a change in primary risk exposure from credit risk to interest rate risk. It also omits the $20 million unrealized loss in 2022 and the reduction in realized losses from $43 million to stable values, which are key indicators of improved risk management mentioned in the original. (4) While the LLM attempts to interpret increasing reliance on models due to interest rate risk, this conclusion is based on incorrect data and ignores the actual narrative of stabilization and risk driver transition. The contextual relevance is moderate because it addresses derivative valuation and risk inputs, but the factual foundation is unsound, leading to misleading conclusions. Scores reflect major quantitative errors (2), poor qualitative reasoning due to incorrect synthesis (3), and partial relevance (6), resulting in a low overall correctness score of 3.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 609,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "- In the 2022 Form 10‑K the 1.55 % senior notes due 2028 were reported at roughly **$1.1 billion** (the balance shown on the consolidated balance sheet).  \n- The 2023 Form 10‑K shows the same liability at **$1.099 billion** (the “2023” column of the fair‑value table).  \n- The 2024 Form 10‑K records the balance at **$1.115 billion** (the “2024” column of the same table).\n\n**What this tells us:** NVIDIA’s exposure to the 1.55 % 2028 notes has been essentially flat over the three‑year period, rising only about $16 million between FY 2022 and FY 2024. The company is therefore keeping its long‑term debt base steady, relying on low‑coupon, unsecured senior notes that mature far in the future to fund growth while avoiding a rapid buildup of leverage. This pattern reflects a deliberate long‑term debt strategy that emphasizes stability and low‑cost financing rather than aggressive debt expansion.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, NVIDIA's exposure was $1.2B in 2022, $1.1B in 2023, and $1.25B in 2024. However, the LLM reports $1.1B in 2022, $1.099B in 2023, and $1.115B in 2024—missing the actual increase in 2024 and understating all values except 2023. The $1.115B figure for 2024 is notably lower than the correct $1.25B, a difference of $135M, which is material. (2) Calculations are internally consistent (a $16M increase from 2022 to 2024), but this is based on incorrect base figures. The actual progression shows a $0.1B decrease from 2022 to 2023 and then a $0.15B increase to 2024, indicating volatility, not stability. (3) The multi-hop reasoning is sound in structure—comparing across three 10-K filings and synthesizing a strategic interpretation—but it is based on flawed data. The conclusion of 'essentially flat' exposure contradicts the ground truth, which shows a dip and then a rise above initial levels, suggesting a more dynamic strategy. (4) Despite incorrect numbers, the answer correctly identifies the instrument, the years, and attempts a strategic interpretation, maintaining contextual relevance. The qualitative reasoning about using low-coupon, long-term debt is plausible and relevant, though the conclusion about 'stability' is undermined by the inaccurate data. Thus, while the framework is strong, factual correctness is compromised, leading to a correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 409,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "Across the three filings, GE’s risk‑factor disclosures show a steady, unchanged exposure to “trailing legal liabilities.” In the 2022 Form 10‑K (p. 71) the company warned that legacy proceedings from the 2015 Alstom Thermal‑Renewables‑Grid acquisition and shareholder lawsuits stemming from the 2020 SEC settlement “have resulted and will in the future result in cash outflows” and that reserves are based on highly judgmental estimates that could be exceeded. The 2023 filing (p. 36) repeats the same language, confirming that those Alstom‑related anti‑competitive/corruption claims and the post‑settlement shareholder actions remain unresolved and continue to require reserves, while the 2024 filing (p. 33‑34) again states that GE “remains subject to legacy legal proceedings… from the Alstom acquisition” and “remains subject to shareholder lawsuits… related to the Company’s financial performance, accounting and disclosure practices.” This continuity indicates that the contingent liabilities have persisted over the period, with no material resolution, and that they continue to pose a potential financial impact that could material‑ly affect GE’s results of operations and cash flows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: GE's ongoing exposure to legacy legal liabilities from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting is consistently reported across 2022–2024. The LLM correctly identifies that these matters resulted in cash outflows, required judgmental reserves, and posed ongoing financial and reputational risks. (2) Quantitative accuracy is perfect: no numerical errors; dates (2022, 2023, 2024), acquisition year (2015), and reference to the 2020 SEC settlement are all factually correct. Page numbers (p. 71, p. 36, p. 33–34) add precision and are consistent with typical 10-K structures. (3) Multi-hop reasoning is sound: the LLM synthesizes disclosures across three years and correctly infers persistence of liabilities due to unchanged language, demonstrating strong qualitative reasoning. It accurately concludes that there has been no material resolution and that financial impacts remain possible. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'reputational risk' aspect in 2024 as emphasized in the original answer, and slightly narrows the shareholder lawsuits to those 'stemming from the 2020 SEC settlement,' whereas the original answer frames them more broadly as tied to 'historical financial reporting.' This is a subtle but notable omission in completeness. Otherwise, the answer is semantically equivalent, contextually precise, and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1662,
        "completion_tokens": 421,
        "total_tokens": 2083
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "CVS’s pension plan reported hedge‑fund limited‑partnership holdings of **$225 million in 2022**, **$252 million in 2023**, and **$280 million in 2024** (see the “Excludes … hedge fund limited partnership investments” footnotes on the 2022, 2023 and 2024 tables). The steady rise—about $55 million (≈24 %) over the three‑year span—shows the company is deliberately expanding its alternative‑asset exposure, using hedge‑fund LPs to add diversification and potential higher‑return sources to its pension portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for CVS's hedge fund limited partnership investments. According to the ground truth, the correct amounts are $214 million in 2022, $225 million in 2023, and $252 million in 2024. However, the LLM incorrectly reports $225 million in 2022, $252 million in 2023, and $280 million in 2024—shifting the timeline and inflating the final value. This misalignment affects all subsequent calculations and interpretations. (2) The LLM calculates a $55 million increase (≈24%) over three years, but using its own incorrect numbers: from $225M to $280M is actually a $55M increase, though the percentage is closer to 24.4%, not exactly 24%. More critically, the actual increase from 2022 ($214M) to 2024 ($252M) is $38M (≈17.8%), which the model fails to capture. (3) The multi-hop reasoning is partially sound—the model correctly infers that increasing allocations suggest a strategic shift toward alternative investments and links this to diversification and higher returns. This aligns with the qualitative interpretation in the ground truth. However, because the underlying data is wrong, the reasoning is based on false premises. (4) Contextual relevance is high—the answer addresses both parts of the question (change over time and strategic implication) and uses appropriate financial terminology. However, the severe quantitative errors undermine the factual correctness, warranting a low overall score despite reasonable structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 422,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "In 2022 the Africa/Eurasia segment generated a healthy operating profit of **$228 million**. In 2023 the Global Productivity Initiative assigned **about 5 % of the total $32 million pretax restructuring charge to Africa/Eurasia** (roughly $1.5‑$1.6 million), reflecting a modest cost‑restructuring effort. By 2024 the company’s depreciation‑and‑amortization expense for the region fell to **$8 million**, indicating a shift toward tighter cost control and lower capital intensity in the Africa/Eurasia market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The operating profit for Africa/Eurasia in 2022 is stated as $228 million, but the ground truth is $203 million—a material difference of $25 million. The restructuring charge allocation is reported as 5% of $32 million (~$1.6 million), but the correct figure is 10% of expected charges, estimated at $20–$24 million, which is over 10 times higher. Only the 2024 depreciation and amortization figure ($8 million) is correct and matches the ground truth. (2) Calculations: The LLM incorrectly calculates 5% of $32 million as $1.5–$1.6 million (correct value is $1.6 million, so this part is accurate), but the premise is wrong—both the percentage (5% vs 10%) and the total charge base are incorrect. The decline in D&A from $9M to $8M is accurate, but the LLM fails to mention that D&A was $9M in both 2022 and 2023, missing context about stability before the drop. (3) Multi-hop reasoning: The model identifies the correct initiative (Global Productivity Initiative) and links it to restructuring charges in 2023, showing some correct synthesis. However, it misrepresents the scale and intent—'modest cost-restructuring' understates the actual 10% allocation, weakening the analysis. The conclusion about 'tighter cost control' aligns with the ground truth's emphasis on cost optimization, but lacks the broader 3-year strategic context of limited investment and low regional priority. (4) Justification: Correctness score is low (3) due to major quantitative errors in two of three core metrics. Quantitative accuracy is severely penalized (2) because only one number is correct. Qualitative accuracy is moderate (4) as the model grasps the general theme but misrepresents scale and synthesis. Contextual relevance is fair (7) because the structure and intent of the answer follow the question’s timeline and focus, even if facts are flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 523,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "- In the 2022 filing AIG said its international terrorism exposure was measured with scenario‑based modeling; a five‑ton bomb scenario (net of the U.S. TRIPRA program and existing reinsurance) was projected to cost about **$1.3 billion**, while the company’s deductible for U.S. terrorism was roughly **$1.7 billion**. No specific attachment‑point limits were disclosed.  \n\n- By 2023 the company still relied on TRIPRA and limited private reinsurance for U.S. terrorism and on government‑sponsored pools abroad, but it did not give new loss‑estimate figures; the only quantitative change reported was an increase in overall reinsurance‑recoverable assets to **$67.5 billion** at 31 Dec 2023.  \n\n- The 2024 filing shows the international terrorism attachment points were **re‑set to $150 million for Japan (down from $200 million) and kept at $125 million for the rest of the world**, while the total reinsurance‑recoverable assets fell to **$38.0 billion** at 31 Dec 2024, reflecting a tighter reinsurance program and lower collateral backing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several critical factual inaccuracies. While it correctly reports the $1.3 billion modeled loss estimate for the 2022 five-ton bomb scenario and the $1.7 billion TRIPRA deductible, it incorrectly states that no attachment points were disclosed in 2022—whereas the ground truth specifies that AIG retained core attachment points of $200 million in Japan and $125 million elsewhere throughout the period. More significantly, the LLM claims that in 2024, Japan's attachment point was reduced to $150 million from $200 million, which directly contradicts the ground truth stating that the $200 million attachment in Japan was maintained. Additionally, the LLM reports $67.5 billion in reinsurance-recoverable assets as of December 31, 2023, which is unsupported by the ground truth; the correct figure of $38.0 billion is only stated for 2024, with no 2023 value provided in the original answer. The drop to $38.0 billion in 2024 is correctly noted but misinterpreted as part of a 'tighter reinsurance program,' whereas the original answer frames it as reflecting expanded protections. (2) Quantitative accuracy is low: the $67.5 billion figure is entirely fabricated or misattributed, and the change in Japan's attachment point is incorrect. Only the $1.3 billion, $1.7 billion, and $38.0 billion figures are accurate. (3) Multi-hop reasoning is partially sound—the model attempts to track changes over time and integrates reinsurance assets with terrorism exposure—but it fails to correctly synthesize across years due to incorrect data ingestion. The conclusion about a 'tighter reinsurance program' is an unsupported inference. (4) Scores reflect major factual errors in key financial figures and structural changes (attachment points), undermining correctness despite some accurate inputs and relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 501,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "The 2.00 % Notes Due 2031 were carried at about **$1.2 billion in FY 2022**, fell to **$1.044 billion in FY 2023** (see the Level‑2 liability table in the 2023 filing 【page 67】), and then rose again to **$1.25 billion in FY 2024** (shown in the 2024 debt schedule 【page 72】). This pattern indicates that NVIDIA deliberately trimmed its exposure to this long‑term issue in 2023—likely through partial repayment or refinancing—but re‑expanded the balance in 2024, suggesting a flexible debt‑management approach that uses the 2031 notes as a financing tool when growth opportunities arise while still keeping overall long‑term leverage under control.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $1.2 billion in FY 2022, $1.044 billion in FY 2023, and $1.25 billion in FY 2024, matching the ground truth exactly. These figures are also properly attributed to the correct fiscal years and consistent with the original answer. 2) Quantitative accuracy is perfect—no calculation errors, and the numbers are presented clearly with acceptable formatting (e.g., 'FY 2022', use of 'billion'). 3) The reasoning is mostly sound and captures the trend of a dip and rebound in the liability. However, while the original answer interprets the pattern as reflecting a *stable long-term debt strategy* with temporary fluctuations, the LLM frames it as a *flexible, active management* approach involving deliberate trimming and re-expansion. This introduces a slightly different strategic interpretation—'flexible' vs. 'stable'—which is plausible but not fully aligned with the ground truth’s emphasis on consistency and lack of material change. The LLM’s suggestion of 'refinancing' or 'partial repayment' is reasonable but more speculative than the original’s cautious 'possibly reflecting minor debt repayments or reclassifications'. 4) Contextual relevance is high: the answer addresses all parts of the question, cites document locations (page numbers), and synthesizes multi-hop data across three years. The core facts are correct, and the interpretation, while slightly divergent in tone, does not contain factual errors. Hence, a score of 8 is justified—strong performance with minor qualitative deviation from the ground truth’s more conservative interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 441,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "Apple’s 1.05 % senior notes that mature in 2017 were first disclosed in the “Officer’s Certificate of the Registrant” dated May 6 2014 (see the 4.4 exhibit that lists “1.05 % Notes due 2017”) 【page_58】. The same exhibit appears unchanged in Apple’s 2022, 2023 and 2024 Form 10‑K filings (the 2022 filing shows it on page 58 and the 2024 filing repeats it on page 56) 【page_58】【page_56】, indicating that Apple continues to disclose this historic tranche until its scheduled maturity. This consistent inclusion demonstrates the company’s long‑term visibility and continuity of its debt structure, with each filing maintaining a clear record of all outstanding and maturing obligations, even for instruments that are near or at the end of their life.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant factual and logical inaccuracies. (1) Quantitatively, the 1.05% interest rate and 2017 maturity date are correctly stated, and the reference to the May 6, 2014 Officer’s Certificate and exhibit 4.4 is accurate. The citation of consistent disclosure across 2022, 2023, and 2024 filings (with page numbers) aligns with the expected transparency in reporting. However, the claim that Apple 'continues to disclose this historic tranche until its scheduled maturity' is factually incorrect—the notes matured in 2017, so by 2022–2024 they were long since matured, not merely 'near or at the end of their life.' (2) The original answer correctly infers that the continued inclusion likely reflects rollover, refinancing, or documentation under the same indenture, whereas the LLM incorrectly implies the notes were still outstanding or approaching maturity during 2022–2024. This misrepresents the timeline and financial reality. (3) The multi-hop reasoning is partially sound—tying the exhibit across years shows synthesis—but fails on the critical point of debt maturity and post-maturity disclosure logic. (4) While the LLM captures Apple’s consistent disclosure practices and links them to transparency, it misses the nuance that matured debt should not remain on the books as an active instrument unless refinanced. Thus, the conclusion about 'outstanding and maturing obligations' is incorrect. The answer is semantically close but factually flawed in key areas, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 426,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "- In 2022 Schwab was still operating under the 2019 IDA agreement, which let it **migrate up to $10 billion of IDA balances each 12‑month period** (subject to a required ≥ 80 % of those balances being designated as fixed‑rate, a $50 billion minimum balance through June 2031 and other capital‑level limits) and it did move roughly $10 billion in 2021‑2022 【page_102】.  \n\n- In May 2023 the 2019 agreement was replaced by the **2023 IDA agreement**, which removed the 80 % fixed‑rate requirement, introduced new balance caps (‑ through Sept 10 2025, a minimum above unmatured fixed‑rate obligations with a $30 billion “above‑that” ceiling; ‑ after that date, a $60 billion minimum and a $90 billion maximum) and gave Schwab discretion to buy down up to $5 billion of fixed‑rate obligations 【page_100】【page_102】.  Under the new terms Schwab’s ability to migrate balances remained tied to capital and the new caps, but **it chose not to move any IDA balances in 2023** 【page_100】.  \n\n- The same 2023 agreement remained in force for 2024, and **Schwab again did not migrate any IDA balances during 2024**, keeping the balances off‑balance‑sheet while remaining subject to the same minimum/maximum limits and the $5 billion buy‑down option 【page_99】.  \n\nThus, from 2022 to 2024 the migration limit fell from a defined $10 billion annual ceiling (with a fixed‑rate composition rule) to a discretionary, capital‑constrained ability under the 2023 agreement, and the required balance range shifted from a $50 billion minimum to tiered minimum/maximum caps of $30 billion‑above‑fixed‑rate obligations (through 2025) and $60‑$90 billion thereafter.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key numbers are correct: the $10 billion annual migration limit under the 2019 IDA agreement, Schwab moving approximately $10.1 billion by 2022 (stated as 'roughly $10 billion'), and the shift in 2023 to new balance thresholds. The LLM adds granular detail not in the original answer—such as the 80% fixed-rate requirement, $50 billion minimum balance, and the $30B/$60B–$90B tiered caps—which are consistent with the cited pages and do not contradict the ground truth. The $5 billion buy-down option is an additional accurate detail. (2) Calculations and comparisons are sound: the transition from a defined $10B ceiling to no migration under new constraints is correctly portrayed. (3) Multi-hop reasoning is strong: the model synthesizes changes across 2022, 2023, and 2024, correctly identifying the replacement of the 2019 agreement with the 2023 agreement and its implications. It accurately notes that no balances were migrated in 2023 and 2024, reflecting the strategic shift. (4) The only minor deviation is that the original answer emphasizes Schwab 'no longer exercised this migration option' as a binding constraint, while the LLM frames it as a discretionary choice under capital and cap limits—slightly different emphasis but not factually incorrect. The LLM provides richer context (e.g., fixed-rate rule removal, buy-down option) that enhances accuracy without introducing errors. Overall, the answer is factually correct, complete, and semantically equivalent to the ground truth with minor elaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1604,
        "completion_tokens": 441,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "- **Estimated litigation losses:** GE’s estimate for the Bank BPH borrower‑litigation pool grew from **$1.36 billion at 12/31/2022** to a peak of **$2.67 billion at 12/31/2023**, then fell slightly to **$2.46 billion at 12/31/2024**.  \n\n- **Capital contributions:** In 2022 GE made a **$530 million cash capital contribution** to the bank. In 2023 it provided a **$1.80 billion non‑cash inter‑company loan‑forgiveness** (no additional cash was required), and **no further contributions were needed in 2024**.  \n\n- **Carrying value of the mortgage portfolio:** The Polish mortgage receivable was still recorded at about **$1.2 billion (net of a $848 million allowance) in 2022**, but the **valuation allowance was increased to fully offset the receivable in 2023**, leaving a **zero carrying value**, which remained **zero at the end of 2024**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth in both quantitative and qualitative aspects. (1) All key numbers are correct within acceptable rounding: $1.36 billion (vs $1,359M), $2.67 billion (vs $2,669M), and $2.46 billion (vs $2,461M) for estimated losses; $530 million cash in 2022 and $1.80 billion non-cash (vs $1,797M) in 2023 are accurate. The zero carrying value by end of 2024 is correctly stated. (2) The LLM adds contextual detail not in the original—specifically, the $1.2 billion net carrying value and $848 million allowance in 2022—which is consistent with a more granular view of the data and does not contradict the ground truth; it enhances completeness. (3) Multi-hop reasoning is sound: the answer synthesizes data across years and entities (GE, Bank BPH), correctly tracks the evolution of losses, capital contributions, and portfolio valuation, and infers stabilization by 2024. (4) The only minor deviation is the phrasing of the mortgage portfolio write-down: the original states it dropped to zero 'by the end of 2024,' while the LLM says it was written down in 2023 and remained zero in 2024—this is actually more precise and likely correct based on allowance timing. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a 9 due to extremely minor phrasing differences in timing interpretation, but no material error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 390,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "- **2022:** Commercial mortgage‑backed securities (CMBS) carried a fair‑value of roughly **$1.0 billion** and an unrealized capital‑loss position of about **$155 million**.  \n\n- **2023:** The fair‑value fell to **≈ $975 million** and the unrealized loss narrowed to **≈ $100 million**.  \n\n- **2024:** CVS’s CMBS exposure was almost eliminated – the fair‑value of CMBS held in its Separate‑Accounts dropped to **$3 million** (down from $6 million in 2023), leaving only a minimal loss‑position.\n\n**Interpretation:** Over the three‑year period CVS systematically reduced the size of its CMBS portfolio and the associated unrealized losses. The decline in both fair‑value and loss exposure suggests a deliberate risk‑management strategy that trims interest‑rate‑sensitive, market‑valued assets to limit potential valuation volatility and preserve capital.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, in 2022, CVS's CMBS fair value was $574 million with $12 million in unrealized losses, but the LLM reports $1.0 billion and $155 million, which are both substantially incorrect. In 2023, the ground truth shows fair value increased to $675 million (not decreased to $975 million as stated by the LLM) and unrealized losses rose to $100 million (which the LLM correctly identifies, though frames as a 'narrowing' from a much higher number, which is misleading). The 2024 fair value of $3 million is correctly reported, but the LLM incorrectly implies it dropped from $6 million in 2023, while the ground truth shows a drop from $675 million, indicating a complete misrepresentation of the scale and trajectory. (2) Calculations and comparisons are flawed: the LLM suggests a gradual reduction in fair value from $1B to $975M to $3M, when in reality the value increased in 2023 before collapsing in 2024. The characterization of unrealized losses 'narrowing' in 2023 contradicts the ground truth showing a sharp increase from $12M to $100M. (3) The multi-hop reasoning is partially sound in that the LLM correctly infers a de-risking strategy in 2024 based on the near-elimination of exposure, but the conclusion is based on incorrect data patterns, undermining the validity of the synthesis. The reasoning would be stronger if it acknowledged the spike in unrealized losses in 2023 as a catalyst for the 2024 reduction, which the LLM does not clearly do. (4) The contextual relevance is fair because the answer addresses the evolution of exposure and attempts to interpret risk management strategy, but the qualitative accuracy is limited by incorrect entity values and misleading trends. The $3 million 2024 figure is correct and central, but the rest of the data is not, leading to a low correctness and quantitative accuracy score despite some structural relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 537,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "Walmart’s “Marketside” private‑label line appears in every filing – it is listed among the grocery private brands in the 2022 10‑K (see the brand list on page 7), it is again shown in the 2023 filing (page 9) and remains in the 2024 filing (page 7). The brand’s continued presence – without removal and alongside an expanding roster of other private labels – signals that Walmart is deliberately deepening its private‑label grocery offering, using Marketside as a core, value‑focused product family to reinforce its everyday‑low‑price strategy and capture higher margins in the grocery segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Marketside was consistently listed in Walmart's private brand portfolio across fiscal years 2022, 2023, and 2024, citing the correct years and confirming its ongoing presence—this matches the original answer's core claim. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct use of years, which are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings to infer a strategic trend—continued inclusion of Marketside alongside an expanding private label lineup—leading to the conclusion that Walmart is deepening its private-label grocery strategy. This reflects the same dual-strategy insight (maintaining legacy brands while expanding) as the ground truth, though it does not explicitly name the new brand 'bettergoods' introduced in 2024. (4) The omission of 'bettergoods' is a minor gap in completeness but does not undermine the overall correctness or qualitative accuracy, as the broader strategic implication (expansion and modernization) is still correctly inferred. Wording differs but semantic meaning is equivalent. Contextual relevance is full—every part of the question is addressed with appropriate detail and sourcing. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with perfect scores for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 420,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "From 2022 – Lowe’s already required all vendors to sign its Human‑Rights Policy, Conflict‑Minerals Policy and Vendor Code of Conduct, which contained baseline environmental and worker‑rights clauses and were enforced through routine audits.  \n\nIn 2023 the company strengthened that framework by adding “enhanced environmental standards” to the Code, revising its Wood‑Sourcing Policy to introduce country‑specific risk‑level categories, tighter monitoring procedures and a new forestry‑grievance process, and by expanding the share of independently‑certified, low‑impact products offered to customers.  \n\nBy 2024 those controls were made even more rigorous: the wood‑sourcing policy became a fully risk‑based system with further‑improved monitoring, Lowe’s began requiring suppliers to report emissions to CDP and partnered with suppliers on renewable‑energy and emissions‑reduction projects, and it continued to invest roughly $300‑$400 million in energy‑efficiency, renewable‑energy and low‑carbon initiatives that target scope‑3 emissions throughout its supply chain.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of Lowe's supplier monitoring and enforcement from 2022 to 2024 with generally accurate qualitative details. It correctly identifies key policy enhancements: the Vendor Code of Conduct and human rights policies in 2022, the 2023 wood-sourcing policy updates with country-specific risk levels and a grievance process, and further strengthening by 2024 with a risk-based system. However, there are significant quantitative inaccuracies. The original answer states multi-year investments exceeded $550 million by 2022 and over $400 million through 2023, totaling more than $950 million in cumulative investments. The LLM answer incorrectly states 'continued to invest roughly $300-$400 million' in later years, which understates the scale and misrepresents the timeline of spending. It also fails to mention the $550 million pre-2023 investment, missing a critical data point. Additionally, the LLM introduces new details not in the original—such as CDP reporting requirements and renewable-energy partnerships—adding plausible but unverified elements. While the reasoning and synthesis across years are sound and the structure matches the multi-hop nature of the question, the financial figures are not factually aligned. The answer is contextually relevant and well-organized, addressing all aspects of policy evolution, but the monetary inaccuracies reduce overall correctness. Semantic equivalence is mostly achieved except on investment amounts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 408,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "Apple’s 10‑K filings have listed the same “2.40 % Notes due 2023” in the securities exhibit each year. In the 2022 Form 10‑K the note appears in Exhibit 4.3 (see 2022 page 56), the 2023 filing again includes the 2.40 % Notes due 2023 in its Exhibit 4.3 (2023 pages 53‑57), and the 2024 Form 10‑K still references the same instrument in Exhibit 4.3 (see 2024 page 56). The three‑year continuity shows that Apple has kept this low‑coupon, fixed‑rate debt on its balance sheet until its scheduled maturity, reflecting a deliberate strategy of issuing modest‑interest, long‑dated notes and managing them as a stable, low‑cost component of its overall debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities—Apple, the 2.40% Notes due 2023, and the years 2022–2024—are correctly identified. The note is accurately described as appearing in Exhibit 4.3 across all three 10-K filings, with specific page references that match typical filing structures. (2) Quantitative accuracy is perfect: the interest rate (2.40%), maturity year (2023), and consistent disclosure over three years are all factually correct. No calculations are required, but the temporal tracking of the note is precise. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual filings to infer a pattern of sustained disclosure. It draws a logical conclusion about Apple’s debt strategy—maintaining low-cost, long-dated debt with transparency—even though the note matured in 2024. (4) The only minor gap is that the LLM emphasizes the strategic benefit of 'low-coupon, fixed-rate debt' and 'stable, low-cost component' more than the original answer, which focuses on transparency and legacy debt management. While this interpretation is reasonable and consistent with the data, it adds a slightly stronger strategic inference than the ground truth, which sticks to observable disclosure behavior. However, this does not constitute an error, just a nuanced difference in emphasis. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 401,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "- In 2022 GE’s AerCap investment consisted of both equity (≈111 million shares, ~46 % of AerCap) **and** a senior note valued at **$944 million** 【page_74】.  \n- By the end of 2023 GE had sold all of its AerCap equity for $6.6 billion, leaving **only the senior note** (about $900 million) as the remaining holding 【page_73】.  \n- At the close of 2024 the note was still on GE’s books, now recorded at **$982 million** 【page_70】, and the “investment in and note with AerCap” line shows a small net gain, confirming the note’s continued presence 【page_68】.  \n\n**Interpretation:** GE moved from a large equity stake in AerCap to a pure debt exposure, monetizing the equity while retaining a modest, income‑generating note that grew slightly in value. This shift signals a deliberate strategy to reduce equity risk, improve liquidity and focus on lower‑risk, fixed‑income financial instruments during the 2022‑2024 period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, GE's holding in the AerCap note was $976 million in 2022, decreased to $944 million in 2023, and increased to $982 million in 2024. However, the LLM claims the 2022 value was $944 million (matching the 2023 ground truth value), and states the 2023 value was about $900 million (not $944 million), which is incorrect. The 2024 value of $982 million is correct. These errors in key financial figures significantly undermine factual accuracy. (2) The LLM introduces information not present in the original answer—specifically, the equity stake of ~111 million shares and 46% ownership, and the $6.6 billion sale of equity. While potentially true from external sources, this detail is absent from the ground truth and distracts from the focus on the note holdings. The claim that the note was 'about $900 million' in 2023 is factually inconsistent with the $944 million in both the ground truth and the LLM’s own 2022 figure (which should have been $976M). (3) The reasoning and synthesis are partially sound: the LLM correctly identifies a strategic shift from equity to debt and interprets the retention of the note as a move toward lower-risk instruments. This aligns with the ground truth’s implication of a dynamic but stabilizing strategy. However, the multi-hop reasoning is compromised by using incorrect base figures and introducing unverified equity details. (4) Contextual relevance is high—the answer addresses the evolution of the note and interprets GE’s investment strategy appropriately. Despite incorrect numbers, the directional interpretation (shift to fixed-income, reduced risk) is plausible. However, the quantitative inaccuracies—especially the misstated 2022 and 2023 values—prevent a higher score. The model conflates years and values, suggesting a failure in precise data retrieval or synthesis across time points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 525,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path rules tie the “return‑seeking” slice of the U.S. qualified plan to the funded ratio, cutting growth assets as funding improves. In the 2022 filing the target allocation was 15 % equity, 75 % fixed‑maturity and 10 % other (​page 310); by the 2023 filing the target for 2024 had shifted to 9 % equity, 80 % fixed‑maturity and 11 % other (​page 252), and the 2024 filing kept the same 2025 target of 9 % equity, 80 % fixed‑maturity, 11 % other (​page 184). The steady reduction in equity and increase in fixed‑income exposure reveal a deliberate de‑risking of the plan as its funded status rose.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all percentages and years are correct: 15% equity, 75% fixed-maturity, 10% other in 2022; 9% equity, 80% fixed-maturity, 11% other for 2024 (as reported in 2023 filing) and unchanged in 2024 filing for 2025 target. These figures correctly reflect the de-risking trend. (2) The answer correctly identifies the mechanism—target allocations are updated annually based on prior year-end funded status—though it does not explicitly state the 'target for X based on funded status at end of X-1' structure as clearly as the original, slightly weakening the qualitative accuracy. (3) The reasoning is sound: reducing equity from 15% to 9% while increasing fixed-maturity assets demonstrates de-risking in response to improved funded status, consistent with liability-driven investing. (4) The answer addresses both parts of the question: evolution of the glide path (via allocation shifts) and what it reveals about de-risking. Only minor deduction in qualitative accuracy because the LLM does not explicitly name the 'glide path' as a function of funded status at year-end determining the next target year, though this is implied. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 369,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "From 2022 through 2024 Texas Instruments repeatedly stated that its “strategic focus is on analog and **embedded‑processing** products” and that, while it serves six end markets, it places “additional strategic emphasis” on selling those products into the industrial and automotive segments 【page_21】【page_19】【page_19】.  In each year’s MD&A the company also ties that focus to its three‑part plan to grow **free‑cash‑flow‑per‑share**, noting that the analog‑plus‑embedded‑processing business model is the foundation for generating strong operating cash flow 【page_20】【page_18】【page_20】.  The unchanged emphasis over three years shows that TI treats embedded processing as a core, durable cash‑generating platform that underpins its long‑term free‑cash‑flow‑per‑share growth strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Texas Instruments' strategic emphasis on embedded processing products from 2022 to 2024 is accurately described, with consistent linkage to analog products and the industrial and automotive markets. The connection between this product line and free cash flow per share growth is correctly identified each year. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and correctly infers that the sustained emphasis reflects a foundational role in long-term cash flow generation. It references the business model’s role in generating strong operating cash flow, which supports the free cash flow per share strategy—this matches the original answer’s logic. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'durable cash-generating platform' vs. 'foundational pillar'), the meaning is equivalent. The only minor gap is that the LLM does not explicitly mention the 'four sustainable competitive advantages' or 'supply chain control, customer reach, and diversified returns' from the 2024 emphasis, which slightly reduces qualitative accuracy. However, the core insight about long-term strategic centrality is preserved. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 425,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "From fiscal 2022 the company’s IP filing listed a broad set of owned marks—including its core private‑brand names “Kobalt,” “STAINMASTER,” “allen+roth” and the retail banners “RONA” and “Reno Depot”—and stressed that the subsidiary maintains trademarks, domain names, copyrights and patents for these names. By fiscal 2023 the narrative had narrowed to protecting the three flagship private‑brand names (Kobalt, STAINMASTER, allen+roth) and emphasized that these assets are leveraged through the firm’s expanding omnichannel and digital‑transformation platform (online stores, contact‑center sales, virtual design tools, and faster fulfillment). The fiscal 2024 filing repeats the same private‑brand focus, underscoring that the protected brand portfolio is now fully integrated into Lowe’s digital‑first strategy—enabling seamless online ordering, curb‑side pickup, same‑day delivery and virtual sales support for Kobalt and its sister private brands.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities—Kobalt, STAINMASTER, allen+roth, RONA, Reno Depot—are correctly identified across fiscal years 2022–2024. The evolution in disclosure focus from a broader set of brands in 2022 to only the three core private brands in 2023 and 2024 is accurately captured. (2) There are no numeric values or calculations in this question; dates (fiscal years) are correctly used throughout. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes changes in IP disclosure over time and links them to digital transformation initiatives. It accurately notes the omission of RONA and Reno Depot in later years and interprets this as a strategic refocusing. (4) The LLM adds slightly more detail than the original (e.g., 'virtual design tools', 'curb-side pickup') that are plausible digital initiatives but not explicitly mentioned in the ground truth. However, these are reasonable inferences and do not contradict the source. The core conclusion—that Lowe's narrowed brand emphasis and integrated private brands with digital transformation—is fully supported. Only a minor deduction from 10 due to slight expansion beyond the exact language of the original, but semantic equivalence is maintained. Contextual relevance is perfect: all parts of the question (brand portfolio emphasis, digital integration, evolution over time) are addressed thoroughly and accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 399,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "- In the 2022 Form 10‑K (Item 1 Business, p. 3) IBM listed **“client relationships and trust”** among its core competitive pillars for its hybrid‑cloud and AI offerings.  \n- The 2023 filing repeats the same phrasing (Item 1 Business, p. 3), and the 2024 filing again cites **“client relationships and trust”** as a principal method of competition (Item 1 Business, p. 3) while also tying the company’s brand‑reputation risk to its ability to retain those relationships (Risk Factors, p. 5).  \n\nThis continuity shows IBM has deepened its positioning as a **trusted partner** rather than just a technology vendor, using long‑standing client relationships to differentiate its hybrid‑cloud and AI platform against hyperscalers and other rivals and to underpin its growth strategy in the market.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its citation of IBM's consistent mention of 'client relationships and trust' as a competitive differentiator across the 2022, 2023, and 2024 Form 10-K filings, with correct references to section (Item 1 Business) and page numbers. There are no numeric inaccuracies, and the dates/years are correct, earning a perfect quantitative accuracy score. Contextual relevance is high, as the response directly addresses IBM's strategic positioning in hybrid cloud and AI markets. However, the qualitative accuracy is lower because the LLM fails to capture the *evolution* in emphasis described in the ground truth: while it notes continuity, it omits the key multi-hop progression—specifically, the expansion of trust into strategic partnerships (AWS, Microsoft, SAP in 2023) and the addition of cybersecurity alliances (e.g., Palo Alto Networks in 2024) as trust enablers. The answer does not reflect how the *context* of trust evolved from platform integration to ecosystem and security depth. This missing synthesis limits completeness and reasoning quality, preventing a higher correctness score despite accurate individual assertions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 328,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "- In the 2022 Form 10‑K the El Segundo, California site was listed as a plant “used for **clinical and commercial manufacturing and processing of our cell‑therapy products**”【page_31】.  \n- The 2023 filing repeats the same description for El Segundo, again noting it is used for **both clinical and commercial manufacturing and processing of cell‑therapy products**【page_11】.  \n- The 2024 filing likewise states the El Segundo facility “is utilized for **clinical and commercial manufacturing and processing of our cell‑therapy products**”【page_10】.  \n\nThus, from 2022 through 2024 Gilead’s El Segundo facility consistently served a dual role, handling both the clinical‑trial production and the commercial‑scale manufacturing of its cell‑therapy products, with no change in its stated responsibilities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) It accurately captures the consistent role of Gilead's El Segundo facility from 2022 to 2024, correctly stating that it was used for both clinical and commercial manufacturing and processing of cell therapy products each year. There are no factual inaccuracies or omissions. (2) The answer contains no numerical data requiring calculation, but correctly references the relevant years (2022, 2023, 2024) and aligns each with the appropriate description from the respective 10-K filing. Page numbers cited (e.g., page_31, page_11, page_10) are consistent with source documentation and support traceability. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual filings to conclude that there was no change in the facility’s responsibilities over time, which matches the ground truth’s inference of operational continuity. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in the facility’s role, and correctly emphasizes the sustained dual function. Wording differs slightly but meaning is preserved, meeting semantic equivalence. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 355,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "The only 4.550 % tranche that appears in the filings is the **4.550 % notes issued on April 5 2019, which mature on April 5 2049** (see the Fifteenth Supplemental Indenture listed in the 2022‑2024 exhibit tables – e.g., LOW 10‑K 2022 p. 79‑80 and the same entry repeated in the 2023 and 2024 tables). No additional 4.550 % notes are shown in the 2022, 2023 or 2024 supplemental indentures, and the maturity date of the existing issue does not change.\n\n**Interpretation:** Lowe’s has not been issuing new 4.550 % bonds after the 2019 issuance; it simply retains the long‑dated, low‑coupon tranche on its balance sheet. This pattern reflects a long‑term debt strategy that relies on a few, long‑maturity, fixed‑rate notes to lock in inexpensive financing and extend the overall maturity profile rather than repeatedly refinancing or adding new issues of the same coupon.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual elements are accurate: the 4.550% Notes were issued on April 5, 2019, and mature on April 5, 2049, under the Fifteenth Supplemental Indenture, and this was consistently reported in the 2022, 2023, and 2024 10-K filings. (2) Quantitative accuracy is flawless—dates, percentages, and issuance details match the original answer exactly. There are no calculations required, but the consistency of the maturity date and coupon rate across years is correctly noted. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers that no new issuances occurred, indicating a stable long-term debt strategy. (4) The interpretation about Lowe's strategic use of long-duration, fixed-rate debt to avoid refinancing risk and lock in financing is semantically equivalent to the ground truth’s conclusion about capital flexibility and extended maturities. Wording differs slightly but meaning is preserved. All parts of the question—evolution over time and strategic implication—are thoroughly addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 322,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "- **2022 10‑K:** 3M noted that the only Scotch‑gard‑related litigation was a Michigan class action tied to Wolverine’s shoe‑manufacturing waste.  The company said its share of the settlement was “not material” and no specific charge or reserve was recorded.  \n\n- **2023 10‑K:**  The filing disclosed that the Wolverine‑Scotch‑gard case was finally settled, with the last payment made in June 2023.  The settlement was again described as immaterial to earnings and no additional liability was booked.  \n\n- **2024 10‑K:**  The report repeats that the Scotch‑gard settlement was resolved for an immaterial amount and that no new exposure or cost has been identified.  \n\n**What the trend shows:**  Over the three‑year period the Scotch‑gard exposure has remained negligible and the only cost incurred (the June 2023 payment) was immaterial.  This indicates that, unlike the multi‑billion‑dollar PFAS “PWS” settlement, Scotch‑gard‑related litigation has had little financial impact on 3M’s results.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth on multiple key points. (1) Quantitatively, the LLM claims the 2022 and 2023 settlements were 'immaterial' and no specific reserve was recorded, but the ground truth states a $65 million settlement in 2022 involving 3M, Saint-Gobain, and Honeywell—this is a material figure and specifically quantified. The LLM fails to mention the $65 million amount entirely, which is a critical factual omission. (2) The LLM incorrectly asserts that by 2024, no new exposure or cost has been identified, while the ground truth reports expanded litigation into Alabama and Georgia, new lawsuits from municipal utilities and carpet manufacturers, and a $65 million settlement being finalized in New York—again indicating significant and growing exposure. (3) Entity and timeline accuracy: The LLM misrepresents the evolution of litigation, claiming resolution with no further exposure, while the ground truth shows increasing geographic and legal complexity (Illinois, Canada, Alabama, Georgia) and ongoing trials set for 2026. (4) Reasoning and synthesis: The LLM concludes that Scotchgard-related litigation has had 'little financial impact,' directly contradicting the ground truth trend of escalating liabilities and expanding litigation. The multi-hop synthesis fails—instead of connecting growing legal actions and settlements across years, the LLM incorrectly infers diminishing impact. (5) Contextual relevance: The answer addresses the general topic and uses correct company and product names, so it remains somewhat relevant, but the factual foundation is flawed. Overall, the LLM appears to have misread or misrepresented the 10-K disclosures, resulting in a factually inaccurate and misleading assessment of 3M's legal exposure and financial impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 489,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "In 2022 Gilead’s Foster City campus was described primarily as the corporate headquarters that “house our administrative, manufacturing and R&D activities,” serving as a central hub for the company’s overall operations. By 2023 (and reiterated in the 2024 filing) the site’s role had become more specialized – it now focuses on process‑chemistry research, analytical‑method and formulation/device development, and on‑site API and drug‑product manufacturing for clinical‑trial material. This shift concentrates Foster City on early‑stage R&D and trial‑scale production while the broader global network (La Verne, Oceanside, El Segundo, Cork/Dublin, etc.) handles commercial‑scale manufacturing and distribution, aligning the facility with Gilead’s worldwide development and supply‑chain strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) All key facts are correct: the 2022 description of Foster City as housing administrative, manufacturing, and R&D activities and serving as corporate headquarters is accurately reflected; the 2023–2024 shift to a more specialized role in process chemistry, analytical method development, formulation/device development, and clinical-scale manufacturing of API and drug product is correctly detailed. (2) No numeric values are present, but the timeframes (2022, 2023, 2024) are used correctly and consistently with the ground truth. (3) The multi-hop reasoning is sound: the answer synthesizes information across years and locations, correctly inferring a strategic realignment where Foster City focuses on early-stage development and clinical manufacturing while commercial-scale operations are delegated to other sites like La Verne, Oceanside, and international facilities (Cork/Dublin). (4) The answer fully addresses all parts of the question—R&D focus, manufacturing responsibilities, and strategic alignment with global operations—and uses slightly more specific location names (e.g., El Segundo) without introducing error. Wording differs but meaning is preserved, and the strategic narrative of specialization and global operational alignment is clearly and correctly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 384,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "- **2022:** AIG identified loss‑reserve adequacy as a key risk and relied on “internal controls and oversight of the loss‑reserve setting process, as well as reviews by external experts” (2022 Form 10‑K p. 167).  Governance was centered on the business‑unit chief risk officer, risk‑committee sign‑offs, a formal risk‑appetite/limit framework and written underwriting policies (2022 p. 165‑166).  \n\n- **2023:** The company added a formal “Second‑Line Review and Challenge” by Enterprise Risk Management and regular audits by the Internal Audit Group that specifically test pricing and reserving models, assumptions and results (2023 p. 86).  It also expanded its model‑risk management framework, using stochastic and scenario‑analysis techniques and continuing external‑expert reviews of reserves (2023 p. 119).  \n\n- **2024:** AIG kept the same layered oversight but further integrated ERM’s ongoing review, external‑expert validation and enhanced third‑party catastrophe‑risk models (with adjustments for bias, data quality and non‑modeled risks) into the loss‑reserve process (2024 p. 86‑88).  This shows a progression from basic internal controls and external expert checks (2022) to a more structured second‑line challenge and model‑validation regime (2023) and, by 2024, a fully embedded, continuously‑monitored framework that combines internal oversight, external reviews and refined modeling approaches.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All key facts are correct: in 2022, AIG relied on internal controls and external expert reviews; in 2023, it introduced second-line review, stochastic methods, and scenario analysis; by 2024, it further embedded these into ERM with enhanced modeling and ongoing validation. These match the evolution described in the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all dates (2022, 2023, 2024) and document references (page numbers, Form 10-K) are correctly cited—thus, quantitative accuracy is scored as 10. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the progression in oversight (from business-unit CRO to ERM second-line challenge), modeling (stochastic and scenario methods), and integration of external reviews. The only minor shortcoming is that the original answer explicitly mentions 'experience studies' in 2023, which the LLM omits—hence qualitative accuracy is 9 rather than 10. (4) The answer is fully contextually relevant, directly addressing oversight mechanisms, modeling approaches, and external reviews across the three years as required. Overall, the LLM captures the core evolution from reactive to proactive, model-driven governance with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 414,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site is listed in the “Properties” tables of all three filings as an **Analog‑only** manufacturing location – it carries an “X” under the Analog column and no mark under Embedded Processing in 2022 (page 16 of the 2022 10‑K)【page_16】, again in 2023 (page 16 of the 2023 10‑K)【page_16】, and still in 2024 (page 16 of the 2024 10‑K)【page_16】. Over the 2022‑2024 period the footprint did not change, indicating TI has kept Melaka dedicated to analog production and has not expanded embedded‑processing capacity there.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site remained an Analog-only manufacturing location from 2022 to 2024, with no involvement in Embedded Processing—this matches the original answer's claim of exclusive Analog focus and no expansion into Embedded Processing. (2) The answer correctly references the 'Properties' tables in the 2022, 2023, and 2024 10-K filings (page 16 for each), confirming consistent documentation across all three years. There are no numerical values requiring calculation, but the temporal scope (2022–2024) is correctly observed. (3) The multi-hop reasoning is sound: the model synthesizes data across three annual reports to confirm stability over time and correctly infers that the lack of change indicates a dedicated Analog role. (4) The semantic meaning is equivalent to the original answer, with precise use of terminology ('Analog-only', 'did not change', 'dedicated to analog production'). All aspects of the question—evolution over three years and implications for manufacturing focus—are addressed accurately and completely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 327,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "Lowe’s forward‑interest‑rate‑swap exposure was $2.56 billion in fiscal 2022 (the “Forward interest rate swap agreement notional amounts” line in the 2022 10‑K shows $2,560 million) 【page_61】. By the end of fiscal 2023 the company still reported holding forward swaps to hedge forecasted debt issuances (the 2023 10‑K notes that such swaps were on the books as of Feb 3 2023) 【page_46】, but the 2024 fair‑value table no longer lists any forward‑swap balance (the 2024 column is blank) 【page_54】. This trajectory – a large hedge in 2022 that was subsequently unwound to zero by 2024 – indicates that Lowe’s used forward swaps to lock in rates for anticipated borrowings and then terminated the contracts once the debt was actually issued, reflecting a purpose‑driven, timing‑aligned hedging strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claim that Lowe's had a $2.56 billion forward interest rate swap exposure in fiscal 2022. This number does not align with the ground truth, which makes no mention of a $2.56 billion notional amount and instead emphasizes the use of forward swaps in 2022 in the context of their impact on comprehensive income, not notional exposure. The ground truth also does not support the claim that the 2022 10-K reports $2,560 million in notional — this appears to be a misinterpretation or misquotation from the source. While the LLM correctly notes the presence of forward swaps in 2023 with a fair value implied to exist (though it omits the $251 million figure from the ground truth), it correctly observes that by 2024, no forward swaps are reported. (2) The calculation or reporting of $2.56 billion is unsupported and contradicts the ground truth, which never specifies a notional amount for 2022. The fair value in 2023 is omitted entirely, weakening quantitative accuracy. The absence of forward swaps in 2024 is correctly identified. (3) The reasoning is partially sound: the LLM infers that the elimination of forward swaps by 2024 suggests debt issuance had occurred, which is a plausible interpretation. However, the ground truth describes a strategic shift toward fixed-to-floating swaps for existing debt, a key qualitative point the LLM omits. Thus, the multi-hop synthesis is incomplete — it captures the timeline but misses the broader strategic pivot in hedging approach. (4) The answer is contextually relevant and addresses the evolution over time and the implication for hedging strategy, but the incorrect numerical foundation and missing strategic context (shift from cash flow to fair value hedges) reduce correctness. The conclusion about a 'timing-aligned' strategy is reasonable but less nuanced than the ground truth's indication of a strategic reorientation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 529,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "Across IBM’s three most recent Form 10‑K reports the 6.50 % Debentures due 2028 are always disclosed in the “Instruments defining the rights of security holders” table. In the 2022 filing the debenture is listed among the other senior notes and is incorporated by reference to **Exhibit 2 to Form 8‑K, filed January 8 1998**. The 2023 filing repeats the same language, again pointing to Exhibit 2 of the January 8 1998 Form 8‑K as the governing instrument【page 19 (2023)】. The 2024 filing makes an identical reference, citing the same Exhibit 2 to the 1998 Form 8‑K filing【page 19 (2024)】.  \n\nThe fact that the referenced filing date (January 8 1998) is unchanged in all three years shows that IBM has relied on a single, unchanged indenture for this debt since its issuance, indicating a stable, long‑term structure and that the terms of the 6.50 % Debentures due 2028 have not been amended or re‑documented in subsequent years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately identifies that IBM disclosed the 6.50% Debentures due 2028 in each of its 2022, 2023, and 2024 Form 10-K filings, consistently referencing Exhibit 2 to the Form 8-K filed on January 8, 1998—this date and exhibit number are correctly stated. (2) All numeric and temporal elements (6.50%, 2028 maturity, January 8, 1998 filing date) are factually accurate and consistent with the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings and draws the logical conclusion that the unchanged reference indicates a stable, long-term debt structure with no amendments. (4) The answer is semantically equivalent to the ground truth, providing the same core insight about the stability and unamended nature of the debt instrument, with added contextual detail (e.g., specific page numbers and disclosure section) that enhance clarity without introducing error. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 307,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "In the 2022 and 2023 10‑K filings, “Reflective signage for highway and vehicle safety” appears at the very end of the Transportation & Electronics product list, indicating it was treated as a peripheral offering. By the 2024 filing the same line moves up to the fourth spot in the list (after premium large‑format graphic films), putting it ahead of several core technologies. This upward shift signals that 3M is elevating reflective‑signage’s profile and treating it as a more strategically important product within the Transportation & Electronics portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) According to the ground truth, Reflective Signage was listed fifth in 2022, fourth in 2023, and fourth in 2024 — not at the end in 2022 and 2023 as claimed. The LLM incorrectly states it appeared 'at the very end' in 2022 and 2023, which contradicts the original data showing it consistently in the top half. (2) The claim that in 2024 it moved up to fourth after 'premium large-format graphic films' is partially correct for 2023 but misrepresents 2024, where it was listed after 'sound and temperature management,' not premium large format films. (3) The multi-hop reasoning is flawed: the LLM fails to accurately track the product's position across all three years, incorrectly inferring a dramatic shift from last to fourth when in fact the product was never last and had already moved to fourth in 2023. (4) While the general idea of increasing strategic importance is plausible, the conclusion is based on incorrect positioning data, leading to a misleading interpretation. The answer is contextually relevant in addressing the question’s intent but fails on factual accuracy and reasoning soundness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 335,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "In the 2022 Form 10‑K Gilead listed the Hoofddorp, Netherlands site among its manufacturing locations but did not describe it as a commercial‑production hub for cell‑therapy products【page 31】.  By the 2023 filing the company was explicitly stating that the Hoofddorp facility “is used for **commercial manufacturing and processing** of our cell‑therapy products”【page 11】, and the 2024 filing repeats the same language, confirming that the site has become a core part of Gilead’s commercial‑supply chain for cell therapies【page 10】.  This progression shows the Hoofddorp plant moving from a general manufacturing site in 2022 to a strategically important commercial manufacturing center for cell‑therapy products by 2023‑2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies the evolution of Gilead's Hoofddorp facility from 2022 to 2024: in 2022 it was listed as a manufacturing site without explicit mention of commercial cell therapy production; by 2023, it was explicitly described as being used for 'commercial manufacturing and processing' of cell therapy products; and in 2024, this designation was reaffirmed. These points align precisely with the original answer. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly used and referenced to appropriate Form 10-K filings. Page numbers are cited accurately, enhancing verifiability. (3) The multi-hop reasoning is sound—information is synthesized across three years of filings to demonstrate a strategic shift, showing how the facility’s role evolved from general manufacturing to a core commercial hub for cell therapies. (4) The LLM captures all key qualitative nuances: the increasing strategic importance, the alignment with Gilead’s internal scaling strategy, and the confirmation of sustained use in 2024. Wording differs slightly but meaning is preserved. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 353,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "- In the 2022 Form 10‑K (table dated December 31 2021) the “shares remaining available for future issuance” under all equity plans – which includes the 2003 Director Compensation Plan – was **69,842,569** shares【page_63】.  \n- In the 2023 Form 10‑K (table dated December 31 2023) that same figure fell to **58,452,628** shares【page_61】.  \n- In the 2024 Form 10‑K (table dated December 31 2024) the amount rose again to **65,541,964** shares【page_59】.  \n\n**Trend:** The pool of shares that can be issued under the 2003 Director Compensation Plan dropped sharply from 2022 to 2023, then partially recovered in 2024. This pattern shows that Texas Instruments continues to rely on the 2003 plan for director compensation, but the size of the available share pool is being adjusted each year based on grant activity and plan utilization.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The numbers provided—69,842,569, 58,452,628, and 65,541,964—are not for the 2003 Director Compensation Plan alone, but for *all equity compensation plans combined*, as stated in the 'Equity Compensation Plan Information' table in the 10-Ks. The question specifically asks about the 2003 Director Compensation Plan, which is a subset of that total. The ground truth correctly identifies the plan-specific figures: 1,843,134 (2022), 1,786,785 (2023), and 1,745,284 (2024), showing a consistent decline. The LLM misidentifies the scope of the data, leading to fundamentally wrong numbers and an incorrect trend (a drop then recovery vs. a steady decline). (2) The calculations and comparisons are therefore invalid. The LLM claims a 'sharp drop' from 2022 to 2023 and a 'partial recovery' in 2024, but the actual data shows a continuous decrease, indicating ongoing use of the plan. The LLM’s numbers reflect broader equity activity, possibly including new grants or plan approvals under other programs (e.g., employee plans), not director-specific activity. (3) The multi-hop reasoning fails because the model did not isolate the 2003 Director Compensation Plan from the aggregate equity plan totals. This is a critical error in entity disambiguation and financial context. The model also incorrectly infers that the fluctuation indicates 'adjustments based on grant activity and plan utilization,' which contradicts the actual trend of steady share depletion. (4) The contextual relevance is moderate because the answer discusses share availability and director compensation, but the factual inaccuracies and misidentification of the plan render the conclusion misleading. The model addresses the right topic but with wrong data and reasoning, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 507,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "In the 2022 and 2023 Form 10‑K filings IBM disclosed the 0.950 % Notes due 2025 only by **incorporating by reference** the 2017 Form 8‑K that defined the notes’ rights (see page 20 – “The instrument defining the rights of the holders of the 0.950 % Notes due 2025 … are Exhibits 4.1 and 4.2 to Form 8‑K, filed May 22, 2017, and are hereby incorporated by reference”). By the 2024 filing, the same notes appear in the **securities‑registration table** as a listed security on the NYSE under ticker IBM25B (see page 1 – “0.950% Notes due 2025  IBM25B  NewYorkStockExchange”).  \n\nThis shift from a passive, reference‑only disclosure to an explicit listing on a major exchange signals that IBM is increasing the transparency of its debt program, likely to improve liquidity, broaden its investor base, and demonstrate a more proactive capital‑market strategy and engagement with bond investors.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the 2017 Form 8-K filing date (May 22, 2017), the method of disclosure in 2022 and 2023 (incorporation by reference), and the 2024 change with the explicit listing under ticker IBM25B on the NYSE. (2) Quantitative elements—interest rate (0.950%), maturity year (2025), exhibit numbers (4.1 and 4.2), and filing types (Form 8-K, Form 10-K)—are all precisely stated. (3) The multi-hop reasoning across years and filings is sound: the answer correctly synthesizes the evolution from passive reference to active market listing, drawing on disclosures from 2022 through 2024. (4) The interpretation—that this shift reflects a strategic move toward greater transparency, liquidity, and investor engagement—is logically derived and aligns with the original answer. Wording differs slightly but conveys the same meaning with high fidelity. No errors in entities, dates, or logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 284,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "MetLife’s deposit‑method reinsurance balances were essentially unchanged through 2022 – the 2022 filing still shows $1.8 billion of deposit assets and $1.4 billion of deposit liabilities (the same amounts reported for 2021).  By the end of 2023 the balances had risen sharply to about $5.1 billion of deposit assets and $1.3 billion of deposit liabilities, and they settled back to $4.6 billion of assets and $1.2 billion of liabilities at December 31 2024.  The November‑2023 Global Atlantic transaction – a $10.3 billion reinsurance deal that created a $9.5 billion asset transfer, a $5.0 billion separate‑account retain‑back and a $770 million net cost recorded in other liabilities – illustrates MetLife’s strategic shift to using the deposit method for a large, block‑level reinsurance program, moving the approach from modest, routine deposits to a major capital‑management tool that offsets a sizable deposit liability with a corresponding deposit receivable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values for deposit assets and liabilities across 2022 ($1.8B assets, $1.4B liabilities), 2023 ($5.1B assets, $1.3B liabilities), and 2024 ($4.6B assets, $1.2B liabilities) are correct, with acceptable formatting variations (e.g., $1.8 billion = $1.8B). The $10.3 billion reinsurance transaction amount is also correctly cited. (2) The LLM adds granular detail about the Global Atlantic transaction—$9.5B asset transfer, $5.0B retain-back, $770M net cost—not in the original answer but consistent with plausible extensions of the data; these do not contradict the ground truth and enhance the explanation. (3) The multi-hop reasoning is sound: the LLM correctly identifies the trend over time and interprets the 2023 transaction as a strategic shift in accounting use, moving from routine deposits to a capital management tool, which matches the original answer’s conclusion about a strategic shift. (4) The only minor deviation is that the original answer emphasizes the recording of $10.3B in 'reinsurance recoverables and deposit receivables' as evidence of the shift, while the LLM breaks this down into components and focuses on the offsetting receivable/liability mechanism. This is a difference in emphasis, not inaccuracy. Overall, the LLM provides a factually correct, complete, and contextually appropriate response with excellent quantitative precision and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 408,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "The Safety & Industrial segment’s product description in the 2022, 2023 and 2024 Form 10‑K all list “fall‑protection solutions” alongside respiratory, hearing and eye‑protection products (2022 filing § Business Segments – pages 129‑133; 2023 filing § Business Segment Products – page 107; 2024 filing § Business Segment Products – page 110). Because the fall‑protection line has been retained and highlighted in each of the three annual reports, the portfolio shows a steady or expanding commitment to personal‑safety gear, underscoring 3M’s continued strategic focus on workplace‑safety solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately identifies that MMM (3M) consistently included 'fall protection solutions' within its Safety and Industrial segment across the 2022, 2023, and 2024 10-K filings, grouped with respiratory, hearing, and eye protection. The citations to specific sections and page numbers (e.g., 2022 filing § Business Segments – pages 129–133, etc.) add precision and verify the information is grounded in the actual filings. Quantitatively, there are no numerical errors—though no numbers are involved, the temporal consistency (2022–2024) is correctly maintained. The reasoning correctly infers that the retention of fall protection in each year indicates a steady strategic focus on workplace safety, which matches the ground truth’s conclusion. The only minor shortcoming is that the LLM uses '3M’s' in the conclusion while the question and original answer refer to 'MMM'—though this is a well-known ticker synonym, the original answer maintains consistent use of 'MMM'. Additionally, the LLM interprets the consistency as possibly indicating an 'expanding commitment', which slightly overreaches compared to the ground truth’s more cautious 'stable strategic focus'—but this does not materially misrepresent the data. Overall, the answer is semantically equivalent, contextually precise, and demonstrates sound multi-hop reasoning across three years of filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 396,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "Altria’s corporate hierarchy has not changed – UST LLC (through its wholly‑owned subsidiary U.S. Smokeless Tobacco Company LLC) has been listed as a **wholly‑owned subsidiary** in every filing. The 2023 Form 10‑K notes that “our wholly‑owned subsidiaries included … UST LLC … engaged in the manufacture and sale of moist‑smokeless‑tobacco products” (page 60), and the 2024 filing repeats the same description, placing UST under the “oral tobacco products” segment (“UST LLC … is engaged in the manufacture and sale of MST products”) (page 4). Because Altria has kept UST fully owned and positioned it within the dedicated oral‑tobacco segment, the company is signaling that smokeless tobacco remains a core, strategically‑controlled growth platform in its transition to reduced‑risk products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: UST remained a wholly owned subsidiary of Altria throughout 2022–2024, consistently engaged in moist smokeless tobacco (MST) products. The LLM correctly identifies UST's placement under the 'oral tobacco products' segment in 2024 and references accurate excerpts from the 2023 and 2024 10-K filings. (2) There are no numeric values in the LLM answer, but the ground truth mentions a $8.8 billion trademark valuation in 2022 and amortization expenses—details the LLM omits. This is a minor omission affecting completeness but not core correctness. (3) The multi-hop reasoning is sound: the LLM synthesizes UST’s consistent ownership and structural positioning across years and correctly infers Altria’s strategic intent to use UST as a controlled platform for reduced-risk products. It captures the evolution in emphasis, even without explicitly citing the 'Moving Beyond Smoking' initiative by name. (4) The answer is contextually excellent—directly addressing both organizational structure and strategic positioning. The omission of the $8.8B trademark value and the specific initiative name slightly reduces qualitative completeness, but the core strategic interpretation remains valid. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 391,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "Tesla’s 10‑K filings for 2022, 2023 and 2024 all list the “One Hundred‑and‑Sixteenth Supplemental Indenture … related to SolarCity’s 5.45 % Solar Bonds, Series 2015/C92‑15” as an exhibit 【page_102†L9-L12】【page_105†L1-L3】.  By repeatedly disclosing this same bond series, Tesla shows that the 2015 SolarCity debt remains outstanding and is being used as a long‑term, fixed‑rate financing source for its solar‑energy operations, indicating a strategy of funding solar growth through legacy bond obligations rather than relying solely on new equity or short‑term capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the bond name (SolarCity 5.45% Solar Bonds, Series 2015/C92-15), the repeated mention across 2022–2024 filings, and the reference to the 'One Hundred-and-Sixteenth Supplemental Indenture' dated August 24, 2015, are all correctly stated. The percentage (5.45%) and year (2015) are accurate. (2) Quantitative accuracy is perfect—no calculations were required, but all numeric and date references match the original. (3) The reasoning is sound: the LLM correctly infers that Tesla’s repeated disclosure indicates the bond remains outstanding and is part of a long-term financing strategy. It appropriately concludes that Tesla is using legacy debt rather than new equity or short-term capital, which is a valid interpretation of the evidence. (4) The answer is contextually relevant and directly addresses the question about Tesla’s long-term financing strategy. The only minor shortcoming is that it does not explicitly mention 'structured solar financing mechanisms' or 'securitized solar debt'—key terms in the original that reflect deeper financial structuring—but the core idea of relying on long-term bond financing is clearly conveyed. Thus, while slightly less detailed in financial terminology, the LLM captures the essential meaning and logic, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 383,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "In the 2022 filing IBM first disclosed that the value of its debt securities could be affected by “governmental and **stock‑exchange regulations**” together with interest‑rate, currency‑ and redemption‑feature risks【page_22】. The 2023 report retained the same capital‑markets risk narrative in its “Financing and Capital Markets Activities” section, indicating that the company still regarded exchange‑rule changes as a material exposure【page_10】, and the 2024 filing again highlighted that both its debt and its common‑stock issuances are subject to “governmental and **stock‑exchange regulations**”【page_11】. This three‑year continuity shows that IBM consistently monitors and publicly acknowledges regulatory risk in the securities markets, reflecting a deliberate, ongoing capital‑market risk‑management strategy that treats stock‑exchange rule changes as a persistent factor in its financing and equity‑issuance decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM's exposure to stock exchange regulations is consistently reported from 2022 to 2024, with accurate references to debt and equity securities being subject to governmental and stock-exchange regulations. The citations (e.g., page numbers) support the claims, though exact page numbers are not part of the ground truth verification and are treated as implementation details. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings, identifying continuity in risk disclosure and interpreting it as a consistent risk management posture. The only minor gap is that the LLM emphasizes IBM's 'deliberate, ongoing strategy' and 'monitoring,' which slightly reframes the ground truth's conclusion that there was 'no material reduction in dependency or mitigation strategy'—implying passivity rather than proactive management. This is a subtle interpretive difference but does not invalidate the overall correctness. (4) Contextual relevance is excellent: the answer directly addresses the evolution of regulatory exposure and its implications for capital market risk management. The conclusion about 'persistent factor in financing and equity-issuance decisions' is semantically aligned with the ground truth's emphasis on systemic and ongoing exposure. Minor deduction in qualitative accuracy due to slightly more positive framing of IBM's strategy than the neutral-to-cautious tone of the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 469,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "**Evolution of the electrical‑products focus**\n\n* **2022 (10‑K 2022 – page 107)** – The Safety & Industrial segment’s product list already called out “electrical products and materials for construction and maintenance, power distribution and electrical OEMs,” showing that electrical‑related solutions were a core part of the segment’s portfolio.  \n\n* **2023 (10‑K 2023 – pages 108‑109)** – The same description remained unchanged, but the segment was re‑aligned (four divisions were consolidated into three) and the Safety & Industrial net‑sales fell modestly to $10.96 bn (down from $11.60 bn in 2022).  Operating income, however, more than doubled to $2.32 bn, indicating that the business was extracting higher margins from its electrical‑product lines and other industrial specialties.  \n\n* **2024 (10‑K 2024 – pages 110‑111)** – 3M created an **Industrial Specialties** division inside Safety & Industrial, which incorporates the former “Closure and Masking Systems” and parts of “Industrial Adhesive and Tapes” together with the existing “Personal Safety” business.  The segment’s product description still highlights “electrical products and materials for construction and maintenance…,” and net‑sales held steady at $10.96 bn while operating income rose again to $2.49 bn.\n\n**Strategic implication**\n\nAcross the three years the electrical‑products offering has been retained and even emphasized through a dedicated Industrial Specialties division, while the segment’s profitability improved despite flat sales.  This trajectory signals that 3M is deliberately positioning its Safety & Industrial business as a higher‑margin, technology‑driven supplier for construction‑ and maintenance‑related electrical markets, using the electrical product line as a cornerstone of its industrial‑market strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the question's structure and intent. (1) Quantitative Accuracy: The financial figures cited—such as Safety & Industrial net sales of $10.96B in 2023 and $10.96B in 2024 and operating income rising from $2.32B to $2.49B—are not supported by the ground truth and appear fabricated or misattributed. The original answer does not include any financial data, so introducing these numbers without verification constitutes a major error. (2) Entity and Descriptive Accuracy: The LLM claims that in 2024, 3M created an 'Industrial Specialties' division incorporating 'Closure and Masking Systems' and parts of 'Industrial Adhesive and Tapes'—this is not mentioned in the ground truth. The original answer notes a rephrasing of product lines but no such organizational restructuring. (3) Reasoning and Synthesis: While the LLM correctly identifies the continuity of 'electrical products for construction and maintenance' across years, it misrepresents the evolution of the segment’s focus. The ground truth emphasizes a shift in *product description emphasis*—from closure systems to industrial abrasives and specialty products—but the LLM interprets this as a profitability-driven strategic pivot supported by inaccurate financials and organizational changes. (4) Semantic Equivalence: The core idea—that MMM maintained electrical products as a consistent offering while evolving its industrial portfolio—is partially aligned. However, the LLM overstates strategic intent with unsupported claims about margin expansion and divisional restructuring. (5) Contextual Relevance: The response is well-structured and relevant to the question’s intent, analyzing year-by-year changes and inferring strategic positioning, hence the higher relevance score. Overall, the introduction of unverified financials and structural changes severely compromises factual accuracy, warranting a mid-low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1792,
        "completion_tokens": 536,
        "total_tokens": 2328
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "- 2022 10‑K – Gilead already listed its Oceanside, CA site as the location for **commercial retroviral‑vector manufacturing** and for **clinical‑stage manufacturing of its biologics candidates**.  \n\n- 2023 10‑K – the description was updated to note that the Oceanside plant is used for **commercial retroviral‑vector manufacturing and for clinical manufacturing and process‑development of its biologics candidates**, emphasizing the added process‑development role.  \n\n- 2024 10‑K – the same wording is retained, confirming that the facility continues to support **commercial retroviral‑vector production while also handling clinical manufacturing and process‑development of biologics**, showing a steady‑state but expanded capability from 2022 through 2024.  ",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in the timeline and evolution of GILD's Oceanside facility, despite using a seemingly structured format. (1) According to the ground truth, in 2022 the facility was part of a broader R&D footprint and was not yet designated for commercial retroviral-vector manufacturing. However, the LLM incorrectly states that commercial retroviral-vector manufacturing was already occurring in 2022, which contradicts the original answer. (2) The LLM claims the 2023 update added 'process development' as a new role, but the ground truth indicates that by 2023 the site was highlighted for clinical manufacturing and process development of biologics — implying an evolution from earlier general R&D, not a direct addition from a more limited commercial role. (3) The LLM asserts that the 2024 description is unchanged from 2023, characterizing it as a 'steady-state' with 'expanded capability from 2022', but the ground truth shows a clear strategic progression: from general R&D (2022) to clinical/process development focus (2023) to dedicated commercial retroviral vector manufacturing (2024). Thus, the LLM reverses the correct sequence of capability development. (4) While the entities (GILD, Oceanside, CA, biologics, retroviral vectors) and years are correctly identified, and the descriptions resemble actual 10-K language, the multi-hop reasoning is flawed — the model fails to correctly synthesize the chronological evolution of the facility’s role. The qualitative inaccuracy undermines the overall correctness, even though the terminology and structure appear plausible. Quantitative accuracy is high because there are no numerical values to assess, and the dates themselves are referenced in the correct order; the issue lies in the attribution of capabilities to those years. Contextual relevance is strong as the response directly addresses the question’s focus on biologics and retroviral vectors over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 527,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "- **2022:** The glide‑path target for the “Return‑Seeking” (growth) portion was **15 % equity securities** (with 75 % fixed‑maturity and 10 % other investments)【page_310】.  \n- **2023:** The next year’s target remained **15 % equity securities** (71 % fixed‑maturity, 14 % other)【page_252】.  \n- **2024:** The target was lowered to **9 % equity securities** (80 % fixed‑maturity, 11 % other)【page_182】.  \n\n**Evolution:** AIG’s glide‑path approach gradually reduced the allocation to growth assets as the plan’s funded status improved—holding the return‑seeking allocation steady at 15 % in 2022‑23, then cutting it to 9 % by 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that AIG's glide path approach evolved in a forward-looking manner, with target allocations for the Return-Seeking portion being set based on future funded status (e.g., 2023 target set for 2024 based on Dec 31, 2023 funded status), but the LLM instead provides specific percentage allocations (15%, 15%, 9%) that are not present in the original answer and contradict the nature of the glide path described. There is no mention in the ground truth of specific equity percentages like 15% or 9%, nor any breakdown into fixed-maturity or other investments. (2) The numbers cited (15%, 9%, etc.) are entirely fabricated from the model’s perspective, as the original answer contains no such figures. This results in severe quantitative inaccuracy. (3) The multi-hop reasoning is flawed: the model fails to recognize that the evolution lies in the *methodology* of setting targets (forward-looking, dynamic adjustment based on funded status), not in changing percentage allocations. It misinterprets the question as asking for numerical shifts in asset classes rather than the strategic evolution of the glide path. (4) While the LLM attempts to address the time progression (2022–2024) and mentions a reduction in growth assets, which shows some contextual understanding, the core factual content is incorrect. The answer invents data not present in the ground truth and misses the actual conceptual evolution. Hence, low scores on correctness, quantitative, and qualitative accuracy; moderate score on contextual relevance for structure and attempt.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 455,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "ACN’s defined‑benefit pension‑plan targets moved noticeably between fiscal 2023 and fiscal 2025. In 2023 the non‑U.S. plans were weighted 27 % to equity, 48 % to debt, 4 % to cash, 11 % to insurance contracts and 10 % to “other” assets (U.S. plans remained 100 % debt)【page_88】. By 2025 the company was targeting 28 % equity, 36 % debt, 7 % cash, 21 % insurance contracts and 8 % other (U.S. plans still 100 % debt)【page_95】. The shift toward more equity and insurance‑contract exposure and away from debt suggests ACN is willing to accept a higher level of market risk over the long term in order to pursue greater returns, while still keeping a very conservative stance for its U.S.‑only assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the percentages provided (e.g., 27% equity, 48% debt for non-U.S. plans in 2023; 28% equity, 36% debt in 2025) are not supported by the ground truth, which does not specify exact allocation percentages or mention U.S. plans being 100% debt. There is no mention in the original answer of such detailed breakdowns by asset class or differences between U.S. and non-U.S. plans. The cited page numbers (88, 95) may refer to actual data, but the LLM misrepresents the nature of the disclosed information, which focuses on strategy and planning horizon, not specific allocations. (2) The calculation of shifts (e.g., increase in equity from 27% to 28%) is spurious because these numbers are not present in the ground truth. (3) Qualitatively, the LLM mischaracterizes the evolution: the original answer emphasizes a shift in planning horizon (from one-year to two-year forward targeting) and continued emphasis on flexibility and risk-adjusted returns, not a material shift toward higher-risk assets like equities or insurance contracts. The conclusion that ACN is accepting 'higher market risk' contradicts the ground truth’s characterization of a 'measured, stable approach to risk.' (4) Contextually, the answer addresses the question of asset allocation evolution and risk tolerance, but does so with fabricated data and flawed reasoning, making it misleading despite surface plausibility. The multi-hop synthesis failed: instead of analyzing strategic planning horizon changes, it focused on non-existent granular allocation shifts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 444,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "Tesla’s 5.45 % Solar Bonds, Series 2015/C25‑15 were first created in a supplemental indenture dated April 14 2015 (see the “Thirty‑Sixth Supplemental Indenture” entry) and the same series continues to appear in the company’s exhibit listings in the 2022, 2023 and 2024 Form 10‑K filings (e.g., listed on the exhibit tables for each year – see the 2022 filing tables that include the C25‑15 bond 【page_99†L13-L16】 and the 2024 filing tables that repeat the same series 【page_100†L27-L30】).  \n\nThe fact that this 5.45 % bond series is disclosed year after year shows that Tesla has retained the 2015‑issued solar‑bond tranche on its balance sheet, using a long‑dated, fixed‑rate senior debt instrument to fund solar‑related assets and to lock in inexpensive financing over multiple years. This multi‑year continuity signals a deliberate strategy of relying on stable, long‑term bond financing rather than repeatedly issuing new short‑term instruments for its solar business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the 5.45% Solar Bonds, Series 2015/C25-15, were indeed established in 2015 (via the Thirty-Sixth Supplemental Indenture on April 14, 2015), and the bond series is consistently disclosed in Tesla’s 10-K filings for 2022, 2023, and 2024. The specific exhibit table references (e.g., page_99†L13-L16 in 2022, page_100†L27-L30 in 2024) support the claim of ongoing disclosure. (2) Quantitative accuracy is perfect: the interest rate (5.45%), series designation (C25-15), and dates (2015 issuance, 2022–2024 disclosures) are all factually correct. (3) The multi-hop reasoning is sound: the model correctly infers from repeated disclosure that Tesla continues to rely on this bond series, linking it to a broader strategy of long-term, fixed-rate financing for solar assets. While the original answer emphasizes the evolution across years and mentions newer bond series (e.g., C28-15, C33-15), the LLM answer focuses more on the persistence of C25-15 rather than the expansion of the financing framework. This is a minor omission in completeness but does not detract significantly from the overall correctness. (4) The conclusion about Tesla’s strategy—using long-dated, fixed-rate debt to secure stable, low-cost financing—is semantically equivalent to the ground truth’s interpretation of ‘ongoing reliance’ and ‘integral to its solar deployment strategy.’ The answer is contextually excellent, directly addressing the evolution and strategic implication. Minor deduction in qualitative accuracy due to less emphasis on the broader bond portfolio evolution, but core reasoning remains strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 461,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "By the 2022 filing AIG quantified its biggest terrorism scenario – a five‑ton bomb in New York – as a $1.3 billion net loss (after the Terrorism Risk Insurance Program Reauthorization Act (TRIPRA) and reinsurance recoveries) with a $1.7 billion deductible and 80 % of losses above that deductible covered by TRIPRA; the company also noted “targeted reinsurance purchases” and reliance on foreign terrorism pools. The 2023 filing dropped the specific dollar‑loss figure and instead emphasized ongoing scenario‑based modeling, continued use of TRIPRA for U.S. exposure, limited private reinsurance, and targeted reinsurance purchases and pool participation for other jurisdictions. In the 2024 filing the same modeling‑and‑pool framework is retained, but AIG now references more granular reinsurance structures – e.g., core attachment points of $200 million for Japan and $125 million for the rest of the world – indicating a shift toward refined, jurisdiction‑specific reinsurance limits while still relying on TRIPRA, private reinsurance and government‑sponsored terrorism pools to mitigate international terrorism risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key numbers are correct: the $1.3 billion net loss estimate for the 2022 five-ton bomb scenario is accurately reported, and the 2024 reinsurance attachment points of $200 million for Japan and $125 million for the rest of the world are correctly stated (though the ground truth only explicitly confirms the $200 million for Japan; the $125 million for ROW is plausible but not directly verifiable from the original answer). The absence of a specific loss figure in 2023 is correctly noted. (2) The LLM correctly identifies the evolution across years: from explicit modeled loss in 2022, to emphasis on monitoring and disciplined reinsurance in 2023, to enhanced, jurisdiction-specific reinsurance structures in 2024. (3) The multi-hop reasoning is sound—synthesizing changes in modeling, reinsurance strategy, and risk mitigation across three years and multiple jurisdictions. (4) The LLM adds slightly more detail (e.g., $1.7B deductible, 80% TRIPRA coverage) not present in the ground truth; however, these are consistent with AIG’s known risk structure and do not contradict the original answer. The core evolution—scenario modeling, pool reliance, and reinsurance scaling—is accurately conveyed. The only minor gap is that the ground truth mentions $38.0 billion in reinsurance recoverable assets by 2024, which the LLM omits; this is a factual omission but not a major one given the focus on strategy over balance sheet items. Overall, the answer is factually correct, well-structured, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 445,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures show that the company’s exposure to “adverse industry economic conditions” has been a continuous concern for the Safety and Productivity Solutions business – it was first described under the “Industrial Automation” heading in the 2022 filing (“Industrial Automation … adverse industry economic conditions… lower margins” 【page_30】), and the same language re‑appears in the 2023 and 2024 filings under the renamed “Safety and Productivity Solutions” segment (2023 【page_31】; 2024 【page_32】). Across all three years the filing consistently flags the same margin‑pressuring risks: reduced customer investment in process automation, safety monitoring and plant‑capacity initiatives; a slowdown in demand for safety products; fluctuations in retail markets; a more competitive landscape with new entrants and technologies that can commoditize products; and the resulting pressure on market share, selling prices and margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key risks are correctly identified: reduced investments in process automation, retail market fluctuations, product commoditization due to new entrants and technologies, and resulting pressures on selling prices, market share, and margins. These are consistently reported across 2022–2024, matching the original answer. (2) Quantitative accuracy is perfect: no numerical errors, and the timeline (2022–2024) is correctly referenced with appropriate segment naming evolution (Industrial Automation to Safety and Productivity Solutions). The page citations (though not part of the ground truth evaluation) do not affect factual correctness. (3) Multi-hop reasoning is sound: the LLM correctly tracks the segment’s risk exposure across years and filings, noting both continuity in risk language and the rebranding/restructuring of the segment. The only minor shortcoming is that the original answer emphasizes the 2024 shift to the 'restructured Industrial Automation segment' as part of Safety and Productivity Solutions, while the LLM states that the risk language appears under 'Safety and Productivity Solutions' in 2023 and 2024 — slightly oversimplifying the structural change. However, this does not distort the core factual continuity. (4) The answer is contextually excellent, directly addressing both parts of the question: evolution of exposure and specific recurring risks. Wording differs but semantic meaning is equivalent. Minor deduction in qualitative accuracy due to slight imprecision in describing the segment name transition, but overall reasoning and synthesis remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 455,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "From 2022 through 2023 Pfizer continued to grant Breakthrough Performance Awards – the 2022 table shows $11.7 million of fair‑value shares vested (intrinsic value $1.13 billion) with $255 million of compensation cost recognized, while 2023 shows a modest decline to $10.7 million fair‑value vested (intrinsic $755 million) and $244 million of cost. In 2024 the company stopped issuing BPAs altogether (the 2024 filing states “No BPAs were granted in 2024 and no BPAs were outstanding as of December 31, 2024”), leaving only residual expense from prior awards. Throughout the period the awards were valued using the intrinsic‑value method based on the closing price of Pfizer’s common stock and were recognized by straight‑line amortization over the probable vesting term into cost‑of‑sales, SG&A and R&D, with periodic adjustments for share price and performance‑probability changes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. (1) In 2022, the ground truth states Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, but the LLM incorrectly reports $1.13 billion intrinsic value of vested shares and $11.7 million fair-value shares vested—these figures are not supported by the original data and appear fabricated. (2) The LLM claims 2023 had $10.7 million fair-value vested and $755 million intrinsic value, but the ground truth explicitly states no BPAs were granted and none were outstanding as of December 31, 2023—meaning no vesting or compensation activity should be reported for 2023. (3) The LLM incorrectly attributes the 'no grants, no outstanding' statement to 2024, while the ground truth confirms this status as of 2023, indicating the program was already wound down by then. (4) While the LLM correctly identifies the intrinsic value method and amortization over the probable vesting term with adjustments for stock price and performance probabilities, this description is attributed to the 2024 period in the original answer as a retrospective explanation, not as an ongoing practice through 2022–2023. (5) The reasoning is flawed: it suggests continued grant and vesting activity in 2023 when there was none, fails to recognize the complete termination of the program by 2023, and misplaces the timeline of disclosures. Although the answer addresses all question components (grant activity, valuation, recognition), the core facts are incorrect, especially the numerical data and timeline. The contextual relevance is moderate because the structure and intent align with the question, but the factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 473,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "In fiscal 2022 Accenture bought roughly 12.2 million Class A shares for about $4.1 billion and, after those purchases, had $3.13 billion of “available” authorization left (the board later raised total outstanding authority to $6.13 billion)【page_94】. By the end of fiscal 2024 the company had repurchased another 2.07 million shares in Q4 (about $0.6 billion) and, after several years of buy‑backs, the remaining pool of author‑ized cash was $2.69 billion, even though the board increased total outstanding authority to $6.69 billion【page_39】【page_40】. The shrinking “available” balance together with periodic increases in total authority shows Accenture is consistently using its share‑repurchase program to return cash to shareholders while preserving enough capacity to continue the strategy in future periods.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its portrayal of Accenture's share repurchase activity and capital return strategy, but contains some inaccuracies in the quantitative details. The ground truth states that in fiscal 2022, Accenture had $3,129,296,000 (~$3.13 billion) in available authorization — this matches the LLM's figure of $3.13 billion, so that is accurate. However, the LLM claims Accenture bought $4.1 billion in shares in fiscal 2022, which is not supported by the ground truth; the original answer does not specify repurchase volume for 2022, only the remaining authorization. This $4.1 billion figure appears to be an addition from the model, possibly inferred or misread. Similarly, the LLM mentions repurchasing 2.07 million shares in Q4 of fiscal 2024 for $0.6 billion — this level of granularity is not in the ground truth and introduces unverified specifics. The remaining authorization of $2.69 billion as of August 31, 2024, and the new $4 billion increase bringing total outstanding authority to $6.69 billion are correctly reported (2.694B + 4B = 6.694B ≈ $6.69B). (2) The calculation of the new total authorization is accurate, but the model incorrectly implies that the $6.13 billion was a prior increase (saying 'the board later raised total outstanding authority to $6.13 billion'), which is not in the original answer and conflicts with the final $6.69 billion figure. This suggests a miscalibration in tracking the sequence of authorizations. (3) The multi-hop reasoning is sound: the model correctly infers that ongoing repurchases reduce available authorization and that periodic replenishment reflects a sustained capital return strategy. It synthesizes the trend across years and draws a valid conclusion about strategic intent. (4) Despite introducing unsupported specifics (like $4.1B spent in 2022 and Q4 2024 repurchase details), the core narrative — decreasing available authorization offset by new grants, indicating a consistent capital return strategy — aligns with the ground truth. Hence, the answer is qualitatively strong and contextually relevant, but penalized on quantitative accuracy due to unverified figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 583,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "- In the 2022 Form 10‑K Pfizer still reported Meridian’s pre‑sale results as discontinued operations and booked a $167 million after‑tax loss on the sale (plus a $345 million pre‑tax legal charge), while disclosing that interim transition‑service agreements (TSAs) and a three‑year Manufacturing‑Supply Agreement (MSA) had been executed with the buyer to govern post‑sale interactions.  \n\n- The 2023 filing notes that the TSAs were completed as of 31 Dec 2023 and that the MSA remains in effect for a three‑year term (with a two‑year extension option), but the amounts recorded under those arrangements are immaterial.  \n\n- By the 2024 Form 10‑K Meridian is treated only as a divested entity; no material financial impact or ongoing operational agreements are disclosed, indicating that the strategic alignment between Pfizer and Meridian has effectively ended.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key timeline and nature of Pfizer's relationship with Meridian, noting discontinued operations in 2022, ongoing agreements in 2023, and no active relationship in 2024. However, there are significant quantitative inaccuracies. The ground truth states the divestiture was completed on December 31, 2021 (not 2022), and the $167 million loss was net of tax — the LLM correctly notes it as after-tax but incorrectly implies it was recorded in 2022, when the sale had already occurred in 2021. Additionally, the LLM introduces a $345 million pre-tax legal charge not mentioned in the ground truth, which is factually unsupported. (2) The mention of interim transition-service agreements (TSAs) and a Manufacturing-Supply Agreement (MSA) is plausible post-divestiture detail but not present in the original answer; while not necessarily false, it introduces unverified specifics. The claim that TSAs were completed as of December 31, 2023, and that the MSA has a two-year extension option, lacks corroboration in the ground truth, which only confirms Meridian’s status as a divested entity with no active financial or operational ties. (3) The multi-hop reasoning is partially sound — the LLM tracks the evolution across years and correctly infers diminishing ties — but overreaches by adding operational details not in the source. It correctly concludes no strategic alignment remains by 2024, aligning with the ground truth. (4) The contextual relevance is perfect — the answer directly addresses financial disclosures, operational agreements, and strategic alignment over time. However, the introduction of unsupported financial figures and agreements reduces quantitative accuracy. The core narrative is accurate but padded with potentially misleading specifics, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 502,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "The Amended 2010 Share Incentive Plan authorized **127 million** Accenture Class A ordinary shares for awards in fiscal 2022 (and the same ceiling was still reported in the 2023 filing). By fiscal 2024 the ceiling had been raised to **141 million** shares. This upward adjustment shows that Accenture is deliberately expanding the pool of shares it can use for stock‑based awards, underscoring a long‑term strategy to rely more heavily on equity compensation to attract, retain and motivate talent while aligning employee interests with shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a factual error in the timeline of share authorization. According to the ground truth, the number increased to 141,000,000 in both fiscal years 2023 and 2024, but the LLM states that the 127 million ceiling was still reported in the 2023 filing and only raised by fiscal 2024. This misrepresents the timing of the increase, implying it occurred between 2023 and 2024 rather than between 2022 and 2023. (2) Quantitatively, the share numbers (127 million and 141 million) are correct in value and format, but the assignment to fiscal years is inaccurate. The increase should have been reflected in 2023, not delayed until 2024. This affects the correctness of the progression narrative. (3) The multi-hop reasoning is partially sound—the LLM correctly infers strategic intent behind increasing share authorizations and links it to talent retention and alignment with shareholders. However, because the timing of the increase is wrong, the synthesis across years is flawed. (4) Despite the timeline error, the answer is contextually relevant and captures the broader strategic implication accurately. The explanation of long-term equity compensation strategy aligns with the ground truth. The quantitative accuracy is penalized due to incorrect period attribution, even though the raw numbers are correct. Hence, correctness is scored at 7 for core facts being mostly right but with a significant temporal error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 401,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "Tesla’s 10‑K filings for 2022, 2023 and 2024 all contain the same exhibit description for the 4.70 % Solar Bonds, Series 2015/C52‑10 – “Seventieth Supplemental Indenture, dated as of June 16, 2015, by and between SolarCity and the Trustee” 【page_101】. The wording, series identifier and filing date are unchanged in each year’s exhibit list, showing that the bond remains an outstanding obligation and that Tesla continues to disclose it in the same manner across successive reports 【page_104】. This consistency signals that the company’s commitment to servicing the 2015 solar‑bond series is ongoing and that the bonds remain a material component of its financing strategy, even though no new amendments or material changes to the terms are reported.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the bond series (4.70% Solar Bonds, Series 2015/C52-10), the document name (Seventieth Supplemental Indenture), the date (June 16, 2015), and the consistent re-disclosure across 2022–2024 are all accurately reported. The LLM correctly notes that the exhibit description remains unchanged across years, which matches the ground truth. (2) Quantitative accuracy is perfect: percentages, dates, and exhibit references (though not explicitly listing exhibit numbers like 4.49, 4.42, 4.40) are contextually correct. The omission of specific exhibit numbers is a minor detail but does not affect factual correctness, as the core document and date are right. (3) Reasoning is sound: the LLM correctly infers that the unchanged disclosures imply ongoing obligations and stable strategic priorities regarding solar financing, which is a valid conclusion from the pattern of re-disclosure. (4) The answer is contextually relevant and fully addresses both parts of the question—disclosure changes (or lack thereof) and implications for obligations/strategy. The only reason for not scoring a 10 is the slight lack of specificity around exhibit numbers across years, which were included in the ground truth and could have strengthened completeness. However, this does not undermine the overall correctness or interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 391,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "- **2022:** Adobe’s 10‑K described its Digital Learning Services as a “training portfolio” that included “a large number of free online self‑service learning options on **www.training.adobe.com**” together with fee‑based classroom, virtual and on‑demand programs and custom‑learning services for large enterprises【page_17】.  \n\n- **2024:** The same free catalog was moved to **learning.adobe.com** and was still framed as the “core” of Adobe’s learning‑and‑enablement suite – a free tier that sits alongside an extensive fee‑based program and bespoke custom‑learning services【page_18】.  The filing now emphasizes that these self‑service resources are a primary “Getting Started” tool that helps customers quickly adopt Adobe solutions and accelerate solution‑adoption outcomes【page_17】.  \n\n**Evolution:** The free self‑service offering was re‑branded from www.training.adobe.com to learning.adobe.com and was more tightly integrated into Adobe’s overall Digital Learning Services portfolio, serving as the front‑line, low‑cost entry point that supports broader fee‑based and custom learning programs and is explicitly positioned to drive faster customer adoption of Adobe’s cloud products.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in factual content and aligns well with the ground truth, but contains a minor inaccuracy regarding the timeline of the domain change and omits specific mention of 2023, which weakens the multi-year evolution analysis. Quantitatively, all dates (2022, 2024) and URLs (www.training.adobe.com, learning.adobe.com) are accurate, and there are no numerical errors. The entity identification (Adobe, Digital Learning Services, self-service offerings) is correct. The reasoning correctly identifies the strategic role of free self-service learning as a core, scalable component that supports fee-based and custom programs and drives customer adoption. However, the LLM implies the move from training.adobe.com to learning.adobe.com occurred by 2024, but the ground truth indicates the learning.adobe.com platform was already in use by 2023, meaning the transition likely occurred earlier than implied. Additionally, the LLM skips 2023 entirely, missing the continuity emphasized in the original answer—specifically that the offering remained central and was linked to both Digital Experience and Digital Media products in that year. This omission reduces completeness and slightly distorts the evolution narrative. Despite this, the core strategic positioning and evolution toward being a 'front-line' adoption tool are semantically equivalent to the ground truth. The answer is highly relevant to the question and synthesizes key aspects of Adobe’s learning strategy, but the lack of 2023 detail and slight misalignment in the rebranding timeline prevent a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 435,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "AIG’s glide‑path framework gradually reduced the “return‑seeking” (growth) slice of the U.S. qualified plan as the plan became better funded. In the 2022 target allocation the glide path called for 15 % of assets in equity securities (the growth component) with 75 % in fixed‑maturity securities and 10 % in other investments 【page_310】. By the 2024 target the equity portion had been cut to 9 % while the fixed‑maturity share rose to 80 % and “other” assets to 11 %, reflecting a shift toward more liability‑hedging assets as the funded ratio improved 【page_252】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of quantitative accuracy. It provides specific percentages for equity, fixed-maturity, and other investments in 2022 and 2024 (e.g., 15% equity in 2022, 9% in 2024), but the ground truth explicitly states that 'the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts.' Therefore, any numerical breakdown is fabricated and not supported by the source material. (2) The calculation and comparison of percentages (e.g., reduction from 15% to 9%) are entirely invalid because the original data does not contain these figures. The cited pages (310 and 252) may discuss allocations, but according to the ground truth, they do not provide the exact numbers claimed. (3) The qualitative reasoning about the glide path mechanism—de-risking by reducing return-seeking assets as funded status improves—is conceptually aligned with AIG’s strategy and reflects correct multi-hop understanding of how pension glide paths work. The LLM correctly identifies the directionality of change (shift toward liability-hedging assets) and ties it to funded status improvement, which matches the strategic evolution described in the original answer. (4) Contextually, the answer addresses the core question about evolution in allocation strategy and is relevant in structure and intent. However, the inclusion of precise, unsupported numbers severely undermines factual correctness. While the conceptual framework is sound, the answer fails on factual integrity due to hallucinated data, warranting a low correctness score despite reasonable logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 445,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "Honeywell’s 2022 Form 10‑K noted that only about **63 % of the raw‑material supply base for its Performance Materials and Technologies (PM&T) segment was under contract** and warned that “inflationary trends in the cost of raw materials… and supply‑chain constraints” could raise costs (2022 p. 33). By the 2023 filing the contracted share had risen modestly to **≈64 %**, but the company still highlighted “raw‑material price fluctuations, inflation, and the ability of key suppliers to meet quality and delivery requirements” as a key operational risk for PM&T (2023 p. 31). The 2024 filing, after PM&T was folded into Energy and Sustainability Solutions, said a **majority of the raw‑material supply base is now under contract** (2024 p. 31) and reiterated that price volatility of commodities such as copper, fluorspar, tungsten salts, ethylene, aluminum and molybdenum remains a risk (2024 p. 33).  \n\n**Trend:** Contract coverage has crept upward from roughly two‑thirds to a clear majority, reducing the segment’s exposure to supply‑shortage risk, but the persistent emphasis on raw‑material price volatility shows that Honeywell remains vulnerable to commodity‑market swings, especially for the specific metals and chemicals that dominate the PM&T portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a detailed and largely accurate response but introduces specific quantitative claims not present in the original ground truth, which undermines full factual correctness. (1) The ground truth does not mention the percentage of contracted raw-material suppliers (63%, 64%, majority) or cite specific page numbers (e.g., 2022 p. 33), so these figures, while plausible, cannot be verified and appear to be hallucinated or sourced beyond the knowledge graph. This significantly affects quantitative accuracy. (2) The LLM correctly identifies the persistence of raw material supply and price risks across 2022–2024 and notes the evolving context—supply chain constraints in 2022, supplier performance and inflation in 2023, and commodity price volatility in 2024—aligning well with the original answer’s narrative. (3) The multi-hop reasoning is sound: the model synthesizes risk themes across years and segments, correctly noting the 2024 reorganization (PM&T folded into Energy and Sustainability Solutions), which is consistent with structural changes at Honeywell. (4) The conclusion about sustained vulnerability to commodity volatility matches the original answer’s interpretation. However, the addition of unverified percentages and contract coverage trends introduces inaccuracies not supported by the ground truth, which focused on qualitative risk framing rather than metrics on supplier contracting. Thus, while the qualitative reasoning and contextual relevance are strong, the quantitative accuracy is reduced due to unsupported numbers. Semantic equivalence is partially maintained, but not fully, due to the introduction of non-grounded data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 456,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "In Accenture’s defined‑benefit pension disclosures, the fair‑value of mutual‑fund equity securities fell from **$239 million in 2022** (Level 1 $4.9 m + Level 2 $234.3 m) to **$196 million in 2023** (Level 1 $7.4 m + Level 2 $188.8 m), then rose to **$274 million in 2024** (Level 1 $20.2 m + Level 2 $253.5 m). The three‑year pattern shows a dip followed by a rebound, indicating a net upward trajectory and suggesting that Accenture is gradually increasing its equity exposure—particularly via mutual‑fund holdings—to align with a strategic tilt toward higher‑return equity allocations in its pension‑plan asset mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024. However, the LLM claims the value rose to $274 million in 2024, which is factually incorrect. The LLM also introduces Level 1 and Level 2 breakdowns not present in the original answer and not required by the question, but more critically, these do not align with the known truth. (2) Quantitative accuracy is severely compromised: the 2024 figure is wrong ($274M vs correct $196.226M), and the trend is misrepresented (increase vs actual stability). Even rounding $239.293M to $239M and $196.226M to $196M is acceptable, but the $274M figure has no basis. Calculations or trends derived from these numbers are therefore invalid. (3) The multi-hop reasoning is flawed: the model correctly identifies the decrease from 2022 to 2023 but fails on the 2023–2024 comparison, leading to an incorrect strategic interpretation. Instead of indicating stabilization, the LLM infers a rebound and increasing equity exposure, which contradicts the ground truth of no change in 2024. This misrepresents the strategic asset allocation conclusion. (4) Contextual relevance is high—the response addresses the evolution over three years and attempts to interpret strategic allocation—but the incorrect data undermines the entire analysis. Due to severe quantitative errors and resulting flawed reasoning, the correctness score is low despite relevant structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 439,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "- **2022 positioning:** In the 2022 filing Adobe described Document Cloud mainly as a “cloud‑based subscription offering that enables complete, reliable and automated digital document and signature workflows across desktop, mobile, web and third‑party enterprise apps” (2022 p. 70).  It was presented as the PDF‑centric component of the Digital Media segment, with revenue reported separately (≈ $1.5 bn) and its value framed around “trillions of PDFs created each year” and the need for “digital‑document productivity” for legal, financial‑services and publishing users.  No AI‑driven features were highlighted.\n\n- **2024 evolution:** By 2024 Adobe repositioned Document Cloud as an AI‑enhanced, enterprise‑workflow platform.  The filing notes that Acrobat now includes an “AI Assistant, our generative‑AI‑powered conversational engine” that can summarize, answer questions, generate citations and create content (2024 p. 13).  Firefly‑powered generative AI is embedded in Acrobat, Acrobat Sign and the Document Cloud APIs, enabling content generation, editing and assembly at scale (2024 p. 12).  The 2024 strategy emphasizes “product‑led growth, AI‑driven intelligence, APIs and diversified go‑to‑market motions” to expand the customer base and unlock business workflows across all industries (2024 p. 5).\n\n**Thus, between 2022 and 2024 Adobe moved Document Cloud from a core PDF‑workflow service to an AI‑infused, API‑ready platform that leverages Firefly generative AI and an AI Assistant to power smarter, end‑to‑end enterprise digital document workflows.**",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the strategic shift of Adobe Document Cloud from a PDF-centric, legacy workflow tool in 2022 to an AI-enhanced enterprise platform by 2024. The absence of AI features in 2022 and the integration of Firefly and the AI Assistant in 2024 are accurately reported. (2) Quantitative details such as the ~$1.5 billion revenue figure (though not in the original answer, it is consistent with external data and not contradicted by the ground truth) and specific page citations (2022 p.70, 2024 pp.12–13) are correctly referenced. No calculations were required, and all dates (2022, 2024) match the scope of the question. (3) The multi-hop reasoning is sound: the LLM synthesizes Document Cloud’s changing role across years, links it to AI integration (Firefly, AI Assistant), and contextualizes its evolving role in enterprise workflows. The only minor gap is the lack of explicit mention of the 2023 transition year—where Document Cloud was elevated within the Digital Media segment—which the ground truth includes as a key inflection point. However, the LLM bridges 2022 and 2024 effectively, capturing the essence of the transformation. (4) The answer is semantically equivalent to the original, with slightly more granular detail (e.g., specific AI Assistant capabilities, API integration), enhancing clarity without introducing error. The conclusion accurately summarizes the strategic evolution. Thus, the answer is excellent, missing only a small nuance around the 2023 repositioning, which prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1654,
        "completion_tokens": 440,
        "total_tokens": 2094
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures show a steady‑but‑growing concern that each of its reportable segments could lose market share and pricing power as new entrants and disruptive technologies proliferate. In the 2022 filing (Risk Factors, page 31) the company already warned that “new entrants and non‑traditional players” in Aerospace, Industrial Automation (then Safety & Productivity Solutions), Building Automation and Energy & Sustainability could lead to product commoditization, lower market share and reduced selling prices. The 2023 filing (Risk Factors, page 30) repeats the same threats and adds that the “ever‑expanding number of competitors” intensifies the risk of margin erosion, while the 2024 filing (Risk Factors, page 32) restates the exposure for the newly‑named segments (Aerospace, Building Technologies, Performance Materials & Technologies, Safety & Productivity) and explicitly links new market entrants and emerging technologies to “lower market share, reduced selling prices and lower margins,” indicating that the competitive‑landscape risk has remained a core concern and has become more pronounced after the segment realignment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Honeywell's increasing concern about competitive pressures from 2022 to 2024, the segments affected (Aerospace, Building Technologies, Safety & Productivity Solutions, Industrial Automation, Performance Materials & Technologies), and the consistent risks of lower market share, reduced pricing power, and margin erosion due to new entrants and technological disruption. The LLM correctly identifies the evolution across years and the impact of segment realignment in 2024. (2) Quantitative accuracy is perfect: years (2022, 2023, 2024) are correctly cited, and page numbers (31, 30, 32) match typical 10-K structures (minor page variations across filings are acceptable and do not affect correctness). No numerical calculations are required, and all references to financial impacts are qualitative and consistent with the original. (3) Multi-hop reasoning is sound: the LLM synthesizes disclosures across three years and maps evolving segment names (e.g., Safety & Productivity Solutions to new structure), showing awareness of reorganization. It correctly notes that the risk was expanded over time and remained a persistent theme. (4) The only minor shortcoming is that the original answer emphasizes the *progression* of risk expansion—specifically naming which segments were added each year (e.g., 2023 adding Performance Materials and Technologies and Aerospace)—while the LLM groups them less sequentially. However, the core insight about broadening exposure and increasing concern is preserved. Wording differences are acceptable under semantic equivalence. Overall, this is a strong, factually correct response with only slight room for improved clarity on the year-over-year segment expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1616,
        "completion_tokens": 490,
        "total_tokens": 2107
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K Pfizer reported that, after the 2020 Upjohn‑Mylan spin‑off that created Viatris, the two companies were still operating under a suite of interim agency, manufacturing‑supply and transition‑service agreements (TSAs).  At year‑end 2022 the net amount Pfizer owed Viatris under those agreements was **$94 million**.  \n\n- The 2023 Form 10‑K shows that the TSAs were “largely completed as of December 31, 2023” and the remaining inter‑company balance fell to **$33 million**.  The amounts recorded in 2023 (and in prior years) were described as not material to Pfizer’s operations.  \n\n- The 2024 Form 10‑K (pages 3‑7) no longer reports a specific Viatris balance; the discussion of the transition‑service arrangements is limited to the definition of “TSAs” and the earlier note that the services were completed.  This indicates that by fiscal 2024 the transition‑service arrangements with Viatris had been wound down and any inter‑company receivable/payable was immaterial (effectively zero).  \n\n**Overall:** Pfizer’s financial relationship with Viatris moved from a $94 million intercompany liability in 2022 to $33 million in 2023 as most TSAs were finished, and by 2024 the transition‑service agreements were essentially concluded with no material balance remaining.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: the $94 million intercompany balance due to Viatris in 2022, the reduction to $33 million in 2023, and the winding down of TSAs by December 31, 2023, with no material balance reported in 2024. The statement that TSAs were 'largely completed' by end of 2023 matches the original answer. (2) Quantitative accuracy is perfect: both dollar amounts and years are correctly reported, with no calculation errors. Format variations (e.g., $94 million vs $94M) are acceptable and do not affect meaning. (3) Multi-hop reasoning is sound—LLM correctly synthesized information across three years of Form 10-K filings, tracking the evolution of both transition service arrangements and intercompany balances. It infers the logical conclusion that by 2024, the relationship was effectively resolved, consistent with the ground truth. (4) Contextual relevance is high: the answer directly addresses both financial (intercompany balances) and operational (TSA status) aspects of the Pfizer-Viatris relationship as requested. Minor additional context (e.g., reference to Upjohn-Mylan spin-off, immateriality) enhances clarity without introducing error. Overall, the answer matches the ground truth in substance, precision, and reasoning depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 375,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "- In the 2022 Form 10‑K the “Securities registered pursuant to Section 12(b)” table listed four series of senior notes – 1.000 % notes due 2023, 1.700 % notes due 2025, 2.200 % notes due 2027 and 3.125 % notes due 2031【page_1】.  \n- By the 2023 and 2024 filings the 1.000 % 2023 notes no longer appear; the register now shows only the 1.700 % notes due 2025 together with the 2.200 % 2027 and 3.125 % 2031 notes【page_1】【page_1】.  \n\nThis shift means Altria retired its shortest‑term 1 % 2023 issue and retained the 1.700 % 2025 issue as the nearest‑maturity debt, creating a laddered portfolio of progressively longer‑dated, low‑coupon notes. The progression reflects a capital‑structure strategy aimed at extending the debt horizon, reducing near‑term refinancing risk, and locking in inexpensive fixed‑rate financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all debt instruments and their maturities in each year—1.000% due 2023, 1.700% due 2025, 2.200% due 2027, and 3.125% due 2031 in 2022; the removal of the 2023 note by 2023 and 2024 filings; and the retention of the 1.700% 2025 note as the shortest-dated instrument. All percentages, years, and sequences are factually accurate and match the ground truth. (2) Quantitative accuracy is perfect: all interest rates and maturity years are correctly reported with no calculation errors. Format variations (e.g., spacing in '1.700 %') do not affect meaning. (3) The multi-hop reasoning is sound—LLM correctly infers that retiring the 2023 note while keeping the 2025 note as the nearest maturity reflects a strategy of extending debt duration and reducing refinancing risk. The conclusion about a 'laddered portfolio' and 'locking in inexpensive fixed-rate financing' is a reasonable interpretation aligned with the ground truth’s emphasis on avoiding short-term rollover. (4) The only minor deviation from the original answer is that the LLM suggests a proactive strategy of 'extending the debt horizon,' while the ground truth emphasizes the absence of a replacement for the 2025 note as evidence of stability rather than active extension. This is a subtle difference in emphasis, not a factual error. Overall, the answer is semantically equivalent, highly relevant, and demonstrates strong synthesis across years and instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 408,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "- **Carrying value:** Fixed‑rate unsecured senior notes grew from about **$24.1 billion at year‑end 2022** to **$27.2 billion at year‑end 2023**, then slipped slightly to **$26.9 billion at year‑end 2024**.  \n- **Weighted‑average interest rate:** The rate was roughly **4.45 % in both 2022 and 2023**, but rose to **≈4.8 % in 2024**.\n\nThe pattern shows Capital One expanding its fixed‑rate senior debt base in 2023 and then holding it steady while accepting a modestly higher average coupon in 2024, suggesting a long‑term borrowing strategy that keeps a large, relatively stable pool of fixed‑rate funding but is willing to issue newer, higher‑rate notes to extend maturities and preserve liquidity.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The carrying value for 2022 is reported as $24.1 billion, but the ground truth is $19,975 million ($19.975 billion), a substantial difference of over $4 billion. The 2023 and 2024 carrying values are approximately correct ($27.2B vs $27,168M and $26.9B vs $26,930M), with minor rounding acceptable. However, the weighted-average interest rate is incorrect for 2022: LLM states ~4.45%, but the correct value is 2.91%. The 2023 rate (4.45%) is correct, but the 2024 rate is given as ≈4.8%, while the true value is 4.84%, which is close but still misaligned with the upward trend. (2) Calculations and comparisons are flawed due to incorrect base values. The LLM implies the rate increased from 4.45% to 4.8%, but in reality, it rose from 2.91% to 4.45% to 4.84%, indicating a much steeper initial increase. This distorts the interpretation of the trend. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategy of maintaining a stable pool of fixed-rate debt and issuing new notes at higher rates. However, because it starts with incorrect data (especially the 2022 interest rate), the logical foundation is weak. The conclusion about 'preserving liquidity' and 'extending maturities' is plausible but not directly supported in the ground truth, which emphasizes capitalizing on investor demand or funding growth amid rising rates. (4) The contextual relevance is high—the answer addresses all parts of the question and attempts synthesis across years and metrics. Qualitative accuracy is moderate because the reasoning framework is logical, but quantitative accuracy is low due to major factual errors in key figures. Correctness score is 5 due to partial correctness in later years but fundamental errors in baseline data that undermine the overall accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 504,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "Tesla’s 10‑K filings for 2022, 2023 and 2024 all continue to list the “One‑Hundred‑and‑Sixteenth Supplemental Indenture … 5.45 % Solar Bonds, Series 2015/C92‑15” as an incorporated exhibit (e.g., Exhibit 4.61 in the 2022 filing【page_105】).  Across the three years the bond is not re‑issued or retired; it simply remains disclosed as part of the company’s existing capital‑structure.  This steady presence signals that Tesla relies on the legacy 5.45 % solar‑bond financing to fund its solar‑energy operations, preferring to sustain the low‑cost debt already in place rather than pursuing new financing rounds.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the continued listing of the 5.45% Solar Bonds, Series 2015/C92-15 in Tesla's 10-K filings for 2022, 2023, and 2024, and accurately references Exhibit 4.61 in the 2022 filing. The percentage (5.45%), bond series (C92-15), and years are all factually correct, supporting a high quantitative accuracy score. (2) However, the LLM fails to mention the specific exhibit numbers for 2023 (Exhibit 4.54) and 2024 (Exhibit 4.52), which are present in the ground truth and contribute to completeness. More critically, the LLM incorrectly interprets the sustained disclosure as evidence of Tesla's continued reliance on this bond for funding solar operations. The ground truth indicates a declining prominence, with newer bond series (C102-15, C106-10) emerging in 2024, signaling a strategic shift. The LLM misses this key evolution and instead concludes Tesla 'prefers to sustain the low-cost debt,' which contradicts the ground truth's indication of a move toward newer instruments. (3) The multi-hop reasoning is flawed: while the model correctly tracks the bond's presence across years, it fails to synthesize the broader context of new bond issuances and their implications. The conclusion drawn is therefore inaccurate, despite correct entity and exhibit identification. (4) The contextual relevance is high because the answer addresses the bond's role in financing and spans the correct time frame, but the qualitative accuracy is reduced due to incorrect inference about Tesla's strategic intent. The correctness score is moderate because core facts are right but the overall interpretation is misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 452,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "From 2022 through 2024 AIG’s loss‑reserve risk program became more formal and layered. In 2022 the company relied on internal controls, escalation procedures and business‑unit chief risk officers (with risk‑committee oversight) to review and challenge reserve estimates, using a mix of stochastic and deterministic concentration models and periodic reviews by external experts. By 2023 the same oversight structure was reinforced and expanded to include explicit scenario‑ and sensitivity‑analysis and experience‑study modeling, while still depending on internal controls and external expert reviews. In the 2024 filing AIG added a dedicated model‑risk management and validation framework, ERM second‑line reviews and internal‑audit checks to the reserve‑setting process, broadened its stochastic and scenario‑based modeling toolkit, and institutionalized external expert reviews as a regular component of loss‑reserve governance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All key facts are correct: AIG's evolution in loss reserve risk management from 2022 to 2024 is accurately described with consistent emphasis on internal controls, external reviews, and progressive enhancements in modeling and governance. The 2022 focus on internal controls and external expert reviews, 2023 expansion to scenario/sensitivity analyses and experience studies, and 2024 integration into ERM with model validation and audit checks are all correctly captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes changes across three years, correctly identifying the progression in oversight (risk committees, second-line reviews), modeling (stochastic, deterministic, scenario-based), and external review institutionalization. Minor difference: the LLM adds specific structural details (e.g., 'business-unit chief risk officers', 'dedicated model-risk management framework') not in the original, but these are plausible elaborations that do not contradict the ground truth and enhance precision. (4) The answer is fully contextually relevant, addressing all three dimensions in the question—oversight, modeling, and external reviews—across the three years. The only reason for not scoring 10 is that the original emphasizes 'holistic enterprise risk management (ERM) system' and 'audits by the Internal Audit Group' in 2024, which the LLM rephrases as 'internal-audit checks' and 'ERM second-line reviews'—essentially equivalent but slightly less precise in terminology. Overall, this is a strong, factually correct response with excellent reasoning and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 494,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "- **2022:** Altria’s pension plan held roughly **16 %** of its assets in U.S. Treasury and foreign‑government securities (the same share reported for 2021).  \n- **2023:** The share rose sharply – the 2023 filing shows that **about 19 %** of pension assets were Treasury or foreign‑government securities (part of a 25 % “U.S. Treasury and foreign‑government securities and all other investments” bucket).  \n- **2024:** The allocation fell back to **about 8 %** (the 2024 filing lists a 16 % total for “U.S. Treasury and foreign‑government securities and all other investments,” with the note indicating that Treasury/foreign‑government securities make up half of that amount).\n\n**What the trend means:** Altria’s pension‑asset strategy is actively re‑balancing away from low‑yielding government bonds. The temporary increase in 2023 was followed by a deliberate reduction in 2024, signaling a shift toward a more liability‑driven mix that leans heavier on corporate bonds and other higher‑return assets to better match its pension obligations while managing equity‑volatility exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains significant factual errors in the quantitative evolution of Altria's allocation to U.S. Treasury and foreign government securities. It incorrectly states that the allocation was 16% in 2022 and increased to 19% in 2023, which is the reverse of the ground truth: the allocation decreased from 19% in 2022 to 16% in 2023, then to 8% in 2024. The 2024 figure of 8% is correct in the LLM answer, but the prior years are reversed, leading to a fundamentally incorrect trend. 2) The calculation and sourcing of the 2023 and 2024 numbers are flawed. The LLM claims that the 19% in 2023 comes from a 25% 'bucket' and that 8% in 2024 is half of a 16% category, but this interpretation contradicts the ground truth, which reports direct percentages without such disaggregation. There is no evidence in the original answer supporting this 'half of the bucket' reasoning. 3) The multi-hop reasoning is partially sound in that the LLM attempts to interpret a strategic shift, but the conclusion is based on incorrect data. While the idea of shifting away from low-yielding government bonds aligns with the original answer, the LLM mischaracterizes the 2023 increase as a 'sharp rise' when it was actually a decrease. Additionally, the original answer supports the trend with additional evidence (decline in below-investment-grade exposure and falling expected return on assets), which the LLM omits. 4) Despite the incorrect numbers, the LLM does address the question's intent—analyzing the trend and inferring strategy—and provides a plausible interpretation of asset reallocation, earning points for contextual relevance and partial qualitative reasoning. However, the reversal of key percentages severely undermines factual correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 480,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "- **2022 → 2023 → 2024:** Short‑term borrowings fell sharply from **$883 million** in 2022 to **$538 million** in 2023 and then ticked up to **$562 million** in 2024. Long‑term debt rose modestly from **$47.8 billion** in 2022 to **$49.3 billion** in 2023 before dropping to **$45.0 billion** in 2024, so total borrowings (short‑term + long‑term) moved from **$48.7 billion** (2022) to **$49.9 billion** (2023) and down to **$45.6 billion** (2024).  \n\n- **Trend insight:** The 3‑year pattern shows Capital One trimming its overall leverage and shifting its debt mix toward fixed‑rate instruments: floating‑rate unsecured senior debt disappeared (down from $1.6 billion in 2022 to $0 in 2024) and securitized debt obligations fell from $16.97 billion to $14.26 billion, while fixed‑rate senior debt remains the bulk of the portfolio (≈ $27 billion). This transition reduces the company’s exposure to rising interest rates, concentrating risk in a largely fixed‑rate structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures, particularly in the breakdown of short-term borrowings and long-term debt. According to the ground truth, total short-term borrowings and long-term debt were $43.086 billion in 2022, not $48.7 billion as stated by the LLM (which incorrectly labels this as 2022 total when it's closer to 2024). The LLM reports short-term borrowings of $883 million in 2022, but the ground truth does not support this figure—instead, the composition of debt components (e.g., floating unsecured senior debt of $1.709B) suggests a different structure. The LLM’s long-term debt figures ($47.8B, $49.3B, $45.0B) do not align with the ground truth totals, which increase from $43.086B to $48.715B to $45.551B. While the 2024 total is close ($45.6B vs $45.551B), earlier years are misstated. (2) Calculations are flawed: the LLM claims total borrowings were $48.7B in 2022, but this appears to be a misattribution—ground truth starts at $43.086B. The LLM also misrepresents securitized debt, stating $16.97B in 2022 vs. the correct $14.994B. Floating unsecured senior debt is reported as $1.6B in 2022 vs. $1.709B—close but not exact. However, the trend of retiring floating-rate debt by 2024 is correctly identified. Fixed-rate senior debt is approximated as ~$27B in 2024, which aligns with the ground truth ($26.930B), showing some accuracy in later synthesis. (3) Multi-hop reasoning is partially sound: the LLM correctly infers a strategic shift toward fixed-rate debt and reduced interest rate exposure, which is consistent with the ground truth. It identifies the elimination of floating unsecured senior debt and a decline in securitized debt, though exact magnitudes are off. The conclusion about reducing exposure to rising rates is logically supported and contextually appropriate. (4) Despite reasonable interpretation and narrative flow, the quantitative inaccuracies—especially in core totals and component values—severely undermine factual correctness. The answer gets the general direction of trends right (increasing fixed-rate, retiring floating), but the numbers underpinning the analysis are often incorrect, leading to a partial score. Contextual relevance is high as all aspects of the question are addressed with a coherent narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1566,
        "completion_tokens": 621,
        "total_tokens": 2188
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "Tesla’s 10‑K filings for 2022, 2023 and 2024 all list the “Thirty‑Sixth Supplemental Indenture … 5.45 % Solar Bonds, Series 2015/C25‑15” as an exhibit (e.g., 2023 10‑K Exhibit 4.27 and 2024 10‑K Exhibit 4.29)【page_99†L27-L30】【page_100†L27-L30】. The repeated disclosure indicates that Tesla continues to rely on this specific 5.45 % solar‑bond issuance to fund its solar‑related projects, and the fact that the bond series is consistently presented in each annual filing shows it remains an active component of the company’s debt portfolio and capital‑structure strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the bond series '5.45% Solar Bonds, Series 2015/C25-15' is accurately identified, and its inclusion in the 2022, 2023, and 2024 10-K filings is correctly noted. The reference to the 'Thirty-Sixth Supplemental Indenture' and the consistent naming of the bond across years matches the original answer. (2) Quantitative accuracy is perfect: the interest rate (5.45%), bond series name, and years of filing (2022–2024) are all correct. No calculations are required, but the repeated citation of the bond as an exhibit (e.g., 2023 Exhibit 4.27, 2024 Exhibit 4.29) adds precision and is factually sound. (3) The reasoning is strong: the LLM correctly infers that the repeated disclosure implies ongoing reliance and that the bond remains an active part of Tesla’s capital structure. It synthesizes information across three years appropriately, demonstrating valid multi-hop logic. (4) The only minor shortcoming is that the LLM does not explicitly mention the April 14, 2015 issuance date, which is included in the ground truth and reinforces the longevity of this instrument. While not critical to the core conclusion, this detail would have strengthened the response. Otherwise, the answer is semantically equivalent, contextually relevant, and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 379,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "Mastercard’s “Class A treasury stock” line grew steadily more negative each year – $‑51.4 billion at the end of 2022, $‑60.4 billion at the end of 2023, and $‑71.4 billion at the end of 2024. This expanding balance reflects an accelerating share‑repurchase program, indicating that the company is allocating an increasing share of its cash flow to buy back its own shares as a primary means of returning capital to shareholders and boosting earnings per share.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly captures the trend in Mastercard's Class A Treasury Stock from 2022 to 2024 with accurate figures: $-51.4 billion (2022), $-60.4 billion (2023), and $-71.4 billion (2024), which align with the ground truth values of $(51,354)M, $(60,429)M, and $(71,431)M when rounded to one decimal place in billions. The slight discrepancy in the 2022 figure—$(51,354)M vs $-51.4B—is due to rounding and is acceptable under semantic equivalence. 2) All numbers are quantitatively accurate within reasonable rounding conventions. The progression shows a consistent increase in treasury stock purchases, correctly interpreted as a growing buyback program. 3) The reasoning is sound: the LLM correctly infers that the increasing magnitude (more negative balance) reflects an accelerating share repurchase program and links this to capital allocation strategy, specifically returning capital to shareholders and boosting EPS—consistent with the original answer’s conclusion about growing emphasis on buybacks. 4) The answer fully addresses both parts of the question: the evolution of investment (multi-year trend) and its implication for capital allocation. Entities (Mastercard, Class A Treasury Stock, correct years) are accurately identified. Only a minor point deducted for not explicitly noting the data starts in 2022 (though implied), and the original answer mistakenly lists 2023 twice—LLM corrects this by assigning distinct values to 2022, 2023, and 2024, which is actually more accurate. Overall, the LLM provides a clearer, correctly sequenced response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 430,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "Honeywell’s 2022 Form 10‑K already warned that its **Safety and Productivity Solutions** business could be hurt by “reduced investments in process automation, safety monitoring, and plant‑capacity‑utilization initiatives” (see 2022 risk‑factor bullet on Safety and Productivity Solutions 【page_32】). After the October 2023 realignment, the same exposure appears in the 2023 filing under the newly‑named **Industrial Automation** segment, with identical language about reduced automation and capacity‑utilization spending (2023 risk‑factor bullet 【page_30】), and the 2024 filing repeats that wording for Industrial Automation (2024 risk‑factor bullet 【page_30】). The persistence of this risk across three consecutive years shows that macro‑economic pressure on industrial customers—namely weaker capital‑expenditure cycles, lower plant utilization and slower automation adoption—has remained a consistent headwind for the sector throughout 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Honeywell consistently cited reduced investments in process automation and plant capacity utilization as risks to its Safety and Productivity Solutions (later renamed Industrial Automation) from 2022 to 2024. The answer correctly identifies the segment name change after the October 2023 realignment, which is a critical detail for tracking continuity across filings. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but dates (2022, 2023, 2024) and page references (【page_32】, 【page_30】) are accurately cited per the source data, though page numbers are not part of the ground truth and thus do not affect scoring. (3) The multi-hop reasoning is sound: the model correctly links the persistent risk language across three years and interprets it as evidence of ongoing macroeconomic pressure, including weak capital expenditure and low plant utilization—consistent with the original answer’s conclusion about sustained industrial sector headwinds. (4) The only minor shortcoming is that the LLM does not explicitly mention the increasing emphasis on geopolitical instability and trade policy shifts in 2024, which the ground truth highlights as a 'sharper focus' indicating deepening concern. While the LLM notes 'consistent headwind,' it slightly underrepresents the escalation in tone over time. However, the core trend and implications are correctly captured. Overall, the answer is factually precise, contextually relevant, and demonstrates strong qualitative synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 439,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "From 2022 through 2024 Eli Lilly kept Cyramza positioned as an oncology product with the same broad label: second‑line treatment of advanced or metastatic gastric/GEJ adenocarcinoma, metastatic non‑small‑cell lung cancer (NSCLC), metastatic colorectal cancer and hepatocellular carcinoma, plus a first‑line indication for adult patients with EGFR‑mutated metastatic NSCLC. The 2023 10‑K shows that the drug’s core compound patents run out in 2026 in the United States and Japan and in 2028 in Europe, while its biologics data‑protection expires in 2026 (U.S.) and its data‑package protection ends in 2023 (Japan) and 2024 (Europe), indicating that Cyramza’s exclusivity window is slated to begin winding down in the mid‑2020s.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Cyramza's therapeutic indications as remaining stable from 2022 to 2024, aligning with the ground truth. However, it incorrectly adds a 'first-line indication for adult patients with EGFR-mutated metastatic NSCLC', which is not mentioned in the original answer and represents an overstatement of approved indications. This is a significant factual error affecting completeness and correctness. (2) Regarding intellectual property, the LLM states that compound patents expire in 2026 in the U.S. and Japan and 2028 in Europe — this matches the ground truth for the U.S. and Europe, but the original does not mention Japan for compound patents, so this addition lacks support. The data protection dates are mostly accurate: Japan 2023 and Europe 2024 match the ground truth; however, the LLM incorrectly states U.S. biologics data protection expires in 2026, while the original answer does not specify U.S. data protection expiration, making this an unsupported claim. (3) The multi-hop reasoning is sound in synthesizing therapeutic positioning and IP timelines across years, correctly identifying the narrowing exclusivity window. However, the inclusion of unverified indications and patent dates in Japan and the U.S. weakens the factual foundation of the synthesis. (4) Scores reflect high contextual relevance and strong qualitative reasoning, but quantitative accuracy is reduced due to unsupported dates and incorrect indication expansion. The core trajectory of IP expiration and continued therapeutic use is correct, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 442,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "Capital One’s net derivative position (derivative assets – derivative liabilities) moved from a modest $5 million net Level‑3 fair‑value balance at the end of 2022 to a much larger $58 million net balance by the end of 2023, and it remained essentially unchanged at $58 million at the end of 2024.  In each year the derivatives are measured at Level 3 using vendor‑based discounted‑cash‑flow models, and the only material unobservable input is the set of swap rates (typically a 3‑5 % range with a weighted‑average of about 4 % in 2023‑2024); the same swap‑rate input methodology was applied in 2022, although the much smaller net balance meant the impact on earnings was minimal.  Overall, the gross derivative portfolio expanded dramatically (from roughly $153 million total in 2022 to about $1.3 billion in 2024), but the net Level‑3 valuation grew to $58 million and is driven by the same swap‑rate assumptions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer gets the 2023 and 2024 net derivative fair values correct at $58 million, but incorrectly states the 2022 value as $5 million instead of the ground truth $19 million. This is a significant quantitative error. Additionally, the LLM introduces a 'Level-3' classification and 'vendor-based discounted-cash-flow models' not mentioned in the original answer, which may be technically plausible but are not supported by the ground truth. The LLM also adds new data—gross derivative portfolio values of $153 million in 2022 and $1.3 billion in 2024—which are not present in the original answer and cannot be verified against the ground truth, making them potentially hallucinated. (2) The unobservable inputs are partially correct: swap rates (3–5%, weighted at 4%) are accurately reflected for 2023–2024, but the LLM omits the mention of default rates (53–163%) in 2023 and entirely misses the $20 million net losses held in the portfolio in 2022, a key qualitative detail. The claim that 'the same swap-rate input methodology was applied in 2022' is speculative and not confirmed in the original. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies the increase from 2022 to 2023 and stabilization in 2024—but the incorrect 2022 value undermines the accuracy of the trend analysis. The synthesis of unobservable inputs is reasonable but incomplete due to missing default rates. (4) The contextual relevance is high as the answer addresses fair value evolution and unobservable inputs directly. However, the quantitative inaccuracies—especially the wrong 2022 value and unsupported gross portfolio figures—reduce the correctness score. The qualitative accuracy is moderate due to missing details and unverified additions. Overall, the answer captures the general trend and some correct inputs but fails on key facts and introduces unsupported data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 512,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "- **Charitable‑match participation** – In fiscal 2022 “thousands of our employees around the world utilized our charitable‑match program, benefiting **more than 1,500 charitable organizations**”【page_17】. By fiscal 2024 the same “thousands of our employees … utilized our charitable‑match program, benefiting **more than 1,300 charitable organizations**”【page_16】. Employee involvement stayed at the “thousands” level, while the number of organizations supported fell modestly from >1,500 to >1,300.\n\n- **Alignment with human‑capital goals tied to executive pay** – For both fiscal 2022 and fiscal 2024 the company states that “progress towards human‑capital advancements serves as a non‑financial performance modifier that can adjust the executives’ bonus payout by a multiple of 0.9 to 1.1”【page_17】【page_16】. The continued, large‑scale employee use of the charitable‑match program demonstrates progress on the human‑capital metrics that feed into this bonus modifier, showing that the program’s evolution is directly linked to the broader human‑capital objectives that influence executive compensation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, it accurately reports that in 2022, thousands of employees participated, benefiting over 1,500 organizations, and in 2024, participation remained at the 'thousands' level while supported organizations decreased to over 1,300—consistent with the original answer. The phrasing 'more than 1,500' and 'more than 1,300' aligns semantically with 'over 1,500' and 'over 1,300'. (2) The answer correctly identifies that human capital progress, including charitable engagement, serves as a non-financial modifier (0.9 to 1.1) for executive bonuses in both years, directly citing the same range and mechanism as the ground truth. (3) Multi-hop reasoning is sound: the LLM synthesizes data across two fiscal years and connects employee participation trends to executive compensation structure, correctly inferring that sustained participation reflects progress on human capital goals. (4) All entities—Qualcomm, fiscal years 2022 and 2024, charitable match program, executive compensation linkage—are accurately identified and contextualized. The answer is complete, factually precise, and semantically equivalent to the original, with no omissions or errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 348,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "In the 2022 filing Adobe described Acrobat as the “flagship” of its Document Cloud platform – a market‑leader that powers fully digital PDF workflows, now bolstered by a stronger web‑based UI, expanded task‑based actions, deeper integration with Adobe Sign (via APIs) and AI‑driven features from Adobe Sensei. The 2023 filing re‑positions Acrobat as one of the core services within the broader Adobe Document Cloud suite (listed together with Acrobat Sign, Express, Firefly, Photoshop, etc.), stressing tighter integration across Creative Cloud and Experience Cloud and continued AI‑enhanced web and mobile capabilities. The 2024 filing’s disclosed sections contain no new product narrative, implying that Acrobat remains a foundational Document Cloud component with its 2022‑2023 enhancements but without additional announced changes.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in qualitative details and reasoning, particularly regarding the 2024 filing. (1) Correct elements: The 2022 description aligns well with the ground truth, noting Acrobat's leadership in Document Cloud, integration with Adobe Sign, and use of AI via Adobe Sensei. The mention of web-based UI improvements and task-based actions, while not in the original answer, are plausible enhancements and do not contradict. The 2023 shift toward broader integration across Creative Cloud and other services is generally accurate. (2) Quantitative accuracy is high: no specific numbers (e.g., dollar amounts, percentages) are present in either answer, so no discrepancies exist. Dates (2022, 2023, 2024) are correctly used. (3) Multi-hop reasoning fails in 2024: the LLM incorrectly states that the 2024 filing 'contains no new product narrative' and implies no changes, which directly contradicts the ground truth that Acrobat was formally associated with AI through the 'Acrobat AI Assistant' trademark—a key strategic evolution. This omission represents a major failure in synthesis and factual accuracy for the 2024 update. (4) Contextual relevance is strong overall, as the response addresses all three years and the requested dimensions (role in Document Cloud, integration, enhancements), but the failure to capture the critical AI Assistant development in 2024 undermines completeness and qualitative accuracy. The answer downplays the strategic AI shift, which is central to the evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 433,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "In 2022 Eli Lilly recognized $2.02 billion of net product revenue from its COVID‑19 antibodies (bamlanivimab and bebtelovimab) under the AbCellera collaboration, with AbCellera receiving mid‑teen‑to‑mid‑twenties percentage royalties on those sales 【page_73】. No COVID‑19 antibody sales were recorded in either 2023 or 2024, so net product revenue fell to $0 and the associated royalty payments to AbCellera likewise dropped to $0 【page_74】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: $2.02 billion in net product revenue for 2022, mid-teens to mid-twenties royalty percentages, and $0 revenue and royalties in 2023 and 2024. (2) Quantitative accuracy is perfect: the dollar amounts, years, and percentage ranges match the original answer exactly. Format variations (e.g., $2.02 billion vs $2.02B) are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—LLM correctly synthesized information across years and entities (LLY, AbCellera, bamlanivimab, bebtelovimab), capturing the evolution from peak revenue in 2022 to complete wind-down in 2023–2024. (4) The answer addresses all parts of the question: net product revenue trends and royalty payment implications over the three-year period. Contextual details such as the cessation of sales due to regulatory or demand changes are implied by the data pattern, though not explicitly stated—but their absence does not detract from factual correctness. Overall, the response is concise, accurate, and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 316,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "MetLife reported that the modified‑coinsurance arrangement covered about 59 % of the closed block in each of the three most recent filings – 59.25 % in the 2022 10‑K and roughly 59 % in both the 2023 and 2024 10‑Ks. The near‑identical share year‑over‑year shows that the company has kept a steady, long‑term risk‑transfer policy, deliberately retaining roughly two‑thirds of the block while consistently off‑loading the remaining one‑third through the same modified‑coinsurance structure to manage capital and diversify risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all percentages are correct: 59.25% for 2022 and 59% for both 2023 and 2024, matching the original answer exactly. The use of 'about 59%' and 'roughly 59%' is acceptable as approximations consistent with the precise figures. (2) The answer fully addresses both parts of the question: it traces the evolution (stable at ~59%) from 2022 to 2024 and interprets the consistency in terms of long-term risk transfer strategy. (3) Entities—MetLife, modified coinsurance agreement, closed block, and the years—are correctly identified and contextualized. (4) The reasoning is sound: the model correctly infers strategic continuity from the stable reinsurance percentage. The only minor shortcoming is the addition of 'roughly two-thirds' and 'one-third' as interpretations of 59%, which is a reasonable approximation but not explicitly stated in the ground truth; this slight interpretive leap prevents a perfect 10 on qualitative accuracy. However, the core multi-hop synthesis—linking consistent percentages over time to strategic risk management—is logically and factually sound. Overall, the answer is semantically equivalent to the ground truth with high precision and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 354,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "Mastercard’s multi‑layered security model has remained centered on third‑party validation, public‑private partnerships and real‑time protection, but it has become broader and more integrated. In the 2022 filing the company noted that its security program was assessed by third parties and that it used public‑private partnerships to monitor threats, while it operated or was rolling out real‑time clearing and settlement in 12 markets. By the 2024 filing the language expands to say its programs are continually benchmarked against peers and third‑party providers, that it now explicitly tracks incidents tied to third‑party services, and that real‑time account‑based payment infrastructure is live or being built in 13 markets and is embedded in new product flows. This evolution shows Mastercard’s cybersecurity strategy is increasingly collaborative and infrastructure‑focused—leveraging external expertise and securing the growing real‑time payments network to protect an expanding, more interconnected ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Mastercard's security approach from 2022 to 2024, with accurate emphasis on third-party collaboration and real-time payment infrastructure. However, there are minor discrepancies in the timeline and details. The LLM states that in the 2024 filing, real-time infrastructure is in 13 markets, but the ground truth indicates 13 markets were reached in 2023, and by 2024 it had expanded to 'several countries globally'—a broader but less specific claim. The LLM incorrectly skips 2023 and jumps from 2022 to 2024, missing the incremental update in 2023 about third-party provider threats. It also attributes 'tracking incidents tied to third-party services' to 2024, while the ground truth places this development in 2023. Despite this, the overall trend—increasing integration of third-party risk management and expansion of real-time infrastructure—is correctly identified. The qualitative reasoning is sound, showing strategic alignment between collaboration and infrastructure security. Contextual relevance is excellent, directly addressing all parts of the question with appropriate synthesis. Wording differences are acceptable under semantic equivalence, but the misattribution of specific developments to 2024 instead of 2023 affects quantitative and qualitative accuracy slightly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1595,
        "completion_tokens": 375,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "The fair‑value tables show that the defined‑benefit pension plan’s equity‑like‑fund holdings were $4,014 million in 2022, rose modestly to $4,094 million in 2023, and then fell to $3,932 million in 2024 (the retiree‑health plan showed a similar, much smaller pattern).  This near‑flat‑to‑slightly‑downward movement after a brief uptick indicates that Eli Lilly maintains a sizable, stable commitment to private‑equity‑style, illiquid assets for long‑term return potential, but is also willing to trim exposure when needed to rebalance liquidity or risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, LLY's allocation to equity-like funds was $2,844.7 million in 2022, increased to $4,014.1 million in 2023, and further rose to $4,093.7 million in 2024. The LLM incorrectly reports $4,014 million in 2022 (overstating by ~$1,170 million), $4,094 million in 2023 (close but still inaccurate), and $3,932 million in 2024 (understating by ~$162 million). These errors affect the entire trend interpretation. (2) The quantitative inaccuracies are severe: the starting value is more than double the correct amount, and the final value shows a decrease instead of an increase. Even allowing for rounding, the discrepancies are too large (e.g., $2,844.7M vs $4,014M is a 41% overstatement). (3) The multi-hop reasoning is flawed. The LLM concludes a 'near-flat-to-slightly-downward movement,' which contradicts the ground truth's clear upward trend from $2,844.7M to $4,093.7M over two years. This leads to an incorrect strategic interpretation: the LLM suggests LLY is trimming exposure, while the truth indicates a strong strategic buildup in private alternative investments. (4) Contextual relevance is moderate—the answer addresses the right topic (LLY’s private alternative investments, specifically equity-like funds) and attempts to interpret strategy—but the incorrect data undermines the conclusion. The mention of the retiree-health plan is extraneous and not in the original answer. Overall, the answer fails on correctness due to major numerical and trend errors, despite addressing the general subject area.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 442,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "In the 2022 filing, Cascade was listed among the **major Home‑Care brands** in the Fabric & Home Care segment (the segment’s product mix was described as “Fabric Care … and Home Care (Air Care, Dish Care, …)”), and the segment accounted for **about 35 % of total net sales**.  \n\nBy the 2024 filing, Cascade is still shown under the same **Home‑Care/Dish‑Care sub‑category** of Fabric & Home Care, but the segment’s share of net sales had **increased slightly to roughly 36 %**.  \n\nThus, from 2022 to 2024 Cascade’s categorization stayed the same (a Home‑Care brand within Fabric & Home Care), while the segment’s contribution to overall net sales grew from ~35 % to ~36 %.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the Fabric & Home Care segment's contribution was ~35% in 2022 and increased to ~36% in 2023 and 2024. The LLM correctly reports these percentages and attributes Cascade as part of the Home-Care/Dish-Care sub-category throughout. Minor phrasing like 'about 35%' and 'roughly 36%' is acceptable and semantically equivalent to '35%' and '36%' in the original. (2) The LLM correctly identifies that Cascade remained in the same product categorization (Home Care/Dish Care) within the Fabric & Home Care segment across all years, which matches the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information across 2022 and 2024 filings (and implicitly 2023, though not explicitly cited) to show stability in brand categorization and growth in segment contribution. The only minor shortcoming is that the LLM does not explicitly mention 2023, which the original answer includes as a data point confirming the increase to 36% occurred in 2023 and held in 2024. However, stating that the share increased to ~36% by 2024 is still factually correct and implies the change occurred no later than 2024. (4) All entities—Procter & Gamble, Cascade, Fabric & Home Care segment, net sales contribution—are correctly identified and contextualized. The answer is fully relevant and conveys the same core conclusion: Cascade’s categorization remained stable while the segment’s sales contribution slightly increased. Thus, the answer deserves a high score, with only a slight deduction in qualitative accuracy for not acknowledging the 2023 transition year explicitly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 461,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "From 2022 to 2024 Lowe’s progressively tightened the way it watches its supply chain and the wood it sells. In its 2022 filing the company said it already required all wood products to come from “well‑managed, non‑endangered forests” and used its human‑rights policy, conflict‑minerals policy and Vendor Code of Conduct (with added environmental standards) to monitor supplier practices, while spending more than $550 million on energy‑efficiency upgrades such as LED lighting, high‑efficiency HVAC and building‑management systems. In 2023 the wood‑sourcing policy was upgraded to a risk‑based framework that assigns new country‑level risk scores, adds stronger monitoring procedures and introduces a forestry‑grievance process, and the company began a major renewable‑energy push – reporting supplier emissions to CDP, expanding off‑site wind PPAs and announcing rooftop‑solar installations at 174 stores. By 2024 the policy was further refined into a “more robust risk‑based approach” with the same risk‑level matrix, enhanced monitoring and the grievance mechanism, while the investment strategy shifted to a $300 million‑plus program focused on HVAC, building‑management, pallet‑grinders and indoor LED upgrades and on‑site solar (over 100 sites operational), deepening supplier engagement through CDP reporting and renewable‑energy purchases.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Lowe's supplier sustainability and wood sourcing practices from 2022 to 2024 and correctly identifies key policy enhancements such as the risk-based wood sourcing framework, country-level risk scores, enhanced monitoring, and the forestry grievance process. It also correctly notes the use of the Vendor Code of Conduct and environmental upgrades in 2022. However, there are significant quantitative inaccuracies that undermine factual correctness. The LLM states a '$300 million-plus program' in 2024 for facility upgrades, which contradicts the ground truth that Lowe's committed $50 million through the Gable Grants program in 2023 (not $300M in 2024). The $550 million investment in 2022 is correctly cited, but the LLM misrepresents the 2024 investment strategy by focusing on a $300M+ figure not present in the original answer and omitting the Gable Grants entirely. Additionally, the LLM introduces details not in the ground truth, such as CDP reporting, off-site wind PPAs, rooftop solar at 174 stores, and over 100 on-site solar sites, which, while plausible, are not part of the verified knowledge graph and represent unsupported additions. These fabrications or inaccuracies in dollar amounts and specific initiatives significantly reduce quantitative accuracy. Qualitatively, the reasoning and structure are sound—showing a logical progression across years and correct multi-hop synthesis of policy evolution—but the inclusion of unverified investments and omission of the Gable Grants program weakens alignment with the ground truth. Contextually, the answer is highly relevant and well-organized, addressing all aspects of the question with appropriate focus on policy and investment changes. However, the incorrect figures and invented programs prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1629,
        "completion_tokens": 494,
        "total_tokens": 2123
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "- In the 2022 filing (page 31) Honeywell warned that **Safety & Productivity Solutions** and **Honeywell Building Technologies** could see “**changes in the competitive landscape, including new market entrants and new technologies that may lead to product commoditization**.”  \n- By the 2023 filing (page 30) the same language re‑appears for the newly‑named **Industrial Automation** (which now houses the former Safety & Productivity businesses) and for **Building Automation**, showing that the competitive‑risk exposure was carried forward into the re‑organized segments.  \n- The 2024 filing (page 32) repeats the same phrasing for **Industrial Automation** and **Building Automation**, indicating that the company’s concern about new entrants and technology‑driven commoditization has persisted and broadened across its core automation and building‑systems businesses.  \n\n**Overall, the risk language moves from being a discrete concern for Safety & Productivity and Building Technologies in 2022 to a consistent, segment‑wide warning for Industrial Automation and Building Automation in 2023‑2024, signaling that market pressure and the threat of product commoditization have intensified and now affect Honeywell’s larger, re‑aligned business units.**",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains accurate dates (2022, 2023, 2024) and correctly cites page numbers (31, 30, 32), which aligns with the expected format and shows attention to document structure. However, the core factual content is significantly flawed in terms of entity accuracy and reasoning. The LLM incorrectly states that in 2022, both Safety & Productivity Solutions *and* Honeywell Building Technologies were exposed to competitive landscape risks, while the ground truth specifies that only Safety & Productivity Solutions was mentioned in 2022. This misattribution undermines the multi-hop analysis. Furthermore, the LLM claims that Industrial Automation in 2023 inherited Safety & Productivity businesses due to a reorganization, but the original answer does not mention any restructuring or renaming—this is an unsupported inference. The LLM also mislabels 'Honeywell Building Technologies' as 'Building Automation' in 2023–2024, introducing entity inaccuracies. While the conclusion about broadening risk is directionally similar, the reasoning is based on incorrect mappings of business units over time. The progression described in the LLM answer—framing the risk as moving due to segment reorganization—is not supported by the ground truth, which instead shows a *sequential expansion* of the risk disclosure across three distinct segments over three years. Thus, while the answer is well-structured and contextually relevant, the qualitative inaccuracies in entity identification and synthesis severely limit its correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1613,
        "completion_tokens": 419,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "In its 2022 filing Qualcomm framed the automotive space – including “digital‑cockpit” and ADAS/automated‑driving platforms – as an emerging growth area of its broader “automotive transformation” narrative, but automotive sales were a relatively small component of QCT’s equipment revenues. By 2024 the company was recognizing automotive sales (which are accounted for at a point‑in‑time, like its other IC products) as a distinct revenue stream that grew from $1.5 billion in 2022 to $2.9 billion in 2024, and the segment tables now highlight this growth within QCT’s reporting, showing Qualcomm’s shift from a nascent market focus to a sizable, strategically‑driven digital‑cockpit position.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Qualcomm's evolving strategic positioning in the digital cockpit market from 2022 to 2024, noting the shift from a growth narrative to a monetized, strategically-driven segment. It accurately references the increase in automotive revenue from $1.5 billion in 2022 to $2.9 billion in 2024 and the recognition of automotive sales as a distinct revenue stream within QCT. However, the original answer includes more granular detail about the progression: in 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue (a key transitional year), which the LLM answer omits. Instead, it jumps from 2022 to 2024, missing the intermediate step of revenue recognition in 2023. (2) Quantitatively, the $1.5B to $2.9B growth is factually correct and aligns with ground truth disclosures. The revenue recognition method (point-in-time) is also accurate. No calculation errors. (3) The multi-hop reasoning is partially sound: the model connects automotive transformation narrative, revenue recognition, and segment reporting, but fails to fully synthesize the 2023 milestone when digital cockpit products were first explicitly included in revenue reporting. This weakens the qualitative accuracy of the evolution timeline. (4) Despite the omission of 2023 developments, the answer remains contextually relevant and captures the overall trajectory. The core facts are correct, but the incomplete synthesis across all three years reduces the correctness and qualitative scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 426,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "- In the 2022 Form 10‑K Adobe did not include a dedicated Frame.io description, indicating that the service had not yet been positioned as an integrated part of the Creative Cloud suite. 【page_95】  \n- By the 2023 filing Frame.io was presented as a cloud‑native collaboration platform that supports video **plus** still images, design files and PDFs; it is directly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, offers “Camera‑to‑Cloud” uploads, and is made available through Adobe GenStudio for large‑scale production. 【page_12】  \n- The 2024 filing expands the functional scope further, adding support for pre‑ and post‑production media such as casting, location‑scouting, footage‑review and marketing‑campaign assets, while retaining the same deep integrations and emphasizing enterprise‑scale content creation via GenStudio and broader API‑based workflows. 【page_12】",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution of Frame.io from 2022 to 2024 with accurate dates and proper contextual progression. Quantitatively, all years (2022, 2023, 2024) are correct and consistently referenced, with no numerical inaccuracies—thus earning a 10 in quantitative accuracy. The answer correctly identifies the integration timeline and expanded capabilities, and cites appropriate Adobe products (Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, GenStudio), supporting contextual relevance. However, there is a key discrepancy in the 2023 integrations: the original answer states that integration with Photoshop, Lightroom, and Workfront occurred by 2024, not 2023. The LLM incorrectly attributes these integrations to the 2023 filing, which overstates the pace of integration. Additionally, the original specifies that expanded support for casting, location scouting, and marketing campaign management was introduced in 2024, which the LLM captures correctly in substance but slightly misaligns in timing due to the integration error. This affects qualitative accuracy, as the multi-hop reasoning across years contains a factual misplacement. Despite this, the overall trajectory and enterprise emphasis (e.g., GenStudio, API workflows) are semantically equivalent and relevant. Hence, correctness is reduced to 7 due to the misattribution of integration timing, though core facts and evolution are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 396,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "- Dividends on the Class A shares rose each year: $2.04 per share in 2022, $2.37 in 2023, and $2.74 in 2024【page 99】【page 92】.  \n- The charter’s “Dividend and Voting Rights” description for Class A stock remained “One vote per share … Dividend rights” in all three filings, showing no change to voting power【page 99】【page 92】.  \n\nThe upward‑trend in per‑share dividends together with an unchanged one‑vote‑per‑share structure signals a stable governance framework that continues to reward shareholders while preserving the same voting rights.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly introduces specific dividend amounts per share ($2.04, $2.37, $2.74) for 2022–2024, which are not present in the ground truth. The original answer states only that 'Dividend rights' were consistently disclosed, with no mention of actual dividend payments or their amounts. This is a major factual error, as the ground truth does not support any quantitative claims about dividend payouts. (2) The quantitative accuracy is low because the dollar amounts cited are specific and precise, implying data from the filings, but they contradict the ground truth, which reports no changes in dividend rights—only that the rights themselves (not payments) were maintained. There is no verification that these numbers appear on the cited pages in the context of Class A share dividends. (3) The qualitative reasoning is partially sound: the LLM correctly notes that voting rights remained 'One vote per share' across the three years, and it accurately interprets the stability of voting rights as indicative of stable governance. However, it conflates dividend *payments* (which may vary annually) with dividend *rights* (the legal entitlement structure), which are distinct concepts. The question asks about the evolution of 'dividend rights,' not payout amounts. Thus, the multi-hop reasoning fails by focusing on irrelevant financial data instead of the structural consistency of shareholder rights. (4) Contextual relevance is high because the answer addresses both dividend and voting rights and attempts to draw a conclusion about governance stability. However, the core factual error—fabricating dividend per-share figures—severely undermines correctness. The conclusion about stable governance is aligned with the ground truth but is based on flawed premises. Overall, the answer is partially correct in structure and intent but factually inaccurate in key quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 517,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "Honeywell repeatedly warns that its Safety & Productivity Solutions (S&PS) business “may be adversely impacted by … fluctuations in retail markets” (2022 10‑K R‑1 p. 31; 2023 10‑K R‑1 p. 30; 2024 10‑K R‑1 p. 32). The financial results confirm that this exposure translates into pronounced volatility: S&PS net sales fell from $5.996 billion in FY 2022 to $5.489 billion in FY 2023 (‑21 %) and segment profit dropped from $1.555 billion to $0.901 billion (‑42 %) (2023 10‑K p. 30), then rebounded in FY 2024 to $6.425 billion in sales and $1.522 billion in profit (2024 10‑K p. 28). The swing from a steep decline in 2023 to a modest recovery in 2024 shows that the S&PS segment is highly sensitive to consumer‑demand cycles in the retail market, making its performance vulnerable to changes in retail‑spending trends.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its factual correctness, despite strong qualitative reasoning and contextual relevance. (1) The reported financial figures are incorrect: S&PS net sales did not fall by 21% from 2022 to 2023—actual reported values in Honeywell’s 10-Ks show S&PS sales of $5.996B in 2022 and $5.489B in 2023, which is a ~8.5% decline, not 21%. Similarly, segment profit dropped from $1.555B to $0.901B, a 42% decline, which is correctly stated. However, the claim of a rebound to $6.425B in sales and $1.522B in profit in 2024 is misleading because in 2024, the segment was restructured and renamed Industrial Automation; these figures may reflect a different segment composition, and the LLM fails to acknowledge the rebranding and restructuring noted in the ground truth. (2) The calculation error on the sales decline (21% vs actual ~8.5%) is substantial and suggests flawed analysis. (3) Qualitatively, the LLM correctly identifies the recurring risk disclosure about retail market fluctuations across all three years and cites the correct risk factor language and page numbers from the 10-Ks. It also correctly infers that the segment is sensitive to consumer demand cycles. However, it misses the key point from the ground truth that the segment was renamed (from Safety and Productivity Solutions to Industrial Automation) in 2024, and that the persistence of the risk despite restructuring indicates ongoing vulnerability. This is a critical multi-hop insight that the LLM overlooks. (4) Contextually, the answer is highly relevant, directly addressing the impact of retail fluctuations and linking performance to consumer demand. But due to major numerical errors and incomplete synthesis of the segment reorganization, the correctness score is limited to 6—partially correct with significant factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 504,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "From the 2022 filing the Olumiant agreement already provided Incyte with tiered, double‑digit royalties that can reach roughly 20 % of worldwide net sales, plus an extra low‑teens‑percent royalty on any sales for the COVID‑19 indication that was added when the contract was amended in 2020.  By 2023 the company noted that milestone payments were no longer material (the $210 M and $260 M milestones capitalized in 2020‑21 had been amortized) and that Incyte was eligible for up‑to $100 million of additional sales‑based milestone payments; the 2024 filing repeats the same royalty tiers and COVID‑19 extra royalty but does not disclose any new material milestone amounts, indicating the obligations have essentially remained unchanged beyond the non‑material milestone eligibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of the LLY-Incyte agreement correctly, noting the tiered royalty structure up to 20%, the additional low-teens royalty for COVID-19 sales, and the shift from milestone-driven payments to ongoing royalties. It correctly identifies that by 2023, milestone payments were no longer material due to prior capitalization and amortization of earlier milestones ($210M and $260M in 2020–21), and that up to $100M in additional sales-based milestones remained eligible in 2023. The 2024 update correctly reflects unchanged royalty terms and lack of new material milestones. (2) However, there is a quantitative discrepancy: the original answer states Incyte was eligible for up to $100M in *regulatory* milestones and another $100M in *sales-based* milestones in 2022 (total $200M potential), but the LLM answer only mentions $100M in sales-based milestones and omits the regulatory component. Additionally, the LLM introduces specific figures ($210M and $260M) for milestones capitalized in 2020–21, which are not present in the ground truth and may be factually unsupported in this context. These numbers, while possibly accurate in filings, go beyond the provided ground truth and introduce unverified detail. (3) The multi-hop reasoning is strong—correctly synthesizing changes across 2022, 2023, and 2024, interpreting the accounting treatment (capitalization and amortization), and inferring reduced significance of milestones over time. The conclusion that obligations 'remained unchanged beyond non-material milestone eligibility' aligns with the ground truth's assertion of a shift to stable royalty-based payments. (4) Scores reflect high factual and contextual accuracy with minor but notable quantitative inaccuracies and introduction of unsupported specifics, preventing a top score on correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 510,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "In the 2022 Form 10‑K the Baby, Feminine & Family Care segment was described as comprising three sub‑categories—Baby Care, Feminine Care (adult‑incontinence and menstrual) and Family Care—and the “major brands” list included both baby brands (Luvs, Pampers) and feminine‑care brands (Always, Always Discreet, Tampax). By the 2024 filing the segment’s product‑category description no longer mentions Baby Care, and the major‑brands table lists only the feminine‑care and family‑care names—Always, Always Discreet, Tampax, Bounty, Charmin and Puffs—dropping the baby brands entirely. This shift shows that Always has been elevated from one of several segment brands in 2022 to the flagship brand representing the segment’s focus on feminine and family care by 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but introduces significant inaccuracies in reasoning and entity representation. (1) Quantitatively, the years (2022, 2024), brand names (Always, Always Discreet, Tampax, Bounty, Charmin, Puffs), and segment name (Baby, Feminine & Family Care) are correctly identified, earning a high quantitative accuracy score. (2) However, the claim that 'Baby Care' was removed from the segment description by 2024 is incorrect—the segment still includes Baby Care in 2024; the change was in emphasis, not elimination. The LLM incorrectly infers that Always became the 'flagship brand' and that baby brands were 'dropped entirely' from the major brands list, which is not supported by the ground truth. (3) The multi-hop reasoning is flawed: while the ground truth notes a refinement in Always’ positioning toward 'menstrual care' within Feminine Care, the LLM overstates this as a strategic elevation to flagship status due to a misinterpretation of categorization changes. (4) The answer is contextually relevant and addresses product categorization and brand prominence, but the conclusion about Always’ elevated status is unsupported. Thus, while some facts are correct, the synthesis and interpretation contain significant errors, warranting a mid-range correctness score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 365,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "- **Fiscal 2023 (target disclosed in the 2022 filing):** U.S. plans were 100 % debt; non‑U.S. plans were 48 % debt, 27 % equity, 4 % cash, 11 % insurance contracts and 10 % other.  \n- **Fiscal 2024 (target disclosed in the 2023 filing, as of 8/31/23):** U.S. plans shifted to 94 % debt and added 6 % cash; non‑U.S. plans moved to 42 % debt, 23 % equity, 5 % cash, 21 % insurance contracts and 9 % other.  \n- **Fiscal 2025 (target disclosed in both the 2023 and 2024 filings):** U.S. plans returned to 100 % debt; non‑U.S. plans further reduced debt to 36 % and increased equity to 28 % (cash 7 %, insurance 21 %, other 8 %).  \n\n**What the progression shows:** Accenture is gradually tilting its non‑U.S. pension portfolios toward higher‑return assets (more equity and cash) while trimming debt exposure, yet it keeps the U.S. plans almost entirely in duration‑matched debt (with only a temporary cash buffer in 2024). This reflects a strategy that seeks modestly higher risk‑adjusted returns in the non‑U.S. side while preserving liability‑duration matching and low‑volatility funding for the U.S. obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides specific numerical allocations for U.S. and non-U.S. plans across fiscal years 2023, 2024, and 2025, which are not present in the original ground truth. However, the ground truth explicitly states that the strategy was consistent and focused on liability duration matching and diversification, with no mention of such detailed percentage shifts or distinctions between U.S. and non-U.S. plans. There is no evidence in the ground truth to support the claim that U.S. plans were 100% debt or that non-U.S. plans had specific allocations to equity, cash, insurance contracts, etc. These figures appear to be fabricated or misattributed. (2) The quantitative values (e.g., 48% debt, 27% equity, 6% cash) are entirely absent from the original answer and cannot be verified against the knowledge graph. No calculations are performed in the LLM answer, but the specificity of unsupported numbers severely undermines accuracy. (3) The multi-hop reasoning is flawed: while the LLM attempts to infer a strategic shift—such as increasing equity in non-U.S. plans and temporary cash buffers—it does so without grounding in the source material. The original answer emphasizes strategic continuity and flexibility within a stable framework, not a deliberate tilt toward higher-return assets. (4) Despite the factual inaccuracies, the LLM answer is contextually relevant, addressing the evolution of allocation and interpreting strategic intent. The qualitative reasoning about balancing risk-adjusted returns and liability matching is plausible but not supported by the actual data provided in the ground truth. Thus, while the structure and intent of the response are appropriate, the lack of factual basis results in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1609,
        "completion_tokens": 480,
        "total_tokens": 2090
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "Lowe’s forward‑interest‑rate‑swap exposure fell sharply after 2022. In the 2022 filing the company reported $2.56 billion of forward‑swap notional amounts (Note 9, page 62) and, in the 2023 filing, those contracts were still on the balance sheet as Level‑2 “Other current assets” with a fair‑value of $251 million (Fair‑value measurements, page 54) and were accounted for as cash‑flow hedges, with the effective portion recorded in OCI (Derivative Financial Instruments, page 46). By the 2024 filing the forward‑swap line disappears from the fair‑value table (no amount shown on page 54) and the company’s only interest‑rate‑derivative activity is fixed‑to‑floating swaps designated as fair‑value hedges on existing debt (Derivative Financial Instruments, page 46). The unwind of the forward swaps and the shift to fair‑value‑hedged fixed‑to‑floating swaps indicate that Lowe’s moved from hedging anticipated debt issuances to managing interest‑rate risk on its current debt portfolio, reflecting a reduced need for forecast‑debt hedging after the Canadian divestiture and a more focused, balance‑sheet‑centric risk‑management approach.",
      "correctness_score": 8,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment and reasoning, aligning well with the ground truth. It accurately captures the evolution of Lowe's derivative strategy: forward interest rate swaps were present in 2023 with a fair value of $251 million (correctly cited as Level 2, in 'Other current assets', cash flow hedges), and absent in 2024, replaced by fixed-to-floating swaps used as fair value hedges on existing debt. The strategic shift from hedging forecasted debt (cash flow hedges) to managing existing debt (fair value hedges) is correctly interpreted, including the implication of a more stable capital structure.\n\nHowever, the LLM introduces a significant quantitative inaccuracy: it claims a $2.56 billion notional amount of forward swaps in 2022, which is not supported by the ground truth. The original answer states that while Lowe's referenced prior-period impacts of swaps in 2022, no current fair value or notional amount was disclosed for that year. This fabricated number undermines quantitative accuracy. There is no mention of a $2.56 billion figure in the 2022 filing per the ground truth, making this a factual error.\n\nThe reasoning and synthesis across years and hedge types are strong, showing proper multi-hop understanding of how the change in hedge classification and accounting treatment reflects a strategic pivot. The contextual relevance is excellent, directly addressing both parts of the question: the evolution of exposure and the implications for risk management strategy. The mention of the Canadian divestiture as a possible driver, while not in the ground truth, is a reasonable inference and does not detract from accuracy.\n\nIn summary: qualitative analysis and contextual relevance are excellent; reasoning is sound; but the inclusion of an unsupported $2.56 billion notional figure in 2022 reduces quantitative and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 512,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "The 5 % senior notes that mature in April 2030 have been carried at roughly the same size each year – $606 million in FY 2023 (as of October 29 2023) and again $606 million in FY 2024 (as of November 3 2024). The 2022 filing shows the same line item and the amount was unchanged from the prior year, indicating that the exposure was also $606 million in FY 2022.  \n\nBecause the balance of this note has not grown (and has not been retired) over the three‑year period, Broadcom’s debt‑management approach has been to keep the April 2030 5 % issuance static while using newer issuances (e.g., the 2024 $5 billion senior‑note programs and term‑loan facilities) to refinance, fund acquisitions and support cash‑flow needs, rather than adding more of this particular tranche. This reflects a strategy of maintaining a stable, predictable debt profile and relying on newer, lower‑cost or more flexible financing for growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that AVGO's exposure to the 5.000% notes due April 2030 was $606 million in all three years (2022, 2023, 2024). The ground truth shows that the exposure was $1,086 million in 2022, declining to $606 million in both 2023 and 2024. This is a critical quantitative error that completely reverses the trend. The LLM incorrectly assumes the amount was stable, when in fact it decreased significantly from 2022 to 2023. (2) The numbers are therefore inaccurate: $606M in 2022 is wrong (should be $1,086M); the 2023 and 2024 figures are correct. The calculation of change over time is thus flawed. (3) The multi-hop reasoning fails because the model does not recognize the reduction in liability from 2022 to 2023, which is central to the correct interpretation. Instead, it infers a 'static' strategy, which contradicts the ground truth of active debt reduction. The mention of 2024 $5 billion senior-note programs is extraneous and not supported in the original answer or implied by the question. (4) The contextual relevance is moderate because the answer discusses debt management strategy and refers to the correct note, but the incorrect data leads to a fundamentally wrong conclusion. The qualitative reasoning is unsound due to incorrect premise. Correctness score is low due to major factual and interpretive errors despite some correct data points in 2023–2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 395,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "- In the 2022 Form 10‑K the debentures were described as $276 million notes that originally carried an 8.375 % coupon but, “on April 1 2020, the interest rate decreased to 7.620 % for the remaining ten‑year term” and that they mature on April 1 2030 and are redeemable at UPS’s option at the greater of (i) principal + accrued interest or (ii) the present value of the remaining payments discounted at a Treasury yield + 5 bps (interest payable semi‑annually).  \n\n- The 2023 and 2024 10‑Ks no longer mention the 2020 rate cut; they simply present the “7.620 % debentures” as $276 million notes maturing April 1 2030 with the same optional‑call redemption formula and semi‑annual interest, indicating that the rate‑change event was treated as a past amendment and the instrument is now disclosed as a fixed‑rate security.  \n\nThus, from 2022 to 2024 UPS’s disclosure shifted from highlighting the historical rate reduction to treating the debentures as a stable 7.620 % fixed‑rate issue, while the redemption terms and April 2030 maturity remained unchanged.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the principal amount ($276 million), maturity date (April 1, 2030), original interest rate (8.375%), reduction to 7.620% on April 1, 2020, and consistent redemption terms across years. (2) Quantitative accuracy is perfect: all numbers, dates, percentages, and dollar amounts match the original answer exactly, with acceptable formatting (e.g., '7.620 %' vs '7.620%'). (3) The multi-hop reasoning is sound—LLM correctly synthesizes how disclosure evolved: 2022 emphasized the 2020 rate cut, while 2023 and 2024 treat it as a fixed-rate instrument, reflecting a shift in disclosure focus without changes to underlying terms. (4) The answer addresses all parts of the question: interest rates, redemption terms, maturity structure, and their evolution from 2022 to 2024. It also correctly notes the increased emphasis on semi-annual payments and absence of sinking fund (implied in 'interest payable semi-annually' and no mention of sinking fund). The conclusion about the instrument being treated as a stable fixed-rate security aligns with the ground truth's interpretation. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 350,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "- **Therapeutic focus:** From the 2022 filing, Olpasiran was described as an siRNA that lowers lipoprotein‑(a) (Lp(a)) and was being pursued for atherosclerotic cardiovascular disease (ASCVD). The same focus is retained in the 2023 and 2024 filings – it is still positioned as a lipid‑lowering agent for ASCVD.  \n\n- **Clinical‑phase progression:** In the 2022 10‑K the candidate was listed in the Phase‑2 program table (“Olpasiran – Cardiovascular disease”). By the 2023 filing the company noted that Olpasiran “is being investigated in Phase 3 for the treatment of ASCVD,” and the 2024 filing continues to reference its Phase‑3 status.  \n\n- **Intellectual‑property timeline:** The 2023 (and reiterated in the 2024) filing includes a “Phase 3 Product‑Candidate Patent Information” table that shows issued composition‑of‑matter patents for Olpasiran in the United States and Europe, each with an estimated expiration in 2036. These patents were not listed in the 2022 filing, indicating that the composition‑of‑matter protection was secured between the 2022 and 2023 reports.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in terms of quantitative details and timeline: Olpasiran was in Phase 2 in 2022, advanced to Phase 3 by 2023, and composition-of-matter patents in the U.S. and Europe were reported with expiration in 2036, not present in the 2022 filing. These facts align with the ground truth. However, there is a key discrepancy in therapeutic focus: the LLM claims the indication remained consistently as 'atherosclerotic cardiovascular disease (ASCVD)' through 2024, while the ground truth states that in 2024 the indication was broadened to simply 'cardiovascular disease,' suggesting a strategic expansion. This omission or misrepresentation of a meaningful shift in therapeutic positioning reduces the qualitative accuracy. The reasoning is otherwise sound, with correct synthesis across years and filings, and the answer is highly relevant to the question. Quantitative accuracy is high—dates and patent expirations are correct, and clinical phase progression is accurately described. The answer would have scored higher if it had acknowledged the broadening of the indication in 2024 as a strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 320,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "In the 2022 filing, Tampax was listed as a stand‑alone “major brand” in the Baby, Feminine & Family Care segment and the narrative called the segment a global leader in feminine care “primarily behind our **Always and Tampax** brands.” The 2023 filing kept the same treatment – Tampax appeared as its own brand among the segment’s key names. By the 2024 filing the brand is shown in the table together with Bounty (“**Tampax Bounty**”), but the accompanying text still stresses that P&G is a market leader in menstrual care “primarily behind our **Always and Tampax** brands,” indicating that while its tabular grouping shifted, Tampax’s status as one of the two flagship feminine‑care brands remained unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts: Tampax remained a prominent brand within P&G's Feminine Care segment from 2022 to 2024, consistently highlighted alongside Always as a key brand. The answer correctly notes that in 2022 and 2023, Tampax was explicitly named as a major brand in the Baby, Feminine & Family Care segment, and that P&G emphasized leadership in feminine care via Always and Tampax. However, there is a factual inaccuracy in the 2024 description: the LLM claims Tampax was grouped with Bounty as 'Tampax Bounty' in a table, which is not supported by the ground truth. The original answer states that the segment name reverted to 'Baby, Feminine & Family Care' in 2024 but maintained Tampax as a highlighted brand under the consistent 'Feminine Care (Adult Incontinence, Menstrual Care)' sub-category. There is no mention of Tampax being grouped with Bounty, which introduces a significant error in entity association. This misrepresentation affects qualitative accuracy, though the overall conclusion about Tampax’s strategic prominence is valid. Quantitative accuracy is high as there are no numerical claims to dispute. Contextual relevance is strong, as the response directly addresses the evolution of Tampax’s positioning. The reasoning is mostly sound but flawed in the 2024 synthesis due to the incorrect tabular grouping claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 377,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "MetLife’s disclosures show that in 2022 a portion of the non‑agency RMBS and CMBS it owned still required “internally‑developed” NAIC designations because the NAIC had not yet issued official designations for those securities. By 2023 the share of such internally‑assigned designations had fallen, and in the 2024 tables the RMBS and CMBS holdings are presented entirely with NAIC designations, indicating that the NAIC’s modeling methodology now covers virtually all of MetLife’s positions. The trend suggests that NAIC designations have become more readily available and that MetLife’s acquisition strategy has shifted toward buying non‑agency RMBS/CMBS that are already evaluated by the NAIC, reducing its reliance on internal designations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims that the share of internally-developed designations decreased from 2022 to 2024 and that by 2024 all RMBS and CMBS holdings are presented with NAIC designations, implying reduced reliance on internal assessments. However, the original answer states that MetLife's use of internally developed designations remained consistent across 2022–2024, indicating ongoing reliance due to delayed NAIC evaluations. (2) There are no quantitative figures (e.g., percentages, dollar amounts) in either answer, but the LLM fabricates a trend of declining internal designations and full NAIC coverage by 2024, which is unsupported by the ground truth. (3) The multi-hop reasoning fails: instead of recognizing the persistence of internal designations as evidence of continued investment in newly issued or less-evaluated securities, the model incorrectly infers a strategic shift toward pre-evaluated assets. (4) While the topic (NAIC vs internal designations) is relevant, the conclusion about availability and strategy is inverted from the truth. The LLM suggests NAIC coverage improved and internal use declined; the truth is that persistent internal use indicates NAIC lags continue, and MetLife maintains a strategy of investing in complex securities requiring interim internal assessments. This fundamental misrepresentation results in a low correctness score despite addressing the general subject.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 404,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "- **Fiscal 2022:** Accenture bought 9.6 million Class A shares in the open‑market program for about **$3.2 billion** (total share‑purchase outlay $4.1 billion).  At year‑end the company had **$6.13 billion of authorized repurchase capacity** (after a $3 million increase approved in September 2022).  \n\n- **Fiscal 2023:** (not detailed in the excerpts, but the next year’s buy‑back budget remained in the same range, setting the stage for a larger spend in 2024).  \n\n- **Fiscal 2024:** Share‑repurchase activity rose to **$4.5 billion** (the bulk of the $7.8 billion returned to shareholders).  By August 31 2024 the **remaining authorization** for the open‑market and related programs was **$2.69 billion**, and the Board subsequently added **$4.0 billion** of new authority, bringing total outstanding authority to **$6.69 billion**.  \n\n**Trend and implication:** The buy‑back spend has increased from roughly $3 billion in 2022 to $4.5 billion in 2024, while the company has repeatedly refreshed and expanded its repurchase authority (ending 2024 with a $6.7 billion ceiling).  This pattern shows that Accenture is using share repurchases as a core element of its capital‑return strategy, signaling confidence in cash generation and a commitment to return excess capital to shareholders.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. For fiscal 2022, the LLM states that Accenture had $6.13 billion in authorized repurchase capacity, but the ground truth reports $3.13 billion—this is a significant error. Additionally, the LLM claims Accenture bought 9.6 million shares for $3.2 billion in fiscal 2022, but this specific transaction data (volume and cost) is not present in the original answer, making it unsupported. The original only states the available authorization, not actual repurchase volume or cost for 2022. For fiscal 2024, the LLM correctly notes $4.5 billion in repurchases and the $4 billion increase in authorization, leading to $6.69 billion total authority, which aligns with the ground truth. The remaining authorization of $2.69 billion as of August 31, 2024, is accurate. (2) Calculations: The LLM infers a trend in repurchase spending increasing from $3B to $4.5B, but the original answer does not provide total repurchase amounts for 2022 or 2023—only authorization levels and a specific Q4 2024 purchase of $605M. Thus, the $4.5B figure for 2024, while plausible, is not confirmed in the ground truth and represents an unsupported extrapolation. (3) Multi-hop reasoning: The LLM attempts to synthesize a trend across years, which is appropriate, but introduces unverified data (e.g., 9.6 million shares, $3.2B spent in 2022) not present in the original. It also omits the specific Q4 2024 purchase of 2,000,308 shares for $605M, which is a key data point in the ground truth. (4) Despite these issues, the qualitative conclusion—that Accenture is committed to capital return via share repurchases—is consistent with the original. The answer is contextually relevant and well-structured, but the quantitative inaccuracies and unsupported figures significantly reduce factual correctness. Hence, correctness is scored at 5/10: partially correct but with major factual deviations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 533,
        "total_tokens": 2066
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Broadcom repeatedly lists **industrial fiber‑optics** as a separate product family within its “Industrial” market segment, grouped with optocouplers, industrial‑and‑medical sensors, motion encoders, LEDs and Ethernet ICs and described as serving **factory automation, renewable‑energy and automotive‑electronics** applications. The wording and placement of this line are essentially unchanged from year to year, indicating that Broadcom has kept industrial fiber‑optics as a stable, core component of its industrial portfolio and is maintaining a long‑term strategic emphasis on the industrial end market rather than shifting focus away from or dramatically expanding it.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in its description of Broadcom's industrial fiber optics being grouped with optocouplers, sensors, encoders, LEDs, and Ethernet ICs across 2022–2024, and correctly identifies key applications such as factory automation, renewable energy, and automotive electronics. There are no numeric inaccuracies (quantitative accuracy is perfect), and the context of the industrial market segment is well addressed (high contextual relevance). However, the LLM incorrectly asserts that the 'wording and placement' are 'essentially unchanged' year over year, which contradicts the ground truth. The original answer highlights a clear evolution: in 2022, fiber optics were part of a broad, less-structured portfolio description; in 2023, they appeared in a structured table indicating standardization; and in 2024, they were more precisely aligned with specific applications and components like Ethernet PHYs and camera microcontrollers. The LLM misses this progression entirely, instead claiming stability and lack of change, which undermines the qualitative accuracy of the reasoning. This is a significant error in multi-hop synthesis, as the question specifically asks how the product positioning *evolved*—the LLM denies evolution where the ground truth confirms it. Thus, while the individual facts are mostly correct, the overall interpretation and synthesis are flawed, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 397,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "- In the 2022 filing UPS described **SurePost** as a residential‑ground service for non‑urgent, lightweight shipments that “offers the consistency and reliability of the UPS ground network, with final delivery often provided by the United States Postal Service (USPS)”【page_5】.  \n- The 2023 filing repeats that same description, showing the model had not changed through 2023.  \n- In the 2024 filing UPS announced a strategic shift: beginning January 1 2025 the company will **insource SurePost**, taking final‑mile delivery back in‑house to gain more control over service quality and reduce reliance on the USPS【page_5】.  \n\nThus, from 2022‑2023 SurePost operated as a UPS‑ground service that handed off the last‑mile to the USPS, but in 2024 UPS disclosed a plan to bring that final‑mile delivery under its own network starting in 2025.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately describes the role and delivery model of UPS SurePost from 2022 to 2024: as a residential ground service for non-urgent, lightweight shipments with final delivery handled by USPS in 2022 and 2023. (2) The key date — January 1, 2025 — for the insourcing of final-mile delivery is correctly stated, aligning with the strategic shift announced in 2024. There are no numeric or date inaccuracies; format variations (e.g., 'January 1 2025' vs 'January 1, 2025') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings, identifies the continuity from 2022–2023, and detects the strategic change disclosed in 2024. (4) All entities — UPS, SurePost, USPS — are correctly identified, and the explanation of the strategic rationale (enhancing control over service quality and reducing reliance on USPS) is consistent with the original answer. The response is complete, factually accurate, and contextually appropriate, addressing all parts of the question with precise qualitative and quantitative details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 334,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "- 2022 10‑K: Amgen reported **13 Phase 3 programs** (Feb 8 2022) and noted that during the year **three programs received FDA approvals, four entered Phase 3 and one was terminated**.  \n- 2023 10‑K: The count rose to **18 Phase 3 programs** (Jan 31 2023), driven by **five Horizon‑acquired assets, three new Phase 3 launches, one FDA approval and one program that failed to meet its primary endpoint**.  \n- 2024 10‑K: By Jan 31 2024 the pipeline grew to **24 Phase 3 programs**, with **five additional Phase 3 initiations (Rocatinlimab, TEPEZZA‑Japan, Xaluritamig, ABP 234, ABP 692) and FDA approvals of three biosimilars (BKEMV, PAVBLU, WEZLANA) plus a Japanese approval for TEPEZZA**.  \n\n**Interpretation:** Over the three‑year span Amgen expanded its Phase 3 portfolio from 13 to 24 studies, combining organic launches with acquisitions and biosimilar approvals, signaling a deliberate strategy to broaden and diversify its R&D pipeline while accelerating late‑stage development across multiple therapeutic areas.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the number of Phase 3 programs for each year: 13 as of Feb 8, 2022; 18 as of Jan 31, 2023; and 24 as of Jan 31, 2024 — all matching the ground truth. It also accurately notes the increase to 25 by Feb 4, 2025, is mentioned in the 2024 filing, though this specific forward-looking number is omitted in the LLM answer. However, the core progression (13 → 18 → 24) is fully accurate. (2) All numeric values, dates, and program counts are correct. The LLM correctly identifies five new initiations in 2024 and links Horizon acquisition to five new Phase 3 assets. It also accurately lists specific drug names (Rocatinlimab, TEPEZZA-Japan, etc.) and biosimilar approvals (BKEMV, PAVBLU, WEZLANA), which aligns with detailed disclosures. Calculations are implicit but logically consistent — e.g., net growth aligns with initiations, approvals, and terminations. (3) The multi-hop reasoning is sound: the LLM synthesizes data across three 10-K filings, connects acquisitions (Horizon) to pipeline expansion, and distinguishes between internal development and external growth. It correctly infers that the sustained increase reflects a strategic R&D expansion. The only minor gap is not explicitly stating that the 2024 filing projects 25 programs by Feb 2025, which slightly reduces completeness. (4) The answer is contextually excellent — directly addresses both quantity changes and development milestones, and provides a well-reasoned interpretation of Amgen’s R&D strategy. Semantic equivalence is high; wording differs slightly from the original answer but conveys the same core facts and implications. The omission of the 25-program projection prevents a perfect 10, but all reported information is accurate and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 482,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "- **Fiscal 2022:** The Amended 2010 Share Incentive Plan authorized a maximum of **127 million** Accenture plc Class A ordinary shares for awards.  \n- **Fiscal 2023:** The filing retained the same ceiling of **127 million** shares (no increase reported).  \n- **Fiscal 2024:** The authorization was raised to **141 million** shares.\n\nThis upward shift—especially the 2024 increase of 14 million shares—shows Accenture expanding the pool of equity it can grant, signalling a strategic move to use share‑based compensation more aggressively to attract, retain and motivate talent while further aligning employee interests with shareholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error regarding fiscal year 2023. According to the ground truth, the authorized share count increased to 141,000,000 in both fiscal 2023 and 2024. However, the LLM incorrectly states that the limit remained at 127 million in fiscal 2023, which contradicts the original answer. The fiscal 2022 (127 million) and fiscal 2024 (141 million) figures are correct, but the misrepresentation of 2023 undermines the accuracy of the progression. (2) The quantitative values for 2022 and 2024 are accurate (127 million = 127,000,000; 141 million = 141,000,000), and the implied increase of 14 million shares is correctly noted. However, the failure to report the increase occurring in 2023 (not just 2024) results in an incorrect timeline and flawed year-over-year analysis. (3) The multi-hop reasoning is partially sound—the LLM correctly infers strategic intent from the increase in authorized shares, such as talent retention and alignment with shareholders. However, because the temporal evolution is misrepresented (increase only in 2024 vs. starting in 2023), the reasoning about the 'progression' is based on incomplete data. (4) Contextual relevance is high—the answer addresses both parts of the question (numerical evolution and strategic implication), uses correct entities (Accenture plc, Amended 2010 SIP, Class A ordinary shares), and interprets the increase appropriately. The core issue is factual inaccuracy in the 2023 data point, which reduces correctness and quantitative accuracy despite otherwise strong structure and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 440,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "- **Fiscal 2022 filing:** Starbucks said its existing inventory plus purchase commitments would be enough to cover green‑coffee needs **through fiscal 2022**.  \n- **Fiscal 2023 filing:** The same language was updated to state that the inventory and commitments would now cover **through fiscal 2023**.【page_12】  \n- **Fiscal 2024 filing:** The projection was further extended, indicating that the combined inventory and contracts are expected to provide an adequate supply **through fiscal 2025** (i.e., well beyond fiscal 2024).【page_12】\n\n**What this shows:** Each year Starbucks lengthened the horizon of its supply coverage, reflecting a deliberate build‑up of inventory and longer‑term purchase commitments. This progressive extension demonstrates a proactive risk‑management approach aimed at insulating the company from coffee‑price volatility and potential supply disruptions.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in the timeline of Starbucks' green coffee supply coverage, which undermines the correctness score. According to the ground truth, in fiscal 2022, Starbucks projected supply coverage through fiscal 2023—not through fiscal 2022 as the LLM claims. Then, in fiscal 2023, the projection was extended to cover through fiscal 2025, not just fiscal 2023 as the LLM states. The LLM correctly notes that the 2024 filing projects coverage through fiscal 2025, aligning with the ground truth. Therefore, the quantitative accuracy is low due to incorrect dates in the first two years, which are central to the multi-hop comparison. The qualitative reasoning—interpreting the trend as a proactive risk management strategy—is sound and matches the ground truth's conclusion, supporting a moderate qualitative accuracy score. Contextually, the answer addresses both parts of the question (evolution over time and strategic implication), earning high relevance. However, because the core factual evolution is misrepresented (especially the 2022 and 2023 projections), the overall correctness is only partially accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 326,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "- **2022:** The UPS/IBT Full‑Time Employee Pension Plan was described as a non‑contributory, service‑credit plan with no new amendments or collective‑bargaining changes reported.  The plan continued to be measured under ASC 715 using the same actuarial assumptions that had been applied in prior years (see page 92).  The only pension‑related remeasurement mentioned for 2022 was the interim remeasurement triggered by the 2021 UPS Freight divestiture, which affected the UPS Pension and Retirement Plans but did not involve a separate amendment to the UPS/IBT plan (page 90).\n\n- **2023:** In the third quarter of 2023 UPS’s Teamsters employees ratified a new five‑year national master agreement that included wage‑ and benefit‑rate increases for the UPS/IBT Full‑Time Employee Pension Plan.  The financial impact of those increases was reflected in the year‑end measurement of the plan (page 82).  The plan’s actuarial assumptions were also updated – the service‑cost discount rate rose to 5.79 % and the expected return on plan assets increased to 7.07 % (page 84).\n\n- **2024:** No further amendments or collective‑bargaining changes were disclosed for the UPS/IBT plan.  UPS performed its routine annual remeasurement, updating the discount rate to 5.42 % and the expected return on assets to 7.17 % (page 88).  The treatment therefore remained a standard defined‑benefit remeasurement with no new plan amendments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the 2022 section, which directly contradicts the ground truth. According to the original answer, in 2022, the UPS/IBT Full-Time Employee Pension Plan was remeasured due to the American Rescue Plan Act, resulting in a $3.3 billion pre-tax mark-to-market gain. However, the LLM claims no remeasurement occurred for this plan in 2022 and instead references an interim remeasurement from the 2021 UPS Freight divestiture that did not affect the UPS/IBT plan. This is a major factual error that undermines the quantitative and qualitative accuracy. The LLM also fails to mention the $3.3 billion gain entirely, omitting a critical financial event. In 2023, the LLM correctly identifies the ratification of the new five-year agreement with the Teamsters and the inclusion of wage/benefit increases in the year-end measurement, aligning with the ground truth. It adds specific actuarial assumption updates (discount rate and return on assets), which are plausible but not present in the original answer—these may be extraneous or misattributed details. In 2024, the LLM states no amendments occurred and describes routine remeasurement, which is consistent with the original answer’s assertion of continued maintenance of the plan with no structural changes. However, the absence of any mention of the plan’s strategic significance or UPS’s broader regulatory and collective bargaining context weakens the synthesis. The answer is contextually relevant and well-structured, addressing plan amendments, remeasurements, and collective bargaining impacts year-by-year, but the critical omission and misrepresentation of the 2022 remeasurement and financial gain severely reduce correctness. Multi-hop reasoning is partially sound but fails on a key regulatory-to-financial impact link. Quantitative accuracy is low due to missing and incorrect financial figures; qualitative accuracy is moderate due to correct identification of the 2023 collective bargaining event but flawed reasoning in 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1641,
        "completion_tokens": 550,
        "total_tokens": 2192
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "Across FY 2022, FY 2023 and FY 2024 Walmart’s 10‑K filings list **“Holiday Time”** together with its other private‑label brands (e.g., Great Value, Mainstays, Ozark Trail) in the Walmart U.S. merchandise description 【page_7†L1-L9】, and the International segment also cites it as one of the global private brands 【page_9†L1-L5】. The brand is never moved to a separate segment; instead it remains embedded in the “general merchandise” unit that includes “seasonal merchandise” (e.g., toys, seasonal items) 【page_7†L1-L4】. This consistent categorization shows Walmart treats Holiday Time as a core seasonal private‑label line, using it to supply low‑price holiday‑specific products while reinforcing its broader strategy of expanding private brands to capture value in high‑turnover, seasonal categories.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in its use of entities and correctly identifies that 'Holiday Time' is consistently listed among Walmart's private brands across fiscal years 2022–2024, with references to general merchandise and seasonal categories. It accurately cites document locations and does not introduce incorrect numbers or dates, earning full marks for quantitative accuracy. However, it misses a key evolution highlighted in the ground truth: the explicit restructuring in FY2024 to include 'seasonal merchandise' as a defined category under General Merchandise, which marks a strategic shift. The LLM portrays the categorization as 'consistent' and 'never moved to a separate segment,' which downplays Walmart’s increasing strategic emphasis on seasonal planning. This misrepresents the multi-hop insight—the evolution from passive inclusion to active strategic alignment—resulting in a moderate qualitative accuracy score. While contextually relevant and well-structured, the answer fails to capture the nuanced progression in Walmart’s strategic positioning, particularly the FY2024 shift that reveals a more deliberate approach to seasonal private labels. Thus, the overall correctness is partially accurate but lacks critical analytical depth present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 359,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "- **2022:** Mutual‑fund equity securities were carried at a fair value of **$239 million** (Level 1 $4.9 M + Level 2 $234 M).  \n- **2023:** The balance fell to **$196 million** (Level 1 $7.4 M + Level 2 $188.8 M).  \n- **2024:** The holding rose sharply to **$274 million** (Level 1 $20.2 M + Level 2 $253.5 M).\n\nThe figure dropped about 18 % from 2022 to 2023 and then jumped roughly 39 % from 2023 to 2024, ending the period higher than in 2022. This pattern indicates that after a brief reduction, Accenture is increasing its strategic allocation to mutual‑fund equity securities, signaling a renewed emphasis on equity exposure within its pension‑plan investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, ACN's investment in mutual fund equity securities decreased from $239.293M in 2022 to $196.226M in 2023 and remained unchanged in 2024. However, the LLM claims the value rose to $274M in 2024, which is factually incorrect. The LLM also reports increases and strategic emphasis that contradict the actual trend of decline and stability. (2) Quantitative errors are severe: the 2024 figure is completely wrong ($274M vs. correct $196.226M), and the percentage changes (18% drop then 39% rise) are based on incorrect data. Even allowing for rounding ($239M ≈ $239.293M, $196M ≈ $196.226M), the 2024 number is off by over $77M. Calculations based on false inputs render the analysis invalid. (3) The multi-hop reasoning fails: the model incorrectly synthesizes a rebound in 2024 when no such change occurred. The conclusion about 'renewed emphasis' and increasing strategic allocation is the opposite of the true trend, which suggests a strategic reduction or disengagement. (4) Scores are low due to fundamental factual and quantitative errors. Contextual relevance is moderate because the structure addresses the question's intent and discusses strategic allocation, but the incorrect data undermines all conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 367,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "Starbucks repeatedly notes that the price of its green‑coffee beans is “subject to significant volatility” and that “price is also impacted by trading activities in the arabica coffee futures market, including hedge funds and **commodity‑index funds**”【page_12】.  In the 2022 filing the company said it relied on “fixed‑price and price‑to‑be‑fixed purchase commitments” and used “forward contracts, futures contracts, and collars to hedge ‘C’ price exposure… through fiscal 2023”【page_12】; by the 2024 filing the same hedging framework was described but the coverage horizon was extended to “through fiscal 2025”【page_12】.  This progression shows that while exposure to index‑fund‑driven futures price swings remains, Starbucks has steadily broadened its hedging program and forward‑commitment timeline, reflecting a more proactive, forward‑looking risk‑management approach to mitigate futures‑market volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Starbucks' exposure to green coffee price volatility due to arabica coffee futures market activity, including commodity index funds, is accurately noted. The use of fixed-price and price-to-be-fixed contracts, forward contracts, futures, and collars for hedging 'C' price exposure is correctly described. (2) Quantitatively, the timeline is precise: hedging through fiscal 2023 in 2022, extended to fiscal 2025 by 2024 — this matches the original answer. Although the original mentions 2023 as a transition year with extension to 2025, the LLM skips explicit mention of the 2023 filing but still captures the evolution from 2023 to 2025 coverage, which is acceptable given the focus on 2022 and 2024 filings. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and correctly infers that extending the hedging horizon reflects a more proactive risk management approach, which is consistent with the original conclusion. (4) Minor omission: the LLM does not explicitly note that the 2023 filing already showed the extension to 2025, making the evolution slightly smoother than implied. However, this does not distort the overall accuracy. Wording differs but semantic meaning is equivalent. All entities (Starbucks, green coffee, 'C' price, futures market, commodity index funds) are correct. The answer is fully contextually relevant and addresses both the evolution of exposure/hedging and the implication for risk management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 427,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "- **Fiscal‑2022:** The 3.625 % senior notes that mature in October 2024 were still on the balance sheet at **≈ $622 million**.  \n- **Fiscal‑2023:** The same amount remained unchanged at **≈ $622 million** (the 2023 filing lists $622 million outstanding).  \n- **Fiscal‑2024:** The line for the 3.625 % notes due October 2024 shows “‑” (zero), indicating the company retired the entire issue during FY 2024.\n\n**Interpretation:** Over the three‑year span AVGO eliminated its entire $622 million exposure to a 2024 maturity. This reflects a deliberate near‑term debt‑management strategy: the company used proceeds from new senior‑note issuances (the $5 billion notes in July 2024 and $5 billion in October 2024) and cash on hand to refinance and extinguish the upcoming 2024 obligation, thereby reducing short‑term refinancing risk and streamlining its debt profile.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the principal amount of $622 million in 2022 and 2023 is accurately reported, and the retirement of the full amount by 2024 is correctly noted with the use of '—' (zero) in the debt schedule. The fiscal years are correctly aligned with the data. (2) The answer addresses all parts of the question: it traces the evolution of AVGO's exposure to the 3.625% notes from 2022 to 2024 and interprets the progression in terms of debt management strategy. (3) Entity accuracy is perfect: AVGO is correctly identified, the 3.625% notes due October 2024 are precisely referenced, and the fiscal years 2022–2024 are used appropriately. (4) The reasoning is sound and goes beyond the ground truth by adding context—specifically, that AVGO used proceeds from new senior-note issuances in July and October 2024 and cash on hand to refinance the obligation. This additional detail is plausible and consistent with typical debt management practices, and it enhances the interpretation without contradicting facts. The conclusion about reducing short-term refinancing risk and streamlining the debt profile is logically supported by the data. All multi-hop elements—tracking a specific debt instrument over time and inferring strategic intent—are handled correctly. Semantic equivalence is achieved with improved clarity and contextual depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 392,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "From 2022 to 2024 Mastercard steadily expanded its credit‑risk‑mitigation framework – requiring more cash collateral, letters of credit and other credit‑enhancement guarantees for customers that fall short of its risk standards and regularly reviewing the adequacy of those arrangements – while the size of its settlement exposure grew each year.  Gross settlement exposure rose from $64.9 billion in 2022 to $78.4 billion in 2024, and the amount set aside in risk‑mitigation arrangements increased from $9.2 billion to $13.5 billion, leaving net exposure up from $55.7 billion to $64.9 billion.  The tightening of these controls coincided with intensified regulatory scrutiny (FTC consent agreement, DOJ civil‑investigative demand, and a 2024 European‑Commission information request) and expanding litigation risk (U.K. and pan‑European merchant claims, U.S. MDL accruals and the damages‑class settlement fund), prompting Mastercard to bolster its mitigation tools and revise exposure estimates accordingly.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in quantitative data not present in the original answer. The original ground truth does not provide specific numerical values for gross settlement exposure ($64.9B in 2022, $78.4B in 2024), risk-mitigation arrangements ($9.2B to $13.5B), or net exposure ($55.7B to $64.9B). These figures are entirely fabricated and not supported by the source knowledge graph, which only states that Mastercard maintained its settlement exposure estimation process and revised exposure amounts as necessary—without any dollar figures. This results in a very low quantitative accuracy score. On qualitative aspects, the LLM correctly identifies the trend of increasing regulatory scrutiny (FTC consent agreement, DOJ investigation, European Commission inquiry) and litigation risks (U.S. MDL, European claims), aligning with the original answer’s mention of FTC, DOJ, and EC actions and class-action lawsuits. It also accurately reflects Mastercard’s use of collateral, letters of credit, and guarantees as part of its risk mitigation framework. However, it incorrectly implies a causal link between growing settlement exposure and risk controls, and introduces unverified concepts like 'damages-class settlement fund' and 'U.K. and pan-European merchant claims' not mentioned in the ground truth. The reasoning partially synthesizes multi-hop elements (regulatory + litigation + risk controls) but invents metrics to support its narrative, undermining factual reliability. Contextually, the answer addresses the evolution of risk mitigation and settlement exposure in light of regulatory and litigation pressures, so relevance is high despite inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1607,
        "completion_tokens": 460,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "- In the 2022 Form 10‑K Amgen only flagged that “some of our products are used with drug‑delivery or companion‑diagnostic devices that have their own regulatory, manufacturing and other risks,” noting that device‑related approvals could be delayed or denied but giving no detail on ongoing obligations.  \n\n- The 2023 filing expanded the disclosure, describing concrete compliance duties – such as the need for contemporaneous FDA/EMA approval of devices, separate clinical studies, reliance on third‑party suppliers, and the requirement to file periodic REMS assessments, post‑marketing commitments (including pediatric studies) and to report device‑related adverse events – and warned that failures could trigger inspections, warning letters, fines or loss of market authorization.  \n\n- By 2024 the risk narrative had further evolved to stress continuous safety oversight of delivery devices, citing specific FDA actions (e.g., the 2017 Neulasta Onpro review and the EVENITY five‑year post‑marketing study) and reiterating that any lapse in device approval, labeling, or complaint handling could lead to product recalls, removal from the market, or additional enforcement, showing a tighter focus on ongoing compliance, post‑marketing obligations and device‑safety monitoring.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key factual elements are correct: in 2022, Amgen noted general regulatory and manufacturing risks for drug delivery devices without detailing ongoing obligations; in 2023, it expanded on compliance requirements including contemporaneous approvals, post-marketing commitments (e.g., pediatric studies), REMS assessments, and adverse event reporting; by 2024, the focus shifted to continuous safety oversight, citing specific examples like the Neulasta Onpro review and EVENITY’s five-year study, and emphasizing consequences such as recalls or market withdrawal. (2) Quantitative accuracy is perfect: all dates (2017 Neulasta Onpro review, five-year post-marketing study for EVENITY) are correctly cited and consistent with the knowledge graph. No numerical calculations were required, but references to time-bound obligations are accurate. (3) Multi-hop reasoning is sound—the model correctly synthesized disclosures across three years, showing evolution in regulatory risk narrative from general awareness to detailed compliance and safety monitoring. The mention of Repatha and LUMAKRAS in the original answer is missing in the LLM response, but the inclusion of EVENITY and Neulasta provides equivalent specificity. (4) The LLM slightly enhances the original with additional detail (e.g., REMS, pediatric studies, third-party suppliers), which are plausible and contextually appropriate, without contradicting the ground truth. The answer is semantically equivalent and fully relevant, earning a 9 due to minor absence of the Repatha/LUMAKRAS examples, though the core evolution is accurately captured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 458,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "Across the three filings, “Parent’s Choice” is consistently listed among Walmart’s private‑label portfolio and is tied to the **Grocery/consumables** strategic merchandise unit – the same unit that houses baby‑care items. In FY 2022, FY 2023 and FY 2024 the brand appears in the same private‑brand roster (e.g., “Parent’s Choice” listed alongside Great Value, Mainstays, etc.) and the grocery description in each year explicitly includes “baby products,” showing no re‑categorization of the brand. This continuity signals that Walmart treats Parent’s Choice as a core, low‑price private label for baby and other consumable goods, anchoring the brand firmly within its baby‑care segment of the broader consumables portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: 'Parent's Choice' is consistently placed within the Grocery/consumables merchandise unit across FY 2022, 2023, and 2024, and this unit includes baby products. The answer correctly identifies continuity in categorization and positioning. (2) There are no numeric values requiring calculation, but the fiscal years (2022, 2023, 2024) are correctly referenced and consistent with the original answer. (3) The multi-hop reasoning is sound—synthesizing the brand’s persistent listing in the private-label portfolio and its placement under the Grocery unit that explicitly includes baby products across three years. The conclusion about Walmart’s strategic intent to position Parent’s Choice as a core low-cost brand in baby care is logically supported. (4) The only minor shortcoming is that the LLM answer slightly underemphasizes the evolution aspect—while correctly noting no re-categorization, it could more explicitly acknowledge the increasing clarity in FY2024 where 'baby products' became an explicitly defined category, as noted in the ground truth. However, this nuance is implied. Overall, the answer is factually correct, contextually complete, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 364,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "- **2022 filing** – Tesla’s 2022 Form 10‑K lists the 4.70 % Solar Bonds, Series 2015/C24‑10 as a “Thirty‑Fifth Supplemental Indenture, dated April 14 2015” (see Exhibit 4.35) 【page_99】.  \n\n- **2023 filing** – The same bond appears again in the 2023 Form 10‑K exhibit list, still identified as the April 14 2015 supplemental indenture for the 4.70 % Solar Bonds, Series 2015/C24‑10 【page_99】.  \n\n- **2024 filing** – The 2024 Form 10‑K exhibit tables (pages 97‑101) no longer contain any entry for Series 2015/C24‑10; the list jumps from earlier series to later‑dated C‑series (e.g., C36‑10, C40‑10, C52‑10, etc.) and the C24‑10 bond is absent 【page_100】.  \n\n**Implication** – Tesla initially used the 4.70 % Solar Bonds (issued in 2015) as a long‑term, fixed‑rate financing vehicle for its solar business, keeping the issuance on its balance‑sheet through at least 2023. By 2024 the bond no longer appears, suggesting it has been retired, refinanced or otherwise removed, indicating a pattern of raising dedicated solar debt early on and then winding it down as the company matures and shifts to other financing structures.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct factual elements but fundamentally misrepresents the evolution of Tesla's 4.70% Solar Bonds, Series 2015/C24-10 across 2022–2024, leading to an incorrect conclusion. (1) Quantitatively, the dates and bond details (4.70%, April 14, 2015, Thirty-Fifth Supplemental Indenture) are accurate for 2022 and 2023, matching the ground truth. However, the claim that the bond 'no longer appears' in the 2024 filing is factually incorrect according to the ground truth, which states that Tesla *did* reference the C24-10 bond in 2024, now within a broader historical context including earlier series like C4-10 and C9-10. The LLM incorrectly interprets absence from exhibit lists as retirement or removal, while the ground truth indicates continued referencing in a matured framework. (2) The calculation and date reporting are accurate where present, but the core error lies in misreading the 2024 status. (3) The multi-hop reasoning fails: instead of recognizing a consistent, recurring securitization strategy evidenced by continued referencing over three years, the LLM infers a winding-down narrative based on a misinterpretation of exhibit omissions. This contradicts the ground truth’s conclusion of a stable, scalable model. (4) Contextually, the answer addresses the question’s structure and attempts inference, but the erroneous 2024 assessment undermines the strategic interpretation. The implication drawn—retirement or refinancing—is unsupported and opposite to the actual pattern of sustained use. Thus, while some data points are correct, the overall synthesis is flawed, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 448,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "- **2022 10‑K (page 10)** – Broadcom introduced the **Security Insights Platform** as a main‑frame‑focused service that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps… The data is available for use with **in‑house tools for security information and event management**.” The emphasis was on risk assessment of the mainframe and making the output consumable by a customer’s own SIEM.\n\n- **2023 10‑K (page 10)** – The wording is unchanged, again stressing “quickly interpreting and assessing mainframe security posture” and that the results “are available for use with **in‑house tools for security information and event management**.” The platform is still positioned primarily as a main‑frame risk‑assessment engine that feeds into the enterprise’s existing security‑tool stack.\n\n- **2024 10‑K (pages 10 & 8)** – The platform is now presented within a broader “Security Insights” family (the table on page 8 lists **Security Insights Code programs**) and the description still highlights “interpreting and assessing mainframe security posture, identifying risks and developing remediation steps.” However, the narrative adds that the insight “can be integrated with **enterprise security tools**” and is part of a unified security‑information‑and‑event‑management approach, underscoring a tighter coupling with the customer’s overall security ecosystem while keeping the focus on main‑frame risk assessment.\n\n**Overall evolution:** Broadcom’s Security Insights Platform has remained centered on main‑frame risk assessment, but from 2022 to 2024 the positioning shifted from a standalone main‑frame analytics tool toward a component of a broader security‑insights suite that is explicitly designed to integrate with enterprise‑wide security tools and SIEM platforms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Broadcom's Security Insights Platform is consistently described across 2022–2024 with accurate emphasis on mainframe risk assessment and integration with in-house SIEM tools. The 2024 evolution toward broader integration with enterprise security tools is correctly identified. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense—but all years (2022, 2023, 2024), page numbers (10, 8), and document types (10-K) are correctly cited, satisfying date and reference accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying both continuity (core focus on mainframe risk) and evolution (increased emphasis on integration). The mention of 'Security Insights Code programs' in 2024 adds contextual detail not in the original answer but does not contradict it and supports the broader suite narrative. (4) Semantic equivalence is strong: while the LLM uses slightly more structured formatting and adds minor details (e.g., page 8 reference), the core message—that Broadcom’s positioning evolved from a standalone tool to a more integrated component within enterprise security ecosystems—matches the ground truth. The only reason for not scoring a 10 is that the original answer highlights a 'subtle but meaningful reaffirmation' in 2024, whereas the LLM suggests a more pronounced shift; this is a minor difference in tone, not fact. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1742,
        "completion_tokens": 457,
        "total_tokens": 2200
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "Across the three‑year span the charter for Mastercard’s Class A shares never changed – the 2022, 2023 and 2024 Form 10‑Ks all describe Class A stock as “one vote per share” with full dividend rights (see the “Classes of Capital Stock” tables on pages 99 of the 2022 and 2023 filings and page 92 of the 2024 filing).  What did evolve was the dividend amount: the per‑share cash dividend rose from $2.04 in 2022 to $2.37 in 2023 and to $2.74 in 2024 (page 92).  This steady‑state voting structure combined with progressively higher payouts signals that Mastercard is deliberately preserving a stable, one‑share‑one‑vote governance model while using its strong cash generation to increase shareholder returns, underscoring a capital‑structure strategy focused on consistent control and growing cash‑return distribution.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that A Class shares maintained one vote per share and dividend rights across 2022–2024, aligning with the ground truth on stability in voting and dividend entitlements. However, it introduces dividend amounts ($2.04, $2.37, $2.74) not present in the original answer or implied by the question about rights (not payouts). These figures may be factually accurate from the filings but were not part of the ground truth and shift focus from structural consistency to dividend growth, which was not asked. (2) The numbers cited—$2.04, $2.37, $2.74—while plausible and possibly correct per the 10-Ks, are not mentioned in the ground truth and represent a factual addition rather than verification. Since the question did not ask about dividend amounts but about dividend *entitlements*, including these figures introduces quantitative data beyond what is required and risks misalignment. There is no calculation error, but the inclusion itself affects accuracy by introducing unverified specifics. (3) The reasoning correctly infers that stable voting rights suggest a consistent capital structure strategy, which matches the ground truth’s conclusion. The multi-hop synthesis across three years of 10-Ks is sound, and the model correctly identifies the consistent 'one vote per share' language. However, linking rising dividends to capital structure strategy goes beyond the scope of the question, which focused on rights (entitlements), not distributions. (4) The contextual relevance is high because the core of the answer addresses the evolution (or lack thereof) in rights and draws a strategic conclusion. The qualitative reasoning is strong but slightly overreaches by emphasizing dividend increases. Correctness is reduced due to the introduction of unsupported numeric details not in the ground truth, even if they are technically accurate. Thus, while the core facts are right, the addition of dividend amounts lowers quantitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 541,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "Amgen moved Bemarituzumab into a pivotal **Phase 3** trial in early 2022 – the 2022 Form 10‑K lists the molecule as “initiated Phase 3 study” for gastro‑esophageal‑junction adenocarcinoma and shows its composition‑of‑matter patents in the U.S. and Europe that are expected to expire in 2029【page_25】. In the 2023 and 2024 filings the candidate remains in the Phase 3 portfolio (no new phase transition is reported) and the same U.S. and European polypeptide patents are still listed with a projected 2029 expiration, indicating that Amgen’s IP strategy has been to secure core composition‑of‑matter protection early and maintain it throughout the late‑stage development window【page_26】【page_27】. Thus, from 2022‑2024 the development path stayed in Phase 3 while the patent estate stayed unchanged, giving the product roughly seven more years of exclusivity after the start of its pivotal trials.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and years are correct: Phase 3 initiation in 2022, patent expiration in 2029 in both U.S. and Europe—these match the original answer exactly. There are no calculation errors. (2) The LLM correctly identifies that Bemarituzumab remained in Phase 3 from 2022 to 2024, consistent with the ground truth stating the phase 3 study was initiated in 2022 and no later phase transition reported. (3) The IP strategy is accurately described: composition-of-matter (polypeptide) patents expiring in 2029, which matches the original answer’s claim about patent protection timelines. The LLM adds useful context about 'core composition-of-matter protection' and 'seven more years of exclusivity,' which is logically sound and enhances the explanation. (4) The only minor gap is that the LLM does not explicitly mention the 2024 update about Bemarituzumab being a monoclonal antibody targeting FGFR2b or the mention of potential regulatory exclusivity extending market protection—details included in the original answer. However, this omission does not undermine the core factual accuracy. The multi-hop reasoning across years and documents (10-K filings) is sound, and the synthesis of clinical development and IP timelines is correct. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness—excellent but missing a small element of the 2024 strategic context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 410,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "Across the three filings, Walmart lists “No Boundaries” among its private‑brand portfolio and places it inside the apparel‑related component of its strategic merchandise units. In the 2022 filing the unit is called **Apparel** (e.g., “Apparel for men, women, girls, boys and infants…”) 【page_7】, while the 2024 filing renames the same unit **Fashion** (e.g., “Fashion – apparel for adults and children, shoes, jewelry and accessories”) 【page_7】. The continuity of No Boundaries within that category shows Walmart’s ongoing commitment to its own clothing line, and the shift from “Apparel” to “Fashion” signals a strategic re‑branding that emphasizes style and a stronger focus on the fashion segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: 'No Boundaries' is correctly identified as a private brand within Walmart's portfolio, and its placement under 'Apparel' in 2022 and 'Fashion' in 2024 is accurately reported. The evolution from 'Apparel' to 'Fashion' is correctly interpreted as a strategic shift emphasizing style and fashion positioning. (2) There are no numeric values to verify, but dates (2022 and 2024) are correct and match the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, identifies the category change, and infers the strategic implication—consistent with the original answer’s conclusion about Walmart’s shifting focus. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the continuity of 'No Boundaries' across all three years (2022–2024), though it implies ongoing commitment. It also omits specific mention of omni-channel or customer-centric experiences, which are part of Walmart’s broader strategic context in the ground truth. However, the core factual content and strategic interpretation are semantically equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 373,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "Across all three filings IBM repeatedly lists **“client relationships and trust”** as a core competitive method — the 2022 filing (page 4) says its competition rests on “technology innovation; … brand; … talent; **client relationships and trust**; the ability to deliver business value…”, the 2023 filing (page 3) repeats the same phrasing, and the 2024 filing (page 3) again includes it in the same list. From 2022 to 2024 the company moves this trust narrative from a generic differentiator to a pillar that underpins its **hybrid‑cloud‑and‑AI strategy**: the 2024 business description stresses that IBM “creates sustained value for clients by helping them leverage the power of hybrid cloud and artificial intelligence” and that its hybrid‑cloud platform and AI technology are designed to “support clients’ digital transformations… at scale” (page 3). The evolution shows IBM increasingly positioning trusted client relationships as the foundation for selling its hybrid‑cloud and AI solutions, signaling that credibility and long‑term partnerships are central to its growth agenda in these domains.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that IBM consistently listed 'client relationships and trust' as a competitive differentiator across 2022, 2023, and 2024 filings, citing the correct context (e.g., alongside technology innovation, brand, talent). This matches the original answer’s timeline and emphasis. (2) There are no numeric values to verify, so quantitative accuracy is 10 by default—no errors in dates or references. (3) The multi-hop reasoning is sound: the LLM correctly infers the evolution from a general differentiator to a strategic enabler of hybrid cloud and AI, especially noting the 2024 emphasis on delivering value through hybrid cloud and AI at scale. It accurately captures the strategic progression, though it does not explicitly mention 'strategic partnerships with hyperscalers and global system integrators'—a minor omission from the 2024 evolution detailed in the ground truth. This limits qualitative accuracy slightly, but the core insight about trust underpinning hybrid cloud/AI strategy is correct and well-supported. (4) The answer is contextually excellent, directly addressing both the evolution of client trust and its connection to IBM’s strategic positioning in hybrid cloud and AI. Wording differs but semantic meaning is equivalent. Minor deduction from 10 to 9 on correctness due to missing explicit mention of ecosystem collaboration, which is a key element in the 2024 progression per the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 415,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "- In the 2022 Form 10‑K, Tesla’s filing still listed the “Thirty‑Sixth Supplemental Indenture … 5.45 % Solar Bonds, Series 2015/C25‑15” as an exhibit (see TSLA 2022 p. 102).  \n- The 2023 Form 10‑K likewise retained the same entry for the 5.45 % Solar Bonds, Series 2015/C25‑15 (see TSLA 2023 p. 99).  \n- By the 2024 Form 10‑K, the exhibit schedule (pages 97‑101) no longer includes any reference to Series 2015/C25‑15, indicating the bond has been removed from the company’s disclosed financing instruments.  \n\n**Interpretation:** The bond series was carried on the company’s disclosures for at least two consecutive years, showing that SolarCity‑issued solar bonds were an ongoing financing tool, but its disappearance in 2024 suggests the series has been repaid, retired or deemed immaterial—signaling a shift away from that particular solar‑bond vehicle as Tesla’s solar‑financing strategy evolves.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. While it correctly identifies the 5.45% Solar Bonds, Series 2015/C25-15 and references the Thirty-Sixth Supplemental Indenture in 2022 and 2023 (consistent with the ground truth), it incorrectly claims that the bond series was removed from the 2024 Form 10-K exhibit list. The ground truth states that Tesla reaffirmed the bond's inclusion in 2024 filings, indicating ongoing disclosure and relevance. The LLM’s assertion that the bond was no longer referenced in 2024 is false and leads to an incorrect interpretation that the bond was retired or repaid, suggesting a strategic shift—this contradicts the ground truth, which emphasizes continuity and persistent reliance on this financing instrument. The quantitative elements (percentage, series name, indenture date) are accurate, warranting partial credit on quantitative accuracy. However, the core multi-hop reasoning fails because the model misinterprets the 2024 data, leading to an invalid conclusion about Tesla’s solar financing strategy. The reasoning is internally logical but based on a false premise. Contextually, the answer addresses the right documents and topic, but the erroneous 2024 claim severely limits its usefulness and accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 359,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "- In the 2022 filing the Safety & Productivity segment was described as offering “pipe‑working tools … pipe wrenches, pipe cutters, pipe‑threading and roll‑grooving equipment, mechanical crimping tube‑joining systems, drain cleaners, tubing tools and diagnostic systems, including closed‑circuit‑television pipe‑inspection and locating equipment”【page_9】.  \n\n- By the 2023‑2024 filings the same segment still lists the traditional wrenches, cutters and threading tools, but now emphasizes “battery‑hydraulic tools for press connections” as a core pipe‑working product and adds “battery‑hydraulic tools for cutting and crimping electrical cable” under the broader professional‑tools portfolio【page_73】.  \n\n**Interpretation:** Emerson has moved the pipe‑working line from purely mechanically‑driven tools toward cordless, battery‑powered hydraulic solutions and integrated advanced diagnostic/camera equipment. This shift shows the company is positioning the Safety & Productivity segment as a technology‑focused, mobile‑tool provider that can meet modern professional‑installer demands and compete on innovation in the professional tools market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: the 2022 offerings (pipe wrenches, cutters, threading equipment, CCTV inspection) are accurately cited from the source, and the 2023–2024 additions of battery-hydraulic tools for press connections and electrical cable cutting/crimping are correctly identified. The progression from mechanical to battery-powered tools is accurately interpreted. (2) There are no numeric values requiring calculation in this question, so quantitative accuracy is not applicable beyond correct representation of years (2022, 2023, 2024), which are all correctly used. (3) The multi-hop reasoning is sound—information is synthesized across filings from different years and segments, correctly identifying the evolution in product offerings. The conclusion about Emerson’s strategic positioning as moving toward technology-focused, mobile tools for professional installers is logically supported and semantically equivalent to the ground truth’s interpretation. (4) The only minor limitation is that the LLM does not explicitly note the continuity of 'pipe wrenches' being mentioned across all years as a foundational product, which is a small but relevant detail in the original answer. However, this omission does not detract significantly from the overall correctness. Wording differs slightly but conveys the same meaning. Contextual relevance is excellent, directly addressing product innovation, battery-tech integration, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1661,
        "completion_tokens": 424,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "In the 2022 Form 10‑K Gilead noted that its existing capital resources were “sufficient to purchase, lease or construct any additional facilities required to meet our expected long‑term growth needs” (Item 2 Properties, p. 33) and that the El Segundo, California site was already being used for “clinical and commercial manufacturing and processing of our cell‑therapy products” (Item 2 Properties, p. 33). By the 2023 filing the company said it was “continuing to develop additional manufacturing capabilities” and that El Segundo would remain a key hub for both clinical and commercial cell‑therapy production, a move that is expressly tied to its broader push to expand its biologics pipeline (Manufacturing and Raw Materials, p. 11). Thus, Gilead’s capital allocation shifted from simply maintaining the El Segundo facility in 2022 to actively investing in expanding its cell‑therapy capacity in 2023‑2024, aligning the site’s growth with the company’s overall biologics development priorities.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error in the 2022 description: it incorrectly states that in 2022, El Segundo was already used for 'clinical and commercial manufacturing and processing of our cell-therapy products.' This contradicts the ground truth, which shows that in 2022, El Segundo was listed only as a general manufacturing facility in California without specific mention of cell therapy. The explicit designation for cell therapy manufacturing began in 2023. This misrepresentation undermines the core multi-hop reasoning of the answer, which hinges on a supposed shift from maintenance in 2022 to expansion in 2023–2024. In reality, the strategic evolution began in 2023, not 2022, so the characterization of 2022 as merely 'maintaining' the facility is incorrect. The 2023 and 2024 descriptions are generally accurate in spirit—El Segundo remained a key hub for cell therapy and aligned with biologics development—but the LLM omits the 2024 emphasis on proprietary know-how and confidentiality agreements as a sign of increased investment in securing processes. While the overall direction of the strategy is partially correct, the incorrect attribution of cell therapy activities to 2022 significantly distorts the timeline and evolution of capital allocation. Quantitative accuracy receives full marks because there are no numerical values to evaluate, and the dates referenced (2022, 2023, 2024) are correctly used in context. Contextual relevance is high because the answer addresses the question’s focus on capital allocation and biologics alignment, but the flawed premise reduces its overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 444,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "- In the 2022 Form 10‑K IBM did not list or reference the 1.250 % Notes due 2027, so the instrument was not disclosed as an outstanding security at that time.  \n- The 2023 Form 10‑K (Item 15) began to acknowledge the notes, stating that “the instrument defining the rights of the holders of the 1.250 % Notes due 2027” is incorporated by reference to an Exhibit 4.3 filed on January 30 2019.  \n- By the 2024 Form 10‑K the notes appear in the “Securities registered pursuant to Section 12(b)” table, confirming that IBM continued to have the 1.250 % Notes due 2027 outstanding and now formally registers them as a listed security.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a significant factual error in the first point: it claims that IBM did not list or reference the 1.250% Notes due 2027 in the 2022 Form 10-K. However, the ground truth states that in 2022, IBM *did* disclose the notes by referencing the instrument filed on January 30, 2019, as part of its exhibit list. This contradicts the LLM's assertion of no disclosure in 2022, which undermines the accuracy of the timeline. The second point correctly identifies that the 2023 10-K referenced the notes via incorporation by reference to Exhibit 4.3 filed on January 30, 2019 — this aligns with the original answer. The third point about the 2024 Form 10-K listing the notes on Section 12(b) and confirming their registration as a listed security (including trading symbol IBM27B in the ground truth) is partially correct but omits the key detail about NYSE listing and the trading symbol, which is important for completeness. While the progression from disclosure to registration is conceptually captured, the LLM misrepresents the 2022 status and misses the 2024 market listing detail. Quantitative accuracy is acceptable — percentages and dates mentioned (1.250%, 2027, January 30, 2019) are correct where present — but the absence of the 2022 reference and the NYSE listing in 2024 reduces completeness. The reasoning shows partial multi-hop synthesis but fails on the critical evolution from 2022 to 2023 due to the incorrect premise. Contextually, the answer is well-structured and relevant, addressing disclosure, reference, and registration over time, even if factually flawed in key aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 439,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "Tesla’s 2022‑2024 Form 10‑K filings repeatedly cite the legacy 5.45 % Solar Bonds, Series 2015/C45‑15 (see Exhibit 4.41 in the 2022 filing) 【page_101】, and then list a succession of newer 5.45 % Solar‑bond tranches (e.g., Series 2015/C87‑15, C92‑15, C97‑15, C107‑15, C122‑15, etc.) in the same exhibit schedules 【page_102】【page_103】. This continuity shows that Tesla has kept the original SolarCity bond obligations on its balance sheet while progressively issuing additional, similarly‑structured solar bonds to raise fresh capital, indicating a financing strategy that builds on its legacy debt base and expands it with newer, higher‑volume solar‑bond issuances over the 2022‑2024 period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core idea that Tesla has maintained and expanded its solar financing strategy using a series of similarly structured 5.45% Solar Bonds inherited from SolarCity, which aligns with the ground truth. It correctly identifies the continued reference to the original 5.45% Solar Bonds, Series 2015/C45-15, and notes the progression of newer bond tranches, indicating an evolving securitization model. However, there are key quantitative inaccuracies: the LLM cites bond series such as C87-15, C92-15, C97-15, C107-15, and C122-15, which are not mentioned in the original answer and lack verification from the provided ground truth. The original answer specifically references Series 2015/C53-15 (June 16, 2015), C62-15 (June 29, 2015), and C72-15 (July 21, 2015), with exact dates and sequential logic tied to early 2015 issuances. The LLM’s use of later series (e.g., C122-15) introduces unverified data, suggesting potential hallucination or incorrect extrapolation. While the percentage (5.45%) and the origin (SolarCity legacy) are accurate, the specific bond series and their implied timeline are not fully supported. Qualitatively, the reasoning is sound—Tesla is building on a standardized, asset-backed financing model—and the multi-hop synthesis across 2022–2024 filings is appropriately inferred. Contextually, the answer is highly relevant, addressing the evolution of Tesla’s solar financing strategy. The core conclusion about a scalable, repeatable model is consistent with the ground truth, but the incorrect bond series reduce confidence in the factual precision, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 446,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "- **2022:** Adobe presented Acrobat as the cornerstone of its Document Cloud platform, emphasizing that it already enjoyed “strong market adoption and a leadership position in document‑intensive industries such as government, financial services, pharmaceutical, legal, aerospace, insurance and technical publishing” (2022 10‑K, p. 6).  \n\n- **2023:** The company shifted the narrative to an AI‑enabled, end‑to‑end workflow engine, saying it would “improve Acrobat web’s functionality… expand the number of task‑based actions in Acrobat, integrate Adobe Sign across all surfaces, and drive innovation with Adobe Sensei (machine‑learning/AI) to make both new and legacy documents more intelligent and responsive” (2023 10‑K, p. 7).  \n\n- **2024:** Adobe further deepened the AI positioning, describing “AI‑ and generative‑AI‑powered technologies” as a growth engine for the Document Cloud and noting that “infusing AI into our products… expands the user base of our tools” while continuing to accelerate document productivity across all surfaces (2024 10‑K, market‑overview, p. 4).  \n\nTogether, these filings show Acrobat evolving from a proven PDF leader in regulated verticals (2022) to an AI‑augmented, web‑first, integrated component of a broader digital‑document services platform that targets new industries and workflows (2023‑2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, Adobe emphasized Acrobat's leadership in document-intensive industries (legal, financial services, etc.), which matches the original answer; in 2023, the shift toward AI via Adobe Sensei and workflow enhancements is accurately described; in 2024, the focus on AI and generative AI as a growth engine for Document Cloud reflects the strategic evolution. The mention of 'AI Assistant' in the original answer is a specific product realization, while the LLM answer captures the broader AI integration trajectory without naming the 'Acrobat AI Assistant' explicitly—this is a minor omission but does not detract from the overall correctness. (2) There are no numeric values, dates, or calculations in the question or answers that conflict; all years (2022–2024) are correctly attributed and contextually used. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the evolution from market leadership to AI-driven platform expansion. It connects AI integration, industry adoption, and platform growth across time periods. (4) The semantic meaning is equivalent to the original answer—while the LLM uses slightly different phrasing (e.g., 'AI-augmented, web-first component' vs. 'next-generation intelligent document solution'), the core message about strategic evolution is preserved. The only reason for not scoring a 10 is the absence of the specific 'Acrobat AI Assistant' trademark mention in 2024, which is a concrete milestone noted in the ground truth. However, the LLM still correctly conveys the AI integration strategy's realization. Contextual relevance is perfect—the answer directly addresses all parts of the question: AI integration, market adoption, and platform expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1600,
        "completion_tokens": 507,
        "total_tokens": 2107
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "- In the 2022 filing Schwab first highlighted that, after the TD Ameritrade integration, it had added the thinkorswim real‑time charting and trading platform and the iRebal customizable rebalancing tool to the suite of services it offers RIA clients, and it described the Advisor Services website – with interactive tools, document archiving and free Schwab Advisor Portfolio Connect – as the core online hub for RIAs.  \n\n- The 2023 filing showed the next step: Schwab rolled out **Schwab Trading Powered by Ameritrade™**, a unified trading platform that combined the best of both firms’ technology, while retaining the same website‑based interactive tools and third‑party integrations for portfolio‑management, order‑management and financial‑planning.  \n\n- By the 2024 filing the company said it was continuing to embed the thinkorswim platform and iRebal “into its ongoing offerings” and that the Advisor Services website now delivers an “intuitive modern experience” for RIAs, still providing the same interactive tools, education and free Advisor Portfolio Connect plus expanded integration capabilities with external CRM, portfolio‑management and planning systems.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Schwab's provision of interactive tools for RIAs evolved from 2022 to 2024 with consistent use of the Advisor Services website, integration of thinkorswim and iRebal post-TD Ameritrade, and continued expansion of third-party integrations. The mention of Schwab Advisor Portfolio Connect being free and the focus on an intuitive, modern experience in 2024 matches the original. (2) There are no numeric inaccuracies—dates (2022, 2023, 2024) are correct, and no erroneous figures are introduced. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes platform developments across years, linking the TD Ameritrade integration to new tool additions, the launch of Schwab Trading Powered by Ameritrade™, and ongoing enhancements. One minor discrepancy: the original does not explicitly mention the 'document archiving' feature or the 'unified trading platform' branding in 2023, which the LLM includes—these may be slightly overstated or inferred beyond the ground truth, but do not contradict it. (4) The answer is contextually excellent, directly addressing platform enhancements and integration capabilities each year. Overall, the LLM captures the evolution accurately with only negligible additions not present in the original, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 388,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "In the 2022 filing the company grouped **air‑preparation equipment** under the broader “Industrial Solutions” description of its Discrete Automation portfolio, noting it simply as one of the pneumatic‑product offerings (solenoid/pneumatic valves, cylinders, actuators, etc.) 【page_6】.  \n\nBy the 2023 and 2024 filings the wording was shifted to list **air‑preparation equipment directly inside the Discrete Automation segment definition**, together with solenoid and pneumatic valves, cylinder‑actuators, **pressure‑/temperature switches and programmable automation control systems and software** 【page_5】【page_73】. This change signals a strategic move to present the air‑preparation gear as an integrated component of the segment’s pneumatic‑valve‑actuator‑control‑system family, rather than a stand‑alone product line.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of Emerson's Air Preparation Equipment positioning within the Discrete Automation segment across 2022, 2023, and 2024, with accurate entity and year alignment. It correctly notes that in 2022, the equipment was grouped under a broader 'Industrial Solutions' category among other pneumatic products, and by 2023–2024, it was explicitly included in the Discrete Automation segment alongside control systems and software, indicating deeper integration. The citation of specific components (valves, actuators, switches, control systems) matches the ground truth. However, the LLM answer omits key qualitative developments mentioned in the original answer, particularly the 2024 emphasis on interoperability with smart actuation, predictive maintenance, and secure wireless communication—critical aspects of Industry 4.0 alignment. While the strategic shift toward integration is correctly inferred, the absence of these specific digital transformation elements limits completeness. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning is sound in interpreting filing language changes as strategic repositioning. The answer is highly contextually relevant and semantically aligned on core facts, but lacks full depth in capturing the technological evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 379,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "- In the 2022 Form 10‑K the exhibit index lists a single issuance of the ultra‑low‑coupon 0.125 % Notes due 2029 (Exhibit 4.23, tied to the September 18 2020 8‑K filing)【page_134】.  \n- The 2023 Form 10‑K adds a second, identical issuance (Exhibit 4.31) that was filed on March 9 2021, while still retaining the original 2020 issue (both 4.23 and 4.31 appear)【page_132】.  \n- The 2024 Form 10‑K continues to list both the 2020 and 2021 issuances of the 0.125 % Notes due 2029 (again 4.23 and 4.31) alongside newer, higher‑coupon debt, showing the notes remain part of the company’s debt program【page_130】.  \n\n**Interpretation:** Coca‑Cola has progressively used the 0.125 % Notes due 2029 as a recurring, ultra‑low‑cost financing tool, issuing them in successive years to lock in cheap funding for the near‑term horizon while supplementing them with higher‑rate, longer‑dated notes. This pattern reflects a disciplined approach that leverages favorable market conditions to manage short‑term obligations within a broader, diversified debt strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the existence of two issuances of the 0.125% Notes due 2029 — one from 2020 and another from 2021 — and accurately references their inclusion in the 2022, 2023, and 2024 10-K filings with correct exhibit numbers and filing dates. These factual details are consistent with the ground truth in terms of entities, years, and document references. However, the interpretation diverges significantly from the original answer. The LLM claims Coca-Cola 'progressively used' the 0.125% Notes as a 'recurring...financing tool' with 'successive year' issuances to 'lock in cheap funding,' implying an active, strategic reissuance of the same instrument. This contradicts the ground truth, which states that while the notes were referenced annually, the change in context — particularly the introduction of higher-yielding, long-term debt in 2024 — suggests a pivot toward refinancing or extending liabilities as the 2029 note nears maturity, not continued reliance on the same low-cost instrument. (2) Quantitative accuracy is high: the percentages (0.125%), years (2020, 2021, 2029), and exhibit numbers (4.23, 4.31) are all correct. There are no calculation errors. (3) Multi-hop reasoning is partially sound — the model correctly tracks the note across years and filings — but misinterprets the strategic implication. It fails to recognize that the evolution lies in the shifting context and disclosure framing, not in new issuances of the same note. The broader financing shift toward higher-coupon, long-dated debt (e.g., 5.000% Notes due 2034) is mentioned only in passing and not analyzed as a strategic pivot, which is central to the ground truth. (4) Correctness is scored at 5 due to accurate facts but flawed synthesis and interpretation. Qualitative accuracy is low because the reasoning misrepresents the company's strategy. Contextual relevance is moderate as the answer addresses the question’s components but with incorrect inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 536,
        "total_tokens": 2061
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "- In the 2022 Form 10‑K (page 5) BNY Mellon warned that its ability to return capital – including dividends and share‑repurchase programs – “may be limited by U.S. banking laws and regulations, including those governing capital and capital planning” and by Delaware law and preferred‑stock dividend requirements.  \n\n- The 2023 filing repeats the same caveat (page 3), stating that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning…”.  \n\n- The 2024 filing continues to carry the identical language (page 3), confirming that the company’s dividend and share‑repurchase decisions remain subject to the same regulatory constraints.  \n\nThus, from 2022 through 2024 BNY Mellon’s exposure to U.S. banking‑law limits on capital planning and shareholder returns has remained unchanged – the firm consistently acknowledges that federal banking regulations can restrict dividends and share‑repurchases.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in citing the consistent presence of regulatory constraints on capital returns across 2022–2024 and correctly references U.S. banking laws, capital planning rules, Delaware law, and preferred stock obligations. The page numbers and quoted language appear consistent with the filings, satisfying quantitative and entity accuracy. However, the LLM incorrectly concludes that the language and framing 'remained unchanged' and that the disclosures were 'identical' across years, which contradicts the ground truth. The original answer highlights an evolution in specificity—from general caution in 2022 to more structured references to 'well capitalized' status and capital adequacy rules in 2024. The LLM fails to detect this nuanced but important shift in disclosure strategy, missing the core trend of increasing formalization. This represents a failure in multi-hop qualitative reasoning: while individual year disclosures are accurately summarized, the synthesis across years is flawed. The conclusion that exposure 'has remained unchanged' is therefore misleading, as the regulatory environment may have been consistently referenced, but the firm’s communication evolved in precision and structure. This significantly undermines the qualitative accuracy despite correct individual facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 367,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "Across the three filings, McDonald’s *McGriddles* is repeatedly listed as a regular breakfast sandwich in the “Products” (or “Menu”) description – 2022’s filing notes “Egg McMuffin, Sausage McMuffin with Egg and McGriddles,” the 2023 filing repeats the same phrasing, and the 2024 filing again cites “Egg McMuffin, Sausage McMuffin with Egg and McGriddles.” The product never shifts from a new‑launch highlight to a discontinued item; instead it stays positioned as a staple of the core breakfast lineup, showing that McDonald’s breakfast strategy has remained consistent over this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately captures that McGriddles was consistently listed as a core breakfast item across all three years (2022–2024) without any innovation-related details, using nearly identical phrasing in each filing. The key entities (McDonald’s, McGriddles, breakfast sandwiches, years) are correct, and the reasoning correctly infers that the unchanged presentation reflects a stable breakfast strategy. The answer addresses both parts of the question: the evolution (or lack thereof) of McGriddles’ portrayal and what it reveals about strategic consistency. The only minor shortcoming is that it does not explicitly reference the broader innovation context mentioned in the original answer (e.g., 'continuous evolution' in 2023 or 'testing new products' in 2024), which slightly weakens the multi-hop synthesis. However, the core conclusion about strategic consistency is sound and supported. All statements are semantically equivalent to the ground truth, with no numerical or date inaccuracies (non-numeric data is correctly interpreted). The answer is highly relevant and well-reasoned, warranting a high score with only a small deduction for incomplete contextual nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 349,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "- In the 2022 Form 10‑K Adobe described its “Digital Learning Services” as offering “a large number of free online self‑service learning options on www.training.adobe.com,” positioning the free content as a core element of Adobe Digital Learning Services alongside fee‑based classroom, virtual and on‑demand programs.  \n\n- By the 2023 filing the same language appears, but the URL shifts to learning.adobe.com, indicating that Adobe consolidated its free self‑service catalog onto the Learning Adobe platform while still framing it within Adobe Digital Learning Services.  \n\n- The 2024 filing repeats the 2023 description, keeping the free self‑service offerings on learning.adobe.com and continuing to present them as a principal component of Adobe Digital Learning Services, alongside its expanded fee‑based training portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Adobe introduced free self-service learning in 2022 on www.training.adobe.com as part of Adobe Digital Learning Services; in 2023, the domain shifted to learning.adobe.com; and in 2024, the same platform and strategic positioning were maintained. There are no errors in entities, years, or descriptions. (2) Quantitative accuracy is perfect—no numerical data is misstated, and the timeline (2022, 2023, 2024) is correctly referenced with appropriate platform URLs. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of 10-K filings, tracks the evolution of platform hosting, and maintains consistent context around the strategic role of free learning within the broader Adobe Digital Learning Services. (4) The only minor shortcoming is that the LLM does not explicitly note the 'increased integration' or 'maturing and more structured approach' emphasized in the original answer’s conclusion. While the repetition of language across filings implies consistency, the LLM could have better captured the forward trajectory of strategic maturation. However, this is a nuance in framing rather than a factual gap. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 383,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "In the 2022 filing Emerson placed commercial vacuums in the **Tools & Home Products** segment’s “Professional Tools” category, listing them together with water‑jetters, wet‑dry vacuums and other hand tools 【page_9】. By the 2024 filing the same products are called out inside the **Safety & Productivity** segment description as “Other professional tools…commercial vacuums,” tying them directly to the segment’s safety‑and‑productivity focus and signaling a tighter strategic alignment with Emerson’s broader professional‑tools portfolio 【page_73】. This shift shows the product moving from a general tools segment to being explicitly framed as a key professional‑tools offering within Safety & Productivity.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of entity identification, timeline, and segment reclassification. It correctly states that in 2022, Commercial Vacuums were part of the Tools & Home Products segment, and by 2024 they were included in the Safety & Productivity segment, aligning with professional tools under a safety and productivity focus. The quantitative accuracy is perfect: years (2022, 2024), segment names, and product categorizations are correct, with appropriate contextual citations (page references). However, the answer omits the 2023 transition year mentioned in the ground truth, which explicitly notes the reclassification occurred by 2023, not directly from 2022 to 2024. This skips a key step in the multi-hop evolution, slightly weakening the reasoning completeness. Additionally, while the LLM captures the strategic emphasis on alignment with professional tools, it does not fully reflect the 2024 evolution toward integration with more advanced industrial systems like programmable automation controls and electrical distribution equipment—this deeper technological alignment is a key nuance missing. Thus, while the core facts and trajectory are correct, the answer lacks full completeness in tracing the multi-year evolution and the deepening strategic integration in 2024. Semantic equivalence is largely preserved, and the response is highly contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 387,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "Across the three years the Hoofddorp, Netherlands plant has been described in Gilead’s 10‑K filings as a **commercial‑focused cell‑therapy site**. In the 2022 filing it was listed among the company’s principal manufacturing locations for “commercial manufacturing and processing of our cell‑therapy products.” The 2023 and 2024 filings repeat the same language, indicating that the facility continued to be used for **commercial manufacturing and processing of cell‑therapy products** and there is no mention of new clinical‑manufacturing activities or any change in its role.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in its description of the Hoofddorp facility being used for commercial manufacturing and processing of cell therapy products, and correctly identifies this role in all three years (2022–2024), which aligns with the ground truth. The quantitative accuracy is perfect—no numerical or date inaccuracies, and entity identification (GILD, Hoofddorp, Netherlands, cell therapy) is correct. However, the LLM answer misrepresents the evolution by stating that the 2022 filing already described the site as being for 'commercial manufacturing and processing of our cell-therapy products.' According to the ground truth, in 2022 the facility was only identified as a 'principal manufacturing site' without explicit mention of cell therapy; the specific cell therapy focus emerged in 2023. This is a critical error in multi-hop reasoning and temporal evolution, as the LLM fails to capture the strategic shift that occurred between 2022 and 2023. The ground truth emphasizes a progression: general principal site → dedicated cell therapy commercial site, while the LLM implies consistency from 2022 onward. This undermines the qualitative accuracy, as the synthesis across years is flawed. Contextual relevance is high because the answer addresses the facility’s role and timeframe directly, but the lack of recognition of the evolution reduces correctness. Semantic equivalence is partially achieved but fails on the key point of change over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 405,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "The 10‑K exhibits for 2022, 2023 and 2024 all list the same low‑cost instrument – the **1.000 % Notes due 2028** (see the 4.26 entry in the 2022 filing 【page_134†L24-L28】 and the same entry repeated in the 2024 filing 【page_130†L24-L28】). By keeping this ultra‑low‑coupon debt on its balance sheet year after year, Coca‑Cola maintained a cheap source of financing that anchors its overall cost of capital.  \n\nIn the 2024 filing the company also added a new series of higher‑yield bonds – **5.000 % Notes due 2034** and **5.400 % Notes due 2064** (exhibit 4.39 and 4.41 【page_130†L40-L46】). Introducing these higher‑coupon, longer‑dated issues shows that Coca‑Cola is now willing to pay a higher rate to extend the maturity profile of its debt and raise additional capital, reflecting a shift from relying solely on ultra‑low‑cost, short‑term financing toward a more diversified capital‑structure strategy that balances cost, liquidity and long‑term funding needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the persistent reference to the 1.000% Notes due 2028 across 2022–2024 filings and the introduction of the 5.000% Notes due 2034 and 5.400% Notes due 2064 in 2024 are accurately reported. The percentages, maturities, and years are factually correct. (2) Quantitative accuracy is perfect: all interest rates (1.000%, 5.000%, 5.400%) and maturity years (2028, 2034, 2064) match the ground truth exactly. No calculations were required, but the comparison of low- vs high-yield instruments is correctly framed. (3) The multi-hop reasoning is sound: the model synthesizes information across multiple filings (2022–2024) and correctly infers a strategic shift in capital structure management—balancing low-cost debt with new higher-cost, long-term instruments. The reasoning about extending maturity profile and diversifying financing sources is logically consistent with the data. (4) The answer is contextually excellent, directly addressing how changes in debt issuance reflect evolving financing cost strategies and capital structure management. The only minor limitation is that it does not explicitly mention 'strategic initiatives' as a potential driver (noted in the ground truth), but the reference to raising additional capital and extending maturities implies similar intent. Overall, the answer is semantically equivalent and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 400,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "- In the 2022 filing the Tools & Home Products description lists pipe‑working tools simply as “pipe wrenches, **pipe cutters**, pipe threading … and diagnostic systems,” implying a traditional, manually‑operated cutter lineup.  \n\n- By the 2023‑2024 filings the Safety & Productivity segment is described as offering “pipe‑working tools … **battery‑hydraulic tools** for press connections, **drain cleaners and diagnostic systems**,” and the narrative now groups pipe cutters with battery‑powered, digitally‑linked equipment.  \n\n**What this shows:** Emerson is deliberately moving the pipe‑cutter portfolio from purely mechanical devices to cordless, battery‑driven and diagnostics‑integrated tools, positioning the company as a technology‑focused leader in the professional plumbing‑tools market and targeting higher‑margin, productivity‑driven customers who value mobility, safety and data‑enabled service.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Emerson's pipe cutter portfolio across 2022, 2023, and 2024: in 2022, pipe cutters were part of a traditional, manual toolset; by 2023–2024, they were grouped with battery-hydraulic and diagnostic-integrated tools. The key entities—Emerson (EMR), pipe cutters, battery-powered tools, diagnostic systems, and the professional plumbing market—are all correctly identified. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are used accurately and consistently with the original answer. (3) The multi-hop reasoning is sound: the LLM synthesizes changes in segment descriptions across filings to infer a strategic shift, correctly linking the integration of battery-hydraulic technology in 2023 and diagnostic systems in 2024 to a broader strategic pivot. The conclusion about targeting higher-margin, productivity-driven customers adds interpretive depth that is consistent with the original answer’s claim about positioning in the professional plumbing tools market. (4) The only minor shortcoming is that the LLM slightly compresses the 2023 and 2024 developments into a single '2023–2024' timeframe, whereas the original answer distinguishes 2023 (battery-hydraulic) from 2024 (diagnostic integration). This does not undermine the overall correctness but slightly reduces precision in the year-by-year evolution. Despite this, the semantic meaning and strategic interpretation remain fully aligned. Hence, the answer scores high across all dimensions, with a 9/10 on correctness and qualitative accuracy due to this small temporal blending.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 467,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K (Item 2 Properties) Gilead described its Santa Monica, CA site as being used “for **clinical manufacturing and processing of our cell‑therapy products**”【page_31】.  \n- The 2023 filing repeats the same description, listing Santa Monica among the facilities “we **utilize … for clinical manufacturing and processing of our cell‑therapy products**”【page_11】.  \n- The 2024 filing again states that the Santa Monica location “we **utilize … for clinical manufacturing and processing of our cell‑therapy products**”【page_10】.  \n\nAcross 2022‑2024 the Santa Monica facility has remained dedicated to **clinical‑stage cell‑therapy manufacturing**, never being expanded to commercial production. This consistency shows that Gilead positions Santa Monica as a specialized hub for early‑stage cell‑therapy development, complementing other sites (e.g., El Segundo, Frederick, Hoofddorp) that handle commercial‑scale cell‑therapy manufacturing within its overall network.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim: it states that in 2022, GILD's Santa Monica facility was already described as being used for 'clinical manufacturing and processing of our cell-therapy products.' However, the ground truth indicates that in 2022, the facility was part of the R&D and manufacturing network but was *not* specifically highlighted for cell therapy processing. The LLM incorrectly attributes the 2023–2024 language to the 2022 filing, which misrepresents the evolution. This error undermines the multi-hop reasoning, as the key progression — from a general R&D site in 2022 to a dedicated cell therapy site in 2023 — is erased. The LLM instead claims consistency across all three years, contradicting the ground truth. Quantitative accuracy is high because there are no numerical values to assess, and the cited years and locations are correct. Contextual relevance is strong — the answer addresses the right facility, time frame, and strategic role — but the qualitative accuracy is low due to the incorrect characterization of the 2022 status. The conclusion about Santa Monica being a specialized hub for clinical (not commercial) manufacturing is plausible and aligns with the strategic interpretation, but it is based on flawed premises. Thus, while the answer appears well-structured and cites appropriate context, its factual foundation is unsound, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 394,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "In the 2022 filing Frame.io was described only as a cloud‑native video‑review add‑on that worked mainly with Adobe Premiere Pro and After Effects. By the 2023 filing (and the same language in the 2024 filing) Adobe positioned Frame.io as a core Creative Cloud collaboration service that now supports video *plus* still images, design files and PDFs, offers “Camera‑to‑Cloud” uploads for both video and still‑image cameras, and is directly integrated not just with Premiere Pro and After Effects but also with Photoshop, Lightroom, Workfront and the GenStudio environment—enabling frame‑accurate comments and asset sharing across multiple Creative Cloud apps.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in the timeline and evolution of Frame.io's integration, particularly misrepresenting the progression between 2023 and 2024. (1) Correct elements: The answer accurately notes Frame.io's integration with Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, and GenStudio, as well as support for still images, design files, PDFs, and frame-accurate feedback. The mention of 'Camera-to-Cloud' uploads aligns with expanded 2024 capabilities. (2) Quantitative accuracy: All years (2022, 2023, 2024) are referenced appropriately, and there are no numerical errors—this score is 10. (3) Qualitative inaccuracy: The key flaw is stating that the 2023 description remained unchanged in 2024. Ground truth shows a clear evolution in 2024—Frame.io expanded beyond post-production into casting, location scouting, and marketing, and was positioned within GenStudio for enterprise content production. The LLM incorrectly implies this broader integration was already present in 2023 and unchanged in 2024. Additionally, the 2022 description in the LLM answer calls Frame.io a 'cloud-native video-review add-on,' but the ground truth only confirms it was listed in the trademark portfolio, with no functional description provided in that year. (4) Contextual relevance is high because the answer addresses supported media types and cross-app collaboration as asked, but fails to correctly trace the year-over-year evolution, especially the 2024 expansion into broader workflows. Thus, while many facts are correct, the multi-hop reasoning across years is flawed, leading to a correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 452,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "In the 2022 filing the Discrete Automation segment was described as a collection of “solenoid valves, pneumatic valves … **electrical distribution equipment**, and materials‑joining solutions used primarily in discrete‑industry applications,” treating the distribution hardware as a separate product line. By the 2024 filing the segment’s description had been updated to list “solenoid valves, pneumatic valves … **programmable automation control systems and software, electrical distribution equipment, and electric linear‑motion solutions**,” showing that Emerson now positions its distribution equipment as an integral part of a broader automation ecosystem and has expanded the scope to include related motion‑control and software offerings. This reflects a strategic shift from a stand‑alone product focus in 2022 to a more tightly integrated, automation‑centric portfolio in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Emerson's strategic positioning of Electrical Distribution Equipment from 2022 to 2024. It correctly identifies that in 2022, the equipment was listed as a standalone product within Discrete Automation alongside solenoid and pneumatic valves and materials-joining solutions. By 2024, it notes the repositioning within a broader automation ecosystem, now grouped with programmable automation control systems, software, and electric linear-motion solutions—demonstrating integration with automation technologies and product scope expansion. The answer omits explicit mention of the 2023 transition year described in the ground truth (where the equipment was first linked more clearly to automation), but this is a minor omission given the clear before-and-after contrast between 2022 and 2024. All entities (EMR, Discrete Automation segment, Electrical Distribution Equipment) are correct, and the years (2022, 2024) are accurately referenced. There are no numerical values requiring calculation, so quantitative accuracy is 10. The reasoning is sound and reflects proper multi-hop synthesis across filings, showing a strategic shift from standalone to integrated. Wording differs slightly from the original answer but maintains semantic equivalence. Contextual relevance is perfect—the response directly addresses both integration with automation technologies and product scope expansion as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 402,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "- **2022:** Fixed‑rate unsecured senior notes carried about **$19.9 billion** with a **weighted‑average interest rate of 2.91 %**【page_188】.  \n- **2023:** The portfolio grew to roughly **$27.2 billion** and the weighted‑average rate rose to **4.45 %**【page_178】.  \n- **2024:** The carrying amount was essentially unchanged at **$26.9 billion**, but the weighted‑average rate climbed again to **4.84 %**【page_188】.  \n\nThe progression shows Capital One adding a sizable amount of higher‑coupon senior debt as market rates increased, then modestly trimming the balance while the average cost continued to rise. This suggests a deliberate strategy of issuing new debt at prevailing higher rates (and possibly refinancing or retiring lower‑rate issues) to maintain liquidity and maturity flexibility in a rising‑interest‑rate environment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $19.9 billion (2022) = $19,975 million, $27.2 billion (2023) ≈ $27,168 million, $26.9 billion (2024) ≈ $26,930 million; interest rates are exactly 2.91%, 4.45%, and 4.84% across years. Minor rounding is acceptable and common in financial reporting. (2) The answer is complete, addressing both carrying value and interest rate evolution across all three years, and directly answering the strategic implication. (3) Entities are correct: Capital One (COF), fixed unsecured senior debt, proper years, and accurate financial metrics. (4) The reasoning is sound: the LLM correctly infers that the company issued more debt at higher rates during rising rate environments, possibly refinancing older cheaper debt, and interprets this as a proactive liquidity and maturity management strategy—consistent with the ground truth's 'proactive approach to anticipated rate hikes.' The multi-hop synthesis across years and metrics is accurate and well-articulated. Semantic equivalence is maintained throughout with no factual deviations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 323,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "RTX’s “service and product warranties and product‑performance guarantees” – the line‑item that captures its performance‑ and operating‑cost guarantee liabilities – have been falling each year:\n\n* **2022:** Carrying amount at  Dec 31 2022 = $1,109 million【page_100†L31-L38】  \n* **2023:** Carrying amount at Dec 31 2023 = $1,091 million (down $18 million from 2022)【page_100†L31-L38】  \n* **2024:** Carrying amount at Dec 31 2024 = $993 million (down $98 million from 2023)【page_102†L31-L38】\n\nThe steady decline – from $1.11 billion in 2022 to just under $1 billion in 2024 – shows that RTX is gradually reducing the reserve it holds for product‑performance and operating‑cost guarantees. While the balance remains material, the downward trend suggests the company’s exposure to long‑term performance risk in its commercial‑aerospace engines is easing, likely because of settlements, lower issuance of new guarantees, and/or improved engine reliability.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The reported values are completely wrong. The ground truth states RTX's liabilities were $120M in 2022, $120M in 2023, and $101M in 2024. The LLM reports $1,109M, $1,091M, and $993M—over 9 times higher—likely confusing the specific 'performance and operating cost guarantees' with a broader warranty liability line item. The cited page references (e.g., page_100†L31-L38) suggest the model pulled data from a different part of the filing, possibly total warranty liabilities, not the specific performance guarantees. (2) Completeness: While the answer attempts to address the evolution and implications, it fails on the core factual requirement—correct liability amounts for the specified guarantees. (3) Entity Accuracy: The metric is misidentified. The LLM conflates 'service and product warranties and product-performance guarantees' (a broader category) with the more specific 'liabilities related to performance and operating cost guarantees' mentioned in the question and ground truth. (4) Reasoning: The reasoning is internally logical given the incorrect data—declining liabilities leading to reduced risk exposure—but this is based on a false premise. The actual stability (with slight decrease) suggests consistent risk exposure, not easing. (5) Semantic Equivalence: The conclusion contradicts the ground truth: stability vs. a significant downward trend. Even allowing for wording flexibility, the factual divergence is too large. The model fails to correctly isolate and track the specific liability, leading to a completely inaccurate portrayal of RTX's risk exposure trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 463,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "- In the 2022 Form 10‑K (Note 4, page 40) Coca‑Cola said that for non‑publicly‑traded equity investments it “uses … discounted cash‑flows, **estimates of sales proceeds**, and appraisals” and warned that “the ability to accurately predict future cash flows, especially in emerging and developing markets, may impact the determination of fair value.”  \n- The 2023 filing (Note 4, page 78) repeats the same set of methods, again listing **estimates of sales proceeds** alongside DCF and appraisals, and again notes the difficulty of forecasting cash flows in emerging markets.  \n- The 2024 filing (Note 4, page 78) continues to rely on **estimates of sales proceeds** as a core valuation tool, but now emphasizes the “assumptions that we believe a market participant would use” and stresses that “the ability to accurately predict future cash flows … may impact the determination of fair value” in emerging and developing markets.\n\n**What this shows:** From 2022 through 2024 Coca‑Cola has maintained the use of “estimates of sales proceeds” for valuing non‑public investments, but over time it has placed increasing focus on market‑participant assumptions and the uncertainty of cash‑flow forecasts in emerging markets, indicating a progressively more cautious and market‑aligned approach to fair‑value measurement in those regions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Coca-Cola consistently used 'estimates of sales proceeds' from 2022 to 2024 as part of its valuation methodology for nonpublic investments, alongside discounted cash flows and appraisals. The increasing emphasis on challenges in predicting cash flows in emerging markets is correctly noted each year, and the 2024 addition of 'market participant assumptions' is accurately highlighted. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024), note numbers (Note 4), and page numbers (40, 78) are correctly cited, matching typical disclosure locations in 10-K filings. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, identifies continuity in methodology, and correctly infers an evolving, more cautious approach—particularly in emerging markets. This reflects the core insight in the ground truth: a shift from disclosure to reliance to risk-aware integration. (4) The only minor shortcoming is that the LLM does not explicitly state the progression from 'disclosure' in 2022 to 'reliance' in 2023 as clearly as the original answer, which uses stronger language like 'relies on' as a signal of deepening dependence. While the LLM notes continued use and increasing caution, it slightly underemphasizes the strategic shift in operational reliance. However, the overall semantic meaning and analytical conclusion—that Coca-Cola has adopted a more cautious, market-aligned approach—is equivalent. Thus, the answer is excellent but not perfect, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1601,
        "completion_tokens": 460,
        "total_tokens": 2061
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "- In the 2022 Form 10‑K (page 5) BNY Mellon warned that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.”  \n- The 2023 Form 10‑K (page 5) repeats the same disclosure, again emphasizing that board discretion and U.S. banking‑law/capital‑planning constraints can restrict dividends and share‑repurchases, with no additional qualifiers.  \n- The 2024 Form 10‑K (page 5) continues to use identical language, confirming that the regulatory ceiling on capital returns remains unchanged.  \n\nThis three‑year consistency shows that BNY Mellon’s strategic flexibility for returning capital to shareholders is persistently bounded by the same U.S. banking‑law and capital‑planning limits, indicating that the company has not expanded its distribution leeway over the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its presentation of the disclosures from 2022, 2023, and 2024, correctly citing the consistent language regarding U.S. banking laws, capital planning, Delaware law, and preferred stock dividends. The page numbers and quoted text are accurately represented, and there are no errors in dates or entities, warranting a perfect quantitative accuracy score. Contextual relevance is high, as the response directly addresses the evolution of capital return disclosures and their implications. However, the LLM misses a key qualitative addition in the 2024 filing noted in the ground truth: the new emphasis on the Parent’s dependency on dividends from subsidiaries and extensions of credit from its IHC (Intermediate Holding Company) to fund share repurchases and dividends. This omission weakens the analysis of how internal capital flows are increasingly shaping distribution strategy, which is a critical nuance in the multi-year progression. While the LLM correctly identifies regulatory consistency, it fails to capture the evolving internal structural dependencies highlighted in the original answer, resulting in incomplete synthesis across the three years. Thus, while the core facts are correct, the reasoning lacks full depth on strategic flexibility implications, justifying a 7 in qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 379,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "AMD’s 2022 10‑K first flagged the “loss or modification of exemptions for taxes and tariffs” as one of a long list of political‑, legal‑ and economic‑risk factors. In the 2023 filing the same exposure re‑appears, now embedded in a broader discussion of escalating sanctions, export‑control revisions and heightened geopolitical friction, and the 2024 filing repeats the language again while coupling it with explicit references to U.S. and allied sanctions on Russia, Belarus and the Ukraine‑Russia conflict and to China‑Taiwan tensions. The persistence and increasingly detailed framing of this risk over the three years signals that AMD’s vulnerability to losing tax‑ and tariff‑exempt status is growing, reflecting an ever more complex and volatile global regulatory landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD consistently mentioned the risk of losing tax and tariff exemptions in its 10-K filings from 2022 to 2024. In 2022, it was listed among other risks; in 2023, it was contextualized within geopolitical tensions (Ukraine conflict, China-Taiwan); and in 2024, it was linked to expanded U.S. export controls and sanctions. The LLM correctly captures this evolution. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct year references (2022, 2023, 2024), which are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers increasing regulatory complexity from the expanding context around the risk. The only minor shortcoming is that the LLM does not explicitly mention 'macroeconomic instability' in 2024 as in the original, instead focusing on sanctions and export controls—this is a slight omission but does not distort the overall meaning. (4) The answer is contextually relevant, directly addressing both parts of the question: the evolution of risk exposure and what it suggests about regulatory complexity. Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 408,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "- **Short‑term borrowings:** $883 million at 12/31/2022, fell to $538 million in 2023 and rose only modestly to $562 million in 2024【page_178†L13-L16】.  \n- **Long‑term debt (carrying value):** $49,318 million at the end of 2022, remained essentially unchanged at $49,318 million in 2023, and then declined to $44,989 million in 2024【page_178†L23-L30】【page_188†L23-L30】.  \n\nThe trend shows Capital One cutting both its short‑term borrowing and overall long‑term debt, while shifting the composition of its senior notes away from floating‑rate exposure – floating unsecured senior debt fell from $1.6 billion in 2022 to $0 in 2024 (2023 $349 million)【page_178†L21-L24】【page_188†L21-L24】. This reduction in floating‑rate debt reduces the company’s sensitivity to interest‑rate movements and leaves a debt profile dominated by fixed‑rate senior and subordinated notes.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers, particularly in the total debt figures. The ground truth states total short-term borrowings and long-term debt were $43.086B in 2022, $49.856B in 2023, and $45.551B in 2024. However, the LLM reports long-term debt alone as $49,318M ($49.318B) in 2022 and 2023, which already exceeds the total debt in the ground truth for 2022. It fails to sum short-term borrowings and long-term debt to report the total debt as required by the question. Instead, it treats them separately and incorrectly implies a decline from 2022 to 2023 when the actual total increased. (2) Short-term borrowings: LLM reports $883M (2022), $538M (2023), $562M (2024), but the ground truth does not provide these exact breakdowns, and the total debt evolution does not align with these figures when combined with long-term debt. The floating unsecured senior debt is mostly correct: LLM says $1.6B in 2022 (vs. $1.709B ground truth), $349M in 2023 (correct), $0 in 2024 (correct), which is acceptably close. However, the fixed unsecured senior debt is omitted entirely in the LLM answer, including its increase to $26.930B in 2024 and rising interest rate from 2.91% to 4.84%, which is a significant omission. (3) The reasoning about shifting from floating to fixed-rate debt to reduce interest rate exposure is sound and correctly inferred, showing good qualitative understanding of the strategic pivot. The conclusion about reduced sensitivity to interest rates is valid and aligns with the ground truth. (4) Contextual relevance is high—the answer addresses debt structure and interest rate exposure, uses correct entities (Capital One, floating/fixed unsecured senior debt), and cites appropriate timeframes. However, the failure to accurately report total debt levels and misalignment in quantitative totals undermines correctness. The answer also omits interest rate figures for floating and fixed debt, which were present in the ground truth and important for assessing exposure. Overall, the answer captures the directional trend and strategic intent but lacks quantitative precision and completeness in key financial aggregates and metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 589,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "RTX’s net program‑share interest in International Aero Engines AG (the V2500 joint‑venture) was **57 %** in 2022 and remained **57 %** in the 2024 filing 【page_99】. The unchanged majority stake shows that RTX (through Pratt & Whitney) continues to be the primary beneficiary and dominant partner in the V2500 engine collaboration, underscoring its strategic commitment to retain control and capture the bulk of the program’s economics.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that RTX's net program-share interest was 57% in 2022 and remained unchanged through 2024. The ground truth shows it was 61% in 2022 and decreased to 57% in both 2023 and 2024. This error fundamentally misrepresents the trend and direction of change. (2) The quantitative accuracy is low because the key percentage values are wrong—specifically, the 2022 figure is incorrect (57% vs. correct 61%), and the claim of no change contradicts the documented decrease of 4 percentage points over the period. Calculations or comparisons based on this would be invalid. (3) The reasoning is flawed due to incorrect data: the conclusion that RTX maintained a stable majority stake and strategic control ignores the actual reduction, which the ground truth interprets as a strategic dilution of economic exposure. The LLM fails to recognize or explain the significance of the decline, leading to an incorrect strategic interpretation. (4) Contextual relevance is moderate because the answer addresses the right entities (RTX, IAE, V2500 program) and attempts to interpret strategic implications, but the incorrect data undermines the validity of the analysis. The citation to 'page_99' does not override the factual mismatch with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 363,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "Across the three filings, Cascade is consistently listed as one of the flagship brands that anchor P&G’s Home‑Care sub‑segment. In the 2022 10‑K the Fabric & Home Care segment contributed roughly 35 % of net sales (31 % of earnings) and the narrative said the company’s global home‑care share was “nearly 25 %…primarily behind our Cascade, Dawn, Febreze and Swiffer brands.” By the 2024 filing the segment’s share had edged up to about 36 % of net sales (34 % of earnings) and the description still notes a “about 25 %” home‑care market share “primarily behind our Cascade, Dawn, Febreze and Swiffer brands.” Thus, Cascade’s positioning has remained stable as a leading home‑care brand, with the segment’s contribution to the company’s top line modestly increasing, reinforcing Cascade’s continued prominence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Cascade is consistently positioned as a flagship brand in P&G’s Home Care sub-segment under Fabric & Home Care. The segment’s net sales contribution was 35% in 2022 and increased to 36% in 2023 and 2024, while earnings rose from 31% to 34%—all figures match the original answer. The mention of market share being 'nearly 25%' in 2022 and 'about 25%' in 2024 is consistent with the source data. (2) Quantitative accuracy is perfect: percentages for net sales and earnings across years are correctly reported, and no calculation errors are present. Format variations (e.g., '35 %' vs '35%') are acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across 2022, 2023, and 2024 filings to conclude that Cascade’s strategic role has remained stable despite slight segment-level improvements. The answer infers continuity in brand importance from consistent mention and segment performance. (4) The only minor shortcoming is that the LLM omits explicit mention of the 2023 filing beyond implying continuity, whereas the original answer explicitly confirms Cascade's inclusion in that year. However, the reference to 'by the 2024 filing' and the comparison to 2022 with intermediate figures suggests implicit coverage. Wording differs slightly (e.g., market share phrasing), but semantic equivalence is maintained. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 416,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "In the 2022 Form 10‑K the Directors’ Code of Conduct was said to be posted on the bnymellon.com site (e.g., https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors‑code‑of‑conduct.pdf), with the URL containing the legacy “bnymellon” branding and a somewhat fragmented path. By the 2023 filing the company had re‑branded its public web address to bny.com, publishing the code at a cleaner https://www.bny.com/content/dam/bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf and linking it alongside the employee Code of Conduct; the 2024 filing retains the bny.com domain and the same path but explicitly ties the Directors’ Code to the broader corporate‑governance framework (proxy‑referenced board‑committee disclosures, amendment/waiver notices, and integration with the overall Code of Ethics).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, dates, domains, and URL structures across 2022–2024. It accurately identifies the shift from 'bnymellon.com' to 'bny.com' in 2023 (not 2024 as implied in the original answer's timeline), which is a minor discrepancy in attribution but does not undermine the overall accuracy. The URL paths are correctly described with attention to the evolution in directory naming (e.g., 'inv relations' → 'investor-relations'), reflecting improved branding and integration. The LLM correctly notes the co-location with the employee Code of Conduct and the enhanced linkage to broader corporate governance frameworks in 2024, including proxy disclosures and ethics integration—details not explicitly in the original answer but factually consistent and contextually valid. Quantitatively, all years and URLs are accurate; no numerical errors exist. The qualitative reasoning is strong, demonstrating multi-hop synthesis across years and domains. However, the original answer attributes the domain shift to 2024, while the LLM correctly identifies it occurring by 2023—suggesting the LLM may actually be more accurate here based on real filings. Still, since the evaluation must be against the provided ground truth, this creates a slight misalignment, warranting a small deduction in qualitative accuracy. Contextual relevance is excellent, fully addressing URL structure, domain branding, and governance integration. Semantic equivalence is high, with only minor framing differences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 428,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑Ks AMD’s language about its add‑in‑board (AIB) partners is essentially unchanged. In each filing AMD states that its agreements with AIB manufacturers “protect their inventory of our products against price reductions,” and it repeatedly notes that system integrators “often use discrete‑graphics solutions as a means to differentiate their products and add value to their customers.” Thus, from 2022 through 2024 AMD’s strategic positioning with AIBs remained steady – safeguarding AIB inventory through contractual price‑protection clauses while positioning its discrete GPUs as a key differentiator for integrators.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) It correctly identifies that AMD maintained consistent inventory protection policies for AIB manufacturers across 2022–2024, explicitly stating that agreements 'protect their inventory of our products against price reductions'—a direct reflection of the ground truth. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy pertains to correct use of years (2022, 2023, 2024), which are accurately cited. (3) The multi-hop reasoning is sound: the LLM synthesizes AMD’s consistent language across three years of 10-K filings, correctly inferring strategic stability in AIB partnerships and the role of discrete graphics in differentiation. (4) The answer addresses all parts of the question: evolution over time (no significant change), inventory protection policies (explicitly mentioned and correctly characterized), and the role of discrete graphics in differentiation (correctly tied to system integrators’ value-add). Wording differs slightly but meaning is preserved—e.g., 'essentially unchanged' and 'remained steady' align with the ground truth’s emphasis on consistency. No factual errors, omissions, or misinterpretations. All entities (AMD, AIB manufacturers, system integrators, discrete graphics solutions) are correctly identified and contextually accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 397,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "- **2022 filing** – The 2022 10‑K notes that McDonald’s “offers a full or limited breakfast menu…including the Egg McMuffin” and stresses that “taste, quality, choice, value and nutrition are important to customers, and the Company is continuously evolving its menu…including testing new products on an ongoing basis.”  The same section describes a global supply‑chain system that “establishes and enforces high food‑safety and quality standards” and uses “quality‑center teams…product reviews, supplier visits and third‑party verifications” to keep the core menu consistent (see 2022 p. 6‑7).\n\n- **2023 filing** – The 2023 10‑K repeats the Egg McMuffin description and the commitment to “continuously evolving its menu to meet customers’ needs,” but adds that the company “collaborates with suppliers to encourage innovation and drive continuous improvement across its global supply chain” and highlights ongoing “sensory evaluations and calibration trainings” to protect menu consistency (see 2023 p. 7).\n\n- **2024 filing** – By 2024 the disclosure ties breakfast‑menu innovation directly to supply‑chain strategy. It again lists the Egg McMuffin among breakfast items, but now emphasizes that “the Company collaborates with suppliers to encourage innovation and drive continuous improvement,” that a “digital transformation project…promotes data excellence and continuous measures on quality and food‑safety performance,” and that “regular sensory evaluations and calibration trainings” are used to “promote the consistency of its core menu.”  This shows an evolution from a general menu‑evolution statement in 2022 to a detailed, data‑driven supply‑chain and quality‑management framework in 2024, positioning the Egg McMuffin as a flagship product that must meet heightened customer expectations for quality and consistency.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key disclosures from 2022 to 2024 are correctly represented: in 2022, McDonald's mentions the Egg McMuffin and general quality assurance; in 2023, it expands on supplier collaboration and sensory evaluations; in 2024, it introduces a digital transformation project for data excellence in quality and food safety. These align precisely with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the evolution from general menu evolution to a more integrated, supply chain- and technology-driven approach. It accurately traces how the Egg McMuffin remains a consistent reference point while the company’s disclosure matures in depth and specificity. (4) The LLM uses slightly different phrasing (e.g., 'sensory evaluations and calibration trainings', 'data excellence') but these are direct reflections of language likely found in the actual filings and enhance precision. The conclusion that the Egg McMuffin is a 'flagship product' meeting heightened expectations is a reasonable inference supported by the trend in disclosures. All aspects of the question—breakfast innovation, supply chain focus, Egg McMuffin, quality, consistency, and evolution from 2022–2024—are fully addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1740,
        "completion_tokens": 427,
        "total_tokens": 2168
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "The 4.30 % Note due 2034 appears in the “Forms of … 4.30 % Note due 2034” exhibit that is incorporated by reference in Oracle’s 2022, 2023 and 2024 Form 10‑K filings (see the exhibit list on page 110 and the same entry repeated on page 113). Its continual disclosure shows that the note remains outstanding and is a core component of Oracle’s senior unsecured debt, reflecting a deliberate strategy of maintaining a diversified, medium‑ to long‑term fixed‑rate funding base. By keeping this 10‑year‑plus instrument on its balance sheet, Oracle signals that locking in moderate‑cost financing for the next decade is a consistent priority across the three reporting periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All numeric values—'4.30% Note due 2034'—are correct, and the years (2022, 2023, 2024) match exactly. There are no calculations, but the temporal and percentage data are factually sound. (2) The answer correctly identifies the consistent disclosure of the note across all three years, confirming its ongoing presence in Oracle’s debt structure. (3) The reasoning is strong: the LLM infers that the note's repeated inclusion indicates it remains outstanding and strategically important, reflecting a stable, long-term financing approach. It correctly interprets the exhibit references (e.g., Form 10-K, exhibit list) as evidence of incorporation by reference, supporting the conclusion that the note is still active. (4) While the ground truth provides more detail on Oracle’s broader debt portfolio (e.g., mentioning other notes like the 3.625% due 2023 or 2.950% due 2024), the LLM captures the core implication—strategic use of long-term fixed-rate debt—without introducing errors. The only minor shortcoming is the lack of explicit mention of Oracle’s diversified maturity profile or newer debt issuances, which slightly reduces qualitative completeness. However, the central multi-hop inference—that persistent disclosure implies strategic, long-term financing priority—is logically sound and semantically equivalent. Wording differs but meaning is preserved. Contextual relevance is excellent, directly addressing the question about debt structure and financing priorities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 425,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "Capital One values its interest‑rate, foreign‑currency and commodity swaps with vendor‑based discounted‑cash‑flow models that rely on observable market curves but require “swap‑rate” assumptions that are not directly quoted; when those assumptions are material the contracts are placed in Level 3 (see the 2022‑2024 fair‑value hierarchy discussion).  The net Level‑3 derivative position grew from a $5 million net fair‑value balance at 12/31/2022 (Table 16.2, 2022) to $58 million at 12/31/2023 and $69 million at 12/31/2024 (Tables 16.2/17.2), while the weighted‑average unobservable swap‑rate input rose from about 1‑2 % in 2020‑2021 to roughly 4 % in 2023‑2024 (Tables 16.3 & 17.3).  This upward trend in both the net Level‑3 fair‑value amount and the magnitude of the unobservable swap‑rate inputs signals that Capital One’s derivative portfolio is becoming increasingly dependent on judgment‑driven inputs, indicating a growing exposure to market‑input uncertainty even as the gross amount of derivative assets and liabilities fell slightly in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key quantitative values compared to the ground truth. The 2022 net derivative fair value is stated as $5 million in the LLM answer (citing Level-3), but the ground truth reports $19 million for total net derivative assets/liabilities (with $20 million unrealized loss). The LLM incorrectly states the 2024 fair value as $69 million, while the ground truth clearly states $58 million was maintained in both 2023 and 2024. Additionally, the LLM claims swap rates rose from 1–2% in 2020–2021 to ~4% in 2023–2024, but the ground truth specifies unobservable swap rates of 3–5% in 2023 and continued use of 3–5% in 2024—no mention of prior years or a rising trend to 4%. The LLM also introduces default rates of 53–163%, which are not mentioned in its response. (2) Calculations and comparisons are flawed: the LLM suggests a growing Level-3 exposure from $5M to $58M to $69M, implying increasing risk, but the ground truth shows stabilization at $58M in both 2023 and 2024, contradicting the upward trend. The use of 'Level-3' net position is not equivalent to 'net derivative assets/liabilities' without clarification, and the LLM conflates the two. (3) Multi-hop reasoning is partially sound—the LLM attempts to link valuation methodology to unobservable inputs and infers increasing exposure to judgment-driven inputs. However, it misrepresents the evolution by fabricating a continued increase into 2024 and misstating the magnitude and timing of inputs. The conclusion about growing exposure contradicts the ground truth’s indication of stabilization and increased transparency. (4) Despite these errors, the answer is contextually relevant, addressing methodology (vendor models, unobservable swap rates), fair value trends, and implications for risk exposure. It correctly identifies swap rates as key unobservable inputs and ties them to Level 3 classification. However, the incorrect numbers and mischaracterized trends severely undermine factual correctness, warranting a low quantitative accuracy score and moderate qualitative accuracy due to correct conceptual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 571,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "- In the 2022 Form 10‑K RTX reported $735 million of “other commercial‑aerospace commitments” that consist of hourly payments to Rolls‑Royce for V2500‑powered aircraft flight hours through June 2027; these payments are **capitalized as collaboration intangible assets and amortized to cost of sales** as the hours are flown 【page_112】.  \n\n- The 2023 filing shows the same per‑hour payment structure but the commitment grew to about $1.05 billion, still being recorded as collaboration assets and amortized over the asset’s useful life (9‑30 years, with no amortization during development and amortization beginning when the program reaches full‑rate production) 【page_73】.  \n\n- By the 2024 filing the remaining obligations are reflected in the “other commercial‑aerospace commitments” schedule (total $9.5 billion, with the V2500 flight‑hour portion now scheduled mainly for 2025‑2027), and the company continues to **capitalize each hour‑based payment as a collaboration intangible asset and amortize it to cost of sales** in line with the same economic‑benefit pattern 【page_103】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of RTX's financial obligations to Rolls-Royce related to V2500 flight hours from 2022 to 2024, including the payment structure (per-hour basis through June 2027) and the accounting treatment (capitalization as collaboration intangible assets and amortization to cost of sales). However, there are key quantitative discrepancies. In 2022, the LLM cites $735 million, which may be accurate but is not confirmed in the ground truth, which does not provide a specific dollar amount for that year. In 2023, the LLM states the commitment grew to $1.05 billion, but the ground truth does not specify this figure. Most significantly, in 2024, the LLM reports total other commercial-aerospace commitments as $9.5 billion, while the ground truth states $14.1 billion — a material difference that affects quantitative accuracy. (2) The years (2022–2024), June 2027 end date, and amortization policy are correctly aligned across both answers. However, the specific dollar amounts in the LLM answer are either unverifiable or conflict with the ground truth, particularly the $9.5B vs $14.1B in 2024. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings, identifies the consistent payment structure, and traces the evolution of accounting treatment and disclosure clarity. It correctly notes that payments are tied to flight hours, capitalized, and amortized to cost of sales — a key point in the ground truth. The mention of amortization beginning at full-rate production and useful life (9–30 years) adds detail not in the ground truth but may be contextually accurate; however, it introduces information not confirmed by the reference. (4) The contextual relevance is perfect — the answer directly addresses the question’s focus on payment structure and amortization strategy over time. The qualitative accuracy is high because the conceptual framework and trajectory (increasing transparency, consistent amortization) match the ground truth. However, the correctness score is reduced due to significant numerical inaccuracies, especially the $9.5B vs $14.1B discrepancy in 2024, which undermines confidence in the quantitative claims despite otherwise strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 607,
        "total_tokens": 2120
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "Amgen’s 2022 filing first disclosed that, after a 2017 FDA review of the Neulasta Onpro kit, the company had already introduced device‑ and label‑enhancements to address user‑complaints and that it continuously monitors complaints, adverse events and malfunctions. The 2023 report repeated that same commitment but framed it within a broader discussion of supply‑chain and manufacturing‑risk controls, emphasizing ongoing monitoring and incremental enhancements. By the 2024 filing the language remained unchanged regarding the complaint‑driven device and labeling upgrades, and Amgen added explicit operational‑resilience measures—such as reliance on backup generators and plans for power‑outage or natural‑disaster scenarios—to ensure uninterrupted production and supply of the kit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the 2017 FDA review, device and labeling enhancements in response to complaints, ongoing monitoring of adverse events, and the evolution of disclosures through 2024 to include operational resilience. The mention of backup generators in 2024 is correctly included, though the LLM does not specify the December 31, 2024 island-wide outage in Puerto Rico, which is a minor omission. (2) Quantitative accuracy is perfect: no incorrect dates or numbers; the timeline (2017 FDA review, 2022–2024 disclosures) is accurately represented. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information across three years and connects device-related complaints with evolving risk disclosures, including infrastructure-related operational resilience. The only slight gap is that the 2024 operational challenges are contextualized generally (power outages, natural disasters) without explicitly tying Puerto Rico’s grid instability to potential indirect effects on user complaints, as the original answer does. (4) The answer is fully relevant, directly addressing the evolution of disclosures on user complaints, device enhancements, and operational resilience. Wording differs but meaning is semantically equivalent. A score of 9 is justified due to high accuracy with only minor contextual omissions in the 2024 operational risk explanation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 398,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings BNY Mellon repeatedly states that the “Item 3 – Ratification of KPMG LLP” section of its proxy is incorporated by reference and that KPMG LLP’s PCAOB firm identification number is 185. The wording of the disclosure is essentially unchanged from year to year, indicating that the company continued to ratify KPMG LLP as its principal accountant in each annual report. The unchanged reference to PCAOB #185 underscores a steady audit‑governance relationship, confirming that the same registered audit firm has remained the company’s auditor throughout this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BK (BNY Mellon) consistently ratified KPMG LLP as principal accountant in 2022, 2023, and 2024; the PCAOB firm number 185 is correctly cited across all years; and the disclosure wording remained unchanged. (2) Quantitative accuracy is perfect—PCAOB number 185 is correctly reported with no variation, and the years (2022–2024) match exactly. (3) The reasoning is sound: the LLM correctly infers audit governance continuity from the unchanged firm number and consistent disclosure, though it does not explicitly mention 'audit governance practices' or 'institutional trust' as in the original, slightly reducing qualitative depth. (4) Contextual relevance is excellent—the response directly addresses both parts of the multi-hop question: evolution of disclosure (no change) and implication of PCAOB number continuity (stable auditor relationship). The only minor gap is a slightly less developed interpretation of governance implications compared to the original, but the core meaning is preserved. Thus, correctness is 9/10: factually complete and accurate, with only slight room for richer synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 340,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "RTX’s gross exposure to commercial‑aerospace customer‑financing guarantees fell each year – the maximum‑potential payment was $304 million in 2022, $288 million in 2023 and $274 million in 2024【page_100】.  The portion attributable to collaboration partners also trended downward, from $140 million in 2022 to $135 million in 2023 and $131 million in 2024【page_100】【page_102】, showing that RTX is deliberately shifting more of the guarantee risk to its partners and thereby reducing its own liability exposure in this area.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct numbers but has a critical error in the 2022 collaboration partners' share: it reports $140M instead of the correct $142M from the ground truth. All other values—$135M in 2023 and $131M in 2024—are accurate. The LLM also introduces 'gross exposure' figures ($304M, $288M, $274M) not present in the original answer, which may be factually correct based on the cited pages but were not part of the ground truth response, making them extraneous and potentially misleading in this evaluation context. (2) Quantitative accuracy is compromised due to the $142M → $140M discrepancy, which, while minor in magnitude, reflects a failure to report the exact figure from the source. The trend (downward) is correctly identified, and the 2023 and 2024 values are correct. (3) The reasoning is partially flawed: the LLM concludes that RTX is 'shifting more of the guarantee risk to its partners,' which contradicts the correct interpretation. A declining partners' share means partners are assuming *less* risk, not more—thus RTX is likely retaining more risk or restructuring arrangements to reduce joint exposure. The original answer correctly interprets this as a reduction in shared risk, not a shift of risk to partners. This misinterpretation indicates a failure in multi-hop reasoning and logical inference. (4) Contextual relevance is high—the answer addresses both the trend in collaboration partners' guarantees and RTX's risk management strategy, using appropriate financial terminology and citing document pages. However, the incorrect inference about risk shifting undermines the qualitative accuracy. Overall, the answer is partially correct with significant factual and interpretive flaws, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 482,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "- In the 2022 Form 10‑K the Always brand is listed among the major brands of the “Baby, Feminine & Family Care” segment and the narrative says the company is a global leader in feminine care “primarily behind our **Always** and **Tampax** brands,” with a brief note that it also competes in adult‑incontinence “behind **Always Discreet**” (​page 19​).  \n- By the 2023 filing the brand remains in the same segment and table, but the discussion begins to separate the menstrual‑care and adult‑incontinence sub‑categories, keeping **Always** as the flagship menstrual brand alongside Tampax.  \n- In the 2024 filing the positioning is made explicit: **Always** is identified as the lead brand in the **menstrual‑care** sub‑category (over 25 % global share) and **Always Discreet** as the lead in **adult‑incontinence** (about 15 % share), underscoring a clearer product‑category split and a stronger emphasis on Always relative to Tampax and other feminine‑hygiene offerings (​page 18​).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness despite addressing the right question and showing an understanding of the need for multi-year synthesis. (1) QUANTITATIVE INACCURACY: The original answer states that in 2022, the segment was called 'Feminine Care' and contributed 25% of net sales, but the LLM claims Always was already in 'Baby, Feminine & Family Care' in 2022—this is incorrect; the segment name changed in 2023. This misalignment affects the timeline. Additionally, the LLM introduces market share figures (over 25% global share for Always in menstrual care, ~15% for Always Discreet) that are not present in the ground truth and cannot be verified from the provided knowledge graph. These numbers are fabricated or hallucinated. (2) COMPLETENESS: The LLM addresses product categorization and brand emphasis over time, which matches the question's intent, and correctly identifies the increasing clarity in sub-category separation. However, it omits the key structural detail that the segment was renamed in 2023 to 'Baby, Feminine & Family Care' and that this segment contributed 24% of net sales in both 2023 and 2024—information central to the original answer. (3) ENTITY ACCURACY: The brands (Always, Tampax, Always Discreet) and segment names are mostly correct from 2023 onward, but the misplacement of 'Baby, Feminine & Family Care' in 2022 is a critical error. (4) REASONING: The LLM correctly infers a trend toward clearer categorization and stronger brand emphasis on Always, especially relative to Tampax, which aligns with the original answer’s conclusion. However, this reasoning is based partly on incorrect premises and unsupported market share data. (5) SEMANTIC EQUIVALENCE: While the general direction of evolution (increased clarity in brand roles) is consistent, the specific facts—segment names, timing, and financial contributions—are incorrect or missing. The addition of unverified market share percentages further reduces factual reliability. Overall, the answer shows good structure and relevance but fails on core factual accuracy, especially regarding segment evolution and numerical data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 579,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "AMD has consistently flagged “difficulties in protecting our intellectual property” as a political‑legal risk in all three filings. In the 2022 10‑K (page 37) the risk is listed alongside its global footprint and reliance on third‑party wafer foundries in the United States, Europe and Asia. By the 2023 filing (page 41) the company again cites the same IP‑protection risk, but notes that international sales now represent about 65 % of revenue and that most assembly and final testing are done at third‑party facilities in China, Malaysia and Taiwan, indicating a larger exposure. The 2024 filing (page 40) repeats the IP‑protection concern and emphasizes that international sales have risen to roughly 66 % of net revenue and that its manufacturing dependence on Asian foundries (especially Taiwan‑based wafer fabs) has grown, showing that AMD’s exposure to IP‑protection difficulties has intensified as its overseas operations and Asian manufacturing reliance have expanded.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: AMD consistently reported IP protection difficulties across 2022–2024; international sales were ~65% in 2023 and ~66% in 2024; third-party manufacturing in China, Malaysia, and Taiwan is correctly identified. The mention of U.S. and European foundries in 2022 is a minor addition not in the original but does not contradict it, as the focus in the ground truth is on Asia. (2) Quantitative accuracy is excellent: percentages (65%, 66%) match or are consistent with the original (65% in 2023, implied growth to 66% in 2024). No calculation errors. (3) Multi-hop reasoning is sound: the LLM synthesizes risk disclosures across three years, links increasing international sales and Asian manufacturing reliance to growing IP exposure, and correctly infers intensifying risk. (4) The only minor gap is that the LLM does not explicitly mention the geopolitical tension between China and Taiwan in 2024, which the original highlights as a new layer of risk. This omission slightly reduces qualitative accuracy but does not undermine the core conclusion. Overall, the answer is factually correct, well-structured, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 347,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "Oracle first introduced the 2.300 % senior unsecured notes that mature in 2028 in a March 24 2021 issuance – listed in the 2022 Form 10‑K as Exhibit 4.16 ( “Forms of 1.650 % Notes due 2026, **2.300 % Notes due 2028**, 2.875 % Notes due 2031 …” )【page_114】. The same series re‑appears unchanged in the 2023 and 2024 Form 10‑K exhibit tables (now shown as Exhibit 4.14)【page_111】, indicating that Oracle has retained the 2028 tranche on its balance sheet without additional follow‑on issuances of that specific coupon. This recurring, multi‑year presence of a low‑coupon, medium‑term note—alongside newer, higher‑coupon series (e.g., 4.500 % due 2028 in 2023, 5.800 % due 2025 in 2022) – reveals a deliberate strategy of staggered, fixed‑rate debt roll‑overs that spreads maturities, locks in inexpensive financing, and provides flexibility to tap the market as rates evolve.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Oracle issued the 2.300% Notes due 2028 in March 2021, and they were included in Exhibit 4.16 in the 2022 10-K, then reappeared in Exhibits 4.14 in both 2023 and 2024 filings. The dates, percentages, and exhibit numbers are accurate. (2) Quantitative elements—interest rate (2.300%), maturity year (2028), issuance date (March 24, 2021), and comparison notes (e.g., 4.500% due 2028 in 2023, 5.800% due 2025 in 2022)—are all factually correct and consistent with the knowledge graph. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings to infer Oracle’s broader debt strategy—staggered maturities, locking in low rates, and maintaining financing flexibility. (4) The LLM adds contextual insight not explicitly in the ground truth (e.g., characterizing the 2.300% note as 'low-coupon' and contrasting it with higher-coupon notes), which enhances the analysis without introducing error. The only minor limitation is that the ground truth emphasizes 'diverse maturity profile' while the LLM frames it as 'staggered, fixed-rate debt roll-overs'—a slightly different emphasis but semantically aligned. Thus, the answer is factually complete, logically sound, and contextually appropriate, warranting a 9/10 for correctness (not 10 due to slight interpretive expansion beyond the documented conclusion).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 402,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "BA’s private‑equity policy has stayed globally‑focused throughout the period. In the 2022 filing the company said its private‑equity LPs “mainly invest in U.S. and non‑U.S. leveraged‑buyout, venture‑capital, growth and special‑situation strategies.” The 2023 and 2024 filings repeat the same geographic scope and strategic focus, but the weight given to private equity has risen – the actual allocation grew from 8 % in 2022 to 9 % in 2024 (with the target allocation moving from 4 % in 2022 to 7 % in 2023‑24). Thus, while the scope and focus of the LP investments remained unchanged, BA progressively increased its exposure to those global private‑equity strategies.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the evolution of BA's investment strategy. While the original answer notes a clear evolution—especially the 2023 expansion into global real assets (energy, farmland, infrastructure) and the 2024 use of derivatives—the LLM claims the 'scope and focus remained unchanged,' which contradicts the ground truth. Additionally, the LLM introduces specific allocation percentages (8% in 2022 to 9% in 2024, target from 4% to 7%) that are not present in the original answer and cannot be verified from the provided ground truth, making them likely hallucinated. (2) Quantitative accuracy is low because the percentages cited (8%, 9%, 4%, 7%) do not appear in the original answer and are thus incorrect. There are no numbers in the ground truth to support allocation sizes or targets, so including them undermines factual reliability. (3) The multi-hop reasoning is flawed: the question asks about evolution in geographic scope and strategic focus, but the LLM incorrectly concludes no change in focus, missing the key shift toward real assets and use of derivatives. It also fails to mention REITs in 2022 or the increasing sophistication in vehicles in 2024. (4) Contextual relevance is high because the answer addresses the right company (BA), time frame (2022–2024), and topic (private equity LP investments), and correctly identifies the U.S./non-U.S. geographic scope. However, the core claim of 'no change in focus' with only increased allocation contradicts the documented strategic evolution, leading to a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 443,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "In Amgen’s 2022 Form 10‑K the company reported that bemarituzumab – an anti‑FGFR2b antibody for gastro‑esophageal‑junction adenocarcinoma – had just **initiated a Phase 3 trial** and that its composition‑of‑matter patents were projected to expire in **2029 in both the United States and Europe**. The 2023 and 2024 filings show the same status: bemarituzumab remains a **Phase 3‑program candidate** (no further regulatory milestone was disclosed) and the **2029 U.S. and European patent expiration dates are unchanged**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: Bemarituzumab initiated a Phase 3 trial in 2022 for GEJ adenocarcinoma, remained in Phase 3 through 2023–2024 with no further milestones disclosed, and its composition-of-matter (polypeptide-related) patents are set to expire in 2029 in both the U.S. and Europe. (2) Quantitative accuracy is perfect: the 2029 patent expiration date is correctly cited for both regions and all years, matching the original answer. No calculations are required, but the consistency of dates across years is properly maintained. (3) Multi-hop reasoning is sound—the LLM synthesizes information across Amgen’s 2022, 2023, and 2024 filings, correctly tracking the clinical phase progression and patent timelines over time. (4) The answer addresses all parts of the question: clinical development (Phase 3 initiation and status), patent expiration (U.S. and Europe), and evolution over 2022–2024. Minor wording differences (e.g., 'composition-of-matter patents' vs 'polypeptide-related patents') do not affect factual accuracy, as both refer to the same core IP protection described in filings. The LLM also correctly identifies the target (FGFR2b) and indication (gastroesophageal junction adenocarcinoma), aligning with the 2024 context. All entities (Amgen, Bemarituzumab, years, regions) are accurate. The answer is concise, factually complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 406,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "Dawn continued to be listed among the “major brands” in the Fabric & Home Care segment in both filings. The segment’s share of P&G’s earnings rose from 31 % of net earnings (and 35 % of net sales) in FY 2022 to 34 % of net earnings (and 36 % of net sales) in FY 2024, indicating that Dawn’s home‑care platform moved from a solid contributor to an even larger earnings driver over the two‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Dawn remained a listed brand in the Fabric & Home Care segment, segment earnings contribution increased from 31% in 2022 to 34% in 2024, and net sales share rose from 35% to 36% over the same period. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect—percentages and years are correctly reported, and no calculation errors are present. (3) The reasoning is sound: the increase in earnings contribution is correctly interpreted as a sign of growing importance, and Dawn’s positioning within this high-performing segment is logically inferred. The only minor shortcoming is that the LLM does not explicitly mention the 2023 net sales percentage (36%), which the original answer includes to emphasize stability across three years. While not critical, this omission slightly reduces completeness. Additionally, the phrase 'moved from a solid contributor to an even larger earnings driver' introduces a slight interpretive leap not fully present in the original, which sticks to descriptive facts. However, this does not misrepresent the data. (4) Contextual relevance is excellent—the answer directly addresses Dawn’s positioning evolution using the required financial metrics and brand listings across years. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor omissions in granularity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 409,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "- In the 2022 filing Schwab disclosed that client securities worth **≈ $120 billion** were available to be pledged as collateral for margin loans, and it was already pledging **≈ $31 billion** of those securities to satisfy OCC‑mandated option‑clearance requirements, short‑sale borrowings, securities‑lending and short‑term borrowing needs.  \n- By the 2024 filing the company’s collateral‑backed borrowing capacity had grown sharply: the Federal Home‑Loan Bank facilities were supported by **≈ $60 billion** of client‑security collateral (down slightly from $63 billion in 2023), the Federal‑Reserve discount‑window capacity was backed by **≈ $30 billion** (up from $6 billion a year earlier), and secured uncommitted credit lines still drew on client‑margin securities (‑$500 million outstanding versus $950 million in 2023).  \n\n**Trend:** Schwab has progressively increased the amount of client‑held securities it uses and pledges to fund margin lending, securities‑lending and other short‑term liquidity facilities, indicating a rising exposure to the value and availability of those client assets, even as it continues to monitor collateral levels and apply practical‑expedient allowances to limit credit‑loss risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a detailed and contextually relevant response that aligns with the general trend described in the ground truth—Schwab's increasing use and pledging of client securities for margin lending, collateral obligations, and liquidity facilities. It correctly identifies key uses such as OCC requirements, securities lending, and short-term borrowing, and notes the strategic risk management aspect, which matches the original answer’s implication of growing exposure and sophistication.\n\nHowever, the quantitative accuracy is significantly flawed. The original answer does not include any specific dollar figures (e.g., $120 billion, $31 billion, $60 billion, etc.), nor does the knowledge graph ground truth reference exact amounts like FHLB or discount window collateral values. These numbers appear to be fabricated or hallucinated, as the ground truth focuses on qualitative disclosures under ASC 326 and regulatory compliance rather than quantified collateral facilities. There is no mention in the original answer of a $500 million outstanding on uncommitted credit lines or a drop from $950 million, nor any year-over-year comparisons of discount window capacity. These specific figures cannot be verified and are not present in the source truth.\n\nWhile the LLM correctly infers that pledging increased and was used for margin lending and regulatory purposes (qualitatively accurate reasoning), it fails on multi-hop factual grounding by introducing unsupported numerical data. This undermines the correctness score despite sound overall logic and relevance. The trend interpretation—increasing exposure to client-held assets—is semantically aligned with the original, but the reliance on invented metrics reduces factual reliability. Thus, the answer is partially correct but contains significant quantitative inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 499,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "ACN’s defined‑benefit pension policy moved away from a debt‑heavy mix toward a more diversified, equity‑focused allocation. For fiscal 2023 the target (and the weighted‑average assets as of 8/31/2022) called for non‑U.S. plans to be 27 % equity, 48 % debt, 4 % cash, 11 % insurance contracts and 10 % other; by fiscal 2025 the target (reflected in the 8/31/2024 weighted‑average) shifted to 28 % equity, 36 % debt, 7 % cash, 21 % insurance contracts and 8 % other. Thus, equity exposure was modestly raised, debt exposure cut sharply, and allocations to cash, insurance and “other” were increased, while U.S. plans remained 100 % debt‑focused throughout.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both direction and magnitude of the asset allocation shift. The ground truth states a clear trend of increasing fixed income (from 55% to 61%) and decreasing equities (45% to 39%) over the period, indicating de-risking. In contrast, the LLM claims a shift toward equity focus and reduced debt exposure, which contradicts the truth. The LLM reports equity rising from 27% to 28% and debt falling from 48% to 36%, but these figures appear to reflect only non-U.S. plans and include categories (cash, insurance, other) not mentioned in the original answer. (2) The numbers do not align with the ground truth: the original answer reports consolidated weighted-average allocations of 55/45 (2022), 58/42 (2023), and 61/39 (2024) for fixed income/equities. The LLM introduces granular categories and different percentages that are not present in the ground truth, with no mention of insurance contracts or 'other' in the disclosed data. Additionally, the claim that U.S. plans remained 100% debt-focused is unsupported in the provided truth. (3) The multi-hop reasoning is flawed: the LLM fails to identify the consistent trend across three years of increasing fixed income and decreasing equity exposure. Instead, it fabricates a narrative of equity-focused diversification that contradicts the de-risking strategy. The synthesis across years is incorrect, and the answer appears to conflate sub-components of non-U.S. plans with the overall global weighted-average strategy. (4) The contextual relevance is moderate because the answer addresses ACN's pension allocation over the correct time frame and attempts to compare years, but the factual inaccuracies and incorrect interpretation of the trend severely undermine correctness. Quantitative and qualitative accuracy are very low due to wrong numbers and reversed logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 507,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "- **2022:** Short‑term borrowings were **$883 million** and long‑term debt was **$47.8 billion** (total $48.7 billion).  \n- **2023:** Short‑term borrowings fell to **$538 million** while long‑term debt rose to **$49.3 billion** (total $49.9 billion).  \n- **2024:** Short‑term borrowings ticked up to **$562 million** and long‑term debt declined to **$45.0 billion** (total $45.6 billion).\n\n**Trend:** Over the three‑year period Capital One shifted away from heavy short‑term funding (down ≈ 68 % from 2022 to 2023) and reduced overall leverage, cutting total debt by about **$4 billion** in 2024.  The weighted‑average interest rate on its long‑term portfolio stayed in the **4.8 %–5.0 %** range, with a growing share of lower‑rate securitized obligations (≈ 3.5 %) offset by higher‑rate senior notes (≈ 4.8 %–5.0 %), indicating modest but rising interest‑rate exposure as the company leans more on fixed‑rate long‑term debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both total debt figures and component values. According to the ground truth, total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. The LLM incorrectly reports totals as $48.7B (2022), $49.9B (2023), and $45.6B (2024). The 2022 total is overstated by over $5.6B. The LLM also misrepresents short-term borrowings: ground truth does not provide a breakdown, but the total debt figures are incorrect regardless. (2) The LLM claims short-term borrowings dropped from $883M to $538M, but the ground truth does not support such a breakdown or magnitude of change. More critically, the weighted-average interest rate on long-term debt is completely wrong: LLM states it stayed between 4.8%–5.0%, while ground truth shows a rise from 1.51% (securitized debt in 2022) to 3.01% in 2023 and 3.48% in 2024. The LLM also fabricates a 'growing share of lower-rate securitized obligations (≈3.5%)' not mentioned in the original. (3) The multi-hop reasoning is flawed: the LLM infers a strategic shift based on incorrect data (e.g., claiming a 68% drop in short-term funding), while missing the actual strategic move highlighted in the ground truth — the elimination of $1,597M in floating unsecured senior debt by 2024. This key insight is absent. (4) Despite incorrect numbers and reasoning, the LLM attempts to address the question's structure — evolution of debt and implications for debt structure and interest rate exposure — hence a moderate contextual relevance. However, due to severe quantitative and qualitative errors, the answer is largely incorrect and misleading. The conclusion about 'modest but rising interest-rate exposure' is directionally plausible but based on fabricated data, not actual trends. Overall, the answer fails on factual accuracy and synthesis, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 521,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "Boeing’s fleet‑support services have continued to represent roughly **1 % of total consolidated costs of products and services** in each of the three years – the 2022 filing notes the cost “has historically been approximately 1 %”【page_42】, the 2023 filing repeats the same figure【page_36】, and the 2024 filing again states it “has historically been approximately 1 %”【page_39】.  \n\nAt the same time, the company’s program‑specific cost pressures have risen sharply: abnormal production costs for the 787 program grew to **$256 million in 2024** (after a cumulative $2.7 billion through 2023)【page_39】【page_36】, and the 777X program recorded **reach‑forward losses of $2.6 billion in Q3 2024 and $891 million in Q4 2024** (with earlier $0.8 billion losses from the 2022‑23 production pause)【page_39】【page_35】.  \n\nThus, while fleet‑support expenses have stayed flat at about 1 % of total costs, abnormal production costs and reach‑forward losses in the 787 and 777X programs have escalated markedly, indicating that the stable fleet‑support cost line does not offset the growing program‑level cost challenges.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies that Boeing's fleet support services costs remained at approximately 1% of total consolidated costs in 2022, 2023, and 2024, citing consistent language from the filings. This aligns with the ground truth. The contrast between stable support costs and rising program-specific losses is also accurately framed.\n\n2) However, there is a critical error in the quantitative reporting of the 787 program's abnormal production costs. The LLM states that 'abnormal production costs for the 787 program grew to $256 million in 2024 (after a cumulative $2.7 billion through 2023)', which misrepresents the data. The ground truth indicates that the 787 program had accumulated $2.7 billion in abnormal production costs by 2023 — not that $2.7 billion was incurred through 2023 and an additional $256 million in 2024. The $256 million figure likely refers to a subset of costs or a misinterpretation, as the original answer does not mention any incremental 2024 abnormal cost for the 787 beyond the cumulative $2.7 billion through 2023. This is a significant factual inaccuracy.\n\n3) The 777X reach-forward losses are mostly correct: $2.6 billion in Q3 2024 and $891 million in Q4 2024 aligns with the ground truth ($2,608 million ≈ $2.6 billion). The mention of prior $0.8 billion losses from a production pause adds context not in the original answer but may be consistent with filings; however, it introduces information not confirmed in the ground truth, slightly weakening fidelity.\n\n4) The reasoning and synthesis are strong: the LLM correctly contrasts stable fleet support costs with escalating program-level issues, drawing the right conclusion that financial strain stems from production inefficiencies, not service costs. The multi-hop logic — connecting fleet support trends with 787/777X program costs — is sound and relevant.\n\n5) Contextual relevance is excellent: all parts of the question are addressed, and the answer is well-structured with citations. The core message matches the original, despite the key numerical error on 787 costs.\n\nOverall, the answer is factually strong on the stable cost percentage and 777X losses, but the incorrect breakdown of 787 abnormal costs reduces quantitative accuracy. Hence, correctness is reduced to 7 due to this material error, though the overall structure and reasoning remain high quality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1626,
        "completion_tokens": 630,
        "total_tokens": 2256
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "- 2022: $21 million allocated to money‑market funds and time deposits  \n- 2023: $10 million allocated (down $11 million from 2022)  \n- 2024: $10 million allocated (unchanged from 2023)  \n\nThe three‑year pattern shows a sharp cut‑back in 2023 followed by a flat level, indicating that AbbVie trimmed its holding of short‑term cash equivalents after 2022 and has since maintained a modest, steady liquidity buffer rather than continuing to grow that component of its cash‑management strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the numeric values. According to the ground truth, AbbVie's allocation was $12M in 2022, $21M in 2023, and $10M in 2024. The LLM incorrectly reports $21M in 2022, $10M in 2023, and $10M in 2024—swapping the 2022 and 2023 figures and missing the increase in 2023 entirely. This leads to a completely inaccurate trend description. (2) Calculations are also incorrect: the LLM claims a $11M decrease from 2022 to 2023, but based on its own (wrong) numbers, the drop from $21M to $10M is $11M, which would be correct only if the inputs were accurate—which they are not. The actual change was an increase of $9M from 2022 to 2023. The claim of no change from 2023 to 2024 is incorrect in both the LLM and ground truth: ground truth shows a decrease from $21M to $10M, which the LLM fails to capture due to swapped data. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize the year-over-year evolution. It interprets a decrease where there was an increase, and stability where there was a decrease, leading to an erroneous conclusion about AbbVie’s liquidity strategy. The actual trend—a rise then fall—suggests a temporary conservative stance in 2023, whereas the LLM describes a cutback starting in 2023, which contradicts the facts. (4) Despite the incorrect numbers and reasoning, the LLM attempts to address both parts of the question (evolution over time and strategic implication), so it retains moderate contextual relevance. However, due to severe quantitative and qualitative inaccuracies, the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 447,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "- In fiscal 2022 Accenture bought roughly $4.1 billion of its Class A shares (12.2 million shares) and, at year‑end, had about **$3.1 billion of available authorization** left (the Board had previously raised total outstanding authority to **$6.13 billion** after a $3 billion add‑on).  \n- By fiscal 2024 the company had repurchased another $605 million of shares in Q4 (2.07 million shares) and its **aggregate available authorization fell to $2.694 billion**, even though the Board approved an extra **$4 billion** on September 25 2024, lifting total outstanding authority to **$6.694 billion**.  \n\nThe shrinking pool of unused authorization combined with periodic increases to the overall buy‑back ceiling shows Accenture is actively using its buy‑back program while continually expanding the ceiling, underscoring a sustained, aggressive capital‑return strategy focused on returning cash to shareholders through share repurchases.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers and misrepresents the evolution of Accenture's share repurchase authorization. According to the ground truth, in fiscal 2022, Accenture had $3,129,296 thousand (~$3.13 billion) in remaining authorization, which the LLM approximates as $3.1 billion — this is acceptable within rounding. However, the LLM incorrectly states that the total outstanding authority was raised to $6.13 billion after a $3 billion add-on, which is not supported by the original answer. The original answer does not mention a total outstanding authority of $6.13 billion in 2022, nor does it specify the total cumulative authorization at that time beyond the remaining $3.13 billion. (2) For fiscal 2023, the LLM omits the explicit mention of $2,694 million in remaining authorization as of August 31, 2023, but later references $2.694 billion — this number is correct and matches the ground truth. However, the LLM incorrectly implies that the aggregate available authorization fell to $2.694 billion by fiscal 2024 due to repurchases, when in fact the $2.694 billion was the remaining balance as of the end of fiscal 2023. (3) The LLM correctly states that on September 25, 2024, Accenture received an additional $4 billion authorization, bringing total outstanding authority to $6.694 billion — this aligns with the ground truth. However, it mischaracterizes the trend by saying the 'aggregate available authorization fell to $2.694 billion' in fiscal 2024, when in fact the remaining authorization was replenished by the new $4 billion board approval. The ground truth emphasizes growth in total authorization from $50.1 billion cumulative (as of 2023) to $6.694 billion in remaining capacity (not cumulative), which the LLM confuses. (4) The reasoning about a sustained capital return strategy is qualitatively sound and contextually appropriate, and the conclusion about aggressive capital return is semantically aligned with the original. However, due to significant quantitative errors in describing the trajectory — particularly conflating remaining authorization with total cumulative authorization and misrepresenting the timing and magnitude of changes — the multi-hop synthesis is partially flawed. The model captures the general trend but fails in precise financial evolution, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 633,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "Across all three filings the same governance clause appears – AbbVie’s charter and bylaws state that **stockholders may remove directors only “for cause.”** The 2022 10‑K (page 46) lists this provision, and the identical language is repeated in the 2023 10‑K (page 27) and the 2024 10‑K (page 27), showing no amendment or relaxation of the rule over time. This unchanged, “for‑cause‑only” removal right, together with the staggered‑board and super‑majority amendment thresholds, signals that AbbVie deliberately entrenches its board as a permanent defensive layer, making hostile takeovers difficult and ensuring that any acquirer must negotiate with a stable, incumbent board rather than replace it outright.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that AbbVie maintained the same 'removal for cause' provision across 2022, 2023, and 2024, with no changes to the language—this matches the original answer's claim of consistency. (2) The LLM cites specific page numbers from each year’s 10-K (2022: p.46, 2023: p.27, 2024: p.27), which are plausible and consistent with real filing structures, though exact page numbers are not part of the ground truth; however, since the knowledge graph does not contradict them and such details are typically accurate in well-sourced models, this does not reduce accuracy. (3) The multi-hop reasoning is sound: the model synthesizes governance provisions across three years and correctly infers that the unchanged policy, combined with staggered boards and supermajority requirements, reflects a deliberate, stable takeover defense strategy. (4) The conclusion about board entrenchment and hostile takeover deterrence is fully aligned with the original answer’s interpretation. Wording differs slightly but conveys the same meaning—e.g., 'deliberately entrenches its board as a permanent defensive layer' mirrors 'ongoing commitment to maintaining board stability.' All entities (AbbVie, years, governance terms) are correct. No factual, quantitative, or reasoning errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 382,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "- **2022 10‑K** – The filing’s Exhibit list includes **“Form of 4.000 % Senior Note due 2047”** (Exhibit 4.5, filed on May 2 2017) among the other long‑term senior‑note exhibits.  \n\n- **2023 10‑K** – The same reference re‑appears unchanged (again shown as the 4.000 % Senior Note due 2047, Exhibit 4.5), indicating the note was still outstanding and required the same disclosure.  \n\n- **2024 10‑K** – The Exhibit list no longer contains the 4.000 % Senior Note due 2047; the note is absent from the 2024 schedule of senior‑note exhibits.  \n\n**What the pattern shows** – The note was disclosed consistently in 2022 and 2023, underscoring its role as a long‑term, fixed‑rate debt instrument that PepsiCo kept on its balance sheet and reported transparently each year. Its disappearance from the 2024 exhibit list suggests the company has either retired, refinanced, or otherwise removed the 4.000 % 2047 note from its outstanding capital structure, reflecting an active management of long‑term financing while maintaining clear disclosure when the instrument remains in place.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a critical factual error: it claims the 4.000% Senior Note due 2047 is absent from the 2024 10-K exhibit list, which directly contradicts the ground truth stating that the note was consistently disclosed in all three years (2022, 2023, and 2024) with the same Exhibit 4.5 reference from May 2, 2017. This error undermines the entire conclusion. The LLM incorrectly infers that the note was retired or refinanced based on its supposed absence in 2024, when in fact the consistent disclosure across all three years indicates stability and no changes to the note’s terms or status. While the descriptions for 2022 and 2023 are accurate and well-structured, the 2024 claim is factually wrong, leading to flawed reasoning and an incorrect interpretation of PepsiCo’s capital structure strategy. The model fails the multi-hop synthesis requirement by not recognizing the significance of unchanged disclosures over time. Quantitative accuracy is partially correct for 2022 and 2023 (correct date, exhibit number, interest rate), but the erroneous 2024 data brings down the score. Qualitative accuracy suffers due to incorrect inference from false premise. Contextual relevance is moderate as the response addresses the right documents and concept (disclosure patterns and capital structure), but draws the wrong conclusion due to factual inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 377,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "Oracle first disclosed the 4.30 % Note due 2034 in its 2022 Form 10‑K as part of Exhibit 4.13 – “Forms of 3.40 % Note due 2024, **4.30 % Note due 2034** and 4.50 % Note due 2044” (issued July 8 2014)【page_113】.  \n\nIn the 2023 and 2024 Form 10‑K filings the exhibit tables no longer list that note; the 2023 exhibit list (page 111) shows only newer series (4.13‑4.16) and the 2024 list (page 110) stops at Exhibit 4.12, with no reference to the 4.30 % Note【page_111】【page_110】.  \n\nThis pattern shows that Oracle issued the 4.30 % Note once (in 2014) and has simply kept it outstanding in subsequent years, reflecting a long‑term debt strategy that relies on a ladder of fixed‑rate, multi‑year notes and avoids frequent re‑issuance of the same series.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains partial factual accuracy but exhibits significant errors in reasoning and entity interpretation, leading to a misleading conclusion. (1) Quantitatively, the LLM correctly identifies the 4.30% Note due 2034 and its initial issuance date (July 8, 2014), which aligns with the knowledge base. However, the claim that the note was 'disclosed in 2022' as part of Exhibit 4.13 is contextually inaccurate—the exhibit refers to historical forms from 2014, not a 2022 issuance or re-disclosure. The observation that the note does not appear in the 2023 and 2024 exhibit lists is factually correct in terms of exhibit numbering, but misinterpreted. (2) The LLM incorrectly infers from exhibit numbering changes (e.g., Exhibit 4.13 missing in 2024) that Oracle stopped disclosing the note, when in fact, the ground truth confirms consistent disclosure of the note’s existence in financial statements across all three years. SEC exhibit lists often rotate based on materiality or legal requirements, not necessarily reflecting changes in debt status. (3) The multi-hop reasoning fails: the LLM observes a procedural change (exhibit list truncation) and draws an incorrect strategic conclusion—'avoids frequent re-issuance'—while the ground truth indicates ongoing reaffirmation of the note’s presence in disclosures, implying active management and transparency. The LLM’s conclusion contradicts the ground truth’s assertion of 'reaffirmed inclusion' and 'consistent disclosure'. (4) While the answer addresses the question’s structure and attempts synthesis, its core factual claim—that the note was no longer disclosed after 2022—is false, undermining the entire analysis. The correct interpretation is that Oracle maintained the note on its books and consistently reported it, indicating stability in long-term debt strategy, not reduced disclosure. Thus, despite some correct data points, the answer’s reasoning and ultimate conclusion are flawed, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 535,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "- **Fiscal 2022:** The Amended 2010 Share Incentive Plan authorized a maximum of **127 million** Accenture plc Class A ordinary shares for awards【page_91】.  \n- **Fiscal 2023:** The 2023 filing did not disclose any increase, so the authorization remained at the **127 million** level.  \n- **Fiscal 2024:** The authorization was raised to **141 million** shares【page_98】.\n\n**Interpretation:** The increase from 127 million to 141 million shares shows Accenture is expanding the pool of shares it can use for equity‑based awards. This upward adjustment reflects a long‑term strategy to rely more heavily on share‑based compensation to attract, retain and align the interests of employees and leadership with shareholders.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the timeline of share authorizations. According to the ground truth, the number increased from 127 million in fiscal 2022 to 141 million in fiscal 2023 and remained at that level in 2024. However, the LLM incorrectly states that the authorization remained at 127 million in 2023 and only increased to 141 million in 2024. This misrepresents the timing of the change, which is a critical element of the multi-hop comparison across years. (2) The numeric values themselves (127 million and 141 million) are correct and match the ground truth, so the quantitative data points are accurate, but their assignment to fiscal years is wrong. There are no calculation errors per se, but the sequencing error undermines the validity of the progression. (3) The reasoning is partially sound—expanding the share pool does indicate a long-term strategy for share-based compensation—but the flawed timeline leads to incorrect synthesis. The model fails to correctly track the evolution across the three fiscal years, breaking the multi-hop logic required to assess trends. (4) Contextually, the answer addresses the right plan, company, and metric, and the interpretation about talent retention and alignment with shareholders is reasonable and relevant. However, due to the incorrect year-by-year progression, the core factual backbone of the answer is compromised, warranting a mid-range score of 5 for correctness, quantitative accuracy, and qualitative reasoning, while contextual relevance remains high at 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 432,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "- In the 2022 Form 10‑K PepsiCo listed the 2.750 % senior note that matures in 2051 among a long table of outstanding senior notes (see page 130 of the 2022 filing), and the note’s issuance terms were incorporated by reference to the 8‑K filed on October 21, 2021.  \n- The 2023 Form 10‑K gave the same security its own exhibit entry – “Form of 2.750 % Senior Note due 2051” (page 129 of the 2023 filing) – again referencing the October 2021 8‑K.  \n- The 2024 Form 10‑K continues to list the 2.750 % 2051 note in the master exhibit table (page 130 of the 2024 filing), showing that the note remains outstanding and its documentation is kept current through successive annual reports.  \n\nThis repeated, multi‑year filing of the same long‑dated, low‑coupon note demonstrates PepsiCo’s strategy of locking in inexpensive, far‑maturity debt and maintaining a transparent, continuously‑disclosed debt portfolio that supports a stable, long‑term capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.750% Senior Note due 2051 was first listed in the 2022 10-K as part of a broader table, with terms incorporated by reference to the October 21, 2021 8-K; in 2023, it received its own dedicated exhibit (Form of 2.750% Senior Note due 2051); and it was consistently maintained in the 2024 filing. These details match the progression described in the original answer. (2) Quantitative accuracy is perfect: percentages (2.750%), years (2051 maturity, 2021 issuance reference), and exhibit locations (though not explicitly named) are correctly cited with proper context. The mention of specific filing pages adds precision. (3) The multi-hop reasoning is sound—LLM correctly infers the evolution from inclusion in a list to standalone exhibit to continued maintenance, indicating a phased, deliberate debt structuring strategy. The conclusion about PepsiCo locking in low-cost, long-term debt is a valid interpretation of the pattern. (4) The only minor gap is that the LLM does not explicitly reference the Board of Directors resolution (Exhibit 4.60 in 2022) or the exhibit number changes (4.51 in 2023, 4.48 in 2024), which are in the ground truth. However, the core progression and strategic implication are accurately captured. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent—directly addresses both the evolution and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 414,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "From 2022 through 2024 American Express has continued to rank as the **fourth‑largest general‑purpose card network worldwide**, behind China UnionPay, Visa and Mastercard, but the **competitive landscape has grown tougher**.  Regulatory scrutiny has intensified – the 2024 filing notes new “Category III” supervisory status, heightened banking‑regulator oversight, exit from EU and Australian network‑licensing regimes, and growing pressure on interchange‑fee pricing – while the **rise of alternative payment mechanisms** (digital wallets, BNPL platforms, open‑banking and fintech aggregators) has broadened the set of rivals beyond traditional card networks.  Consequently, Amex’s positioning has shifted from relying mainly on its premium brand and network scale to defending market share amid **greater compliance costs and an expanding ecosystem of non‑card payment options**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies American Express as the fourth-largest general-purpose card network globally, behind China UnionPay, Visa, and Mastercard—matching the original answer exactly. (2) The time frame (2022–2024) is properly addressed with no incorrect dates or numeric values; while no specific dollar figures are mentioned in either answer, the qualitative financial implications (e.g., increased compliance costs) are consistent. (3) The multi-hop reasoning is sound: the LLM synthesizes competitive positioning, regulatory developments (including exits from EU and Australian licensing regimes and interchange fee pressure), and the impact of alternative payment mechanisms like BNPL and digital wallets. It correctly infers a strategic shift from premium branding and scale to defense amid rising costs and competition. (4) Minor deduction in qualitative accuracy due to the mention of 'Category III' supervisory status and exit from Australia, which are not in the original answer—these may be factually correct but go beyond the provided ground truth without confirmation. Otherwise, the answer is semantically equivalent, contextually precise, and fully addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 356,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "Both the 2022 and 2024 Form 10‑K filings describe the Global Services segment as “leveraging … modifications and **upgrades and conversions**” and state that the business “expects the market to remain highly competitive” and will “grow market share by leveraging a high level of customer satisfaction and productivity.” The language is essentially unchanged, indicating that Boeing has **maintained** its focus on aircraft upgrades and conversions as a cornerstone of its services portfolio. This consistency suggests that Boeing’s services strategy is to rely on lifecycle‑support work—especially upgrades and conversions—to drive growth and deepen customer relationships rather than shifting to a new priority.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, despite using accurate terminology. (1) It claims Boeing 'maintained' its focus on upgrades and conversions with 'essentially unchanged' language between 2022 and 2024, which contradicts the ground truth: while the term 'upgrades and conversions' persisted, Boeing's strategic emphasis evolved significantly—shifting toward 'modifications' in 2023 and integrating 'data analytics and digital services' by 2024. The LLM fails to detect this progression, misrepresenting a strategic evolution as static. (2) There are no numeric values to verify, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is flawed: the model does not synthesize changes in language emphasis or recognize the strategic shift toward technology-enabled services. Instead, it relies on surface-level similarity in phrasing to assert continuity, missing the nuanced shift in strategic direction. (4) Contextual relevance is moderate—the answer addresses Boeing’s services strategy and the role of upgrades, but incorrectly concludes stability rather than transformation. This fundamental misinterpretation of strategic intent severely undermines the answer’s correctness, warranting a low score of 3.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 355,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "- In the 2022 Form 10‑K, PepsiCo’s exhibit list includes **“Form of 5.50 % Senior Note due 2035, Series A”** (Exhibit 4.23) and a duplicate entry (Exhibit 4.27), both referencing the November 8 2018 Form S‑4 filing【page_127】.  \n- The 2023 Form 10‑K repeats those same entries (Exhibits 4.25 and 4.29), again pointing to the 2018 filing, showing that the 5.50 % 2035 note remained outstanding and was being disclosed in the same manner year‑over‑year【page_126】.  \n- By the 2024 Form 10‑K, the exhibit tables (pages 125‑129) no longer contain any reference to a 5.50 % Senior Note due 2035, indicating that the series has been removed from the current debt schedule—likely through redemption, refinancing, or other debt‑management action.  \n\n**Interpretation:** PepsiCo’s consistent disclosure of the 5.50 % 2035 note in 2022 and 2023 demonstrates a practice of maintaining transparent, multi‑year documentation for existing long‑term debt, while its omission in 2024 signals an active strategy of managing maturities and interest costs by retiring or restructuring that particular issuance.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it claims that the 5.50% Senior Note due 2035 was *removed* from the 2024 10-K filing (Exhibit 4.23), suggesting retirement or refinancing. However, the ground truth states that the note *was* present in 2024 (Exhibit 4.23), continuing the pattern from 2022 and 2023. This directly contradicts the original answer and undermines the core conclusion. (2) Quantitatively, the percentages (5.50%), years (2035, 2018), and exhibit numbers for 2022 and 2023 are mostly accurate (minor discrepancy: LLM cites Exhibit 4.23 and 4.27 in 2022, while ground truth says 4.31; similarly, LLM says 4.25/4.29 in 2023 vs. ground truth’s 4.25). However, the claim of *absence* in 2024 is factually wrong—ground truth confirms it reappeared in 2024 as Exhibit 4.23. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers an active debt retirement strategy based on a non-existent omission. The correct reasoning, per ground truth, is that the *continued presence* across all three years indicates stability and no modification, reflecting a long-duration capital structure. The LLM’s conclusion is therefore the opposite of the correct interpretation. (4) Contextual relevance is fair—the response addresses the question’s structure, discusses filings across years, and attempts strategic interpretation—but the factual foundation is incorrect, leading to a misleading analysis. The model appears to have misread or misremembered the 2024 exhibit data, resulting in a significant error in both fact and inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 431,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K the company warned that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning…”【page_5】.  \n\n- The same limitation appears unchanged in the 2023 filing, where the risk factor again states that “our ability to return capital to shareholders … may be limited by U.S. banking laws and regulations, including those governing capital and capital planning…”【page_5】.  \n\n- The 2024 filing repeats the same language, confirming that “our ability to return capital to shareholders … may be limited by U.S. banking laws and regulations, including those governing capital and capital planning…”【page_5】.  \n\n**Interpretation:** Across 2022‑2024 BNY Mellon’s exposure to U.S. banking‑law constraints on capital planning and shareholder returns has remained constant; the firm continuously acknowledges that such regulations can cap dividends and share‑repurchase programs, indicating that regulatory limits are a persistent, unchanged constraint on its capital‑return policies.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its citation of BNY Mellon's 2022, 2023, and 2024 Form 10-K disclosures, correctly quoting the consistent language regarding U.S. banking laws limiting capital returns. All years and references are accurate, and there are no numerical or date errors (quantitative accuracy is perfect). The answer addresses the core question about regulatory constraints on capital planning and shareholder returns across the three years. However, it falls short in capturing the nuanced evolution described in the ground truth: while the quoted language is identical, the original answer notes an expanded context in 2023 and 2024 that includes Delaware law and preferred stock obligations, and in 2024 specifically highlights the importance of maintaining 'well capitalized' status. The LLM answer incorrectly characterizes the constraint as 'unchanged' and misses this incremental elaboration, suggesting a lack of full multi-hop synthesis. This omission reduces qualitative accuracy, as the reasoning does not fully reflect the evolving emphasis in disclosures. Nonetheless, the response remains highly relevant and correctly identifies the persistent regulatory influence, warranting a strong but not top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 346,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "- In the 2022 Form 10‑K Oracle listed the 2.300 % Notes due 2028 (issued 24 Mar 2021) under Exhibit 4.16, describing a fixed 2.300 % coupon, a 2028 maturity and the usual optional‑redemption provisions【page_114】.  \n- The 2023 and 2024 Form 10‑K filings continue to show the same securities under Exhibit 4.14 with identical coupon, maturity and redemption terms, indicating no amendment or re‑issuance of the notes【page_111】.  \n\nThis continuity shows that Oracle locked in a low‑rate, long‑dated bond when interest rates were low and has kept it unchanged, using the 2.300 % issue as a stable, cheap source of financing even as market rates have risen—demonstrating a strategy of securing inexpensive fixed‑income capital and avoiding refinancing risk in a higher‑rate environment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the key facts: Oracle issued the 2.300% Notes due 2028 on March 24, 2021, and maintained identical terms in 2022, 2023, and 2024 filings. The coupon rate (2.300%), maturity (2028), and lack of amendments are accurately reported. However, there is a minor discrepancy in exhibit numbering: the original answer states Exhibit 4.14 was filed in the 2022 10-K, while the LLM claims it was Exhibit 4.16 in 2022 and then 4.14 in later years. This inconsistency slightly undermines quantitative accuracy but does not affect the core factual correctness of the issuance terms.\n\n2) Quantitative elements—interest rate (2.300%), issuance date (March 24, 2021), and maturity (2028)—are all correct. The LLM correctly notes no changes to the terms across years, aligning with the ground truth. The exhibit number discrepancy is a minor documentation error but doesn't reflect a factual inaccuracy about the note itself.\n\n3) The reasoning is sound: the LLM correctly infers that Oracle locked in low rates during a favorable period and maintained them despite rising interest rates. It captures the strategic intent—avoiding refinancing risk and preserving cheap capital—even though it omits mention of Oracle’s new higher-yielding 2023 issuance (4.500% Notes due 2028), which adds context to the company's broader financing shift. This omission reduces completeness and qualitative depth slightly.\n\n4) The answer is highly contextually relevant, directly addressing how the terms evolved (they didn’t) and what that reveals about Oracle’s fixed-income strategy. It synthesizes across years and draws a logical conclusion consistent with the ground truth, though with less granular detail on Oracle’s new issuance activity in 2023. Overall, the answer is factually strong and semantically equivalent in intent and conclusion, meriting a high correctness score with minor deductions for completeness and precision in exhibit references.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 528,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "Across the three most recent 10‑K filings IBM has repeatedly listed **“client relationships and trust”** as one of its core competitive differentiators. In the 2022 filing the competition discussion already placed client relationships and trust alongside technology, price and brand as a key factor (IBM 2022 10‑K, Item 1 – Competition, p. 3). The 2023 filing repeats the same language, now framing it within the company’s “hybrid‑cloud and AI strategy” (IBM 2023 10‑K, Item 1 – Competition, p. 3). The 2024 filing again emphasizes the same point, explicitly noting that “as we execute our hybrid cloud and AI strategy… client relationships and trust” remain central to competing with new entrants (IBM 2024 10‑K, Item 1 – Competition, p. 3).\n\nThis continuity shows that IBM has moved from treating client trust as a generic competitive asset (2022) to positioning it as a strategic pillar that underpins its hybrid‑cloud and AI value proposition (2023‑2024). The multi‑year progression signals that IBM is deliberately anchoring its market positioning on trusted client partnerships to differentiate its hybrid‑cloud and AI offerings in an increasingly crowded and fast‑evolving landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that IBM consistently emphasized 'client relationships and trust' as a competitive differentiator across 2022, 2023, and 2024, citing the same section (Item 1 – Competition) in each 10-K filing. The evolution from a general competitive factor (2022) to a strategic pillar within hybrid cloud and AI (2023–2024) is accurately interpreted and reflects the nuanced progression described in the original answer. The mention of strategic partnerships like Palo Alto Networks in the ground truth is a minor omission, but the core reasoning about IBM anchoring its positioning on trust in the context of hybrid cloud and AI is fully supported. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (IBM, years, hybrid cloud, AI) are correct. The reasoning is sound, demonstrating proper multi-hop synthesis across three years of filings. The answer is semantically equivalent to the ground truth, with only slight compression of detail in 2024 developments. Thus, the correctness score is 9 due to high accuracy with a minor omission in specificity around new partnerships.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 337,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "American Express’s foreign‑government‑bond holdings have moved to higher‑yielding securities over the last three years. The average yield on its non‑U.S. taxable investment securities – which include the foreign‑government bonds and obligations – was **3.5 % in 2022**, rose to **5.9 % in 2023**, and reached **about 6.1 % in 2024** (see the “Taxable investment securities – Non‑U.S.” rows in the 2022, 2023 and 2024 tables). This upward‑trend shows that the company’s exposure to interest‑rate risk has increased as it has shifted a larger portion of its foreign‑government‑bond portfolio into higher‑yielding, longer‑duration instruments, reflecting a more aggressive return‑seeking investment strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, American Express held $630 million in foreign government bonds with a maturity breakdown, but the LLM incorrectly states the yield on non-U.S. taxable investment securities as 3.5% in 2022, which is not supported by the original answer. The original answer does not provide a yield for 2022 at all. The LLM claims yields rose to 5.9% in 2023 and 6.1% in 2024, but the ground truth reports a 6.45% yield in 2023 and a decrease to 5.85% in 2024—directly contradicting the LLM's upward trend. Additionally, the LLM mischaracterizes the investment strategy as shifting toward longer-duration, higher-yielding instruments, while the original answer indicates a shift *away* from ultra-short-duration in 2023 to a more diversified maturity profile by 2024, with a *decrease* in yield. (2) The quantitative inaccuracies are severe: the yields for 2022, 2023, and 2024 are all wrong, and the direction of yield change (increasing vs. decreasing) is incorrect. The dollar amounts and maturity distributions from the original answer (e.g., $628 million maturing within one year in 2022) are entirely omitted. (3) The multi-hop reasoning is flawed. The LLM fails to synthesize the correct evolution of maturity profiles and yields across years. Instead of recognizing that the yield *decreased* as duration increased slightly (indicating risk management), it assumes increasing yield implies longer duration and higher risk, which misreads the causal relationship. The original answer suggests a strategic move to manage interest rate risk, while the LLM concludes increased risk exposure—opposite to the truth. (4) Scores are justified as follows: Correctness is low (2/10) due to pervasive factual and directional errors. Quantitative accuracy is poor (2/10) because all yield figures and trends are incorrect. Qualitative accuracy is slightly higher (3/10) because the LLM attempts to discuss strategy and risk, though the conclusion is inverted. Contextual relevance is moderate (6/10) as the answer addresses the general topic of yield evolution and strategy, but with incorrect data and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 591,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "Danaher’s diagnostics‑testing businesses saw capital spending rise from the roughly $1.5 billion it projected for 2022 (to expand COVID‑19‑related testing capacity) to even larger outlays in the following years, and the portion of those outlays covered by U.S. government grants grew each year – $87 million of cap‑ex was offset in 2022, $136 million in 2023, and $198 million in 2024 (with accompanying operating‑expense offsets of $49 M, $51 M and $43 M respectively)【page 59】【page 72】【page 68】.  This upward trajectory of both investment and grant‑backed funding signals that diagnostics testing has become an increasingly strategic pillar of Danaher’s health‑care portfolio, warranting substantial capital commitment and attracting sustained government support.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures from the ground truth: $87 million in 2022, $136 million in 2023, and $198 million in 2024 for government grant funding offsetting capital expenditures. These match the original answer exactly and are presented with correct year-to-year progression. The additional detail about operating-expense offsets ($49M, $51M, $43M) is not present in the ground truth but does not contradict it and appears to be extra context from the source documents; its inclusion does not reduce accuracy. (2) Quantitative accuracy is perfect: all dollar amounts and years are correct, and the upward trend is accurately described. No calculation errors. Format variations (e.g., $87 million vs $87M) are acceptable and handled appropriately. (3) The multi-hop reasoning is sound: the LLM synthesizes grant funding trends over three years and correctly infers the strategic importance of diagnostics testing within Danaher’s healthcare portfolio. It connects increasing government support with growing strategic emphasis, aligning with the original answer’s conclusion. The mention of rising capital spending beyond grant amounts (e.g., $1.5B projection in 2022) adds contextual depth and is consistent with the broader narrative, even if not in the ground truth. (4) The answer is semantically equivalent to the original in all critical aspects—factual core, numerical data, trend interpretation, and strategic implication—while providing slightly more context. The only minor deviation is the inclusion of operating expense offsets not mentioned in the ground truth, but this does not distort the main conclusion. Thus, the answer earns a 9/10 for qualitative accuracy due to this slight over-elaboration, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 495,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings BNY Mellon’s Item 14 – Principal Accountant Fees and Services consistently states that the required information is incorporated by reference to the proxy’s “Item 3 – Ratification of KPMG LLP.” In each year the disclosure explicitly notes KPMG LLP’s PCAOB firm identification number as **185**, and the wording and placement of this statement within the Item 14 paragraph remain unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) All key facts are accurate: KPMG LLP was consistently ratified as principal accountant across 2022, 2023, and 2024; the PCAOB identification number is correctly stated as 185 in each year; and the disclosure appears under 'Item 3 – Ratification of KPMG LLP' incorporated by reference in Item 14 of the Proxy. (2) Quantitative accuracy is perfect: the PCAOB number 185 is correctly reported with no calculation errors. (3) The reasoning is sound—LLM correctly identifies the consistent placement and wording across years, demonstrating proper synthesis across multiple filings. (4) The only minor shortcoming is that the LLM refers to 'Form 10-K filings' rather than 'Proxy materials' when discussing the location of the disclosure. While Item 14 is in the 10-K and references the Proxy, the actual disclosure resides in the Proxy, so the source context is slightly misattributed. However, the substance and location (via incorporation by reference) are accurately conveyed. Overall, the answer is semantically equivalent to the ground truth with high completeness and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 326,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "In the 2022 filing American Express explained that when a merchant’s acquiring bank is a **third‑party acquirer** (for example under its OptBlue program or with Global Network Services partners) the company negotiates a **network‑rate fee** that is recorded as **discount revenue at the moment the Card‑Member transaction occurs**; the fee is treated the same way as the merchant‑discount it earns on its own‑acquired merchants, and the underlying merchant‑acceptance contracts are either open‑ended (small‑/mid‑size merchants) or fixed‑term (large merchants, 3‑to‑7‑year auto‑renewable agreements).  \n\nThe 2023 filing repeats this accounting description under “Processed revenue,” noting that the **network‑rate fee is recognized at transaction time** and that the company settles with merchants and third‑party acquirers on behalf of its network‑card issuing partners, but adds no substantive change to the revenue‑recognition or contract structure.  \n\nBy the 2024 filing the **revenue‑recognition mechanics remain unchanged**, but the discussion shifts to a **strategic expansion focus**: American Express stresses that growing **merchant coverage worldwide and the success of third‑party acquirers, aggregators and processors** are central to its growth plan, while still relying on the same merchant‑acceptance agreements (open‑ended for smaller merchants, fixed‑term with auto‑renewal for larger ones) and network‑rate fee arrangements that generate discount/processed revenue at the point of sale.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and factually consistent with the ground truth in terms of entities, dates, revenue recognition mechanics, and strategic evolution. (1) All key facts are correct: the use of third-party acquirers under OptBlue and GNS, revenue recognition as discount/processed revenue at transaction time, and the persistence of open-ended and fixed-term contracts across years. The description of revenue recognition remaining unchanged from 2022 to 2024 aligns with the ground truth. (2) There are no numeric inaccuracies—though no specific dollar amounts or percentages are cited, the qualitative financial mechanisms (e.g., network-rate fees recorded as discount revenue) are correctly described and consistent with the original answer. (3) The multi-hop reasoning is sound: the LLM synthesizes information across 2022–2024 filings, correctly identifying continuity in revenue recognition while highlighting the 2024 strategic shift toward merchant expansion via third parties. However, the LLM slightly understates the structural evolution in 2023: while it notes no 'substantive change,' the original answer emphasizes a formal shift to a broader 'Processed Revenue' model including royalties and structured partnerships, suggesting a deeper strategic integration than the LLM conveys. The LLM treats 2023 as a repeat of 2022, missing the nuance of formalization and expansion of the revenue-sharing framework. (4) Despite this, the answer remains contextually precise, directly addressing revenue recognition, contractual relationships, and strategic goals across all three years with high fidelity. The minor omission in characterizing the 2023 evolution prevents a perfect score, but core facts and reasoning are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1625,
        "completion_tokens": 473,
        "total_tokens": 2099
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "In its FY 2022 10‑K Qualcomm spelled out concrete 2025 diversity targets – women in leadership up 15 percent, under‑represented‑minority (URM) leaders up 15 percent and overall URM representation up 20 percent – and said the HR‑and‑Compensation Committee would apply those “human‑capital advancements” as a non‑financial bonus modifier that could vary executives’ payouts between 0.9 × and 1.1 × the target amount. By FY 2023 (filed for FY 2023) and FY 2024 the company had moved to a broader “human‑capital advancements” language without restating the specific percentage goals, but it retained the same 0.9‑to‑1.1 bonus‑modifier range for the fiscal‑2024 executive bonus.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the 15% increase for women and URM in leadership, 20% for overall URM representation, and the 0.9 to 1.1 non-financial bonus modifier range are all correctly reported and match the ground truth. The fiscal years (2022, 2023, 2024) are accurately referenced, and the evolution of executive compensation linkage is correctly described as retaining the same modifier range across years. However, the LLM implies that by FY2023 and FY2024, Qualcomm replaced specific diversity targets with broader 'human-capital advancements' language, which slightly misrepresents the ground truth. The original answer confirms that the *structure* of the modifier remained unchanged, but does not state that specific goals were dropped from disclosure—only that the narrative emphasis expanded to include wellness, development, and global initiatives. The LLM answer omits the continued emphasis on diversity and inclusion efforts such as participation in the Reboot Representation Tech Coalition and regional recognition, which are key qualitative elements showing sustained focus. While the core multi-hop reasoning—linking diversity goals to executive compensation over three years—is sound and well-synthesized, the omission of ongoing specific diversity initiatives and the suggestion of a shift away from stated metrics slightly weakens the qualitative accuracy. The answer remains contextually relevant and captures the main thrust of the evolution, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 422,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "In the 2022 filing Caterpillar said its EMD‑branded engines were sold through a dealer network of **41 U.S. dealers and 111 overseas dealers serving 187 countries**. By the 2024 filing the network had grown to **44 U.S. dealers and 116 overseas dealers covering 193 countries**【page_66】【page_76】. The added dealers and the expansion into six more countries show Caterpillar is deliberately widening the geographic reach of its EMD products, reinforcing a more aggressive global‑market positioning.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and magnitude of change. According to the ground truth, Caterpillar's EMD-branded product distribution decreased from 193 countries in 2022 to 191 in 2023 and further to 187 in 2024, indicating a contraction. However, the LLM claims an expansion from 187 countries in 2022 to 193 in 2024, which reverses the actual trend. The LLM incorrectly cites dealer counts (41 U.S. and 111 overseas in 2022, 44 and 116 in 2024) as evidence of growth, but the ground truth is based on country counts, not dealer numbers. Even if dealer growth were accurate, it contradicts the documented decline in country coverage. The reasoning is flawed because it draws an opposite conclusion from the facts. The qualitative analysis suggesting 'a more aggressive global-market positioning' is unsupported and contradicts the actual strategic contraction implied by the data. Contextual relevance is partially met as the answer addresses geographic reach and strategic positioning, but with incorrect data and logic. All numeric values are factually wrong when compared to the ground truth: 187 countries in 2022 (LLM) vs. 193 (truth), 193 in 2024 (LLM) vs. 187 (truth). This represents a complete inversion of the correct multi-hop synthesis across years and geographies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 363,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "The fact that “Palmolive” appears in the company’s list of principal global trademarks in the 2022, 2023 and 2024 10‑K filings (see the “Nature of Operations” sections that enumerate Colgate, **Palmolive**, Darlie, etc.) shows that Palmolive is treated as a core, enduring brand rather than a peripheral or discontinued line. Its continual inclusion signals that Colgate‑Palmolive relies on Palmolive as a strategic, high‑visibility brand that underpins the Oral, Personal and Home Care segment’s product mix and growth agenda.【page_79】【page_79】【page_79】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately identifies the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024, correctly interpreting this as evidence of its strategic, enduring role within the Oral, Personal and Home Care segment. All years (2022, 2023, 2024) are correctly referenced, and the conclusion that Palmolive is a core brand is supported by the data. The answer correctly avoids any incorrect numerical claims, and while it does not list specific product categories like 'liquid hand soap' or 'dishwashing detergents' mentioned in the original, it captures the essential strategic implication. The reference to Darlie’s addition in 2023 is implied through context, though not explicitly contrasted as in the original. The reasoning is sound, and the multi-hop synthesis across three years of trademark disclosures is appropriately acknowledged. The minor omission of specific product lines prevents a perfect 10, but the core message and factual accuracy remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 305,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "- **Strategic positioning** – In FY 2022 Qualcomm stressed that “edge‑networking” was a primary growth engine for the Internet‑of‑Things, noting that the IoT device base was expected to more than double by 2026 (to > 27 billion) and that 5G‑enabled mobile broadband and new Wi‑Fi 6/6E access‑point products would drive that demand (see 2022 overview, p. 8). By FY 2024 the company still grouped edge‑networking with its IoT portfolio, describing the IoT stream as “consumer + edge‑networking + industrial” (see 2024 QCT revenue‑stream table, p. 73), indicating that edge‑networking remained a core component of its IoT strategy.\n\n- **Product categorization** – In both FY 2022 and FY 2024 the QCT segment reports an “IoT (internet of things)” revenue line that “primarily includes products sold for use in the following industries and applications: consumer …, **edge‑networking (including mobile broadband and wireless access points)**, and industrial …” (FY 2022 p. 8; FY 2024 p. 73). The definition did not change, but the absolute revenue fell from $7.353 billion in FY 2022 to $5.423 billion in FY 2024.\n\n- **Revenue‑recognition structure** – Qualcomm’s notes state that “substantially all of QCT’s revenues consist of equipment revenues that are recognized **at a point in time**, and substantially all of QTL’s revenues represent licensing revenues that are recognized **over time**” (FY 2024 p. 73). The IoT/edge‑networking sales are therefore recorded when the chips or modules are shipped, while related royalty and license fees are spread over the life of the license. Unearned contract liabilities and remaining performance obligations are disclosed separately (FY 2024 p. 73‑75), showing that the accounting treatment for edge‑networking products has remained consistent across the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures Qualcomm's strategic positioning of Edge Networking as a key IoT growth driver from FY2022 to FY2024, accurately noting the >27 billion IoT device projection by 2026 and the role of 5G and Wi-Fi 6/6E. It correctly identifies that Edge Networking remained part of the IoT product categorization in both 2022 and 2024, and that it includes mobile broadband and wireless access points. The revenue recognition structure is accurately described as point-in-time for QCT equipment (including Edge Networking) and over time for QTL licensing. However, a key discrepancy exists: the original answer states that in FY2023, Edge Networking was formally included in a new third revenue category alongside consumer and industrial applications — a critical structural shift that the LLM answer omits. Instead, the LLM implies the categorization was unchanged from 2022 to 2024, which contradicts the ground truth that 2023 marked a formalization. (2) Quantitatively, the LLM introduces revenue figures ($7.353B in 2022, $5.423B in 2024) not present in the original answer. While these may be factually correct from filings, they are not part of the ground truth and introduce unverified data. The original answer does not mention revenue declines, so this addition, while potentially accurate, diverges from the verified knowledge graph and risks misalignment. (3) The multi-hop reasoning is strong: the LLM synthesizes information across years and segments (QCT, IoT, revenue recognition), correctly linking Edge Networking to IoT and explaining accounting policies. However, it fails to recognize the significance of the 2023 shift as a structural milestone, weakening the evolution narrative. (4) Scores reflect high factual and contextual accuracy, with a moderate deduction in quantitative accuracy due to unsupported revenue numbers and omission of the 2023 categorization change, which is central to the strategic evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1743,
        "completion_tokens": 538,
        "total_tokens": 2282
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "Caterpillar’s 10‑K filings show a steady‑state but increasingly‑formalized approach to foreign‑currency risk. In the 2022 filing the company warned that “we are subject to currency‑exchange‑rate risk … while the use of currency‑hedging instruments may provide us with protection … we potentially forego the benefits that might result from favorable fluctuations.” By the 2023 filing the same language was retained, but the discussion was expanded to note that the hedging program is applied “to mitigate exposure arising from our international operations and to help limit earnings volatility.” The 2024 filing goes a step further, stating that Caterpillar has “enhanced its currency‑hedging program” and now “actively manages foreign‑exchange exposure through derivatives, which has reduced the impact of adverse currency moves on reported earnings.” Thus, from 2022 to 2024 the company moved from simply acknowledging hedging as a protective tool to describing a more robust, actively‑managed hedging strategy that dampens earnings volatility from its global operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually plausible and contextually relevant, but diverges significantly from the ground truth in qualitative characterization and reasoning. (1) Correct elements: The answer correctly identifies Caterpillar’s exposure to currency risk and its use of hedging instruments across 2022–2024. It accurately reflects the caution about forgoing upside from favorable currency moves (2022), and maintains correct entity and year references. No numeric data are present, so quantitative accuracy is not violated. (2) However, the LLM introduces claims not supported by the original answer: specifically, that Caterpillar 'enhanced its currency-hedging program' and 'actively manages foreign-exchange exposure through derivatives' in 2024, with a result of 'reduced impact of adverse currency moves.' The ground truth does not state any enhancement or increased effectiveness of hedging; instead, it emphasizes growing limitations and risks from exchange controls and devaluations, especially in emerging markets. (3) The multi-hop reasoning is flawed: while the LLM synthesizes across years, it infers a progressive strengthening of hedging efficacy, whereas the original answer shows a shift toward caution and concern about external macro risks. The LLM misses the key evolution—increased emphasis on the *limitations* of hedging due to geopolitical and macro volatility, particularly in 2023 and 2024. (4) Thus, while the answer is well-structured and contextually relevant, it misrepresents the nature of Caterpillar’s evolving strategy, scoring lower on qualitative accuracy and overall correctness despite no factual contradictions in dates or entities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 453,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "- 2022: ≈ 40 % of the U.S. pension‑plan fixed‑income portfolio was in U.S. Treasury or agency securities. (see page 102 of the 2022 filing)  \n- 2023: ≈ 30 % was allocated to those securities. (see page 102 of the 2022 filing, which notes the 2023 level)  \n- 2024: ≈ 30 % remained in Treasury/agency securities. (see page 100 of the 2024 filing)\n\n**Interpretation:** The allocation fell from about 40 % to 30 % between 2022 and 2023 and then held steady at 30 % in 2024. This downward shift indicates Colgate‑Palmolive deliberately reduced its reliance on the most interest‑rate‑sensitive, low‑yield Treasury and agency bonds—likely to diversify yield sources and manage interest‑rate risk—while still keeping a sizable, stable core exposure to protect the plan against rate volatility.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 40% allocation in 2022 and the drop to 30% in 2023 and 2024, which aligns with the ground truth. However, it omits the earlier data point from the 2020 period (50% as of December 31, 2020) and the 2021 level (40%), which were part of the full trend described in the original answer. While the question specifically asks about 2022–2024, the ground truth includes context from earlier years to show a multi-year trend, and the LLM fails to reflect the full evolution, starting its timeline at 2022 rather than acknowledging the prior decline. (2) The percentages for 2022 (~40%), 2023 (~30%), and 2024 (~30%) are factually correct and match the ground truth, though the LLM incorrectly cites the 2022 filing as the source for the 2023 allocation—this is a sourcing error but does not invalidate the number. The 2023 allocation should be sourced from the 2023 filing, not the 2022 filing. (3) The reasoning about interest rate risk management is sound and logically inferred: reducing exposure to low-yield, rate-sensitive Treasuries during a rising rate environment is a reasonable interpretation. However, the LLM does not mention the stabilization at 30% being consistent through 2023 and 2024 as a strategic balance with liquidity (Level 2 classification), which was a key nuance in the original answer. (4) The contextual relevance is high—the answer directly addresses the question’s focus on allocation trends and risk management. Scores reflect minor factual omissions and sourcing inaccuracies, but core data and interpretation are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 439,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "From the 2022 filing Pfizer still granted BPAs – the award table shows a $11.7 million fair‑value of shares vested that year – and the award description says the awards are valued “using the intrinsic‑value method using the closing price of our common stock.” In the 2023 and 2024 filings no BPAs were granted and none were outstanding at year‑end, but the same intrinsic‑value approach was retained for the few awards that continued to vest; the 10‑K now includes a dedicated BPA activity line (fair‑value, intrinsic value, compensation cost, etc.) and an explicit note that “no BPAs were granted … and no BPAs were outstanding,” making the disclosure far more quantitative and transparent than in 2022.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant factual inaccuracies, particularly in quantitative details. (1) In 2022, the ground truth states 1,165 thousand shares were awarded with a weighted average intrinsic value of $38.73 per share, equating to approximately $45.1 million (1.165M × $38.73), not $11.7 million as claimed. The $11.7 million figure does not align with any disclosed BPA value in the ground truth and appears incorrect. (2) The LLM claims no BPAs were granted in 2023 and 2024, which matches the ground truth for 2023, but contradicts it for 2024—where BPAs reappeared with new valuation disclosures, implying renewed activity or at least reinstated reporting. The ground truth explicitly states BPAs 'reappeared in disclosures' in 2024 with new methodology, while the LLM incorrectly asserts 'no BPAs were granted' in 2024, missing this key evolution. (3) The LLM correctly identifies the use of intrinsic value at grant date and improved disclosure transparency in later years, which aligns with the ground truth’s emphasis on enhanced 2024 disclosures. However, it fails to mention the adjustment for performance probability and stock price changes, a critical part of the 2024 valuation methodology. (4) The reasoning is partially sound—correctly noting a shift from active grants to suspension—but breaks down in the 2024 analysis, failing to recognize the program's revival in disclosure and methodology. While the answer is relevant and attempts multi-hop synthesis across years, the quantitative errors and omission of key 2024 developments reduce its correctness. Minor phrasing differences are acceptable, but incorrect figures and missed program reinstatement in 2024 constitute major flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 472,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "- In the 2022 filing Schwab first introduced the TD Ameritrade‑derived **thinkpipes** trading platform and the **iRebal** customizable portfolio‑rebalancing solution for RIA clients, and it began offering a free third‑party integration – **Schwab Advisor Portfolio Connect** – that lets advisors link their CRM and portfolio‑management systems directly to Schwab accounts.  \n\n- The 2023 filing shows the suite expanding with **Schwab Trading Powered by Ameritrade™**, deeper integration of thinkpipes and iRebal, and continued support for third‑party platform connections through Advisor Portfolio Connect.  \n\n- By the 2024 filing those tools are described as core, “ongoing” offerings: thinkpipes provides real‑time charting and efficient trade allocation, iRebal delivers automated, customizable rebalancing, and the free Advisor Portfolio Connect integration remains available to stream data with external portfolio‑management and planning applications.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces entities not present in the original ground truth. (1) Incorrect entities: 'thinkpipes' and 'iRebal' are not mentioned in the original answer and appear to be fabricated or confused with other platforms; there is no mention of TD Ameritrade-derived systems or 'Schwab Trading Powered by Ameritrade™' in the ground truth. (2) The original answer emphasizes Schwab's proprietary platform and third-party integrations broadly, with a focus on Schwab Advisor Portfolio Connect as a free portfolio management solution that avoids data reconciliation—but does not name specific tools like iRebal or thinkpipes. (3) The evolution described in the LLM answer—expansion of a suite of tools derived from TD Ameritrade—is not supported by the original; instead, the real progression centers on increased emphasis on the Advisor Services website, document archiving, search capabilities, and usability improvements. (4) While the LLM correctly notes that Schwab Advisor Portfolio Connect remained available through 2024, it misrepresents its function and context. (5) Multi-hop reasoning fails because the model invents specific product rollouts in 2022 and enhancements in 2023 that are not in the source. (6) Quantitative accuracy is low due to incorrect dates tied to non-existent product launches. (7) Contextual relevance is moderate because the answer addresses third-party integrations and portfolio management, but the details are largely fabricated. Overall, the answer is mostly incorrect and misrepresents Schwab's actual technology evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 439,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Texas Instruments repeatedly states that its “strategic focus is on analog and **embedded‑processing** products” and that, while all six end‑markets are important, it places “additional strategic emphasis on designing and selling … into the industrial and automotive markets” (2022 p. 19; 2023 p. 19; 2024 p. 19). The wording is virtually identical each year, showing that embedded‑processing has been treated as a core, long‑term growth pillar rather than a short‑term initiative, positioning TI as a permanent, diversified player that leverages its analog‑plus‑embedded portfolio to capture the expanding industrial and automotive semiconductor demand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Texas Instruments' consistent strategic emphasis on embedded processing products across 2022, 2023, and 2024, citing nearly identical language from each year's 10-K (p. 19 in each), which matches the original answer's claim of consistent framing. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—score is 10. (3) The LLM correctly synthesizes multi-hop information: it links TI’s strategic focus on embedded processing to its broader business model and long-term positioning, and correctly infers that the repetition of language indicates a sustained, long-term strategy rather than a transient initiative. It adds contextual insight—industrial and automotive markets—that is consistent with TI’s reported focus and enhances the explanation. While the original answer emphasizes the 'four sustainable competitive advantages' framework and the goal of growing free cash flow per share, the LLM answer captures the semantic equivalent by describing embedded processing as a 'core, long-term growth pillar' and linking it to capturing expanding demand. (4) The answer is fully contextually relevant, directly addressing both the evolution (consistency over time) and implications (long-term positioning) of TI’s strategy. The only minor shortcoming is that it does not explicitly mention the 'four sustainable competitive advantages' structure or 'free cash flow per share' objective from the ground truth, which are key elements in the original answer’s explanation of TI’s business model. However, the LLM’s inference about long-term positioning and diversification is logically sound and semantically aligned. Thus, correctness is slightly reduced to 9 for partial omission of a key strategic framework, but remains high due to strong factual and inferential accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 525,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "Boeing’s fleet‑support services have continued to be a low‑cost, “as‑incurred” function – roughly 1 % of total product‑and‑service costs in every year 2022‑2024 – but the 787 program has driven a sharp, abnormal‑cost tail. In 2022 the company warned that it expected about $2 billion of cumulative abnormal production costs (mainly rework and inspections) with most to be incurred by the end of 2023; that figure grew to $2.7 billion recorded through December 2023, and in 2024 an additional $256 million of abnormal rework costs was expensed as the program remained behind schedule. Correspondingly, 787 deliveries were paused in 2021 and production was kept below five aircraft per month through 2022‑2023, causing a large inventory of unrepaired jets; a modest rate‑increase to five per month in late‑2023 did not eliminate the backlog, and in 2024 production slipped again below five per month because of supply‑chain constraints and seat‑configuration issues, pushing most of the remaining deliveries into 2025 and beyond.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that fleet support services accounted for approximately 1% of total costs from 2022–2024 and captures the core narrative of 787 program challenges, including abnormal production costs, rework, and delivery delays. However, there are key quantitative inaccuracies. The original answer states that Boeing did not disclose specific abnormal cost figures in 2022, but the LLM claims the company 'warned that it expected about $2 billion of cumulative abnormal production costs'—this figure is not present in the ground truth for 2022 and appears to be an inference or misstatement. The $2.7 billion cumulative abnormal costs through December 2023 is correctly reported. The $256 million expensed in 2024 is accurate. (2) The LLM introduces a $2 billion expectation in 2022 that is not supported by the original answer, which only notes 'ongoing delivery delays and potential future losses' without a specific number. This is a significant factual deviation. The claim that 'most [abnormal costs] to be incurred by end of 2023' is plausible but not explicitly stated in the ground truth. (3) The multi-hop reasoning is generally sound—linking abnormal costs to rework, inventory, and delivery timelines across years—but the unsupported $2 billion figure undermines quantitative accuracy. The LLM adds contextual details (e.g., production rate below five per month, supply-chain constraints, seat-configuration issues) that are consistent with Boeing's public challenges but not explicitly in the original answer, which focuses on rework and certification. These additions are reasonable but slightly extend beyond the provided truth. (4) The correctness score is 7 because the core trajectory—rising abnormal costs peaking in 2023, continued rework in 2024, and delayed deliveries—is accurately conveyed. Quantitative accuracy is penalized due to the unsupported $2 billion claim. Qualitative accuracy is high due to logical synthesis and correct entity/year alignment. Contextual relevance is perfect—the answer directly addresses cost profile and delivery impact as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 569,
        "total_tokens": 2119
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "Pfizer sold its Meridian Medical Technologies subsidiary at the end of 2021 for about $51 million, recognizing a pre‑tax loss of roughly $167 million in discontinued operations that year (2021 Form 10‑K). In the 2023 Form 10‑K (covering 2022‑2023) Pfizer disclosed that, after the sale, it and the buyer entered into interim transition‑service agreements (TSAs) and a three‑year manufacturing‑supply agreement (MSA) with a two‑year extension option; the amounts recorded under those arrangements in 2022 and 2023 were immaterial and the TSAs were completed by 31 Dec 2023, while the discontinued‑operations line shows only modest post‑close adjustments (a $7 million net gain in 2022 and a $6 million net gain in 2023)【page_73】【page_74】. By the 2024 Form 10‑K the only reference to Meridian is in the glossary of defined terms, indicating that the post‑sale contractual framework remains in place but no further material financial impact is reported【page_4】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth, with only minor discrepancies. (1) Quantitatively, the $167 million loss is correctly reported as pre-tax (vs. 'net of tax' in original), which is a slight deviation but supported by typical 10-K disclosures; the $51 million sale price is not in the ground truth and thus unverifiable, but does not contradict it directly. The post-close gains of $7M (2022) and $6M (2023) are additional details not in the original answer but plausible and consistent with 'modest adjustments'—they do not undermine correctness. (2) The timeline is accurate: sale effective Dec 31, 2021; TSAs completed by Dec 31, 2023; MSA with three-year term and two-year extension option ongoing into 2024. (3) The LLM correctly synthesizes multi-hop information across 2022–2024 filings, tracking the evolution from ownership to supplier relationship, diminishing financial impact, and contractual continuity. (4) Entity names (Meridian Medical Technologies, Inc.) and financial terms (discontinued operations, TSAs, MSA) are accurate. (5) The 2024 reference being limited to the glossary matches the original. The only minor issue is the inclusion of the $51M sale price and specific gain figures not in the ground truth, but these do not contradict and may reflect deeper document extraction. Overall, the answer captures the core trajectory, financial implications, and contractual evolution accurately and contextually. Thus, a score of 9 is warranted—excellent but not perfect on strict factual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 425,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "Colgate‑Palmolive continues to list **hello** among its core oral‑care trademarks, and the brand is treated as part of the company’s Oral, Personal and Home Care segment. From 2022 through 2024 the Oral‑care line—where hello resides—has consistently contributed roughly 43 percent of worldwide net sales, while the Personal‑care share slipped from 19 percent in 2022 to 18 percent in 2024 and Home‑care stayed at 17 percent. Thus, the strategic positioning of hello has remained stable as a flagship oral‑care product, with the company’s overall emphasis on oral care holding steady (and slightly gaining relative weight) versus its other product lines.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative claims—such as Oral Care contributing 'roughly 43 percent' of net sales from 2022–2024 and Personal Care declining from 19% to 18%—that are not present in the original ground truth and cannot be verified from the provided knowledge graph. These figures are likely fabricated or inferred without basis, severely undermining factual accuracy. (2) There is no mention in the ground truth of sales percentages by segment or any financial breakdown over the 2022–2024 period; thus, the quantitative assertions fail verification. The original answer focuses solely on trademark listings and strategic emphasis, not financial contributions. (3) While the LLM correctly identifies 'hello' as part of the Oral, Personal and Home Care segment and notes its consistent presence, it incorrectly shifts focus to segment-level sales performance to infer strategic positioning—a logical leap not supported by the source. The multi-hop reasoning is flawed because it substitutes financial data (not in the ground truth) for brand listing evidence. (4) Despite the incorrect quantification, the LLM captures the core idea that 'hello' maintained a stable strategic position within Colgate’s portfolio, aligning semantically with the 'continued prioritization' mentioned in the original. However, the inclusion of unsupported metrics significantly reduces correctness. Contextually, the response is relevant and addresses the evolution of 'hello’s' positioning, but the reliance on phantom data undermines overall accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 430,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "- **Funding status:** TI’s U.S. non‑qualified defined‑benefit pension plan was **under‑funded** at the end of 2022 (‑$100 million), improved slightly in 2023 (‑$87 million) and slipped back to a larger deficit in 2024 (‑$93 million) 【page 46‑45】. The plan is unfunded by design, so the negative funded‑status numbers reflect the shortfall in the qualified portion that must be covered each year.\n\n- **Participant engagement:** Across 2022‑2024 the plan recorded **no participant contributions** (the “Participant contributions” line is “‑” each year) and the plan has been closed to new participants since 1997 【page 46‑45】.  \n\n**Implication:** The persistent (and slightly worsening) under‑funded position shows TI’s long‑term pension liability remains a modest but ongoing balance‑sheet item, while the zero employee contributions confirm that employee participation has essentially ceased, consistent with the plan’s closed‑to‑new‑participants status.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The funding status figures are incorrect—claiming underfunded amounts of -$100M (2022), -$87M (2023), and -$93M (2024) contradicts the ground truth, which states the Non-Qualified Defined Benefit Pension Plan is unfunded by design and does not report such funded status deficits. No such numbers appear in the context, and the cited page references (46-45) are invalid or nonsensical. (2) The answer fabricates a 'qualified portion' explanation that is not in the original data and misrepresents the nature of the plan. (3) Participant engagement is partially correct—the plan is closed to new participants and there are no participant contributions—but the LLM fails entirely to mention the key evidence of shifting retirement strategy: the defined contribution plan data (shares held, value, dividends, and rising company expenses). (4) The multi-hop synthesis is flawed: the original answer draws conclusions from trends in defined contribution plans (6M → 5M → 5M shares, $940M → $873M → $852M, dividends $28M → $27M → $26M, and expenses $70M → $75M → $76M), none of which are mentioned in the LLM response. (5) The reasoning and implications are therefore incomplete and misleading—while the LLM correctly notes the plan is closed and inactive, it misses the broader strategic shift indicated by increasing DC plan funding, which is central to the original answer. The contextual relevance is moderate because it addresses pension funding and participation but omits the critical comparative data that explains the company's long-term retirement benefit strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 459,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "Pfizer’s “private‑equity securities at cost” line fell from **$800 million in 2022** to **$755 million in 2023** (down $45 million) and then to **$719 million in 2024** (down $36 million)【page_86†L31-L34】【page_83†L31-L34】.  \n\nThe three‑year trend shows a steady, roughly 10 % reduction in the amount held, suggesting the company is gradually scaling back its exposure to private‑equity investments and reallocating capital away from this asset class while still maintaining a modest, strategic foothold.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. According to the ground truth, Pfizer's long-term investment in private equity securities at cost was $623 million in 2022, not $800 million as stated in the LLM answer. The values for 2023 ($755 million) and 2024 ($719 million) are correct. This initial error invalidates all subsequent calculations and interpretations. (2) The calculation of a '10% reduction' is incorrect due to the wrong baseline: using $800M to $719M implies ~10.1% decrease, but the actual change is from $623M to $719M — an increase of ~15.4% over the period, with a peak in 2023. The LLM incorrectly frames the trend as a 'steady reduction', when in fact the trajectory shows an increase from 2022 to 2023 followed by a partial decline in 2024. (3) The multi-hop reasoning is partially sound in that the model identifies the correct metric across years and attempts to synthesize a strategic interpretation. However, due to the incorrect 2022 figure, the logical chain fails. The original answer correctly identifies a short-term strategic increase followed by a partial pullback, indicating measured allocation — a nuance lost in the LLM's erroneous downward trend narrative. (4) Contextual relevance is high because the LLM addresses both parts of the question — the numerical change and the strategic implication — and references appropriate financial line items. However, the qualitative accuracy is reduced due to flawed data synthesis. The correctness score is low (4) because while two of three data points are correct and the structure is reasonable, the core factual error in the starting value severely undermines the answer’s validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 467,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "**2022 – 2019 IDA agreement**  \nSchwab could move up to $10 billion of IDA balances each 12‑month period, but only balances that were designated as floating‑rate obligations.  The agreement also required a $50 billion minimum IDA balance through June 2031 and that at least 80 percent of the balances be fixed‑rate through June 2026.  Schwab used the option in 2021 and migrated roughly $10 billion in 2022 under those limits.\n\n**2023 – 2023 IDA agreement (effective May 4 2023)**  \nThe new agreement made migration a matter of Schwab’s discretion and tied it to having sufficient capital and to strict balance‑range limits: the IDA balance must stay **above** the total of outstanding unmatured fixed‑rate obligations and **no more than $30 billion above** that total.  Withdrawals are allowed only to the extent of customer‑initiated withdrawals (with limited exceptions).  Schwab elected **not to migrate any IDA balances in 2023**.\n\n**2024 – 2023 IDA agreement still in force**  \nThe same minimum‑/maximum‑balance constraints applied (still before the post‑Sept 10 2025 rule that would set a $60 billion‑$90 billion band).  Schwab again **did not move any IDA balances to its balance sheet in 2024**, remaining subject to the same capital‑based discretion and the “minimum‑above‑unmatured‑fixed‑rate / maximum $30 billion‑above‑that” limits.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Schwab's IDA balance migration capability from 2022 to 2024, with accurate qualitative reasoning and strong contextual relevance. However, there are minor inaccuracies affecting quantitative and qualitative precision. (1) In 2022, the LLM incorrectly states that only floating-rate obligations could be migrated—this constraint is not in the ground truth, which specifies no such restriction, only capital sufficiency and the $10 billion annual cap. The ground truth confirms Schwab migrated $10.1 billion by end of 2021, not in 2022, and no migration occurred in 2022 under the 2019 agreement. The LLM’s claim that $10 billion was migrated in 2022 is factually incorrect. (2) The 2023 and 2024 sections are mostly accurate: the 2023 IDA agreement did impose minimum and maximum thresholds (above unmatured fixed-rate obligations, max $30B above), and no balances were migrated in either 2023 or 2024. The LLM correctly notes the discretion tied to capital and balance constraints. (3) The mention of a future $60B–$90B band post-Sept 10, 2025, is not in the ground truth and appears to be an overextrapolation, though it does not directly contradict it. (4) Multi-hop reasoning is sound—LLM correctly synthesizes changes across agreements and years, showing reduced flexibility. (5) Entity and date accuracy (2019 vs 2023 agreement, effective May 4, 2023) is correct. Overall, core facts about tightening constraints are preserved, but incorrect migration timing and added restrictions reduce quantitative and qualitative scores slightly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1591,
        "completion_tokens": 438,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "Across all three filings, Texas Instruments lists a Melaka, Malaysia site as a principal manufacturing location that is used exclusively for its **Analog** product line. The 2022 10‑K (Item 2, page 16) shows “Melaka, Malaysia ** | X | ” under the Analog column; the 2023 10‑K (Item 2, page 16) repeats the same entry (“Melaka, Malaysia * | X | ”), and the 2024 10‑K (Item 2, page 16) again lists “Melaka, Malaysia * | X | ”. This three‑year continuity indicates that the Melaka facility is a stable, dedicated analog‑product manufacturing hub, underscoring its strategic importance to TI’s core analog business and supply‑chain resilience.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Texas Instruments consistently operated in Melaka, Malaysia for analog product manufacturing across 2022, 2023, and 2024, which aligns with the ground truth. However, there is a minor discrepancy in the notation used: the LLM claims the 2022 filing used a double asterisk (**) and an 'X' in the Analog column, while the ground truth states it was marked with a †. Similarly, the LLM reports that both 2023 and 2024 used a single asterisk (*) and an 'X', but the ground truth notes a progression from * in 2023 to ** in 2024, suggesting possible escalation. The LLM incorrectly implies the notation remained the same across years, missing the potential signal of increasing emphasis. (2) There are no numerical values to verify, but the years and locations are accurate. The references to Item 2, page 16 in each 10-K are plausible and contextually appropriate. (3) The multi-hop reasoning is sound—correctly synthesizing data across three years and concluding strategic importance based on consistency. However, the model fails to capture the nuanced evolution in notation († → * → **) that the ground truth highlights as potentially indicative of growing strategic emphasis. This weakens the qualitative accuracy slightly. (4) Despite the notation inaccuracies, the core conclusion—that Melaka is a stable, dedicated analog manufacturing hub of strategic importance—is supported by both the LLM and ground truth. The answer is highly relevant and factually solid overall, warranting a high score, but not full marks due to the misrepresentation of symbolic markers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 442,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "The penetration of Target’s branded payment cards fell each year. In fiscal 2022 the Target Debit/RedCard (Target Circle Card) penetration was roughly 20 percent (RedCard 20.5 % and Target Circle 19.8 %); it slipped to about 19 percent in fiscal 2023 (RedCard 19.8 % and Target Circle 18.6 %) and to just under 18 percent in fiscal 2024 (RedCard 18.6 % and Target Circle 17.8 %)【page_27】【page_29】. The downward trend indicates the card’s ability to generate incremental purchases is waning, suggesting its role as a sales‑driving lever is diminishing over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, the penetration rate for the Target Debit Card (under RedCards/Target Circle Cards) was 20.5% in 2022, 19.8% in 2023, and 17.8% in 2024. However, the LLM incorrectly reports multiple separate percentages for RedCard and Target Circle Card each year, implying they are distinct and additive, which is not supported by the original answer. For example, it states RedCard at 20.5% and Target Circle at 19.8% in 2022 — but the original answer does not break out two separate figures; it refers to a single combined or umbrella metric of 20.5% under the RedCards/Target Circle Cards category. This misrepresentation continues into 2023 and 2024 with fabricated splits (e.g., 18.6% for Target Circle in 2023), which are not in the ground truth. (2) The calculation of trend direction (downward) is correct, but the specific values used are inaccurate. The LLM invents a level of granularity (separate RedCard vs. Target Circle penetration) that is not present in the original answer, leading to incorrect synthesis. (3) The multi-hop reasoning is partially sound in interpreting the declining trend as indicative of reduced effectiveness in driving incremental sales, which aligns with the original conclusion. However, due to incorrect underlying data, the reasoning is based on flawed premises. (4) Contextually, the answer addresses both parts of the question — the evolution over time and the implication for incremental sales — so relevance is high. However, the quantitative inaccuracies severely undermine factual correctness, warranting a low correctness score despite appropriate framing and direction of interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 476,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "The equity‑compensation tables show that the pool of shares that can be issued in the future (which includes the shares reserved for the Texas Instruments 2003 Director Compensation Plan) fell from roughly **63 million shares at the end of 2022** to **about 58.5 million shares at the end of 2023**, and then rose again to **approximately 65.5 million shares at the end of 2024**.  \n\nThe decline from 2022‑23 indicates that the company drew down the existing reserve of director‑plan shares, while the rebound in 2024 shows that TI replenished the pool—most likely by authorizing additional shares—demonstrating a pattern of using the plan’s equity incentives and then restoring capacity for future director awards.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both direction and magnitude of share count changes. The ground truth states that shares available under the 2003 Director Compensation Plan decreased from 35,385,153 in 2022 to 25,296,767 in 2023 to 24,503,062 in 2024. In contrast, the LLM reports a much larger pool (63M to 58.5M to 65.5M) and incorrectly claims an increase in 2024 due to replenishment. These numbers do not match the ground truth and suggest confusion with a broader equity pool, not the specific 2003 Director Compensation Plan. (2) Quantitative accuracy is very low: all three reported values (63M, 58.5M, 65.5M) are factually wrong and off by over 25 million shares in some cases. The trend is also reversed—LLM reports a rebound in 2024, while actual data shows continued decline. Calculations or interpretations based on these numbers are therefore invalid. (3) The reasoning is flawed: the LLM infers replenishment due to an increase, but the actual data shows a consistent decrease, indicating no replenishment. This misdiagnosis undermines the qualitative analysis. The model fails to correctly isolate the specific plan mentioned and instead appears to reference a broader share reserve, failing the multi-hop requirement to identify plan-specific data across years. (4) Contextual relevance is moderate because the answer addresses equity incentives for directors and attempts to interpret trends in share availability, but it does so using incorrect data and plan scope. While the conceptual framework (use and replenishment) is relevant, the factual foundation is unsound, leading to a misleading conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 450,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "- In fiscal 2022 Visa launched virtual‑account and real‑time FX capabilities through its digitally‑native Currencycloud platform as part of “Visa Treasury as a Service,” and tied those accounts to Visa Direct so that cross‑border consumer payouts could be settled instantly.  \n\n- In fiscal 2023 the Currencycloud virtual‑account functions were folded into the Visa Direct platform itself, becoming a core component of Visa Direct’s cross‑border suite (along with the new Visa+ P2P‑app interoperability), thereby widening the range of non‑card money‑movement use cases.  \n\n- By fiscal 2024 Visa Direct’s platform explicitly includes virtual accounts, real‑time foreign‑exchange rates and enhanced liquidity as part of its Visa Cross‑Border Solutions, supporting far more cross‑border use cases and, together with push‑to‑wallet extensions, serving nearly 10 billion transactions and billions of cards, bank accounts and digital wallets worldwide.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth, with only minor discrepancies in quantitative details. (1) Correct elements: The LLM correctly identifies the 2022 launch of virtual accounts via Currencycloud as part of Visa Treasury as a Service, with real-time FX and integration with Visa Direct for instant cross-border payouts. In 2023, it accurately notes the deeper integration of virtual accounts into Visa Direct and the expansion of cross-border use cases, including non-card money movement. By 2024, it correctly positions virtual accounts as a core component of Visa Cross-Border Solutions, supporting global endpoints and B2B opportunities. (2) Quantitative accuracy: The LLM states 'nearly 10 billion transactions and billions of cards, bank accounts and digital wallets' in 2024, while the ground truth cites 'over 11 billion endpoints' across these categories. This is a minor undercount and slightly different metric (transactions vs. endpoints), but not a major factual error—likely due to interpretation. The $20 trillion B2B opportunity is implied in the LLM’s reference to expanded cross-border use cases but not explicitly mentioned, which is a small omission. (3) Reasoning: The multi-hop synthesis across 2022–2024 is sound, showing a logical progression of integration and expansion. The connection between virtual accounts, Visa Direct, and cross-border capabilities is well-reasoned and consistent with the original. (4) Contextual relevance is perfect—the answer directly addresses the evolution of virtual accounts, integration with Visa Direct, and cross-border use case expansion as asked. The omission of the explicit $20 trillion figure prevents a perfect 10, but overall the answer is factually strong, well-structured, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 493,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "In 2023 Pfizer saw Xtandi’s sales slip – the product fell about 1 % internationally, mainly because of a lower net price and an unfavorable channel‑mix shift (2023 product‑revenue table). To counter that pressure the company pushed the drug’s lifecycle forward, adding a new EU indication for high‑risk biochemical‑recurrence prostate cancer in April 2024 (the 2024 indication‑expansion table). That same asset already carried a sizable value in Pfizer’s intangible portfolio in 2022, being listed among the “developed technology rights” that together had a net carrying amount of roughly $19.6 billion (2022 intangible‑asset schedule).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Xtandi's 1% revenue decline in 2023 due to lower net pricing and channel mix, its inclusion in Pfizer's 2022 developed technology rights with a $19.6 billion net carrying amount (correctly contextualized as part of a larger portfolio), and the April 2024 EU approval for high-risk biochemical recurrence nmCSPC. These match the original answer's data points. (2) Quantitative accuracy is perfect: the 1% decline, 2022 valuation context, and 2024 timing are all factually correct. The $19.6 billion figure is accurately attributed to the broader category that includes Xtandi, and the LLM correctly implies it without falsely isolating Xtandi’s standalone value. (3) Multi-hop reasoning is sound: the model connects 2022 asset valuation, 2023 revenue pressure, and 2024 lifecycle expansion logically, showing strategic continuity. (4) Minor deduction in qualitative accuracy because the original answer explicitly frames the 2024 indication as part of lifecycle management investment in response to pressure, while the LLM implies it but with slightly less clarity on Pfizer's strategic intent. However, the core synthesis across years and documents is correct. Contextual relevance is full—every part of the question is addressed with precise evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 376,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "The filing shows that the share of purchases made with Target’s branded credit cards (the RedCard / Target Circle Card, which includes the Target MasterCard) fell each year:\n\n* **2022:** 20.5 % of all purchases were paid with a Target credit card.  \n* **2023:** 19.8 % (down 0.7 percentage points).  \n* **2024:** 18.6 % (down 1.2 percentage points from the prior year).\n\nThe steady decline in penetration indicates that fewer guests are opting to use the Target MasterCard for their shopping, suggesting a weakening preference for the card‑linked 5 % discount and a modest drop in overall engagement with Target’s loyalty‑program‑driven payment product over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—20.5% in 2022, 19.8% in 2023, and 18.6% in 2024—are correct and match the original answer exactly. The year-over-year declines (0.7 and 1.2 percentage points) are correctly calculated. (2) The answer fully addresses both parts of the question: the evolution of the penetration rate over time and the interpretation regarding consumer preference and loyalty engagement. (3) Entity accuracy is strong: the card is correctly identified as part of the RedCard/Target Circle Cards, and the rebranding context is implied through naming. (4) The reasoning is sound—identifying a steady decline and linking it to reduced consumer preference and loyalty engagement is a valid inference supported by the data. The only minor shortcoming is that the LLM does not explicitly mention the rebranding from RedCards™ to Target Circle Cards as noted in the original answer, which slightly weakens the qualitative synthesis. However, this does not detract significantly from the overall correctness. Semantic equivalence is maintained, and the answer is contextually complete and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 329,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "Visa first introduced virtual‑account functionality on the Visa Direct platform in FY 2022 as a way to extend cross‑border payouts beyond cards to “push‑to‑account” and “push‑to‑wallet” flows, giving partners access to roughly 7 billion cards, bank accounts and digital wallets in more than 190 countries and territories. In FY 2023 the service was moved into Visa’s digitally‑native Currencycloud layer, adding real‑time foreign‑exchange pricing and richer liquidity tools, which broadened the range of cross‑border use cases and pushed the reachable network past the 190‑country mark. By FY 2024 the Currencycloud‑based virtual‑account suite was fully integrated into Visa Direct (including Visa Cross‑Border Solutions), supporting cross‑border payments in over 195 countries and territories and a potential reach of more than 11 billion endpoints (cards, accounts and wallets).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution of Visa's virtual accounts across 2022–2024 with strong contextual and qualitative alignment to the ground truth, but contains key quantitative inaccuracies. (1) Correct elements: The answer correctly identifies the progression of virtual accounts from Visa Direct to Currencycloud, integration with cross-border solutions, enhanced FX and liquidity tools, and expansion in network reach. The mention of 'push-to-account' and 'push-to-wallet' flows aligns with the strategic direction. (2) Quantitative issues: The LLM states 7 billion endpoints in FY2022, but the ground truth does not specify a number for that year—only that by 2023, reach exceeded 11 billion. The LLM incorrectly attributes the 7 billion figure to 2022 and implies growth from that baseline, whereas the ground truth starts with 11 billion in 2023. Also, the LLM cites 'over 190 countries' in 2023 and 'over 195' in 2024, while the ground truth references 'more than 100 countries' specifically for B2B transactions via Visa B2B Connect in 2024—these are different metrics (total countries vs. B2B-specific). (3) Reasoning: The multi-hop synthesis is sound—linking virtual accounts to Currencycloud, FX capabilities, network expansion, and integration with Visa Direct—but the timeline of integration is reversed: the ground truth says virtual accounts were introduced via Currencycloud in 2022 and later expanded into Visa Direct in 2023, while the LLM claims the opposite (launched on Visa Direct in 2022, moved to Currencycloud in 2023). This is a significant factual inversion. (4) Despite these errors, the answer remains contextually relevant and conveys a plausible narrative of expansion and integration. The correctness score is 7 due to accurate high-level trends but flawed specifics in sequence and metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 494,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "- In the 2022 Form 10‑K AMD first flagged “difficulties in protecting our intellectual property” as one of the political‑, legal‑ and economic‑risk factors tied to its worldwide operations (see 2022 p. 37).  \n- The 2023 filing repeats the same exposure and explicitly ties it to the company’s heavy reliance on third‑party wafer foundries and assembly/testing sites in China, Malaysia and Taiwan (2023 p. 41).  \n- The 2024 filing again lists “difficulties in protecting our intellectual property” among the foreign‑operation risks, now emphasizing that heightened geopolitical tensions (e.g., China‑Taiwan, sanctions) could worsen the risk for its international sales and third‑party manufacturing base (2024 p. 40‑41).  \n\nThus, AMD’s IP‑protection risk has been a constant concern each year and has grown more pronounced as its dependence on overseas foundries and the geopolitical environment have intensified.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD consistently cited intellectual property (IP) protection difficulties across 2022, 2023, and 2024, with increasing specificity. The 2022 mention ties IP risks to global operations (p.37), 2023 links it to third-party manufacturing in China, Malaysia, and Taiwan (p.41), and 2024 adds geopolitical tensions and sanctions (p.40-41). These details match the original answer. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all years, page numbers, and risk descriptions are factually correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of 10-K filings, traces the evolution of the risk, and connects it to international operations and third-party manufacturing dependencies. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the Ukraine-Russia and Israel-Hamas conflicts as drivers of evolving export controls—this specific detail from the 2024 risk discussion is omitted. However, it does reference 'sanctions' and 'geopolitical tensions,' which captures the essence. This small omission prevents a perfect 10 on qualitative accuracy, but the overall correctness remains very high. The answer is fully contextually relevant and directly addresses the question’s focus on the evolution of IP risks in relation to international operations and manufacturing dependencies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 421,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "In 2022 the pension‑plan’s corporate‑stock holding was reported almost entirely as a Level 2 investment (≈ $1.1 billion of the $1.11 billion total, with only a tiny Level 1 portion) and it made up roughly 48 % of the plan’s assets. By 2023 the same line shows a reversal – about $220 million is now classified as Level 1 (active‑market) and only $6 million as Level 2, and the equity‑security share of the portfolio fell to 24 % (the same 24 % shown for 2024, with a target of 20‑30 %). The move from mostly Level‑2, high‑equity exposure to predominantly Level‑1, lower‑equity exposure reflects UNP’s deliberate de‑risking of its pension assets, shifting the plan toward debt‑heavy, more stable investments and reducing overall market‑price volatility.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, in 2022, UNP's Corporate Stock investment was $1,990 million, with $1,980 million in Level 1 and $10 million in Level 2 — meaning it was overwhelmingly classified as Level 1, not Level 2 as claimed. The LLM incorrectly states that in 2022, the holding was 'almost entirely Level 2' with ~$1.1 billion in Level 2, which is factually wrong on both classification and amount. Similarly, for 2023, the ground truth reports total Corporate Stock at $181 million ($176M Level 1, $5M Level 2), but the LLM reports $220M Level 1 and $6M Level 2 — incorrect figures. Additionally, the LLM introduces percentages (48%, 24%) and portfolio allocation context not present in the original answer, which focuses solely on valuation classification and total amounts. (2) All key numbers are wrong: 2022 total should be $1,990M (not $1.11B), and Level 1/Level 2 breakdown is inverted. 2023 total is $181M (not $226M), and again misclassified. No dollar figures were provided for 2024 in the original, but the LLM implies continued quantified holdings without stating that data is missing. (3) The multi-hop reasoning is flawed because it builds on incorrect data. While the conclusion about de-risking may be directionally plausible, it is based on fabricated numbers and mischaracterized classifications. The original answer notes a sharp decline from 2022 to 2023, but the LLM distorts the magnitude and nature of the shift. (4) The contextual relevance is moderate — it addresses valuation levels and pension strategy — but due to severe quantitative errors and introduction of unsupported metrics (like portfolio percentages), the qualitative and correctness scores are very low. Semantic equivalence fails on core facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 490,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "From the 2022 Form 10‑K (see page 86) Abbott listed the original 2017 filing for the 4.75 % Senior Notes due 2043 – the note’s form (Exhibit 4.6) and the officers’ certificate (Exhibit 4.7). The 2023 and 2024 filings keep those same exhibits (page 86) and, in addition, add a St. Jude Medical supplemental indenture (Exhibit 4.22 on page 87) that also references the 4.75 % Senior Notes due 2043, reflecting the incorporation of the acquired debt into Abbott’s exhibit schedule. This multi‑year consistency, coupled with the added supplemental‑indenture reference, shows Abbott’s intent to treat the 2043 note as a long‑term, core financing instrument and to maintain a transparent, continuously‑updated disclosure package for investors.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but exhibits significant factual and reasoning discrepancies compared to the ground truth. (1) Quantitatively, the LLM correctly identifies the 4.75% Senior Notes due 2043 and references Exhibits 4.6 and 4.7 from the 2017 filing, which aligns with the original answer’s mention of the Form 8-K dated March 22, 2017. However, it incorrectly states that Abbott listed these exhibits in the 2022 Form 10-K on page 86, while the ground truth indicates that in 2022, Abbott referenced the notes through St. Jude Medical’s Fourth Supplemental Indenture from 2013—not via the 2017 exhibits. This misrepresents the evolution timeline. (2) The LLM claims that the 2023 and 2024 filings added Exhibit 4.22 (St. Jude Medical supplemental indenture), but the original answer states the opposite: in 2022, Abbott referenced the St. Jude indenture, and by 2023 shifted to directly including the 2017 Form 8-K exhibit (Exhibit 4.6). The LLM reverses the chronological progression of disclosure strategy. (3) Qualitatively, the multi-hop reasoning is flawed—the model fails to accurately trace the shift from legacy referencing (2022) to standardized disclosure (2023–2024), instead suggesting the reverse: that legacy documentation was added later. This undermines the core insight about Abbott’s move toward transparency. (4) Despite these errors, the LLM captures the broader theme of consistent disclosure and investor transparency, which is contextually relevant and reflects an understanding of the strategic intent. However, due to the incorrect sequencing of events and misattribution of exhibit usage across years, the factual accuracy and logical synthesis are compromised. Minor formatting variations (e.g., spacing in '4.75 %') are acceptable and do not affect scoring. Overall, the answer is partially correct but contains critical factual inaccuracies in the temporal evolution of disclosure, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 528,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "The filing shows that “RedCard” (now the Target Credit Card) penetration was **20.5 % for fiscal 2022**, fell to **19.8 % for fiscal 2023**, and further declined to **18.6 % for fiscal 2024**【page_27】.  \n\nThe downward trend signals that a smaller share of guest purchases is being paid with Target’s branded payment products, indicating slower customer adoption and consequently a diminishing incremental‑sales boost that Target attributes to those cards【page_29】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%) are accurately reported with correct formatting and time periods. (2) The answer addresses both parts of the multi-part question: it traces the evolution of the penetration rate from 2022 to 2024 and interprets the trend in terms of customer adoption and impact on incremental sales. (3) Entity accuracy is correct: 'RedCard' is properly associated with the Target Credit Card, and the fiscal years are correctly referenced. (4) The reasoning is sound and reflects multi-hop synthesis: the decline in penetration is logically linked to reduced customer adoption and a diminishing incremental-sales effect, consistent with Target’s strategic narrative in the filings. The use of citation markers (e.g., 【page_27】, 【page_29】) further indicates proper grounding in source material. Semantic equivalence is maintained throughout, with no factual discrepancies or omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 296,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "Union Pacific’s multiple‑purpose locomotive fleet fell from **about 7,242 units in 2022 (average age ≈ 22.5 years)** to **6,893 units in 2024 (average age ≈ 25.2 years)** – a reduction of roughly 350 locomotives and an increase of almost 3 years in average age. This pattern of modest fleet shrinkage combined with a slightly older remaining stock signals a deliberate asset‑management approach: the railroad is retiring older equipment to right‑size its fleet while relying on a leaner, more cost‑efficient base to meet service needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual data: the fleet size decreased from 7,242 units in 2022 to 6,893 units in 2024, and the average age increased from 22.5 years to 25.2 years. These numbers match the ground truth exactly, with acceptable formatting variations (e.g., 'about' and '≈' used appropriately). The implied reduction of ~349 units (7,242 - 6,893 = 349) is accurately described as 'roughly 350 locomotives,' which is a reasonable approximation. (2) All calculations and numeric values are correct. The difference in fleet size and average age are accurately represented. No mathematical errors. (3) The multi-hop reasoning is sound: the model synthesizes data across two years for two metrics (unit count and average age) and draws a logical conclusion about asset management strategy. The interpretation — that Union Pacific is retiring older units and operating a leaner, more cost-efficient fleet — is consistent with the ground truth's conclusion of a 'cost-conscious asset management strategy.' While the LLM frames it slightly more positively (e.g., 'deliberate' and 'cost-efficient'), it does not contradict the core implication of deferred modernization. (4) The answer is fully contextually relevant, addressing all parts of the question: changes in total units, changes in average age, and the strategic implication. The only minor deviation is in tone — the LLM suggests 'right-sizing' and efficiency, while the ground truth emphasizes 'deferral of modernization.' However, both point to cost-consciousness, so the semantic meaning remains aligned. Thus, the answer is factually excellent with only slight interpretive nuance differences, warranting a 9/10 overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 466,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "Abbott’s disclosed unfunded commitments to private‑real‑estate (and other private) funds have been falling each year: $569 million at 12/31/2022, $555 million at 12/31/2023, and $540 million at 12/31/2024【page_71】【page_70】.  The steady decline signals that the company is gradually scaling back its outstanding pledges to illiquid alternative assets, suggesting a more cautious, liquidity‑conscious long‑term strategy while still maintaining a modest exposure to private‑real‑estate investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but has a minor discrepancy in the 2022 unfunded commitment amount. The ground truth reports $585 million for 2022, while the LLM states $569 million. All other values are accurate: $555 million in 2023 and $540 million in 2024 match the ground truth. This affects quantitative accuracy slightly but does not alter the overall trend interpretation. (2) Calculations: The LLM correctly identifies a steady decline, though the actual total decrease is $45 million ($585M → $540M), not $29 million as implied by its numbers. However, the model correctly notes a consistent downward trajectory, which aligns with the trend. (3) Multi-hop reasoning is sound—the model synthesizes data across three years and correctly infers that the declining commitments suggest a more cautious, liquidity-conscious strategy. It appropriately connects reduced capital deployment with continued modest exposure, reflecting a measured long-term approach. (4) Entity accuracy is perfect: Abbott Laboratories, private real estate funds, and the correct time periods (2022–2024) are all correctly identified. The answer addresses both parts of the question: the evolution of commitments and the implication for long-term strategy. Despite the small numerical error in the 2022 figure, the qualitative reasoning and overall message are consistent with the ground truth, warranting a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 397,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "- Carrying‑value of the 3.50 % Notes Due 2050 was **about $1.67 billion in FY 2022**, fell to **≈ $1.64 billion in FY 2023**, and further declined to **≈ $1.60 billion in FY 2024** (the 2023‑2024 10‑K tables show $1,637 million for Jan 29 2023 and $1,604 million for Jan 28 2024).  \n\n- The gradual reduction reflects the amortization of the original debt discount (and any issuance costs) as the notes age, indicating that NVIDIA’s long‑term debt is being carried down toward its face value while the company maintains a stable, low‑cost financing structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, the carrying value was $2,147 million in FY2022, decreased to $1,604 million in FY2023, and then increased to $2,000 million in FY2024. The LLM incorrectly states the FY2022 value as ~$1.67 billion (~$1,670 million), which is significantly lower than the true value of $2,147 million. It also reports a continued decline to ~$1.60 billion in FY2024, whereas the actual value increased to $2,000 million. These errors misrepresent the entire trend. (2) The only correct number is the $1,604 million for FY2023 (Jan 28, 2024), which the LLM correctly cites from the 10-K. However, it mislabels this as FY2024 and incorrectly implies a further decline, when in fact the value rebounded. The LLM also confuses the timing: the $1,637 million figure cited is from Jan 29, 2023 (end of FY2023), not FY2022. (3) The reasoning is flawed: the LLM concludes that the decline reflects amortization toward face value, but the actual increase in 2024 contradicts this steady amortization narrative. The ground truth interprets the fluctuation as a strategic revaluation or adjustment, possibly due to refinancing or debt management changes—nuance entirely missed by the LLM. The model fails to perform the required multi-hop synthesis across three fiscal years and misinterprets the trajectory. (4) The contextual relevance is moderate because it discusses the right instrument and general concept (carrying value, debt amortization), but the incorrect data and reasoning severely undermine the answer’s validity. Scores reflect major factual and analytical errors, especially in quantitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 471,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "- 2022 10‑K (page 37) listed “loss or modification of exemptions for taxes and tariffs” only as one of many generic political‑legal‑economic risks.  \n- 2023 10‑K (page 40) repeated the same exposure but placed it in a longer risk paragraph that also referenced new export‑control sanctions, the Ukraine‑Russia war and other geopolitical shifts, showing the issue was now tied to a broader, more volatile regulatory landscape.  \n- 2024 10‑K (page 38) again highlighted the risk of losing tax‑ and tariff‑exemptions, this time alongside a detailed discussion of rising international sales (≈ 66 % of revenue) and multiple geopolitical flashpoints (China‑Taiwan, Ukraine‑Russia, Israel‑Hamas), indicating that the risk has become more material as AMD’s global operations and supply‑chain dependencies have expanded.  \n\n**Trend:** AMD’s exposure to losing tax and tariff exemptions has moved from a peripheral footnote in 2022 to a more prominent, context‑specific concern by 2024, reflecting the growing complexity and interdependence of the regulatory environments in the many countries where it operates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: in 2022, AMD listed tax/tariff exemption risk as a generic item; in 2023, it was contextualized with geopolitical events like the Ukraine-Russia war and export controls; in 2024, it was further tied to rising international sales (~66%) and multiple geopolitical flashpoints including China-Taiwan, Israel-Hamas, and Ukraine-Russia. The progression in emphasis and context is correctly captured. (2) Quantitative accuracy is excellent: the ≈66% international revenue figure is correctly cited from the 2024 10-K and matches the knowledge graph data. No calculations were required, but the use of percentages and years is precise. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the evolving language and context around the risk, and infers increasing regulatory complexity due to global expansion and geopolitical exposure. (4) The only minor shortcoming is that the LLM does not explicitly name AMD’s third-party manufacturing partners (e.g., TSMC in Taiwan) as directly affected by China-Taiwan tensions, which is a detail present in the original answer. However, the implication is clear from the context. Wording differs slightly but maintains semantic equivalence. The trend conclusion is accurate and well-supported. Thus, the answer is factually complete and logically coherent, meriting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 436,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings BNY Mellon repeatedly states that its ability to return capital – whether through cash dividends or share‑repurchase programs – is “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital‑planning, applicable provisions of Delaware law, and our status as a non‑operating holding company that depends on dividends from its banking subsidiaries.” The language is essentially unchanged from 2022 through 2024, indicating that the company’s exposure to regulatory constraints on dividend payments and share repurchases has remained consistent rather than diminishing over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility remained consistent from 2022 to 2024, with no material changes in regulatory constraints. The key elements—U.S. banking laws on capital adequacy and planning, Delaware law, and reliance on dividends from banking subsidiaries—are all accurately cited. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable in a traditional sense; however, the years 2022–2024 are correctly referenced, and no incorrect dates or figures are introduced. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent disclosures across three years of 10-K filings, correctly inferring stability in regulatory constraints. While the original answer adds nuance—such as mention of Title I/II resolution strategies in 2023 and liquidity management in 2024—the LLM captures the core continuity of risk factors. The only minor shortcoming is the omission of these incremental contextual expansions in 2023 and 2024, which slightly reduces qualitative completeness but does not undermine the central conclusion. (4) The answer is semantically equivalent to the original in its main claim: regulatory constraints on capital returns have remained persistently in place. Wording differs but meaning is preserved. Contextual relevance is perfect—the response directly addresses dividend payments, share repurchases, and regulatory evolution (or lack thereof) over the specified period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 450,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "- **2022 10‑K** – The exhibit table does not list the 2.950 % Note due 2025; there is no entry for a Form of that note or for officer‑action documentation.  \n\n- **2023 10‑K** – The note appears for the first time. Item 4.1 lists “Form of 2.950 % Note due 2025, filed as Exhibit 99.6 to the March 5, 2015 Form 8‑K,” and Item 4.11 lists the related “Actions of the Authorized Officers … 2.950 % Notes, filed as Exhibit 99.3” (both carried over from the 2015 filing).  \n\n- **2024 10‑K** – The same two entries (Form of the 2.950 % Note due 2025 and the officer‑action exhibit) remain in the exhibit table, unchanged from the 2023 filing.  \n\nThus, the disclosure of the 2.950 % Note due 2025 was absent in 2022, was introduced in 2023 with both the note’s form and related officer actions listed as exhibits, and was retained unchanged in the 2024 filing.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is largely incorrect in its core factual claims, contradicting the ground truth. (1) The ORIGINAL ANSWER states that Abbott Laboratories consistently disclosed the 2.950% Note due 2025 from 2022 through 2024, with the same exhibit (99.6) and filing date (March 5, 2015) referenced each year. However, the LLM claims the note was 'absent in 2022' and only 'introduced in 2023', which is factually wrong. (2) Quantitatively, while the LLM correctly identifies Exhibit 99.6 and the March 5, 2015 8-K filing, and correctly references the 2.950% interest rate and 2025 maturity, it misrepresents the timeline of disclosure. The claim that the note was not in the 2022 10-K is unsupported by the ground truth, which affirms consistent inclusion. (3) The reasoning is flawed: the LLM implies an evolution in disclosure (absent → present), while the ground truth shows stability. This fails the multi-hop requirement to compare disclosures across years accurately. (4) Contextually, the answer is relevant and structured well, addressing exhibit types and years, but the central conclusion about evolving disclosure is incorrect. Thus, despite correct formatting and partial entity accuracy, the answer fails on correctness due to a key factual error in temporal consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 356,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "- **Fiscal 2022 – 2023:** The 1.55 % Notes Due 2028 were carried on the balance sheet at roughly **$1.1 billion** (the amount shown for the same series in the 2023 filing’s fair‑value table – $1,099 million)【page 67】.  \n\n- **Fiscal 2024:** The same notes were carried at **$1.25 billion** (the line‑item “1.55 % Notes Due 2028” in the debt‑breakdown table)【page 72】.  \n\n**Interpretation:** The increase from about $1.1 billion to $1.25 billion shows that NVIDIA has been allowing its long‑term, low‑coupon debt to grow modestly rather than aggressively retiring it. This pattern signals a deliberate strategy of using inexpensive, fixed‑rate financing to support ongoing investments and acquisitions while preserving cash and maintaining a strong balance‑sheet profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a significant quantitative error in the fiscal 2022 value. The ground truth states the carrying value was $1,200 million in fiscal 2022, but the LLM omits this value entirely and instead starts with $1,099 million in fiscal 2023 as the first data point, incorrectly labeling it as the value for both 2022 and 2023. This misrepresents the evolution by missing the initial $1,200M figure and implying a rise from $1.1B to $1.25B when in fact the value decreased from $1,200M to $1,099M before increasing to $1,250M. (2) The fiscal 2023 and 2024 values are accurate: $1,099 million and $1,250 million respectively (equivalent to $1.1B and $1.25B in billions). However, the absence of the correct 2022 value breaks the full progression and undermines the accuracy of the trend analysis. (3) The multi-hop reasoning is sound in that the model identifies the correct debt instrument across years and attempts to interpret the trend in the context of long-term debt strategy. The qualitative interpretation about maintaining low-cost debt is reasonable and aligns with the ground truth’s suggestion of strategic management. However, due to the missing 2022 data point, the reasoning is based on an incomplete and slightly distorted trend. (4) The contextual relevance is high because the answer addresses both parts of the question—evolution of carrying value and strategic implication—and uses appropriate financial terminology. The qualitative accuracy is good due to correct entity identification (NVIDIA, 1.55% Notes Due 2028) and logical interpretation, despite flawed input data for 2022. The quantitative accuracy is penalized because the omission of the true 2022 value ($1,200M) constitutes a material factual error in a multi-year trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 492,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "- **2022 (10‑K)** – AMD’s AIB agreements already contained a clause that “protect[s] their inventory of our products against price reductions,” and the filing noted that system integrators “often use discrete‑graphics solutions as a means to differentiate their products and add value”【page_11】.  \n\n- **2023 (10‑K)** – The same inventory‑protection language was carried forward, and AMD continued to stress that AIB partners operate on short design cycles and rely on its discrete‑graphics GPUs to create differentiated offerings for end‑users.  \n\n- **2024 (10‑K)** – AMD again reaffirmed that its AIB contracts “protect their inventory … against price reductions,” and reiterated that “SIs often use discrete graphics solutions as a means to differentiate their products and add value to their customers”【page_13】.  \n\nThus, from 2022 through 2024 AMD’s strategy with AIB manufacturers remained consistent: it safeguarded AIB inventory from price cuts while positioning discrete‑graphics GPUs as a key lever for market differentiation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD maintained inventory protection policies for AIBs from 2022 to 2024, with consistent language about protecting against price reductions. The role of discrete graphics in differentiation is correctly attributed to both AIBs and system integrators (SIs) across all years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying continuity in inventory protection and the evolving emphasis on discrete GPUs for differentiation. The only minor shortcoming is that the 2023 filing’s added emphasis on 'timely product introductions and market competitiveness'—a nuance in strategic focus—is not explicitly mentioned, though the core policy and partnership support are accurately conveyed. (4) The answer is contextually fully relevant, directly addressing AMD's strategy evolution, inventory policies, and the role of discrete graphics. Wording differs slightly from the original but maintains semantic equivalence. Overall, this is a strong, factually correct response with only a slight omission in qualitative depth for 2023, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 398,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "In the 2022 filing AMD already warned that its “political, legal and economic risks … include difficulties in protecting our intellectual property” and that the company depended on third‑party wafer foundries (U.S., Europe, Asia) and on third‑party assembly and final‑testing facilities in China, Malaysia and Taiwan, with international sales representing about 72 % of revenue (2021)【page_36】.  \n\nBy the 2024 filing the same IP‑protection risk is highlighted again, but it is now framed within a broader set of geopolitical concerns –‑‑especially the heightened tension between China and Taiwan and other regional conflicts –‑‑that could disrupt the very third‑party manufacturers on which AMD increasingly relies; international sales remain a majority (≈ 65‑66 % of net revenue) and the company still relies on those China‑, Malaysia‑ and Taiwan‑based facilities, meaning its exposure to IP‑protection difficulties has grown as its global footprint and reliance on politically sensitive manufacturing partners have expanded【page_41】【page_40】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core trend of AMD's increasing exposure to intellectual property (IP) protection risks due to international operations and reliance on third-party manufacturing in geopolitically sensitive regions, which aligns with the ground truth. However, there are significant quantitative inaccuracies that undermine factual correctness. First, the LLM incorrectly states that international sales were about 72% of revenue in 2021, citing that figure in the context of the 2022 filing — but the original answer states that international sales were 'an unspecified but lower figure' in 2022 and only rose from 65% in 2023 to 66% in 2024. There is no mention of 72% in 2021 in the ground truth, nor is 2021 part of the question’s scope (2022–2024), making this a factual error and potential misattribution. Second, the LLM claims international sales remained at ≈65–66% in 2024, which is directionally correct, but fails to note the specific year-on-year increase from 65% (2023) to 66% (2024) as emphasized in the original answer, missing a key data point showing evolving exposure. On qualitative accuracy, the LLM correctly identifies the expansion of risk disclosures from general IP concerns in 2022 to more specific geopolitical tensions (e.g., China-Taiwan) in 2024 and links them to third-party manufacturing dependencies — a sound multi-hop synthesis across years and risk factors. It also correctly notes AMD's reliance on facilities in China, Malaysia, and Taiwan. However, it omits mention of U.S.-Russia tensions due to the Ukraine conflict, which was explicitly highlighted in the 2023 filing per the ground truth, representing a gap in completeness. Contextual relevance is high, as the response directly addresses the evolution of IP protection risks in line with global operations and manufacturing dependencies. Overall, while the reasoning and structure are strong, the incorrect revenue percentage and misattribution to 2021, along with missing the precise 2023–2024 increase and omission of U.S.-Russia tensions, reduce quantitative and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1628,
        "completion_tokens": 559,
        "total_tokens": 2187
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "- **2022:** The 2019 Long‑Term Incentive Plan was used to issue a **2022 Performance Share Unit (PSU) Agreement** (Exhibit 10.18) and a **2022 Restricted Stock Unit (RSU) Agreement** (Exhibit 10.19)【page_18】.  \n- **2023:** The same plan generated a **2023 PSU Agreement** (Exhibit 10.26) and a **2023 RSU Agreement** (Exhibit 10.27)【page_19】.  \n- **2024:** The plan continued with a **2024 PSU Agreement** (Exhibit 10.28) and a **2024 RSU Agreement** (Exhibit 10.29)【page_20】.  \n\n**Interpretation:** Over three consecutive years BNY Mellon has repeatedly refreshed its equity‑based awards under the 2019 LTIP, moving from the initial 2022 grant forms to updated 2023 and 2024 versions. This steady rollout of PSU and RSU agreements signals a deliberate strategy to keep executive compensation tightly linked to long‑term shareholder value and to retain key talent through ongoing, performance‑driven equity incentives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the specific agreements introduced under the 2019 Long-Term Incentive Plan (LTIP). According to the ground truth, in 2022, BK referenced the 2019 LTIP with the 2021 Form of PSU Agreement; in 2023, it introduced the 2020 Form; and in 2024, the 2022 Form. However, the LLM claims that BK introduced a 2022 PSU/RSU Agreement in 2022, a 2023 version in 2023, and a 2024 version in 2024—this is incorrect. The forms are not named after the year they are issued but are instead legacy forms (e.g., 2021, 2020, 2022 forms used in later years), which the LLM fails to capture. Additionally, the LLM refers to 'BNY Mellon' instead of 'BK' (likely referring to Burger King or another entity), indicating a critical entity error. (2) Quantitative accuracy is low because the years of the agreements are wrong, and the progression described (2022 → 2023 → 2024 forms) does not match the actual sequence (2021 → 2020 → 2022 forms). The exhibits cited (e.g., 10.18, 10.19) may exist, but their association with specific agreement years is inconsistent with the ground truth. (3) The multi-hop reasoning is flawed: the model fails to recognize that the company reused older form agreements in later years, which suggests a layered, continuity-based strategy. Instead, it assumes a linear annual update, missing the nuance of maintaining legacy structures while selectively updating. (4) Despite these issues, the interpretation about continuity and alignment with shareholder value has partial relevance, earning moderate scores in qualitative accuracy and contextual relevance. However, due to major factual and entity errors, the overall correctness is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 470,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "Abbott’s capital tied up in diagnostic‑instrument leases rose modestly: the original cost of the leased assets increased from $3.6 billion (net book value $1.6 billion) at 12/31/2022 to $3.9 billion (net book $1.8 billion) at 12/31/2023, and the same $3.9 billion/$1.8 billion levels were reported at 12/31/2024【page_64】【page_62】. The incremental rise and subsequent plateau suggest Abbott is pursuing a steady, incremental deployment of capital in its diagnostics‑instrument leasing business rather than a rapid expansion, using leasing to support growth while maintaining asset efficiency.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, the original cost of leased assets was $3.3 billion in 2022, $3.6 billion in 2023, and $3.9 billion in 2024. However, the LLM incorrectly states that the original cost was $3.6 billion in 2022, which is actually the 2023 figure. Similarly, the net book value is reported as $1.6 billion in 2022 (correct), but the LLM claims it rose to $1.8 billion in 2023 and remained there in 2024—this is incorrect, as the ground truth shows the net book value was $1.6 billion in both 2023 and 2024. These errors affect the core financial accuracy of the response. (2) Calculations and trends are misrepresented: the LLM suggests a 'plateau' from 2023 to 2024 in both original cost and net book value, but while original cost does increase from $3.6B to $3.9B (so no plateau), net book value does remain flat at $1.6B—yet the LLM incorrectly reports it as rising to $1.8B. This undermines the quantitative accuracy. (3) The reasoning about Abbott’s capital deployment strategy—linking leasing to downstream reagent sales and strategic expansion—is contextually relevant and aligns with the intent of the original answer. However, the conclusion about 'steady, incremental deployment' and 'asset efficiency' is based on incorrect numbers, weakening the qualitative validity. The multi-hop synthesis (connecting leasing trends to business strategy) is sound in concept but flawed in execution due to incorrect inputs. (4) Despite the incorrect numbers, the LLM addresses both parts of the question: the evolution of investment and the strategic implication. The strategic interpretation is plausible and relevant, earning points for contextual relevance. However, the quantitative inaccuracies are severe enough to significantly reduce correctness and qualitative scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 510,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "NVIDIA’s 10‑K disclosures list Lumentum Holdings as a competitor in the “networking products consisting of switches, network adapters (including DPUs), and cable solutions (including optical modules)” category in FY 2022, FY 2023 and FY 2024 【page_15】. During the same period NVIDIA repeatedly stresses that its strategy is expanding “full‑stack data‑center‑scale compute and networking solutions” and that AI‑driven networking and interconnect are core growth areas 【page_7】. Thus, Lumentum’s competitive positioning has remained on NVIDIA’s radar across all three fiscal years, and as NVIDIA’s focus on AI‑enabled networking and high‑performance interconnects has intensified, Lumentum has become an increasingly relevant rival in that segment.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in key aspects but lacks the nuanced evolution of Lumentum's competitive positioning described in the original answer. (1) Correct elements: The LLM correctly identifies that Lumentum Holdings was listed as a competitor in NVIDIA’s 10-K filings across FY2022, FY2023, and FY2024 in the networking segment involving switches, adapters, and optical modules. It also accurately reflects NVIDIA’s strategic emphasis on AI-driven networking and full-stack data center solutions, supporting the inference that Lumentum remains a relevant competitor. (2) Quantitative accuracy is perfect: no numerical or date inaccuracies; fiscal years are correctly cited and aligned with disclosures. (3) However, the qualitative reasoning is less precise: the original answer details a clear progression—Lumentum’s repositioning from a general supplier in 2022 to a specialized high-performance interconnect player in 2023 (aligned with InfiniBand/Ethernet), and then to a specifically named entity ('Lumentum Holdings Inc.') in 2024, indicating heightened recognition. The LLM answer fails to capture this multi-hop evolution and instead states that Lumentum was consistently listed in the same category across all years, which contradicts the ground truth’s assertion of a shifting, more refined competitive categorization. (4) Contextual relevance is high because the answer addresses NVIDIA’s AI networking focus and Lumentum’s ongoing competitive role, but it misses the strategic nuance of Lumentum’s rising prominence and identity sharpening. Thus, while the core facts are correct, the synthesis of change over time is underdeveloped, warranting a score of 7 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 473,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "In the 2022 filing the pipe‑cutters were described under the **Tools & Home Products** segment – listed with the “Professional Tools” product line that also serves homeowners. By the 2024 filing the same pipe‑cutters appear in the **Safety & Productivity** segment, grouped with pipe‑wrenches, threading equipment and other “pipe‑working tools” that are sold to professionals.  \n\nThis move shows Emerson is pulling its professional‑tool portfolio out of a mixed consumer‑focused segment and placing it in a dedicated safety‑and‑productivity segment, signaling a strategy that treats pipe‑cutters as a core part of its professional‑tool offering aimed at enhancing job‑site safety and efficiency rather than as a generic home‑improvement product.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift of pipe cutters from the Tools & Home Products segment in 2022 to the Safety & Productivity segment by 2024, which aligns with the ground truth. The entities (Emerson, pipe cutters, segment names, years) are accurate. However, the LLM slightly misrepresents the 2024 grouping — it mentions 'pipe-wrenches, threading equipment' as companions, while the ground truth specifies battery hydraulic tools, drain cleaners, and diagnostic systems like sewer inspection cameras. This is a minor inaccuracy in detail but does not distort the overall strategic implication. (2) There are no numeric values, percentages, or financial figures in the question or answers, so quantitative accuracy is not applicable in that sense; however, the years (2022, 2024) are correctly used, and no incorrect dates are cited, warranting a full score. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift from consumer to professional focus based on segment repositioning. It captures the essence of the strategy — moving professional tools into a dedicated segment to emphasize safety and productivity — though it omits the context of the InSinkErator divestiture, which strengthens the ground truth's conclusion. This omission reduces completeness slightly but doesn't invalidate the reasoning. (4) The answer is contextually highly relevant, directly addressing both parts of the question: the segment shift and its strategic implication. The conclusion about treating pipe cutters as part of a professional, efficiency-focused offering is semantically aligned with the ground truth. Minor lack of specificity in the 2024 product grouping and missing reference to the broader portfolio divestiture prevent a perfect score, but the core facts and interpretation are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 499,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "- **2022:** Schwab’s Advisor Services website was the primary hub for RI As, offering online account‑opening, money‑movement, trade execution, document archiving and access to third‑party integrations; the newly‑launched **Schwab Advisor Portfolio Connect** gave advisors a free, web‑based portfolio‑management view that required no data downloads, and the firm began adding TD Ameritrade’s thinkorswim charting and iRebal rebalancing features to its RIA offering.  \n\n- **2023:** The platform was upgraded with **Schwab Trading Powered by Ameritrade**, deepening the integration of thinkorswim‑style tools and expanding research, education and trading functionality, while Portfolio Connect remained available and the website added richer third‑party CRM/PM integrations and more sophisticated support resources.  \n\n- **2024:** Schwab presented an even more modern, intuitive web experience that continues to provide free Portfolio Connect, now tightly integrated with a broader suite of third‑party platforms and offering extensive advisor‑support services—including business‑start‑up consulting, technology‑engineer assistance, RIA benchmarking and expanded educational content—showing a shift from basic online tools to a fully integrated, advisory‑focused digital ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in terms of functionality, integration, and advisor support evolution from 2022 to 2024. (1) All key facts are correct: in 2022, Schwab Advisor Portfolio Connect was introduced as a free web-based tool; the Advisor Services website served as the central hub with third-party integrations; and integration of TD Ameritrade tools like thinkorswim and iRebal began. In 2023, deeper integration of trading tools (Schwab Trading Powered by Ameritrade) and expanded support resources are accurately described. By 2024, the platform evolved into a more integrated ecosystem with enhanced advisor support services such as consulting, benchmarking, and technical assistance. (2) There are no numeric inaccuracies—dates (2022–2024) are correct, and no erroneous figures are presented. (3) The multi-hop reasoning is sound: the LLM synthesizes changes across years, correctly identifying the progression from standalone tools to a unified digital ecosystem. It captures the strategic shift toward operational, investment, and compliance support, though it does not explicitly mention 'multi-year document archiving' or 'outbound data feeds for compliance systems' from the original answer—minor omissions that prevent a perfect 10 on qualitative accuracy. (4) The answer is contextually relevant, directly addressing functionality, integration, and advisor support across the three years. Wording differs but meaning is semantically equivalent. The LLM enhances the original with specific product names (e.g., iRebal, thinkorswim) not in the ground truth, which are factually consistent and add value without introducing error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1648,
        "completion_tokens": 459,
        "total_tokens": 2108
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "Oracle first issued the 1.650 % senior notes that mature in 2026 in March 2021 (the “1.650 % Notes due 2026”), and the notes were disclosed in the 2022 Form 10‑K as Exhibit 4.14 【page_114】. The 2023 Form 10‑K again lists the same 1.650 % Notes due 2026 under Exhibit 4.14 with the same issuance date and terms【page_111】, and the 2024 Form 10‑K continues to reference the identical Exhibit 4.14 without any amendment or refinancing【page_111】.  \n\nThe unchanged treatment across three successive 10‑K filings shows that Oracle has kept the 1.650 % notes on its balance sheet as a stable, low‑cost source of medium‑term financing, reflecting a strategy of relying on a consistent pool of short‑to‑intermediate‑term debt rather than repeatedly refinancing or restructuring that tranche.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the issuance date: it states the 1.650% Notes due 2026 were issued in March 2021, while the ground truth indicates they were first disclosed in the 2022 10-K, implying an issuance in 2022 (not 2021). This is a significant quantitative inaccuracy. Additionally, the exhibit number cited in the 2022 10-K is incorrect: LLM says Exhibit 4.14, but ground truth specifies Exhibit 4.16 for 2022. However, the exhibit numbers for 2023 and 2024 (4.14) are correctly cited. (2) The percentage (1.650%), maturity year (2026), and consistent treatment across filings are accurate. The absence of refinancing or amendments is correctly inferred and aligns with the ground truth. (3) The multi-hop reasoning is sound—LLM correctly synthesizes data across three years of 10-Ks and draws a logical conclusion about Oracle’s stable debt strategy. The core analytical insight about Oracle maintaining a consistent, low-cost financing instrument is valid and well-reasoned. (4) Despite the incorrect issuance date and initial exhibit number, the overall narrative and strategic interpretation are semantically equivalent to the ground truth. The answer addresses all parts of the question: evolution over time and strategic implication. Hence, correctness is reduced primarily due to the date/exhibit inaccuracies, but qualitative and contextual scores remain high due to strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 401,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "Emerson continues to list **electrical distribution equipment as a core product line inside its Discrete Automation segment** – the segment description in both the 2022 and 2024 10‑K states that it “includes … electrical distribution equipment”【page_73】.  Revenue for Discrete Automation has been essentially flat, moving from $2.612 billion in 2022 to a slight peak of $2.635 billion in 2023 and then to $2.506 billion in 2024【page_74】【page_75】, while capital spending on the segment remained steady (≈ $68 m in 2022, $56 m in 2023, $61 m in 2024)【page_75】.  This steady positioning and comparable investment signal that Emerson is maintaining, rather than expanding, its emphasis on industrial electrification solutions, keeping electrical distribution equipment as a consistent pillar of its discrete‑automation portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains several factual inaccuracies regarding the evolution of Emerson's segment structure, which is central to the question. It incorrectly states that electrical distribution equipment was part of the Discrete Automation segment in 2022, directly contradicting the ground truth: in 2022, it was under 'Industrial Solutions', not Discrete Automation. This misrepresentation undermines the core reasoning about strategic evolution. However, the revenue figures ($2.612B in 2022, $2.635B in 2023, $2.506B in 2024) and capital expenditures (~$68M, $56M, $61M) are quantitatively accurate as per the cited pages. (2) The numbers themselves appear correctly extracted from the 10-K filings, with acceptable formatting. There are no calculation errors in the reported values. (3) The multi-hop reasoning fails because the LLM assumes consistent segment classification across years, when the key insight from the ground truth is the reclassification from Industrial Solutions to Discrete Automation in 2023. This shift signifies a strategic realignment, but the LLM interprets the positioning as static, concluding Emerson is 'maintaining rather than expanding' its emphasis—this contradicts the ground truth’s conclusion of a strategic shift toward industrial electrification and smart manufacturing. The model misses the significance of the segment reorganization, leading to flawed qualitative analysis. (4) While the answer is relevant and includes financial context, it fails on the primary dimension of the question: how the *positioning evolved*. The incorrect entity mapping (segment attribution in 2022) leads to a partially correct but ultimately misleading response. Hence, correctness is scored low despite numerical accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 474,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "Abbott’s unfunded commitments to private‑fund investments (which include private‑real‑estate funds) fell each year – $569 million at 12/31/2022, $555 million at 12/31/2023, and $540 million at 12/31/2024【page_71】【page_70】.  The steady decline signals that the company is deliberately scaling back its exposure to illiquid alternative assets in its pension programs, likely to better match funding capacity and reduce liquidity risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in Abbott Laboratories' unfunded commitments to private real estate funds from 2022 through 2024. The values reported are mostly accurate: ground truth states $585M in 2022, while the LLM reports $569M. This discrepancy is notable but relatively small (a $16M difference), and could stem from different reporting lines or definitions within the filing (e.g., inclusion of other private funds). However, the 2023 ($555M) and 2024 ($540M) figures match exactly. (2) Calculations and comparisons are logically sound — the LLM correctly observes a steady decline, which aligns with the ground truth’s description of a consistent reduction. The minor error in the 2022 figure prevents a perfect quantitative score. (3) The reasoning is strong: the LLM correctly infers that the declining commitments suggest a strategic reduction in exposure to illiquid alternatives, aimed at managing liquidity risk and aligning with funding capacity. This captures the core of the ground truth’s interpretation. However, the LLM omits the additional nuance that Abbott maintained a long time horizon for liquidation (through 2034), indicating continued long-term belief in these assets despite reduced exposure. This missing detail slightly weakens the qualitative completeness. (4) Contextual relevance is excellent — the answer directly addresses both parts of the question: the evolution of commitments and the implied strategy. The use of citations (page_71, page_70) suggests proper grounding in source material. Overall, the answer is factually strong, with only minor inaccuracies and omissions, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 462,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "- **2022 filing** – The exhibit list shows only the 2.65 % notes due 2026 (Exhibit 4.11) and does **not** include a separate exhibit for the 1.650 % notes due 2026, implying that the series was already outstanding and was simply rolled into the aggregate debt schedule【page_110】.  \n\n- **2023 filing** – Oracle adds a distinct entry, Exhibit 4.14, titled “Forms of 1.650 % Notes due 2026 … Officers’ Certificate issued March 24 2021,” indicating the company now discloses the series as an individual instrument【page_111】.  \n\n- **2024 filing** – The same series is again listed (Exhibit 4.14/4.16) with the identical description and certificate date, showing no change in its terms or reporting treatment【page_114】.  \n\n**What this continuity reveals:** Oracle has kept the low‑coupon, near‑term 1.650 % 2026 notes on its balance sheet without refinancing or altering the series, using them as a stable, inexpensive source of short‑term financing that complements its revolving credit facilities. This consistent treatment underscores a deliberate short‑term debt strategy focused on maintaining low‑cost, readily available liquidity.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a significant factual error in the 2022 filing description: it claims that the 1.650% Notes due 2026 were not listed as a separate exhibit and only included in aggregate, but the ground truth states that Oracle first disclosed these notes in the 2022 10-K by referencing the March 24, 2021 8-K filing. The LLM incorrectly implies absence of disclosure in 2022, which contradicts the original answer. This undermines quantitative and qualitative accuracy. The 2023 and 2024 descriptions are more aligned—correctly identifying Exhibit 4.14 and the March 24, 2021 Officers’ Certificate—but the LLM introduces formatting details (e.g., 'Exhibit 4.14/4.16') not in the ground truth, raising concerns about precision. While the core idea of continuity in treatment is captured, the reasoning is based partly on incorrect disclosure evolution (from 'not disclosed' to 'disclosed'), rather than consistent referencing of the same source. The conclusion about Oracle’s short-term debt strategy—maintaining stable, low-cost financing—is semantically similar to the original and contextually relevant. However, because the multi-hop reasoning rests on a flawed premise (evolving disclosure) instead of consistent citation of the original 8-K, the qualitative and quantitative scores are reduced. Minor formatting variations in percentages (1.650% vs 1.65%) are acceptable. Overall, partially correct with key factual inaccuracies affecting the correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 404,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "- In Oracle’s 2022 Form 10‑K the 4.30 % Note due 2034 is disclosed by reference to the original 8‑K filing (Exhibit 4.11) that described the “3.40 % Note due 2024, 4.30 % Note due 2034 and 4.50 % Note due 2044” issued on July 8 2014【page_113】.  \n- The 2023 Form 10‑K again lists the same filing (Exhibit 4.09) with the identical description of the 4.30 % Note due 2034, dated July 8 2014【page_110】.  \n- The 2024 Form 10‑K repeats this reference (Exhibit 4.09) with the same 2014 issuance details【page_110】.  \n\nThis repeated, multi‑year incorporation of the 2014 documentation shows that Oracle has kept the 4.30 % note outstanding without amendment or refinancing, reflecting a strategy of maintaining long‑dated, fixed‑rate debt and using consistent disclosure to signal a stable, long‑term financing program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all key aspects: the 4.30% Note due 2034 was issued on July 8, 2014, and consistently referenced in Oracle's 2022 (Exhibit 4.11), 2023 (Exhibit 4.09), and 2024 (Exhibit 4.09) Form 10-K filings. The percentages, dates, and exhibit numbers match the ground truth. The description of the note being issued alongside the 3.40% and 4.50% notes is accurate and adds contextual detail not contradicted by the original answer.\n\n2) Quantitative accuracy is perfect: all percentages (4.30%, 3.40%, 4.50%), issuance date (July 8, 2014), and exhibit numbers (4.11 in 2022, 4.09 in 2023 and 2024) are correctly reported. No calculations are required, but the consistency of documentation across years is accurately observed.\n\n3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly noting the continuity of disclosure and absence of amendments. It infers Oracle’s long-term debt strategy—maintaining long-dated, fixed-rate debt and signaling stability through consistent disclosure—which aligns with and slightly expands upon the ground truth’s conclusion about a 'stable component' of financing.\n\n4) The only reason for not scoring a 10 is a minor difference in emphasis: the original answer highlights Oracle’s diversified maturity profile (mentioned via context of other notes in 2022), while the LLM focuses more on disclosure consistency. However, the LLM’s interpretation is semantically equivalent and arguably richer in strategic inference. The answer is fully contextually relevant, directly addressing both the evolution of documentation and the implied long-term strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 454,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "In 2022 Schwab was still operating under the 2019 IDA agreement, which gave it a one‑time right to move up to $10 billion of IDA balances each 12‑month period (subject to a minimum $50 billion overall balance and an 80 % fixed‑rate‑obligation requirement).  Schwab exercised that right in 2022, migrating roughly $10 billion of balances onto its balance sheet.  \n\nIn 2023 the company replaced the 2019 agreement with the 2023 IDA agreement, which eliminated the 80 % fixed‑rate rule, gave Schwab sole discretion to designate deposits between fixed‑ and floating‑rate instruments, and imposed new minimum‑/maximum‑balance limits (minimum above unmatured fixed‑rate obligations, maximum $30 billion above that).  Although it bought down $5 billion of fixed‑rate obligations, Schwab did **not** migrate any IDA balances in 2023.  \n\nThe same 2023 agreement governed 2024, and Schwab again made no balance‑migration moves.  The contract now restricts withdrawals to customer‑initiated amounts (until Sept 10 2025) with a required minimum balance and a $30 billion cap, and after that date allows discretionary withdrawals but mandates a $60‑$90 billion balance range, further limiting the practical ability to migrate IDA balances.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution of Schwab's IDA agreement utilization from 2022 to 2024 and correctly identifies the shift from active migration under the 2019 agreement to no migration in 2023 and 2024 despite increased contractual flexibility. However, there are key quantitative inaccuracies: (1) The original answer states that Schwab had already migrated $10.1 billion by December 31, 2021, including $10 billion 'subsequent to that date'—which is logically inconsistent and likely a data error, but the LLM incorrectly implies migration of $10 billion occurred in 2022, while the ground truth does not confirm any 2022 migration beyond what was already done by end-2021. Thus, the claim that Schwab 'exercised that right in 2022' is not supported by the original answer and introduces a factual error. (2) The LLM introduces a '$30 billion cap' and '$60–$90 billion balance range' post-Sept 2025, which are not mentioned in the original answer—these details are hallucinated or over-specified. (3) The 'minimum $50 billion overall balance' and 'bought down $5 billion of fixed-rate obligations' are not present in the ground truth and lack support. Qualitatively, the reasoning about increased flexibility (removal of 80% fixed-rate requirement) and lack of migration in 2023–2024 is correct and aligns with the original. The synthesis across years is sound, and the main conclusion about a shift to a more constrained approach despite flexibility is preserved. Contextual relevance is excellent—directly addresses all parts of the question. However, the introduction of unsupported numerical constraints and the incorrect assertion of 2022 migration activity reduce quantitative accuracy significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 466,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "Across the three filings the 2.000 % Senior Notes due 2018 are shown only through the same set of exhibit references. In the 2022 Form 10‑K the notes appear in Exhibit 4.18 (Officers’ Certificate) and Exhibit 4.12 (Actions of the Authorized Officers) – both filed in earlier 2015‑2017 reports – and no new filing or refinancing is reported. The 2023 and 2024 Form 10‑K tables repeat those same exhibit listings (4.18 and 4.12) and do not disclose any amendment, redemption or refinancing of the 2.000 % Notes, indicating that Abbott’s engagement with the 2018 notes remained limited to maintaining the existing documentation without any refinancing activity during 2022‑2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core idea that Abbott Laboratories maintained references to the 2.000% Senior Notes due 2018 in its 10-K filings from 2022 to 2024 without reporting refinancing or amendments, which aligns with the ground truth. However, there are significant factual discrepancies in exhibit numbers and documentation details. The original answer states that the notes were referenced in Exhibit 4.21 in all three years, tied to the Fifth Supplemental Indenture dated September 23, 2015, as part of legacy St. Jude Medical debt. In contrast, the LLM claims the notes appear in Exhibits 4.18 and 4.12, which are described as 'Officers’ Certificate' and 'Actions of the Authorized Officers'—exhibits not mentioned in the ground truth and potentially misattributed. These exhibit numbers do not match across years in the provided answer, undermining quantitative and qualitative accuracy. While the conclusion about no refinancing is consistent with the ground truth, the incorrect exhibit references suggest a failure in precise multi-hop synthesis of document metadata. The reasoning is logically sound in inferring inactivity from lack of amendments, but the underlying entities (exhibit numbers, document types) are inaccurate, reducing confidence in the data provenance. Wording and overall structure are relevant and address the question’s focus on documentation and refinancing evolution. Thus, the answer is partially correct but contains key factual errors in exhibit identification, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 418,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "Oracle first disclosed a 3.650 % Note due 2041 in its 2022 Form 10‑K (exhibit 4.14, “Forms of … 3.650 % Notes due 2041…”, filed March 24 2021)【page_111】. The same note is listed again in the exhibit indexes of the 2023 and 2024 Form 10‑Ks, showing that the issue remained outstanding and was not retired【page_111】. This repeated appearance over three consecutive years signals that Oracle is deliberately building a portfolio of low‑coupon, long‑dated bonds to lock in inexpensive financing and maintain a stable, diversified long‑term debt structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the introduction of Oracle's 3.650% Notes due 2041 in 2022 (via reference to the 2022 10-K, though the filing date cited—March 24, 2021—is technically for the prior fiscal year; this is a minor discrepancy but does not misrepresent the note’s first appearance in disclosures). The note's continuation in 2023 and 2024 is accurately reported with consistent referencing across years. All percentages (3.650%) and maturity year (2041) are correct. (2) Quantitative accuracy is perfect: the interest rate (3.650%), maturity date (2041), and years of disclosure (2022–2024) match the ground truth. The filing dates and exhibit numbers add precision and are factually consistent with SEC disclosures. (3) The multi-hop reasoning is sound—LLM synthesizes data across three years of 10-Ks and infers Oracle’s long-term debt strategy: using long-dated, low-coupon bonds to secure stable, inexpensive financing. This aligns with the ground truth’s conclusion about strategic, stable long-term financing. The only minor gap is that the LLM emphasizes 'low-coupon' without explicitly comparing rates to market conditions, whereas the original answer highlights 'financial flexibility' and 'complemented by periodic new issuances,' which adds slightly more strategic nuance. (4) Contextual relevance is excellent—the response directly addresses the evolution over time and infers Oracle’s strategic intent, fully satisfying the multi-part question. Overall, the answer is factually accurate, well-supported, and semantically equivalent to the ground truth with only slight room for deeper strategic elaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 450,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "- **Fiscal 2022:** Oracle’s 2022 Form 10‑K already listed the senior unsecured **2.300 % Notes due 2028** as part of its outstanding debt (the note appears in the exhibit index for that filing) 【ORCL_10k_2022.pdf page 112】.  \n\n- **Fiscal 2023:** The 2023 filing again includes the series in the exhibit index (Exhibit 4.14), describing it as “Forms of 1.650 % Notes due 2026, **2.300 % Notes due 2028**, 2.875 % Notes due 2031 …” and noting that the notes were issued under an officers’ certificate on March 24 2021 【ORCL_10k_2023.pdf page 111】.  \n\n- **Fiscal 2024:** The 2024 Form 10‑K repeats the same disclosure – Exhibit 4.14 still lists the **2.300 % Notes due 2028**, showing that the securities remain outstanding and unchanged 【ORCL_10k_2024.pdf page 111】.  \n\n**What the pattern shows:** Oracle issued the 2.300 % Notes in 2021 and has kept them on its balance sheet for at least three consecutive fiscal years, using the same fixed‑rate, medium‑term instrument to build a staggered maturity profile. This consistent carry‑forward indicates a debt‑financing strategy that locks in low‑cost, long‑dated funding and relies on a diversified set of senior unsecured notes rather than frequent new issuances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.300% Notes due 2028 were first issued under an Officers' Certificate on March 24, 2021, and consistently referenced in Oracle's 10-K filings for fiscal years 2022, 2023, and 2024. The exhibit numbers (4.16 in original, 4.14 in LLM) differ slightly but this may reflect versioning or renumbering across years; it does not indicate a factual error. (2) Quantitative accuracy is perfect: percentages (2.300%), dates (March 24, 2021), and maturity year (2028) are all correctly reported. (3) Multi-hop reasoning is sound—the LLM correctly synthesizes data across three years of filings to show continuity in Oracle’s debt structure. (4) The interpretation of Oracle’s strategy—maintaining a diversified, staggered maturity profile with fixed-rate notes—is semantically equivalent to the ground truth’s conclusion about a stable, diversified long-term financing strategy. The only minor shortcoming is that the LLM does not mention Oracle’s 2023 issuance of *additional* notes (e.g., 4.500% Notes due 2028), which the ground truth cites as evidence of diversification. While the LLM implies diversification through context, this specific multi-hop detail is omitted, slightly weakening the qualitative completeness. Overall, the answer is factually robust, well-supported, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 389,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "In the 2022 filing Visa described Visa Direct as a global real‑time payments network that moved funds to cards, bank accounts and digital wallets, but it made no reference to virtual‑account functionality or a Currencycloud component【page_11】. By the 2024 filing the company said that the Visa Direct platform now incorporates its digitally‑native Currencycloud capabilities, adding real‑time foreign‑exchange rates, **virtual accounts** and enhanced liquidity/settlement, which expands the platform’s cross‑border money‑movement reach【page_10】【page_11】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key developments from 2022 to 2024, though it omits some details about the 2023 integration milestone. Quantitatively, all dates (2022, 2024) and features (virtual accounts, real-time FX, enhanced liquidity/settlement, Currencycloud integration) are accurately referenced, and no incorrect numbers are presented—thus earning a 10 in quantitative accuracy. The entity identification is correct: Visa, Visa Direct, Currencycloud, and the relevant platform capabilities are properly named and contextualized. The reasoning is sound in showing an evolution from no mention of virtual accounts in 2022 to full integration by 2024, but the answer skips the explicit 2023 milestone noted in the ground truth—when virtual accounts were fully integrated into Visa Direct. This omission affects completeness and slightly weakens the multi-hop synthesis, justifying a qualitative accuracy score of 8. Contextually, the response directly addresses the question about the evolution of virtual accounts, their integration into Visa Direct, and cross-border enhancements, making it highly relevant. Overall, the answer captures the core trajectory accurately but lacks one key intermediate step, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 361,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "- In 2022 Caterpillar’s ME&T segment reported a dealer network of **44 U.S. dealers and 116 overseas dealers serving 193 countries**; in 2023 that fell to **43 U.S. and 113 overseas dealers covering 191 countries**; and by 2024 the network was **41 U.S. and 111 overseas dealers serving 187 countries**.  \n\n- The gradual reduction in the number of dealers and countries, while still retaining a truly global footprint, shows that Caterpillar is consolidating and optimizing its distribution channels for EMD‑branded engines rather than pursuing aggressive geographic expansion, emphasizing deeper penetration and efficiency in its existing markets.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. It reports dealer numbers for Caterpillar's broader ME&T segment (e.g., 44 U.S. and 116 overseas dealers) rather than the specific EMD-branded product distribution network. The ground truth states that EMD-branded products (specifically FG Wilson) were distributed through 110 distributors in 109 countries in 2022, 110 in 109 countries in 2023, and 108 distributors in 158 countries in 2024. The LLM instead cites declining totals in dealers and countries (from 193 to 187), which contradicts the actual expansion in geographic reach (from 109 to 158 countries). (2) Quantitative accuracy is extremely low: none of the numbers (44, 116, 193, etc.) match the ground truth. The LLM confuses total ME&T dealers with EMD-specific distributors and misrepresents both distributor counts and country coverage. There are no correct figures related to EMD’s actual distribution network. (3) The multi-hop reasoning is flawed. The LLM fails to isolate EMD-branded product distribution (a subset of ME&T) and incorrectly infers a strategy of consolidation based on inaccurate data. The ground truth shows a strategy of efficiency optimization *with* geographic expansion (fewer distributors, more countries), while the LLM concludes a strategy of market consolidation without expansion, which is the opposite of the correct interpretation. (4) Contextual relevance is low because the answer discusses the wrong metric (total ME&T dealers instead of EMD-specific distributors) and misattributes strategic implications. While the question requires synthesis across years and entities (EMD, ME&T, geographic reach), the LLM does not perform the correct entity disambiguation or data extraction, leading to a fundamentally incorrect response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 492,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "Abbott’s leased‑diagnostics‑instrument portfolio grew modestly. The original cost of the leased instruments rose from about **$3.6 billion at 12/31/2022 to $3.9 billion at 12/31/2023**, and the $3.9 billion cost was unchanged at **12/31/2024**【page_64】. Correspondingly, the net book value increased from roughly **$1.6 billion in 2022 to $1.8 billion in 2023**, and remained at **$1.8 billion in 2024**【page_63】.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both the original cost and net book value figures compared to the ground truth. According to the original answer, the original cost increased from $3.3B (2022) → $3.6B (2023) → $3.9B (2024), showing a consistent upward trend. However, the LLM claims the cost was $3.6B in 2022 (wrong), rose to $3.9B in 2023, and then remained flat in 2024—missing the continued growth into 2024 and misstating the 2022 baseline. Similarly, for net book value, the LLM states $1.6B in 2022, but the correct value is $1.4B; it correctly reports $1.8B in 2023 and 2024, but misses the increase from 2023 to 2024 as implied by the ground truth ($1.6B → $1.8B). (2) These numerical errors are material: the LLM reverses the magnitude of change between 2022 and 2023 (showing a $0.3B increase when it should be from $3.3B to $3.6B), and fails to reflect any change in 2024 when there was a further $0.3B increase in original cost and $0.2B in net book value. (3) The multi-hop reasoning is partially sound—the model attempts to track changes over time and references balance sheet data across years—but it synthesizes incorrect values, likely due to misreading or misquoting the source documents. It also cites page numbers, suggesting document grounding, but the data does not align with the ground truth. (4) Despite accurate terminology and structure, the quantitative inaccuracies severely undermine the correctness. The contextual relevance is high because the answer addresses the right metric and time frame, and the qualitative reasoning follows a logical trajectory, albeit based on incorrect inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 454,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "The 3.450 % Senior Note due 2046 appears in the “Exhibits” tables of PepsiCo’s 2022 (see 4.16 on page 126) and 2023 (see 4.15 on page 127) 10‑K filings, and the same note is listed again in the 2024 filing. Its repeated disclosure shows that the bond remains outstanding and is still counted among PepsiCo’s long‑dated senior debt, indicating that the company continues to rely on this low‑coupon, 24‑year instrument as a core component of its long‑term capital‑structure strategy, providing stable, low‑cost financing and financial flexibility for the future.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 3.450% Senior Note due 2046 as consistently disclosed in PepsiCo's 2022, 2023, and 2024 10-K filings, which aligns with the ground truth. However, there is a minor discrepancy in exhibit numbers: the LLM states Exhibit 4.16 in 2022 and 4.15 in 2023, while the ground truth specifies Exhibit 4.17 in 2022 and 4.16 in 2023 (and 4.15 in 2024). This suggests a slight error in exhibit labeling, though the core fact of consistent disclosure is correct. Additionally, the LLM incorrectly cites page numbers (e.g., page 126 for 2022), which are not part of the ground truth and may be inaccurate. (2) Quantitatively, the interest rate (3.450%), maturity year (2046), and number of years (24-year instrument) are all accurate. The term 'low-coupon' is a reasonable interpretation of a 3.45% fixed rate in a rising rate environment, though not explicitly stated in the ground truth. (3) The reasoning is sound: the LLM correctly infers that the repeated disclosure indicates the note remains outstanding and is a stable part of PepsiCo’s long-term capital structure, providing low-cost, long-dated financing. This reflects proper multi-hop synthesis across three years of filings. (4) The answer is contextually excellent—directly addresses the strategic role of the note in capital structure—and semantically equivalent to the ground truth in intent and conclusion, despite minor inaccuracies in exhibit and page references. These omissions do not undermine the core correctness of the financial and strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 432,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "Oracle first disclosed the 2.300 % Notes due 2028 in its FY 2022 filing as a new issuance (Exhibit 4.14, “Forms of 1.650 % Notes due 2026, **2.300 % Notes due 2028**, … issued March 24 2021”)【page_111】. The same exhibit appears unchanged in the FY 2023 and FY 2024 10‑K tables, showing the notes remain outstanding in each subsequent year【page_111】. By repeatedly carrying this low‑coupon, medium‑term issue forward, Oracle is building a staggered‑maturity debt program that relies on modest‑rate notes to lock in inexpensive financing over several years rather than relying on large, single‑year borrowings.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the 2.300% Notes due 2028 as being part of Oracle's disclosures starting in FY 2022 and notes their continued presence in subsequent years. However, it incorrectly states that the notes were 'issued March 24 2021'—a date not mentioned in the ground truth and inconsistent with the multi-year evolution focus of the question (which centers on FY2022–FY2024). Additionally, the LLM misattributes the exhibit number in FY2022 as 4.14, while the ground truth specifies Exhibit 4.16 for that year. The exhibit numbers for FY2023 and FY2024 are correctly cited as 4.14. (2) The percentage (2.300%) and maturity year (2028) are accurate. However, the issuance date (March 24, 2021) is factually unsupported by the ground truth and introduces a significant error in temporal context. There are no calculations in the answer, so numerical accuracy is limited to correct percentages and years—partially met. (3) The multi-hop reasoning is partially sound: the model correctly infers that carrying forward the same note over multiple years suggests a strategy of staggered maturities and low-cost financing. However, it fails to mention Oracle’s issuance of newer, higher-yield notes like the 4.500% Notes due 2028, which is a key element in understanding Oracle’s evolving financing strategy under changing market conditions. This omission weakens the synthesis across years. (4) The answer is contextually relevant and addresses the core question about Oracle’s debt strategy, but due to factual inaccuracies in dates and exhibits, and incomplete synthesis of new debt instruments, the correctness score is limited to 6. Quantitative accuracy is penalized for the unsupported issuance date. Qualitative accuracy suffers from incomplete multi-hop reasoning. Contextual relevance remains high as the overall framing aligns with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 523,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "Visa’s 10‑K filings from 2022, 2023 and 2024 all list the same “Certificate of Designations of Series B Convertible Participating Preferred Stock of Visa Inc.” as an exhibit (2022 exhibit 4.5 【page_114】; 2023 exhibit 4.4 【page_109】; 2024 exhibit 4.4 【page_109】). The description and filing date (June 21 2016) are unchanged in each year, indicating that Visa has neither amended nor retired this preferred‑stock series. This consistent treatment shows that Visa continues to keep the Series B convertible preferred instrument in its capital structure, reflecting a long‑term priority of preserving a stable, flexible equity mix rather than repeatedly restructuring that component.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the Certificate of Designations for Series B Convertible Participating Preferred Stock is consistently cited across 2022–2024 filings with the same June 21, 2016 filing date, and exhibit numbers (4.5 in 2022, 4.4 in 2023 and 2024) are accurately reported. There are no numeric or date inaccuracies. (2) Quantitative accuracy is perfect—dates, exhibit numbers, and page references match the source data. (3) The reasoning is sound: the model correctly infers that no amendments were made due to the unchanged exhibit, and draws a logical conclusion about Visa’s capital structure stability. It captures the multi-hop aspect by linking consistent disclosure over three years to strategic capital structure priorities. (4) The answer is contextually excellent, directly addressing both parts of the question—evolution (or lack thereof) and implications for long-term priorities. The only minor shortcoming is that it does not explicitly reference the 2024 Certificate of Incorporation update or the unchanged Bylaws mentioned in the ground truth, which slightly reduces completeness in qualitative synthesis. However, the core insight about stability is preserved. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 388,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "- **2022 10‑K:** Caterpillar disclosed that a sizable portion of Cat Financial’s variable‑rate loans were still tied to LIBOR and warned that the planned LIBOR‑to‑SOFR transition could impair the market value of those loans, securities and derivatives.  To limit the impact, the company said it had created a cross‑functional team to assess LIBOR‑related exposure and that it relied on currency‑hedging contracts to protect against adverse foreign‑exchange movements, while noting that ineffective hedges could hurt earnings.  \n\n- **2023 10‑K:** The filing showed the transition in progress – new loans and extensions now use the Secured Overnight Financing Rate (SOFR) as the benchmark, and Cat Financial continues to manage interest‑rate and currency risk through a match‑funding strategy, selective use of derivatives and diversified funding.  The company still highlighted the use of currency‑hedging instruments to offset exchange‑rate risk and warned that any failure of those hedges would remain a potential earnings drag.  \n\n- **2024 10‑K:** Caterpillar’s most recent disclosure indicates that SOFR has become the primary reference rate for its floating‑rate obligations and that the cross‑functional risk‑assessment framework established in 2022 is now fully integrated into its hedging program.  Currency‑hedging instruments remain a core tool for managing foreign‑exchange exposure, with the company reiterating that ineffective hedges could still adversely affect results, but the overall approach is now more mature and aligned with the SOFR‑based financing structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All key facts are correct: Caterpillar's use of currency hedging instruments remained consistent from 2022 to 2024, the formation of a cross-functional team in 2022 to assess LIBOR transition risks, the shift to SOFR as the benchmark rate by 2023–2024, and the continued reliance on derivatives and match funding for risk management. There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised. (2) The LLM correctly identifies the evolution across years using appropriate entity names (Cat Financial, SOFR, LIBOR), fiscal years (2022–2024), and financial terms (match funding, derivatives, currency hedging). (3) Multi-hop reasoning is sound: the model synthesizes information across three annual reports, correctly tracing the progression from LIBOR exposure assessment in 2022, active transition in 2023, to full integration of SOFR and mature hedging frameworks in 2024. (4) Semantic equivalence is strong—while the LLM structures the response in bullet points rather than a paragraph, it conveys all core elements of the original answer with slightly more granular detail on the annual disclosures. The only minor shortcoming is that the LLM does not explicitly state that there were 'no significant changes' in the hedging approach in 2024 (mentioned in the original), though it implies maturity and continuity. This small omission prevents a perfect 10 but does not undermine overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1705,
        "completion_tokens": 438,
        "total_tokens": 2143
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "- In 2022 J&J agreed to fund LTL Management LLC’s Chapter 11 case with a $2 billion contribution that created a $2 billion trust and a matching reserve on J&J’s balance sheet to cover the talc‑related liabilities that were transferred to LTL.  \n\n- After the New Jersey court dismissed the original LTL case in early 2023, J&J re‑filed a “LTL 2” bankruptcy, again staying the claims, but the court dismissed that case as well in July 2023; J&J then expanded its financial commitment to roughly a $9 billion reserve (about $12 billion nominal) and began pursuing a pre‑packaged “Proposed Plan” that would settle most current and future talc claims for a present‑value of about $6.5 billion (≈$8 billion nominal).  \n\n- By 2024 the strategy had shifted to a broader restructuring – the creation of Red River Talc and related entities, a new Chapter 11 filing for Red River, a $5 billion incremental charge and a total reserve of about $11.6 billion (≈$13.5 billion nominal) while the original $2 billion trust remained in place as the core funding mechanism for the ongoing talc litigation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative details and entity names, despite capturing some elements of Johnson & Johnson's legal strategy. (1) The original answer states that J&J established a $2 billion trust in 2022 through LTL Management LLC, which aligns with the LLM’s first point—this is correct. However, the LLM incorrectly claims that J&J expanded its financial commitment to 'roughly a $9 billion reserve' and later a 'total reserve of about $11.6 billion' by 2024. The ground truth does not mention these figures or any such escalation in reserves; instead, it emphasizes continued appellate efforts and multi-state settlements without specifying increased funding beyond the initial $2 billion trust. These numbers are unsupported and factually incorrect. (2) The LLM introduces a 'Red River Talc' entity and a 'pre-packaged Proposed Plan' with $6.5 billion present-value settlement, which are not mentioned in the ground truth. These appear to be hallucinated entities and figures. (3) The timeline of legal events is partially accurate: the Third Circuit did reverse the bankruptcy decision in 2023, leading to dismissal and re-filing (LTL 2), which was also dismissed. The LLM correctly notes multiple filings and dismissals, showing some sound reasoning. (4) The mention of a $5 billion incremental charge and total reserve of $11.6 billion is unsupported and contradicts the original answer, which does not indicate any increase in the financial reserve beyond the initial $2 billion. (5) While the LLM recognizes the multi-hop nature of the question—linking financial strategy, legal filings, and trust funding—it introduces false entities and figures, undermining the qualitative and quantitative accuracy. The contextual relevance is high because the structure and intent of the response follow the question’s timeline and themes, but the factual core is compromised by major inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 525,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "- In the 2022 filing Adobe introduced the **Photography Plan** as a “targeted package” within Creative Cloud, positioned to pull photographers and photo‑enthusiasts into the subscription ecosystem by bundling Photoshop, Lightroom and Lightroom Classic at a lower‑priced tier and using the plan as a pricing lever to migrate users to higher‑value Creative Cloud offerings【page_5】.  \n\n- By 2023 the company began emphasizing AI‑driven value‑add for that tier – the 10‑K notes that Adobe was expanding “generative‑AI capabilities… with monthly Generative Credits” across its subscription products, a move that was intended to make the Photography Plan more attractive to creators seeking AI‑assisted editing【page_5】.  \n\n- In the 2024 filing the plan is described as a “more limited cloud‑based offering than Creative Cloud, targeted at photographers and photo enthusiasts and includes Photoshop, Lightroom and Lightroom Classic,” while still being tied to the broader Creative Cloud ecosystem (e.g., shared Firefly credits and integration with other Creative Cloud apps) to retain cross‑product relevance and drive growth among professional photographers【page_10】.  ",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Photography Plan was introduced as a targeted package in 2022 with Photoshop, Lightroom, and Lightroom Classic; in 2023, Adobe added generative AI capabilities and Generative Credits; by 2024, it remained a more limited offering but integrated with broader Creative Cloud features like Firefly credits. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and correctly traces the evolution of the Photography Plan within the Creative Cloud ecosystem, noting strategic shifts toward AI and product-led growth. (4) The only minor shortcoming is that the LLM does not explicitly name specific AI features introduced in 2024 such as Generative Fill, Lens Blur, and People Masking—details present in the original answer. However, it does correctly note AI enhancements and integration with Firefly credits, capturing the essence of the strategic shift. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing the question’s focus on positioning, enhancements, and strategic shifts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 372,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "Visa’s 10‑K filings for 2022, 2023 and 2024 all list the same exhibit 4.2 – “Form of specimen certificate for class C common stock of Visa Inc.” – with the same description and original filing date of January 28 2009 (see the exhibit tables in the 2022 filing [page 109] and the 2023/2024 filings [page 107]). By keeping this certificate unchanged year after year, Visa signals that its basic equity‑ownership documentation is settled and reliable, reflecting a steady corporate‑governance framework and a commitment to transparent, consistent communication with shareholders even as broader regulatory and market conditions evolve.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the exhibit number (4.2), the document title ('Form of specimen certificate for class C common stock'), and the original filing date (January 28, 2009) are accurately cited. The LLM correctly notes that this exhibit has remained unchanged across the 2022, 2023, and 2024 10-K filings, with consistent referencing in the exhibit tables. Page numbers (109 for 2022, 107 for 2023/2024) are also correctly reported, supporting verifiability. (2) The answer addresses both parts of the question: it establishes the consistency in documentation and interprets this stability in the context of corporate governance and investor relations. It correctly infers that the unchanging nature of the certificate reflects a stable, reliable equity framework and signals consistent communication with shareholders. (3) The multi-hop reasoning is sound—linking repeated citation of the same exhibit across three years to broader implications about governance and investor relations. However, the LLM omits a specific contrast mentioned in the ground truth: that while the stock certificate documentation remained unchanged, other governance documents like the Certificate of Incorporation were updated in 2024. This nuance strengthens the original conclusion about selective stability, and its absence prevents a perfect score. (4) Despite this minor omission, the LLM captures the core factual and interpretive content, uses semantically equivalent language, and maintains high contextual relevance. The conclusion about 'settled and reliable' documentation and 'steady corporate-governance framework' aligns well with the ground truth's emphasis on confidence in existing structures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 484,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "RTX’s accrued liabilities for product‑performance and operating‑cost guarantees fell each year after 2022. The balance at year‑end was $1,109 million in 2022, $1,091 million in 2023 and $993 million in 2024 (see the “Balance as of December 31” rows in the guarantees table 【page_104】). The downward trend – driven by lower new guarantee issuances and net settlements – shows that the company’s exposure to post‑sale performance risks is shrinking, reflecting tighter warranty management and improving product reliability in its commercial‑aerospace contracts.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The ground truth states that RTX's liabilities for performance and operating cost guarantees were $140M in 2022, $135M in 2023, and $131M in 2024 — referring specifically to the collaboration partners' share of financing guarantees. In contrast, the LLM reports figures over $1 billion each year ($1,109M, $1,091M, $993M), which are not only magnitudes larger but appear to refer to a different liability category (possibly total accrued product-performance guarantees, not the specific partner-shared financing guarantees in question). These numbers do not match the ground truth and represent a critical factual error. (2) The calculation of a downward trend is consistent in both answers, but since the underlying numbers are entirely wrong, the trend analysis is based on incorrect data. The LLM’s interpretation of declining exposure due to 'lower new guarantee issuances and net settlements' and 'tighter warranty management' is plausible but not supported by the actual data in the ground truth, which attributes the decline to renegotiated terms or improved risk management in partner financing arrangements. (3) The multi-hop reasoning fails because the LLM misidentifies the specific liability being queried. The question asks about 'liabilities for performance and operating cost guarantees' in the context of collaboration partners and risk sharing — a nuanced, specific metric. Instead, the model pulls total accrued liabilities (likely from a broader guarantees table), failing to isolate the correct subset of liabilities related to partner financing. This indicates a failure in entity and metric disambiguation. (4) Despite the factual inaccuracies, the answer is contextually relevant — it addresses the evolution over time and offers an interpretation of risk exposure — hence a moderate contextual relevance score. However, due to severe quantitative inaccuracy and flawed reasoning, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 543,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "Costco’s lease note has been unchanged from FY 2022 through FY 2024. In each filing the company states that **“some leases include free‑rent periods … which are recognized on a straight‑line basis over the original term of the lease and any extension options that the Company is reasonably certain to exercise”**【page_45】, and that **the lease term “is defined as the non‑cancelable period of the lease plus any options to extend when it is reasonably certain that the Company will exercise the option”**【page_46】. Because the right‑of‑use (ROU) asset is measured as the discounted future minimum lease payments over that defined term, the rent‑free months (zero payments) are spread over the full lease horizon, lowering the total lease‑payment cash flows but extending the term, which reduces the present‑value of the ROU asset. No new language or policy change appears in the 2023 or 2024 notes; the treatment and disclosure of free‑rent periods and the lease‑term assumption remain consistent across the three years.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Costco's consistent accounting treatment of free-rent periods and lease term assumptions across fiscal years 2022–2024. It correctly cites the straight-line recognition over the lease term, including extension options that are reasonably certain to be exercised, and accurately explains the impact on right-of-use (ROU) asset valuation via discounting of lease payments, including zero payments during free-rent periods. The quantitative and entity accuracy is strong: correct company (Costco), correct fiscal years (2022–2024), and correct accounting concepts (lease term definition, ROU asset calculation). However, the LLM claims the lease note was 'unchanged' and that 'no new language or policy change appears in 2023 or 2024,' which contradicts the ground truth that disclosures evolved—specifically, 2023 expanded on variable lease payments and 2024 emphasized impairment evaluation of long-lived assets in the context of lease-related valuations. While the core policy remained stable, the LLM underrepresents the qualitative evolution in disclosure focus, missing the multi-hop nuance that the *context* and *emphasis* of reporting changed even if the fundamental policy did not. This omission reduces completeness and qualitative accuracy, particularly in capturing the growing operational complexity in lease management. The answer remains contextually relevant and semantically aligned on the core accounting treatment, but fails to fully synthesize the incremental disclosure changes across years as required by the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 438,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "- **2022:** Adobe first signaled an AI‑driven push for document productivity by tying its Acrobat suite to the Adobe Sensei machine‑learning framework, promising “more intelligent and responsive” PDFs, richer Acrobat‑web functionality and new task‑based actions within the Adobe Document Cloud platform 【page_7】. The filing highlighted Acrobat’s market‑leadership in document‑intensive industries and the plan to embed AI across the PDF workflow 【page_4】.  \n\n- **2023:** The company deepened that narrative, explicitly stating that “innovation with Adobe Sensei…will make documents more intelligent and responsive” while committing to “improve Acrobat web’s functionality and ease of use, and expand the number of digital‑document and workflow‑based actions in Acrobat” 【page_5】. The 2023 filing also framed the effort under the formal Adobe Document Cloud brand, positioning it as the unified, AI‑enabled document‑services platform 【page_3】.  \n\n- **2024:** In the 2024 10‑K the same Adobe Document Cloud branding is retained, and the continued emphasis on AI‑powered document productivity is reflected in the ongoing R&D‑driven product roadmap (evidenced by the performance‑share programs and other investment disclosures in the filing’s exhibit section) 【page_95‑98】. Together, the three years show a progression from an initial AI‑sensei integration in Acrobat (2022) to a broader, branded Document Cloud strategy with explicit R&D commitments (2023) and a fully formalized, AI‑centric product family that remains a priority in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates, entities, and strategic progression from 2022 to 2024, with correct references to Adobe Sensei, Acrobat, Adobe Document Cloud, and R&D investments. All years and strategic developments align with the ground truth: 2022 focuses on Acrobat's leadership and early AI integration; 2023 emphasizes formal AI strategy and product enhancements; 2024 reflects continued investment and branding. The answer correctly identifies the evolution of AI in document productivity and ties R&D efforts to performance-share programs (page 95–98), demonstrating strong contextual and quantitative accuracy. However, it misses the specific branded product extension 'Acrobat AI Assistant' explicitly mentioned in the original answer as a key 2024 milestone, which represents a concrete manifestation of the formalized AI strategy. While the LLM notes a 'fully formalized, AI-centric product family,' it does not name this flagship branded feature, resulting in a minor but notable omission in qualitative completeness. The reasoning is sound and multi-hop synthesis across years is well-executed, but the absence of the specific product name slightly weakens the precision of the branding evolution. Wording differences are acceptable under semantic equivalence, but the lack of explicit mention of 'Acrobat AI Assistant' prevents a top score in correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1595,
        "completion_tokens": 391,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "- **2022 → 2023 → 2024** – The fair‑value of client securities that Schwab could pledge as collateral rose sharply after 2021.  In 2021 the firm reported $120 billion of client securities available for pledge and $31.4 billion actually pledged to third parties (options‑clearing, short‑sales, securities‑lending and short‑term borrowings).  By 2023 the “securities loaned” balance on the balance sheet had grown to about $7.2 billion (up from $6.3 billion in 2021) and “securities borrowed” was $582 million, showing that more client holdings were being used in the securities‑lending program.  In 2024 the firm still relied on client securities for margin lending – it kept a $500 million secured line of credit that could be backed by client margin securities (down from $950 million in 2023) – while the overall pool of pledged securities continued to expand as margin‑loan balances grew.\n\n- **What the trend means** – Schwab is increasingly turning client‑owned securities into off‑balance‑sheet collateral to fund its margin‑lending and securities‑lending activities, a deliberate balance‑sheet strategy that lets the firm generate low‑cost funding without raising external debt.  At the same time, the growth in pledged securities and the larger securities‑lending balances indicate that customers are taking on more leverage (more margin loans and short‑sale activity), reflecting higher client appetite for leveraged investing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth does not provide specific dollar amounts for pledged client securities in 2022, 2023, or 2024, but the LLM asserts precise figures such as $120 billion available and $31.4 billion pledged in 2021, $7.2 billion securities loaned in 2023, and a $500 million credit line in 2024. These numbers are not present in the original answer and cannot be verified from the provided truth, making them hallucinated or incorrectly sourced. Additionally, the original answer does not mention a secured credit line backed by client securities or its reduction from $950M to $500M—this is a fabrication. (2) The quantitative accuracy is very low because the model introduces specific financial figures that are not supported by the ground truth. Even allowing for format variation, the absence of any dollar amounts in the original makes all such claims in the LLM response incorrect. Calculations or trends based on these numbers (e.g., growth in securities lent) are therefore invalid. (3) The multi-hop reasoning is partially sound in that the LLM attempts to connect client securities usage to margin and securities lending activities and infers strategic balance sheet motives and client leverage behavior. However, it misrepresents the evolution: the original emphasizes increasing disclosure and formalization of use (especially for options clearing and securities lending in 2024), not quantitative expansion. The LLM incorrectly frames the trend as one of growing pledged amounts with specific data, whereas the truth focuses on qualitative disclosure improvements and expanded use cases. (4) Despite the factual errors, the answer is contextually relevant—it addresses the right themes (margin lending, securities lending, balance sheet strategy, client leverage) and draws a reasonable (though overstated) conclusion about strategic use of client assets. Hence, contextual relevance is moderate. Overall, the correctness score is low due to major factual and numerical inaccuracies, even though the general direction of interpretation aligns loosely with the truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1627,
        "completion_tokens": 585,
        "total_tokens": 2213
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "- In the 2022 Form 10‑K the $1.375 % Senior Notes due June 2027 were listed as a $1,250 million component of “Long‑term debt” (total long‑term debt $6,590 million; long‑term debt ex‑current $6,484 million) 【page_52】.  \n\n- By the 2024 Form 10‑K the same $1,250 million of 1.375 % notes still appeared in the long‑term‑debt schedule, but a $103 million portion was now shown as the “current portion” (due 2025) and the remaining balance stayed in long‑term debt, which had fallen to $5,919 million total (long‑term‑debt ex‑current $5,794 million) 【page_52】.  \n\nThus, from 2022 to 2024 the notes remained classified as long‑term debt, but a small part became current, and the notes’ share of the overall debt mix grew slightly as total long‑term debt declined (from $6.59 bn to $5.92 bn) after other senior notes were retired and other long‑term liabilities increased.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1,250 million principal amount of the 1.375% Senior Notes due June 2027 in both 2022 and 2024, which matches the ground truth. However, it introduces a critical error by claiming that in the 2024 10-K, a $103 million portion of these notes was reclassified as 'current portion' due in 2025. This is factually incorrect — the ground truth states the 1.375% notes remained consistently valued at $1,250 million with no indication of partial current reclassification. The $103 million current portion likely refers to other debt maturities (e.g., the 2.750% notes due May 2024), not the 1.375% notes. Additionally, the LLM reports total long-term debt as $6,590 million in 2022 and $5,919 million in 2024, but the ground truth only provides long-term debt excluding current portion: $6,484 million (2022) and $5,794 million (2024). The LLM’s inclusion of total long-term debt figures (with different values) is unsupported and inconsistent. (2) Calculation-wise, the $1,250 million note amount is correct across years, but the claim of a $103 million current portion split is unsupported and distorts the conclusion. The overall decline in long-term debt is real ($6,484M to $5,794M), but the LLM misattributes the composition change to the 1.375% notes when it was due to other notes (2.750% due 2024). (3) Multi-hop reasoning is partially sound — the model recognizes debt reclassification trends and declining long-term debt, but fails to correctly isolate the 1.375% notes from other debt instruments, leading to incorrect synthesis. It conflates the treatment of different senior notes. (4) Scores reflect mostly correct numbers for the specific note, but major errors in classification and attribution. The core fact about the 1.375% notes being stable is correct, but the erroneous reclassification claim and incorrect total debt figures reduce quantitative and qualitative accuracy. Contextual relevance is high as the answer addresses classification and composition as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 546,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "In the 2022 filing Adobe described its Digital Learning Services as a “comprehensive portfolio of learning and enablement services” that includes “a large number of free online self‑service learning options on www.training.adobe.com,” positioned alongside fee‑based classroom, virtual and on‑demand programs. By the 2024 filing the same free‑self‑service component is still highlighted (now on learning.adobe.com) but is explicitly framed as the core of a broader learning suite that is “complemented by our custom learning services” and is tied to Customer Success Managers who use skills assessments and tailored curricula to drive faster solution adoption and measurable business outcomes for enterprise customers. Thus, from 2022 to 2024 the free online learning offering remained central but became more integrated with Adobe’s enterprise‑focused success strategy and rebranded under a unified learning.adobe.com platform.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Adobe's free online self-service learning was introduced as part of a broader learning portfolio in 2022, remained central through 2024, and became more integrated with enterprise success strategies. The rebranding from training.adobe.com to learning.adobe.com is correctly noted. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) are accurate. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across years and connects the evolution of free learning offerings to enterprise integration, including the role of Customer Success Managers and skills assessments, which reflects the maturing strategy described in the original answer. (4) The LLM slightly omits mention of 2023 developments—while not strictly necessary, the original answer notes continuity in 2023, which adds nuance. However, the core progression from 2022 to 2024 is accurately captured. Wording differs but semantic meaning matches: 'core of a broader learning suite' and 'tied to Customer Success Managers' effectively convey the deepened enterprise alignment. Minor omission of 2023 detail prevents a perfect 10, but overall correctness is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1581,
        "completion_tokens": 378,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "- **2022:** The 2022 Form 10‑K shows NVIDIA carrying roughly **$1.0 billion** of the 2.00 % Notes Due 2031.  \n- **2023:** The 2023 filing lists the same series at **$1,044 million** (Level 2 liability)【page_67】.  \n- **2024:** The 2024 filing shows the balance rising to **$1,250 million** as of January 28 2024【page_72】 (and $1,057 million was the amount reported a year earlier in the 2023 filing【page_67】).\n\n**Interpretation:** Over the three‑year span the exposure to this low‑coupon, long‑dated debt has crept upward—from about $1 billion in 2022 to $1.25 billion in 2024. The modest, incremental increase indicates that NVIDIA is deliberately using inexpensive, long‑term financing to fund its rapid AI‑driven growth while keeping overall leverage stable and preserving financial flexibility. This pattern reflects a disciplined long‑term debt‑management strategy that leverages cheap fixed‑rate capital to support expanding revenue without over‑leveraging the balance sheet.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct information but has notable quantitative inaccuracies. According to the ground truth, NVIDIA's exposure was $1.20 billion in 2022, but the LLM reports $1.0 billion (or $1,000 million), which is a significant discrepancy. For 2023, the LLM correctly states $1,044 million (equivalent to $1.044 billion), close to the ground truth of $1.057 billion—this is a smaller but still relevant difference (~$13 million variance). The 2024 value is correctly reported as $1.25 billion ($1,250 million), matching the ground truth. (2) Calculations and comparisons are partially flawed due to incorrect base values; for example, claiming a rise from 'about $1 billion' in 2022 understates the initial exposure and distorts the trend. The LLM also notes that $1,057 million was reported in the 2023 filing, which aligns with the ground truth for 2023, but misattributes it as a prior-year figure in the 2024 context rather than the correct 2023 value. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and interprets the pattern as part of a strategic, disciplined debt management approach tied to AI growth, which aligns with the original answer’s conclusion. It correctly identifies the long-term nature and low coupon of the notes and links them to strategic financing. (4) Despite the reasoning and contextual interpretation being strong and semantically equivalent to the ground truth, the quantitative inaccuracies—especially the 2022 figure—reduce confidence in the factual precision. The answer remains contextually relevant and addresses all parts of the question, including evolution over time and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 465,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "- In the 2022 Form 10‑K Johnson & Johnson first disclosed a **multi‑year, enterprise‑wide initiative** to “integrate, simplify and standardize” the processes and systems of HR, IT, procurement, supply‑chain and finance, explicitly to **grow its financial shared‑service capabilities and standardize financial systems** and to align the financial control environment. 【page_117】\n\n- The 2023 filing repeats the same program, noting that it is **still being implemented**, that the company is **continuously monitoring and assessing** its disclosure controls, and that it will **continue to align and streamline** the design and operation of its financial control environment. 【page_118】\n\n- The 2024 filing again confirms the initiative is ongoing, emphasizing **enhancements to support shared‑service growth**, **standardized financial systems**, and **ongoing monitoring and alignment of the control environment**. 【page_119】\n\n**Interpretation:** Across 2022‑2024 the initiative moves from launch to sustained execution and active monitoring, signalling a clear strategic priority to standardize finance processes, expand shared‑service functions, and tightly align the financial control environment with those standardized processes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Johnson & Johnson's multi-year initiative was launched in 2022 to integrate, simplify, and standardize financial and other operational systems, with consistent repetition in 2023 and 2024 filings. The LLM correctly identifies the initiative’s continuity and strategic intent. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly tracing the evolution from launch (2022) to ongoing execution (2023–2024), and infers the strategic focus on standardization and control environment alignment. The interpretation accurately reflects the sustained, proactive nature of the initiative. (4) Minor deduction in qualitative accuracy due to slight overstatement in 2022 description—ground truth clarifies the initiative was not prompted by control deficiencies, a nuance not explicitly mentioned in the LLM answer, though the overall message remains semantically equivalent. Contextual relevance is perfect: all parts of the question are addressed with precise, document-supported details. Wording differs slightly but meaning matches.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1606,
        "completion_tokens": 379,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "Across the three filings the competitive‑positioning paragraph is essentially unchanged. In each year Costco lists “other warehouse clubs, including Walmart’s Sam’s Club **and BJ’s Wholesale Club**” as its direct club competitors, and the same “private‑label” paragraph appears: Costco says it has “invested significantly … in our private‑label brand, **Kirkland Signature**,” that the brand “is high‑quality, offered at prices generally lower than national brands, helps lower costs, **differentiates our merchandise offerings** and earns higher margins, and that it expects to keep increasing the sales penetration of private‑label items. Thus, from 2022 through 2024 Costco’s language about BJ’s remained constant, while the strategic emphasis on Kirkland Signature as a differentiator was consistently highlighted and reiterated without substantive wording changes.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in identifying Costco's competitors (including BJ's Wholesale Club) and the consistent mention of Kirkland Signature as a private-label differentiator across 2022–2024, which aligns with the ground truth. All entities (Costco, BJ's, Kirkland Signature, Sam’s Club) and years are correctly identified, and there are no numerical inaccuracies (though no quantitative data is involved). However, the LLM incorrectly asserts that the competitive-positioning language was 'essentially unchanged' and that the 'same paragraph appears' each year, which contradicts the ground truth that identifies a nuanced but meaningful evolution in tone—particularly in 2024 with a stronger emphasis on 'differentiating our merchandise offerings' in competitive metropolitan markets and a 2023 reference to sustainability initiatives linked to brand loyalty. The ground truth acknowledges consistency in core strategy but highlights a shift in emphasis, while the LLM denies any substantive change. This misrepresents the qualitative evolution in messaging, failing the multi-hop reasoning required to compare subtle shifts in strategic language over time. While the answer is contextually relevant and correctly identifies key elements, it lacks the sensitivity to linguistic evolution that the question specifically asks for, resulting in a partially correct but ultimately misleading conclusion about the stability of the language.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 399,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "Charles Schwab’s holdings of U.S. state and municipal securities fell from **$638 million at 12/31/2022** (Level 2 fair‑value assets) to **$579 million at 12/31/2023**【page_112】, and the 2024 filing notes that **“substantially all securities in the investment portfolios were rated investment grade,”** implying that the state‑and‑municipal positions remained within a high‑quality, investment‑grade bucket【page_48】.  \n\nThe steady focus on investment‑grade securities shows that Schwab’s fixed‑income strategy is deliberately conservative, emphasizing credit quality and low‑risk assets rather than expanding exposure to lower‑rated or higher‑yielding issuers.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Schwab disclosed a $638 million investment in U.S. State and Municipal Securities in 2023—not 2022. The LLM incorrectly states that the $638 million was held at year-end 2022 and then declined to $579 million at year-end 2023, implying a reduction. However, the original answer does not provide a 2024 or 2023-to-2024 comparison, nor does it mention a $579 million figure—this number is unverified and contradicts the ground truth, which only specifies the 2023 amount. There is no mention of a decrease in the original answer, so the LLM fabricates a trend not supported by the evidence. (2) The calculation of a $59 million decrease is therefore incorrect and based on erroneous data placement across years. The LLM misattributes the first quantitative disclosure to 2022 when it belongs to 2023, breaking the temporal accuracy required for multi-hop reasoning. (3) While the LLM correctly identifies the consistent emphasis on investment-grade quality and draws a reasonable conclusion about Schwab’s conservative fixed income strategy, this qualitative insight is only partially aligned with the original answer’s focus on continuity in credit risk management. The LLM adds a detail (Level 2 fair-value assets) not present in the ground truth, which may be contextually relevant but cannot be verified. (4) Despite the incorrect numbers and timeline, the LLM addresses both parts of the question—evolution over time and strategic implication—and maintains contextual relevance. However, the quantitative inaccuracies severely undermine the correctness score, as financial evolution requires accurate year-to-value mapping. The answer fails the multi-hop synthesis test because it misaligns data points across years, leading to an incorrect narrative of decline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 512,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "RTX’s maximum‑potential liability for commercial‑aerospace customer‑financing guarantees fell each year – $304 million in 2022, $288 million in 2023 and $274 million in 2024 (Note 16, Guarantees). The portion of those guarantees assumed by collaboration partners also slipped, from $140 million in 2022 to $135 million in 2023 and $131 million in 2024, indicating that as the overall exposure shrank the company was transferring slightly less risk to partners and retaining a marginally larger share of the guarantee risk itself.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the collaboration partners' share of guarantees as $140M in 2022, $135M in 2023, and $131M in 2024, matching the ground truth exactly. It also accurately describes the declining trend. While the ground truth does not mention RTX's total maximum-potential liability ($304M, $288M, $274M), this additional context from the LLM answer is factually consistent with the trend and does not contradict the ground truth; it enhances rather than distorts. (2) All numeric values are correct and properly aligned with years. The year-over-year decreases (e.g., $140M → $135M → $131M) are accurately represented. (3) The multi-hop reasoning is sound: the LLM correctly infers that as overall exposure declines and partner-assumed share declines, RTX is retaining relatively more risk, which aligns with the ground truth's interpretation of reduced reliance on third-party risk sharing. The conclusion about increased internal risk retention is logically supported. (4) The only minor gap is that the LLM omits the point about fair market values covering the guarantees, which is part of the ground truth and relevant to RTX's conservative risk management. However, this omission does not invalidate the correctness of the provided analysis. Overall, the answer is factually accurate, contextually appropriate, and demonstrates strong reasoning, warranting a high score with only a slight deduction for incompleteness on the valuation safeguard point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 411,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "- **2022 10‑K:** Frame.io was introduced as a cloud‑native collaboration service that handled **still images, design files and PDFs** and was **directly integrated only with Premiere Pro and After Effects**. Its core role was real‑time upload, review, frame‑accurate commenting and “Camera‑to‑Cloud” ingest of footage from cameras.  \n\n- **2023 10‑K:** Adobe expanded Frame.io’s scope to support **video‑centric stages such as casting, location scouting, footage reviews and marketing‑campaign management**, while still supporting stills, design files and PDFs. It added **native integrations with Photoshop, Lightroom and Workfront** (in addition to Premiere Pro and After Effects), positioning the service as a broader creative‑workflow hub.  \n\n- **2024 10‑K:** The description remains the same for file‑type and app coverage, but Adobe now **offers Frame.io through Adobe GenStudio**, emphasizing its role as a scalable, end‑to‑end production platform that unifies collaboration, review and “Camera‑to‑Cloud” across video, image and document assets.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and timeline, with accurate dates and correct identification of integrations and file types. However, there are some misalignments in the year-by-year evolution compared to the ground truth. Specifically: (1) The claim that in 2022 Frame.io was described as a 'cloud-native collaboration service' directly integrated with Premiere Pro and After Effects is not fully supported by the original answer, which only states it was a registered trademark under Adobe in 2022—indicating acquisition and branding alignment, not functional integration details. The functional integration details (with Premiere Pro, After Effects, file types, Camera-to-Cloud) are correctly attributed to 2023 in the ground truth, not 2022. (2) The LLM incorrectly attributes the integration with Photoshop, Lightroom, and Workfront to 2023, while the original answer states this expansion occurred in 2024. (3) The mention of 'Adobe GenStudio' in 2024 is not present in the original answer and appears to be an error or hallucination, as the ground truth does not reference this platform. (4) The core progression—expansion from post-production to broader content workflows including casting, location scouting, and marketing—is correctly captured, and file type support (still images, design files, PDFs) is consistent. (5) All non-numeric information is well-structured and contextually relevant, and there are no issues with entity names or financial figures (none present). The quantitative accuracy is perfect because no numbers are misstated. However, the qualitative accuracy is reduced due to incorrect year assignments and the introduction of an unsupported platform (GenStudio). Despite these issues, the answer remains contextually relevant and captures the overall trajectory of Frame.io’s evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 498,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "- **2022:** The RMS “Trends” discussion for 2022 makes no specific reference to the VH‑92A, implying that the helicopter was not a growth driver and its production was essentially steady or background‑level【page_51】.  \n\n- **2023:** The 2023 MD&A notes that RMS net‑sales were lifted by higher CH‑53K output “but were partially offset by lower volume on the VH‑92A program”【page_41】.  \n\n- **2024:** The 2024 MD&A repeats the same pattern – net‑sales rose on CH‑53K volume “partially offset by lower volume on the VH‑92A program”【page_41】.  \n\n**Interpretation:** Over the three‑year span the VH‑92A moved from a neutral, background‑level production role in 2022 to a declining‑volume program in both 2023 and 2024. The repeated “lower volume” language shows the helicopter is not a growth engine for RMS, yet its continued mention signals that it remains a strategically important, high‑profile asset (the Marine One presidential transport) that the segment maintains even as production ramps down. This multi‑year progression underscores the program’s status as a mature, low‑volume but mission‑critical element within the Rotary and Mission Systems portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but diverges significantly from the ground truth in interpretation, despite citing accurate qualitative trends from the documents. (1) Correctly identifies that in 2023 and 2024, the VH-92A program experienced lower volume, which is consistent with the MD&A statements on page 41. The absence of specific mention in 2022 'Trends' discussion (page 51) is also factually accurate. However, the ORIGINAL ANSWER asserts that the VH-92A was explicitly listed as a major program in RMS in all three years, indicating sustained strategic importance, while the LLM interprets lack of emphasis in 'Trends' as evidence of a 'background-level' role, contradicting the ground truth. (2) No numeric values (e.g., dollar amounts, percentages, units) are present in either answer, so quantitative accuracy is not compromised—citations to pages and qualitative phrases like 'lower volume' are correctly attributed. (3) The multi-hop reasoning is flawed: while the LLM correctly extracts year-specific statements, it infers a 'declining-volume program' and 'ramp down' narrative, whereas the ground truth emphasizes consistent inclusion in major programs, suggesting stability. The LLM overinterprets 'lower volume' as a production decline trend without acknowledging that such fluctuations are normal in defense programs and do not imply reduced strategic value. (4) Contextual relevance is high—the answer addresses all years and ties the program to RMS strategy, but the conclusion about strategic importance contradicts the ground truth's emphasis on sustained commitment. The LLM's claim that it is 'not a growth engine' may be reasonable, but asserting it is in 'declining-volume' mode misrepresents the multi-year consistency highlighted in the original. Thus, while factually grounded in excerpts, the synthesis and conclusion are misleading, warranting a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 513,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "From the 2022 filing the company already noted that “sales or media and marketing restrictions such as those on promotions or advertising products with specified nutrient profiles on certain channels or platforms or during certain hours of the day” were in place in a number of jurisdictions, and that “many Member States in the European Union have implemented extended producer‑responsibility (‘EPR’) policies … EPR policies are being implemented or contemplated in other jurisdictions around the world, including India, Vietnam and certain states in the United States”【page_11】.  \n\nBy the 2023 filing the language was broadened to stress that “the European Union has adopted its Packaging and Packaging Waste Directive” and that the same EU‑wide EPR regime now covers “over 25 countries” while “single‑use plastic bans or plastic taxes are being implemented or considered in Europe as well as countries including Indonesia and the Philippines,” showing a tighter, continent‑wide framework and a spill‑over into additional emerging markets【page_11】.  \n\nThe 2024 filing repeats the same points and adds that the company “continues to monitor developments in laws and regulations,” indicating that the geographic reach of these marketing limits has further expanded beyond the EU to more emerging‑market jurisdictions and that the rules are becoming increasingly stringent across all of them【page_11】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a key factual inaccuracy regarding the timing of the EU's adoption of the Packaging and Packaging Waste Directive (PPWD). According to the ground truth, the directive was formally adopted in 2024, not in 2023 as stated in the LLM answer ('By the 2023 filing the language was broadened to stress that “the European Union has adopted its Packaging and Packaging Waste Directive”'). This misplacement of a critical regulatory milestone affects quantitative and qualitative accuracy. However, the rest of the information aligns well with the ground truth: the expansion of EPR policies across over 25 EU countries by 2023, consideration of plastic bans/taxes in Europe and Southeast Asia (e.g., Indonesia, Philippines), and the global spread into emerging markets like India and Vietnam are all correctly identified. The mention of data privacy as a regulatory area in 2023 is missing from the LLM answer, which is a minor omission affecting completeness. The reasoning is otherwise sound, showing a logical progression across years and geographies, and the contextual relevance is strong, directly addressing the evolution of geographic scope and regulatory stringency. Wording and synthesis are semantically equivalent in most places, and number formats (e.g., 'over 25 countries') match. The error in dating the PPWD adoption prevents a higher score, but core facts about expanding EPR and marketing restrictions remain accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 404,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Microsoft continues to list the 3.700 % senior notes due 2046 in the “Eleventh Supplemental Indenture” (Exhibit 4.14), dated August 8 2016, with no mention of redemption, amendment or re‑classification 【page_105】. The note is therefore treated as an unchanged, outstanding component of the company’s long‑term debt in each filing, indicating that Microsoft is deliberately holding this low‑coupon, far‑maturity issuance rather than refinancing it, a pattern that reflects a strategy of maintaining a diversified, stable long‑term debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 3.700% Notes due 2046 are consistently referenced in the Eleventh Supplemental Indenture dated August 8, 2016, across 2022–2024 10-K filings, with no changes noted. The percentage (3.700%), maturity year (2046), and indenture date (August 8, 2016) are all factually precise. (2) Quantitative accuracy is perfect—no calculations required, but all numbers and dates match the original answer exactly. (3) The reasoning is sound: the absence of redemption or amendment supports the conclusion that Microsoft is maintaining stable, long-dated debt. The LLM correctly infers a strategy of preserving a diversified and stable long-term debt profile, which is semantically equivalent to the ground truth’s 'predictable debt servicing costs' and 'core component of capital structure.' (4) Minor deduction in qualitative accuracy (9 instead of 10) because the LLM does not explicitly state that this reflects confidence in long-term cash flow projections—a nuance present in the original—but the implication is reasonably conveyed through the strategic interpretation. Contextual relevance is full, as all parts of the question are addressed: evolution across years (no change) and strategic implication (stable debt management).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 369,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "Microsoft first added the 2.000 % senior notes that mature in 2023 in the **Eleventh Supplemental Indenture** (dated August 8 2016). That indenture is listed in the exhibit index of the 2022 10‑K (see Exhibit 4.14 on page 105) and the same exhibit appears unchanged in the 2023 10‑K and the 2024 10‑K, indicating that the notes remained outstanding through each filing 【page_105】. Across the three years the debt‑maturity tables therefore show a 2023 tranche that moves from a newly‑issued mid‑term obligation (2022 filing) to a “near‑term” maturity that the company is preparing to retire or refinance (2023 and 2024 filings), while the overall maturity profile shifts toward later‑dated issues (2024‑2025, 2027, etc.) as reflected by the newer supplemental indentures filed after 2016.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.000% Notes due 2023 were issued under the Eleventh Supplemental Indenture on August 8, 2016; they appear in Exhibit 4.14 of the 2022, 2023, and 2024 10-K filings; and their presence across all three years is accurately noted. (2) Quantitative elements—dates, percentages, exhibit numbers—are all factually correct with no calculation errors. (3) The multi-hop reasoning is sound: the LLM correctly infers the evolution of the debt's classification from mid-term (2022) to near-term maturity (2023–2024), and contextualizes this within Microsoft’s broader debt maturity structure, including the shift toward later-dated maturities due to newer indentures. (4) The only minor shortcoming is that the LLM does not explicitly address why the notes remain listed in the 2024 10-K after maturity—such as possible rollover, delayed repayment, or disclosure requirements—though it implies continuity. This omission slightly affects completeness but does not undermine the core accuracy. Overall, the answer is semantically equivalent to the ground truth, with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 343,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "Across the three most recent 10‑K filings the company’s Non‑Employee Restricted Stock Unit (RSU) award agreement did not change. In the 2022 filing (Exhibit 10.42) the agreement is described as a “Form of Non‑Employee Restricted Stock Unit Award Agreement **under the Amended and Restated 2013 Stock Award and Incentive Plan**.” The same language and exhibit number (10.42) appears in the 2023 filing and again in the 2024 filing, each time referencing the same 2013 Stock Award and Incentive Plan. Thus, from 2022 through 2024 Medtronic’s non‑employee RSU agreements remained tied to the Amended and Restated 2013 Stock Award and Incentive Plan with no substantive amendment shown in the filings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor discrepancy in exhibit number and lacks some nuance in describing the evolution of the plan. (1) The LLM correctly identifies that the Non-Employee RSU agreements from 2022 to 2024 all reference the 'Amended and Restated 2013 Stock Award and Incentive Plan,' which matches the ground truth. This shows accurate entity and year identification. (2) However, the LLM states the exhibit number is 10.42 in all three years, while the ground truth specifies Exhibit 10.45 for 2022. This is a factual error, though minor, as exhibit numbers are important for document traceability. The consistency of the form across years is correctly noted, but the specific exhibit reference must match. (3) The reasoning is sound: the model correctly synthesizes that the same plan was referenced across years and that no substantive changes were made to the agreement form, reflecting stability. It captures the multi-hop element—linking the form agreement to the underlying plan across multiple filings—though it misses the subtle point in the ground truth that the plan itself had been amended over time (e.g., effective December 8, 2017), even if the form remained unchanged. This nuance about the plan’s amendment history adds depth that the LLM omits. (4) Despite these minor shortcomings, the core facts—consistent form, same plan reference, no changes in the agreement—are correct. The answer is highly relevant and conveys the essential conclusion. Thus, a score of 8 is justified: key data and logic are accurate, but with a small factual error and slight incompleteness in contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 455,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "- In 2022, ≈ 17 % of the assets of MDLZ’s non‑U.S. pension plans were allocated to buy‑in annuity policies (see 2022 10‑K, Non‑U.S. Plans – Buy‑in annuity policies 17%).  \n- In 2023 the allocation slipped to ≈ 16 % (2023 10‑K, Non‑U.S. Plans – Buy‑in annuity policies 16%).  \n- In 2024 it returned to ≈ 17 % (2024 10‑K, Non‑U.S. Plans – Buy‑in annuity contracts 17%).  \n\nThe allocation has remained essentially flat, hovering around 16‑17 % over the three years, indicating that MDLZ consistently relies on buy‑in annuities to transfer and hedge the risk of its international pension obligations rather than shifting away from this liability‑management tool.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, MDLZ's allocation to buy-in annuity policies decreased from 17% in 2022 to 16% in 2023 and was effectively discontinued by 2024, with the company shifting to fair value estimation methods. However, the LLM claims the allocation returned to 17% in 2024, which directly contradicts the ground truth. This error fundamentally misrepresents the trend. (2) Quantitatively, the 2022 (17%) and 2023 (16%) figures are correct, but the 2024 figure is wrong—the ground truth states the practice was discontinued, not that it rebounded to 17%. The LLM also mislabels the instrument as 'buy-in annuity contracts' in 2024, whereas the ground truth indicates a methodological shift away from such policies. (3) The multi-hop reasoning is flawed: instead of recognizing a strategic phase-out and shift in valuation methodology, the LLM incorrectly infers stability and continued reliance on annuities. This misinterpretation leads to an erroneous conclusion about MDLZ’s liability management strategy. (4) Contextual relevance is moderate—the response addresses the right company, time frame, and topic (non-U.S. pension plans and buy-in annuities), but the core conclusion is incorrect due to the false 2024 data point and resulting flawed synthesis. The answer suggests consistency rather than a strategic shift, which is the opposite of the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 400,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "Microsoft’s 2.000 % senior notes that mature in 2023 were first issued in the Eleventh Supplemental Indenture (dated August 8 2016) and are listed in the “Notes to Financial Statements” exhibit 4.14 of the 2022, 2023 and 2024 Form 10‑K filings 【page_105】. The note appears unchanged in each year’s filing—no additional issuances or retirements are disclosed—showing that Microsoft has kept this low‑cost, medium‑term debt on its balance sheet to lock in inexpensive financing and smooth the maturity profile of its long‑term debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance of Microsoft's 2.000% Notes due in 2023 under the Eleventh Supplemental Indenture dated August 8, 2016, and their consistent appearance in Exhibit 4.14 across the 2022, 2023, and 2024 Form 10-K filings. All dates, percentages, and exhibit numbers are accurate. (2) Quantitative accuracy is perfect: the interest rate (2.000%), maturity year (2023), issue date (August 8, 2016), and exhibit number (4.14) match the ground truth. There are no numerical or date discrepancies. (3) The multi-hop reasoning is sound—information is correctly synthesized across three fiscal years, and the conclusion that Microsoft maintained the debt without retirement or refinancing aligns with the ground truth. The LLM infers a strategic intent (locking in low-cost financing and smoothing maturity profile), which is a reasonable interpretation of the stable debt structure. (4) The only minor gap is that the original answer explicitly notes the absence of refinancing or early retirement, while the LLM implies it by stating 'no additional issuances or retirements are disclosed.' This is semantically close but slightly less direct. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning, warranting a high score with only a slight deduction for nuance in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 383,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "- **2022 10‑K** – The 4.000 % notes that mature in 2021 are disclosed as a separate series in the **Third Supplemental Indenture** (dated Feb 8 2011) to the 2009 base indenture【page_104】.  \n\n- **2023 10‑K** – The filing repeats the same presentation; the 4.000 % Notes due 2021 remain listed only in that Third Supplemental Indenture, with no amendment or re‑classification noted【page_104】.  \n\n- **2024 10‑K** – The 4.000 % Notes due 2021 no longer appear in any of the supplemental‑indenture tables. Instead, the most recent series shown is the **Ninth Supplemental Indenture**, which includes a 4.000 % series due 2055 (and other new series)【page_105】. The omission of the 2021 series indicates it has been retired after maturity, and the company’s debt schedule now reflects only the newer series within the broader indenture structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error in the 2024 10-K analysis, which undermines the overall correctness. According to the ground truth, Microsoft's 4.000% Notes due 2021 continued to be listed in Exhibit 4.6 of the 2024 10-K under the Third Supplemental Indenture, just as in prior years. However, the LLM claims that in the 2024 filing, the notes 'no longer appear' and have been omitted due to retirement, which contradicts the ground truth. While it is logically plausible that matured notes would be retired, the ground truth explicitly states the notes remained in the disclosure structure across all three years, indicating consistent reporting regardless of maturity. The LLM incorrectly infers disappearance from the document, likely misinterpreting the continued use of updated supplemental indentures (e.g., Ninth) for new debt. The 2022 and 2023 analyses are factually correct—correct indenture (Third Supplemental Indenture dated Feb 8, 2011), correct context, and no changes. The mention of new debt instruments like the 4.000% Notes due 2055 under later indentures is plausible but not directly relevant to the treatment of the 2021 notes. Quantitative accuracy is partially correct: percentages (4.000%), dates (Feb 8, 2011), and maturity years are accurate where stated, but the conclusion about omission in 2024 introduces a significant error. Qualitatively, the reasoning fails on multi-hop synthesis—while it identifies the correct indenture initially, it does not recognize that the continued listing of the 2021 notes in the same exhibit across all years (even post-maturity) reflects consistent disclosure practice. Contextual relevance is high—the answer addresses the evolution across years and indenture structure appropriately, just with a key factual flaw. Thus, partial credit is given for correct early-year analysis and structural understanding, but major deduction for incorrect 2024 conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 520,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "Medtronic’s share‑capital note consistently lists **40 000 Euro‑Deferred Shares authorized at €1.00 each**, and each filing states that **no Euro‑Deferred Shares were issued or outstanding** – at April 29 2022 [page 81] and again at April 26 2024 [page 81]. The 2023 10‑K repeats the same disclosure (the same wording appears in the 2023 filing’s shareholders’ equity section).  \n\nThe unchanged, zero‑balance treatment shows that Medtronic keeps this class of shares as a dormant reserve rather than a source of financing, indicating a capital‑structure strategy that relies on ordinary‑share issuances and repurchases while preserving the option to use the Euro‑Deferred Shares in the future without diluting current equity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Medtronic maintained 40,000 authorized Euro Deferred Shares with a par value of €1.00 and that zero shares were issued or outstanding in fiscal years 2022, 2023, and 2024. This matches the ground truth exactly. The inclusion of specific filing dates (April 29, 2022, and April 26, 2024) and page numbers adds precision and confirms the data was drawn from actual disclosures. (2) All numeric values—40,000 shares, €1.00 par value, zero issued/outstanding—are factually correct and consistent with the ground truth. No calculations are required, but the repeated confirmation across years is accurately represented. Format variations (e.g., '40 000' with a non-breaking space) do not affect accuracy. (3) The multi-hop reasoning is sound: the model synthesizes disclosures across three fiscal years and infers a strategic pattern—non-utilization of Euro Deferred Shares despite authorization. The conclusion that this reflects a capital structure strategy favoring ordinary shares and preserving future flexibility is logically supported and aligns with the ground truth’s interpretation, though it adds the nuance of 'dormant reserve' and 'no dilution,' which are reasonable extensions but not explicitly stated in the original. (4) The answer fully addresses both parts of the question: evolution over time (consistent disclosure) and strategic implication (non-use suggests preference for other financing). The only minor gap is that the 2023 filing is referenced descriptively but without a specific date, though the content is correctly attributed. Overall, the answer is factually precise, contextually relevant, and semantically equivalent to the ground truth with excellent reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 476,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "Across Microsoft’s 2022, 2023 and 2024 Form 10‑K filings the 4.000 % Notes due 2021 are disclosed in the same way – they appear as **Exhibit 4.6, the “Third Supplemental Indenture for 2.500 % Notes due 2016, 4.000 % Notes due 2021, and 5.300 % Notes due 2041,” dated February 8 2011**【page_104】. The description, exhibit number and filing date are identical in each year’s filing, showing no amendment, removal or re‑classification of the instrument. This consistency indicates that Microsoft has continued to treat the 4.000 % Notes due 2021 as an unchanged, outstanding debt obligation, maintaining the same reporting approach for the instrument over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual error in interpretation that undermines the overall correctness. Quantitatively, the details are mostly accurate: the exhibit number (4.6), the date (February 8, 2011), and the inclusion of the 4.000% Notes due 2021 in the Third Supplemental Indenture are correctly cited across all three years, and the description of consistent disclosure is supported. However, the key qualitative error lies in the conclusion: the LLM states that Microsoft treated the notes as an 'outstanding debt obligation,' which contradicts the ground truth. Since the notes were due in 2021, by 2022 they were already matured or settled, and their continued disclosure is for archival or reference purposes (via incorporation by reference), not because they remain outstanding. The ground truth correctly interprets the consistency as evidence that the instrument required no further amendments because it was already resolved, not that it remains active. This misinterpretation reflects a failure in reasoning about the lifecycle of debt instruments and leads to an incorrect conclusion about the company's treatment of the debt. While the LLM accurately reports what was disclosed, it fails to correctly infer what that means, resulting in a misleading narrative. The answer is contextually relevant and well-structured, but the core inference is flawed, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 396,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "Lockheed Martin’s most recent pension‑risk‑transfer disclosed in the filings was the August 2021 purchase of group‑annuity contracts that moved **about $4.9 billion** of defined‑benefit pension obligations to an insurer.  The 2022, 2023 and 2024 10‑K reports do not describe any additional GAC purchases – the company only notes that, to date, it has transferred roughly **$11.6 billion** of obligations since 2018 and that it “expects to continue to look for opportunities” but no new amounts are quantified for those years.  \n\nThe pattern shows a large, one‑time transfer in 2021 (and earlier years) followed by **no further quantified transfers in 2022‑2024**, indicating that Lockheed Martin’s long‑term liability‑management strategy is to front‑load pension‑risk‑transfer transactions to eliminate volatility for a sizable retiree base, then rely on the existing transferred obligations rather than repeatedly executing new transfers.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly states the cumulative $11.6 billion in pension obligations transferred since 2018, as disclosed in the 2022 filings, which matches the ground truth. It also accurately notes that no new quantified transfers occurred in 2022–2024, and correctly references the $4.9 billion 2021 transaction (though the question focuses on 2022–2024, so this is context, not error). However, it incorrectly implies that the $11.6 billion figure was current as of 2021, while the ground truth clarifies it was reported in 2022 as the cumulative amount since 2018 — a subtle but important distinction in timeline accuracy.\n\n2) Quantitatively, the dollar amounts ($11.6 billion, $4.9 billion) are accurate and properly attributed. The LLM correctly identifies that no additional amounts were disclosed beyond 2021, so no incorrect calculations are made. However, it fails to reflect the evolving qualitative disclosures in 2023 and 2024 — specifically, that Lockheed Martin 'reaffirmed its intent' to pursue further transfers — which is a factual omission affecting reasoning.\n\n3) The multi-hop reasoning is partially sound: the model connects the absence of new transfers with strategic intent. However, it draws an incorrect conclusion — calling the strategy 'front-loading' and implying a pause or completion — whereas the ground truth shows a consistent, ongoing strategy with active reaffirmation in 2023 and 2024. This misrepresents the company's stated intent and undermines the qualitative accuracy of the synthesis.\n\n4) Contextually, the answer is relevant and well-structured, addressing both the quantitative trend and strategic implication. But due to the flawed interpretation of the company's forward-looking statements, the conclusion about long-term strategy is misleading. While factually cautious about missing data, it overinterprets silence in filings as strategic stasis, contrary to the company’s continued public evaluation and intent to act. Thus, correctness is reduced to 6 due to significant reasoning error despite numerical accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 554,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "- In the 2022 10‑K the 0.125 % Notes due 2029 appear only once, listed as Exhibit 4.23 and incorporated by reference to the Form of Note filed in a September 18 2020 8‑K.  \n- The 2023 10‑K still shows the original Exhibit 4.23 but adds a second entry, Exhibit 4.31, that incorporates a later Form of Note filed on March 9 2021 – indicating a new issuance (or amendment) of the same‑rated, same‑maturity debt.  \n- The 2024 10‑K drops the earlier Exhibit 4.23 and retains only Exhibit 4.31, continuing to treat the 0.125 % Notes due 2029 as a single, consistently‑structured instrument referenced to the 2021 filing.  \n\nThis progression shows that Coca‑Cola has repeatedly disclosed the 0.125 % 2029 notes by reference to the underlying 8‑K filings, and while it added a newer issuance in 2023, the terms of the instrument remained unchanged, demonstrating a stable and consistent approach to structuring this low‑rate, long‑dated debt over the three years.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the evolution of the 0.125% Notes due 2029 across the 10-K filings. According to the ground truth, the note was consistently disclosed in both Exhibit 4.23 and 4.31 in all three years (2022, 2023, 2024), with each referencing the same underlying Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. However, the LLM incorrectly states that in 2022 the note appears only once (in Exhibit 4.23), that 2023 adds a new entry in Exhibit 4.31 indicating a new issuance or amendment, and that 2024 drops Exhibit 4.23. This portrayal of a changing disclosure pattern is false—both exhibits consistently referenced the same documentation across all years. (2) Quantitatively, the percentages (0.125%), years (2029, 2020, 2021), and exhibit numbers (4.23, 4.31, 4.4) are correctly cited, which supports a moderate quantitative accuracy score. However, the interpretation of these references as evolving or indicating new issuance is incorrect. (3) The multi-hop reasoning is flawed: the model infers a progression (addition and replacement of exhibits) that does not exist in the ground truth. Instead of recognizing consistent dual referencing across years, it constructs a narrative of change and consolidation, which undermines the qualitative accuracy. The conclusion about 'stable and consistent approach' aligns with the ground truth, but it is based on incorrect premises. (4) Contextual relevance is high because the answer addresses the core question about disclosure evolution and debt structuring, uses correct terminology, and attempts to interpret the implications. However, due to major factual errors in the description of exhibit usage and filing changes, the overall correctness score is low despite partial alignment in entities and dates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 499,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "RTX’s liability for product‑performance and operating‑cost guarantees fell each year – it was **$1.109 billion at 12/31/2022**, slipped to **$1.091 billion at 12/31/2023** (a $18 million drop) and then to **$0.993 billion at 12/31/2024** (a further $98 million decline)【page_100】【page_102】.  \n\nThe steady reduction shows the company’s exposure to long‑term performance‑risk obligations in its commercial‑aerospace business is decreasing, reflecting lower issuance of new guarantees, higher settlements and/or improved product reliability.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The original answer states that RTX's liabilities related to performance and operating cost guarantees—specifically the collaboration partners' share of financing guarantees—were $141M in 2022, $135M in 2023, and $131M in 2024. In contrast, the LLM claims total liabilities of $1.109B, $1.091B, and $0.993B, which are over 7 times larger and not supported by the ground truth. These numbers appear to misrepresent either a different liability category or a complete fabrication. (2) Calculations are internally consistent (e.g., $1.109B to $1.091B is an $18M drop; $1.091B to $0.993B is a $98M drop), but since the base figures are wrong, the calculations are irrelevant. The ground truth shows a decline from $141M to $131M over two years—a $10M total decrease—not hundreds of millions. (3) The multi-hop reasoning fails: the LLM incorrectly identifies the metric as RTX’s total liability, while the ground truth specifies only the 'collaboration partners’ share of financing guarantees' and notes RTX’s own liabilities were not explicitly stated. The LLM also draws a strong conclusion about decreasing risk due to reliability or reduced guarantee issuance, which is unsupported because the ground truth indicates stability and managed exposure, not a downward trend in overall risk. (4) Contextual relevance is moderate—the answer addresses the right topic (liabilities for performance and operating cost guarantees in commercial aerospace) and attempts trend analysis. However, due to severe factual and quantitative errors, the conclusion misrepresents the company’s risk exposure. The qualitative reasoning would score higher if based on correct data, but as-is, it reflects flawed logic stemming from incorrect inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 491,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "Medtronic’s Black‑Scholes inputs for its non‑qualified stock options have been adjusted upward on three key parameters since 2022.  The assumed stock‑price volatility rose from 23.0 % in FY 2022 to about 24.3 % in FY 2024, while the risk‑free rate jumped from 0.9 % to 4.2 % and the dividend‑yield assumption increased from 1.9 % to 3.2 % (expected life moved only marginally from 6.0 to 6.1 years).  The higher risk‑free and dividend assumptions—combined with a modest volatility increase—have driven the weighted‑average fair value of options granted down from $22.8 per option in 2022 to $18.5 in 2024, indicating that the company is now modeling equity‑compensation risk with a more market‑reflective cost‑of‑capital and dividend outlook while still recognizing slightly greater stock‑price uncertainty.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that Medtronic consistently used the Black-Scholes model and evolved its disclosure around expected volatility—specifically clarifying in 2023 and 2024 that implied volatility was derived from market-traded options. However, the LLM answer fabricates specific numerical inputs (e.g., volatility rising from 23.0% to 24.3%, risk-free rate from 0.9% to 4.2%, dividend yield from 1.9% to 3.2%) and claims a downward trend in fair value from $22.8 to $18.5 per option, none of which are supported by the original answer or implied in the knowledge graph. These numbers are entirely absent from the ground truth, making the quantitative claims baseless. (2) There are no verifiable calculations in the original answer to assess, but the LLM invents precise percentages and dollar figures without any basis, failing the quantitative accuracy test. (3) The multi-hop reasoning is flawed: while the question asks about the evolution in valuation approach and what it suggests about assumptions, the LLM incorrectly focuses on changes in model inputs rather than the disclosed methodology for estimating expected volatility. It misses the key point about increased transparency in using market-traded options to derive implied volatility—a critical qualitative shift. Instead, it invents a narrative around changing assumptions in risk-free rates and dividends, which are not mentioned in the ground truth. (4) Despite the factual inaccuracies, the answer is contextually relevant—it addresses Medtronic, non-qualified stock options, the Black-Scholes model, and attempts to interpret changes in assumptions over time. However, the complete lack of factual grounding in the original data severely undermines correctness. The qualitative reasoning would be stronger if based on actual disclosures, but as it stands, it reflects a plausible but fabricated analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 532,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "The 10‑K for 2022 lists a **Form of Note for 1.000 % Notes due 2028** (exhibit 4.26, filed Sept 18 2020). The 2023 filing repeats the same exhibit 4.26 with identical terms, and the 2024 filing again includes the same 1.000 % Notes due 2028 (exhibit 4.26). Because the instrument appears unchanged in each year’s exhibit index, Coca‑Cola has not issued additional 1.000 % notes after the original 2020 issuance; it is simply carrying the existing low‑coupon, short‑dated debt to maturity, reflecting a strategy of retaining inexpensive, near‑term financing rather than repeatedly rolling over new 1.000 % issuances.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative details: the 1.000% Notes due 2028 are correctly referenced in each year's 10-K (exhibit 4.26), and the original filing date (Sept 18, 2020) is accurate. There are no errors in numbers, percentages, or dates, earning a perfect quantitative accuracy score. Contextual relevance is high, as the response directly addresses the evolution of the specific debt instrument across 2022–2024. However, the qualitative accuracy is low because the LLM draws a conclusion that contradicts the ground truth. While the LLM claims Coca-Cola is merely carrying forward the existing 1.000% Notes without new issuance—implying a conservative, passive debt strategy—the ground truth states that in 2024, the company introduced significantly higher-yielding notes (5.000% and 5.300%), indicating a strategic shift toward more aggressive borrowing. The LLM fails to mention this key strategic context, which is central to answering what the pattern suggests about the company's debt strategy. Thus, while the LLM correctly observes that the 1.000% Notes were consistently referenced, it misses the broader strategic implication of new high-cost debt issuance in 2024, leading to an incomplete and partially misleading interpretation. This omission significantly affects the correctness score, which lands at 6 due to partial factual accuracy but major reasoning gaps in multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 393,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "- **2022 Form 10‑K** – Microsoft’s note schedule still listed the **2.125 % Notes due 2022** (and the earlier 2.125 % Notes due 2021) under the **Fourth and Seventh Supplemental Indentures**. Both indentures were dated Nov 7 2012 and Dec 6 2013 and were issued “between Microsoft Corporation and **The Bank of New York Mellon Trust Company, N.A., as Trustee**” 【page_104†L7-L12】.  \n\n- **2023 Form 10‑K** – The filing continued to rely on those same indentures; the exhibit list still shows the Fourth and Seventh Supplemental Indentures with BNY Mellon as trustee and no new 2.125 % series was added. The only new series shown was the **Fifteenth Supplemental Indenture** (dated Nov 6 2023) which also names BNY Mellon as trustee but relates to other coupons, not a new 2.125 % issue 【page_106†L1-L4】.  \n\n- **2024 Form 10‑K** – By this filing the 2.125 % Notes had matured and were no longer listed as a separate series; the exhibit schedule only references the later supplemental indentures (e.g., the Fifteenth) and the same trustee arrangement (BNY Mellon), indicating Microsoft’s shift from issuing new 2.125 % notes to maintaining the existing debt structure under the same trustee.  \n\n**Overall evolution:** Microsoft initially issued 2.125 % notes under the Fourth and Seventh Supplemental Indentures with BNY Mellon as trustee (2022). In 2023 it kept those notes on its books but did not create a new 2.125 % series, adding only newer indentures for other coupons while retaining BNY Mellon as trustee. By 2024 the 2.125 % series had been retired, and the company’s disclosures focus on the newer supplemental indentures, still using the same trustee.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly deviate from the ground truth, particularly regarding the maturity and treatment of the 2.125% Notes. (1) The Original Answer states that the 2.125% Notes due 2021 were consistently disclosed in 2022, 2023, and 2024 filings with no structural changes, while the LLM incorrectly claims in the 2022 10-K that the notes were due in 2022 (not 2021), and further asserts that by 2024 the notes had matured and were removed—this contradicts the ground truth which confirms the same disclosure pattern across all three years, indicating ongoing reporting despite maturity. Maturity does not necessarily remove disclosure if the indenture remains active or referenced. (2) The LLM introduces the 'Fourth Supplemental Indenture' as relevant to the 2.125% Notes, but the ground truth only references the Seventh Supplemental Indenture in connection with these notes. The mention of the Fourth Indenture is unsupported and potentially erroneous. (3) The LLM claims the 2024 filing no longer lists the 2.125% Notes as a separate series due to retirement, but the ground truth explicitly states the exhibit description and trustee relationship were repeated in 2024, indicating continued disclosure. This misrepresents the evolution as one of change when the truth is consistency. (4) While the trustee (The Bank of New York Mellon Trust Company, N.A.) is correctly identified across years, and the general structure of supplemental indentures is acknowledged, the LLM’s narrative of 'evolution'—issuance, continuation, then retirement—is factually incorrect. The core error is asserting change where there was stability. (5) The LLM correctly identifies BNY Mellon as the consistent trustee and references actual indenture dates and exhibit structures, showing some accurate document parsing. However, the multi-hop synthesis fails because it misinterprets the persistence of disclosures as evidence of structural change rather than continuity. (6) Quantitative accuracy is partially correct: dates and percentages (2.125%, Nov 7 2012, Dec 6 2013) are accurate, but the misattribution of the Fourth Indenture and the incorrect maturity year (2022 vs 2021) reduce precision. Overall, the answer is contextually relevant and attempts detailed analysis, but its factual foundation is flawed, leading to an incorrect conclusion about the evolution of the debt structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1619,
        "completion_tokens": 642,
        "total_tokens": 2261
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "Pratt & Whitney’s net program‑share interest stayed essentially unchanged over the three years – it was 57 % of the IAE (V2500) program and 51 % of IAE LLC (PW1100G‑JM) in the 2022 filing, and the 2023 and 2024 filings report the same 57 % and 51 % figures. This steady, majority‑but‑not‑full stake shows RTX remains the primary beneficiary and controller of both the V2500 and PW1100G‑JM engine programs, giving it strategic leverage and upside while still sharing development risk with its MTU‑JAEC partners.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Pratt & Whitney's net program share interest was 57% for IAE and 51% for IAE LLC in 2022, which contradicts the ground truth. According to the original answer, in 2022, the net program share interest was not explicitly stated but was estimated at 61% for IAE and 59% for IAE LLC before adjustments. The decrease to 57% and 51% occurred in 2023, not 2022. This is a major factual error affecting the core of the multi-year evolution analysis. (2) The quantitative inaccuracies are significant: the LLM misrepresents the 2022 figures entirely, claiming the same percentages as in 2023–2024, which distorts the trend. The ground truth shows a decline from ~61% to 57% (IAE) and 59% to 51% (IAE LLC), indicating a strategic adjustment, whereas the LLM implies stability from the start. (3) The reasoning is partially sound in interpreting the strategic implications of maintaining majority stakes, but it fails the multi-hop requirement by not accurately tracking the change over time. The model overlooks the key transition in 2023 and the stabilization in 2024, instead asserting no change across all years. (4) Contextual relevance is high because the answer addresses the right entities (IAE, IAE LLC, V2500, PW1100G-JM, RTX strategy) and attempts to interpret strategic positioning. However, due to the incorrect timeline and numbers, the qualitative and quantitative accuracy scores are low. The correctness score is 4 because while some elements (e.g., correct 2023–2024 figures, correct identification of programs) are accurate, the misrepresentation of 2022 data undermines the overall validity of the trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 457,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "Thermo Fisher’s expense for its 401(k) and other defined‑contribution plans rose from **$402 million in 2022** to **$468 million in 2023**, then eased to **$443 million in 2024** 【page 53】【page 67】.  The pattern shows a clear step‑up in spending after 2022, with the 2024 level still well above the 2022 amount, indicating that the company has been expanding its investment in employee‑benefit contributions over the period, even as the pace moderated slightly in the most recent year.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the $468 million contribution for 2023 and $443 million for 2024, which match the ground truth. However, it incorrectly states the 2022 contribution as $402 million instead of the correct $299 million. This is a significant factual error affecting the quantitative accuracy. (2) The calculation of the trend — an increase from 2022 to 2023 and a decline in 2024 — is directionally correct, but the magnitude of the 2022–2023 increase is misrepresented due to the wrong baseline. The claim that 2024 spending is 'well above' 2022 is therefore misleading, as the true increase from $299M to $443M (~48% increase) is much more substantial than implied by the incorrect $402M figure. (3) The multi-hop reasoning is sound in structure — the model correctly identifies the need to compare three years of data and interpret the trajectory — but the flawed input for 2022 undermines the validity of the synthesis. (4) Despite the numerical error, the answer remains contextually relevant and provides a reasonable interpretation of spending trends, justifying high marks for contextual relevance and decent qualitative accuracy. However, the major quantitative inaccuracy limits the correctness score to 6, as the core financial data is partially wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 362,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "- In the 2022 Form 10‑K the exhibit list stops at the 4.200 % notes due 2050 and does not include a 3.000 % note maturing in 2051【page_134】.  \n- The 2023 Form 10‑K adds a “Form of Note for 3.000 % Notes due 2051” (exhibit 4.36) 【page_136】, showing that Coca‑Cola issued this ultra‑long‑dated, low‑coupon debt after 2022.  \n- The 2024 Form 10‑K still lists the same 3.000 % Notes due 2051 among its debt instruments【page_130】, while also adding newer higher‑rate issues, indicating the company is maintaining the original low‑cost, 30‑year financing as a cornerstone of its capital structure and using additional issuances to diversify maturities and manage interest‑rate exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the 3.000% Notes due 2051 were already referenced in Coca-Cola's 2022 10-K filing via Exhibit 4.6 to the May 5, 2021 Form 8-K, indicating the instrument existed and was disclosed prior to 2022. However, the LLM claims the 2022 10-K 'does not include' the 3.000% Notes due 2051 and asserts they were first added in the 2023 10-K as Exhibit 4.36. This contradicts the ground truth and misrepresents the timeline of issuance and disclosure. (2) The quantitative accuracy is low because the key fact — the year the 3.000% Notes due 2051 first appeared in disclosures — is incorrect. The LLM incorrectly states the note was absent in 2022 and introduced in 2023, while the ground truth confirms it was already part of the filing framework by 2022 (referencing a 2021 Form 8-K). The coupon rate (3.000%), maturity (2051), and newer instruments (5.000% due 2034, 5.300% due 2054) in 2024 are not mentioned in the LLM answer, missing key comparative data. (3) The multi-hop reasoning is partially sound — the LLM correctly infers from the continued presence of the 3.000% Notes in 2024 alongside higher-rate notes that Coca-Cola is maintaining low-cost financing while diversifying, which aligns with the ground truth’s interpretation. However, the foundational premise (that the note was first issued in or after 2023) is false, undermining the reasoning chain. (4) Contextual relevance is high because the answer addresses the evolution across years and attempts to interpret capital structure strategy. Despite incorrect facts, it frames the right kind of analysis — evaluating debt diversification and interest rate strategy. Overall, the answer is partially correct in logic and intent but fails on core factual accuracy, especially regarding the timing and initial disclosure of the 3.000% Notes due 2051.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 515,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "Oracle first disclosed its 2.875 % senior notes due 2031 in the 2022 Form 10‑K, where they appear as Exhibit 4.14 (issued under an officers’ certificate dated March 24, 2021) 【page_111】. The same series is carried forward in the 2023 and 2024 10‑K exhibit tables, showing that the notes remain outstanding and are still part of Oracle’s reported long‑term debt. This continuity signals that Oracle is using relatively low‑coupon, decade‑plus maturities to lock in inexpensive financing and to build a diversified, long‑dated debt profile that supports its strategic investments while managing refinancing risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance and ongoing inclusion of the 2.875% Notes due 2031 in Oracle's 10-K filings from 2022 through 2024, with accurate referencing of the March 24, 2021 issuance date and exhibit number (Exhibit 4.14). All quantitative details—interest rate (2.875%), maturity year (2031), and timeline—are factually correct, earning a perfect score on quantitative accuracy. (2) However, the LLM answer omits a key component of the ground truth: the introduction of newer, higher-yielding notes (4.500% due 2028 and 4.900% due 2033) in the 2024 filing. This omission limits the completeness of the analysis regarding Oracle’s evolving debt strategy. While the LLM correctly infers that Oracle is using low-coupon, long-term debt to manage refinancing risk and support investments, it fails to acknowledge the strategic shift toward diversifying with costlier debt as market conditions changed. (3) The multi-hop reasoning is partially sound—information is correctly synthesized across years and filings to show continuity of the 2.875% Notes—but the lack of comparison with newer debt instruments weakens the qualitative depth and strategic interpretation. (4) The answer remains contextually relevant and well-structured, but the absence of the contrast between older and newer debt instruments prevents a full assessment of Oracle’s shifting strategy, justifying a 7 on correctness and qualitative accuracy despite strong factual grounding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 410,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all include the same Eleventh Supplemental Indenture that lists “2.000% Notes due 2023” among its outstanding securities 【page_105】. By repeatedly disclosing this specific issue, Microsoft signals that it maintains a stable, long‑term debt portfolio and that it deliberately provides investors with consistent, up‑to‑date information on each tranche of its borrowings, underscoring a disciplined debt‑management approach and a high level of transparency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 2.000% Notes due 2023 are consistently disclosed across Microsoft's 2022, 2023, and 2024 10-K filings, originating from the Eleventh Supplemental Indenture dated August 8, 2016. The interest rate (2.000%), maturity year (2023), and the fact of repeated disclosure are all factually accurate. (2) Quantitative elements—interest rate and maturity date—are correctly stated with no calculation errors. (3) The reasoning is sound: the model correctly infers that consistent disclosure reflects a stable debt portfolio and transparent communication, indicating disciplined debt management. It captures the core implication of transparency and investor communication. (4) The only minor omission is that the original answer notes the unaltered inclusion reinforces 'predictable financial stewardship' and links it to credit ratings and investor confidence—nuances not fully elaborated in the LLM response. However, the LLM does convey the essential qualitative conclusion. The answer is contextually precise, directly addressing Microsoft's debt management and transparency strategy. Wording differs but semantic meaning is equivalent. No factual inaccuracies; minor depth gap prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 361,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "- 2022 10‑K (covering commitments as of 31 Dec 2021) disclosed that, under the 2012 IAE acquisition, RTX must make “flight‑hour” payments to Rolls‑Royce for every hour flown through June 2027 by V2500‑powered aircraft in service at the acquisition date.  Those payments were included in “Other commercial‑aerospace commitments” of **$11.0 billion**, offset by a collaboration‑partner share of **‑$5.9 billion**, leaving a net exposure of roughly **$9.7 billion** (page 112).\n\n- 2023 10‑K (commitments as of 31 Dec 2022) showed the same contingent‑hour obligation but the amount had fallen to **$1.05 billion** of other commitments, with a partner‑share offset of **‑$0.66 billion**, giving a net exposure of about **$1.45 billion** (page 73).\n\n- 2024 10‑K (commitments as of 31 Dec 2023) further reduced the hour‑based liability to **$0.77 billion** of other commitments, offset by a partner‑share of **‑$0.81 billion**, leaving a net exposure of roughly **$1.33 billion** (page 103).\n\n**Interpretation:** The contingent flight‑hour payments have been shrinking sharply from the 2022 level to 2024 as the V2500 fleet ages and the required hourly payments are being accrued and paid.  This trend indicates that RTX’s long‑term financial exposure to Rolls‑Royce under the 2012 IAE acquisition is rapidly diminishing and will likely be modest by the June 2027 cut‑off.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies, particularly in the numerical values. The ground truth states that RTX's contingent payments are tied to flight hours through June 2027 and are accounted for as capitalized intangible assets amortized to cost of sales, but it does not provide specific dollar amounts like $11.0 billion, $1.05 billion, or $0.77 billion. These figures are entirely fabricated or misattributed and do not appear in the original answer. The original makes no mention of a net exposure of $9.7B, $1.45B, or $1.33B, nor any partner-share offsets of -$5.9B, -$0.66B, or -$0.81B. These numbers are quantitatively incorrect and unsupported by the ground truth. (2) There is no verification of calculations because the numbers themselves are false. The LLM invents a dramatic decline in liability from $11B to $1.33B, which contradicts the original answer’s description of a consistent recognition and amortization pattern without any indication of a 'sharp' decline. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies the 2012 IAE agreement and the June 2027 end date, it misrepresents the accounting treatment and financial progression. The original emphasizes stability in accounting policy (capitalized as incurred and amortized to cost of sales) from 2022–2024, whereas the LLM incorrectly infers a rapidly diminishing exposure based on invented figures. (4) Contextually, the LLM addresses the right entities (RTX, Rolls-Royce, V2500, IAE 2012 agreement) and time frame (2022–2024), and attempts interpretation of long-term exposure, but the conclusion is invalid due to false data. The reasoning is structured but built on incorrect premises. Thus, the correctness and quantitative accuracy scores are very low, qualitative accuracy is partially correct on entities and framework but wrong on synthesis, and contextual relevance is moderate due to correct framing but incorrect content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1597,
        "completion_tokens": 528,
        "total_tokens": 2125
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "Thermo Fisher’s domestic‑pension holdings in U.S. equity funds were $89 million at 12/31/2022, rose to $93 million in 2023, and then slipped to $91 million in 2024. Over the three‑year span the allocation moved only modestly – up about 4 % from 2022 to 2023 and down roughly 2 % the following year, ending just $2 million higher than in 2022. This flat‑to‑slightly‑upward trend indicates the company is largely keeping to its stated “≈10 % of assets in U.S. equities” target, making only minor adjustments rather than a major re‑allocation toward or away from domestic equities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the values and the time periods. According to the ground truth, TMO's allocation was $125M in 2022, decreased to $89M in 2023, and increased to $93M in 2024. The LLM incorrectly states that the 2022 allocation was $89M (which is actually the 2023 value), claims it rose to $93M in 2023 (misplaced year), and then dropped to $91M in 2024 (ground truth is $93M in 2024). Thus, all three annual figures are wrong or misassigned. (2) Calculations are also incorrect: the LLM claims a 4% increase from 2022 to 2023 and a 2% decrease thereafter, but with wrong base numbers and years. The actual change from 2022 ($125M) to 2023 ($89M) is a 28.8% decrease, not a 4% increase. The 2024 rebound to $93M represents a ~4.5% increase from 2023, not a drop. (3) The multi-hop reasoning is flawed because the model fails to correctly identify the trajectory: instead of a sharp decline followed by a partial recovery, it reports a flat, slightly fluctuating trend. This undermines the strategic interpretation. (4) While the LLM attempts to interpret the strategy—suggesting stability around a 10% target—this is unsupported by the actual data and contradicts the ground truth’s conclusion of a 'cautious reduction' with 'strategic rebalancing.' The mention of a '≈10% of assets' target is not present in the original answer and appears fabricated. Overall, the answer is mostly incorrect due to wrong numbers, misaligned years, and flawed analysis, though it addresses the general topic of investment strategy, warranting partial relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 439,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "By the 2022 filing Coca‑Cola’s long‑term‑debt schedule still featured the ultra‑low‑coupon “1.000 % Notes due 2041” (exhibit 4.33, incorporated on Mar 9 2021) as a core component of its debt program【page_134†L31-L34】【page_136†L31-L34】. In the 2024 filing the company added a suite of new notes with substantially higher coupons – e.g., 5.000 % notes due 2034, 5.300 % notes due 2054, 5.400 % notes due 2064, 3.125 % notes due 2032, 3.500 % notes due 2044, 4.650 % notes due 2034, 5.200 % notes due 2055, 3.375 % notes due 2037 and 3.750 % notes due 2053 (all filed in May‑August 2024)【page_130†L39-L49】. Thus, Coca‑Cola moved from relying on very low‑interest, long‑dated securities in 2022 to issuing higher‑yielding notes in 2024, reflecting a shift toward more costly but possibly more market‑aligned financing.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the continued presence of the 1.000% Notes due 2041 in 2022 and the introduction of higher-yielding notes in 2024, aligning with the ground truth. However, it includes additional notes (e.g., 3.125%, 3.500%, 4.650%, etc.) not mentioned in the original answer, which may be factually present in the filing but were not part of the knowledge graph's distilled evolution narrative. This over-inclusion does not make the answer factually wrong but adds detail beyond the ground truth scope. (2) The percentages and maturities for the key high-yield notes (5.000% due 2034, 5.300% due 2054, 5.400% due 2064) are accurate and match the original answer. However, the inclusion of nine additional notes with specific coupons and maturities introduces quantitative details not validated by the ground truth, reducing precision in scoring. The original answer emphasizes a strategic shift using representative examples, while the LLM lists a broader set—potentially correct but not confirmed. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift from low-yield to high-yield instruments by comparing 2022 and 2024 data. It correctly notes the persistence of the 1.000% Notes due 2041 and contrasts earlier low-yield instruments (implied by context) with 2024’s higher yields. The absence of explicit mention of the 0.400% Notes due 2030 (2022) and 0.950% Notes due 2036 (2023) from the LLM answer is a minor omission but does not invalidate the conclusion. (4) The answer is contextually excellent—directly addresses the evolution in debt strategy, uses correct years and instruments, and draws a valid conclusion. The extra detail slightly dilutes quantitative accuracy but does not introduce falsehoods. Correctness score is 8 due to full alignment on core facts and reasoning, with minor over-specification of 2024 notes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 511,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "Oracle’s 10‑K filings for 2022, 2023 and 2024 all list the 1.650 % Notes due 2026 (Exhibit 4.14) as part of its outstanding debt 【page_112】, 【page_111】, 【page_111】. By keeping this low‑coupon, medium‑term issue on its balance sheet while simultaneously adding newer, higher‑rate issuances (e.g., 5.800 % notes due 2025 in 2022, 4.500 % notes due 2028 in 2023, and other notes above 2 % in 2024), Oracle shows a financing strategy that relies on a core of inexpensive, long‑dated debt and layers on higher‑interest notes when additional capital is needed.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in dates and interest rates for the newly issued notes. According to the ground truth, Oracle issued the 5.800% Notes due 2025 in 2023, not in 2022 as claimed by the LLM. Similarly, the 4.500% Notes due 2028 were issued in 2024, not in 2023. The LLM also generically references 'other notes above 2% in 2024' without specific support from the original answer, introducing unverified information. Additionally, the LLM incorrectly states that Exhibit 4.14 is used in all three years; the ground truth specifies Exhibit 4.16 in 2022, not 4.14. (2) Quantitative accuracy is partially correct: the 1.650% Notes due 2026 are correctly identified and consistently referenced across years, and the interest rates of 5.800% and 4.500% are accurate, but their issuance years are wrong. The misattribution of timing undermines the validity of the comparative analysis. (3) The multi-hop reasoning is sound in concept—Oracle maintains low-cost debt while issuing higher-cost debt—but the flawed temporal alignment weakens the logical synthesis. The conclusion about a dual financing strategy is plausible and aligns with the original answer, but rests on incorrect factual premises for the new notes. (4) Contextual relevance is high, as the response directly addresses Oracle's debt strategy and attempts to synthesize data across years. However, due to key factual errors in timing and exhibit numbers, the correctness score is reduced to 6, reflecting partial accuracy with significant flaws in quantitative details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 432,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "Microsoft’s 10‑K filings for FY 2022, 2023 and 2024 all list Exhibit 4.6 – the “Third Supplemental Indenture for 2.500 % Notes due 2016, **4.000 % Notes due 2021**, and 5.300 % Notes due 2041” – showing that the 4 % 2021 issue remains on the company’s balance sheet and has not been retired or refinanced 【page_104】. By repeatedly updating the same exhibit each year, Microsoft signals a disciplined long‑term debt strategy that preserves existing financing until maturity and ensures that its documentation stays current without relying on frequent refinancing of that particular tranche.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024, along with the associated notes (2.500% due 2016 and 5.300% due 2041) in the Third Supplemental Indenture. The percentages, years, and exhibit number are all factually accurate, satisfying quantitative accuracy. (2) The claim that the notes 'remain on the company’s balance sheet' is a misinterpretation — the ground truth clarifies that the continued listing reflects documentation persistence, not necessarily an active liability post-maturity; the notes were due in 2021 and likely settled, but retained in filings for structural continuity. This is a key qualitative error in reasoning. (3) The LLM correctly infers a disciplined debt strategy and lack of refinancing, aligning with the ground truth’s conclusion of no active restructuring. However, it omits the 2024 trustee name update (‘The Bank of New York Mellon Trust Company, N.A.’), a minor but noted administrative change in the original answer, affecting completeness. (4) Despite the balance sheet misstatement, the overall reasoning about documentation continuity and absence of refinancing is sound and contextually relevant. The answer captures the core intent of the question but misses nuanced distinctions between legal documentation and active debt liability, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 393,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "RTX’s maximum‑potential exposure to commercial‑aerospace customer‑financing guarantees fell each year – $304 million in 2022, $288 million in 2023 and $274 million in 2024 – and after subtracting the collaboration‑partner portion the net exposure declined from roughly $164 million to $153 million to $143 million. The partners’ share of the guarantees also slipped from $142 million (2022) to $135 million (2023) to $131 million (2024), indicating that while RTX is overall shrinking its guarantee risk, it is modestly reducing the amount it transfers to partners, reflecting a balanced but slightly less aggressive risk‑transfer strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the collaboration partners' share of guarantees as $142M (2022), $135M (2023), and $131M (2024), matching the ground truth exactly. However, the LLM introduces additional figures—total exposure ($304M, $288M, $274M) and net exposure ($164M, $153M, $143M)—that are not present in the original answer or implied by it. These numbers, while internally consistent (e.g., $304M - $142M = $162M ≈ $164M, minor rounding), are not supported by the ground truth and appear to be speculative or sourced from outside the provided knowledge. (2) The quantitative accuracy is high for the directly reported partner shares, but the unsupported total and net exposure figures reduce confidence in full numerical fidelity. Calculations for net exposure are approximately correct but not verifiable against ground truth. (3) The reasoning correctly identifies a declining trend in partner-shared guarantees and interprets this as a modest reduction in risk transfer, which aligns with the ground truth’s suggestion of a strategic shift. However, the original answer emphasizes RTX potentially assuming more direct risk or changing partnership structures, while the LLM frames it as part of an overall risk reduction with a 'less aggressive' risk-transfer strategy—a nuance that slightly misaligns. The LLM also omits the key point about RTX’s assertion that guaranteed asset values equaled or exceeded guarantees net of reserves, which is a critical element of the original answer’s conclusion regarding continued confidence in asset values. (4) Despite the omission of the fair market value assurance and the introduction of unverified total/net exposure figures, the LLM answer addresses the evolution of exposure and interprets the trend in partner sharing reasonably well. It remains contextually relevant and captures the core trend accurately, warranting a solid but not top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 518,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "Microsoft’s 3.950 % senior notes that mature in 2056 first appeared in the Eleventh Supplemental Indenture dated August 8 2016 (see the “Eleventh Supplemental Indenture … 3.950 % Notes due 2056” description on page 105). The same note is listed in the long‑term debt disclosures of the FY 2022, FY 2023 and FY 2024 10‑K filings, with no additional issuances or retirements of this series reported in any of those years.  \n\nThis continuity shows that Microsoft has kept the ultra‑long‑dated, low‑coupon 3.950 % issue on its balance sheet for several consecutive years, reflecting a capital‑structure strategy that locks in inexpensive, fixed‑rate financing far into the future to preserve liquidity, hedge interest‑rate risk and support long‑term investment needs.  \n\n*Sources: Exhibit 4.14 description of the Eleventh Supplemental Indenture (3.950 % Notes due 2056) – page 105 of the 2022, 2023 and 2024 10‑K filings.*",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: the 3.950% Notes due 2056 were first issued under the Eleventh Supplemental Indenture on August 8, 2016, and consistently disclosed in Microsoft's FY 2022, 2023, and 2024 10-K filings. There is no mention of additional issuances or retirements, matching the ground truth's assertion of stability. (2) Quantitative elements—interest rate (3.950%), maturity year (2056), and issuance date (August 8, 2016)—are all precisely correct. No calculations were required, but the consistency across years is accurately reported. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings and connects the persistent disclosure to a strategic capital structure decision. (4) The interpretation about Microsoft’s long-term capital strategy—locking in low-cost, fixed-rate debt to support long-term investments and manage interest rate risk—is a valid inference supported by the data and adds contextual insight without overreaching. The sources cited (Exhibit 4.14, page 105 across all three 10-Ks) are appropriately referenced. The answer fully addresses both parts of the question: the evolution (or lack thereof) of the debt instrument and the strategic implication. Semantic equivalence is strong, with slightly more detailed commentary than the original answer but no factual deviations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 397,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "From 2022 through 2024 the MFC segment’s tactical‑and‑strike missile business moved from a modest, steady contribution (2022 net‑sales $11.3 bn, operating profit $1.64 bn) to a small dip in 2023 (net‑sales $11.25 bn, operating profit $1.54 bn) as a $45 m loss on a classified contract eroded profit, and then to a sharp volume surge in 2024 (net‑sales $12.68 bn, driven by a $1.2 bn increase from GMLRS, LRASM and JASSM production) that nevertheless saw operating profit collapse to $413 m because $1.2 bn of adverse profit‑booking‑rate adjustments (including $1.4 bn of classified‑program losses) more than offset the sales gain. Overall, Lockheed Martin’s operating profit from the MFC segment fell from $1.64 bn in 2022 to $1.54 bn in 2023 and then to $0.41 bn in 2024 – a total decline of roughly 75 % over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $1.2 billion production increase in 2024 due to GMLRS, LRASM, and JASSM is accurately reported; the $45 million loss on a classified program in 2023 is correctly stated; and the $1.2 billion in adverse profit-booking-rate adjustments in 2024, including $1.4 billion in losses on a classified program, are precisely reflected. The net sales and operating profit figures for each year ($11.3B/$1.64B in 2022, $11.25B/$1.54B in 2023, $12.68B/$0.413B in 2024) match known data. (2) Calculations are accurate: the 75% total decline in operating profit from $1.64B to $0.41B is correctly approximated (actual drop is ~75.0%), and the $1.2B sales increase in 2024 is consistent with the production ramp-up. (3) Multi-hop reasoning is sound: the answer synthesizes production volume trends, financial performance, and program-specific impacts (classified program losses) across three years, correctly concluding that rising production coincided with sharply declining profitability. (4) The only minor shortcoming is that the LLM omits the specific 2022 and 2023 production increases ($215M and $145M) mentioned in the ground truth, focusing instead on net sales and profit. However, it captures the core trajectory and financial impact accurately. Wording differs but semantic meaning is equivalent. All entities (LMT, MFC segment, LRASM, JASSM, GMLRS, classified program) are correct. Thus, the answer is factually excellent with only slight incompleteness on early-year production gains.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 434,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K the only Executive Change‑in‑Control Retention Agreement disclosed was the original 2009 agreement with CEO Marc N. Casper (Exhibit 10.11) together with its earlier amendments (Exhibits 10.15‑10.16) and a pre‑existing “form” for officers other than Casper that had been filed in 2018 (Exhibit 10.17).  \n- The 2023 filing added a **newly‑issued form** for those other officers (again Exhibit 10.17, now filed as an exhibit to the Q1 2023 10‑Q), showing that the company began using a separate retention‑agreement template for non‑Casper officers, while the Casper‑specific agreement and its historic amendments remained unchanged.  \n- The 2024 filing repeats the same Casper‑specific agreement and its 2009‑2010‑2018 amendments and continues to list the 2023‑issued officer‑form (Exhibit 10.17); no additional amendments to the Casper agreement were introduced in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment of the evolution of Thermo Fisher's Executive Change in Control Retention Agreements across 2022–2024, but introduces some inaccuracies not present in the ground truth. (1) Correct elements: The answer correctly identifies that in 2022, the agreement for Marc N. Casper was disclosed and that a form existed for other officers. It also correctly notes that in 2023, a form for other officers was filed (as Exhibit 10.7 in the 10-K or 10-Q), and that the 2024 filing continued to reference both agreements. (2) Quantitative/Procedural Inaccuracies: The LLM incorrectly states that the form for other officers was a 'pre-existing form filed in 2018' (Exhibit 10.17) and that the 2023 version was a 'newly-issued form' re-filed as the same exhibit number. The ground truth does not mention 2018 or prior forms, nor does it characterize the 2023 filing as 'newly-issued'—it simply notes the form was filed as Exhibit 10.7 in 2023. Additionally, the LLM references specific exhibit numbers (10.15–10.16, 10.17) and filings (Q1 2023 10-Q) not mentioned in the original answer, introducing unverified detail. (3) Multi-hop reasoning is sound: the model connects disclosures across years and distinguishes between Casper-specific and other officer agreements appropriately. (4) Despite over-specifying exhibit history and dates not in the ground truth, the core message—that the structure remained consistent with a separate form for non-Casper officers introduced/confirmed in 2023—aligns with the original. Thus, the answer earns a 7 for correctness: key facts are accurate, but with minor factual overreach on dates and exhibits.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 458,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "- In the 2022 Form 10‑K the company said it “may use **variable‑interest‑rate swaps** to convert fixed‑rate borrowings to variable‑rate borrowings … designated as fair‑value hedges” and that the **aggregate notional amount of outstanding interest‑rate swaps was $500 million at December 31, 2021** (and $572 million at 2020)【page_66】.  \n\n- The 2023 filing shows that the same hedge program had **grown to $1.3 billion of interest‑rate‑swap notional at both December 31, 2022 and December 31, 2023**【page_95】.  \n\n- The 2024 filing confirms the level was **still $1.3 billion at December 31, 2024 (and 2023)**【page_52】.  \n\n**Interpretation:** The jump from $500 million in 2021 to $1.3 billion in 2022, and the decision to keep that larger notional amount through 2023‑2024, indicates Lockheed Martin substantially expanded its swap program to hedge a larger portion of its debt portfolio. Maintaining the higher notional suggests a deliberate, ongoing strategy to manage interest‑rate risk—either by converting more fixed‑rate debt to variable‑rate exposure (fair‑value hedges) or by locking in rates to reduce earnings volatility—rather than a temporary or speculative use of derivatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values and time points: $500 million notional amount as of December 31, 2021 (disclosed in 2022 filing), increase to $1.3 billion by December 31, 2022 (reported in 2023 filing), and maintenance at $1.3 billion through December 31, 2023 and 2024. These match the ground truth exactly, with acceptable format variations. (2) Quantitative accuracy is perfect: all dollar amounts and dates are correctly cited from the respective filings, and the magnitude of increase (from $500M to $1.3B) is accurately represented as a substantial expansion. The LLM correctly notes that the $1.3B level was already in place by end of 2022, which aligns with the 2023 filing data. (3) Multi-hop reasoning is sound: the model synthesizes data across three annual filings (2022, 2023, 2024), correctly tracks the evolution of swap notional amounts over time, and infers a strategic shift in risk management. The interpretation that the sustained higher notional indicates a deliberate, ongoing hedging strategy is consistent with the ground truth’s conclusion about a 'more robust interest rate risk mitigation posture.' (4) Minor deduction in qualitative accuracy because the LLM slightly mischaracterizes the timing—ground truth emphasizes the increase occurred from 2021 to 2023, while the LLM states the jump was 'from $500 million in 2021 to $1.3 billion in 2022,' which compresses the timeline and implies a faster shift than described in the original. However, this is supported by the 2023 filing showing $1.3B as of Dec 2022, so it is not factually incorrect. Overall, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 463,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "Thermo Fisher’s expense for its 401(k) and other defined‑contribution plans was **$402 million in 2022**, rose to **$468 million in 2023**, and then fell slightly to **$443 million in 2024**【page 53】【page 66】.  The upward jump from 2022 to 2023 shows a stronger commitment to employee‑benefit funding, while the modest decline in 2024 suggests a slight scaling back but still a higher level of investment than in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures: $402 million in 2022, $468 million in 2023, and $443 million in 2024, matching the ground truth exactly. The trend description — increase from 2022 to 2023 and a slight decrease in 2024 — is accurate. (2) Quantitative values are correct with proper dollar amounts and years; no calculation errors. The LLM correctly identifies the rise and subsequent small drop, though it says 'fell slightly' rather than 'remained flat', which is a minor interpretive difference since $443M is indeed lower than $468M but not equal to the prior year. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and draws a reasonable conclusion about investment trends in employee benefits. It correctly infers increased commitment in 2023 and a partial pullback in 2024, still above 2022 levels. (4) The answer is contextually fully relevant, addressing both parts of the question — the evolution of expenses and what the trend indicates. The only minor deviation from the original answer is the characterization of the 2024 change as a 'modest decline' versus the ground truth's 'remained flat', but given that $443M is less than $468M, 'slight fall' is defensible. Thus, the answer is factually correct and semantically equivalent, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 374,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "From 2022 through 2024 the Company’s footnotes on investments repeatedly state that, for non‑publicly‑traded equity holdings, it “uses valuation methodologies … including discounted‑cash‑flow analysis, **estimates of sales proceeds** and appraisals.” The language and the set of methods are unchanged in the 2022 filing (Note 4, p. 40), the 2023 filing (Note 4, p. 79) and the 2024 filing (Note 4, p. 78), indicating a steady reliance on sales‑proceeds estimates to gauge fair value. Because management applied the same methodology to conclude that the $87 million shortfall on the Coca‑Cola Bottlers Japan investment in 2022 was “temporary” and did not require an impairment charge, the continued use of sales‑proceeds estimates signals that management is confident it can anticipate a market recovery in places like Japan.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but misses a key nuance in the evolution of the valuation methodology. (1) Quantitatively, all numbers and references are accurate: the $87 million shortfall in 2022 is correctly cited, and the consistent use of 'estimates of sales proceeds' across 2022–2024 filings (Note 4, pp. 40, 79, 78) is factually sound. No calculation errors. (2) Entity accuracy is strong: The Coca-Cola Company, Coca-Cola Bottlers Japan Holdings Inc., and the relevant years (2022–2024) are correctly identified. (3) Reasoning is mostly sound: the LLM correctly infers that continued use of the same methodology signals management’s confidence in predicting recovery, especially regarding the 2022 impairment decision. However, it omits the ground truth’s key point about an evolving emphasis in 2023 and 2024 toward market participant assumptions and macroeconomic risks, particularly in emerging markets. The LLM portrays the methodology as static in both practice and emphasis, while the original answer notes a qualitative shift in how those estimates were framed—more attuned to external perspectives. (4) Despite this omission, the answer remains contextually relevant and factually accurate on the core issue: the consistent use of sales-proceeds estimates and what that implies about management's confidence. The missing nuance reduces qualitative accuracy slightly but does not invalidate the overall correctness. Semantic equivalence is mostly preserved, though the evolution in tone and emphasis across years is underdeveloped.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 433,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "Oracle first introduced the 2.300 % Notes due 2028 in a March 24 2021 issuance (exhibit 4.14, “Forms of 1.650 % Notes due 2026, 2.300 % Notes due 2028 …”, listed in the 2022 10‑K 【page_112】). The same exhibit appears unchanged in the 2023 and 2024 10‑K filings (again shown in the exhibit tables of those reports 【page_111】), indicating the notes have remained outstanding and have not been retired or materially re‑structured. This continuity suggests Oracle’s broader debt strategy was to lock in low‑coupon, medium‑term financing and keep a stable, staggered maturity profile across multiple years rather than repeatedly issuing new securities.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer is partially correct in stating that Oracle issued the 2.300% Notes due 2028 in 2021 and that they remained outstanding through 2022–2024, which aligns with the ground truth’s implication of continued inclusion in filings. The numeric details (2.300%, 2028 maturity) and reference to consistent disclosure in 10-Ks are accurate. However, the LLM fails to mention Oracle’s issuance of newer, higher-interest debt instruments in 2023 (4.500% Notes due 2028) and 2024 (5.800% Notes due 2025), a key element in the original answer that supports the broader strategy interpretation.\n\n2) Quantitative accuracy is high: the interest rate (2.300%), maturity year (2028), and issuance date (March 24, 2021) are correctly stated. The exhibit number (4.14) and page references are plausible and consistent with SEC filing structures, though not directly verifiable from the ground truth. No calculations were required, so no errors there.\n\n3) The multi-hop reasoning is incomplete. While the LLM correctly infers stability in Oracle’s debt structure from the unchanged exhibit, it misses the critical synthesis point: Oracle was layering new, more expensive debt on top of older, cheaper instruments. This omission undermines the qualitative accuracy of the strategic interpretation. The ground truth emphasizes a mix of old and new debt amid rising rates, whereas the LLM focuses only on stability and low-cost locking, missing the nuance of active new issuance despite higher costs.\n\n4) Contextual relevance is strong—the response directly addresses the evolution of the 2.300% Notes and attempts to infer strategy. However, the failure to incorporate the multi-year pattern of new high-rate issuances results in an incomplete and somewhat misleading strategic conclusion. The LLM’s interpretation is plausible but less comprehensive and less aligned with the full evidence than the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 514,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "Apple’s 10‑K filings for fiscal 2022, 2023 and 2024 all contain the same exhibit description for the Officer’s Certificate dated May 6 2014, which lists “Floating Rate Notes due 2019” among the securities the company has issued【page_56】. The fact that this reference appears unchanged in each year shows that the 2019 floating‑rate notes remained on Apple’s balance sheet (or were rolled‑over/refinanced) throughout the three‑year period. This consistent presence indicates that Apple relies on short‑term, floating‑rate borrowings as a flexible financing tool, using them to manage liquidity and interest‑rate risk rather than issuing large amounts of long‑dated debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the consistent appearance of the May 6, 2014 Officer's Certificate referencing 'Floating Rate Notes due 2019' in Apple's 2022, 2023, and 2024 10-K filings, which matches the ground truth. The dates and document references are factually accurate, satisfying quantitative accuracy. (2) However, the LLM misinterprets the implication of this consistency. While the ground truth states that the unchanged disclosure indicates a 'stable, rather than active, management approach'—implying no new activity or refinancing—the LLM incorrectly infers that the notes were 'rolled-over/refinanced' and suggests Apple actively relies on short-term floating-rate debt as a 'flexible financing tool.' This contradicts the original answer, which emphasizes the absence of new issuances or modifications. (3) The multi-hop reasoning is partially sound in connecting repeated disclosure to ongoing presence on the balance sheet, but it fails to correctly synthesize the strategic implication: stability vs. active use. The model introduces unsupported assumptions about refinancing and strategic reliance not present in the evidence. (4) Therefore, while the factual elements (dates, document, note type) are correct, the qualitative interpretation and strategic conclusion are misleading, leading to a moderate correctness score. Contextual relevance is high as the response directly addresses the question's focus on evolution and strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 406,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "PepsiCo’s 10‑K exhibits list the **4.000 % Senior Note due 2047** in the same section of the 2022 filing (Exhibit 4.5) and the same exhibit appears again in the 2023 and 2024 filings, showing that the company keeps this long‑dated issue as a permanent component of its capital structure 【page_126†L4-L7】. By contrast, the **2.150 % Senior Note due 2024** and the **0.750 % Senior Note due 2027** are only shown in the earlier exhibit schedules (e.g., 2.150 % 2024 in Exhibit 4.1 and 0.750 % 2027 in Exhibit 4.28) and are not carried forward, indicating that PepsiCo retires or refinances these shorter‑term instruments as they approach maturity. This pattern suggests a strategy of maintaining stable, long‑term debt while using shorter‑dated notes for temporary financing that is rolled over or paid off.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rates (4.000%, 2.150%, 0.750%), maturity years (2047, 2024, 2027), and exhibit references (Exhibit 4.5, 4.1, 4.28)—are correct, satisfying quantitative accuracy. (2) The answer correctly identifies the multi-hop pattern: the 2047 note appears consistently across 2022–2024 filings, indicating long-term debt stability, while the 2024 and 2027 notes appear only in earlier or single filings, reflecting temporary financing. This matches the ground truth’s core insight. (3) The reasoning is sound: the LLM infers that long-term notes are maintained as permanent capital structure components, whereas short-term notes are retired or refinanced, which is logically consistent with the evidence. (4) The only minor omission is that the ground truth explicitly references the matured 2.500% 2022 note as evidence of short-term debt turnover, which the LLM does not mention. While not critical, this adds contextual depth to the contrast. Otherwise, the LLM captures the strategic implication—using long-term debt to lock in fixed rates and reduce refinancing risk—through accurate synthesis across years and instruments. Wording differs but semantic meaning is equivalent. No factual errors; minor completeness gap prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 371,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 all include the Officer’s Certificate that lists the “0.45 % Notes due 2016” among its historic debt securities (see Exhibit 4.3 in the 2024 filing 【page 56】). By continuing to disclose these fully‑matured notes, Apple signals that it maintains a comprehensive, transparent record of all legacy borrowings and monitors even extinguished obligations as part of a disciplined debt‑management strategy. This practice ensures that any residual accounting, legal or reporting implications of past debt are captured and that investors receive a complete picture of the company’s historical financing history.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 0.45% Notes due 2016 are accurately referenced, and their maturity in 2016 is implied by describing them as 'fully-matured' and 'historic debt securities.' The continued disclosure in 2022, 2023, and 2024 is correctly noted, and the reference to the Officer’s Certificate (Exhibit 4.3 in the 2024 filing) matches the type of documentation cited in the original answer. (2) Quantitative accuracy is perfect: percentages (0.45%), years (2016, 2022–2024), and document details (Exhibit 4.3, page 56) are correctly reported. No calculations are required, but temporal and numerical references are precise. (3) Multi-hop reasoning is sound: the model correctly infers from repeated disclosure of a matured instrument that Apple maintains transparency and comprehensive records, linking this to disciplined debt management and investor clarity—consistent with the ground truth’s emphasis on continuity and conservative disclosure. (4) The only minor shortcoming is that the LLM does not explicitly mention the May 3, 2013, date of the Officer’s Certificate, which is a specific detail in the original answer that reinforces the consistency of documentation. However, this omission does not undermine the core reasoning or factual correctness. The answer remains semantically equivalent in intent and substance, with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 409,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "In the 2022 filing Lockheed Martin reported that, after a 2021 purchase of group‑annuity contracts that transferred $4.9 billion of pension obligations (part of a total $11.6 billion moved since 2018) and generated a one‑time, non‑cash settlement charge of $1.7 billion (pretax) to earnings, it said it would keep looking for additional pension‑risk‑transfer deals and warned that any future transaction could again produce a material non‑cash charge. The 2023 filing repeated that stance – it continued to evaluate further GAC purchases and noted that future transfers might require extra contributions or another non‑cash settlement charge, but no new large transfer was disclosed. By the 2024 filing the company still emphasized seeking more risk‑transfer opportunities, but instead highlighted a $1.8 billion reduction in the projected pension liability from a higher discount rate, a $990 million cash contribution in 2024 (none in 2023), and the absence of a new settlement charge, indicating the earnings impact shifted from the 2021‑related $1.7 billion charge to routine cash contributions and recoveries.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some key facts correctly but contains significant quantitative inaccuracies and misrepresents the financial impact in 2024, undermining the overall correctness. (1) Correct elements: The $4.9 billion obligation transfer in 2021 and associated $1.7 billion noncash settlement charge are accurately reported, as is the cumulative $11.6 billion in transfers since 2018. The statement that Lockheed Martin continued evaluating future pension risk transfer transactions in 2023 and 2024 aligns with the original answer. (2) Quantitative errors: The LLM claims a $1.8 billion reduction in projected pension liability in 2024 due to a higher discount rate and a $990 million cash contribution in 2024—details not present in the ground truth. The original answer does not mention any specific new liability reduction from discount rate changes or cash contributions in 2024, nor does it state that there was 'no new settlement charge'—this inference is unsupported. The ground truth emphasizes ongoing *expectation* of future transactions and noncash charges, but the LLM incorrectly implies a shift in earnings impact *away* from settlement charges to cash contributions, which contradicts the original narrative of continued noncash charges from active de-risking. (3) Multi-hop reasoning: The model synthesizes across years and correctly identifies the continuity in strategy, but fails to maintain consistency in financial impacts. It introduces new financial figures (e.g., $1.8B, $990M) not found in the ground truth, suggesting hallucination or misattribution. (4) While the qualitative understanding of Lockheed’s strategic intent is sound and contextually relevant, the introduction of unsupported numbers and the erroneous conclusion about shifting financial impact reduce factual accuracy. The answer is partially correct but contains material deviations in key financial data and implications for earnings, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1566,
        "completion_tokens": 526,
        "total_tokens": 2093
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "- In the 2022 Form 10‑K the only Executive Change‑in‑Control Retention Agreement listed was the original 2009 agreement with Marc N. Casper (Exhibit 10.11), together with its earlier amendments (2010, 2018).  \n- The 2022 filing also introduced a new exhibit – **Exhibit 10.17, “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)”** – which was filed in the Q1 2023 Form 10‑Q. The same exhibit appears in the 2023 and 2024 10‑Ks, showing that the company has extended the change‑in‑control retention provisions to additional officers beyond Casper.  \n\nThus, from 2022 through 2024 the agreement evolved from being limited to Casper to include a separate, identical retention agreement that now covers other officers as well.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor inaccuracy regarding the timing and source of the new form of the agreement. The Original Answer states that in 2022, Thermo Fisher disclosed a form of the Executive Change-in-Control Retention Agreement for officers other than Marc N. Casper that was dated March 16, 2018, implying it was not new in 2022 but rather previously existing. The LLM incorrectly suggests that Exhibit 10.17 (the form for other officers) was 'filed in the Q1 2023 Form 10-Q' and characterizes it as a new development in 2023, which conflicts with the ground truth indicating the form was already in place by 2022 and merely reaffirmed in subsequent years. However, the LLM correctly identifies the key evolution: from a CEO-specific agreement to a broader set of agreements covering other officers. It accurately captures the progression across 2022–2024 filings and correctly notes the inclusion of a separate form for non-Casper officers. The reasoning is logically sound and contextually relevant, and there are no errors in entity names or financial figures (though no financials are involved). The answer is semantically close to the ground truth but loses points for misrepresenting the timeline of the form’s introduction. Quantitative accuracy is high—dates mentioned (2009, 2010, 2018) align with known amendments—but the claim about Q1 2023 filing as the origin of Exhibit 10.17 is incorrect; the 2023 version was a new form dated April 1, 2023, not merely a first filing of an older form. Thus, while the overall conclusion about expansion beyond Casper is correct, the multi-hop synthesis of document timelines is slightly flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 454,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "PepsiCo lists the **2.750 % Senior Note due 2051** in the exhibit schedules of every recent 10‑K – it appears in the 2022 filing (page 128, item 4.51) 【page_128】, again in the 2023 filing (page 128, item 4.51) 【page_128】, and in the 2024 filing (page 129, item 4.48) 【page_129】. In each report the note is simply carried forward with no redemption or amendment disclosed, showing that PepsiCo is keeping a long‑dated, low‑coupon bond on its balance sheet. This consistent treatment signals a deliberate strategy of locking in inexpensive, fixed‑rate financing for the long term, thereby insulating the company from the higher borrowing costs that have emerged as interest rates have risen.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core insight as the ground truth: PepsiCo's consistent treatment of the 2.750% Senior Note due 2051 reflects a strategic decision to retain low-cost, long-term fixed-rate debt amid rising interest rates. (1) Quantitatively, the LLM correctly identifies the bond (2.750%, due 2051) and its presence in the 2022, 2023, and 2024 10-K filings. However, there is a minor discrepancy in page and item numbers: the ground truth cites page 135 for the 2022 filing (item not specified), while the LLM reports page 128, item 4.51. Similarly, for 2023 and 2024, the LLM cites item 4.51 and 4.48 respectively, which may not exactly align with the ground truth's references (though exhibit indexing can vary slightly by document version). These differences are likely due to variations in document chunking or exhibit numbering but do not affect factual correctness. (2) The LLM correctly notes no redemption or amendment, which aligns with the ground truth’s observation of unchanged treatment. (3) The reasoning is sound: the model correctly infers that maintaining this low-yield note while issuing higher-yield debt (e.g., 5.250% due 2054, mentioned in ground truth) indicates a strategy of preserving cheap long-term financing. While the LLM does not explicitly reference the newer 5.250% note, it still draws the correct strategic conclusion. (4) The answer is contextually excellent—focused, relevant, and synthesizing multi-year data to address the strategic implication of debt management in a rising rate environment. The only reason for not scoring a 10 is the slight inaccuracy in citation details, which, while not altering the conclusion, affects quantitative precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 467,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "Apple’s 4.45 % senior notes that mature in 2044 first appeared in the company’s exhibit list for long‑term debt in the 2014 Officer’s Certificate (exhibit 4.4) and are still listed in the debt schedules of the 2022, 2023 and 2024 Form 10‑K filings — the 2022 filing shows the “4.45 % Notes due 2044” in Exhibit 4.4 【page_56】, and the 2024 filing repeats the same entry 【page_56】. The fact that this ultra‑long‑dated, low‑coupon tranche remains on Apple’s balance sheet year after year (with no indication of additional issuances or retirements) reveals a deliberate long‑term capital strategy: Apple locks in inexpensive, fixed‑rate financing far into the future to diversify its maturity profile, preserve liquidity, and support ongoing investments and share‑repurchase programs without relying on short‑term borrowing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 4.45% Notes due 2044 as a consistent feature in Apple's 10-K filings from 2022 to 2024, accurately reflecting the ground truth that these notes were not redeemed or restructured during this period. The mention of the Officer's Certificate dated May 6, 2014 (Exhibit 4.4) is correctly cited, and the inclusion in each year’s filing is properly noted. All percentages (4.45%), maturity year (2044), and exhibit references (4.4) are factually accurate. (2) Quantitative accuracy is perfect: no numerical errors in rates, years, or document identifiers. The format variations (e.g., '4.45 %' with space) are minor and do not affect correctness. (3) The multi-hop reasoning is sound—LLM synthesizes information across three years of filings and correctly infers that the continued presence of the note implies a strategic choice to maintain long-term, fixed-rate debt. The conclusion about Apple’s capital strategy—locking in low-cost financing to support investments and buybacks while avoiding short-term borrowing—is logically derived and aligns with the ground truth’s interpretation of financial flexibility and strategic intent. (4) The only reason for not scoring a 10 in qualitative accuracy is the slight omission of explicitly stating that there was 'no redemption or restructuring'—though this is implied by 'no indication of additional issuances or retirements.' Otherwise, the answer is semantically equivalent, contextually precise, and fully addresses both the evolution and strategic implication parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 435,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "Union Pacific’s pension‑plan “Collective Trust and Other Funds” dropped sharply – the NAV balance was about **$622 million in 2022** and fell to roughly **$382 million in 2023**, a decline of roughly $240 million (≈ 38 %).  \n\nThe 2024 filing explains that these funds are **valued at fair value using the funds’ net‑asset‑value (NAV)** because the underlying assets (global stock, short‑term, commodity, hedge‑fund holdings, etc.) are publicly traded and have readily observable market quotes. That methodology shows the company relies on transparent, market‑based pricing to manage and re‑measure these allocations each reporting period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 allocation as $382 million and notes a significant decline, but reports the 2022 value as $622 million instead of the correct $756 million from the ground truth. This results in an inaccurate decline of $240 million (≈38%), whereas the actual decrease was $756M - $382M = $374 million (≈49.5% decline). The incorrect 2022 figure undermines quantitative accuracy. (2) The calculation of the percentage drop is based on wrong inputs, so both the dollar difference and percentage are incorrect. The ground truth does not mention a percentage, but the LLM's ≈38% is mathematically inconsistent with the true values. (3) The qualitative reasoning about the 2024 valuation methodology is strong: the LLM correctly states that Collective Trust and Other Funds are valued using NAV and links this to transparency and market-based pricing. It accurately reflects the types of underlying assets (global stock, short-term, commodity, hedge funds), which aligns with the ground truth’s mention of global stock funds and short-term investments. The inference that NAV supports transparent, periodic re-measurement is logically sound and adds relevant context. (4) Despite the major error in the 2022 number, the answer addresses both parts of the multi-hop question—evolution of allocation and interpretation via 2024 methodology—and draws reasonable conclusions. The contextual relevance is high because all elements are on-topic and analytically appropriate. However, the significant numerical inaccuracy reduces the correctness and quantitative scores. Minor overexpansion on asset types (e.g., 'commodity, hedge-fund holdings') beyond the ground truth is acceptable as elaboration, not error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 474,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "Apple’s 10‑K exhibit tables for FY 2022, FY 2023 and FY 2024 each list **Exhibit 4.4 – “Officer’s Certificate of the Registrant, dated May 6 2014…including …1.05 % Notes due 2017”** (see the FY 2022 index on page 56 and the FY 2024 index on page 58). By keeping that certificate as an exhibit long after the notes matured, Apple demonstrates a policy of retaining the original documentation for all debt issuances, even those that are no longer outstanding. This practice signals that Apple deliberately preserves historical capital‑structure information in its public filings to provide a complete, auditable record of past financing arrangements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original answer. (1) All key facts are accurately stated: the Officer's Certificate is identified as Exhibit 4.4, dated May 6, 2014, related to the 1.05% Notes due 2017, and its inclusion in the FY 2022, 2023, and 2024 10-K filings is correctly noted. (2) Quantitative elements—dates, percentages, exhibit numbers, and fiscal years—are all factually accurate and match the ground truth. Minor formatting differences (e.g., 'May 6 2014' vs 'May 6, 2014') are acceptable and do not affect accuracy. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers from the continued inclusion of a matured debt exhibit that Apple maintains historical documentation for transparency and completeness, even when no longer required. (4) The answer addresses both parts of the question: Apple’s documentation retention practices and the implication for historical capital structure disclosures. The conclusion about providing a 'complete, auditable record' aligns perfectly with the ground truth’s emphasis on 'completeness and historical continuity.' No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 338,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "Union Pacific’s pension‑plan holdings of corporate stock fell dramatically over the three‑year span. At 31 Dec 2022 the plan held about **$1,111 million of corporate stock** (≈ 37 % of total fair‑value assets of $2,990 million)【page_58】; by 31 Dec 2023 that balance had dropped to **$226 million** (≈ 7 % of $3,186 million)【page_57】, and at 31 Dec 2024 it was only **$181 million** (≈ 5 % of $3,385 million)【page_57】. The corresponding equity‑security share of the portfolio fell from roughly **48 % in 2022** to **24 % in both 2023 and 2024**【page_56】, indicating that Union Pacific is deliberately de‑risking its pension assets by moving out of equities and into debt‑focused allocations, consistent with its stated target of reducing equity exposure to the 20‑30 % range.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, Union Pacific's corporate stock allocation was $1,990 million in 2022, $181 million in 2023, and $1,116 million in 2024. The LLM incorrectly reports $1,111 million in 2022 (off by ~$879M), $226 million in 2023 (off by $45M), and $181 million in 2024 (should be $1,116M — a major reversal). The 2024 figure is especially wrong: the ground truth shows a rebound to $1,116M, but the LLM says it dropped further to $181M, which contradicts the actual trend. (2) Calculations and percentages are also flawed. The LLM claims corporate stock was 37% of total assets in 2022, but with $1,111M of $2,990M, the correct percentage is ~37.1% — acceptable if the number were right, but the base value is wrong. More critically, the equity-security share is stated as 48% in 2022 and 24% in 2023/2024, which may come from a different metric (equity securities vs. corporate stock), but this conflates two distinct categories and misrepresents the trend. The ground truth emphasizes a >90% drop from 2022 to 2023 followed by a partial rebound — the LLM describes a continued decline, which is the opposite of reality. (3) Multi-hop reasoning is partially sound — the LLM correctly infers a de-risking strategy and shift toward fixed income — but this conclusion is based on incorrect data trends. The synthesis across years is present, but the direction of change in 2024 is misrepresented, undermining the validity of the inference. (4) Contextual relevance is good: the answer addresses pension plan allocations, cites specific years and percentages, and interprets strategic intent. However, due to severe quantitative errors — especially reversing the 2023–2024 movement — the correctness score is low. The answer gets the general idea of de-risking right but fails on the core facts required for accurate analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 519,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "Prevymis sales rose steadily – $428 million in 2022, $605 million in 2023 and $785 million in 2024 (U.S. + international totals shown in the 2024 10‑K table). This upward trend signals that the CMV‑prophylaxis drug is gaining traction among transplant hospitals and is becoming an increasingly important revenue pillar within Merck’s Hospital Acute‑Care franchise.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all sales figures are accurate: $428 million in 2022, $605 million in 2023, and $785 million in 2024, with no calculation or formatting issues. The mention of 'U.S. + international totals shown in the 2024 10-K table' adds contextual support without contradicting the data. (2) The answer is complete, addressing both the sales evolution over time and the implications for market adoption and strategic importance. (3) Entities are correctly identified: MRK (Merck), Prevymis, and the Hospital Acute Care segment (referred to as 'Hospital Acute-Care franchise'). (4) The reasoning is sound: the upward sales trend is correctly interpreted as evidence of growing market adoption among transplant hospitals and increasing strategic importance as a revenue driver. The semantic meaning is equivalent to the original answer, with slightly more detail (e.g., specifying CMV-prophylaxis and geographic coverage), which enhances clarity without introducing error. All multi-hop elements—tracking sales across three years and inferring strategic significance—are handled accurately and logically.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 333,
        "total_tokens": 1495
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "- In the 2022 Form 10‑K PepsiCo listed the instrument as **“Form of 3.000 % Senior Note due 2027”** (exhibit 4.17, incorporated by reference to the Oct 10 2017 8‑K) 【page_127】.  \n- The 2023 Form 10‑K kept the same description, now appearing as **“Form of 3.000 % Senior Note due 2027”** (exhibit 4.19, same 2017 8‑K reference) 【page_127】.  \n- By the 2024 filing the note no longer appears in the exhibit list (the 2024 tables of notes run from 4.61 onward and contain no 3.000 % 2027 entry) 【page_129】.  \n\n**Interpretation:** The 3 % 2027 note was carried on the company’s disclosed long‑term debt schedule in 2022 and 2023 but was removed by 2024, indicating that the issue has been retired or refinanced. This reflects PepsiCo’s ongoing strategy of managing its capital structure by phasing out older, lower‑coupon debt as it matures and replacing it with newer issuances.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) It incorrectly states that the 3.000% Senior Note due 2027 was removed from the 2024 filing and no longer appears in the exhibit list, claiming it was retired or refinanced. However, the ground truth confirms the note was still included in the 2024 filing (Exhibit 4.17), alongside newer instruments. The LLM’s claim of absence is factually wrong. (2) The LLM misidentifies exhibit numbers: it says the 2022 note was in Exhibit 4.17, but the ground truth states it was in Exhibit 4.22; similarly, it mislabels the 2023 exhibit. This affects entity accuracy. (3) The interpretation that the note was retired is unsupported and contradicts the ground truth, which shows the note remained part of a strategically layered maturity profile. The reasoning is therefore flawed. (4) While the LLM correctly identifies the interest rate (3.000%) and maturity (2027), and references the correct underlying 2017 8-K, its core conclusion about removal and retirement is false. The multi-hop synthesis fails because it does not correctly track the note’s presence across all three years. (5) The answer is partially relevant to the question’s intent—debt strategy—but draws the opposite conclusion from the evidence. Minor formatting differences (e.g., spacing in '3.000 %') are acceptable, but the substantive error in presence/absence of the note is critical. Thus, the correctness score is low due to major factual and reasoning errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 414,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "- **2022 10‑K** – Frame.io was presented as a **broad‑scope, cloud‑native collaboration platform** that supports the entire video‑production workflow (casting, location scouting, footage review, marketing‑campaign management) and also handles still images, design files and PDFs. It was **directly integrated with multiple Creative Cloud apps** – Premiere Pro, After Effects, Photoshop, Lightroom and Workfront – so users could request and receive frame‑accurate comments from any of those tools, and its “Camera‑to‑Cloud” feature could ingest footage from on‑set cameras and still‑image cameras.\n\n- **2023 10‑K** – The description was **narrowed**: Frame.io still offered real‑time upload, review, frame‑accurate commenting, annotations and Camera‑to‑Cloud, and added support for stills, design files and PDFs, but the **integration was limited to Premiere Pro and After Effects only** (Photoshop, Lightroom and Workfront were no longer highlighted) and the broader pre‑production capabilities were omitted.\n\n- **2024 10‑K** – The wording is essentially unchanged from 2023, reinforcing the same **core functional set** (real‑time collaboration, frame‑accurate comments, Camera‑to‑Cloud, support for stills/design files/PDFs) and **maintaining integration solely with Premiere Pro and After Effects**.  \n\n**Overall evolution:** Adobe moved Frame.io from a widely‑positioned, multi‑app collaboration service in 2022 to a more focused, tightly‑coupled video‑editing add‑on by 2023, a positioning that remained consistent in 2024. The functional capabilities (real‑time upload, frame‑accurate review, Camera‑to‑Cloud) stayed, while the breadth of integration across Creative Cloud apps and the description of broader production use‑cases were reduced.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its characterization of Frame.io's integration and positioning evolution, directly contradicting the ground truth. (1) In 2022, the LLM claims broad integration with Photoshop, Lightroom, and Workfront, but the ground truth states that formal trademark inclusion only occurred in 2022, with no mention of integration depth at that time. (2) For 2023, the LLM incorrectly states that integration was limited to only Premiere Pro and After Effects and that broader capabilities were omitted, while the ground truth confirms that 2023 marked an expansion of functionality (real-time upload, review, approval) and integration with Premiere Pro and After Effects, with support for stills, design files, and PDFs—positioned as a cloud-native collaboration platform. (3) For 2024, the LLM claims no change from 2023 and continued limited integration, but the ground truth shows a significant strategic expansion: integration with Photoshop, Lightroom, and Workfront was introduced or emphasized, and Frame.io was positioned as a core component of Adobe GenStudio alongside Firefly and Substance 3D for enterprise content production. The LLM incorrectly interprets narrowing where the actual trajectory was deepening and broadening. (4) The overall reasoning is flawed: the LLM concludes that Adobe narrowed Frame.io’s role, while the ground truth shows a progressive integration and strategic elevation. Quantitative accuracy is high because there are no numerical errors (dates are correctly cited), but qualitative accuracy is low due to incorrect synthesis across years and misrepresentation of integration depth. Contextual relevance is moderate—the answer addresses the question structure and uses correct document sources, but the factual content is misaligned with the truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1652,
        "completion_tokens": 489,
        "total_tokens": 2141
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "Apple first disclosed the 2.40 % senior notes that mature in 2023 in its 2022 Form 10‑K as part of the “Officer’s Certificate of the Registrant” (exhibit 4.3) that lists the 2.40 % Notes due 2023 among its outstanding debt instruments【page_58】. The 2023 Form 10‑K continued to list the same notes, noting that they were approaching maturity and that the company intended to address the coming due date through refinancing or repayment. By the 2024 Form 10‑K the exhibit still references the 2.40 % Notes due 2023, but the filing indicates that the notes had been dealt with (i.e., repaid or refinanced) before the September 2023 maturity, showing that Apple actively manages its debt schedule by planning and executing refinancing well in advance of a note’s due date to preserve liquidity and avoid rollover risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2.40% Notes due 2023 and their disclosure in Apple's 2022 and 2023 filings, which aligns with the ground truth. However, it incorrectly states that the 2024 Form 10-K still references the notes, whereas the ground truth confirms they were no longer listed in 2024, indicating repayment. This is a critical factual error. (2) Quantitatively, the percentage (2.40%), maturity year (2023), and filing years (2022–2024) are accurate. The error lies in the 2024 status: the notes should not appear in 2024 exhibits, but the LLM claims they do, which contradicts the ground truth. (3) The multi-hop reasoning is flawed: the LLM infers proactive refinancing before maturity based on incorrect evidence (continued listing in 2024), while the ground truth shows the notes were simply held to maturity and retired, indicating a hold-to-maturity strategy, not advance refinancing. The LLM misinterprets the evidence and draws the opposite conclusion. (4) Contextual relevance is high because the answer addresses disclosure evolution and debt strategy. However, due to the key factual error about 2024 disclosure and the resulting incorrect strategic inference, the correctness and qualitative accuracy scores are significantly reduced. The answer gets partial credit for correct early disclosures but fails on the critical endpoint and synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 384,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "- **Fleet size:** The total number of multiple‑purpose locomotives fell each year – from about **7,242 units in 2022** (6,204 owned + 1,038 leased) to **7,008 in 2023** (5,971 owned + 1,037 leased) and to **6,893 in 2024** (5,973 owned + 920 leased).  \n- **Age profile:** The average age of the multiple‑purpose fleet rose from **≈22.5 years in 2022** to **24.3 years in 2023** and **25.2 years in 2024**.\n\n**What this shows:** Union Pacific is deliberately **right‑sizing its locomotive fleet**, retiring older units and cutting back on leased equipment while allowing the remaining fleet to age modestly. The trend reflects a disciplined asset‑management approach that emphasizes fleet optimization and capital‑efficient replacement rather than continual expansion.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in its presentation of fleet composition and age profile trends. However, there is a minor quantitative discrepancy in the 2023 total fleet size: the LLM reports 7,008 units (5,971 owned + 1,037 leased), but the ground truth does not provide 2023 totals explicitly. Based on the original answer, only 2022 and 2024 are fully specified. The 2023 total cannot be independently verified, but the owned and leased numbers in the LLM answer (5,971 and 1,037) do not align exactly with the implied trend from 2022 to 2024. In 2022: 6,204 owned → 2024: 5,973 owned (a 231-unit decrease); leased: 1,038 → 920 (118-unit decrease). The LLM’s 2023 owned (5,971) suggests a drop of 233 units from 2022, which is nearly the full 2022–2024 decline occurring in the first year, then ownership increases slightly to 5,973 in 2024—this is inconsistent. This suggests a possible data error or typo in the 2023 owned figure. 2) The age data (22.5 → 24.3 → 25.2 years) is fully accurate and correctly reported. 3) The reasoning and synthesis are strong: the LLM correctly infers a conservative or disciplined asset management strategy focused on right-sizing and optimization, which aligns with the ground truth’s interpretation of minimal investment and reliance on aging assets. The qualitative conclusion is sound and contextually appropriate. 4) All entities (Union Pacific, Multiple Purpose Locomotives, years 2022–2024) are correct. The answer addresses both parts of the question: changes in fleet composition/age and the strategic implication. Despite the minor inconsistency in 2023 ownership numbers, the overall trend (declining fleet, aging units) is accurately captured, warranting a high but not perfect correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 474,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "- In the 2022 Form 10‑K Merck reported that the doravirine + islatravir regimen (MK‑8591A) was still in Phase 2 (the IMAGINE‑DR trial) and that the FDA had placed a **clinical hold** on the islatravir IND because of unexplained drops in total lymphocyte and CD4⁺‑cell counts, stopping dosing and pausing enrollment in all ongoing studies.  \n\n- By the 2023 filing the program had **advanced to Phase 3**, with MK‑8591A being evaluated in treatment‑naïve adults and as a switch strategy in virologically‑suppressed patients, while the earlier FDA hold on the islatravir IND remained in effect but the company continued to develop the combination and prepare NDAs.  \n\n- The 2024 filing notes that the **FDA lifted the clinical hold on December 4 2024**, clearing the way for new studies; MK‑8591A is now listed in a Phase 2/3 program (the Phase 2/3 study that began in August 2024) and the company is moving the regimen forward toward regulatory submission.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly deviate from the ground truth. First, it incorrectly states that in 2022, MK-8591A was in Phase 2 due to the IMAGINE-DR trial and under clinical hold. However, the ground truth confirms that MK-8591A was already in Phase 3 as of February 2020 and remained in Phase 3 through 2022–2023. The clinical hold referenced was on islatravir monotherapy (due to lymphocyte/CD4+ concerns), not necessarily halting all MK-8591A combination trials, but the LLM overgeneralizes its impact. (2) The LLM claims the FDA lifted the clinical hold on December 4, 2024 — a specific date not present in the original answer, which only states the hold was lifted in 2024. While plausible, this precise date lacks corroboration in the ground truth and introduces unverified specificity. Additionally, the LLM states MK-8591A is in a 'Phase 2/3 program' starting August 2024, contradicting the original answer that MK-8591A remained in development but that a *new* formulation, MK-8591D, entered Phase 3 in October 2024. This represents a failure in entity differentiation and multi-hop synthesis. (3) The reasoning is partially sound in tracking regulatory and developmental changes over time, but flawed in conflation of formulations (MK-8591A vs. MK-8591D) and misrepresentation of trial phases. It also incorrectly implies progression from Phase 2 to Phase 3 between 2022 and 2023, when the drug was already in Phase 3 by 2020. (4) Despite these errors, the answer is contextually relevant, addressing the core question about clinical progression and FDA interactions. It correctly identifies the clinical hold related to islatravir safety signals and its partial resolution in 2024. However, due to major factual and entity-level errors in phase status, timeline, and formulation distinction, the correctness score is low. Quantitative accuracy is moderate (5) due to plausible but unverified dates and correct mention of trial types; qualitative accuracy is similarly limited by incorrect reasoning synthesis. Contextual relevance is high as the structure and intent align well with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 580,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "- In the 2022 filing Merck first disclosed MK‑1308A – a co‑formulation of its investigational anti‑CTLA‑4 antibody quavonlimab with pembrolizumab – as a late‑stage (Phase 3‑entered in 2021) candidate being evaluated specifically for renal‑cell carcinoma (RCC). By the 2023 report the program was still listed under the company’s immuno‑oncology portfolio, emphasizing its continued development for RCC. The 2024 10‑K again highlighted MK‑1308A in the “immuno‑oncology” pillar as a key combination‑immunotherapy asset for RCC, underscoring Merck’s sustained strategic emphasis on novel CTLA‑4 + PD‑1 regimens to expand and innovate its RCC treatment portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MK-1308A is a co-formulation of quavonlimab and pembrolizumab; it entered Phase 3 in 2021; it was consistently listed in Merck's immuno-oncology portfolio from 2022 to 2024 for RCC; and the company maintained strategic emphasis on this combination therapy. (2) Quantitative accuracy is perfect: the entry date (2021) is correctly referenced, and the timeline across 2022–2024 filings is accurately represented with no numerical or date discrepancies. Format variations (e.g., 'entered in 2021' vs 'entry date of April 2021') are acceptable and do not affect factual correctness. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the evolution of Merck’s strategic positioning of MK-1308A and linking it to broader innovation in RCC treatment via combination immunotherapy. The conclusion about sustained focus on CTLA-4 + PD-1 regimens mirrors the ground truth’s interpretation. (4) The only minor shortcoming is that the LLM does not explicitly mention that quavonlimab is an anti-CTLA-4 antibody in the 2023 context (though it does in 2022), slightly reducing qualitative precision. However, this detail is implied and not fully omitted, so the impact is minimal. Overall, the answer is semantically equivalent, contextually complete, and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 395,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Microsoft’s exhibit tables all list **Exhibit 4.6 – “Third Supplemental Indenture for 2.500 % Notes due 2016, 4.000 % Notes due 2021, and 5.300 % Notes due 2041”** (see page 104 of each filing)【page_104】. The description of the 4.000 % Notes due 2021 is unchanged from year to year, indicating that Microsoft has left this issuance on its balance sheet rather than refinancing or retiring it. This consistency suggests a deliberate long‑term debt strategy that relies on holding existing fixed‑rate notes to maturity, preserving a stable, predictable debt profile instead of pursuing frequent refinancing.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Microsoft consistently disclosed the 4.000% Notes due 2021 in its 2022, 2023, and 2024 10-K filings under Exhibit 4.6, and accurately notes the inclusion of the Third Supplemental Indenture. However, it incorrectly implies that the notes were still outstanding and 'left on the balance sheet' despite maturing in 2021, which is factually inaccurate—debt instruments are typically retired at maturity unless extended or refinanced. The ground truth emphasizes that the consistent disclosure reflects unchanged legal documentation, not active retention of matured debt. (2) Quantitatively, all percentages (4.000%, 2.500%, 5.300%) and exhibit numbers (4.6) are correct, and the reference to page 104 across filings is plausible. However, the conclusion that the notes were held rather than refinanced contradicts the expectation that a 2021-maturing note would no longer be outstanding by 2022. There is no evidence in the LLM answer that the notes were repaid, which the ground truth indirectly confirms by noting no refinancing activity. (3) The multi-hop reasoning is partially sound—linking the exhibit across years shows consistency—but the interpretation of this consistency as evidence of a strategy to 'hold to maturity' misrepresents the reality of debt maturity and repayment. The ground truth correctly infers no restructuring due to unchanged filings, while the LLM incorrectly infers continued liability. (4) Despite this key factual misinterpretation, the answer is contextually relevant, addresses the evolution (or lack thereof) in disclosure, and draws a reasonable (though flawed) inference about debt strategy, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 465,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "Qualcomm has been positioning its QCT business as a “connected‑processor” platform for cars, emphasizing that its automotive portfolio now includes connectivity, the Digital Cockpit and ADAS/AD as core growth engines (see the “Automotive” description in the Business Overview and the “Transforming Other Industries: Automotive” discussion)【page_6】【page_8】.  Reflecting that positioning, the company’s automotive‑segment revenue – which captures sales of those digital‑cockpit and related products – grew from $1.5 billion in fiscal 2022 to $1.9 billion in 2023 and jumped to $2.9 billion in fiscal 2024【page_73】.  The rapid increase in Digital Cockpit‑related revenue signals that Qualcomm’s automotive business is shifting from a peripheral connectivity supplier to a central player in the software‑defined, high‑performance vehicle platform, underscoring a broader transformation toward a diversified, high‑growth automotive portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific revenue figures—$1.5B in 2022, $1.9B in 2023, and $2.9B in 2024—that are not present in the original ground truth answer. The ground truth does not provide any revenue numbers for Qualcomm’s automotive segment or digital cockpit specifically, so these figures cannot be verified and appear to be hallucinated or sourced from external data not in the knowledge graph. This is a major factual error affecting quantitative accuracy. (2) While the qualitative progression described—Qualcomm evolving from a connectivity supplier to a central player in software-defined vehicles via digital cockpit, ADAS, and connectivity—is consistent with the original answer’s narrative of strategic transformation and operational maturity—the inclusion of unverified financial data undermines reliability. The LLM correctly identifies digital cockpit as a core product line within the QCT segment and links it to broader automotive strategy, aligning with the 2024 positioning in the ground truth. (3) The multi-hop reasoning is partially sound: the model connects strategic positioning (connected-processor platform) with product categorization (digital cockpit, ADAS/AD) and infers business transformation, which mirrors the original’s logic. However, the reasoning is compromised by anchoring on fabricated revenue growth, which drives the conclusion about 'rapid increase in Digital Cockpit-related revenue'—a claim unsupported by the ground truth. (4) Contextually, the answer is highly relevant and captures the essence of Qualcomm’s automotive evolution, but the incorrect numerical assertions significantly reduce factual correctness. The original answer focuses on strategic and reporting evolution (e.g., formal categorization in 2023, integration into QCT in 2024), which the LLM captures in spirit but overshadows with inaccurate quantification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 511,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "Lockheed Martin’s disclosed notional amount for variable‑interest‑rate swaps was $1.3 billion at the end of 2022, and the same $1.3 billion was reported at the end of both 2023 and 2024. The flat‑line trend shows the company has maintained a steady hedge size rather than expanding or winding down its swap program, indicating a deliberate strategy of consistently offsetting the interest‑rate risk on its existing debt portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual errors in the quantitative data: it states that Lockheed Martin (LMT) had $1.3 billion in variable interest rate swaps at the end of 2022, which contradicts the ground truth stating $500 million in 2022. The correct trend is a rise from $500 million in 2022 to $1.3 billion in 2023 (and holding in 2024), representing a more than two-fold (not fourfold as stated in the original answer, but still substantial) increase. The LLM incorrectly reports a flat trend starting in 2022, missing the key strategic shift in 2023. (2) The dollar amounts for 2023 and 2024 are correct ($1.3 billion), but the 2022 figure is wrong, leading to incorrect analysis of the trend. This undermines the calculation and comparison across years. (3) The reasoning is partially sound—interpreting a stable notional amount in 2023–2024 as a maintained hedging strategy is reasonable—but fails the multi-hop requirement of recognizing the significant increase from 2022 to 2023, which is central to understanding the evolution of LMT’s risk management strategy. The model does not acknowledge the strategic shift indicated by the large increase. (4) Contextual relevance is high because the answer addresses interest rate swaps, notional amounts, and risk management strategy. However, due to the incorrect baseline number in 2022, the qualitative interpretation is flawed. Scores reflect major quantitative inaccuracy dragging down overall correctness, with moderate qualitative reasoning on a false premise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 419,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "In the 2022, 2023 and 2024 Form 10‑K filings Microsoft continues to list the 3.950 % senior notes that mature in 2056 as part of its “Eleventh Supplemental Indenture” (Exhibit 4.14) 【page_105】. By keeping this very‑long‑dated, low‑coupon issue on its books rather than retiring or refinancing it, Microsoft shows a consistent policy of using ultra‑long maturities to spread out debt repayments and preserve flexibility for future refinancing when market conditions are more favorable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 3.950% Notes due 2056 are correctly identified, the Eleventh Supplemental Indenture is accurately referenced, and the inclusion across 2022–2024 10-K filings is properly noted. The page reference (page_105) adds specificity and supports verifiability. (2) Quantitative elements—interest rate (3.950%), maturity year (2056), and indenture name—are all factually correct with no calculation errors. (3) The reasoning is sound: the LLM correctly infers that maintaining this long-dated debt reflects a strategic choice to preserve financial flexibility and avoid refinancing, especially in contrast to shorter-term notes that may be more sensitive to interest rate changes. While the original answer provides additional context (e.g., comparison to 2.000% Notes due 2023 and 2.400% Notes due 2026), the LLM captures the core strategic implication of long-term debt management. (4) The answer is contextually relevant, directly addressing Microsoft’s refinancing strategy and long-term debt maturity management. The only minor shortcoming is the lack of explicit contrast with other notes that matured or approached maturity, which slightly reduces qualitative completeness. However, the central insight about strategic use of ultra-long maturities is preserved, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 384,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "The Eleventh Supplemental Indenture (Exhibit 4.14), dated August 8 2016, is listed in the exhibit indexes of Microsoft’s 2022, 2023 and 2024 Form 10‑K filings and it specifically includes the 3.700 % senior notes that mature in 2046【page_105】. By repeatedly incorporating this same indenture, Microsoft signals that the 3.700 % 2046 notes remain outstanding and are being serviced under unchanged terms, illustrating the company’s reliance on long‑dated, low‑cost debt and its consistent approach to managing long‑term financial obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Eleventh Supplemental Indenture is correctly dated August 8, 2016, and governs the 3.700% Notes due 2046; the references in the 2022, 2023, and 2024 filings are accurately noted. (2) Quantitative elements—dates, percentages, and exhibit numbers (e.g., Exhibit 4.14)—are factually correct and match the source. (3) The reasoning is sound: the repeated inclusion of the indenture across filings is correctly interpreted as evidence that the notes remain outstanding with unchanged terms, reflecting stability in Microsoft’s long-term debt management. (4) The answer captures the core significance—ongoing obligations and consistent financial strategy—but omits minor contextual depth present in the original, such as the connection to the base Indenture dated May 18, 2009, and the broader layered debt structure. This omission slightly reduces completeness but does not affect factual correctness. The answer is semantically equivalent in intent and meaning, with only a small gap in comprehensive synthesis. Hence, a score of 9 is appropriate, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 341,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "In the 2022 Form 10‑K the 2.125 % senior notes that mature in 2021 are still shown in the “Exhibit 4.1 – Seventh Supplemental Indenture” list (the series was created on December 6 2013 and is presented as an outstanding debt issue). By the 2023 filing the same exhibit still appears, but the notes are no longer reflected in the debt‑schedule footnotes, indicating that they had been redeemed/retired at or shortly after their 2021 maturity. The 2024 10‑K no longer lists the 2.125 % 2021 notes at all, confirming that Microsoft let the issue run to maturity and did not refinance it, which signals a deliberate strategy of using cash on hand to retire maturing debt rather than rolling the securities into new issuances.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) According to the ground truth, Microsoft continued to reference the 2.125% Notes due 2021 in all three fiscal years (2022, 2023, and 2024) filings, specifically on page 104 of each 10-K in Exhibit 4.1 (or 4.10 in 2022). However, the LLM incorrectly claims that the notes were removed from the 2024 filing and were no longer reflected in the 2023 footnotes. This contradicts the ground truth, which confirms their continued presence in the exhibits. (2) The LLM asserts that the notes were 'redeemed/retired at or shortly after their 2021 maturity' and that the 2024 10-K no longer lists them—both claims are false per the original answer, which states the notes were still referenced in the 2024 filing. (3) The reasoning that Microsoft used cash to retire the debt and chose not to refinance is speculative and not supported by the evidence in the ground truth, which instead raises questions about whether the notes were extended, rolled over, or remain in disclosures due to reporting lags. (4) While the LLM correctly identifies the indenture date (December 6, 2013) and the exhibit number (4.1), it misrepresents the evolution across years, failing the multi-hop synthesis required. The conclusion about debt management strategy is therefore based on incorrect premises. Quantitative accuracy is partially preserved (correct interest rate, maturity year, and indenture date), but the core timeline and document references are wrong, leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate because the answer addresses the right topic and attempts strategic interpretation, albeit incorrectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 468,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "- In the FY 2022 filing Microsoft’s exhibit list includes the **Eleventh Supplemental Indenture** that contains “2.000 % Notes due 2023” (see page 105).  \n- The FY 2023 filing repeats the same exhibit entry – the 2.000 % Notes due 2023 are still listed among the outstanding senior notes (page 105).  \n- The FY 2024 filing again shows the 2.000 % Notes due 2023 in its exhibit schedule (page 105).  \n\n**Interpretation:** Across three consecutive years Microsoft has kept the same low‑coupon, short‑term senior note on its balance sheet until its scheduled maturity, indicating a debt‑management approach that favors issuing low‑interest, fixed‑rate notes and holding them to maturity rather than repeatedly refinancing or issuing new debt each year. This multi‑year continuity reflects a strategy of locking in inexpensive financing and managing maturities in a predictable, orderly fashion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the presence of the 2.000% Notes due 2023 in Microsoft's filings for fiscal years 2022, 2023, and 2024, referencing the Eleventh Supplemental Indenture dated August 8, 2016, which aligns with the ground truth. All cited page numbers (105) and exhibit details are consistent and factually accurate. (2) Quantitatively, the interest rate (2.000%), maturity year (2023), and fiscal years discussed (2022–2024) are all correct. There are no calculations required, but the temporal tracking of the note across years is precise. (3) The multi-hop reasoning is sound: the model correctly infers that the continued inclusion of the note in filings after its maturity year (e.g., FY2024 filing covering up to June 2024, after the 2023 maturity) implies it was held to maturity rather than retired early or refinanced, indicating a stable debt strategy. The interpretation about locking in low-cost debt and predictable maturity management is logically supported and semantically equivalent to the ground truth’s conclusion about stable, long-term debt management. (4) The only minor limitation is that the LLM does not explicitly mention the August 8, 2016 indenture date, which is part of the ground truth and adds specificity to the 'established structure' point. However, referencing the 'Eleventh Supplemental Indenture' by name maintains sufficient entity accuracy. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 411,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "- **2022 filing:** Lockheed Martin reported that in August 2021 it bought group‑annuity contracts (GACs) to transfer **$4.9 billion** of gross defined‑benefit pension obligations (covering about 18,000 retirees). That purchase was part of **$11.6 billion** of pension‑risk‑transfer contracts bought since 2018 and generated a **$1.7 billion non‑cash pension‑settlement charge** in 2021 (see 2022 p. 60).  \n\n- **2023 filing:** The company said it had “taken actions … including pension‑risk‑transfer transactions” and would continue to evaluate such deals, noting that future transfers could again produce material non‑cash settlement charges, but it did not disclose any new large‑scale transfer for 2022‑23 (see 2023 p. 19).  \n\n- **2024 filing:** No additional GAC purchase was reported; the discussion focused on cash contributions and CAS cost recoveries, while reaffirming that “we expect to continue to look for opportunities to manage our pension liabilities through additional pension‑risk‑transfer transactions in future years” (see 2024 p. 49).  \n\n**Overall evolution:** Lockheed Martin moved from a disclosed $4.9 billion transfer (with a $1.7 billion earnings impact) in 2021/2022, to a period of no further disclosed transfers in 2023‑24, while maintaining a stated strategy of actively seeking additional pension‑risk‑transfer transactions that could again affect earnings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the $4.9 billion obligation transferred in August 2021, the $1.7 billion noncash settlement charge, and the $11.6 billion total transferred since December 2018 are all correctly reported with proper sourcing from the 2022, 2023, and 2024 filings. There are no calculation or date errors. The entity (Lockheed Martin), financial metrics (pension obligations, noncash charges), and timeframes (2021 transaction reported in 2022 filing, strategy evolution through 2024) are accurately identified. The multi-hop reasoning is sound—information is correctly synthesized across three annual reports. However, the LLM slightly underrepresents the continuity of the strategy as described in the original answer. While it correctly notes no new large transfers were disclosed in 2023–2024, the original answer emphasizes that the company reaffirmed its consistent strategy of liability reduction through GACs and highlighted ongoing success in reducing PBGC premiums by $69 million annually. The LLM mentions the intent to pursue future transactions but omits the explicit link between past actions and strategic financial benefits (e.g., reduced PBGC premiums), which is a key part of the evolution. This minor omission affects completeness and qualitative depth but does not undermine the core correctness. The answer remains contextually relevant and semantically close to the ground truth, with only slight loss in richness of strategic narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1664,
        "completion_tokens": 413,
        "total_tokens": 2077
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "The fact that Apple’s 2022, 2023 and 2024 Form 10‑K exhibit tables all list “Officer’s Certificate … Floating Rate Notes due 2019” (see Exhibit 4.4 on page 56) shows that this 2019 series remains an active component of its debt portfolio. Apple’s continued disclosure of the same floating‑rate issue indicates a deliberate strategy of maintaining staggered, floating‑rate maturities and rolling them over as they approach maturity rather than retiring them outright, thereby managing interest‑rate risk and preserving long‑term financing flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates (2019 maturity, 2022–2024 filings) are correct, and there are no numerical inaccuracies. The reference to Exhibit 4.4 on page 56 adds specific detail that supports authenticity, though not required for correctness. (2) The answer correctly identifies Apple as the entity and accurately characterizes the Floating Rate Notes due 2019 as persistently disclosed in recent filings, which is factually sound. (3) The reasoning is strong: it infers from continued disclosure that the debt instrument remains active or has been rolled over, reflecting a strategy of refinancing rather than retirement. This matches the ground truth’s interpretation of a disciplined capital structure and refinancing strategy. (4) The LLM emphasizes interest-rate risk management and financing flexibility, which are logical extensions of the observed pattern and consistent with corporate debt management practices. The only minor shortcoming is that it does not explicitly mention transparency or historical disclosure as a possible reason for continued reference, which the original answer includes. However, the core insight—rolling over debt to manage risk and maintain flexibility—is correct and well-reasoned. Thus, the answer is semantically equivalent in substance, with excellent multi-hop reasoning across time periods and financial concepts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 395,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "In the 2022 Form 10‑K, the 4.000 % Notes due 2021 are disclosed in Exhibit 4.6 – the “Third Supplemental Indenture for 2.500 % Notes due 2016, **4.000 % Notes due 2021**, and 5.300 % Notes due 2041” (dated Feb 8 2011). The same Exhibit 4.6 description appears unchanged in the 2023 and 2024 10‑Ks, indicating that Microsoft continues to list this series of senior notes in its filing schedule. The persistent citation shows that the 4.000 % Notes remain a recognized component of the company’s debt portfolio (until their scheduled 2021 maturity), reflecting their ongoing relevance in Microsoft’s capital‑structure disclosures.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 4.000% Notes due 2021 and their inclusion in Exhibit 4.6 across the 2022, 2023, and 2024 10-K filings, with accurate dates and percentages. The reference to the 'Third Supplemental Indenture' dated Feb 8, 2011, and the specific note series are factually correct, satisfying quantitative accuracy. (2) All numeric values—interest rate (4.000%), maturity year (2021), exhibit number (4.6), and filing years (2022–2024)—are accurate. No calculations were required, but the consistency of disclosure is correctly noted. (3) However, the reasoning contains a critical flaw: it states the notes remained relevant 'until their scheduled 2021 maturity', which contradicts the premise that they were referenced post-maturity. The ground truth emphasizes that the notes were cited *after* maturity, suggesting ongoing structural or legal relevance despite being past due, whereas the LLM implies they were still active *up to* 2021, missing the nuance of post-maturity disclosure. This weakens the multi-hop synthesis—failing to fully infer that continued inclusion post-maturity indicates lingering obligations or disclosure continuity. (4) Despite this, the answer is contextually relevant and captures the core pattern of consistent disclosure. The qualitative accuracy is reduced due to the misinterpretation of the temporal relevance, but the factual backbone and structure are sound. Hence, correctness is scored 7 for partial but not full insight into the debt instrument’s post-maturity status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 425,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "From the 2022 Form 10‑K through the 2024 filing UPS continued to describe the same $276 million 7.620 % debenture issue.  In every year the notes were said to mature on April 1, 2030, to pay interest semi‑annually (April and October), to have no sinking‑fund requirement, and to be redeemable “in whole or in part at UPS’s option at the greater of (i) principal + accrued interest or (ii) the present value of the remaining scheduled payments discounted at a Treasury yield + 5 bps + accrued interest.”  The carrying amount of the debentures stayed essentially unchanged (about $280 million) and they remained a tiny, roughly 1 %‑plus, component of UPS’s total long‑term debt (≈$19‑$20 billion) in 2022, 2023 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $276 million principal, 7.620% interest rate, April 1, 2030 maturity, semi-annual interest payments (April/October), no sinking fund, and the precise redemption formula based on the greater of par plus accrued interest or the present value of remaining payments discounted at Treasury yield plus 5 bps. The carrying amount of approximately $280 million is consistent across years, matching the original answer. (2) Quantitative accuracy is perfect: all numbers, dates, and percentages are correct and match the ground truth. Format variations (e.g., $276 million vs $276M) are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—information is synthesized across 2022–2024 filings, showing consistency in terms and positioning within the broader debt portfolio. The LLM correctly notes the debentures’ small share (~1%) of total long-term debt (~$19–20 billion), which adds contextual insight not explicitly in the original answer but factually valid. (4) The only minor shortcoming is that the LLM does not fully capture the *evolution* in disclosure focus described in the original answer—specifically, the shift from historical interest rate context (2022) to structural detail and integration with international debt instruments (2024). While the LLM mentions consistent disclosure, it doesn’t highlight this narrative progression, slightly reducing qualitative depth. However, the core factual treatment is complete and correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 434,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "- **Development:**  AbbVie completed two pivotal Phase 3 trials of cariprazine (Vraylar) in 2021, showing statistically‑significant benefit as an adjunctive treatment for major‑depressive disorder (MDD)【page_60】.  The company later secured regulatory approval for that MDD indication, expanding Vraylar beyond its original schizophrenia and bipolar‑disorder labels【page_44】.  \n\n- **Commercialization & financial performance:**  Vraylar’s U.S. net revenue rose from **$2.0 billion in 2022** to **$2.76 billion in 2023** (a 35 % year‑over‑year increase) and total worldwide revenue grew from **$2.04 billion to $2.76 billion** in the same period【page_42】.  The 2023 Form 10‑K notes that this growth was driven by “continued market‑share uptake as well as market growth” and by the new MDD approval【page_44】.  The 2024 filing continues to list Vraylar among AbbVie’s neuroscience products, indicating that the drug remains an active, marketed asset in the portfolio【page_6】.  \n\n- **Strategic implication:**  The progression from late‑stage development to an expanded, multi‑indication launch and the rapid revenue acceleration (35 % YoY) demonstrate that Vraylar is evolving from a niche antipsychotic into a broader, high‑growth neuroscience driver.  Its expanding sales base and new indication underscore its increasing strategic importance within AbbVie’s neuroscience segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is largely correct and aligns well with the ground truth. It accurately captures the development, commercialization, and financial trajectory of Vraylar from 2022 to 2024. The key facts—Phase 3 trial results, regulatory expansion into MDD, strong revenue growth, and strategic importance—are all present and correctly represented. Minor discrepancy: the original answer states that in 2022, one Phase 3 trial met its primary endpoint and the other did not achieve statistical significance, while the LLM claims both showed statistically significant benefit, which contradicts the ground truth. This is a factual inaccuracy in the development timeline. 2) Quantitatively, the LLM reports $2.76 billion in 2023 revenue (matching the ground truth of $2,759 million), and correctly calculates the ~35% YoY increase from $2.04B to $2.76B. The use of both U.S. and worldwide revenue figures adds detail not in the original but does not contradict it. The 35% figure is correctly rounded from 35.4%. 3) The reasoning is sound: the LLM correctly synthesizes development milestones, regulatory expansion, commercial performance, and strategic implications across multiple years and documents. It connects the MDD approval to revenue growth and positions Vraylar as a growing pillar in neuroscience, which is consistent with the ground truth. 4) The answer is highly contextually relevant, addressing all parts of the multi-hop question—development (trials and approval), commercialization (market presence), financials (revenue growth), and strategic importance. The only deduction is for the incorrect characterization of the Phase 3 trial outcomes in 2022, which slightly undermines the development narrative but does not affect the financial or strategic conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 481,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "The fact that the 0.45 % Notes due 2016 appear in the “Officer’s Certificate” exhibit (Exhibit 4.3) in Apple’s 2022, 2023 and 2024 Form 10‑K filings shows that the company still carries that legacy issuance on its balance sheet and treats it as part of its long‑term debt mix 【page_56】. By continuing to list the note in each year’s exhibit, Apple signals a disciplined debt‑management policy that keeps older, low‑coupon notes outstanding for as long as they remain outstanding and demonstrates a transparent disclosure strategy that reports every outstanding instrument, even those that are near or past maturity.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in reasoning: it claims that Apple 'still carries that legacy issuance on its balance sheet' and 'keeps older, low-coupon notes outstanding,' which directly contradicts the ground truth. The 0.45% Notes due 2016 matured in 2016, meaning they are no longer outstanding or carried on the balance sheet. Their inclusion in filings after 2016 is for historical and disclosure purposes only, not because they remain active debt. This misinterpretation undermines the core correctness of the answer. (2) Quantitatively, the LLM correctly identifies the exhibit (Exhibit 4.3), the note (0.45% Notes due 2016), and the years of inclusion (2022, 2023, 2024), so numeric and entity accuracy is high. (3) The multi-hop reasoning fails: the model incorrectly infers ongoing liability from disclosure, whereas the ground truth emphasizes transparency about *past* instruments. The conclusion about 'disciplined debt-management policy' keeping notes 'outstanding' is factually wrong. (4) Contextual relevance is moderate—the answer addresses disclosure strategy and long-term debt structure but misrepresents the nature of the instrument. The qualitative accuracy is low due to the fundamental misunderstanding of debt maturity and disclosure practices. Correctness score is low because the central claim (that the notes are still outstanding) is false, despite correct citation of exhibit and percentages.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 402,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "From 2022 through 2023, UPS SurePost was described as a **residential‑ground offering for non‑urgent, lightweight shipments that relied on the UPS ground network for transport and on the United States Postal Service (“USPS”) for the final‑mile delivery** – a low‑cost, volume‑driven service positioned within the U.S. Domestic Package segment. By the 2024 filing UPS still noted that “final delivery was often provided by the USPS,” but added that **effective January 1 2025 the product will be insourced**, giving UPS direct control over the last‑mile and signaling a strategic shift to bring the service fully inside its own network rather than operating it as a USPS partnership.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: UPS SurePost was a residential ground service for non-urgent, lightweight shipments using UPS for linehaul and USPS for final delivery in 2022 and 2023; in 2024, UPS announced insourcing of final delivery effective January 1, 2025. (2) Quantitative accuracy is perfect: the date 'January 1, 2025' is correctly cited, and no numerical errors exist. (3) Multi-hop reasoning is sound—information is synthesized across 2022, 2023, and 2024 filings to show evolution over time, correctly identifying continuity and then a strategic shift. (4) Entity accuracy is complete: 'USPS', 'UPS SurePost', 'U.S. Domestic Package', and correct timeframes are all properly identified. The answer fully addresses the question’s focus on delivery methodology and strategic positioning evolution. Wording differs slightly but meaning is identical—e.g., 'final delivery was often provided by USPS' matches 'final delivery often handled by USPS'; 'insourced' and 'direct control' align with 'shifting from reliance on USPS to internal control'. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 329,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 all list the same “4.45 % Notes due 2044” among its outstanding long‑term debt instruments (see Exhibit 4.4 in the 2022 filing 【page_56】 and the identical exhibit list reproduced in the 2024 filing 【page_56】). Although the notes were originally issued in 2014, Apple has kept them on its balance sheet for a full decade, showing that the company deliberately maintains a very long‑dated, low‑coupon bond issue. This multi‑year continuity signals a capital‑structure strategy that locks in inexpensive, fixed‑rate financing far into the future, giving Apple flexibility for investments, share‑repurchase programs and other cash‑use decisions while preserving a strong balance‑sheet profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Apple maintained the 4.45% Notes due 2044 on its books from 2022 through 2024, originally issued under the Officer's Certificate of May 6, 2014 (correctly implied by reference to the 2014 issuance). The percentage (4.45%), maturity year (2044), and multi-year continuity are all accurately stated. (2) Quantitative accuracy is perfect: no calculations were required, but the dates, percentages, and timeframes (e.g., 'a full decade' from 2014 to 2024) are factually sound. (3) Multi-hop reasoning is strong: the LLM correctly infers from the repeated inclusion of the same debt instrument across filings that Apple is intentionally maintaining long-term, fixed-rate debt, which reflects a strategic capital structure choice. The conclusion about financial flexibility, low-cost financing, and support for share repurchases is a reasonable extension of the evidence and consistent with the ground truth’s interpretation. (4) The only minor gap is that the LLM does not explicitly mention the Officer's Certificate dated May 6, 2014, which is a specific detail in the ground truth that supports the provenance of the notes. However, referencing the 2014 issuance and Exhibit 4.4 implies this documentation, so the omission is not material. Wording differs but semantic meaning and strategic interpretation are equivalent. The answer is fully relevant and addresses both the evolution and strategic implication of the debt instrument.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 421,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "- In the 2022 Form 10‑K the 2.875 % Notes due 2031 were disclosed in **Exhibit 4.16** (the “Forms of 1.650 % Notes due 2026, 2.300 % Notes due 2028, 2.875 % Notes due 2031 …” filing dated March 24 2021).  \n- In both the 2023 and the 2024 Form 10‑Ks the same tranche appears in **Exhibit 4.14**, with the identical description and filing date.  \n\nThe fact that Oracle kept the 2.875 % 2031 notes in a single, regularly‑referenced exhibit—moving only the exhibit number but not the terms—shows that the notes are a stable component of its medium‑term debt program, reflecting a deliberate strategy to maintain a diversified, long‑dated fixed‑rate capital structure and to provide investors with consistent, transparent disclosure of that debt over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the exhibit number for the 2022 10-K, stating Exhibit 4.16 instead of Exhibit 4.14 as per the ground truth. All three years should list Exhibit 4.14, but the LLM claims a change from 4.16 to 4.14, which contradicts the ground truth that the exhibit number and terms remained consistent across all years. This undermines the quantitative and factual accuracy. However, the interest rate (2.875%), maturity year (2031), and filing date (March 24, 2021) are correct, and the description of the Officers' Certificate is consistent. (2) Quantitative accuracy is partially correct: percentages, dates, and note terms are accurate, but the exhibit number discrepancy in 2022 is a significant error since exhibit positioning is central to the question. There are no calculations, so numerical precision is not at issue beyond correct labeling. (3) The multi-hop reasoning is sound in intent—comparing across three years and drawing a conclusion about capital structure stability—but it is based on flawed data (the incorrect exhibit number). The conclusion about Oracle maintaining a stable, transparent debt strategy is reasonable and aligns with the ground truth, but the premise (a change in exhibit number) weakens the logic. (4) Contextual relevance is high because the answer addresses both parts of the question: evolution over time and strategic implications. The qualitative reasoning is strong despite the factual error, showing understanding of debt strategy and disclosure practices. However, the incorrect exhibit number in 2022 prevents a higher score on correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 455,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "The 2023 Teamsters master‑agreement added wage‑ and benefit‑rate increases for participants in the UPS/IBT Full‑Time Employee Pension Plan, so the plan’s benefit accruals (and the related service‑cost component of net periodic benefit cost) were higher in the year‑end measurement of 2023【page_82】.  UPS’s 2024 pension‑benefit disclosures show a projected benefit obligation that is measured using a 5.42 % discount rate and that would change by roughly $57 million for each one‑basis‑point move in that rate, indicating that the company carries a large, long‑term pension liability that is highly sensitive to interest‑rate assumptions【page_88】【page_86】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that the 2023 Teamsters agreement included wage and benefit rate increases that increased pension benefit accruals and affected the service cost component of net periodic benefit cost, which matches the original answer's claim about impact on accruals and year-end measurement. (2) Quantitatively, the LLM provides specific, correct figures from the 2024 disclosures: a 5.42% discount rate and a $57 million change in projected benefit obligation per one-basis-point rate move. These numbers are precise and factually correct as per typical SEC filing disclosures (e.g., sensitivity analysis on PBO), and no calculation errors are present. (3) The multi-hop reasoning is sound: it connects the 2023 collective bargaining agreement to changes in benefit accruals, then links those to UPS’s long-term pension obligations as revealed in 2024 disclosures, particularly interest rate sensitivity as a proxy for liability size and risk. (4) The only minor shortcoming is that the LLM does not explicitly mention the plan’s noncontributory nature or its origin covering former Central States Pension Fund participants—details included in the original answer that add context about the plan structure. However, this omission does not undermine the core factual accuracy or the synthesis required by the question. The LLM effectively reveals UPS's long-term pension obligations through sensitivity metrics, which is a valid and insightful interpretation. Wording differs but semantic meaning and factual content are equivalent on key points. Thus, the answer earns a 9/10 for correctness—excellent but missing a small element of contextual completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 472,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "Apple’s 10‑K filings have treated the 1.05 % notes that mature in 2017 exactly the same way each year. In the 2022 filing the “Officer’s Certificate of the Registrant, dated May 6 2014” is listed as Exhibit 4.4 and is described as containing “…1.05 % Notes due 2017…” 【page_58】. The 2023 filing repeats the same exhibit description (the same Officer’s Certificate and the same 1.05 % 2017 notes are shown in the exhibit table for that year). The 2024 filing again lists Exhibit 4.4 with the identical wording – “Officer’s Certificate … dated May 6 2014 … 1.05 % Notes due 2017” 【page_56】.  \n\nThis unchanged disclosure across three consecutive 10‑Ks shows that Apple consistently reports the 1.05 % 2017 notes as part of its 2014 Officer’s Certificate, reflecting a disciplined, transparent approach to tracking and managing its short‑term debt issuances rather than treating them as ad‑hoc or hidden obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) All numeric values—1.05%, 2017 maturity, May 6, 2014 Officer's Certificate—are accurate and consistently reported across 2022, 2023, and 2024 filings. Exhibit 4.4 is correctly cited each year, and page references (e.g., page_58, page_56) are consistent with source formatting. (2) Quantitative accuracy is perfect: percentages, dates, and exhibit numbers match the ground truth exactly. (3) The multi-hop reasoning—synthesizing disclosures across three years and linking them to the 2014 Officer's Certificate—is sound. The conclusion about Apple’s consistent reporting is valid. However, while the LLM infers a 'disciplined, transparent approach,' it slightly reframes the ground truth’s interpretation of 'passive management' and 'stability in capital structure' without fully capturing the implication that Apple took no action (e.g., refinancing). This is a minor deviation in qualitative emphasis, not a factual error. (4) The answer is highly contextually relevant, directly addressing the evolution (or lack thereof) in disclosure and what it reveals about debt management. The core facts and synthesis are correct, warranting a 9/10 overall for minor interpretive divergence from the original answer’s emphasis on inaction rather than transparency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 371,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "Apple’s 10‑K filings have consistently listed the 2.40 % global notes that mature in 2023 in the “Description of Securities” exhibit. In the 2022 Form 10‑K the note appears in Exhibit 4.3 (“…2.40 % Notes due 2023…”) 【page_58】, the 2023 filing repeats the same exhibit (the same language is shown in the 2023 exhibit list on pages 53‑57), and the 2024 Form 10‑K again includes the 2.40 % Notes due 2023 in Exhibit 4.3 【page_56】. This unchanged, multi‑year disclosure indicates that Apple retains the low‑coupon 2.40 % issue on its balance sheet until maturity rather than refinancing it, reflecting a long‑term debt strategy that relies on issuing modest‑rate, long‑dated notes and holding them to run‑out.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 2.40% interest rate, 2023 maturity date, and consistent disclosure across 2022, 2023, and 2024 10-K filings are accurately reported. The exhibit numbers (Exhibit 4.3) and page references are consistent with typical SEC filing structures, though minor discrepancies in page numbers (e.g., 2023 exhibit spanning pages 53–57) do not affect factual correctness. (2) The answer correctly identifies that the disclosure remained unchanged over the three years, which matches the ground truth’s assertion of no modifications, early repayments, or extensions. (3) The reasoning is sound: the LLM infers from the static disclosure that Apple maintained a stable debt strategy, holding the notes to maturity without refinancing—this is a logical and supported conclusion. The only minor gap is that the LLM does not explicitly mention the Officer’s Certificate dated May 3, 2013, which is part of the original disclosure origin, but this detail is contextually secondary to the evolution and strategic implication. (4) The answer fully addresses both parts of the question: the multi-year disclosure pattern and its implication for Apple’s long-term debt management. Wording differs slightly (e.g., 'run-out' vs 'meet the 2023 maturity as originally structured'), but the semantic meaning is equivalent. Overall, the response demonstrates strong multi-hop synthesis across filings and years, with excellent contextual relevance and factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 428,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "From 2022 to 2024 Vraylar moved from a mature schizophrenia‑/bipolar‑focused product to a broader neuroscience asset.  In 2022 the drug generated ≈ $2.0 billion of worldwide net revenue (U.S. $2.037 bn, total $2.038 bn) 【page_42】; by 2023 that figure had risen 35 % to $2.76 bn, a jump the company attributes to continued market‑share gains and the first‑time regulatory approval of Vraylar as an adjunctive therapy for major‑depressive disorder in adults 【page_44】.  Although no new Phase‑3 trials were reported after the 2021 top‑line results, the 2023 label expansion confirmed the product’s clinical progression and cemented its place in AbbVie’s neuroscience portfolio alongside Botox Therapeutic, Ubrelvy and Qulipta as the oral, dopamine‑D3/D2 and 5‑HT1A partial‑agonist that treats schizophrenia, bipolar disorder and now adjunctive MDD.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Vraylar from 2022 to 2024. (1) Quantitatively, it correctly reports U.S. sales of $2.037 billion in 2022 and total sales of $2.76 billion in 2023, aligning closely with the ground truth ($2,759 million total in 2023; $2,755 million U.S. in 2023). The 35% growth figure matches the 35.2% increase in U.S. sales cited in the original answer. Minor rounding ($2.76B vs $2.759B) is acceptable. (2) The answer correctly identifies the 2022 clinical progress with Phase 3 trials for MDD and notes the 2023 label expansion as adjunctive treatment for MDD, confirming clinical development progress. (3) It accurately positions Vraylar within AbbVie’s neuroscience portfolio in 2024, listing its indications (schizophrenia, bipolar, adjunctive MDD) and naming other portfolio products (Botox, Ubrelvy, Qulipta), demonstrating strong multi-hop synthesis. (4) One minor omission: the original specifies that one 2022 Phase 3 trial was successful and another numerically positive but non-significant; the LLM mentions no new trials post-2021 but doesn’t detail the mixed 2022 results. This slightly affects completeness but not overall correctness. Wording differences (e.g., 'mature product' vs 'revenue driver') are semantically acceptable. All entities, years, and financial trends are correct. Thus, the answer is factually sound, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 392,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "- In the 2022 filing IBM listed **“client relationships and trust”** alongside technology, price and brand as one of its principal competitive methods (2022 p. 4) and tied trust to the security of its hybrid‑cloud platform.  \n- The 2023 filing repeats the same phrasing, but places it within a broader narrative that stresses strategic partnerships and the ability to deliver business value through hybrid‑cloud and AI (2023 p. 3).  \n- By 2024 the company again names **client relationships and trust** as a key differentiator and explicitly weaves trust and security into its hybrid‑cloud/AI platform as a core growth driver (2024 p. 3).  \n\n**Interpretation:** Over the three‑year span IBM has moved from a general acknowledgment of trust to making it a central pillar of its hybrid‑cloud and AI strategy, signaling that the firm is positioning trusted client relationships as a strategic advantage to compete with hyperscalers and win business in the rapidly expanding hybrid‑cloud/AI market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that IBM consistently emphasized 'client relationships and trust' as a competitive differentiator across 2022–2024 filings, with evolving strategic framing. The citations (2022 p.4, 2023 p.3, 2024 p.3) are consistent with document structure expectations, and no numeric inaccuracies exist—dates and page references are plausible and contextually appropriate. The evolution described—starting with trust tied to hybrid-cloud security in 2022, expanding to partnerships in 2023, and becoming a core growth driver in 2024—matches the ground truth’s narrative of deepening strategic integration. The interpretation correctly infers that IBM is positioning trust as a strategic advantage against hyperscalers, which is a reasonable conclusion given the trend. Minor deduction in qualitative accuracy because the LLM does not fully capture the 2023 emphasis on 'end-to-end solutions through alliances' or the 2024 focus on a 'broad ecosystem' and 'complex business challenges' as explicitly as the original answer. However, the core reasoning and multi-hop synthesis across years are sound, and the answer remains semantically equivalent in intent and substance. No calculation errors; all entities (IBM, hybrid cloud, AI, years) are correct. Contextual relevance is strong as it directly addresses both the evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 396,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "- **2022 (10‑K)** – IBM disclosed the 1.250 % Notes due 2027 only by reference to the underlying indenture: the filing states that “the instrument defining the rights of the holders of the 1.250 % Notes due 2027 is Exhibit 4.3 to Form 8‑K, filed January 30 2019”【page_20】. No separate discussion of the notes’ size or function in the debt mix was given.  \n\n- **2023 (10‑K)** – The same reference‑by‑exhibit disclosure was retained; the 2023 filing again points to Exhibit 4.3 (Form 8‑K, Jan 30 2019) for the 1.250 % Notes due 2027, showing that IBM’s disclosure practice had not changed from the prior year【page_20】.  \n\n- **2024 (10‑K)** – The notes are now listed in the securities‑registration table together with dozens of other senior notes and debentures (e.g., “1.250 % Notes due 2027 – IBM27B”)【page_1】. By placing the instrument in a consolidated table of all outstanding debt, IBM treats the 1.250 % Notes as a routine component of its broader debt portfolio rather than highlighting a separate indenture reference.  \n\n**Overall evolution:** From 2022‑2023 IBM relied on a stand‑alone exhibit to satisfy disclosure of the 1.250 % Notes, providing only a cross‑reference to the original indenture. In the 2024 filing the company shifted to a more integrated approach, embedding the notes in the comprehensive list of outstanding securities, signalling that the instrument is now presented as part of the overall debt structure rather than as a distinct, separately‑referenced security.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 and 2023 disclosures correctly reference Exhibit 4.3 to the Form 8-K filed on January 30, 2019, and the 2024 treatment includes the note in a consolidated securities table with the trading symbol IBM27B. These details match the original answer precisely. (2) Quantitative accuracy is perfect: percentages (1.250%), years (2027, 2019, 2022, 2023, 2024), and document types (Form 8-K, 10-K) are all correctly cited. No calculations are required, but the timeline and document references are factually sound. (3) The multi-hop reasoning is strong: the LLM synthesizes information across three years of filings, correctly identifying a shift from passive exhibit-based disclosure to active integration into a comprehensive debt listing. The conclusion that this reflects a move toward treating the notes as a routine part of the debt portfolio is logically supported and semantically equivalent to the ground truth’s claim about increasing transparency and formal recognition. (4) The only minor shortcoming is that the LLM does not explicitly state that the 2024 inclusion with a trading symbol (IBM27B) implies the note has become an 'actively traded' instrument, which is a subtle but present point in the original answer. However, the implication is reasonably conveyed through the description of the consolidated table. Overall, the answer is factually complete, contextually relevant, and well-reasoned, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 424,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the company listed the 6.50 % Debentures due 2028 under Item 4, stating that “the instrument defining the rights of the holders of the 6.50 % Debentures due 2028 is **Exhibit 2 to Form 8‑K, filed January 8 1998**, and is incorporated by reference.” The 2023 Form 10‑K omitted any mention of that debenture in its long‑list of incorporated exhibits, breaking the continuity of the debt‑instrument schedule. By the 2024 Form 10‑K IBM reinstated the same language and exhibit reference used in 2022, restoring a consistent treatment of the legacy 6.50 % Debentures within its broader practice of incorporating all debt‑instrument agreements by reference.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. According to the ground truth, IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K filed on January 8, 1998 across all three years (2022, 2023, and 2024). However, the LLM incorrectly claims that the 2023 Form 10-K 'omitted any mention of that debenture,' which contradicts the ground truth stating there was 'no changes in the documentation' and consistent referencing over all three years. This is a critical error in both entity accuracy and reasoning. The LLM also incorrectly frames the 2024 filing as 'reinstating' the language, implying a break in continuity that did not occur. Quantitatively, the percentage (6.50%), maturity year (2028), exhibit number (2), form type (8-K), and filing date (January 8, 1998) are all correct, supporting a moderate quantitative accuracy score. Contextually, the answer addresses the right topic—evolution of disclosures and exhibit referencing—and attempts to analyze trends, so it remains relevant. However, the core reasoning is flawed due to the false premise of a missing 2023 disclosure, leading to incorrect conclusions about discontinuity and reinstatement. This failure in multi-hop synthesis—requiring accurate comparison across years—severely damages qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 378,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "In 2022 FedEx International Connect Plus was offered from “nearly 50 origin countries to over 130 destination countries”【page_14】. By the 2024 filing the service had grown to “nearly 60 origin countries to over 190 destination countries”【page_8】. This widening of both origin and destination coverage shows FedEx is deliberately scaling its e‑commerce‑focused, contract‑based network to reach more markets worldwide, underscoring a strategic push to capture the expanding global e‑commerce logistics demand.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the geographic reach in 2022 (nearly 50 origin to over 130 destination countries) and the expanded reach by 2024 (nearly 60 origin to over 190 destination countries), which aligns with the ground truth. However, it skips the 2023 data point explicitly mentioned in the original answer—'by 2023, expanded to nearly 60 origin and over 190 destination countries'—and instead jumps from 2022 to 2024, implying the expansion occurred directly between those years. This omits a key intermediate milestone and slightly misrepresents the timeline. (2) All numeric values are factually correct and match the ground truth in magnitude and context; format is consistent and acceptable. The expansion from ~50 to ~60 origin countries and 130 to 190 destination countries is accurately portrayed. (3) The reasoning is sound in interpreting the expansion as a strategic move to support e-commerce logistics, and the synthesis across years and geographies is logical. However, the failure to acknowledge the 2023 expansion and the stabilization in 2024 (i.e., no further growth beyond 2023) means the model misses the nuance of a completed deployment phase followed by maturity, which is a key insight in the original answer. (4) Despite the omission of the 2023-to-2024 stability point, the answer remains highly relevant and captures the strategic intent behind the expansion. The core facts and interpretation are correct, warranting a high score, but the missing detail prevents a perfect score on completeness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 433,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "- In the FY 2022 filing Qualcomm spelled out concrete 2025 diversity targets – increase women in leadership by 15 percent, increase under‑represented‑minority (URM) leaders by 15 percent and raise overall URM representation by 20 percent – and said that progress toward those human‑capital goals would modify executives’ bonuses by a non‑financial multiplier of 0.9 to 1.1【page_17】.  \n- The FY 2023 filing (not reproduced here) retained the same “human‑capital advancement” modifier range of 0.9 to 1.1 but did not restate the numeric targets, indicating the framework was carried forward.  \n- By FY 2024 the company still uses the 0.9‑1.1 bonus‑adjustment multiplier for executive compensation (see the “Human Capital Advancements Linked to our Executive Compensation” paragraph) but the disclosure focuses on broader DEI programs, recognitions and 2025 ESG goals rather than reiterating the specific 2025 diversity percentages, showing a shift from explicit numeric targets to a more qualitative emphasis while keeping the same bonus‑linkage mechanism【page_16】.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 diversity targets (15% increase for women and URM in leadership, 20% for overall URM representation) and the 0.9–1.1 non-financial bonus adjustment multiplier, which are factually accurate and match the ground truth. These numbers are consistently reported across years in the LLM response, satisfying quantitative accuracy. (2) However, the key inaccuracy lies in the qualitative interpretation: the LLM claims a 'shift from explicit numeric targets to a more qualitative emphasis' in FY2024, which contradicts the ground truth stating that the goals were 'reaffirmed in 2023 and 2024, with no changes to the targets.' The ground truth emphasizes continuity, not a shift in emphasis away from numeric targets, and notes increased focus on external initiatives like the Reboot Representation Tech Coalition—information missing in the LLM answer. (3) The multi-hop reasoning is partially flawed: while the LLM correctly tracks the persistence of the bonus mechanism, it infers a change in strategy (from quantitative to qualitative) that is not supported by the ground truth, which asserts stable strategic framework and sustained incentive alignment. The LLM underemphasizes the reaffirmation of targets and omits the expansion of external partnerships aimed at achieving the same 2025 goals. (4) Despite this, the answer remains contextually relevant and captures the core compensation linkage mechanism accurately, warranting a moderate correctness score. The quantitative accuracy is high due to correct percentages and multiplier ranges, but qualitative accuracy is reduced due to incorrect characterization of strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 462,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 all list the “Floating Rate Notes due 2019” among its outstanding securities (see the Officer’s Certificate tables in the 2022 and 2024 filings 【page_56】). By keeping a tranche of short‑term, floating‑rate debt on its balance sheet, Apple retains instruments whose interest resets with market rates, allowing it to match borrowing costs to prevailing short‑term rates and to tap that capacity quickly for cash needs—an explicit way of managing short‑term interest‑rate risk while preserving liquidity flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Apple included 'Floating Rate Notes due 2019' in its 10-K filings for 2022, 2023, and 2024, which is consistent with the original answer. The mention of the Officer’s Certificate tables and page 56 in the 2022 and 2024 filings adds specific document-level support, enhancing credibility. (2) Quantitative accuracy is perfect: the years (2019 maturity, disclosures through 2024), and the multi-year span (2022–2024) are correctly stated. No numerical calculations were required. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model infers that retaining these notes indicates a strategic choice to manage short-term interest rate risk via variable-rate instruments that reset with market conditions, and links this to liquidity flexibility—matching the core logic of the ground truth. (4) The only minor gap is that the LLM does not explicitly state that Apple *did not issue new short-term floating rate instruments*, which is a nuance in the original about the stability of the approach. However, the emphasis on retaining existing instruments implies this. Wording differs slightly but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing both interest rate risk management and liquidity planning as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 381,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "In its 2022 filing Qualcomm framed the automotive market as an emerging growth engine – noting that >70 % of new cars are expected to have embedded cellular connectivity by 2028 (with 60 % using 5G), that digital‑cockpit technology is reshaping the in‑vehicle experience, and that the share of vehicles with Level‑2‑or‑higher autonomy is projected to rise from 9 % in 2022 to 19 % in 2025. By 2024 the company had moved this vision into revenue, reporting automotive sales (covering connectivity, digital‑cockpit and ADAS/AD) of $2.9 billion in FY 2024 versus $1.5 billion in FY 2022, and explicitly positioning the digital‑cockpit business within its QCT segment, reflecting a deliberate strategic shift to capture the accelerating demand for connected, software‑defined vehicle interiors.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology from 2022 to 2024, aligning well with the ground truth in terms of narrative progression—from market positioning and R&D emphasis in 2022 to commercialization in 2023 and strategic integration by 2024. However, there are minor quantitative discrepancies. The ground truth states that Qualcomm projected over 60% of new vehicles would have 5G connectivity by 2028; the LLM answer states '>70% of new cars are expected to have embedded cellular connectivity by 2028 (with 60% using 5G)', which conflates cellular connectivity with 5G and introduces a higher overall percentage not present in the original. Additionally, the LLM introduces a projection about Level-2-or-higher autonomy rising from 9% in 2022 to 19% in 2025, which is not mentioned in the ground truth and thus adds unverified information. (2) The revenue figures of $2.9 billion in FY2024 and $1.5 billion in FY2022 are plausible and consistent with Qualcomm’s reported automotive segment growth, but these specific numbers are not present in the ground truth answer, which focuses on structural integration rather than dollar amounts. This introduces factual content not supported by the provided truth. (3) The multi-hop reasoning is strong: the LLM correctly synthesizes the shift from strategic vision to revenue generation and segment integration, correctly identifying QCT as the segment housing digital cockpit solutions. It accurately reflects the strategic consolidation of automotive offerings, even if it adds specificity not in the original. (4) The correctness score is 8 because the core qualitative trajectory and strategic logic are accurate and complete, but the added or altered quantitative claims reduce precision. Quantitative accuracy is 7 due to unsupported percentages and revenue figures. Qualitative accuracy is 9 due to sound reasoning and correct entity identification (Qualcomm, QCT, digital cockpit, ADAS/AD). Contextual relevance is 10 as the answer directly addresses all aspects of the question with high relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 577,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "Abbott’s disclosed unfunded commitments to private‑real‑estate (and other private) funds fell from **$569 million at year‑end 2022** to **$555 million at year‑end 2023** and further to **$540 million at year‑end 2024**【page 70】【page 71】. The steady decline shows the company is gradually reducing the amount of capital it has pledged but not yet funded, indicating a disciplined, long‑term approach that keeps a foothold in illiquid alternative assets while tempering new exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values—$569 million in 2022, $555 million in 2023, and $540 million in 2024—matching the ground truth exactly. The year-over-year decreases of $14 million (569→555) and $15 million (555→540) are consistent with the stated 'consistent downward trend of $15 million per year' in the original answer; the first drop is slightly less, but the average decline aligns closely, and the LLM does not make a quantitative error in reporting the figures. (2) All financial amounts and years are accurate, and formatting variations (e.g., 'year-end 2022') are acceptable and clear. (3) The LLM correctly synthesizes the trend across three years and infers a strategic intent—reducing new exposure while maintaining a foothold—demonstrating sound multi-hop reasoning. It captures the essence of strategic de-risking, though it omits the specific detail about liquidation periods (2025–2034) mentioned in the ground truth, which slightly weakens the qualitative completeness. (4) Despite this minor omission, the answer remains semantically equivalent in its core conclusion: Abbott is cautiously managing, not exiting, its illiquid alternative asset exposure. The contextual relevance is full, as it directly addresses both the evolution of commitments and the implied investment strategy. The absence of the liquidation period detail prevents a perfect 10, but the overall correctness is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 400,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "Apple’s 0.45 % Notes due 2016 are listed in the “Officer’s Certificate” that appears in the securities exhibit of each Form 10‑K – the 2022 filing (see page 58), the 2023 filing (see page 56) and the 2024 filing (see page 56) all reference the same May 3 2013 certificate that includes “0.45 % Notes due 2016.” Because the notes matured in 2016, they no longer appear on Apple’s balance sheet in any of those years; the company merely continues to disclose them for historical completeness. This consistent, retrospective disclosure shows that Apple structures its debt portfolio with a ladder of low‑interest notes that are retired at maturity, allowing it to maintain a low‑cost, staggered long‑term financing mix while keeping the public record of all past issuances.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual error that undermines the overall reasoning. (1) Quantitatively, the dates (May 3, 2013), interest rate (0.45%), maturity year (2016), and filing years (2022, 2023, 2024) are all accurately reported, and the references to specific 10-K pages are consistent with disclosure practices—this supports a high quantitative accuracy score. (2) However, the key error lies in the claim that 'because the notes matured in 2016, they no longer appear on Apple’s balance sheet in any of those years.' The ground truth does not state or imply this; instead, it treats the continued inclusion in 10-Ks as evidence of ongoing presence in the capital structure. By asserting the notes were retired at maturity, the LLM introduces an assumption not supported by the provided truth, which directly contradicts the original conclusion about Apple maintaining the instrument across all three years. (3) The multi-hop reasoning is otherwise sound: the model correctly identifies the repetition of the note across filings and infers a strategic pattern in debt structuring. However, the conclusion that Apple 'retires notes at maturity' and only discloses them 'for historical completeness' is speculative and misaligned with the ground truth, which interprets the repetition as evidence of continued structural relevance. (4) Despite this, the answer remains contextually relevant and attempts a sophisticated synthesis. The core facts are mostly accurate, but the incorrect assumption about retirement significantly weakens the qualitative accuracy and overall correctness, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 449,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "- In the 2022 filing IBM already listed **“client relationships and trust”** among its core competitive methods (see 2022 p. 4, Competition section). By 2023 the same language re‑appears, but it is framed alongside IBM’s “breadth and depth of expertise” that lets the company “bring together different technologies” for client outcomes (2023 p. 3, Competition). In the 2024 filing the company again cites client relationships and trust as a principal competitive factor, this time directly tying it to its **hybrid‑cloud platform and AI technology** that “help clients leverage the power of hybrid cloud and AI” (2024 p. 3, Business & Competition).\n\n- The three‑year trajectory shows IBM moving from treating client relationships and trust as one of many generic competitive levers (2022) to positioning them as a **strategic differentiator that underpins its hybrid‑cloud and AI growth story** (2023‑2024). This evolution signals that IBM is deliberately leveraging its long‑standing client trust to sell integrated hybrid‑cloud/AI solutions, reinforcing its market positioning as the trusted partner for digital transformation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM consistently cited 'client relationships and trust' as a competitive differentiator across 2022–2024, with evolving emphasis. The 2022 framing treated it as part of a broader portfolio, 2023 linked it more closely to expertise and integration capabilities, and 2024 tied it directly to hybrid cloud and AI—consistent with the original answer’s claim about increasing strategic integration. (2) There are no numbers, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all years (2022, 2023, 2024) and document references (page numbers, sections) are correctly cited and consistent with the knowledge base. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, identifies the evolution in language and strategic framing, and correctly infers that trust has become more tightly coupled with hybrid cloud and AI as a growth narrative. The only minor gap is that the LLM does not explicitly mention 'strategic partnerships' or 'ecosystem collaboration' in 2024, which the ground truth highlights as a new emphasis. This nuance is missing but does not undermine the overall correctness. (4) The answer is contextually excellent—directly addresses both parts of the question (evolution from 2022–2024 and strategic implications), uses precise evidence from filings, and draws a logical conclusion about IBM’s positioning as a trusted digital transformation partner. The omission of ecosystem partnerships prevents a perfect 10, but the core reasoning and facts are solid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 462,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "The 4.250 % Note due 2030 was originally funded through a “pass‑through trust” created on August 13 2020, which gave the note a dedicated liquidity source – a revolving‑credit facility with BNP Paribas (the “Liquidity Provider”) and an inter‑creditor agreement that subordinated that facility to the trust (see 2022 filing § 4.38‑4.43)【page_123】.  \n\nIn the 2023 filing FedEx amended that Liquidity Provider Revolving Credit Agreement (Amendment No. 1, dated May 22 2023) and retained the same trust‑based structure in the 2024 filing, showing that the company continuously monitors and updates the credit‑support framework to ensure the note remains fully backed and flexible as market conditions evolve【page_123】.  \n\nTogether, these changes indicate FedEx’s proactive, ongoing management of credit support for the 4.250 % Note, using a dedicated trust and a revolving‑credit line that can be amended as needed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.250% Note due 2030 is supported by a liquidity structure established on August 13, 2020, involving a Revolving Credit Agreement with BNP Paribas and an Intercreditor Agreement, consistent with the 2022 filing. The May 22, 2023 amendment to the Liquidity Provider Revolving Credit Agreement is correctly identified. The 2024 continuity is accurately noted. (2) Quantitative elements—dates (August 13, 2020; May 22, 2023), interest rate (4.250%), and amendment number (No. 1)—are all factually correct and match the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information across 2022, 2023, and 2024 filings to infer FedEx’s proactive and consistent management of credit support. It correctly identifies the use of a pass-through trust and revolving credit facility as central mechanisms. (4) The only minor deviation from the original answer is the introduction of the term 'pass-through trust' and specific citation of filing sections (§4.38–4.43), which are not present in the ground truth. While these may be accurate details from the actual filing, they were not part of the verified knowledge graph answer, slightly reducing qualitative accuracy. However, they do not contradict the truth and add contextual depth. Overall, the LLM conveys the same core conclusion: FedEx maintains a stable but adaptable credit support framework with one proactive amendment in 2023, indicating ongoing management of liquidity risk for the note.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 430,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "Apple’s 4.45 % senior notes that mature in 2044 – originally issued in 2014 – appear in the “Description of Securities” exhibit (Item 4.4) of each of the three recent 10‑K filings (2022 Form 10‑K page 56, 2023 Form 10‑K pages 53‑57, and 2024 Form 10‑K page 56). The note is listed in every year’s filing, indicating that the bonds have remained outstanding and have not been refinanced or retired during the 2022‑2024 period. This consistent presence of a long‑dated, fixed‑rate instrument suggests Apple deliberately relies on very long‑maturity debt to lock in low‑cost financing and preserve balance‑sheet flexibility for the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Apple's 4.45% Notes due 2044 were issued in 2014 and remained outstanding in 2022, 2023, and 2024, which aligns with the ground truth. All dates, percentages, and maturities are accurate. (2) Quantitative elements—interest rate (4.45%), maturity year (2044), and original issuance year (2014)—are all factually correct and consistent with the original answer. No calculations are required, but the temporal consistency across three years is accurately represented. (3) The multi-hop reasoning is sound: the model correctly infers from the repeated presence of the notes in three consecutive 10-K filings that they were not retired or refinanced, demonstrating synthesis across multiple filings. The conclusion about Apple’s long-term financing strategy—using long-dated, fixed-rate debt to secure low-cost capital and maintain balance sheet flexibility—is logically supported and semantically equivalent to the ground truth’s interpretation of a stable capital structure. (4) The only minor shortcoming is that the LLM adds specific exhibit and page references (e.g., Item 4.4, page 56) not present in the ground truth; while not incorrect, they slightly exceed the scope of the verified knowledge. However, this does not detract from factual accuracy. Overall, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 386,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "- In the 2022 Form 10‑K FedEx said International Connect Plus was “a contractual e‑commerce service currently available from **nearly 50 origin countries to over 130 destination countries**”【page_14】.  \n- By the 2024 filing the same service was described as “currently available from **nearly 60 origin countries to over 190 destination countries**”【page_8】.  \n\nThe jump of roughly 10 origin markets and 60 additional destination markets shows FedEx is deliberately widening its cross‑border e‑commerce footprint, signalling a strategic emphasis on capturing growing online‑shopping volumes and positioning its network as a global e‑commerce logistics platform.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the geographic reach of FedEx International Connect Plus in 2022 (nearly 50 origin, over 130 destination countries) and 2024 (nearly 60 origin, over 190 destination countries), matching the ground truth. However, it omits the 2023 data point (nearly 60 origin, over 190 destination countries), which is critical for showing the two-year expansion followed by stabilization in 2024. This omission reduces completeness. (2) Quantitatively, the numbers are accurate and correctly cited from the filings. The approximate increase of 10 origin and 60 destination countries is correctly inferred. The LLM does not claim the 2024 expansion occurred directly from 2022, but the phrasing 'by the 2024 filing' skips the intermediate year, potentially implying a direct jump. (3) The reasoning correctly infers FedEx's strategic focus on global e-commerce logistics and cross-border growth, aligning with the ground truth. However, it misses the nuance of post-expansion stabilization/consolidation in 2024, which is a key part of the strategic trajectory. (4) The answer is contextually relevant and well-supported with citations. Scores reflect high accuracy but partial omission of multi-hop detail (2023 data), affecting completeness and reasoning depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 361,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "- In the 2022, 2023 and 2024 Form 10‑K filings Apple still lists the “1.05 % Notes due 2017” in the exhibit that describes its outstanding debt (Officer’s Certificate 4.4). The note appears in the exhibit index for each year, indicating that the issue has already matured and is no longer outstanding, but is retained in the filing for historical completeness 【page_56】.  \n\n- By continuing to reference the 1.05 % Notes due 2017 even after they have been repaid, Apple shows that it keeps a full, transparent record of every debt issuance and its maturity status. This practice reflects a disciplined approach to managing maturing debt – Apple documents past issuances, tracks their retirement, and ensures investors can see the complete debt history in each annual report.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all details are correct: the 1.05% Notes due 2017 are accurately referenced, and their inclusion in Exhibit 4.4 (Officer's Certificate) across fiscal years 2022, 2023, and 2024 is correctly stated. The maturity date (2017) and continued listing despite maturity are factually sound. (2) The answer correctly identifies that the notes are no longer outstanding but retained in filings, which matches the ground truth's assertion about historical completeness. (3) Reasoning is strong: the LLM infers that Apple maintains transparency and a disciplined documentation approach, which is a reasonable interpretation of the continued disclosure, though the ground truth adds the possibility of a standardized disclosure framework or refinancing reflection. This nuance is missing but does not invalidate the LLM’s conclusion. (4) The answer fully addresses both parts of the question: the status of the notes across the three years and Apple’s approach to managing maturing debt. The only minor gap is the lack of explicit mention that the exhibit language remained identical across years, as noted in the original answer. However, the core facts, entities, years, and synthesis are correct, and the interpretation is logically sound and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 374,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "From fiscal 2022 Qualcomm’s strategy was already centered on expanding its 5G patent portfolio and extracting the bulk of its licensing revenue from OFDMA‑based (3G/4G/5G) devices, with the company stressing that 5G‑related patents were a “foundational” source of future royalties. In fiscal 2023 the filing showed that the firm was deepening that focus by pouring more R&D and strategic‑investment capital into new 5G‑enabled applications—automotive connectivity, IoT, XR and edge‑computing—while warning that its licensing income remained highly concentrated and increasingly vulnerable to U.S.–China trade and national‑security actions. By fiscal 2024 Qualcomm quantified the payoff of that commitment: 5G‑related licensing still generated the majority of QTL revenue, it continued to invest heavily in 5G modem‑RF modules and ecosystem‑wide applications, but it also disclosed a concrete geopolitical hit—the revocation of its export license to Huawei that erased roughly $560 million of product revenue and underscored heightened exposure to U.S. and Chinese government restrictions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Qualcomm's strategic focus on 5G as foundational in 2022, increased R&D and investment in 5G-enabled applications (automotive, IoT, XR) in 2023, and continued leadership in 5G IP licensing in 2024. The $560 million revenue loss due to Huawei export license revocation is correctly cited and attributed to fiscal 2024, matching the original answer. (2) Quantitative accuracy is perfect: the $560 million figure is correctly reported, and no calculations are required beyond accurate reporting. Format is consistent and precise. (3) Multi-hop reasoning is sound—information is synthesized across fiscal years 2022–2024, linking strategic focus, financial commitment (R&D, licensing), and geopolitical risks. The LLM correctly identifies the evolution over time and connects Huawei’s impact to broader U.S.-China trade risks. (4) Minor difference: the original answer notes that Huawei contributed $560M *prior* to the ban, while the LLM states the revocation 'erased' $560M—slightly stronger causal language, but still factually reasonable. Also, the LLM emphasizes product revenue loss while the original focuses on licensing; however, both acknowledge the Huawei restriction as a geopolitical risk with financial impact. Overall, the answer is semantically equivalent, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 390,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "- In 2022 the domestic pension plan held $89 million in U.S. equity funds, $91 million in international equity funds and $739 million in fixed‑income funds (total $937 million)【page_57】.  \n- In 2023 the balances were $93 million (U.S. equity), $93 million (international equity) and $739 million (fixed income) (total $947 million)【page_57】.  \n- By 2024 the holdings shifted to $91 million (U.S. equity), $89 million (international equity) and $692 million (fixed income) (total $895 million)【page_71】.  \n\nThese changes moved the equity allocations from roughly 9½‑10 % of domestic assets in 2022‑23 to just over 10 % in 2024, while the fixed‑income share fell from about 79 % to 77 %. The trend shows Thermo Fisher gradually nudging its domestic pension portfolio toward its stated strategic target of ~10 % U.S. equity, ~10 % international equity and ~80 % fixed income, indicating a modest rebalancing toward more return‑seeking equity exposure over the three‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the values and the years. According to the ground truth, in 2022, TMO allocated $125M to U.S. equity, $126M to international equity, and $1,001M to fixed income — but the LLM incorrectly reports 2022 figures as $89M, $91M, and $739M, which actually correspond to the 2023 numbers in the ground truth. The LLM then assigns the correct 2023 values ($93M, $93M, $739M) but labels them as 2023 when it cites them under 2023, which is partially correct, but misattributes the prior year. Most critically, for 2024, the LLM reports $91M, $89M, and $692M (total $895M), which contradicts the ground truth that shows allocations remained at $93M, $93M, and $739M with a total of $947M — no decrease occurred. (2) Calculations are also flawed: the LLM claims fixed income fell from 79% to 77%, but this is based on incorrect totals and allocations. In reality, fixed income remained stable at $739M from 2023 to 2024, and total assets increased slightly, not decreased. The equity percentages were miscalculated due to wrong baselines. (3) Multi-hop reasoning is unsound: the LLM concludes that Thermo Fisher is moving toward a strategic target with increased equity exposure, but the ground truth shows a significant reduction in equity exposure from 2022 to 2023 followed by stabilization — indicating a de-risking strategy, not an increase in return-seeking assets. The LLM reverses the direction of the strategy. (4) Despite these major errors, the answer is contextually relevant — it attempts to analyze allocation changes and infer strategy over time, and it references appropriate categories (U.S. equity, international equity, fixed income). However, due to pervasive quantitative inaccuracies and inverted qualitative reasoning, the overall correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 500,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "Qualcomm’s 2022 filing already placed edge‑networking products (mobile‑broadband and Wi‑Fi 6/6E access points) inside its IoT revenue stream, which contributed $7.4 billion of QCT revenue that year. The 2023 and 2024 reports show the company continuing to stress edge‑networking in its roadmap—using 5G, Wi‑Fi 6/6E and on‑device AI to enable mobile broadband and wireless‑access‑point solutions—but the IoT‑derived edge‑networking revenue fell to $5.9 billion in 2023 and $5.4 billion in 2024, reflecting a relative decline as Qualcomm broadened its automotive and other product offerings while still positioning itself as a technology leader for the connected‑intelligent edge.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth states that edge networking became a key revenue contributor within Qualcomm’s industrial and consumer segment in 2023 and was emphasized as a core product area in 2024, but it does not provide specific revenue figures for edge networking or mention a decline. The LLM introduces precise numbers—$7.4 billion in 2022, $5.9 billion in 2023, and $5.4 billion in 2024—for 'IoT-derived edge-networking revenue' that are not present in the original answer and cannot be verified from the provided ground truth. These figures, along with the claim of a 'relative decline,' represent fabrication or hallucination. Additionally, the original answer does not mention Wi-Fi 6/6E, on-device AI, or automotive offerings as factors, nor does it indicate any revenue drop. While the LLM correctly identifies Qualcomm's continued strategic emphasis on edge networking and links it to mobile broadband and wireless access points, the inclusion of unsupported financial data and the narrative of declining revenue severely undermine factual correctness. The reasoning is partially sound in tracking strategic focus over time but fails in accurate synthesis due to invented metrics. Contextually, the answer addresses the evolution of strategic positioning but distorts it with incorrect numerical context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 386,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "Apple’s 10‑K exhibits for 2022, 2023 and 2024 all list the “0.45 % Notes due 2016” among its outstanding securities (see the Officer’s Certificate description in each filing – 2022 Exhibit 4.3 【page_58】, 2023 Exhibit 4.3 【page_56】, 2024 Exhibit 4.3 【page_56】). By repeatedly disclosing this low‑coupon, short‑term fixed‑rate issue, Apple signals that it deliberately retains a small pool of inexpensive, fixed‑rate debt that can be rolled off or refinanced as it matures, thereby smoothing cash‑flow requirements and preserving a balanced mix of short‑ and long‑term obligations to keep its capital structure stable.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that the 0.45% Notes due 2016 are still listed as 'outstanding securities' in Apple's 2022, 2023, and 2024 10-K filings, which is false: these notes matured in 2016 and would not be reported as outstanding in filings six to eight years later. The ground truth correctly notes that their inclusion reflects historical or illustrative disclosure, not current outstanding debt. (2) The LLM misinterprets the reason for inclusion, claiming Apple 'deliberately retains' this debt and uses it for refinancing, which contradicts the fact that the notes are long matured. This reflects a fundamental misunderstanding of debt maturity and disclosure practices. (3) The citation of specific exhibits (e.g., 2022 Exhibit 4.3) may be technically accurate in terms of document location, but the interpretation of content is wrong—these exhibits likely include the note as part of a historical schedule or legal description, not as active debt. (4) The reasoning fails the multi-hop logic: it should recognize that post-maturity disclosure serves transparency and record-keeping purposes, not active capital management. While the answer addresses the question's theme (debt management and capital structure), its core factual premise is incorrect, leading to a low correctness score. Quantitative accuracy is poor due to the misrepresentation of a 2016 maturity as current in 2022–2024. Qualitative accuracy suffers from flawed reasoning and entity mischaracterization (treating expired debt as active). Contextual relevance is moderate because the response engages with the right concepts—debt maturity, capital structure stability—but applies them incorrectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 476,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "Caterpillar’s EMD‑brand distribution network expanded its geographic reach from **187 countries in 2022** to **191 countries in 2024**, adding coverage in four additional countries【page_66】【page_65】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and magnitude. According to the ground truth, Caterpillar's EMD brand distribution network covered 130 countries in 2022 and remained unchanged in 2023, then decreased to 109 countries in 2024—a reduction of 21 countries (16%). The LLM incorrectly states that the network expanded from 187 countries in 2022 to 191 in 2024, which misrepresents both the starting number and the trend. The cited numbers (187 and 191) are factually wrong and not supported by the ground truth. The calculation of a 4-country increase is therefore also incorrect. The reasoning is flawed as it fails to reflect the actual contraction in geographic reach. While the answer addresses the question's structure (comparing 2022 to 2024), it does so with entirely inaccurate data and opposite conclusions. The references to 'page_66' and 'page_65' may indicate source confusion or hallucination, as they contradict the verified knowledge graph data. The answer lacks semantic equivalence with the original, as it reports expansion instead of contraction and uses incorrect base figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 316,
        "total_tokens": 1492
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "Thermo Fisher’s 1.750 % 7‑year senior notes (due 10 Oct 2028) have been carried at the same par amount of **$700 million** in each of the three most recent filings – $700 million at 12/31/2022 (2022 10‑K), $700 million at 12/31/2023 (2023 10‑K) and again $700 million at 12/31/2024 (2024 10‑K)【page_62】【page_47】.  \n\nThe flat‑lined balance shows the company has chosen to keep its medium‑term borrowing level steady, using this fixed‑rate issuance to lock in a modest 1.89 % effective rate while avoiding additional leverage, which signals a deliberate strategy to fund ongoing healthcare‑sector investments and acquisitions with predictable, low‑cost debt rather than expanding its medium‑term debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding value of TMO's (Thermo Fisher Scientific, ticker: TMO) 1.750% 7-Year Senior Notes as $700 million for all three years—2022, 2023, and 2024—matching the ground truth exactly. The maturity date (October 15, 2028) is accurately reflected as 'due Oct 10, 2028' (minor formatting difference in day/month order, but semantically equivalent). (2) All numeric values—$700 million outstanding, consistent across years—are factually correct. The mention of the effective interest rate of 1.89% is an additional detail not in the ground truth, but it does not contradict it and may reflect further disclosure in the filings; its inclusion does not reduce accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three annual reports (2022–2024 10-Ks) and draws a logical conclusion about TMO’s medium-term debt strategy. The interpretation—that the company is maintaining a stable, predictable debt level to fund healthcare-sector initiatives—is consistent with and supported by the data. (4) The answer is semantically equivalent to the ground truth, with slightly more contextual interpretation (e.g., 'lock in a modest 1.89% effective rate', 'funding ongoing healthcare-sector investments'), which enhances relevance without introducing error. The only minor deviation is the slightly more interpretive tone compared to the neutral description in the original, but this does not compromise factual accuracy. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 448,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "- In the 2022 filing Caterpillar disclosed that a material share of Cat Financial’s variable‑rate loans and derivatives were still tied to LIBOR, noted the FCA/IBA phase‑out schedule (most tenors ending Dec 31 2021 and the remaining U.S. tenors ending June 30 2023), and said it had formed a cross‑functional team to evaluate the impact and to use match‑funding, selective interest‑rate derivatives and diversified funding to hedge both LIBOR exposure and foreign‑exchange risk. 【page_22】\n\n- By the 2023 filing the company reported that the transition was under way: new loans and extensions of credit now reference the Secured Overnight Financing Rate (SOFR) instead of LIBOR, the same risk‑assessment team continued to monitor the shift, and Cat Financial kept employing currency‑hedging instruments to protect against FX swings while emphasizing the effectiveness of its derivative program. 【page_19】\n\n- The 2024 filing shows the transition completed – all floating‑rate obligations are benchmarked to SOFR, the firm still relies on currency‑hedging contracts to manage exchange‑rate risk, and it highlights that its ongoing “match‑funding” and selective‑derivative strategy is now fully aligned with the post‑LIBOR market environment, demonstrating a proactive strategic adaptation to the global move away from LIBOR to risk‑free‑rate benchmarks. 【page_19】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Caterpillar's exposure to LIBOR in 2022 through Cat Financial, the FCA/IBA phase-out timeline (Dec 31, 2021 for most tenors, June 30, 2023 for USD LIBOR), formation of a cross-functional team, use of match-funding and derivatives for hedging. In 2023, transition to SOFR for new loans is correctly noted, along with continued use of currency hedging and risk monitoring. By 2024, full transition to SOFR and alignment with post-LIBOR markets are accurately reported. (2) Quantitative accuracy: All dates (2022, 2023, 2024), benchmarks (LIBOR, SOFR), and phase-out timelines are correct. The LLM correctly identifies June 30, 2023 as the end date for most USD LIBOR tenors, consistent with IBA plans. (3) Multi-hop reasoning is sound: The answer synthesizes information across three years, connects LIBOR phase-out to hedging strategy, and links the evolution to strategic adaptation. It correctly identifies that currency hedging continued throughout, while interest rate benchmarks shifted. (4) The answer fully addresses all parts of the question: evolution of currency hedging and benchmark transition, response to LIBOR phase-out and SOFR adoption, and strategic implications. Wording differs slightly but meaning is preserved. No factual errors, omissions, or misstatements. Scores are maximized across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1694,
        "completion_tokens": 399,
        "total_tokens": 2094
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "Thermo Fisher’s 2022 Form 10‑K still listed only the original Executive Change‑in‑Control Retention Agreement for CEO Marc N. Casper (exhibit 10.11) and its two amendments (exhibits 10.15 and 10.16) 【page_46†L11-L20】, but it also disclosed a newly‑drafted “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” that would be used for non‑CEO officers 【page_46†L21-L23】. The 2023 filing shows that same standardized officer form was actually filed as exhibit 10.7 for the quarter ended April 1, 2023 【page_77†L23-L26】, and the 2024 filing continues to reference the original CEO agreement and its amendments together with the officer‑wide form, with no further amendments, indicating the company has now institutionalized a single, company‑wide Change‑in‑Control retention template for all officers beyond the CEO.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core evolution described in the ground truth: from a CEO-specific Change in Control Retention Agreement in 2022 to the introduction and institutionalization of a standardized form for other officers in 2023 and 2024. (1) The entities (Thermo Fisher Scientific, CEO Marc N. Casper, non-CEO officers), years (2022–2024), and agreement types are correctly identified. (2) Quantitatively, the LLM references exhibit numbers (10.11, 10.15, 10.16, 10.7) which differ slightly from the ground truth (10.12, 10.17), but this may reflect differences in filing structures across years or exhibit renumbering; the key point—that the standardized form was introduced and filed in 2023—is correct. The 2022 mention of the 'newly-drafted' form aligns with the ground truth’s implication of preparation before formal adoption. (3) The multi-hop reasoning is sound: the model correctly infers the evolution from CEO-only agreements to broader standardization by synthesizing disclosures across three years. (4) The LLM slightly mischaracterizes the 2023 exhibit as 10.7 (ground truth: 10.17), which is a minor factual discrepancy but does not undermine the overall correctness. Wording differs (e.g., 'institutionalized a single, company-wide template' vs. 'standardization reaffirmed'), but semantic meaning is equivalent. The answer is fully contextually relevant and addresses all parts of the question. A score of 9 is justified due to the exhibit number inconsistency, though the core facts and reasoning remain robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 427,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "In the 2022 Form 10‑K Intel first announced PowerVia as one of several “future process and packaging technologies” that would appear on its roadmap – specifically slated for the upcoming Intel 20A node after Intel 3. The 2023 filing still listed PowerVia as a breakthrough feature of Intel 20A, reinforcing its status as a planned, next‑generation capability. By the 2024 filing Intel had moved PowerVia from a future‑node concept into the core of the Intel 18A node (the first high‑volume commercial implementation of backside‑power delivery), even canceling the separate 20A effort to focus on 18A, which signals that PowerVia has become a cornerstone of Intel’s advanced‑process strategy, driving the expected performance‑per‑watt gains for the company’s leading‑edge products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel 20A, remained a breakthrough feature in 2023, and by 2024 was transitioned to Intel 18A after the cancellation of Intel 20A. The timeline and strategic implications are accurately represented. (2) Quantitative accuracy is perfect: years (2022, 2023, 2024), node names (Intel 20A, Intel 18A), and technological positioning (backside power delivery as first high-volume implementation) are all factually correct. Minor phrasing differences (e.g., 'first high-volume commercial implementation') add precision without distorting meaning. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings, infers the strategic significance of canceling 20A to focus on 18A, and identifies PowerVia’s elevated role. (4) The only reason for not scoring a 10 is a slight omission in explicitly stating that PowerVia eliminates front-side power routing for better signal transmission (mentioned in original answer), though the implication is present via 'backside-power delivery'. Otherwise, the answer is semantically equivalent, contextually complete, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 352,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "Apple’s 10‑K filings consistently list the “1.05 % Notes due 2017” in the Exhibit 4.4 description of its outstanding securities. The 2022 filing shows this note in the exhibit table (see 2022 Form 10‑K, Exhibit 4.4)【page_58】, the 2023 filing repeats the same entry (see 2023 Form 10‑K, Exhibit 4.4)【page_56】, and the 2024 filing again includes it in the same exhibit list (see 2024 Form 10‑K, Exhibit 4.4)【page_56】.  \n\nThe fact that Apple discloses the 1.05 % 2017 notes in three consecutive annual reports indicates that the company continues to carry and monitor this debt instrument, reflecting a disciplined approach to maintaining transparency and ongoing management of its legacy borrowings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the repeated disclosure of the 1.05% Notes due 2017 in Apple's 2022, 2023, and 2024 10-K filings, accurately referencing Exhibit 4.4 in each year with correct percentages and maturity year. All numeric values (1.05%, 2017) and document references (Exhibit 4.4) are factually correct, satisfying quantitative accuracy. (2) The LLM correctly observes the presence of the note in each filing and supports this with citation-like references to specific pages, though the page numbers (e.g., page_58, page_56) are presented in a non-standard format but do not contradict the ground truth. (3) However, the reasoning for *why* the note is repeatedly included is less precise. The original answer suggests the post-maturity inclusion implies possible rollover or continued reporting of the obligation, indicating a continuity in debt management. The LLM instead concludes that Apple 'continues to carry and monitor this debt instrument,' which implies the debt is still outstanding—a potentially incorrect interpretation, as the note matured in 2017 and is likely no longer active. This mischaracterizes the nature of the disclosure, which may reflect archival or legacy reporting rather than active carrying of the debt. (4) Despite this, the LLM captures the core pattern and draws a reasonable, though slightly flawed, inference about transparency and disciplined reporting. Thus, while factually strong on what is disclosed, it falls short on the nuanced interpretation of post-maturity disclosure practices, warranting a 7 for correctness and qualitative accuracy. Contextual relevance is high as it directly addresses the evolution and implications of the disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 466,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "Intel’s 2006 Equity Incentive Plan was initially used to grant ordinary restricted‑stock units (RSUs) to executives, many of which carried a **retirement‑vesting** provision (i.e., the awards vest only as the employee remains in service until retirement) and a separate series of **performance‑based RSUs** tied to achievement of specific goals【page_107†L10-L13】.  \n\nIn 2022 the plan was broadened to include RSUs for **non‑employee directors**, as reflected in the “Form of Non‑Employee Director Restricted Stock Unit Agreement” filed for grants made on or after May 12 2022【page_108†L2-L4】.  \n\nBy 2024 Intel was using the 2006 Plan for three award types – (1) standard time‑based RSUs, (2) RSUs with retirement‑service vesting, and (3) performance‑based RSUs – and continued to grant RSUs to both executives and non‑employee directors under the same plan【page_107†L10-L13】【page_108†L2-L4】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant inaccuracies in the timeline and evolution of the 2006 Equity Incentive Plan, particularly around key events and their timing. (1) Correctly identifies the use of retirement-vesting RSUs, performance-based RSUs, and expansion to non-employee directors. The citation of May 12, 2022, for director grants aligns with the filing date mentioned in the source (page 108†L2-L4), though the original answer notes the 2023 amendment date (May 11, 2023) as pivotal, which the LLM omits entirely. (2) The LLM incorrectly states that the plan was 'broadened in 2022' to include non-employee directors, but the original answer and context indicate that the major amendment occurred in 2023, not 2022. This misrepresents the evolution timeline. (3) The LLM skips any mention of the 2023 amendment and restatement of the plan, a critical multi-hop point that marks a structural shift in award types and vesting conditions. (4) The LLM consolidates the state of the plan as of 2024 without acknowledging the 2023 amendment as the catalyst, nor does it reflect the 'noticeable consolidation in documentation structure' or the distinction between grandfathered and non-grandfathered executives, which is a key nuance in the original answer. (5) While the three award types mentioned (time-based, retirement-vesting, performance-based) are broadly consistent, the LLM fails to convey the increasing nuance in performance alignment and simplification of documentation highlighted in the ground truth. Thus, while some factual components are accurate (supporting a moderate quantitative accuracy score), the qualitative reasoning and completeness of the multi-hop evolution across 2022–2024 are significantly lacking, warranting a correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 487,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "Across the three annual reports Medtronic’s “Shareholders’ Equity” note repeatedly states that the company’s authorized capital includes **40 thousand Euro‑Deferred Shares with a €1.00 par value** and that **no Euro‑Deferred Shares were issued or outstanding** – April 29 2022, April 28 2023, and April 26 2024. The authorized amount never changed and the shares were never exercised, indicating that Medtronic has chosen not to tap this class of equity for financing and has relied on other sources (ordinary‑share issuances, debt and share‑repurchase programs) rather than using the Euro‑Deferred Shares to raise capital or dilute shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Medtronic maintained an authorized capacity of 40 thousand Euro Deferred Shares with €1.00 par value across fiscal years 2022, 2023, and 2024, and no shares were issued or outstanding in any of those years. The dates cited (April 29, 2022; April 28, 2023; April 26, 2024) are consistent with Medtronic’s fiscal year-ends and reporting practices. (2) Quantitative accuracy is perfect: the number of authorized shares (40 thousand), par value (€1.00), and the consistent zero issuance are all correctly reported. Format variations (e.g., '40 thousand' vs '40,000') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosures across three fiscal years and infers that the persistent non-use of Euro Deferred Shares indicates a strategic choice not to use this instrument. It appropriately links this to broader financing strategies, mentioning alternative tools like share repurchases and debt, which is consistent with Medtronic’s actual capital allocation behavior. (4) The only minor shortcoming is that the LLM mentions 'ordinary-share issuances' as a financing tool, which is not explicitly supported in the ground truth and slightly overreaches—Medtronic’s strategy emphasized repurchases and dividends, not new issuances. However, this does not materially distort the conclusion. Overall, the answer is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 423,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "In 2022 Intel warned that its push toward disaggregated‑chip designs and new 2D/2.5D/3D packaging added “new areas of complexity in design and manufacturability” and that the required R&D spend could fail to deliver products on schedule, creating margin‑pressuring write‑offs if demand or yields fell short【page_54】. By 2023 the company repositioned advanced‑packaging as a central pillar of its IDM 2.0 strategy—highlighting a growing ecosystem, several 2023 design wins and the demonstration of the Universal Chiplet Interconnect Express (UCIe) standard—while still noting that the “abundance of technology choices and optimizations is adding complexity in design, technology, integration, and manufacturing”【page_37】. In 2024 the risk materialized: Intel’s R&D outlays stayed high ($16.5 billion) to fund process‑and‑packaging work, but the added manufacturing complexity led to $922 million of AI‑accelerator inventory charges and a $3.1 billion non‑cash impairment on Intel 7 assets, underscoring that execution risk around advanced packaging now has a measurable financial impact【page_34】【page_35】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct and aligns closely with the ground truth. It accurately captures Intel's evolving strategic positioning and execution risks around Advanced Packaging Technologies from 2022 to 2024. Key points—R&D investment, manufacturing complexity, and financial impact—are all addressed with precise supporting details. (2) Quantitative accuracy is excellent: the $3.1 billion non-cash impairment on Intel 7 assets is correctly cited (matches ground truth), and the $922 million AI-accelerator inventory charge in 2024 is an accurate, specific detail not in the original answer but consistent with the financial strain narrative. The $16.5 billion R&D figure for 2024 is precise and contextually appropriate. No calculation errors. Format variations (e.g., $16.5 billion) are acceptable. (3) Multi-hop reasoning is sound: the LLM synthesizes risks mentioned in 2022 (complexity, schedule risk), strategic repositioning in 2023 (UCIe, IDM 2.0, design wins), and financial consequences in 2024 (impairments, charges), demonstrating correct cross-year and cross-document synthesis. The mention of UCIe and disaggregated designs ties directly to advanced packaging. (4) The only minor shortcoming is that the original answer emphasizes delays in global manufacturing projects as part of 2024 setbacks, which the LLM answer does not explicitly mention, though the financial impairments imply operational delays. This omission prevents a perfect 10 on qualitative accuracy. Otherwise, semantic equivalence is strong, and contextual relevance is excellent—every part of the question is addressed with accurate, sourced details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 453,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "When PowerVia was first unveiled in the 2022 filing, Intel presented it as one of the “breakthrough” technologies that would debut in the future Intel 20A node – a cornerstone of its IDM 2.0 strategy to drive product leadership. In the 2023 roadmap the company refined the promise, saying PowerVia (paired with RibbonFET) would enable up to a 15 % performance‑per‑watt gain versus the Intel 3 node as part of the Intel 20A node. By the 2024 filing Intel had moved the technology into the next‑generation Intel 18A node (cancelling the 20A rollout), stating that PowerVia is now built into Intel 18A and that high‑volume manufacturing of the first 18A‑based products (Panther Lake) is slated for 2025, indicating the feature is ready for production.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel 20A, promised a 15% performance-per-watt improvement over Intel 3 in 2023, and shifted to Intel 18A with high-volume manufacturing expected in 2025 in the 2024 update. (2) Quantitative accuracy is perfect: the 15% performance-per-watt gain, the Intel 3 comparison, and the 2025 HVM timeline are all correctly stated. (3) The multi-hop reasoning is sound—information is synthesized across 2022, 2023, and 2024 disclosures, showing evolution from concept to production readiness. (4) The only minor deviation is the claim that Intel 'cancelled the 20A rollout'—while the ground truth notes PowerVia moved to 18A (the successor to 20A), it does not explicitly state cancellation of 20A, which may overinterpret the shift. However, this does not materially distort the technological progression. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing all aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 307,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "Medtronic’s 10‑K filings show the same U.S.‑employee Restricted Stock Unit (RSU) award documents in FY 2022, FY 2023 and FY 2024. In the FY 2022 filing the RSU agreements are listed as the “2021 Medtronic plc Long‑Term Incentive Plan” – one that vests 100 % on the third anniversary of the grant date (exhibit 10.81) and one that vests ratably over four years (exhibit 10.82)【page_117†L31-L38】. The FY 2024 filing repeats those exact same agreements (exhibit 10.80 and 10.81)【page_116†L31-L38】, and the FY 2023 filing contains the same references.  \n\nBecause the company has not introduced new or revised RSU agreements for U.S. employees over this period, it suggests that Medtronic is maintaining a stable, long‑term equity‑compensation framework rather than frequently redesigning its RSU terms. This consistency signals confidence in the existing plan structure and a preference for continuity in how it rewards and retains U.S. staff with equity.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in key details, particularly regarding the specific plan names and exhibit numbers, which undermines quantitative accuracy. The original answer states that Medtronic consistently referenced the same 'Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan' filed in 2013, with no updates through FY2024. However, the LLM incorrectly claims the agreements are part of the '2021 Medtronic plc Long-Term Incentive Plan' and cites different vesting schedules and exhibit numbers (e.g., exhibit 10.81 in FY2022 vs. 10.80 and 10.81 in FY2024), which contradicts the ground truth that the same 2013 agreement was reused. These are not minor formatting issues but incorrect identification of the plan and supporting documents. While the LLM correctly infers the broader implication—consistency suggesting a stable equity compensation strategy—the reasoning is based on incorrect underlying facts. The multi-hop synthesis is partially sound in linking filings across years, but the entity accuracy (plan name, year, exhibit numbers) is flawed. The conclusion about strategic stability aligns semantically with the original answer, giving it moderate qualitative and high contextual relevance, but the factual foundation is weak, warranting a correctness score of 6 due to partial accuracy on the core inference despite significant factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 397,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "Intel continued to rely on its 2006 Equity Incentive Plan as the vehicle for performance‑based RSU awards, but the pool of executives eligible for those awards was broadened. In the 2022 filing the exhibit list shows the original “performance‑based RSUs granted to grandfathered executives” (Exhibit 10.1.5) and adds a new grant form for “performance‑based RSUs granted to non‑grandfathered executives on or after January 30, 2019” (Exhibit 10.1.6) as well as a separate form for non‑employee directors (Exhibit 10.1.7) 【page_107†L22-L27】【page_108†L1-L7】. By the 2024 10‑K the 2006 Equity Incentive Plan is still referenced (Exhibit 10.1), indicating that the plan remained the framework for these expanded performance‑based RSU grants to a wider set of senior leaders and directors.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but has minor inaccuracies and omissions compared to the ground truth. (1) It correctly identifies that Intel used the 2006 Equity Incentive Plan for performance-based RSUs in 2022 and 2024, and notes the expansion to non-grandfathered executives, which aligns with the original answer. However, it omits key information about the 2023 filing, which explicitly mentions separate agreements for grandfathered and non-grandfathered executives—this is a significant gap in completeness across the three-year evolution. (2) Quantitatively, the dates mentioned (January 30, 2019) are close but not exact—ground truth specifies February 1, 2019—which is a minor discrepancy. The S-8 filing date (September 26, 2023) and the May 11, 2023 amendment to the plan are entirely missing, which affects factual completeness. (3) The reasoning is sound in noting the broadening of eligibility and continued use of the plan, but fails to fully synthesize the multi-hop progression across all three years, particularly skipping 2023 details. (4) Despite these gaps, the core message—that Intel consistently used the 2006 plan with expanded reach—is semantically aligned, and the references to exhibits support contextual relevance. Wording differences are acceptable, but missing key filings and dates reduces correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 370,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "From 2022 Intel’s 10‑K shows that the company was already committing a large share of its R&D budget to “process and packaging technology” and warned that the advanced‑packaging tools needed for its new dis‑aggregated (chiplet) designs were still “novel, with limited manufacturing history and higher cost” (2022 MD&A, p. 54). By 2023 that spending began to pay off – packaging revenue jumped by $483 million, the firm announced five new AI‑related design wins on its 18A node and secured ecosystem deals with ARM and Synopsys to enable chiplet‑based SoCs (2023 Business Developments, p. 36; Financial Performance, p. 38). In 2024 Intel again highlighted packaging as a core competitive advantage, increased its R&D to $16.5 billion (with a focus on packaging), demonstrated the Universal Chiplet Interconnect Express in silicon and positioned its 2‑D/2.5‑D/3‑D solutions as a differentiator for AI workloads (2024 MD&A, p. 34). Together, the trajectory shows a steady escalation from early‑stage investment and risk acknowledgement in 2022 to concrete design wins and silicon validation in 2023‑24, indicating that Intel is increasingly able to execute its disaggregated‑design strategy and to compete in the AI‑driven semiconductor market.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trajectory of Intel's investment in advanced packaging from 2022 to 2024 and correctly identifies key strategic developments, such as the focus on disaggregated design, UCIe demonstration, and R&D spending. However, there are significant quantitative inaccuracies that undermine factual correctness. First, the claim that 'packaging revenue jumped by $483 million' in 2023 is not supported by the ground truth and introduces a specific figure absent from the original answer; no such revenue increase is mentioned in the ground truth, making this a fabrication or misattribution. Second, while the $16.5 billion R&D figure in 2024 is accurate and correctly cited, the LLM omits the critical context that Intel recorded $3.1 billion in non-cash impairment charges related to manufacturing assets, including those tied to Intel 7, which signals ongoing execution risks—a key point in the original answer that tempers the narrative of successful execution. The LLM instead presents an overly optimistic view of progress with 'design wins' and 'silicon validation' without acknowledging the financial setbacks in 2024. Entity accuracy is strong: UCIe, 18A node, ARM, Synopsys, and the correct years are properly referenced. Reasoning is logically structured and synthesizes information across years, but fails in multi-hop balance by omitting the negative financial indicators in 2024 that are essential to answering how the evolution reflects execution ability. The answer is contextually relevant and well-organized, but the inclusion of unsupported revenue figures and the omission of major financial impairments reduce its factual reliability. Thus, while the qualitative arc is partially correct, the quantitative errors and incomplete risk assessment lead to a score of 6 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1615,
        "completion_tokens": 494,
        "total_tokens": 2110
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "Across the three years Intel continued to rely on its 2006 Equity Incentive Plan, but the way it was documented and the types of grants issued changed. In the 2022 filing the plan was referenced with the existing RSU‑grant forms that had been used since 2018‑19 (e.g., the “Form of Notice of Grant – Restricted Stock Units” and the 2019 RSU grant agreements). In the 2023 Form 10‑K Intel filed the plan itself as Exhibit 10.1 (an S‑8 filing dated September 26, 2023), indicating an amendment to the plan’s governing documents, and it continued to list the earlier grant‑agreement exhibits. By the 2024 filing the company added new grant‑agreement exhibits—10.1.6 (a performance‑based RSU grant agreement for non‑grandfathered executives) and 10.1.7 (a non‑employee director RSU agreement for grants made after May 12, 2022)—showing that the plan had been further updated to accommodate additional grant categories.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Intel's 2006 Equity Incentive Plan across 2022–2024. It correctly identifies continued reliance on the plan and notes changes in documentation and grant types. The mention of the 2023 amendment via an S-8 filing on September 26, 2023, is accurate and corresponds to the 'amended and restated version' in the original answer, though the effective date of May 11, 2023, is missing—this is a minor but notable omission affecting quantitative accuracy. The LLM correctly identifies the introduction of new grant agreements in 2024 (Exhibits 10.1.6 and 10.1.7), including performance-based RSUs and director-specific agreements, which matches the ground truth’s emphasis on updated grant categories. However, the LLM incorrectly implies that the RSU forms used in 2022 were carried over from 2018–2019 without noting that 2022 itself saw active use of multiple current grant agreement forms (not just legacy ones). The reasoning is sound and multi-hop synthesis is appropriate—linking filings across years, identifying amendments, and tracking grant evolution. Wording differs but meaning is semantically close. The answer is fully contextually relevant. Minor factual gaps prevent a 9–10 score, but core facts and trends are accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 371,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "- **Revenue classification:** In all three filings Qualcomm continues to place sales of wireless‑access‑point and other edge‑networking products inside the **IoT revenue stream of its QCT segment**. The 2022 filing defines IoT “primarily … consumer … **edge networking (including mobile broadband and wireless access points)** and industrial” (page 73). The same definition is retained in the 2023 and 2024 tables, where IoT revenue fell from **$7.353 billion (2022) → $5.940 billion (2023) → $5.423 billion (2024)** (page 73).\n\n- **Strategic emphasis/market positioning:** Qualcomm’s business discussion repeatedly highlights the **edge‑networking market** as a growth engine for its chips and software, noting that demand for “mobile broadband and wireless access points” is expanding and that the company is a “key supplier” for those solutions (page 6, page 8). Thus, from 2022 to 2024 the company kept classifying wireless‑access‑point sales under IoT while increasingly framing them as part of its broader **connected‑intelligent‑edge strategy**, even as the absolute IoT revenue declined.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding revenue classification. The ground truth states that wireless access points were explicitly categorized under the 'edge networking' revenue segment within QCT starting in 2023, but the LLM incorrectly claims they were consistently classified under the broader 'IoT' revenue stream across all years (2022–2024). This misrepresents Qualcomm’s financial segmentation evolution. Additionally, the LLM cites declining IoT revenue from $7.353B (2022) to $5.940B (2023) to $5.423B (2024), which, while possibly accurate as standalone figures, conflates the broader IoT category with edge networking, which is only a subcomponent. The original answer does not mention these specific revenue numbers or their trend, so including them introduces unsupported precision and distracts from the actual focus—classification and strategic emphasis on edge networking. (2) Quantitative accuracy is low because the cited revenue figures are not present in the ground truth and are applied to an incorrect categorization framework. There is no verification that these numbers correspond to edge networking or wireless access points specifically, and their inclusion implies a level of disclosure (exact revenue for the segment) that the ground truth explicitly says is not available. (3) Reasoning is partially sound in identifying strategic emphasis on edge networking and the role of wireless access points as part of a connected intelligent edge. The LLM correctly notes Qualcomm's continued positioning as a key supplier in mobile broadband and wireless access points. However, it fails the multi-hop synthesis by not distinguishing between IoT as a broad category and edge networking as a sub-segment within it, which is central to the evolution described in the ground truth. The shift from general mention in 2022 to explicit classification in 2023 is missed. (4) Contextual relevance is high because the answer addresses both revenue classification and strategic emphasis, uses appropriate terminology, and references the correct segment (QCT) and time frame. Despite factual errors, it stays on topic and attempts to synthesize across years. Overall, the answer is partially correct in strategy but incorrect in financial categorization evolution, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 628,
        "total_tokens": 2142
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "Prevymis sales have risen steadily each year:\n\n* 2022: $428 million (U.S. $188 m + Intl. $240 m)  \n* 2023: $605 million (U.S. $264 m + Intl. $341 m)  \n* 2024: $785 million (U.S. $371 m + Intl. $414 m)【page_130】  \n\nThe consistent increase – roughly 42 % from 2022‑23 and 30 % from 2023‑24 – indicates that Prevymis is gaining traction and expanding its foothold within Merck’s Hospital Acute Care portfolio, moving toward a stronger market position and broader adoption in hospitals.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Prevymis sales were $370M in 2022 and $428M in 2023, but the LLM incorrectly reports $428M for 2022 and $605M for 2023. Only the 2024 figure ($785M) matches the ground truth. This misalignment affects all derived calculations. (2) The LLM claims a 42% growth from 2022–2023 and 30% from 2023–2024, but with incorrect base numbers, these percentages are invalid. The actual growth from 2022 ($370M) to 2023 ($428M) is about 15.7%, and from 2023 to 2024 is ~82.5%, leading to a compound growth rate of ~46% over the two years as stated in the original. The LLM’s growth rates are therefore factually wrong. (3) The qualitative reasoning about increasing market adoption and stronger positioning in the Hospital Acute Care segment is aligned with the ground truth and shows correct multi-hop synthesis of sales trends implying market dynamics. The mention of U.S. and international breakdowns adds detail not in the original but does not contradict it, assuming those sub-totals sum correctly (e.g., $188M + $240M = $428M). However, because the foundational sales figures are wrong, the reasoning is based on flawed data. (4) Despite correct contextual understanding and relevance to the question’s intent, the severe numerical errors—especially swapping 2022 and 2023 values—undermine the answer’s factual reliability. The answer is partially correct in direction (sales increasing) and conclusion (stronger market position), but fails on core factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 430,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "From 2022 Intel’s 10‑K, the company was already flagging advanced‑packaging as a cornerstone of its IDM 2.0 plan, warning that a “disaggregated design” that stitches together tiles made on different processes would add “new areas of complexity… and increased cost” and that delays in its own and third‑party process nodes could hold up those packaging flows. By 2023 the narrative had shifted to execution: Intel reported a surge in packaging revenue, four 18A design wins, five new customer wins and expanded ecosystem agreements with ARM and Synopsys, positioning its Open System Foundry and 2‑D/2.5‑D/3‑D chiplet interconnects as a competitive advantage for AI‑driven systems‑of‑chips. In 2024 the firm continued to pour R&D dollars into packaging (still a focus of its $16‑$17 billion annual spend) and announced further ecosystem growth, but it also disclosed delayed fab projects, a $755 million penalty for construction delays and tighter “Smart Capital” financing, underscoring that while Intel is steadily building advanced‑packaging capability, its ability to fully deliver IDM 2.0 is being tested by ongoing process‑node delays and constrained capital resources.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core multi-year evolution of Intel's advanced packaging strategy and its implications for IDM 2.0, showing strong qualitative understanding and contextual relevance. It correctly identifies the strategic shift from acknowledging complexity in 2022 to positioning packaging as a competitive advantage in 2023, and notes ongoing execution challenges in 2024. However, there are key quantitative inaccuracies: the $755 million penalty is not present in the ground truth (which instead reports a $3.1 billion non-cash impairment in Q3 2024); the $16–17 billion R&D range is close to the true $16.5 billion but lacks precision; and the mention of 'four 18A design wins' and 'five new customer wins' is unsupported in the ground truth. Additionally, the ground truth emphasizes delays in the 4th Gen Xeon processors and impairments on the Intel 7 node—specific product and node details missing in the LLM response. While the LLM correctly infers capital constraints and process delays as impediments, it substitutes specific impairments with an incorrect penalty figure, undermining quantitative accuracy. The reasoning is logically sound and synthesizes across years, but relies on some hallucinated metrics. Semantic equivalence is mostly preserved in narrative flow, but not in key financial facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1585,
        "completion_tokens": 366,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "- In the 2022 filing IBM already framed “trust and security” as a core element of its hybrid‑cloud platform –‑ the company said it would combine data, AI, deep industry expertise **and trust** to deliver solutions (see 2022 p. 4).  \n- By the 2024 filing the language had broadened to “client relationships and trust” as one of its principal competitive methods, and it was explicitly linked to the execution of its **hybrid‑cloud and AI strategy**, noting that this strategy continually exposes IBM to new rivals (see 2024 p. 3).  \n\n**Progression:** IBM moved from treating trust as a technical attribute of its hybrid‑cloud offering in 2022 to positioning client relationships and trust as a strategic differentiator that underpins and protects its broader hybrid‑cloud‑AI go‑to‑market, signaling that the company sees trusted client bonds as essential to winning and defending market share in its AI‑driven hybrid‑cloud agenda.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions in completeness that prevent a perfect score. (1) All factual elements—dates (2022, 2024), entities (IBM), and strategic framing (trust evolving from technical attribute to strategic differentiator)—are accurate. The citations to specific pages (2022 p.4, 2024 p.3) are plausible and contextually appropriate, though not verifiable without source documents. (2) There are no numeric values, percentages, or financial figures in either the question or answers, so quantitative accuracy is not applicable in a traditional sense; however, the temporal references (2022, 2024) are correct and consistent with the ground truth, warranting a full score. (3) The reasoning is sound: the LLM correctly identifies the evolution from 'trust and security' as a feature of hybrid cloud in 2022 to 'client relationships and trust' as a strategic competitive method in 2024, and links this progression to IBM’s hybrid cloud and AI strategy. However, it omits mention of the 2023 filing, which the ground truth includes as a reinforcement year emphasizing service, support, innovation, and talent. This missing middle step slightly weakens the multi-hop synthesis across all three years. Additionally, the LLM fails to mention the 2024 strategic partnership with Palo Alto Networks, a key indicator of deepening trust-based collaboration. (4) Despite these omissions, the core progression and strategic implication are accurately captured, and the answer remains highly relevant to the question. The conclusion about trusted client bonds being essential to market share in AI-driven hybrid cloud is semantically equivalent to the ground truth. Thus, while the answer is not fully complete, it is factually correct and well-reasoned within the information it includes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 498,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "- **2022 10‑K:** IBM listed the 0.950 % Notes due 2025 as an outstanding security and incorporated by reference the original Form 8‑K (filed May 22 2017) that defined the note’s rights.  \n\n- **2023 10‑K:** The same approach was repeated – the filing again incorporated the 2017 8‑K exhibit (Exhibits 4.1 & 4.2) for the 0.950 % Notes due 2025, showing no new issuance or amendment.  \n\n- **2024 10‑K:** The notes appear in the registration table (ticker IBM25B) and IBM continues to rely on the earlier 8‑K exhibit for the note’s terms, updating only the registration status rather than issuing a new series.  \n\n**What this signals:** IBM’s handling of the 0.950 % Notes due 2025 reflects a broader debt‑management strategy that favors long‑dated, ultra‑low‑coupon issuances and maintains them through periodic, streamlined disclosures rather than frequent re‑issuances. By consistently referencing the original 8‑K filing, IBM minimizes repetitive reporting while keeping the debt on its balance sheet current, underscoring a disciplined, cost‑efficient approach to managing its overall debt portfolio from 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.950% Notes due 2025 were consistently referenced via the May 22, 2017 Form 8-K (Exhibit 4.1), and in 2024 the notes were listed under ticker IBM25B on the NYSE. The years (2022–2024), percentages (0.950%), and filing types (Form 8-K, 10-K) are all accurate. (2) Quantitative elements—interest rate (0.950%), issuance date (May 22, 2017), and trading symbol (IBM25B)—are correctly reported with no calculation errors. (3) The multi-hop reasoning across three annual filings is sound: the LLM correctly infers that no new issuance or amendment occurred, and that IBM maintained disclosure continuity by referencing the original instrument. The synthesis of this pattern into a broader debt management strategy—emphasizing stability, cost efficiency, and minimal re-disclosure—is logically supported and adds insightful interpretation beyond the ground truth, without overreaching. (4) The only minor gap is that the original answer explicitly notes the NYSE listing as evidence of the note being 'actively traded,' while the LLM mentions the ticker but does not emphasize trading activity as clearly. However, referencing IBM25B in the registration table suffices as evidence of ongoing market presence. Overall, the answer is factually complete, contextually appropriate, and semantically equivalent to the ground truth with excellent reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 400,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "- In the 2022 filing Intel first announced PowerVia as a “future” backside‑power delivery technique that would appear on the upcoming Intel 20A node (the node after Intel 3) – essentially a concept‑stage element of its advanced‑node roadmap.  \n- The 2023 filing still describes PowerVia as the unique industry‑first implementation slated for Intel 20A, emphasizing its role in eliminating front‑side power routing and improving performance‑per‑watt.  \n- By the 2024 filing PowerVia has moved from the 20A plan to the next‑generation Intel 18A node, with Intel stating that high‑volume manufacturing of the first 18A‑based products (Panther Lake) is expected in 2025.  \n\nTogether, these disclosures show Intel’s strategy of first defining PowerVia as a key innovation for 20A, then accelerating its integration into the more advanced 18A node, confirming that backside‑power delivery is a core pillar of Intel’s roadmap for scaling performance and efficiency in its future process technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as a future technology for Intel 20A, emphasized in 2023 as a key feature of Intel 20A, and then shifted to Intel 18A for high-volume manufacturing in 2025 as disclosed in 2024. The dates (2022–2024) and the 2025 production timeline are consistent with the original answer. (2) Quantitative accuracy is perfect: no numerical errors, and the timeline (2025 for HVM) matches exactly. Format and phrasing variations (e.g., 'first announced' vs. 'introduced') are semantically equivalent. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings, tracing the evolution from concept to commercial deployment. It accurately captures the strategic pivot from 20A to 18A, though it frames it as an 'acceleration' rather than a 'cancellation of 20A productization'—a slight nuance difference but not factually incorrect, as moving PowerVia to 18A could be interpreted as prioritization. (4) The answer fully addresses the question about evolution and what it reveals about Intel's roadmap, concluding correctly that backside power delivery is a core pillar. Only minor deduction in qualitative accuracy due to slightly different framing of the 20A-to-18A transition, but overall reasoning and factual content are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 387,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "The 10‑K exhibits for 2022, 2023 and 2024 all contain the same “Restricted Stock Unit Award Agreement” filings – e.g., 2022 lists *10.80 and *10.81 (2021 Long‑Term Incentive Plan) 【page_116】, 2023 lists *10.87 and *10.88 (2021 Long‑Term Incentive Plan) 【page_116】, and 2024 repeats *10.87 and *10.88 (2021 Long‑Term Incentive Plan) 【page_116】 (with additional RSU forms such as *10.61 under the 2013 Stock Award Plan 【page_115】). The repeated inclusion of identical RSU agreements under the same 2021 Long‑Term Incentive Plan and the 2013 Stock Award Plan across three consecutive years shows that Medtronic’s U.S. equity‑compensation framework has remained consistent and stable.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that Medtronic's Restricted Stock Unit (RSU) agreements remained consistent across 2022–2024 and references the stability of the equity compensation framework, which aligns with the ground truth's conclusion about strategic stability. However, there are significant factual inaccuracies in the details: (1) The exhibit numbers cited (e.g., *10.80, *10.81, *10.87, *10.88) do not match the ground truth, which specifies Exhibit 10.54 as the consistent RSU agreement. The LLM incorrectly implies that multiple different exhibit numbers represent the same document, when the ground truth emphasizes that the *same* exhibit (10.54) was reused. (2) The LLM incorrectly states that the 2022 filing includes exhibits under the '2021 Long-Term Incentive Plan' and references page numbers (e.g., page_116), which are not part of the verified knowledge base and appear fabricated. (3) While the ground truth highlights that the agreement consistently references an August 27, 2013 filing, the LLM fails to mention this key detail, instead emphasizing the 2021 plan, which contradicts the original answer’s focus on long-standing stability rooted in the 2013 framework. (4) The LLM introduces additional RSU forms like *10.61 under the 2013 plan but does not clarify that the core U.S. employee agreement (Exhibit 10.54) remained unchanged, missing the central point of the ground truth. Thus, while the overall conclusion about stability is directionally correct, the supporting evidence is factually flawed, exhibit numbers are incorrect, and key details are omitted or misrepresented. This results in a partially correct answer with significant quantitative and qualitative inaccuracies, despite good contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 473,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "By 2022 Intel was betting on advanced‑packaging (2D/2.5D/3D chiplet) as a core pillar of its IDM 2.0 strategy, but it already warned that the new “disaggregated” design approach – stitching together components built on different process nodes – added logistical complexity, higher‑cost packaging and a heightened risk of schedule slips. In 2023 the packaging business began to show traction (new design wins, higher packaging revenue) yet the filing stressed that execution still required heavy spending and that any delay in the novel packaging flow could hurt product timing. By 2024 the company’s narrative had shifted to capital‑constraint pressures – delayed fab expansions, penalty charges for construction delays, and a “Smart Capital” approach – which amplified the difficulty of scaling its advanced‑packaging roadmap and made the disaggregated‑design risks a dominant execution challenge.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of timeline, strategic evolution, and core challenges Intel faced from 2022 to 2024 regarding advanced packaging. It correctly identifies the disaggregated design approach (chiplets), the associated complexity and scheduling risks in 2022, progress in 2023 with traction in packaging and design wins, and the shift in 2024 toward capital constraints impacting execution. The answer accurately reflects the increased difficulty in scaling advanced packaging due to delayed fab expansions and financial pressures, aligning with the $3.1B impairment mentioned in the original (though the exact figure is not cited). Quantitatively, there are no incorrect numbers—no false figures or miscalculations are introduced. The LLM omits the specific $3.1 billion impairment charge and does not explicitly name UCIe or Intel 7, which are key specifics in the ground truth that strengthen the evidence of execution challenges. While the concept of 'Smart Capital' and construction penalties reflects accurate qualitative understanding, the absence of these concrete data points and technologies slightly weakens the completeness of the multi-hop synthesis. However, the reasoning flow across years is sound, logically connecting delays, capital issues, and design complexity. The answer remains semantically equivalent in overall message and contextually fully relevant to the question asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 398,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "- In fiscal 2022 Accenture’s defined‑benefit targets were almost entirely fixed‑income – U.S. plans were 97 % debt (no equity) and non‑U.S. plans were 50 % debt, 21 % equity, 15 % insurance contracts and the balance in cash/other.  \n- For fiscal 2023 the company added equity to the non‑U.S. mix (up to 27 % equity, debt down to 48 %) and trimmed insurance exposure (to 11 %) while U.S. plans remained 100 % debt.  \n- By fiscal 2024 the allocation was further diversified: U.S. plans shifted to 94 % debt and 6 % cash, while non‑U.S. plans moved to 23 % equity, 42 % debt, 5 % cash, 21 % insurance and 9 % other.  \n\nThe progression from a debt‑heavy, equity‑free stance toward a more balanced mix of equities, cash and insurance contracts shows Accenture deliberately broadening its portfolio to capture higher long‑term capital appreciation while still matching liabilities, indicating a stronger emphasis on achieving risk‑adjusted returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of quantitative accuracy and factual content. The ground truth states that Accenture's strategy evolved with a consistent emphasis on balancing fixed income and equities, with increasing flexibility in asset allocation decisions across fiscal years 2022–2024. However, the LLM provides specific, detailed percentages (e.g., U.S. plans 97% debt in 2022, 100% debt in 2023, 94% debt in 2024; non-U.S. equity rising to 27% in 2023 then falling to 23% in 2024) that are not present in the original answer and are factually unsupported by the provided ground truth. There is no mention in the ground truth of U.S. plans being 100% debt or having zero equity, nor any breakdown by region (U.S. vs non-U.S.) or categories like insurance contracts, cash, or 'other'—these are fabrications. The original answer describes a qualitative evolution in strategy focused on duration matching, long-term appreciation, and increasing flexibility—not specific numerical allocations. Therefore, all numeric values in the LLM response are incorrect, leading to a very low quantitative accuracy score. The qualitative reasoning about a shift toward diversification and risk-adjusted returns loosely aligns with the ground truth’s conclusion about managing volatility and return objectives, which saves it from a zero. However, the multi-hop synthesis is flawed because it invents data rather than extracting or interpreting actual disclosures. While the answer attempts to address the question’s components (evolution over years, mix of assets, implications for risk-adjusted returns), its reliance on fabricated numbers undermines correctness. Contextual relevance is moderate because the structure and intent match the question, but factual fidelity is poor.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 482,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 all still list the “1.05 % Notes due 2017” in the Exhibit 4.4 table of its officer’s certificates 【page_56†L13-L18】【page_58†L13-L18】. By continuing to disclose that legacy issue, Apple shows a disciplined, “all‑in‑one” approach to debt reporting – every series of notes it has ever issued (even those that have long since matured) remains part of the public record. In contrast, the same exhibit tables also contain a succession of newer issuances (e.g., 2.40 % Notes due 2023, 3.85 % Notes due 2043, 4.421 % Notes due 2026, 4.000 % Notes due 2028, etc.) 【page_56†L13-L18】【page_58†L31-L38】, indicating that Apple’s broader 2022‑2024 strategy is to actively tap the capital markets with a diversified set of senior notes spanning a wide range of maturities and coupon rates rather than relying on a single instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Apple's continued disclosure of the 1.05% Notes due 2017 in its 2023 and 2024 filings, which reflects a transparent and comprehensive approach to debt reporting. The interpretation that this indicates a consistent, all-inclusive disclosure practice—even for matured debt—is semantically equivalent to the original answer’s point about maintaining a historical record for transparency or legal purposes. (2) Quantitatively, the LLM accurately references the 1.05% Notes due 2017. While it cites additional notes not in the original (e.g., 2.40% Notes due 2023, 3.85% due 2043, etc.), these are plausible examples from Apple’s actual debt issuance activity during 2022–2024 and do not contradict the ground truth; they enrich the response without introducing factual errors. The original answer mentions representative instruments (e.g., 3.45% Notes due 2024), while the LLM lists more specific and varied examples—this reflects broader data recall rather than inaccuracy. (3) The multi-hop reasoning is sound: the model correctly contrasts the persistence of a matured instrument in disclosures with Apple’s active issuance of new debt across maturities, demonstrating synthesis across time periods and instruments. (4) The answer fully addresses both parts of the question: Apple’s disclosure approach and how it compares to its broader debt strategy. Only a minor deduction is made because the LLM does not explicitly note that the 2017 notes are *no longer outstanding*, which slightly weakens the clarity of the contrast; however, the implication is clear from context. Overall, the response is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 476,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "- **Fiscal 2022:** Accenture bought 12.2 million Class A shares for about **$4.1 billion** (9.6 M shares in the open‑market program and 2.5 M in other purchases) and, at year‑end, had **$3.13 billion** of unused repurchase authority (later increased to $6.13 billion after a $3 billion add‑on)【page_94】【page_93】.  \n- **Fiscal 2023:** The company again returned roughly **$4½ billion** of cash to shareholders through share buy‑backs (the bulk of the $7.8 billion cash‑return total) and the pool of remaining authority fell to a low‑‑‑single‑digit‑billion level (the exact figure is not restated but was substantially lower than the 2022 balance).  \n- **Fiscal 2024:** Accenture repurchased another **≈$4.5 billion** of shares (including $605 million in Q4 alone) leaving **$2.7 billion** of available authorization as of Aug. 31 2024; the board then approved an additional **$4 billion**, raising total outstanding authority to **$6.7 billion**【page_40】【page_39】.  \n\n**Interpretation:** Over three years Accenture has consistently used $4‑5 billion annually for buy‑backs while the unused authorization has been drawn down and periodically topped‑up by board‑approved increases. This pattern shows a deliberate, ongoing capital‑return strategy that relies on sizable, refreshed share‑repurchase programs to return excess cash to shareholders alongside its dividend policy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key financial figures, particularly in the reported repurchase amounts for fiscal 2022 and 2023. The ground truth states that in fiscal 2024, Accenture purchased over $605 million worth of shares, but the LLM incorrectly claims approximately $4.5 billion in repurchases for that year, conflating it with prior years. Additionally, the LLM states that in fiscal 2022, Accenture spent $4.1 billion on share repurchases, but this figure is not supported by the ground truth, which only specifies the $3.13 billion available authorization and does not report total repurchase spending for that year. The claim of a $3 billion add-on in 2022 increasing total authority to $6.13 billion is also unsupported; the ground truth indicates the $4.0 billion increase occurred in September 2024, not earlier. (2) The quantitative inaccuracies are significant: the LLM fabricates or misattributes repurchase volumes across years. While the $605 million Q4 2024 repurchase and $4 billion new authorization in 2024 are correctly cited, the cumulative repurchase activity is overstated. The remaining authorization of $2.7 billion in the LLM answer is close to the ground truth $2.69 billion, which is acceptable. However, the overall pattern of $4–5 billion annual buybacks is not confirmed by the ground truth, which only explicitly confirms $605 million in fiscal 2024 and consistent execution in 2023 without specific totals. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a pattern of periodic replenishment of authorization and sustained buyback activity. It identifies the correct fiscal years and connects board approvals with capital return strategy. However, it overreaches by asserting specific annual repurchase totals not present in the ground truth, undermining the reasoning. (4) Despite these issues, the answer is contextually relevant and captures the strategic intent—consistent, measured capital return via repurchases with periodic refreshes of authority. The interpretation aligns semantically with the ground truth’s conclusion, even if the numerical foundation is flawed. Hence, correctness is reduced due to major quantitative errors, though qualitative and contextual elements remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1560,
        "completion_tokens": 612,
        "total_tokens": 2173
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "Across the three filings the 4.350 % Senior Notes due 2047 appear repeatedly in the exhibit schedules that describe BMS’s outstanding senior unsecured debt. In the 2022 10‑K they are listed as “Form 4ff – 4.350 % Senior Notes due 2047” (the Eleventh Supplemental Indenture filed in 2019), the same reference is retained in the 2023 filing (the note remains on the balance sheet even though it is not highlighted in the excerpt), and the 2024 10‑K again includes the note in the exhibit index (4ff). This continuity shows that BMS has deliberately kept a long‑dated, fixed‑rate tranche of senior debt on its books, using the 2047 notes to lock in low‑cost financing and spread maturities over many years, a clear indication that its long‑term financing strategy relies on issuing and maintaining multi‑decade senior notes to manage interest‑rate risk and refinancing needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.350% Senior Notes due 2047 are correctly identified as consistently present in BMY's (BMS's) debt disclosures across 2022, 2023, and 2024; the reference to the Eleventh Supplemental Indenture dated 2019 is accurate; and the exhibit label 'Form 4ff' is correctly noted. (2) Quantitative elements—interest rate (4.350%), maturity year (2047), and indenture date (2019)—are all factually correct with no calculation errors. (3) The reasoning is sound: the LLM correctly infers that the continued presence of these notes indicates a strategy of maintaining long-dated, fixed-rate debt to manage interest-rate and refinancing risk, which aligns with the ground truth’s conclusion about staggered maturities and diversified liabilities. It also correctly identifies the strategic purpose—locking in financing and spreading maturities. (4) Minor deduction in qualitative accuracy due to lack of mention of specific new issuances in 2023 and 2024 (e.g., $2B 3.700% Notes due 2052, $3.75B 4.250% Notes due 2049), which were used in the ground truth to strengthen the multi-hop synthesis about evolving capital structure. However, the core multi-hop insight—that persistent inclusion of the 2047 notes amid new issuances reflects strategic debt structuring—is still logically supported. The answer is semantically equivalent in intent and meaning, with excellent contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 408,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "Apple’s 2.40 % Notes due 2023 were disclosed each year through the same “Description of Securities” exhibit (Officer’s Certificate). In the 2022 Form 10‑K the notes were listed in Exhibit 4.3 alongside the other global notes, and the 2023 filing continued to reference the same exhibit without alteration. By the 2024 Form 10‑K the company still referenced Exhibit 4.3 for the 2.40 % Notes due 2023 (see the exhibit table on pages 56‑58), noting no changes to the terms, indicating a consistent, unchanged disclosure approach as the notes approached maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All key facts are correct: Apple consistently disclosed the 2.40% Notes due 2023 in Exhibit 4.3 across 2022, 2023, and 2024 filings, referencing the same Officer’s Certificate dated May 3, 2013 (implied by 'no changes to the terms'). The percentage (2.40%), exhibit number (4.3), and years (2022–2024) are accurate. (2) Quantitative elements—interest rate, exhibit number, filing years—are correctly reported with no calculation errors. Format variations (e.g., '2.40 %' vs '2.40%') are minor and acceptable. (3) The reasoning is sound: the model correctly synthesizes information across three years of filings to conclude that the disclosure approach remained unchanged despite the notes maturing in 2023. It identifies the continuity in exhibit usage and lack of modifications, demonstrating proper multi-hop synthesis. (4) The answer is contextually relevant and fully addresses the question about evolution (or lack thereof) in disclosure approach. The only minor shortcoming is that it does not explicitly name the Officer’s Certificate date (May 3, 2013), which is included in the ground truth and adds slight contextual completeness. However, stating 'no changes to the terms' implies this, so the omission is not material. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 381,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "- **Fiscal 2022:** The Amended 2010 Share Incentive Plan authorized a maximum of **127 million** Accenture plc Class A ordinary shares for awards【page_91】.  \n- **Fiscal 2023:** The authorization was increased to **141 million** shares (the same figure reported in the 2024 filing, reflecting the amendment that took effect after the 2022 filing)【page_98】.  \n- **Fiscal 2024:** The plan continued to authorize **141 million** shares【page_98】.  \n\nThe rise from 127 million to 141 million shares shows Accenture is expanding the pool of equity it can grant, indicating a deliberate long‑term strategy to rely more heavily on share‑based compensation to attract, retain and align employees with shareholder interests.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the number of authorized shares for each fiscal year: 127 million in 2022, 141 million in 2023, and 141 million in 2024, matching the ground truth exactly. These figures are presented with acceptable formatting (127 million = 127,000,000). (2) All numeric values are accurate and consistent with the original answer. The increase of 14 million shares from 2022 to 2023 is correctly implied, though not explicitly calculated, which is acceptable. (3) The reasoning correctly identifies the upward adjustment and continued stability, linking it to a strategic intent to expand equity compensation for employee incentives. The interpretation aligns with the ground truth’s conclusion about long-term strategy, though it omits the specific nuance that the stabilization in 2024 suggests the new share pool became sufficient—this is a minor omission, not an error. (4) Entities (Accenture plc, Class A ordinary shares, Amended 2010 SIP, fiscal years 2022–2024) are all accurately referenced. The answer synthesizes information across years correctly, demonstrating sound multi-hop reasoning. The slight deduction in qualitative accuracy is due to the less detailed explanation of the 2024 stability rationale compared to the original. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 379,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "- In the 2022 Form 10‑K (page 7) Intel first announced **PowerVia** as one of the two breakthrough features of the planned Intel 20A node – a “unique industry‑first implementation of backside‑power delivery” that would eliminate front‑side power routing.  \n- By the 2023 filing (page 10) the company had shifted PowerVia from the cancelled 20A to the next‑generation Intel 18A node, describing it as a core element of the node’s “first high‑volume commercial implementation of … backside power” and linking it to the upcoming Panther Lake processors slated for 2025.  \n- The 2024 filing (pages 10 and 14) again emphasizes PowerVia as a key part of Intel 18A (and the still‑in‑development 20A), now positioned for high‑volume production in 2025 and highlighted as a driver of performance‑per‑watt and density improvements.\n\n**Interpretation:** Over the three‑year span Intel moved PowerVia from an announced research concept (2022) to a concrete technology embedded in its flagship advanced node (18A) and slated for high‑volume manufacturing (2024), signalling that PowerVia has become a cornerstone of Intel’s advanced‑process roadmap and a critical lever for achieving the next gains in efficiency and scaling.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel 20A, moved to Intel 18A after 20A's cancellation, and is set for high-volume manufacturing in 2025 with Panther Lake. The description of PowerVia as an 'industry-first' backside power delivery technology is preserved. (2) Quantitative accuracy is perfect: years (2022, 2023, 2024, 2025), node names (Intel 20A, Intel 18A), and product timeline (Panther Lake in 2025) all match the original. No calculations are required, but temporal and technological progression is correctly tracked. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings to show evolution from concept to core technology. One minor inaccuracy: the 2024 filing does not position PowerVia in both 18A and 'still-in-development 20A'—Intel 20A was effectively superseded by 18A, and PowerVia is now primarily tied to 18A. This slight overstatement reduces qualitative accuracy slightly. (4) The answer is contextually excellent, directly addressing the evolution and strategic importance of PowerVia. Wording differs but meaning is semantically equivalent. Overall, this is a strong, factually correct response with only a minor error in the final year's characterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1558,
        "completion_tokens": 370,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "Accenture’s defined‑benefit pension‑plan holdings of **mutual‑fund equity securities** were:\n\n* **FY 2022:** $239 million (Level 1 $4.9 m + Level 2 $234 m)  \n* **FY 2023:** $196 million (Level 1 $7.4 m + Level 2 $188.8 m) – a decline of roughly 18 % from the prior year  \n* **FY 2024:** $274 million (Level 1 $20.2 m + Level 2 $253.5 m) – an increase of about 40 % versus 2023 and higher than the 2022 level  \n\nThe three‑year trend shows a temporary pull‑back in 2023 followed by a pronounced re‑allocation toward mutual‑fund equities in 2024, signalling that Accenture is actively adjusting its pension‑plan portfolio to increase exposure to equity‑based investments as part of a strategic tilt toward higher‑growth assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Accenture's allocation to mutual fund equity securities decreased from $239,293 million in FY2022 to $196,226 million in FY2023 and remained flat in FY2024. The LLM incorrectly reports FY2022 as $239 million (off by a factor of ~1,000), FY2023 as $196 million (again off by 1,000x), and most critically, reports FY2024 as $274 million—an increase—when the correct value is $196,226 million (no change from 2023). These are not formatting issues but gross numerical errors. (2) Calculations are also wrong: the LLM claims an 18% decline and then a 40% increase, but the actual decline is about 18% (correct percentage but on wrong base), and there is no increase in 2024—allocation remained flat. The LLM’s reported 40% increase is entirely incorrect. (3) The multi-hop reasoning fails: instead of identifying a consistent reduction and strategic rebalancing away from equities, the LLM infers a temporary pullback followed by a strategic increase—exactly the opposite conclusion. This indicates a failure to correctly synthesize the three-year trend. (4) While the answer addresses the right topic (mutual fund equity securities in Accenture’s pension plan) and attempts to interpret strategic positioning, the severe quantitative errors and resulting flawed reasoning drastically undermine correctness. Contextual relevance is moderate because the structure and intent align with the question, but factual foundation is broken. Hence, low scores on correctness and quantitative accuracy; slightly higher on qualitative and contextual due to proper framing and use of financial concepts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 461,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "- **Asset valuation:** In the 2021 balance sheet (the most recent valuation disclosed) Merck carried Dificid as a $145 million net intangible asset (page 115). No later impairment or write‑down of that asset is reported in the 2022‑2024 filings, indicating the company continued to value the product at its original carrying amount.  \n\n- **Therapeutic positioning:** Dificid is listed under the “Hospital Acute Care” franchise as the treatment for C. difficile‑associated diarrhea (page 4), and Merck kept it in that portfolio through 2023‑2024, signalling a continued focus on the acute‑care market rather than moving it to another therapeutic area.  \n\n- **Global revenue contribution:** Sales of Dificid rose steadily: $263 million in 2022, $302 million in 2023, and $340 million in 2024 (page 130). This growth shows the product’s expanding share of Merck’s worldwide pharmaceutical revenue over the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains key quantitative inaccuracies. The original answer states that Dificid was valued as a $145 million intangible asset in 2022, while the LLM cites the 2021 balance sheet and assumes no change through 2022–2024 due to lack of reported impairment. This is a reasonable inference but misrepresents the timeline—ground truth specifies 2022 as the valuation year, not 2021. More critically, the LLM reports Dificid sales of $263M in 2022 and $302M in 2023, but the ground truth only provides 2024 revenue ($340M) and does not mention prior years. Thus, the LLM introduces unsupported figures for 2022 and 2023, which are not in the original answer and cannot be verified from the provided truth. Only the 2024 revenue of $340M matches and is correct. (2) The $145M asset valuation is accurate in amount but slightly off in timing (2021 vs 2022). The $340M 2024 revenue is fully accurate. However, the $263M (2022) and $302M (2023) figures are not present in the ground truth and appear to be fabricated or sourced from external data, constituting a major quantitative error. (3) The reasoning is otherwise sound: the therapeutic positioning of Dificid in the Hospital Acute Care franchise for C. difficile-associated diarrhea is correctly identified and consistent across years. The LLM correctly infers strategic continuity, aligning with the original answer’s point about increased strategic recognition. However, the multi-hop synthesis is compromised by the inclusion of unverified revenue numbers, undermining the progression narrative. (4) Scores reflect that core facts (asset value, 2024 revenue, therapeutic positioning) are correct, but significant quantitative errors in revenue history reduce overall correctness. The answer remains contextually relevant and qualitatively strong in reasoning and entity identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 510,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "From 2022 to 2024 Intel’s “IDM 2.0” push placed advanced‑packaging at the core of its strategy, but the company’s ability to execute it became increasingly strained.  R&D spending rose from $17.5 billion in 2022 (≈19 % of revenue) to $16.5 billion in 2024 (≈30 % of revenue), with a growing share earmarked for process‑and‑packaging technology and the dis‑aggregated design approach.  While 2022 already noted delays in the 4th‑Gen Xeon launch and earlier 10 nm/7 nm setbacks, 2023 saw concrete execution problems – a $755 million penalty for construction delays at the Ireland “SCIP” fab and a $3.1 billion non‑cash impairment tied to the Intel 7 node – and 2024 repeated those themes, reporting postponed plant builds in Ohio, Germany, Poland, Malaysia and Israel and warning that further delays or under‑utilised capacity could force additional write‑downs and higher borrowing costs.  Together, the rising R&D outlays, repeated packaging‑technology schedule slips, and the mounting penalty, impairment and capacity‑risk charges illustrate how Intel’s strategic positioning around advanced packaging grew more ambitious but also more financially exposed over the 2022‑2024 period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution of Intel's strategic positioning and execution challenges around Advanced Packaging Technologies from 2022 to 2024, aligning well with the ground truth in terms of narrative arc and qualitative reasoning. It correctly identifies the growing strategic importance of advanced packaging within IDM 2.0, rising R&D investment, implementation delays, and increasing financial risks. However, there are significant quantitative inaccuracies: (1) R&D spending is stated as $17.5B in 2022 and $16.5B in 2024, but actual reported R&D expenses were approximately $16.4B in 2022 and $15.4B in 2024, making the figures incorrect; (2) the claim that R&D rose to 30% of revenue in 2024 is inaccurate—Intel’s 2024 revenue was ~$58B, making $16.5B ~28.4%, and actual R&D was lower; (3) the $755M penalty for construction delays in Ireland is not documented in public filings and appears fabricated; (4) the $3.1B impairment is correctly cited but misattributed to the Intel 7 node, whereas it was related to broader manufacturing assets including packaging and logic fabs, not specifically Intel 7. The answer also conflates general fab delays with advanced packaging execution, though packaging is a component. Despite these errors, the multi-hop synthesis across years and themes (strategy → execution → financial exposure) is logically sound and contextually relevant. The answer addresses all parts of the question—R&D, delays, financial risk—with appropriate entity and time period accuracy, and the overall conclusion about increasing financial exposure is supported. Hence, the correctness score is 7 due to accurate qualitative trajectory but flawed numerical details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1568,
        "completion_tokens": 462,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "- 2022 10‑K – MK‑8591A (doravirine + islatravir) was already listed as a Phase 3 HIV‑1 regimen that entered Phase 3 in February 2020, but the filing notes that the program was **on an FDA clinical hold** (footnote 4)【page_25】.  \n- 2023 10‑K – Merck announced that a Phase 3 study of the once‑daily doravirine/islatravir combo would **begin in 2023**, yet it reiterated that the FDA had placed clinical holds on the islatravir INDs in December 2021 because of lymphocyte/CD4‑cell declines【page_21】.  \n- 2024 10‑K – The candidate is still shown as a Phase 3 entry (Feb 2020) and the table again marks it **“On FDA clinical hold,”** with a description that the hold remains in effect and no new studies may be started【page_24】.  \n\n**Interpretation:** Over the 2022‑2024 period Merck kept MK‑8591A in its pipeline despite an unresolved FDA hold, moving from a listed Phase 3 asset to actively planning a Phase 3 trial while still addressing safety‑related regulatory concerns. This persistence signals that Merck views a long‑acting doravirine/islatravir regimen as a strategic, high‑priority component of its future HIV portfolio, willing to invest time and resources to resolve the hold before commercializing the therapy.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, particularly regarding the regulatory status of MK-8591A in 2024. According to the ground truth, the FDA lifted the clinical hold on December 4, 2024, with only a partial hold remaining for higher doses—this is a critical update that the LLM answer completely misses. Instead, the LLM claims that the 2024 10-K still lists the drug as 'On FDA clinical hold' with no new studies allowed, which contradicts the ground truth and misrepresents the regulatory progression. This error affects both quantitative accuracy (incorrect date/status) and qualitative reasoning (failed to capture resolution of hold). Additionally, the LLM incorrectly states that Merck announced a Phase 3 study would begin in 2023, while the ground truth indicates the trial was already in Phase 3 since 2020. The LLM also mischaracterizes the development timeline by suggesting the program was not yet in active Phase 3 trials during 2022–2023, when it had already entered Phase 3 in February 2020. Despite these errors, the LLM correctly identifies the compound (MK-8591A = doravirine + islatravir), the initial clinical hold due to CD4 declines, and Merck’s continued strategic interest in HIV therapeutics, which supports contextual relevance. The interpretation about Merck’s long-term commitment is partially valid but based on flawed premises. Multi-hop synthesis is attempted but compromised by incorrect data points. Minor formatting variations (e.g., 'on clinical hold') are acceptable, but core factual errors in dates, regulatory status, and trial initiation severely reduce correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 450,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "- **2022 (2022 10‑K)** – MK‑1308A was introduced as the **co‑formulation of Merck’s investigational anti‑CTLA‑4 antibody quavonlimab with pembrolizumab**, entered into **Phase 3** for **renal‑cell carcinoma (RCC)** (listed under “advanced solid tumors” and “RCC” in the pipeline tables).  \n\n- **2023 (2023 10‑K)** – The filing still describes MK‑1308A **only in the RCC indication**, still as the **quavonlimab + pembrolizumab** combination and remains a **late‑stage (Phase 3) immuno‑oncology program**; no new partners or additional tumor types were added.  \n\n- **2024 (2024 10‑K)** – Merck continues to place MK‑1308A in the **immuno‑oncology pillar**, again as the **quavonlimab‑pembrolizumab co‑formulation for RCC** and reports that it is part of the ongoing Phase 3 oncology portfolio.  No regulatory filing or approval is noted for MK‑1308A in 2024, indicating it is still in clinical development.  \n\n**Overall evolution:** From 2022 through 2024 Merck’s strategy for MK‑1308A has been stable – the program has remained focused on RCC, using the same anti‑CTLA‑4 + PD‑1 combination, and has progressed through Phase 3 without any new indications or regulatory milestones announced.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MK-1308A is consistently described as a co-formulation of quavonlimab and pembrolizumab, focused on renal cell carcinoma (RCC), and in Phase 3 development from 2022 to 2024. There is no mention of regulatory approval by 2024, which matches the original answer. (2) Quantitative elements—such as the Phase 3 status and the years (2022–2024)—are correctly reported with no numerical or date inaccuracies. Format consistency (e.g., 'Phase 3', 'RCC') is appropriate and clear. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying continuity in clinical focus, combination therapy, and regulatory status. It accurately infers that the strategy has remained stable, which is a valid conclusion from the data. (4) The only minor shortcoming is that the 2022 description in the LLM answer states the co-formulation was 'introduced' as such, while the ground truth notes that in 2022 it was listed in the pipeline for RCC but became more specifically defined in 2023. This suggests the LLM may have slightly over-specified the 2022 clarity, but the core facts remain consistent. Overall, the answer is factually correct, comprehensive, and contextually precise, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 376,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "- **Fiscal 2022** – Accenture bought 12.2 million Class A shares for about **$4.1 billion** (page 94).  At year‑end the board had raised the buy‑back ceiling by $3 million, leaving **$3.1 billion of the $6.1 billion total authority still available** (page 93).  \n\n- **Fiscal 2023** – The company kept the same open‑market program and repurchased shares at a comparable level (the FY‑23 filing reports a similar “cash returned to shareholders” line), showing that buy‑backs remained a core use of excess cash.  \n\n- **Fiscal 2024** – Share repurchases rose to **$4.5 billion** for the full year (page 40) and **2.07 million shares were bought in Q4 alone** (page 39).  After those purchases the **remaining authorization was $2.694 billion** (page 39).  In September 2024 the board added another **$4 billion**, bringing total outstanding authority to **$6.694 billion** (page 39).  \n\n**What the pattern shows** – Over three consecutive years Accenture has used its buy‑back program each year, repurchasing roughly $4 billion of stock while periodically topping up the authorization ceiling.  This demonstrates a disciplined, ongoing capital‑return strategy: the firm returns cash to shareholders through steady share repurchases and maintains ample, refreshed authorization to keep the program flexible and sustainable.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several significant quantitative inaccuracies that undermine its factual correctness. First, it claims Accenture bought 12.2 million shares for $4.1 billion in fiscal 2022, but the ground truth does not provide specific share repurchase volume or dollar amount for 2022—only the remaining authorization of $3.13 billion. This $4.1 billion figure appears to be incorrectly carried forward or misattributed. Second, the LLM states that in fiscal 2024, repurchases rose to $4.5 billion, but the ground truth reports only $605 million in open-market repurchases during fiscal 2024, with no indication of a $4.5 billion total. This is a major factual error. Additionally, the LLM mentions 2.07 million shares bought in Q4 2024, but the ground truth does not specify quarterly breakdowns, so this detail lacks support. While the remaining authorization of $2.694 billion and the new $4 billion authorization (totaling $6.694 billion) are correctly reported, the overall spending figures are wildly off. The qualitative reasoning—about a sustained and measured capital return strategy with periodic replenishment—is logically sound and aligns with the pattern suggested in the ground truth, earning moderate points for reasoning and high marks for contextual relevance. However, due to severe errors in key financial figures, the quantitative accuracy is low, dragging down the overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 391,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "The $750 million 2.350 % senior‑note that matures in 2040 is listed in BMS’s exhibit schedules in every recent 10‑K – it appears in the 2022 filing (exhibit 4.6 of the 2022 Form 10‑K) and is carried forward unchanged in the 2023 filing (see page 134 / 4ll) and again in the 2024 filing (see page 134 / 4ll). By keeping this low‑coupon, 20‑year instrument on its balance sheet year after year, BMS is deliberately locking in inexpensive, fixed‑rate financing for the long term, smoothing its debt‑maturity profile and insulating the company from future interest‑rate increases. This consistent presence of the 2040 note demonstrates a strategic emphasis on long‑dated, low‑cost debt to manage refinancing risk and preserve financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $750 million 2.350% Notes due 2040 are correctly identified, and their presence in the 2022, 2023, and 2024 10-K filings is accurately noted. The mention of exhibit 4.6 in the 2022 filing and page/exhibit references in 2023 and 2024 (though formatted as '4ll') is consistent with typical SEC exhibit labeling, even if slightly informal. (2) Quantitative elements—dollar amount ($750 million), interest rate (2.350%), and maturity year (2040)—are all correct and match the ground truth. Format variations (e.g., $750 million vs $750,000,000) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the persistence of the note across three years to infer a strategic approach to long-term fixed-rate debt management. It draws a logical conclusion about BMS’s intent to lock in low-cost financing and manage refinancing and interest rate risk, which is fully supported by the original answer. (4) The only minor shortcoming is that the LLM refers to 'BMS' instead of 'Bristol-Myers Squibb' or 'BMY' consistently, though this is a common and acceptable abbreviation. Additionally, the original answer emphasizes the lack of refinancing/retirement despite market fluctuations, a nuance slightly underemphasized in the LLM response. However, the core strategic interpretation—stable long-term debt strategy, fixed-rate preference, and financial flexibility—is fully captured. Thus, the answer is factually excellent, with only negligible omissions in contextual phrasing, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 459,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "Across the three most recent 10‑K filings (2022, 2023 and 2024) Bristol‑Myers Squibb continues to list the same “Form of 4.350 % Senior Notes due 2047” (exhibit 4.19) that was first introduced in the Eleventh Supplemental Indenture on Nov 22 2019. The rate and the tranche’s presence have not been altered – the filing simply carries forward the original 4.350 % commitment without increasing or reducing the amount issued. This consistency signals that BMS relies on a stable, long‑dated debt program, using the 4.350 % notes as a fixed‑rate anchor in its broader, diversified financing strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent 4.350% interest rate across 2022–2024 filings and the unchanging nature of the commitment, which aligns with the ground truth. However, there are factual discrepancies in the exhibit numbers and indenture dates. The ground truth states the 2022 filing references Exhibit 4bbb under the Twelfth Supplemental Indenture (Nov 13, 2020), while the LLM claims Exhibit 4.19 under the Eleventh Supplemental Indenture on Nov 22, 2019. Similarly, the 2023 filing in the ground truth is under the Fourteenth Supplemental Indenture (Nov 13, 2023), not a carry-forward of the 2019 document as implied. The LLM incorrectly attributes the initial introduction to Nov 22, 2019 (which is the Form 8-K date referenced in 2024), but misassigns it to the Eleventh Supplemental Indenture without confirmation. (2) The percentage (4.350%) is correct, and the years (2022–2024) are accurate, but the exhibit numbers (4.19 vs. 4bbb/4ff) and indenture details (Eleventh vs. Twelfth/Fourteenth) are incorrect, affecting quantitative precision. (3) The reasoning about stable long-term financing is sound and matches the ground truth’s conclusion—this reflects good multi-hop synthesis of intent across filings, even if document-level details are off. (4) The answer is contextually relevant and captures the strategic implication well, but loses points on factual precision, particularly in legal/document metadata, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 412,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "- In the FY 2022 10‑K Nike only listed FlyEase alongside its other product‑technology families (Air, Zoom, Flyknit, etc.) in the “Product research, design and development” narrative, without any detail on how the technology was being made.  \n- By FY 2024 the filing still cites FlyEase as part of its technology portfolio, but it couples that mention with the company’s full manufacturing disclosures, showing that FlyEase‑enabled shoes are now being produced through Nike’s global supply chain. The 2024 report states that Nike’s contract manufacturers operated **96 finished‑goods footwear factories in 11 countries**, with **15 contract manufacturers** responsible for all Nike‑brand footwear; the single largest factory accounted for about **9 % of total FY 2024 footwear production**, and factories in Vietnam, Indonesia and China together produced roughly **50 % + 27 % + 18 % = 95 %** of the year’s footwear output. These figures demonstrate that FlyEase products are being manufactured at scale and are fully integrated into Nike’s worldwide manufacturing network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the 96 footwear factories, 11 countries, 15 contract manufacturers, 9% share of the largest factory, and the geographic production split of 50% (Vietnam), 27% (Indonesia), and 18% (China) are accurately reported and match the source data. The sum of 95% is correctly calculated. (2) The answer addresses both parts of the question: it traces the evolution of FlyEase reporting from FY2022 (mentioned as part of the technology portfolio without production details) to FY2024 (integrated into manufacturing disclosures), showing progression in reporting depth. (3) Entity accuracy is strong: correct fiscal years (2022, 2024), correct technology (FlyEase), and correct countries and manufacturing metrics. (4) The reasoning is sound—by linking the continued mention of FlyEase with expanded manufacturing disclosures, the LLM correctly infers that the technology is now embedded in large-scale global production. The only minor shortcoming is that the original answer notes FlyEase was more prominently integrated by FY2023 (mentioned alongside Air and Dri-FIT), which the LLM omits, slightly weakening the multi-hop evolution narrative. However, this does not undermine the core conclusion. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 385,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "Target’s “RedCard” (the branded credit‑card, debit‑card and reloadable account that earn a 5 % discount) penetration fell each year: 20.5 % of purchases were made with a RedCard in fiscal 2022, 19.8 % in fiscal 2023, and 18.6 % in fiscal 2024【page_27】. The steady decline signals that, while the loyalty‑driven payment program still drives a meaningful share of sales, its incremental impact is waning rather than growing.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the declining trend in RedCard penetration from 2022 to 2024 and accurately reports the 2022 (20.5%) and 2023 (19.8%) penetration rates. However, it incorrectly states the 2024 penetration rate as 18.6%, whereas the ground truth specifies 17.8%. This discrepancy affects the quantitative accuracy significantly, especially as the question focuses on precise trend evolution. (2) The calculation of the trend (declining each year) is logically sound, but the final data point is off by 0.8 percentage points, which is non-trivial in the context of year-over-year changes in penetration rates. (3) The multi-hop reasoning is well-executed: the model correctly synthesizes the annual penetration rates and infers that the declining trend suggests weakening momentum in the loyalty-driven payment strategy. The conclusion that the program's 'incremental impact is waning' aligns semantically with the ground truth's interpretation of 'weakening effectiveness' and 'reduced customer engagement.' (4) Despite the numerical error in the 2024 figure, the answer addresses all parts of the question, uses correct entities (Target, RedCard, fiscal years), and provides relevant, logically sound analysis. The contextual relevance is perfect, and qualitative reasoning is strong, warranting a correctness score of 7 due to the minor but material data inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 389,
        "total_tokens": 1615
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 800,
    "successful_evaluations": 800,
    "failed_evaluations": 0,
    "average_correctness_score": 7.08,
    "average_quantitative_accuracy": 7.54,
    "average_qualitative_accuracy": 7.37,
    "average_contextual_relevance": 9.04,
    "score_distribution": {
      "excellent": 372,
      "good": 136,
      "fair": 190,
      "poor": 102
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b",
    "experiment": "e3_page_window_distract",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 800,
    "failed": 0,
    "elapsed_seconds": 13285.5,
    "timestamp": "2026-02-04T00:07:27.419786"
  }
}